INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23125, 'Mustela foam shampoo for new borns 150ml', 'موستلا شامبو لحديثي الولادة 150 مل', '259', NULL, 'Baby care', 'Avocado perseose+salicylic acid+coco glucoside', 'Laboratoires expanscience-france > biotech egypt', 'Amp', 'أمبول', '150ml', '1', NULL, 'specially formulated for use right from day one mustela foam shampoo for newborns is ideal for treating and preventing cradle cap in newborn babies: leaves your babyï-s hair perfectly clean thanks to its ultra-gentle cleansing action. respects the delicat', NULL, NULL, 605, '2022-08-03', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23126, 'Mustela gentle soap with cold cream nutri-protective 200 gm', 'موستلا صابون مع الكريم البارد 200 جم', '94', NULL, 'Baby care', 'Avocado perseose+nutri-protective complex+coco glucoside', 'Laboratoires expanscience-france > biotech egypt', 'Cream', 'كريم', '200 gm', '1', NULL, 'specially formulated for use from birth on mustela bï-bï- gentle soap with cold cream - nutri-protective is ideal as a part of daily hygiene for temporarily or naturally dry skin: delicately cleanses babyï-s face and body thanks to its ultra-gentle cleans', NULL, NULL, 612, '2022-08-03', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23127, 'Mustela hydra-bebe body lotion 300 ml', 'موستلا هيدرا بيبي لوشن 300 مل', '315', NULL, 'Baby care', 'Avocado perseose+jojoba oil+vitamin f+shea butter', 'Laboratoires expanscience-france > biotech egypt', 'Lotion', 'لوشن', '300 ml', '1', NULL, 'specially formulated for use right from day one * mustela hydra bï-bï-ï- body lotion is designed for the daily care of your babyï-s skin: vegetable oils and vitamins e and f instantly hydrate the skin with lasting effects. shea butter leaves the skin feel', NULL, NULL, 662, '2022-08-03', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23128, 'Mustela nursing comfort balm 30ml', 'موستيلا نيرسينج كومفرت بالم 30 مل', '360', NULL, 'Moisturizing topicals', 'Elastoregulator+lupeol+shea butter+avocado peptides+oligo-elements', 'Laboratoires expanscience-france > biotech egypt', 'Unknown', 'غير محدد', '30ml', '1', NULL, 'specially formulated for the nipple area (which is particularly exposed and sensitive during breastfeeding) mustela 9 months nursing comfort balm soothes nourishes and helps restructure delicate breast skin thanks to its combination of vitamins and natura', NULL, NULL, 635, '2022-08-04', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23129, 'Mustela post-partum body restructuring gel 200ml', 'موستلا جل ما بعد الولادة 200 مل', '212', NULL, 'Firming topical', 'Elastoregulator+lupeol+sophora japonica+avocado peptides', 'Laboratoires expanscience-france > biotech egypt', 'Gel', 'جل', '200ml', '1', NULL, 'specially formulated for post-partum skin care mustela 9 months post-partum body restructuring gel firms up slackened skin and reduces unsightly puffiness with its naturally-derived ingredients: restores firmness to skin tissue thanks to its combination o', NULL, NULL, 619, '2022-08-02', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23130, 'Mustela skin freshener 200ml', 'موستلا منعش للجلد 200 مل', '185', NULL, 'Baby care', 'Avocado perseose', 'Laboratoires expanscience-france > biotech egypt', 'Unknown', 'غير محدد', '200ml', '1', NULL, 'specially formulated for use right from day one * mustela bï-bï- skin freshener is ideal for your babyï-s daily hygiene: perfect for rinsing mustela bï-bï- cleansing milk leaving the skin soft. can also be used for delicately scenting or refreshing your b', NULL, NULL, 676, '2022-07-28', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23131, 'Mustela stelactiv diaper care cream 75ml', 'موستلا ستيل اكتيف كريم حفاضات 75 مل', '79', NULL, 'Baby care', 'Lupin extract+zinc oxide', 'Laboratoires expanscience-france > biotech egypt', 'Cream', 'كريم', '75ml', '1', NULL, 'stelactivï- skincare for the diaper area has been specially formulated for non-oozing moderate to severe diaper rash. it soothes both the cause and the symptoms of diaper rash thanks to its innovative natural-origin active ingredients: the enzymes respons', '3504105000462', NULL, 735, '2022-07-17', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23133, 'Mustela stelatopia cream cleanser 200ml', 'موستلا ستيلاتوبيا كريم منظف 200 مل', '235', NULL, 'Baby care', 'Sunflower oil distillate', 'Laboratoires expanscience-france > biotech egypt', 'Cream', 'كريم', '200ml', '1', NULL, 'stelatopiaï- cream cleanser has been specially formulated for eczema prone skin in babies and young children. it gently cleanses the skin thanks to an innovative combination of natural-origin ingredients: skin is left completely clean without being damage', NULL, NULL, 681, '2022-08-03', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23134, 'Mustela stelatopia emollient cream 200ml', 'موستلا ستيلاتوبيا كريم ملطف 200 مل', '425', NULL, 'Baby care', 'Sunflower oil distillate+plum oil', 'Laboratoires expanscience-france > biotech egypt', 'Cream', 'كريم', '200ml', '1', NULL, 'stelatopiaï- moisturizing cream has been specially formulated for dry and eczema-prone skin in babies and young children. it replenishes lipids and soothes skin with its innovative natural-origin ingredients: the skinï-s lipids are replenished using activ', NULL, NULL, 915, '2022-08-02', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23135, 'Mustela stelatopia lipid-replenishing balm 200ml', 'موستلا ستيلاتوبيا ليبيد بالم 200 مل', '445', NULL, 'Baby care', 'Sunflower oil distillate+plum oil', 'Laboratoires expanscience-france > biotech egypt', 'Unknown', 'غير محدد', '200ml', '1', NULL, 'stelatopiaï- lipid-replenishing balm has been specially formulated for extremely dry and eczema-prone skin. it replenishes lipids and soothes skin with its innovative combination of natural origin ingredients: itching sensations and irritations are soothe', NULL, NULL, 856, '2022-08-02', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23136, 'Mustela stelatopia milky bath oil 200ml', 'موستلا ستيلاتوبيا زيت للاستحمام 200 مل', '279', NULL, 'Baby care', 'Sunflower oil distillate+sweet almond oil+camomile oil', 'Laboratoires expanscience-france > biotech egypt', 'Oil', 'زيت', '200ml', '1', NULL, 'stelatopiaï- milky bath oil has been specially formulated for eczema-prone dry skin in babies and children and should be used to cleanse the face and body particularly in the event of intense redness and pulling. simply mix it into the bath water ï- no ne', NULL, NULL, 616, '2022-08-04', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23137, 'Mustela stelatria purifying recovery cream 40ml', 'موستلا ستيلاتريا كريم 40 مل', '189', NULL, 'Baby care', 'Bioecolia+complex of copper-zinc-manganese micro-nutrients', 'Laboratoires expanscience-france > biotech egypt', 'Cream', 'كريم', '40ml', '1', NULL, 'stelatriaï- purifying recovery cream has been specially formulated for the skin of newborns babies and young children. it has been designed to soothe localised irritations and redness which can lead to the spread of bacteria (face and body) such as: irrit', NULL, NULL, 921, '2022-08-03', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23138, 'Mustela stretch marks double action 150ml', 'موستلا لمعلاجة اثار التمدد 150 مل', '419', NULL, 'Firming topical', 'Elastoregulator+lupeol+galactoarabinan+sophora japonica+oligo-elements+shea butter+avocado peptides', 'Laboratoires expanscience-france > biotech egypt', 'Unknown', 'غير محدد', '150ml', '1', NULL, 'specially formulated for expectant mothers mustela 9 months stretch marks double action helps prevent and reduce stretch marks thanks to its innovative combination of naturally-derived active ingredients: a patented anti-stretch marks formula activates th', NULL, NULL, 1095, '2022-07-27', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23139, 'Mustela stretch marks intensive action lotion 75ml', 'موستلا لعلاج اثار الحمل وعلامات التمدد لوشن 75مل', '409', NULL, 'Firming topical', 'Elastoregulator+lupeol+galactoarabinan+vitamin b5+copper gluconate+shea butter+avocado peptides', 'Laboratoires expanscience-france > biotech egypt', 'Lotion', 'لوشن', '75ml', '1', NULL, 'specially formulated for post-partum skin care mustela 9 months stretch marks intensive action reduces existing stretch marks with its exclusive combination of vitamins and naturally-derived ingredients: restores skin quality with its patented anti-stretc', NULL, NULL, 643, '2022-08-03', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23140, 'Mustela stretch marks recovery serum 45 ml', 'موستلا لعلاج اثار الحمل وعلامات التمدد سيرم 75مل', '525', NULL, 'Firming topical', NULL, 'Laboratoires expanscience-france > biotech egypt', 'Serum', 'سيروم', '45 ml', '1', NULL, 'specially formulated for expectand and new mothers stretch marks recovery serum helps reduce the appearance of stretch marks thanks to its unique combination of active ingredients and ingredients of natural origin: - avocado peptides a patented ingredient', NULL, NULL, 671, '2022-07-27', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23141, 'Mustela very high protection sun lotion 100ml', 'موستلا للحماية من الشمس لوشن 100مل', '475', NULL, 'Baby care', NULL, 'Laboratoires expanscience-france > biotech egypt', 'Lotion', 'لوشن', '100ml', '1', NULL, 'developed following major new advances in sun protection for children very high protection sun lotion from mustela has been specially designed to protect the delicate skin of babies and children from dangerous solar radiation right from birth. children ag', NULL, NULL, 597, '2022-08-03', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23142, 'Mustela vitamin barrier cream 100ml', 'موستلا كريم مانع بالفيامينات 100 مل', '199', NULL, 'Baby care', 'Avocado perseose+alcacea oxeoline+sunflower oil', 'Laboratoires expanscience-france > biotech egypt', 'Cream', 'كريم', '100ml', '1', NULL, 'fragile and delicate your baby s bottom is exposed to constant stresses and can easily become irritated. after 10 years of research and fundamental discoveries about babies skin mustela has revolutionized skin care for the diaper area with its new 1>2>3 v', NULL, NULL, 620, '2022-08-03', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23143, 'Mustela vitamin barrier cream 50ml', 'موستلا فيتامين كريم 50 مل', '139', NULL, 'Baby care', 'Avocado perseose+alcacea oxeoline+sunflower oil', 'Laboratoires expanscience-france > biotech egypt', 'Cream', 'كريم', '50ml', '1', NULL, 'fragile and delicate your baby s bottom is exposed to constant stresses and can easily become irritated. after 10 years of research and fundamental discoveries about babies skin mustela has revolutionized skin care for the diaper area with its new 1>2>3 v', '3504105024802', NULL, 599, '2022-08-17', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23144, 'Muvista massage gel 50 gm', 'موفيستا مساج جل 50 جم', '90', '50', 'Massage', 'Camphor+menthol', 'Chemica > nova pharma', 'Gel', 'جل', '50 gm', '1', NULL, NULL, '6223002143634', NULL, 1387, '2023-08-14', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23145, 'Muvista massage gel 50 sachet', 'موفيستا جل مساج 50 كيس', '250', NULL, 'Massage', 'Menthol crystals 5%+camphor crystals 3%', 'Chemica > nova pharma', 'Gel', 'جل', NULL, '1', 'كريم مساج يعمل على توفير الراحة من الألم والأوجاع والالتهاب المرتبط بالشد العضلي والالتواء والكدمات · تقليل الالتهاب والتورم · تعزيز الاسترخاء وتعافي العضلات', 'massage gel topical pain relief', NULL, NULL, 2133, '2022-07-12', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23147, 'Myafibrol 150 mg 10 caps.', 'ميافبرول 150مجم 10 كبسول', '32', NULL, 'Anti-epileptic.gaba analogs', 'Pregabalin', 'International drug agency (idi) > mira international', 'Cap', 'كبسولة', '150 mg', '1', NULL, 'about pregabalin a gaba agonist anticonvulsant. mechanism of action of pregabalin pregabalin is a gaba neurotransmitter analog. it produces its action by modulating calcium channels and also reduces the release of neurotransmitters such as glutamate norep', NULL, NULL, 767, '2022-07-20', 0, 'Pregabalin is indicated for the management of neuropathic pain associated with diabetic peripheral neuropathy, postherpetic neuralgia, fibromyalgia, neuropathic pain associated with spinal cord injury, and as adjunctive therapy for the treatment of partial-onset seizures in patients 1 month of age and older.[L7066]', 'Although the mechanism of action has not been fully elucidated, studies involving structurally related drugs suggest that presynaptic binding of pregabalin to voltage-gated calcium channels is key to the antiseizure and antinociceptive effects observed in animal models.[L7066]  



By binding presynaptically to the alpha2-delta subunit of voltage-gated calcium channels in the central nervous system, pregabalin modulates the release of several excitatory neurotransmitters including glutamate, substance-P, norepinephrine, and calcitonin gene related peptide.[A31163] In addition, pregabalin prevents the alpha2-delta subunit from being trafficked from the dorsal root ganglia to the spinal dorsal horn, which may also contribute to the mechanism of action.[A36628] 



Although pregabalin is a structural derivative of the inhibitory neurotransmitter gamma-aminobutyric acid (GABA), it does not bind directly to GABA or benzodiazepine receptors.[A31165]  ', 'Although the structure of pregabalin is similar to gamma-aminobutyric acid (GABA), it does not bind to GABA receptors.[A31163,A187190] Instead, it binds the alpha2-delta subunit of presynaptic voltage-gated calcium channels in the central nervous system.[A31163,A187190] Pregabalin does not modulate dopamine receptors, serotonin receptors, opiate receptors, sodium channels or cyclooxygenase activity.[A187190] ', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23148, 'Myafibrol 75mg 20 caps.', 'ميافبرول 75مجم 20 كبسول', '49', NULL, 'Anti-epileptic.gaba analogs', 'Pregabalin', 'International drug agency (idi) > mira international', 'Cap', 'كبسولة', '75mg', '2', NULL, 'about pregabalin a gaba agonist anticonvulsant. mechanism of action of pregabalin pregabalin is a gaba neurotransmitter analog. it produces its action by modulating calcium channels and also reduces the release of neurotransmitters such as glutamate norep', NULL, NULL, 739, '2022-07-23', 0, 'Pregabalin is indicated for the management of neuropathic pain associated with diabetic peripheral neuropathy, postherpetic neuralgia, fibromyalgia, neuropathic pain associated with spinal cord injury, and as adjunctive therapy for the treatment of partial-onset seizures in patients 1 month of age and older.[L7066]', 'Although the mechanism of action has not been fully elucidated, studies involving structurally related drugs suggest that presynaptic binding of pregabalin to voltage-gated calcium channels is key to the antiseizure and antinociceptive effects observed in animal models.[L7066]  



By binding presynaptically to the alpha2-delta subunit of voltage-gated calcium channels in the central nervous system, pregabalin modulates the release of several excitatory neurotransmitters including glutamate, substance-P, norepinephrine, and calcitonin gene related peptide.[A31163] In addition, pregabalin prevents the alpha2-delta subunit from being trafficked from the dorsal root ganglia to the spinal dorsal horn, which may also contribute to the mechanism of action.[A36628] 



Although pregabalin is a structural derivative of the inhibitory neurotransmitter gamma-aminobutyric acid (GABA), it does not bind directly to GABA or benzodiazepine receptors.[A31165]  ', 'Although the structure of pregabalin is similar to gamma-aminobutyric acid (GABA), it does not bind to GABA receptors.[A31163,A187190] Instead, it binds the alpha2-delta subunit of presynaptic voltage-gated calcium channels in the central nervous system.[A31163,A187190] Pregabalin does not modulate dopamine receptors, serotonin receptors, opiate receptors, sodium channels or cyclooxygenase activity.[A187190] ', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23149, 'Mycamine 50 mg vial for i.v inf.', 'ميكامين 50مجم فيال للحقن الوريدي', '951', NULL, 'Antifungals.echinocandins', 'Micafungin', 'Astellas toyoma co.ltd-japan > hikma pharma', 'Vial', 'فيال', '50 mg', '1', NULL, 'about micafungin an echinocandin ?-glucan synthase inhibitor antifungal.', NULL, NULL, 599, '2022-08-05', 0, 'Indicated for the treatment of candidemia, acute disseminated candidiasis, and certain other invasive <i>Candida</i> infections, as well as esophageal candidiasis, and prophylaxis of <i>Candida</i> infections in patients undergoing hematopoietic stem cell transplantation. Micafungin is also used as an alternative for the treatment of oropharyngeal candidiases and has been used with some success as primary or salvage therapy, alone or in combination with other antifungals, for the treatment of invasive aspergillosis.



Indicated for the prophylaxis of Candida infections in patients undergoing hematopoietic stem cell transplantation.', 'Micafungin inhibits the synthesis of beta-1,3-D-glucan, an essential component of fungal cell walls which is not present in mammalian cells. It does this by inhibiting beta-1,3-D-glucan synthase.', 'Formerly known as FK463, micafungin is a semisynthetic lipopeptide synthesized from a fermentation product of <i>Coleophoma empetri</i> that works as an antifungal agent. It is a glucan synthesis inhibitor of the echinocandin structural class. The U.S. Food and Drug Administration approved micafungin in March 2005. Micafungin inhibits an enzyme essential for fungal cell-wall synthesis. Depending on its concentration, micafungin may be fungicidal against some <i>Candida</i>, but is usually fungistatic against <i>Apergillus</i>. Micafungin can be used concomitantly with a variety of other drugs, including the HIV protease inhibitor ritonavir and the transplant medications cyclosporine and tacrolimus.', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23150, 'Champi-bone 20 tab', 'شامبي بون 20 قرص', '85', NULL, 'Supports bone health', 'Vit d+calcium+magnesium+selenium+zinc+copper+manganese+boron', 'La vie', 'Tab', 'أقراص', NULL, '1', NULL, NULL, NULL, NULL, 825, '2025-02-09', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23151, 'Mycomic 250 mg 10 tab.', 'ميكومك 250مجم 10 اقراص', '27', NULL, 'Antifungals.allylamines', 'Terbinafine', 'Future pharmaceutical industries (fpi) > tabuk pharmaceutical manufacturing company', 'Tab', 'أقراص', '250 mg', '1', 'مضاد للفطريات', 'about terbinafine a synthetic allylamine derivative antifungal. mechanism of action of terbinafine terbinafine is a fungicidal drug. it interfere the conversion of squalene to ergosterol by inhibiting the enzyme squalene epoxidase.this results in accumula', NULL, NULL, 1544, '2022-07-15', 0, 'Terbinafine hydrochloride is indicated to treat fungal skin and nail infections caused by _Trichophyton_ species, _Microsporum canis_, _Epidermophyton floccosum_,[L9068] and _Tinea_ species.[L9065] Terbinafine hydrochloride also treats yeast infections of the skin caused by _Candida_ species and _Malassezia furfur_.[L9068]', 'Terbinafine inhibits the enzyme squalene monooxygenase (also called squalene epoxidase), preventing the conversion of squalene to 2,3-oxydosqualene, a step in the synthesis of ergosterol.[A1279,A1281,L9068] This inhibition leads to decreased ergosterol, which would normally be incorporated into the cell wall, and accumulation of squalene.[A1281,L9068]



Generation of a large number of squalene containing vesicles in the cytoplasm may leach other lipids away from, and further weaken, the cell wall.[A1281]', 'Terbinafine is an allylamine antifungal that inhibits squalene epoxidase (also known as squalene monooxygenase) to prevent the formation of ergosterol and cause an accumulation of squalene, weakening the cell wall of fungal cells.[A1279,A1281,L9068] Terbinafine distributes into tissues and has a long terminal elimination half life, so the duration of action is long.[A1279] Overdose with terbinafine is rare, even above the therapeutic dose, so the therapeutic index is wide.[L9065,L9068] Patients taking oral terbinafine should have liver function tests performed prior to treatment to reduce the risk of liver injury.[L9065]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23153, 'Mycopedis 1% topical spray 120 ml', 'ميكوبيديس 1% سبراي 120 مل', '51', '32.4', 'Antifungals.allylamines', 'Terbinafine', 'Andalous pharma > novell pharma', 'Spray', 'بخاخ', '1%', '1', 'مضاد فطريات', 'about terbinafine a synthetic allylamine derivative antifungal. mechanism of action of terbinafine terbinafine is a fungicidal drug. it interfere the conversion of squalene to ergosterol by inhibiting the enzyme squalene epoxidase.this results in accumula', '6224000743208', NULL, 2151, '2025-08-20', 0, 'Terbinafine hydrochloride is indicated to treat fungal skin and nail infections caused by _Trichophyton_ species, _Microsporum canis_, _Epidermophyton floccosum_,[L9068] and _Tinea_ species.[L9065] Terbinafine hydrochloride also treats yeast infections of the skin caused by _Candida_ species and _Malassezia furfur_.[L9068]', 'Terbinafine inhibits the enzyme squalene monooxygenase (also called squalene epoxidase), preventing the conversion of squalene to 2,3-oxydosqualene, a step in the synthesis of ergosterol.[A1279,A1281,L9068] This inhibition leads to decreased ergosterol, which would normally be incorporated into the cell wall, and accumulation of squalene.[A1281,L9068]



Generation of a large number of squalene containing vesicles in the cytoplasm may leach other lipids away from, and further weaken, the cell wall.[A1281]', 'Terbinafine is an allylamine antifungal that inhibits squalene epoxidase (also known as squalene monooxygenase) to prevent the formation of ergosterol and cause an accumulation of squalene, weakening the cell wall of fungal cells.[A1279,A1281,L9068] Terbinafine distributes into tissues and has a long terminal elimination half life, so the duration of action is long.[A1279] Overdose with terbinafine is rare, even above the therapeutic dose, so the therapeutic index is wide.[L9065,L9068] Patients taking oral terbinafine should have liver function tests performed prior to treatment to reduce the risk of liver injury.[L9065]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23154, 'Mycopharm 2% tincture 30 ml', 'ميكوفارم 2% 30مل', '6', NULL, 'Antifungals.imidazoles', 'Miconazole', 'Sigma > egyptian pharmacists company', 'Unknown', 'غير محدد', '2%', '1', NULL, 'about miconazole an imidazole derivative broad spectrum antifungal. mechanism of action of miconazole miconazole is fungicidal or fungistatic depending on the drug concentrations. i t inhibits the conversion of lanosterol to 14 demethyl lanosterol by inhi', '6221035003062', NULL, 1012, '2022-07-21', 0, 'Miconazole is indicated for the local treatment of oropharyngeal candidiasis in adult patients and for the adjunctive treatment of diaper dermatitis complicated by candidiasis in immunocompetent patients aged four weeks and older.[L14021, L14024] Miconazole is available as both a suppository and cream for the treatment of vaginal yeast infections and the relief of associated vulvar itching and irritation.[L14027] Lastly, miconazole cream is effective in treating athlete''s foot (tinea pedis), jock itch (tinea cruris), ringworm infections (tinea corporis),[L14033] pityriasis (formerly tinea) versicolor,[A203633] and cutaneous candidiasis.[A203630]', 'Miconazole is an azole antifungal used to treat a variety of conditions, including those caused by _Candida_ overgrowth. Unique among the azoles, miconazole is thought to act through three main mechanisms.[A203636] The primary mechanism of action is through inhibition of the CYP450 14α-lanosterol demethylase enzyme, which results in altered ergosterol production and impaired cell membrane composition and permeability, which in turn leads to cation, phosphate, and low molecular weight protein leakage.[A203636, A203639]



In addition, miconazole inhibits fungal peroxidase and catalase while not affecting NADH oxidase activity, leading to increased production of reactive oxygen species (ROS).[A203636, A203639, A203642] Increased intracellular ROS leads to downstream pleiotropic effects and eventual apoptosis.[A203636]



Lastly, likely as a result of lanosterol demethylation inhibition, miconazole causes a rise in intracellular levels of farnesol. This molecule participates in quorum sensing in _Candida_, preventing the transition from yeast to mycelial forms and thereby the formation of biofilms, which are more resistant to antibiotics.[A203645, A203648] In addition, farnesol is an inhibitor of drug efflux ABC transporters, namely _Candida_ CaCdr1p and CaCdr2p, which may additionally contribute to increased effectiveness of azole drugs.[A203648]', 'Miconazole is an azole antifungal that functions primarily through inhibition of a specific demethylase within the CYP450 complex.[A203636] As miconazole is typically applied topically and is minimally absorbed into the systemic circulation following application, the majority of patient reactions are limited to hypersensitivity and cases of anaphylaxis.[L14021] Patients using intravaginal miconazole products are advised not to rely on contraceptives to prevent pregnancy and sexually transmitted infections, as well as not to use tampons concurrently.[L14027]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23155, 'Mycophenolate mofetil-accord pd. for i.v. inf.(n/a yet)', 'ميكوفينولات للاطفال حقن وريدي', '730', NULL, 'Immunosuppressants', 'Mycophenolate mofetil', 'Accord healthcare limited > united group pharmaceutical(u.g.p.)', 'Unknown', 'غير محدد', NULL, '1', NULL, NULL, NULL, NULL, 747, '2022-08-03', 0, 'Mycophenolate mofetil is indicated in combination with other immunosuppressants to prevent the rejection of kidney, heart, or liver transplants in adult and pediatric patients ≥3 months old.[L42020] Mycophenolate mofetil may also be used off-label as a second-line treatment for autoimmune hepatitis that has not responded adequately to first-line therapy.[A180814] Other off-label uses of this drug include lupus-associated nephritis and dermatitis in children.[A180817]', 'The active metabolite of mycophenolate, mycophenolic acid, prevents T-cell and B-cell proliferation and the production of cytotoxic T-cells and antibodies. Lymphocyte and monocyte adhesion to endothelial cells of blood vessels that normally part of inflammation is prevented via the glycosylation of cell adhesion molecules by MPA.[A180892] MPA inhibits de novo purine biosynthesis (that promotes immune cell proliferation) by inhibiting inosine 5’-monophosphate dehydrogenase enzyme (IMPDH), with a preferential inhibition of IMPDH II.[A180826] IMPDH normally transforms inosine monophosphate (IMP) to xanthine monophosphate (XMP), a metabolite contributing to the production of guanosine triphosphate (GTP).[A180799,A180805,A180817] GTP is an important molecule for the synthesis of ribonucleic acid (RNA), deoxyribonucleic acid (DNA), and protein. As a result of the above cascade of effects, mycophenolate mofetil reduces de-novo production of guanosine nucleotides, interfering with the synthesis of DNA, RNA, and protein required for immune cell production.[A180826] Further contributing to the above anti-inflammatory effects, MMF depletes tetrahydrobiopterin, causing the decreased function of inducible nitric oxide synthase enzyme, in turn decreasing the production of peroxynitrite, a molecule that promotes inflammation.[A180907]', 'Mycophenolate mofetil is a prodrug of mycophenolic acid (MPA). The active form of mycophenolate, MPA, prevents the proliferation of immune cells and the formation of antibodies that cause transplant rejection.[A180805] The above effects lead to higher rates of successful transplantation, avoiding the devastating effects of graft rejection.



', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23156, 'Mycophenolate mofetil-sandoz 500 mg 50 tabs.', 'ميكوفينوليت موفتيل-ساندوز 500مجم 50 قرص', '1,020', '550', 'Immunosuppressant', 'Mycophenolate mofetil', 'Sandoz', 'Tab', 'أقراص', '500 mg', '5', NULL, 'indication for the prophylaxis of organ rejection in patients receiving allogeneic renal cardiac or hepatic transplants. mycophenolate mofetil should be used concomitantly with cyclosporine and corticosteroids. mechanism of action mycophenolate mofetil is', '6221035003062', NULL, 3628, '2025-05-03', 0, 'Mycophenolate mofetil is indicated in combination with other immunosuppressants to prevent the rejection of kidney, heart, or liver transplants in adult and pediatric patients ≥3 months old.[L42020] Mycophenolate mofetil may also be used off-label as a second-line treatment for autoimmune hepatitis that has not responded adequately to first-line therapy.[A180814] Other off-label uses of this drug include lupus-associated nephritis and dermatitis in children.[A180817]', 'The active metabolite of mycophenolate, mycophenolic acid, prevents T-cell and B-cell proliferation and the production of cytotoxic T-cells and antibodies. Lymphocyte and monocyte adhesion to endothelial cells of blood vessels that normally part of inflammation is prevented via the glycosylation of cell adhesion molecules by MPA.[A180892] MPA inhibits de novo purine biosynthesis (that promotes immune cell proliferation) by inhibiting inosine 5’-monophosphate dehydrogenase enzyme (IMPDH), with a preferential inhibition of IMPDH II.[A180826] IMPDH normally transforms inosine monophosphate (IMP) to xanthine monophosphate (XMP), a metabolite contributing to the production of guanosine triphosphate (GTP).[A180799,A180805,A180817] GTP is an important molecule for the synthesis of ribonucleic acid (RNA), deoxyribonucleic acid (DNA), and protein. As a result of the above cascade of effects, mycophenolate mofetil reduces de-novo production of guanosine nucleotides, interfering with the synthesis of DNA, RNA, and protein required for immune cell production.[A180826] Further contributing to the above anti-inflammatory effects, MMF depletes tetrahydrobiopterin, causing the decreased function of inducible nitric oxide synthase enzyme, in turn decreasing the production of peroxynitrite, a molecule that promotes inflammation.[A180907]', 'Mycophenolate mofetil is a prodrug of mycophenolic acid (MPA). The active form of mycophenolate, MPA, prevents the proliferation of immune cells and the formation of antibodies that cause transplant rejection.[A180805] The above effects lead to higher rates of successful transplantation, avoiding the devastating effects of graft rejection.



', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23157, 'Mycospor 1% cream 15 gm', 'ميكوسبور 1% كريم 15جم', '16', NULL, 'Antifungals.imidazoles', 'Bifonazole', 'Hikma pharma > bayer healthcare', 'Cream', 'كريم', '1%', '1', NULL, 'about bifonazole bifonazole is a substituted imidazole antifungal agent. mechanism of action of bifonazole bifonazole is an imidazole antifungal.it inhibits the conversion of lanosterol to 14 demethyl lanosterol by inhibiting the cytochromep450 enzyme 14', NULL, NULL, 723, '2022-07-28', 0, 'Used for the treatment of various topical fungal infections, including athlete''s foot (tinea pedis).', 'Bifonazole works by inhibiting the production of a substance called ergosterol, which is an essential component of fungal cell membranes.It acts to destabilize the fungal cyctochrome p450 51 enzyme (also known as Lanosterol 14-alpha demethylase). This is vital in the cell membrance structure of the fungus. Its inhibition leads to cell lysis. The disruption in production of ergosterol disrupts the cell membrane and causes holes to appear. The cell membranes of fungi are vital for their survival. They keep unwanted substances from entering the cells and stop the contents of the cells from leaking out. As bifonazole causes holes to appear in the cell membranes, essential constituents of the fungal cells can leak out. This kills the fungi.', 'Bifonazole is a type of antifungal medicine known as an imidazole. It kills fungi and yeasts by interfering with their cell membranes.', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23158, 'Mycospor 1% topical solution 15 ml', 'ميكوسبور 1% محلول 15مل', '16', NULL, 'Antifungals.imidazoles', 'Bifonazole', 'Hikma pharma > bayer healthcare', 'Solution', 'محلول', '1%', '1', NULL, 'about bifonazole bifonazole is a substituted imidazole antifungal agent. mechanism of action of bifonazole bifonazole is an imidazole antifungal.it inhibits the conversion of lanosterol to 14 demethyl lanosterol by inhibiting the cytochromep450 enzyme 14', NULL, NULL, 727, '2022-07-24', 0, 'Used for the treatment of various topical fungal infections, including athlete''s foot (tinea pedis).', 'Bifonazole works by inhibiting the production of a substance called ergosterol, which is an essential component of fungal cell membranes.It acts to destabilize the fungal cyctochrome p450 51 enzyme (also known as Lanosterol 14-alpha demethylase). This is vital in the cell membrance structure of the fungus. Its inhibition leads to cell lysis. The disruption in production of ergosterol disrupts the cell membrane and causes holes to appear. The cell membranes of fungi are vital for their survival. They keep unwanted substances from entering the cells and stop the contents of the cells from leaking out. As bifonazole causes holes to appear in the cell membranes, essential constituents of the fungal cells can leak out. This kills the fungi.', 'Bifonazole is a type of antifungal medicine known as an imidazole. It kills fungi and yeasts by interfering with their cell membranes.', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23160, 'Mycoster 1% topical soln. 30 ml', 'ميكوستير 1% محلول 30مل', '9', NULL, 'Antifungals.miscellaneous', 'Ciclopirox olamine', 'Global napi pharmaceuticals > pierre - fabre', 'Sol', 'محلول', '1%', '1', 'مضاد موضعى للفطريات', 'about ciclopiroxolamine a synthetic antifungal agent a hydroxypyridone derivaive.topical antifungal agent. mechanism of action of ciclopiroxolamine ciclopiroxolamine is a chelating agent. it forms complexes with polyvalent metal cations eg.fe3+ al 3+. the', NULL, NULL, 1814, '2022-07-08', 0, 'Used as a topical treatment in immunocompetent patients with mild to moderate onychomycosis of fingernails and toenails without lunula involvement, due to <i>Trichophyton rubrum</i>.', 'Unlike antifungals such as itraconazole and terbinafine, which affect sterol synthesis, ciclopirox is thought to act through the chelation of polyvalent metal cations, such as Fe<sup>3+</sup> and Al<sup>3+</sup>. These cations inhibit many enzymes, including cytochromes, thus disrupting cellular activities such as mitochondrial electron transport processes and energy production. Ciclopirox also appears to modify the plasma membrane of fungi, resulting in the disorganization of internal structures. The anti-inflammatory action of ciclopirox is most likely due to inhibition of 5-lipoxygenase and cyclooxygenase.

ciclopirox may exert its effect by disrupting DNA repair, cell division signals and structures (mitotic spindles) as well as some elements of intracellular transport. ', 'Ciclopirox is a broad-spectrum antifungal medication that also has antibacterial and anti-inflammatory properties. Its main mode of action is thought to be its high affinity for trivalent cations, which inhibit essential co-factors in enzymes. Ciclopirox exhibits either fungistatic or fungicidal activity in vitro against a broad spectrum of fungal organisms, such as dermatophytes, yeasts, dimorphic fungi, eumycetes, and actinomycetes. In addition to its broad spectrum of action, ciclopirox also exerts antibacterial activity against many Gram-positive and Gram-negative bacteria. Furthermore, the anti-inflammatory effects of ciclopirox have been demonstrated in human polymorphonuclear cells, where ciclopirox has inhibited the synthesis of prostaglandin and leukotriene. Ciclopirox can also exhibit its anti-inflammatory effects by inhibiting the formation of 5-lipoxygenase and cyclooxygenase.', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23161, 'Mycovrex 1% cream 15 gm', 'ميكوفريكس 1% كريم 15جم', '14', NULL, 'Antifungals.allylamines', 'Butenafine hydrochloride', 'Eva pharma', 'Cream', 'كريم', '1%', '1', NULL, 'uses: this medication is used to treat a variety of fungal skin infections such as ringworm athlete s foot and jock itch. this medication is also used to treat a skin condition known as pityriasis (tinea versicolor) a fungal infection that causes a lighte', NULL, NULL, 847, '2022-07-27', 0, 'For the topical treatment of the following dermatologic infections: tinea (pityriasis) versicolor due to <i>M. furfur</i>, interdigital tinea pedis (athlete&rsquo;s foot), tinea corporis (ringworm) and tinea cruris (jock itch) due to <i>E. floccosum</i>, <i>T. mentagrophytes</i>, <i>T. rubrum</i>, and <i>T. tonsurans</i>.', 'Although the  mechanism of action has not been fully established, it has been suggested that butenafine, like allylamines, interferes with sterol biosynthesis (especially ergosterol) by inhibiting squalene monooxygenase, an enzyme responsible for converting squalene to 2,3-oxydo squalene. As ergosterol is an essential component of the fungal cell membrane, inhibition of its synthesis results in increased cellular permeability causing leakage of cellular contents. Blockage of squalene monooxygenase also leads to a subsequent accumulation of squalene. When a high concentration of squalene is reached, it is thought to have an effect of directly kill fungal cells.', 'Butenafine is a synthetic antifungal agent that is structurally and pharmacologically related to allylamine antifungals. The exact mechanism of action has not been established, but it is suggested that butenafine''s antifungal activity is exerted through the alteration of cellular membranes, which results in increased membrane permeability, and growth inhibition. Butenafine is mainly active against dermatophytes and has superior fungicidal activity against this group of fungi when compared to that of terbinafine, naftifine, tolnaftate, clotrimazole, and bifonazole. It is also active against <i>Candida albicans</i> and this activity is superior to that of terbinafine and naftifine. Butenafine also generates low MICs for <i>Cryptococcus neoformans</i> and <i>Aspergillus spp.</i> as well.', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23162, 'Mycutin d top. cream. 15 gm', 'ميكوتين دي كريم 15جم', '6', NULL, 'Antifungal with glucocorticoid', 'Clotrimazole+dexamethasone', 'Alexandria', 'Cream', 'كريم', '15 gm', '1', NULL, 'about clotrimazole a broad-spectrum antifungal antibiotic imidazole derivative oral nonabsorbed antifungal agent. mechanism of action of clotrimazole clotrimazole is fungicidal or fungistatic depending on the drug concentrations. it inhibits the conversio', NULL, NULL, 726, '2022-07-27', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23163, 'Mydrapid 0.5% eye drops 10 ml', 'ميدرابيد 0.5% قطرة للعين 10مل', '27', '17.5', 'Mydriatic', 'Tropicamide', 'Alexandria', 'Drops', 'نقط', '0.5%', '1', NULL, 'about tropicamide anticholinergic (muscarinic blocker) ophthalmic agent mydriatic cycloplegic. mechanism of action of tropicamide tropicamide is a muscarinic receptor blocker. it nonselectively inhibits the muscarinic actions of acetylcholine. tropicamide', '6223000172124', NULL, 1123, '2025-05-28', 0, 'Tropicamide is indicated to induce mydriasis (dilation of the pupil) for diagnostic procedures and in conditions where short-term pupil dilation is desired, either as monotherapy [L32103] or in combination with [hydroxyamphetamine] [L32178] or [phenylephrine].[L46332] It provides clinically significant mydriasis with partial cycloplegia.[L32178]', 'Muscarinic acetylcholine receptors are involved in numerous ocular functions. The M<sub>3</sub> subtype is predominantly expressed by smooth muscle cells of the sphincter pupillae, which is a circular muscle of the iris, and ciliary muscles. In response to light or binding of acetylcholine, M<sub>3</sub> receptor signalling leads to contraction of the sphincter pupillae and pupil constriction. Contraction of the ciliary muscle via M<sub>3</sub> receptor signalling also leads to accommodation, adjusting the lens for near vision.[A230178] The eye is also innervated by parasympathetic nerves: ciliary ganglion neurons project to the ciliary body and the sphincter pupillae muscle of the iris to control ocular accommodation and pupil constriction.[A230183] 



Tropicamide is a non-selective muscarinic antagonist that binds to all subtypes of muscarinic receptors. By binding to muscarinic receptors, tropicamide relaxes the pupillary sphincter muscle and causes pupil dilation.[A229958] By blocking the muscarinic receptors of the ciliary body, tropicamide also prevents accommodation.[A230178] Like other muscarinic antagonists, tropicamide inhibits the parasympathetic drive, allowing the sympathetic nervous system responses to dominate.[A229958] Tropicamide is thought to ameliorate sialorrhea by blocking M<sub>4</sub> receptors expressed on salivary glands and reducing hypersalivation.[A229958]', 'Tropicamide is an anticholinergic drug and that works by non‐selectively blocking muscarinic receptors to cause mydriasis and cycloplegia. It relaxes the pupillary sphincter to dilate the pupil.[A229958] The onset of tropicamide‐induced mydriasis is about 10 to 15 minutes,[A230103] with optimal effect occurring 25 to 30 minutes post-administration. Mydriasis caused by tropicamide wears off within four to eight hours, but it was seen up to 24 hours in some individuals. Tropicamide hinders accommodation by causing the contraction of the ciliary muscle. The cycloplegic effect occurs within 20 to minutes following administration, with a duration of action of four to 10 hours. Tropicamide can elevate intraocular pressure.[A229958] The ophthalmic use of tropicamide is not typically associated with serious systemic adverse events.[A230173]



One randomized pilot study showed that oral tropicamide alleviated perceived symptoms of sialorrhea in patients with Parkinson''s Disease: anticholinergics are believed to restore the dopaminergic to cholinergic activity imbalance in neurodegenerative diseases.[A229958] Similarly in one case report, tropicamide administered via ophthalmic solution relieved clozapine-induced sialorrhea.[A230093] Interestingly, in rodent models, tropicamide suppressed drug-induced tremulous jaw movements which are often used as a model of parkinsonian tremor: the significance of this finding requires further investigations.[A5677]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23164, 'Loxy probiotic drinkable amoules 10 x 12 ml', 'لوكسي بروبيوتيك امبولات للشرب 10 * 12 مل', '750', '520', 'Immunity booster', 'Bacillus coagulans spores+curcumin+niacin', 'Loxymore pharma', 'Unknown', 'غير محدد', '12 ml', '10', NULL, NULL, NULL, NULL, 1061, '2025-10-31', 0, 'Indicated for intravesical use in the treatment and prophylaxis of carcinoma in situ (CIS) of the urinary bladder and for the prophylaxis of primary or recurrent stage Ta and/or T1 papillary tumors following transurethral resection (TUR). ', NULL, NULL, 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23166, 'Fast freeze magnesium massage spray 200 ml', 'فاست فريز مغنسيوم مساج سبراي 200 مل', '250', NULL, 'Massage', 'Camphor+menthol+magnesium', 'Rotabiogen', 'Spray', 'بخاخ', '200 ml', '1', NULL, NULL, '6224011378222', NULL, 799, '2023-01-20', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23168, 'Myhep 400mg 28 tablets', 'مايهيب 400مجم 28 قرص', '900', NULL, 'Antiviral', 'Sofosbuvir', 'Mylan > one pharma tech', 'Tablet', 'أقراص', '400mg', '1', NULL, 'indications and usage: it is a hepatitis c virus (hcv) nucleotide analog ns5b polymerase inhibitor indicated for the treatment of chronic hepatitis c (chc) infection as a component of a combination antiviral treatment regimen. *efficacy has been establish', NULL, NULL, 1010, '2022-06-18', 0, 'Sofosbuvir is used in combination therapy with other antiviral medications to treat chronic hepatitis C virus (HCV) infected patients with HCV genoptypes 1-6, and to treat HCV and HIV co-infected patients. Depending on the level of cirrhosis or decompensation, combination therapy can also include either ribavirin alone or ribavirin and peg-interferon alfa.



When used in combination with [DB09027], sofosbuvir has the following indications: treatment of genotypes 1, 4, 5, or 6 infection without cirrhosis or with compensated cirrhosis; in combination with [DB00811] for genotype 1 infection with decompensated cirrhosis; or in combination with [DB00811] for the treatment of genotype 1 or 4 infection who are liver transplant recipients without cirrhosis or with compensated cirrhosis.



When used in combination with [DB11613] as the combination product Epclusa, sofosbuvir is indicated for the treatment of adult patients with chronic hepatitis C virus (HCV) genotypes 1, 2, 3, 4, 5, or 6 infection without cirrhosis or with compensated cirrhosis, or in combination with [DB00811] if associated with decompensated cirrhosis.



Resistance: Reduced susceptibility to sofosbuvir has been associated with the NS5B substitution mutation S282T [A19634].', 'Sofosbuvir is nucleotide analog inhibitor, which specifically inhibits HCV NS5B (non-structural protein 5B) RNA-dependent RNA polymerase. Following intracellular metabolism to form the pharmacologically active uridine analog triphosphate (GS-461203), sofosbuvir incorporates into HCV RNA by the NS5B polymerase and acts as a chain terminator [synthesis, A7533]. More specifically, Sofosbuvir prevents HCV viral replication by binding to the two Mg2+ ions present in HCV NS5B polymerase''s GDD active site motif and preventing further replication of HCV genetic material [A19638, FDA Label].



', 'Sofosbuvir acts against HCV and is categorized as a direct-acting antiviral agent (DAA).



At a dose 3 times the recommended dose, sofosbuvir does not prolong QTc to any clinically relevant extent [FDA Label].', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23169, 'Mykotral 2% topical powder 20 gm', 'ميكوترال 2% بودر 20جم', '6', NULL, 'Antifungals.imidazoles', 'Miconazole', 'Sigma', 'Powder', 'بودرة', '2%', '1', NULL, 'about miconazole an imidazole derivative broad spectrum antifungal. mechanism of action of miconazole miconazole is fungicidal or fungistatic depending on the drug concentrations. i t inhibits the conversion of lanosterol to 14 demethyl lanosterol by inhi', '6221051030196', NULL, 790, '2023-04-21', 0, 'Miconazole is indicated for the local treatment of oropharyngeal candidiasis in adult patients and for the adjunctive treatment of diaper dermatitis complicated by candidiasis in immunocompetent patients aged four weeks and older.[L14021, L14024] Miconazole is available as both a suppository and cream for the treatment of vaginal yeast infections and the relief of associated vulvar itching and irritation.[L14027] Lastly, miconazole cream is effective in treating athlete''s foot (tinea pedis), jock itch (tinea cruris), ringworm infections (tinea corporis),[L14033] pityriasis (formerly tinea) versicolor,[A203633] and cutaneous candidiasis.[A203630]', 'Miconazole is an azole antifungal used to treat a variety of conditions, including those caused by _Candida_ overgrowth. Unique among the azoles, miconazole is thought to act through three main mechanisms.[A203636] The primary mechanism of action is through inhibition of the CYP450 14α-lanosterol demethylase enzyme, which results in altered ergosterol production and impaired cell membrane composition and permeability, which in turn leads to cation, phosphate, and low molecular weight protein leakage.[A203636, A203639]



In addition, miconazole inhibits fungal peroxidase and catalase while not affecting NADH oxidase activity, leading to increased production of reactive oxygen species (ROS).[A203636, A203639, A203642] Increased intracellular ROS leads to downstream pleiotropic effects and eventual apoptosis.[A203636]



Lastly, likely as a result of lanosterol demethylation inhibition, miconazole causes a rise in intracellular levels of farnesol. This molecule participates in quorum sensing in _Candida_, preventing the transition from yeast to mycelial forms and thereby the formation of biofilms, which are more resistant to antibiotics.[A203645, A203648] In addition, farnesol is an inhibitor of drug efflux ABC transporters, namely _Candida_ CaCdr1p and CaCdr2p, which may additionally contribute to increased effectiveness of azole drugs.[A203648]', 'Miconazole is an azole antifungal that functions primarily through inhibition of a specific demethylase within the CYP450 complex.[A203636] As miconazole is typically applied topically and is minimally absorbed into the systemic circulation following application, the majority of patient reactions are limited to hypersensitivity and cases of anaphylaxis.[L14021] Patients using intravaginal miconazole products are advised not to rely on contraceptives to prevent pregnancy and sexually transmitted infections, as well as not to use tampons concurrently.[L14027]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23170, 'Mykotral 200mg 6 vag. tabs.', 'ميكوترال 200مجم 6 اقراص مهبلية', '7', NULL, 'Antifungals.imidazoles', 'Miconazole', 'Sigma', 'Tab', 'أقراص', '200mg', '2', NULL, 'about miconazole an imidazole derivative broad spectrum antifungal. mechanism of action of miconazole miconazole is fungicidal or fungistatic depending on the drug concentrations. i t inhibits the conversion of lanosterol to 14 demethyl lanosterol by inhi', '6221051011270', NULL, 749, '2023-04-21', 0, 'Miconazole is indicated for the local treatment of oropharyngeal candidiasis in adult patients and for the adjunctive treatment of diaper dermatitis complicated by candidiasis in immunocompetent patients aged four weeks and older.[L14021, L14024] Miconazole is available as both a suppository and cream for the treatment of vaginal yeast infections and the relief of associated vulvar itching and irritation.[L14027] Lastly, miconazole cream is effective in treating athlete''s foot (tinea pedis), jock itch (tinea cruris), ringworm infections (tinea corporis),[L14033] pityriasis (formerly tinea) versicolor,[A203633] and cutaneous candidiasis.[A203630]', 'Miconazole is an azole antifungal used to treat a variety of conditions, including those caused by _Candida_ overgrowth. Unique among the azoles, miconazole is thought to act through three main mechanisms.[A203636] The primary mechanism of action is through inhibition of the CYP450 14α-lanosterol demethylase enzyme, which results in altered ergosterol production and impaired cell membrane composition and permeability, which in turn leads to cation, phosphate, and low molecular weight protein leakage.[A203636, A203639]



In addition, miconazole inhibits fungal peroxidase and catalase while not affecting NADH oxidase activity, leading to increased production of reactive oxygen species (ROS).[A203636, A203639, A203642] Increased intracellular ROS leads to downstream pleiotropic effects and eventual apoptosis.[A203636]



Lastly, likely as a result of lanosterol demethylation inhibition, miconazole causes a rise in intracellular levels of farnesol. This molecule participates in quorum sensing in _Candida_, preventing the transition from yeast to mycelial forms and thereby the formation of biofilms, which are more resistant to antibiotics.[A203645, A203648] In addition, farnesol is an inhibitor of drug efflux ABC transporters, namely _Candida_ CaCdr1p and CaCdr2p, which may additionally contribute to increased effectiveness of azole drugs.[A203648]', 'Miconazole is an azole antifungal that functions primarily through inhibition of a specific demethylase within the CYP450 complex.[A203636] As miconazole is typically applied topically and is minimally absorbed into the systemic circulation following application, the majority of patient reactions are limited to hypersensitivity and cases of anaphylaxis.[L14021] Patients using intravaginal miconazole products are advised not to rely on contraceptives to prevent pregnancy and sexually transmitted infections, as well as not to use tampons concurrently.[L14027]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23171, 'Mykotral 400mg 3 vag. tabs.', 'ميكوترال 400مجم 3 اقراص مهبلية', '8', NULL, 'Antifungals.imidazoles', 'Miconazole', 'Sigma', 'Tab', 'أقراص', '400mg', '1', NULL, 'about miconazole an imidazole derivative broad spectrum antifungal. mechanism of action of miconazole miconazole is fungicidal or fungistatic depending on the drug concentrations. i t inhibits the conversion of lanosterol to 14 demethyl lanosterol by inhi', '6221051011294', NULL, 814, '2023-04-21', 0, 'Miconazole is indicated for the local treatment of oropharyngeal candidiasis in adult patients and for the adjunctive treatment of diaper dermatitis complicated by candidiasis in immunocompetent patients aged four weeks and older.[L14021, L14024] Miconazole is available as both a suppository and cream for the treatment of vaginal yeast infections and the relief of associated vulvar itching and irritation.[L14027] Lastly, miconazole cream is effective in treating athlete''s foot (tinea pedis), jock itch (tinea cruris), ringworm infections (tinea corporis),[L14033] pityriasis (formerly tinea) versicolor,[A203633] and cutaneous candidiasis.[A203630]', 'Miconazole is an azole antifungal used to treat a variety of conditions, including those caused by _Candida_ overgrowth. Unique among the azoles, miconazole is thought to act through three main mechanisms.[A203636] The primary mechanism of action is through inhibition of the CYP450 14α-lanosterol demethylase enzyme, which results in altered ergosterol production and impaired cell membrane composition and permeability, which in turn leads to cation, phosphate, and low molecular weight protein leakage.[A203636, A203639]



In addition, miconazole inhibits fungal peroxidase and catalase while not affecting NADH oxidase activity, leading to increased production of reactive oxygen species (ROS).[A203636, A203639, A203642] Increased intracellular ROS leads to downstream pleiotropic effects and eventual apoptosis.[A203636]



Lastly, likely as a result of lanosterol demethylation inhibition, miconazole causes a rise in intracellular levels of farnesol. This molecule participates in quorum sensing in _Candida_, preventing the transition from yeast to mycelial forms and thereby the formation of biofilms, which are more resistant to antibiotics.[A203645, A203648] In addition, farnesol is an inhibitor of drug efflux ABC transporters, namely _Candida_ CaCdr1p and CaCdr2p, which may additionally contribute to increased effectiveness of azole drugs.[A203648]', 'Miconazole is an azole antifungal that functions primarily through inhibition of a specific demethylase within the CYP450 complex.[A203636] As miconazole is typically applied topically and is minimally absorbed into the systemic circulation following application, the majority of patient reactions are limited to hypersensitivity and cases of anaphylaxis.[L14021] Patients using intravaginal miconazole products are advised not to rely on contraceptives to prevent pregnancy and sexually transmitted infections, as well as not to use tampons concurrently.[L14027]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23172, 'Dueceptiol 0.25/0.035mg 21 f.c. tabs.', 'ديوسبتيول 21 قرص', '30', NULL, 'Contraceptives', 'Ethinyl estradiol+norgestimate', 'Acdima international trading', 'Tab', 'أقراص', '0.035mg', '1', NULL, NULL, NULL, NULL, 1075, '2024-07-10', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23173, 'Asmazon spray 60 ml', 'اسمازون سبراي 60 مل', '65', '55', NULL, 'Climbazole', 'Pharmakon', 'Spray', 'بخاخ', '60 ml', '1', NULL, NULL, '6224008056553', NULL, 2462, '2025-06-01', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23175, 'Fatroxim 550 mg 30 f.c. tab', 'فاتروكسيم 550مجم 30 قرص', '516', '360', 'Travelers diarrhea', 'Rifaximin', 'Egpi > atm pharmaceutical industries', 'Tab', 'أقراص', '550 mg', '3', NULL, NULL, NULL, NULL, 815, '2024-07-15', 0, 'Rifaximin has multiple indications by the FDA: for the treatment of patients (≥12 years of age) with traveller''s diarrhea caused by noninvasive strains of Escherichia coli; for the reduction of overt hepatic encephalopathy recurrence in patients ≥18 years of age; and in May 2015 it was approved for irritable bowel syndrome with diarrhea (IBS-D) treatment in adult men and women. ', 'Rifaximin acts by inhibiting RNA synthesis in susceptible bacteria by binding to the beta-subunit of bacterial deoxyribonucleic acid (DNA)-dependent ribonucleic acid (RNA) polymerase enzyme. This binding blocks translocation, which stops transcription.', 'Rifaximin is a structural analog of rifampin and a non-systemic, gastrointestinal site-specific antibiotic. This non-systemic property of the drug is due to the addition of a pyridoimidazole ring, which renders it non-absorbable. Rifaximin acts by inhibiting bacterial ribonucleic acid (RNA) synthesis and contributes to restore intestinal microflora imbalance. Other studies have also shown rifaximin to be an pregnane X receptor (PXR) activator. As PXR is responsible for inhibiting the proinflammatory transcription factor NF-kappa B (NF-κB) and is inhibited in inflammatory bowel disease (IBD), rifaximin was proven to be effective for the treatment of IBS-D.', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23177, 'Mylon vag.douche 120ml', 'ميلون غسول مهبلي 120ملي', '14', NULL, 'Vaginal wash', 'Sodium lauryl ether sulphate+cocamido triethanolamine+carboxy methyl cellulose+chlorhexidine glucona', 'Egyptian company for cosmetics > tadawi egypt', 'Unknown', 'غير محدد', '120ml', '1', NULL, NULL, NULL, NULL, 846, '2022-07-26', 0, 'For the treatment of small uncomplicated varicose veins of the lower extremities that show simple dilation with competent valves.', 'Sodium tetradecyl sulfate is a potent toxin for endothelial cells in that brief exposure to even low concentrations are effective in stripping endothelium over a considerable distance and exposing highly thrombogenic endothelium in the process. Diluted sodium tetradecyl sulfate is also able to induce a hypercoagulable state, possibly by selective inhibition of protein C, and can also promote platelet aggregation.', 'Sodium tetradecyl sulfate is an anionic surfactant which occurs as a white, waxy solid. It is used as a sclerosing agent in sclerotherapy. Sclerotherapy is an injection of a sclerosing agent directly through the skin into a lesion and is used primarily for slow-flow vascular anomalies, particularly for venous malformation and lymphatic malformation. Intravenous injection causes intima inflammation and thrombus formation. This usually occludes the injected vein. Subsequent formation of fibrous tissue results in partial or complete vein obliteration that may or may not be permanent.', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23178, 'Mylotarg 500mg/100ml vial for i.v. inf.', 'ميلوتارج 500مجم /100مل فيال وريد', '35', NULL, 'Antibiotic.quinolone', 'Levofloxacin', 'Grand pharma > vodachem pharmaceuticals', 'Vial', 'فيال', '500mg', '1', NULL, 'about levofloxacin third generation fluoroquinolone (or quinolone) a broad spectrum antiinfective. mechanism of action of levofloxacin levofloxacin is a broad spectrum antibacterial agent. it act by inhibiting the enzyme dna gyrase (topoisomerase 2) and t', NULL, NULL, 1043, '2022-07-08', 0, 'In oral and intravenous formulations, levofloxacin is indicated in adults for the treatment of various infections caused by susceptible bacteria, including infections of the upper respiratory tract, lower respiratory tract, skin, skin structures, urinary tract, and prostate.[L11638,L11692] The oral formulation is also indicated in both adults and children 6 months of age and older for the post-exposure management of inhalational anthrax caused by _Bacillus anthracis_ and for the treatment and/or prophylaxis of plague caused by _Yersinia pestis_.[L11638]



In its ophthalmic formulation, levofloxacin is indicated for the treatment of bacterial conjunctivitis caused by susceptible organisms.[L11641] An inhalational solution available in Canada is indicated for the management of cystic fibrosis patients aged 18 years or older with chronic pulmonary _Pseudomonas aeruginosa_ infections.[L11689]', 'Levofloxacin, like other fluoroquinolone antibiotics, exerts its antimicrobial activity via the inhibition of two key bacterial enzymes: DNA gyrase and topoisomerase IV.[L11638] Both targets are type II topoisomerases, but have unique functions within the bacterial cell. DNA gyrase is an enzyme found only in bacteria that introduces negative supercoils into DNA during replication - this helps to relieve torsional strain caused by the introduction of positive supercoils during replication, and these negative supercoils are essential for chromosome condensation and the promotion of transcription initiation.[A31453] It is comprised of four subunits (two A subunits and two B subunits) of which the A subunits appear to be the target of fluoroquinolone antibiotics.[A190663] Bacterial topoisomerase IV, in addition to contributing to the relaxation of positive supercoils, is essential at the terminal stages of DNA replication and functions to “unlink” newly replicated chromosomes to allow for the completion of cell division.[A31453]



Inhibition of these enzymes by levofloxacin likely occurs via complexation with the topoisomerase enzymes.[A31453] The end result is a blockade of DNA replication, thus inhibiting cell division and resulting in cell death.', 'Levofloxacin is bactericidal and exerts its antimicrobial effects via inhibition of bacterial DNA replication.[L11638] It has a relatively long duration of action in comparison with other antibiotics that allows for once or twice daily dosing. Levofloxacin is associated with QTc-interval prolongation and should be used with caution in patients with other risk factors for prolongation (e.g. hypokalemia, concomitant medications).[L11638]



Levofloxacin has demonstrated _in vitro_ activity against a number of aerobic gram-positive and gram-negative bacteria and may carry some activity against certain species of anaerobic bacteria[L11638] and other pathogens such as _Chlamydia_ and _Legionella_.[A190663] Resistance to levofloxacin may develop, and is generally due to mutations in DNA gyrase or topoisomerase IV, or via alterations to drug efflux.[L11638,A31453] Cross-resistance may occur between levofloxacin and other fluoroquinolones, but is unlikely to develop between levofloxacin and other antibiotic classes (e.g. macrolides) due to significant differences in chemical structure and mechanism of action.[L11638]



As antimicrobial susceptibility patterns are geographically distinct, local antibiograms should be consulted to ensure adequate coverage of relevant pathogens prior to use.', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23179, 'Myo fast cream 100 gm', 'ميو فاست كريم 100جم', '50', NULL, 'Massage', 'Salicylic acid+oils(camphor+lemongrass+horse chestnut+rosemary+peppermint+sesame+paraffin)+panthenol', 'Mash premiere', 'Cream', 'كريم', '100 gm', '1', NULL, 'massage cream for fast relief from pain.', NULL, NULL, 712, '2022-07-13', 0, 'Key additive in many skin-care products for the treatment of acne, psoriasis, callouses, corns, keratosis pilaris and warts.', 'Salicylic acid directly irreversibly inhibits COX-1 and COX-2 to decrease conversion of arachidonic acid to precursors of prostaglandins and thromboxanes. Salicylate''s use in rheumatic diseases is due to it''s analgesic and anti-inflammatory activity. Salicylic acid is a key ingredient in many skin-care products for the treatment of acne, psoriasis, calluses, corns, keratosis pilaris, and warts. Salicylic acid allows cells of the epidermis to more readily slough off. Because of its effect on skin cells, salicylic acid is used in several shampoos used to treat dandruff. Salicylic acid is also used as an active ingredient in gels which remove verrucas (plantar warts). Salicylic acid competitively inhibits oxidation of uridine-5-diphosphoglucose (UDPG) with nicotinamide adenosine dinucleotide (NAD) and noncompetitively with UDPG. It also competitively inhibits the transferring of the glucuronyl group of uridine-5-phosphoglucuronic acid (UDPGA) to a phenolic acceptor. Inhibition of mucopoly saccharide synthesis is likely responsible for the slowing of wound healing with salicylates.', 'Salicylic acid treats acne by causing skin cells to slough off more readily, preventing pores from clogging up. This effect on skin cells also makes salicylic acid an active ingredient in several shampoos meant to treat dandruff. Use of straight salicylic solution may cause hyperpigmentation on unpretreated skin for those with darker skin types (Fitzpatrick phototypes IV, V, VI), as well as with the lack of use of a broad spectrum sunblock. Subsalicylate in combination with bismuth form the popular stomach relief aid known commonly as Pepto-Bismol. When combined the two key ingredients help control diarrhea, nausea, heartburn, and even gas. It is also very mildly anti-biotic.', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23180, 'Myo fast cream 50 gm', 'ميو فاست كريم 50 جرام', '30', NULL, 'Massage', 'Salicylic acid+oils(camphor+lemongrass+horse chestnut+rosemary+peppermint+sesame+paraffin)+panthenol', 'Mash premiere', 'Cream', 'كريم', '50 gm', '1', NULL, 'massage cream for fast relief from pain.', NULL, NULL, 1707, '2022-07-05', 0, 'Key additive in many skin-care products for the treatment of acne, psoriasis, callouses, corns, keratosis pilaris and warts.', 'Salicylic acid directly irreversibly inhibits COX-1 and COX-2 to decrease conversion of arachidonic acid to precursors of prostaglandins and thromboxanes. Salicylate''s use in rheumatic diseases is due to it''s analgesic and anti-inflammatory activity. Salicylic acid is a key ingredient in many skin-care products for the treatment of acne, psoriasis, calluses, corns, keratosis pilaris, and warts. Salicylic acid allows cells of the epidermis to more readily slough off. Because of its effect on skin cells, salicylic acid is used in several shampoos used to treat dandruff. Salicylic acid is also used as an active ingredient in gels which remove verrucas (plantar warts). Salicylic acid competitively inhibits oxidation of uridine-5-diphosphoglucose (UDPG) with nicotinamide adenosine dinucleotide (NAD) and noncompetitively with UDPG. It also competitively inhibits the transferring of the glucuronyl group of uridine-5-phosphoglucuronic acid (UDPGA) to a phenolic acceptor. Inhibition of mucopoly saccharide synthesis is likely responsible for the slowing of wound healing with salicylates.', 'Salicylic acid treats acne by causing skin cells to slough off more readily, preventing pores from clogging up. This effect on skin cells also makes salicylic acid an active ingredient in several shampoos meant to treat dandruff. Use of straight salicylic solution may cause hyperpigmentation on unpretreated skin for those with darker skin types (Fitzpatrick phototypes IV, V, VI), as well as with the lack of use of a broad spectrum sunblock. Subsalicylate in combination with bismuth form the popular stomach relief aid known commonly as Pepto-Bismol. When combined the two key ingredients help control diarrhea, nausea, heartburn, and even gas. It is also very mildly anti-biotic.', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23181, 'Myocool cream 100 gm', 'ميوكول كريم 100 جرام', '125', '105', 'Massage', 'Winter green oil+peppermint oil+silicon oil+cetyl alcohol+propyl paraben+petrolium jelly+stearic aci', 'Leader cosmetics > purex health care', 'Cream', 'كريم', '100 gm', '1', NULL, 'indications * osteoarthritis * rheumatoid arthritis * chronic low back pain * chronic musculoskeletal disorders mode of action myocool cream as a treatment for arthritis& joint and muscle pain through containing topical glucosamine and chondroitin sulphat', '6224001085017', NULL, 4057, '2025-03-09', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23182, 'Levopride 25 mg 30 tabs', 'ليفوبرايد 25مجم 30 قرص', '84', '54', 'Antipsychotics', 'Levosulpiride', 'Penta pharma', 'Tab', 'أقراص', '25 mg', '3', NULL, NULL, NULL, NULL, 1685, '2025-08-23', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23184, 'Myodonia 50 mg 30 f.c. tabs', 'مايودونيا 50مجم 30 قرص', '60', NULL, 'Psychiatric.antidepressants', 'Milnacipran hydrochloride', 'Amoun', 'Tab', 'أقراص', '50 mg', '3', NULL, 'milnacipran is a serotonin-norepinephrine reuptake inhibitor (snri). exactly how milnacipran works to treat fibromyalgia is not known. it may work by restoring the balance of certain natural substances in the brain (serotonin and norepinephrine).', '6221025036643', NULL, 1052, '2022-07-07', 0, 'Milnacipran is a selective serotonin and norepinephrine reuptake inhibitor (SNRI) indicated for the management of fibromyalgia in patients that are 18 years old or above [F3925]. 



While milnacipran may be used for the treatment of major depressive disorder (MDD), it is only recommended in adult patients who are 18 years old or above [F3922] due to an increased risk for suicidal ideation, thinking, and behavior in children, adolescents, and young adults taking antidepressants for major depressive disorder (MDD) and other psychiatric disorders. Some regional prescribing information notes that the use of the medication is specifically for the short-term symptomatic relief of MDD [F3919]. Nevertheless, it is important to note that the regulatory approval of and/or indications listed here for milnacipran may or may not exist and/or vary greatly between regions and nations [F3928, F3934].', 'The dual ability for milnacipran to inhibit the reuptake of both serotonin (5HT) and norepinephrine (NE) facilitates its treatment of both fibromyalgia and major depressive disorder (MDD).



In particular, it is generally believed that 5HT and NE participate in the modulation of endogenous analgesic mechanisms by way of the descending inhibitory pain pathways in the brain and spinal cord [A175759, A175843, A175846]. Although the specific mechanism of action remains unclear, some studies have proposed that low levels of 5HT may be associated with increased sensitivity to pain - a condition that could subsequently be improved by milnacipran''s capacity to enhance the presence of 5HT by inhibiting its reuptake via serotonin transporters at synaptic clefts [A175846, F3937, L5659]. Furthermore, in the CNS it is also generally believed that NE released from descending pathways can mitigate pain sensations via eliciting inhibitory effects on alpha-2A-adrenoceptors on central terminals of primary afferent nociceptors, by direct alpha-2-adrenergic action on pain-relay neurons, and by alpha-1-adrenoceptor-mediated activation of inhibitory interneurons [A175843]. Such NE pain mitigation is consequently also enhanced by milnacipran''s ability to enhance the presence of NE by inhibiting its reuptake via norepinephrine transporters at synaptic clefts [F3937].



Concurrently, milnacipran''s capacity to inhibit the reuptake of both 5HT and NE also facilitates its treatment of MDD. Given the monoamine hypothesis'' assertion that decreased 5HT can be associated with anxiety, obsessions, compulsions, and decreased NE can result in lowered alertness, energy, attention, and general interest in life, it is proposed that milnacipran''s basic activities as a serotonin and norepinephrine reuptake inhibitor could assist in treating such symptoms of MDD by increasing the presence of both 5HT and NE in the body by inhibiting their reuptake [A175840]. ', 'When utilized to treat fibromyalgia, the effect of milnacipran on the QTcF interval in patients was measured in a double-blind placebo-and positive-controlled parallel study in 88 healthy subjects using three to six times the recommended therapeutic dose for fibromyalgia at 600 mg/day [F3925]. After baseline and placebo adjustment, the maximum mean QTcF change was 8 ms - an increase that is generally not considered to be clinically significant [F3925].



Conversely, when used for treating major depressive disorder (MDD), non-clinical studies have shown that levomilnacipran binds with high affinity to the norepinephrine (NE) and serotonin (5-HT) transporters (Ki = 71-91 nM and 11 nM respectively at human transporters) [F3919, F3922, F3925]. Levomilnacipran inhibits the uptake of both NE and 5-HT in vitro and in vivo; preferentially inhibiting reuptake of NE over 5-HT by approximately 2-fold [F3919, F3922, F3925]. Levomilnacipran does not directly affect the uptake of dopamine or other neurotransmitters [F3919, F3922, F3925]. Levomilnacipran has no significant affinity for serotonergic (5-HT1-7), α- and β-adrenergic, muscarinic (M1-5), histamine (H1-4), dopamine (D1-5), opiate, benzodiazepine, and γ-aminobutyric acid (GABA) receptors in vitro [F3919, F3922]. Levomilnacipran has no significant affinity for Ca++, K+, Na+, and Cl– channels and does not inhibit the activity of human monoamine oxidases (MAO-A and MAO-B) or acetylcholinesterase [F3919, F3922, F3925].



Moreover, in ECG studies with levomilnacipran used to treat MDD, although no clinically significant changes in QTcF interval (QTcF=QT/RR0.33) were noted, it appears that the agent can cause increases in heart rate and blood pressure [F3919]. In particular, it appears that the maximum therapeutic dose of levomilnacipran at 120 mg/day is capable of causing a maximum mean difference in heart rate from placebo of 20.2 bpm and a mean difference in systolic and diastolic blood pressure from placebo ranging from 3.8 to 7.2 mmHg and 6.1 to 8.1 mmHg, respectively [F3919]. Alternatively, a supratherapeutic dose of 300 mg/day is capable of causing a maximum mean difference in heart rate from placebo of 22.1 bpm and a mean difference in systolic and diastolic blood pressure from placebo ranging from 5.4 to 7.9 mmHg and 7.9 to 10.6 mmHg, respectively [F3919].', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23191, 'Myogrel plus 75/75mg 30 f.c. tab', 'ميو جريل بلاس 75/75مجم 30 قرص', '207', '147', 'Antiplatelet.adp receptor blocker', 'Clopidogrel+acetylsalicylic acid', 'Adwia', 'Tab', 'أقراص', '75mg', '3', 'مضاد للتجلط -- الحفاظ علي صحة القلب -- علاج الجلطات التي تتكون في الجسم -- الحفاظ علي سيولة الدورة الدموية', NULL, '6223002978489', NULL, 1818, '2025-03-12', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23192, 'Myolastan 50mg 20 coated tab.', 'ميولاستان 50مجم 20 اقراص', '22', NULL, 'Psychiatric.anxiolytics-hypnotics', 'Tetrazepam', 'Global napi pharmaceuticals > sanofi', 'Tab', 'أقراص', '50mg', '2', NULL, NULL, '6223002140718', NULL, 1064, '2022-07-24', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23194, 'Myoldin 4mg 20 tab.', 'ميولدين 4مجم 20 قرص', '16', NULL, 'Cns.analgesic.skeletal muscle relaxant.alpha2 agonist', 'Tizanidine', 'Sigma', 'Tab', 'أقراص', '4mg', '2', NULL, 'about tizanidine a centrally acting a-2 adrenergic agonist centrally acting muscle relaxant (short-acting). mechanism of action of tizanidine this drug is a centrally acting alpha2 agonist at alpha2-adrenergic receptor sites and presumably reduces spastic', '6221051012390', NULL, 1054, '2022-12-06', 0, 'Tizanidine is indicated for the relief of muscle spasticity, which can interfere with daily activities.  The general recommendation is to reserve tizanidine use for periods of time when there is a particular need for relief, as it has a short duration of action [FDA label, F4471]. ', 'Tizanidine reduces spasticity by causing presynaptic inhibition of motor neurons via agonist actions at Alpha-2 adrenergic receptor sites.

This drug is centrally acting and leads to a reduction in the release of excitatory amino acids like glutamate and aspartate, which cause neuronal firing that leads to muscle spasm. The above reduction and excitatory neurotransmitter release results in presynaptic inhibition of motor neurons. The strongest effect of tizanidine has been shown to occur on spinal polysynaptic pathways.   The anti-nociceptive and anticonvulsant activities of tizanidine may also be attributed to agonist action on Alpha-2 receptors.  Tizanidine also binds with weaker affinity to the Alpha-1 receptors, explaining its slight and temporary effect on the cardiovascular system [T574]. ', '**A note on spasticity**



Spasticity is an increase in muscle accompanied by uncontrolled, repetitive contractions of skeletal muscles which are involuntary.

The patient suffering from muscle spasticity may have reduced mobility and high levels of pain, contributing to poor quality of life and problems performing activities of personal hygiene and care [A177640]. 



**General effects**



Tizanidine is a rapidly acting drug used for the relief of muscle spasticity when it is required for performing specific activities. It acts as an agonist at Alpha-2 adrenergic receptor sites and relieves symptoms of muscle spasticity, allowing the continuation of normal daily activities. In animal models, tizanidine has not been shown to exert direct effects on skeletal muscle fibers or the neuromuscular junction, and has shown no significant effect on monosynaptic spinal reflexes (consisting of the communication between only 1 sensory neuron and 1 motor neuron) [L6064]. The frequency of muscle spasm and clonus are shown to be decreased by tizanidine [T574]. Tizanidine shows a stronger action on polysynaptic reflexes, which involve several interneurons (relay neurons) communicating with motor neurons stimulating muscle movement [L6064].



**Effects on blood pressure and heart rate**



This drug decreases heart rate and blood pressure in humans [A177559, A177589].  Despite this, rebound hypertension and tachycardia along with increased spasticity can occur when tizanidine is abruptly discontinued [A177643]. ', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23195, 'Myoleptin cla 1000 mg 90 softgels (illegal import)', 'ميولبتين كلا 1000مجم 90 كبسول', '0', NULL, NULL, 'Myoleptin cla(conjugated linoleic acid)', 'Puritans pride', 'Gel', 'جل', '1000 mg', '1', NULL, 'cla (conjugated linoleic acid) supports a healthy body composition** derived from safflower oil cla supports your dieting goals** rapid release softgels are formulated for quick release into your system use with a reduced calorie diet and daily exercise p', NULL, NULL, 651, '2022-07-13', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23196, 'Myoleptin cla 1500 mg 90 softgels (illegal import)', 'ميولبتين كلا 1500مجم 90 كبسول', '0', NULL, NULL, 'Myoleptin cla(conjugated linoleic acid)', 'Puritans pride', 'Gel', 'جل', '1500 mg', '1', NULL, 'cla (conjugated linoleic acid) supports a healthy body composition** derived from safflower oil cla supports your dieting goals** rapid release softgels are formulated for quick release into your system extra strength formula is 50% stronger compared to o', NULL, NULL, 679, '2022-07-22', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23197, 'Myoleptin cla extreme 104 softgels (illegal import)', 'ميولبتين كلا اكستريم 104 كبسول', '0', NULL, NULL, 'Myoleptin cla+caffeine+green tea ext.+cocoa ext.+guarana ext.+l-carnitine fumarate+hoodia gordonil', 'Puritans pride', 'Gel', 'جل', NULL, '1', NULL, 'myoleptinï- cla is a form of conjugated linoleic acid produced from safflower oil. maximum thermogenesis with added synergistic ingredients.** used for metabolism support energy production and weight management goals.** cla is best known for supporting a', NULL, NULL, 681, '2022-07-15', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23198, 'Myolgin 250/300mg 20 caps.', 'ميولجين 250/300مجم 20 كبسولة', '16', NULL, 'Muscle relaxant', 'Chlorzoxazone+paracetamol(acetaminophen)', 'Glaxo smithkline', 'Cap', 'كبسولة', '300mg', '2', NULL, NULL, '6221045009696', NULL, 4489, '2022-07-07', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23199, 'Myonil 10 sachet', 'ميونيل 10 اكياس', '220', '150', 'Healthy for joints', 'Collagen+vitamin c+multi vitamin', 'Nutrixia > infnil', 'Sachet', 'أكياس', NULL, '1', 'علاج حالات الخشونة -- علاج التهاب المفاصل -- للحفاظ على سلامة وصحة العظام والمفاصل', 'powder', NULL, NULL, 4575, '2025-08-20', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23200, 'Myoprox 250mg 20 f.c.tab.', 'ميوبروكس 250مجم 20 قرص', '11', NULL, 'Nsaid.propionic acid derivatives', 'Naproxen', 'El-obour', 'Tab', 'أقراص', '250mg', '2', NULL, 'about naproxen nsaid 2-arylpropionic acid (profen) derivative analgesic anti-inflammatory antipyretic. mechanism of action of naproxen naproxen has analgesic anti-inflammatory and antipyretic action. it acts by inhibiting prostaglandin (pgs) synthesis and', '6221077584246', NULL, 957, '2023-01-14', 0, 'Naproxen is indicated for the management of rheumatoid arthritis, osteoarthritis, ankylosing spondylitis, polyarticular juvenile idiopathic arthritis, tendinitis, bursitis, acute gout, primary dysmenorrhea, and for the relief of mild to moderate pain.[L6582][L6583][A178975] Further, it is first-line therapy for osteoarthritis, acute gouty arthritis, dysmenorrhea, and musculoskeletal inflammation and pain.[A178975]', 'As with other non-selective NSAIDs, naproxen exerts it''s clinical effects by blocking COX-1 and COX-2 enzymes leading to decreased prostaglandin synthesis.[A178975] Although both enzymes contribute to prostaglandin production, they have unique functional differences.[A178975] The COX-1 enzymes is constitutively active and can be found in normal tissues such as the stomach lining, while the COX-2 enzyme is inducible and produces prostaglandins that mediate pain, fever and inflammation.[A178990] The COX-2 enzyme mediates the desired antipyretic, analgesic and anti-inflammatory properties offered by Naproxen, while undesired adverse effects such as gastrointestinal upset and renal toxicities are linked to the COX-1 enzyme.[A178990]', 'Naproxen is an established non-selective NSAID and is useful as an analgesic, anti-inflammatory and antipyretic.[A179098] Similar to other NSAIDs, the pharmacological activity of naproxen can be attributed to the inhibition of cyclo-oxygenase, which in turn reduces prostaglandin synthesis in various tissues and fluids including the synovial fluid, gastric mucosa, and the blood.[A179098] 



Although naproxen is an effective analgesic, it can have unintended deleterious effects in the patient. For instance, naproxen can adversely affect blood pressure control.[A179224] A study found that use of naproxen induced an increase in blood pressure, although the increase was not as significant as that found with ibuprofen use.[A179224]



Further, studies have found that the risk of upper gastrointestinal bleeding is on average four-fold higher for individuals taking NSAIDs.[A179227] Other factors that increase the risk of upper gastrointestinal bleeding include concurrent use of corticosteroids or anticoagulants, and a history of gastrointestinal ulcers.[A179227]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23201, 'Myorel cream 50 gm', 'ميوريل كريم 50جم', '70', '45', 'Massage cream', 'Methyl salicylate+turpentine oil+peppermint oil+peanut oil+eucalyptus oil+clove ext.+stearic acid+mineral oil', 'Leader cosmetics > original pharma', 'Cream', 'كريم', '50 gm', '1', NULL, 'massage cream', '6518868477', NULL, 1476, '2025-09-10', 0, 'For topical use, in combination with 570 to 670 nm wavelength red light illumination, in the treatment of non-hyperkeratotic actinic keratoses of the face and scalp in immunocompetent patients when used in conjunction with lesion preparation (debridement using a sharp dermal curette).', 'Photosensitization following application of methyl aminolevulinate cream occurs through the metabolic conversion of methyl aminolevulinate (prodrug) to photoactive porphyrins (PAP), which accumulates in the skin lesions to which the cream has been applied. When exposed to light of appropriate wavelength and energy, the accumulated photoactive porphyrins produce a photodynamic reaction, resulting in a cytotoxic process dependent upon the simultaneous presence of oxygen. The absorption of light results in an excited state of porphyrin molecules, and subsequent spin transfer from photoactive porphyrins to molecular oxygen generates singlet oxygen, which can further react to form superoxide and hydroxyl radicals.', 'After topical application of methyl aminolevulinate, porphyrins will accumulate intracellularly in the treated skin lesions. The intracellular porphyrins (including PpIX) are photoactive, fluorescing compounds and, upon light activation in the presence of oxygen, singlet oxygen is formed which causes damage to cellular compartments, in particular the mitochondria. Light activation of accumulated porphyrins leads to a photochemical reaction and thereby phototoxicity to the light-exposed target cells.', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23202, 'Myorel spray 60ml', 'ميوريل سبراي 60 مل', '65', '40', 'Massage spray', 'Silicone oil+onion extract+calendula extract+allantoin+retinol+dimethicone', 'Leader > original pharma', 'Spray', 'بخاخ', '60ml', '1', NULL, 'massage cream', '6224010525795', NULL, 809, '2025-11-16', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23203, 'Myorelax 10 caps.', 'ميوريلاكس 10 كبسولات', '5', NULL, 'Muscle relaxant', 'Carisoprodol+paracetamol(acetaminophen)', 'Amoun', 'Cap', 'كبسولة', NULL, '1', 'باسط للعضلات.', NULL, '6221025009432', NULL, 1428, '2022-12-06', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23204, 'Myrin 100 mg 30 tabs', 'ميرين 100مجم 30 قرص', '4,975', NULL, 'Immunosuppressants', 'Thalidomide', 'Lipomed ag > egyptian pharmaceutical trading company', 'Tab', 'أقراص', '100 mg', '3', 'يعمل علي تقليل المناعة في حالات زراعة الأعضاء ليجعل الجسم يتقبل العضو الجديد', NULL, NULL, NULL, 1142, '2022-04-10', 0, 'Thalidomide is primarily used for the acute treatment and maintenance therapy to prevent and suppress the cutaneous manifestations of moderate to severe erythema nodosum leprosum (ENL).[L41235]  ', 'The mechanism of action of thalidomide is not fully understood. Previous research indicate that thalidomide binds to cerebron, a component of the E3 ubiquitin ligase complex, to selectively degrade the transcription factor IKZF3 and IKZF1. These 2 transcription factors are vital for the proliferation and survival of malignant myeloma cells. [A246125] 



Regarding TNF-alpha, thalidomide seems to block this mediator via a variety of mechanism. Thalidomide can inhibit the expression myeloid differentiating factor 88 (MyD88), an adaptor protein that is involved in the TNF-alpha production signalling pathway, at the protein and RNA level. Additionally, thalidomide prevents the activation of Nuclear Factor Kappa B (NF-kB), another upstream effector of the TNF-alpha production pathway. Finally, some evidences suggest that thalidomide can block alpha-1 acid glycoprotein (AGP), a known inducer of the NF-kB/MyD88 pathway, thus inhibiting the expression of TNF-alpha [A246195]. The down-regulation of NF-kB and MyD88 can also affect the cross talk between the NF-kB/MyD88 and VEGF pathway, resulting in thalidomide''s anti-angiogenic effect. [A246200]', 'Thalidomide, originally developed as a sedative, is an immunomodulatory and anti-inflammatory agent with a spectrum of activity that is not fully characterized. However, thalidomide is believed to exert its effect through inhibiting and modulating the level of various inflammatory mediators, particularly tumor necrosis factor-alpha (TNF-a) and IL-6. [A714] Additionally, thalidomide is also shown to inhibit basic fibroblast growth factor (bFGF) and vascular endothelial growth factor (VEGF), suggesting a potential anti-angiogenic application of thalidomide in cancer patients. [A246185]



Thalidomide is racemic &mdash; it contains both left and right handed isomers in equal amounts: the (+)R enantiomer is effective against morning sickness, and the (&minus;)S enantiomer is teratogenic. The enantiomers are interconverted to each other in vivo; hence, administering only one enantiomer will not prevent the teratogenic effect in humans [A246190].', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23205, 'N.p plus cream 50 gm', 'ان بي بلس 50جم كريم', '60', '45', 'Moisturizing topicals', 'Panthenol+whey casein+honey+glycerin+olive oil+lanolin+paraffin oil', 'Hi-care > pixel pharmaceutical company', 'Cream', 'كريم', '50 gm', '1', NULL, 'for nipple fissures', '6224001661181', NULL, 1063, '2024-05-31', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23206, 'Nabutone 500mg 10 f.c. tab.', 'نابيوتون 500 مجم 10 قرص', '17', NULL, 'Nsaid.acetic acid derivatives', 'Nabumetone', 'October pharma > pharmagin-egypt', 'Tab', 'أقراص', '500mg', '1', NULL, 'about nabumetone nsaid arylalkanoic acid derivative analgesic anti-inflammatory. mechanism of action of nabumetone the parent compound is a prodrug which undergoes hepatic biotransformation to the active component 6-methoxy-2-naphthylacetic acid (6mna) th', '6221088010789', NULL, 715, '2022-12-06', 0, '**Indicated** for:[label]



1) Symptomatic relief in rheumatoid arthritis.



2) Symptomatic relief in osteoarthritis.', 'Nabumetone''s active metabolite, 6-MNA, is an inhibitor of both COX-1 and COX-2 although it exhibits some COX-2 selectivity.[label,A178903] Inhibition of COX-1 and COX-2 reduces conversion of arachidonic acid to PGs and thromboxane (TXA<sub>2</sub>). This reduction in prostanoid production is the common mechanism that mediates the effects of nambutone.



PGE<sub>2</sub> is the primary PG involved in modulation of nociception.[A179023] It mediates peripheral sensitization through a variety of effects.[T116,A179023] PGE<sub>2</sub> activates the G<sub>q</sub>-coupled EP<sub>1</sub> receptor leading to increased activity of the inositol trisphosphate/phospholipase C pathway. Activation of this pathway releases intracellular stores of calcium which directly reduces action potential threshold and activates protein kinase C (PKC) which contributes to several indirect mechanisms. PGE<sub>2</sub> also activates the EP<sub>4</sub> receptor, coupled to G<sub>s</sub>, which activates the adenylyl cyclase/protein kinase A (AC/PKA) signaling pathway. PKA and PKC both contribute to the potentiation of transient receptor potential cation channel subfamily V member 1 (TRPV1) potentiation, which increases sensitivity to heat stimuli. They also activate tetrodotoxin-resistant sodium channels and inhibit inward potassium currents. PKA further contributes to the activation of the P2X3 purine receptor and sensitization of T-type calcium channels. The activation and sensitization of depolarizing ion channels and inhibition of inward potassium currents serve to reduce the intensity of stimulus necessary to generate action potentials in nociceptive sensory afferents. PGE<sub>2</sub> act via EP<sub>3</sub> to increase sensitivity to bradykinin and via EP<sub>2</sub> to further increase heat sensitivity. Central sensitization occurs in the dorsal horn of the spinal cord and is mediated by the EP<sub>2</sub> receptor which couples to G<sub>s</sub>. Pre-synaptically, this receptor increases the release of pro-nociceptive neurotransmitters glutamate, CGRP, and substance P. Post-synaptically it increases the activity of AMPA and NMDA receptors and produces inhibition of inhibitory glycinergic neurons. Together these lead to a reduced threshold of activating, allowing low intensity stimuli to generate pain signals. PGI<sub>2</sub> is known to play a role via its G<sub>s</sub>-coupled IP receptor although the magnitude of its contribution varies. It has been proposed to be of greater importance in painful inflammatory conditions such as arthritis. By limiting sensitization, both peripheral and central, via these pathways NSAIDs can effectively reduce inflammatory pain.



PGI<sub>2</sub> and PGE<sub>2</sub> contribute to acute inflammation via their IP and EP<sub>2</sub> receptors.[T116,A179044] Similarly to β adrenergic receptors these are G<sub>s</sub>-coupled and mediate vasodilation through the AC/PKA pathway. PGE<sub>2</sub> also contributes by increasing leukocyte adhesion to the endothelium and attracts the cells to the site of injury.[T116] PGD<sub>2</sub> plays a role in the activation of endothelial cell release of cytokines through its DP<sub>1</sub> receptor.[A179044] PGI<sub>2</sub> and PGE<sub>2</sub> modulate T-helper cell activation and differentiation through IP, EP<sub>2</sub>, and EP<sub>4</sub> receptors which is believed to be an important activity in the pathology of arthritic conditions. By limiting the production of these PGs at the site of injury, NSAIDs can reduce inflammation.



PGE<sub>2</sub> can cross the blood-brain barrier and act on excitatory G<sub>q</sub> EP<sub>3</sub> receptors on thermoregulatory neurons in the hypothalamus.[T116] This activation triggers an increase in heat-generation and a reduction in heat-loss to produce a fever. NSAIDs prevent the generation of PGE<sub>2</sub> thereby reducing the activity of these neurons.



The adverse effects of NSAIDs stem from the protective and regulatory roles of prostanoids which have been well-characterized.[T116] PGI<sub>2</sub> and PGE<sub>2</sub> regulate blood flow to the kidney by similar mechanisms to the vasodilation they produce in inflammation. Prevention of this regulation by NSAIDs produces vasoconstriction which limits renal function by reducing blood flow and the hydrostatic pressure which drives filtration. PGE<sub>2</sub> also regulates gastric protection via EP<sub>3</sub> receptors which are, in this location, coupled to G<sub>i</sub> which inhibits the AC/PKA pathway. This reduces the secretion of protons by H<sup>+</sup>/K<sup>+</sup> ATPase in parietal cells and increases the secretion of mucus and HCO<sub>3</sub><sup>-</sup> by superficial endothelial cells. Disruption of this protective action by NSAIDs lead to ulceration of the gastric mucosa. Lastly, disruption of PGI<sub>2</sub>, which opposes platelet aggregation, generation by COX-2 selective agents leads to an imbalance with TXA<sub>2</sub> generated by COX-1, which promotes aggregation of platelets, leading to increased risk of thrombosis. Since nabumetone is somewhat COX-2 selective it is thought to promote this imbalance and increase thrombotic risk.[A178903]', 'NSAIDs, like nabumetone, are well established as analgesics. NSAIDs reduce both peripheral and central sensitization of nociceptive neurons due to inflammation which contribute to hyperalgesia and allodynia.[T116,A179023] This sensitization occurs through reducing the action potential threshold in peripheral neurons, reducing the intensity of painful stimuli needed to produce a painful sensation. Centrally, activation of dorsal horn neurons occurs along with increased release of glutamate, calcitonin gene-related peptide (CGRP), and substance P which increase the transmission of painful stimuli. Coupled with this is an inhibition glycinergic neurons which normally inhibit pain transmission, a phenomenon known as disinhibition. Increased activity ofn-methyl d-aspartate (NMDA) and α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors leads to the establishment of central sensitization, allowing both mild painful and innocuous stimuli to produce action potentials in nociceptive projection neurons. NSAIDs are effective in reducing mild-moderate acute and chronic nociceptive pain, however, the usefulness of NSAIDs in neuropathic pain is limited.



The anti-inflammatory effect of NSAIDs is mediated by preventing vasodilation, increases in vascular permeability, and the release of cytokines from endothelial cells.[T116,A179044] These three effects together prevent immunocompetent cells from migrating to the site of injury thereby preventing additional damage and inflammation due to activation of the immune system at the site of damage. PGs also modulate T-helper cell activation and differentiation, an activity which is thought to be of importance in arthritic conditions.



The anti-pyretic effect of NSAIDs is mediated through preventing increases in temperature by prostaglandins (PGs) via the hypothalamus.[T116] Activation of this process by other inflammatory mediators relies upon subsequent action by PGs, therefore NSAIDs are able to reduce fever due to these mediators as well.



The adverse effects of NSAIDs are related to their therapeutic effects.[T116] The same vasodilatory action which occurs in inflammation also serves to regulate blood flow to the kidneys through the afferent renal arteries. NSAIDs are widely known as nephrotoxic agents as the reduction in PGs produces vasoconstriction of these arteries resulting in reduced blood flow to the kidneys and a subsequent decline in renal function. Reductions in mucus and HCO<sub>3</sub><sup>-</sup> secretion in the stomach increases the risk of ulceration by limiting the protection mediated by PGs. Lastly, COX-2 selective agents like nabumetone can unbalance prothrombotic and antithrombotic prostanoid generation leading to increased platelet aggregation and increased risk of thrombosis.', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23207, 'Nabutone 750mg 5 f.c.tab.', 'نابيوتون 750مجم 5 اقراص', '7', NULL, 'Nsaid.acetic acid derivatives', 'Nabumetone', 'October pharma > pharmagin-egypt', 'Tab', 'أقراص', '750mg', '1', NULL, 'about nabumetone nsaid arylalkanoic acid derivative analgesic anti-inflammatory. mechanism of action of nabumetone the parent compound is a prodrug which undergoes hepatic biotransformation to the active component 6-methoxy-2-naphthylacetic acid (6mna) th', NULL, NULL, 746, '2022-08-23', 0, '**Indicated** for:[label]



1) Symptomatic relief in rheumatoid arthritis.



2) Symptomatic relief in osteoarthritis.', 'Nabumetone''s active metabolite, 6-MNA, is an inhibitor of both COX-1 and COX-2 although it exhibits some COX-2 selectivity.[label,A178903] Inhibition of COX-1 and COX-2 reduces conversion of arachidonic acid to PGs and thromboxane (TXA<sub>2</sub>). This reduction in prostanoid production is the common mechanism that mediates the effects of nambutone.



PGE<sub>2</sub> is the primary PG involved in modulation of nociception.[A179023] It mediates peripheral sensitization through a variety of effects.[T116,A179023] PGE<sub>2</sub> activates the G<sub>q</sub>-coupled EP<sub>1</sub> receptor leading to increased activity of the inositol trisphosphate/phospholipase C pathway. Activation of this pathway releases intracellular stores of calcium which directly reduces action potential threshold and activates protein kinase C (PKC) which contributes to several indirect mechanisms. PGE<sub>2</sub> also activates the EP<sub>4</sub> receptor, coupled to G<sub>s</sub>, which activates the adenylyl cyclase/protein kinase A (AC/PKA) signaling pathway. PKA and PKC both contribute to the potentiation of transient receptor potential cation channel subfamily V member 1 (TRPV1) potentiation, which increases sensitivity to heat stimuli. They also activate tetrodotoxin-resistant sodium channels and inhibit inward potassium currents. PKA further contributes to the activation of the P2X3 purine receptor and sensitization of T-type calcium channels. The activation and sensitization of depolarizing ion channels and inhibition of inward potassium currents serve to reduce the intensity of stimulus necessary to generate action potentials in nociceptive sensory afferents. PGE<sub>2</sub> act via EP<sub>3</sub> to increase sensitivity to bradykinin and via EP<sub>2</sub> to further increase heat sensitivity. Central sensitization occurs in the dorsal horn of the spinal cord and is mediated by the EP<sub>2</sub> receptor which couples to G<sub>s</sub>. Pre-synaptically, this receptor increases the release of pro-nociceptive neurotransmitters glutamate, CGRP, and substance P. Post-synaptically it increases the activity of AMPA and NMDA receptors and produces inhibition of inhibitory glycinergic neurons. Together these lead to a reduced threshold of activating, allowing low intensity stimuli to generate pain signals. PGI<sub>2</sub> is known to play a role via its G<sub>s</sub>-coupled IP receptor although the magnitude of its contribution varies. It has been proposed to be of greater importance in painful inflammatory conditions such as arthritis. By limiting sensitization, both peripheral and central, via these pathways NSAIDs can effectively reduce inflammatory pain.



PGI<sub>2</sub> and PGE<sub>2</sub> contribute to acute inflammation via their IP and EP<sub>2</sub> receptors.[T116,A179044] Similarly to β adrenergic receptors these are G<sub>s</sub>-coupled and mediate vasodilation through the AC/PKA pathway. PGE<sub>2</sub> also contributes by increasing leukocyte adhesion to the endothelium and attracts the cells to the site of injury.[T116] PGD<sub>2</sub> plays a role in the activation of endothelial cell release of cytokines through its DP<sub>1</sub> receptor.[A179044] PGI<sub>2</sub> and PGE<sub>2</sub> modulate T-helper cell activation and differentiation through IP, EP<sub>2</sub>, and EP<sub>4</sub> receptors which is believed to be an important activity in the pathology of arthritic conditions. By limiting the production of these PGs at the site of injury, NSAIDs can reduce inflammation.



PGE<sub>2</sub> can cross the blood-brain barrier and act on excitatory G<sub>q</sub> EP<sub>3</sub> receptors on thermoregulatory neurons in the hypothalamus.[T116] This activation triggers an increase in heat-generation and a reduction in heat-loss to produce a fever. NSAIDs prevent the generation of PGE<sub>2</sub> thereby reducing the activity of these neurons.



The adverse effects of NSAIDs stem from the protective and regulatory roles of prostanoids which have been well-characterized.[T116] PGI<sub>2</sub> and PGE<sub>2</sub> regulate blood flow to the kidney by similar mechanisms to the vasodilation they produce in inflammation. Prevention of this regulation by NSAIDs produces vasoconstriction which limits renal function by reducing blood flow and the hydrostatic pressure which drives filtration. PGE<sub>2</sub> also regulates gastric protection via EP<sub>3</sub> receptors which are, in this location, coupled to G<sub>i</sub> which inhibits the AC/PKA pathway. This reduces the secretion of protons by H<sup>+</sup>/K<sup>+</sup> ATPase in parietal cells and increases the secretion of mucus and HCO<sub>3</sub><sup>-</sup> by superficial endothelial cells. Disruption of this protective action by NSAIDs lead to ulceration of the gastric mucosa. Lastly, disruption of PGI<sub>2</sub>, which opposes platelet aggregation, generation by COX-2 selective agents leads to an imbalance with TXA<sub>2</sub> generated by COX-1, which promotes aggregation of platelets, leading to increased risk of thrombosis. Since nabumetone is somewhat COX-2 selective it is thought to promote this imbalance and increase thrombotic risk.[A178903]', 'NSAIDs, like nabumetone, are well established as analgesics. NSAIDs reduce both peripheral and central sensitization of nociceptive neurons due to inflammation which contribute to hyperalgesia and allodynia.[T116,A179023] This sensitization occurs through reducing the action potential threshold in peripheral neurons, reducing the intensity of painful stimuli needed to produce a painful sensation. Centrally, activation of dorsal horn neurons occurs along with increased release of glutamate, calcitonin gene-related peptide (CGRP), and substance P which increase the transmission of painful stimuli. Coupled with this is an inhibition glycinergic neurons which normally inhibit pain transmission, a phenomenon known as disinhibition. Increased activity ofn-methyl d-aspartate (NMDA) and α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors leads to the establishment of central sensitization, allowing both mild painful and innocuous stimuli to produce action potentials in nociceptive projection neurons. NSAIDs are effective in reducing mild-moderate acute and chronic nociceptive pain, however, the usefulness of NSAIDs in neuropathic pain is limited.



The anti-inflammatory effect of NSAIDs is mediated by preventing vasodilation, increases in vascular permeability, and the release of cytokines from endothelial cells.[T116,A179044] These three effects together prevent immunocompetent cells from migrating to the site of injury thereby preventing additional damage and inflammation due to activation of the immune system at the site of damage. PGs also modulate T-helper cell activation and differentiation, an activity which is thought to be of importance in arthritic conditions.



The anti-pyretic effect of NSAIDs is mediated through preventing increases in temperature by prostaglandins (PGs) via the hypothalamus.[T116] Activation of this process by other inflammatory mediators relies upon subsequent action by PGs, therefore NSAIDs are able to reduce fever due to these mediators as well.



The adverse effects of NSAIDs are related to their therapeutic effects.[T116] The same vasodilatory action which occurs in inflammation also serves to regulate blood flow to the kidneys through the afferent renal arteries. NSAIDs are widely known as nephrotoxic agents as the reduction in PGs produces vasoconstriction of these arteries resulting in reduced blood flow to the kidneys and a subsequent decline in renal function. Reductions in mucus and HCO<sub>3</sub><sup>-</sup> secretion in the stomach increases the risk of ulceration by limiting the protection mediated by PGs. Lastly, COX-2 selective agents like nabumetone can unbalance prothrombotic and antithrombotic prostanoid generation leading to increased platelet aggregation and increased risk of thrombosis.', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23208, 'Nabuxan 500mg 20 coated tab.', 'نابوكسان 500مجم 20 اقراص', '18', NULL, 'Nsaid.acetic acid derivatives', 'Nabumetone', 'Unipharma co.', 'Tab', 'أقراص', '500mg', '2', NULL, 'about nabumetone nsaid arylalkanoic acid derivative analgesic anti-inflammatory. mechanism of action of nabumetone the parent compound is a prodrug which undergoes hepatic biotransformation to the active component 6-methoxy-2-naphthylacetic acid (6mna) th', '6221507010048', NULL, 696, '2022-12-06', 0, '**Indicated** for:[label]



1) Symptomatic relief in rheumatoid arthritis.



2) Symptomatic relief in osteoarthritis.', 'Nabumetone''s active metabolite, 6-MNA, is an inhibitor of both COX-1 and COX-2 although it exhibits some COX-2 selectivity.[label,A178903] Inhibition of COX-1 and COX-2 reduces conversion of arachidonic acid to PGs and thromboxane (TXA<sub>2</sub>). This reduction in prostanoid production is the common mechanism that mediates the effects of nambutone.



PGE<sub>2</sub> is the primary PG involved in modulation of nociception.[A179023] It mediates peripheral sensitization through a variety of effects.[T116,A179023] PGE<sub>2</sub> activates the G<sub>q</sub>-coupled EP<sub>1</sub> receptor leading to increased activity of the inositol trisphosphate/phospholipase C pathway. Activation of this pathway releases intracellular stores of calcium which directly reduces action potential threshold and activates protein kinase C (PKC) which contributes to several indirect mechanisms. PGE<sub>2</sub> also activates the EP<sub>4</sub> receptor, coupled to G<sub>s</sub>, which activates the adenylyl cyclase/protein kinase A (AC/PKA) signaling pathway. PKA and PKC both contribute to the potentiation of transient receptor potential cation channel subfamily V member 1 (TRPV1) potentiation, which increases sensitivity to heat stimuli. They also activate tetrodotoxin-resistant sodium channels and inhibit inward potassium currents. PKA further contributes to the activation of the P2X3 purine receptor and sensitization of T-type calcium channels. The activation and sensitization of depolarizing ion channels and inhibition of inward potassium currents serve to reduce the intensity of stimulus necessary to generate action potentials in nociceptive sensory afferents. PGE<sub>2</sub> act via EP<sub>3</sub> to increase sensitivity to bradykinin and via EP<sub>2</sub> to further increase heat sensitivity. Central sensitization occurs in the dorsal horn of the spinal cord and is mediated by the EP<sub>2</sub> receptor which couples to G<sub>s</sub>. Pre-synaptically, this receptor increases the release of pro-nociceptive neurotransmitters glutamate, CGRP, and substance P. Post-synaptically it increases the activity of AMPA and NMDA receptors and produces inhibition of inhibitory glycinergic neurons. Together these lead to a reduced threshold of activating, allowing low intensity stimuli to generate pain signals. PGI<sub>2</sub> is known to play a role via its G<sub>s</sub>-coupled IP receptor although the magnitude of its contribution varies. It has been proposed to be of greater importance in painful inflammatory conditions such as arthritis. By limiting sensitization, both peripheral and central, via these pathways NSAIDs can effectively reduce inflammatory pain.



PGI<sub>2</sub> and PGE<sub>2</sub> contribute to acute inflammation via their IP and EP<sub>2</sub> receptors.[T116,A179044] Similarly to β adrenergic receptors these are G<sub>s</sub>-coupled and mediate vasodilation through the AC/PKA pathway. PGE<sub>2</sub> also contributes by increasing leukocyte adhesion to the endothelium and attracts the cells to the site of injury.[T116] PGD<sub>2</sub> plays a role in the activation of endothelial cell release of cytokines through its DP<sub>1</sub> receptor.[A179044] PGI<sub>2</sub> and PGE<sub>2</sub> modulate T-helper cell activation and differentiation through IP, EP<sub>2</sub>, and EP<sub>4</sub> receptors which is believed to be an important activity in the pathology of arthritic conditions. By limiting the production of these PGs at the site of injury, NSAIDs can reduce inflammation.



PGE<sub>2</sub> can cross the blood-brain barrier and act on excitatory G<sub>q</sub> EP<sub>3</sub> receptors on thermoregulatory neurons in the hypothalamus.[T116] This activation triggers an increase in heat-generation and a reduction in heat-loss to produce a fever. NSAIDs prevent the generation of PGE<sub>2</sub> thereby reducing the activity of these neurons.



The adverse effects of NSAIDs stem from the protective and regulatory roles of prostanoids which have been well-characterized.[T116] PGI<sub>2</sub> and PGE<sub>2</sub> regulate blood flow to the kidney by similar mechanisms to the vasodilation they produce in inflammation. Prevention of this regulation by NSAIDs produces vasoconstriction which limits renal function by reducing blood flow and the hydrostatic pressure which drives filtration. PGE<sub>2</sub> also regulates gastric protection via EP<sub>3</sub> receptors which are, in this location, coupled to G<sub>i</sub> which inhibits the AC/PKA pathway. This reduces the secretion of protons by H<sup>+</sup>/K<sup>+</sup> ATPase in parietal cells and increases the secretion of mucus and HCO<sub>3</sub><sup>-</sup> by superficial endothelial cells. Disruption of this protective action by NSAIDs lead to ulceration of the gastric mucosa. Lastly, disruption of PGI<sub>2</sub>, which opposes platelet aggregation, generation by COX-2 selective agents leads to an imbalance with TXA<sub>2</sub> generated by COX-1, which promotes aggregation of platelets, leading to increased risk of thrombosis. Since nabumetone is somewhat COX-2 selective it is thought to promote this imbalance and increase thrombotic risk.[A178903]', 'NSAIDs, like nabumetone, are well established as analgesics. NSAIDs reduce both peripheral and central sensitization of nociceptive neurons due to inflammation which contribute to hyperalgesia and allodynia.[T116,A179023] This sensitization occurs through reducing the action potential threshold in peripheral neurons, reducing the intensity of painful stimuli needed to produce a painful sensation. Centrally, activation of dorsal horn neurons occurs along with increased release of glutamate, calcitonin gene-related peptide (CGRP), and substance P which increase the transmission of painful stimuli. Coupled with this is an inhibition glycinergic neurons which normally inhibit pain transmission, a phenomenon known as disinhibition. Increased activity ofn-methyl d-aspartate (NMDA) and α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors leads to the establishment of central sensitization, allowing both mild painful and innocuous stimuli to produce action potentials in nociceptive projection neurons. NSAIDs are effective in reducing mild-moderate acute and chronic nociceptive pain, however, the usefulness of NSAIDs in neuropathic pain is limited.



The anti-inflammatory effect of NSAIDs is mediated by preventing vasodilation, increases in vascular permeability, and the release of cytokines from endothelial cells.[T116,A179044] These three effects together prevent immunocompetent cells from migrating to the site of injury thereby preventing additional damage and inflammation due to activation of the immune system at the site of damage. PGs also modulate T-helper cell activation and differentiation, an activity which is thought to be of importance in arthritic conditions.



The anti-pyretic effect of NSAIDs is mediated through preventing increases in temperature by prostaglandins (PGs) via the hypothalamus.[T116] Activation of this process by other inflammatory mediators relies upon subsequent action by PGs, therefore NSAIDs are able to reduce fever due to these mediators as well.



The adverse effects of NSAIDs are related to their therapeutic effects.[T116] The same vasodilatory action which occurs in inflammation also serves to regulate blood flow to the kidneys through the afferent renal arteries. NSAIDs are widely known as nephrotoxic agents as the reduction in PGs produces vasoconstriction of these arteries resulting in reduced blood flow to the kidneys and a subsequent decline in renal function. Reductions in mucus and HCO<sub>3</sub><sup>-</sup> secretion in the stomach increases the risk of ulceration by limiting the protection mediated by PGs. Lastly, COX-2 selective agents like nabumetone can unbalance prothrombotic and antithrombotic prostanoid generation leading to increased platelet aggregation and increased risk of thrombosis.', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23211, 'Nactalia premature milk 400 gm', 'نكتاليا بريماتيور لبن اطفال 400 جم', '290', '265', 'Milk products.prematue milk formula', 'Premature milk formula', 'Nutribio > interpharma', 'Unknown', 'غير محدد', '400 gm', '1', NULL, 'specially formulated for preterm and low birth weight infants. it could be discontinued under medical advice after a weight of 3 kgm has been reached or until 2 months corrected age. to be used within one month from opening.', '3575410872389', NULL, 1325, '2025-08-02', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23212, 'Nadina soap 100 gm', 'نادينا صابون 100 جم', '15', NULL, 'Soap', 'Kojic acid+vitamin e+zinc oxide+titanium dioxide+liquorice extract+vitamin c+glycerin+chamomile', 'Hi-care > innova pharma', 'Soap', 'صابون', '100 gm', '1', NULL, 'skin smoothing & emollient soap', NULL, NULL, 928, '2022-08-01', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23213, 'Nadvulg 1% topical cream 25 gm', 'نادفولج 1% كريم 25جم', '35', NULL, 'Antibiotic.quinolone', 'Nadifloxacin', 'Egpi > quadra pharm', 'Cream', 'كريم', '1%', '1', NULL, 'nadifloxacin is a topical fluoroquinolone antibiotic for the treatment of acne vulgaris. it is also used to treat bacterial skin infections. nadifloxacin inhibits the enzyme dna gyrase that is involved in bacterial dna synthesis and replication thus inhib', NULL, NULL, 747, '2022-08-04', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23214, 'Nafenira eye drops 15 ml', 'نافينيرا قطرة للعين 15 مل', '8', NULL, 'Corneal vascularity.antihistamine combined with alpha 1 agonist', 'Naphazoline+pheniramine', 'Chemipharm', 'Drops', 'نقط', '15 ml', '1', 'علاج حساسية العين -- تقليل إحتقان العين -- علاج إحمرار العين و تهيجه.', 'about naphazoline imidazoline derivative alpha-adrenergic agonist a decongestant vasoconstrictor. mechanism of action of naphazoline naphazoline exerts its vasoconstrictor action by acting as a selective alpha-1 adrenergic agonist. thus it reduces blood f', NULL, NULL, 1629, '2022-06-02', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23215, 'Naftidur 200mg 20 caps.', 'نافتيدور 200مجم 20 كبسولة', '40', NULL, 'Anti-ischemic', 'Naftidrofuryl', 'International drug agency (idi) > novell pharma', 'Cap', 'كبسولة', '200mg', '2', NULL, NULL, '6223004070617', NULL, 1976, '2022-08-23', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23216, 'Naglovic 750 mg 10 f.c.tabs.', 'ناجلوفيك 750مجم 10 اقراص', '74', '50', 'Antibiotic.quinolone', 'Levofloxacin', 'Jedco int. co. for pharmaceuticals > elrazy pharmaceuticals-egypt', 'Tab', 'أقراص', '750 mg', '1', 'مضاد حيوي.', 'about levofloxacin third generation fluoroquinolone (or quinolone) a broad spectrum antiinfective. mechanism of action of levofloxacin levofloxacin is a broad spectrum antibacterial agent. it act by inhibiting the enzyme dna gyrase (topoisomerase 2) and t', NULL, NULL, 1555, '2025-05-14', 0, 'In oral and intravenous formulations, levofloxacin is indicated in adults for the treatment of various infections caused by susceptible bacteria, including infections of the upper respiratory tract, lower respiratory tract, skin, skin structures, urinary tract, and prostate.[L11638,L11692] The oral formulation is also indicated in both adults and children 6 months of age and older for the post-exposure management of inhalational anthrax caused by _Bacillus anthracis_ and for the treatment and/or prophylaxis of plague caused by _Yersinia pestis_.[L11638]



In its ophthalmic formulation, levofloxacin is indicated for the treatment of bacterial conjunctivitis caused by susceptible organisms.[L11641] An inhalational solution available in Canada is indicated for the management of cystic fibrosis patients aged 18 years or older with chronic pulmonary _Pseudomonas aeruginosa_ infections.[L11689]', 'Levofloxacin, like other fluoroquinolone antibiotics, exerts its antimicrobial activity via the inhibition of two key bacterial enzymes: DNA gyrase and topoisomerase IV.[L11638] Both targets are type II topoisomerases, but have unique functions within the bacterial cell. DNA gyrase is an enzyme found only in bacteria that introduces negative supercoils into DNA during replication - this helps to relieve torsional strain caused by the introduction of positive supercoils during replication, and these negative supercoils are essential for chromosome condensation and the promotion of transcription initiation.[A31453] It is comprised of four subunits (two A subunits and two B subunits) of which the A subunits appear to be the target of fluoroquinolone antibiotics.[A190663] Bacterial topoisomerase IV, in addition to contributing to the relaxation of positive supercoils, is essential at the terminal stages of DNA replication and functions to “unlink” newly replicated chromosomes to allow for the completion of cell division.[A31453]



Inhibition of these enzymes by levofloxacin likely occurs via complexation with the topoisomerase enzymes.[A31453] The end result is a blockade of DNA replication, thus inhibiting cell division and resulting in cell death.', 'Levofloxacin is bactericidal and exerts its antimicrobial effects via inhibition of bacterial DNA replication.[L11638] It has a relatively long duration of action in comparison with other antibiotics that allows for once or twice daily dosing. Levofloxacin is associated with QTc-interval prolongation and should be used with caution in patients with other risk factors for prolongation (e.g. hypokalemia, concomitant medications).[L11638]



Levofloxacin has demonstrated _in vitro_ activity against a number of aerobic gram-positive and gram-negative bacteria and may carry some activity against certain species of anaerobic bacteria[L11638] and other pathogens such as _Chlamydia_ and _Legionella_.[A190663] Resistance to levofloxacin may develop, and is generally due to mutations in DNA gyrase or topoisomerase IV, or via alterations to drug efflux.[L11638,A31453] Cross-resistance may occur between levofloxacin and other fluoroquinolones, but is unlikely to develop between levofloxacin and other antibiotic classes (e.g. macrolides) due to significant differences in chemical structure and mechanism of action.[L11638]



As antimicrobial susceptibility patterns are geographically distinct, local antibiograms should be consulted to ensure adequate coverage of relevant pathogens prior to use.', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23217, 'Nail 15 topical lotion 15 ml', 'نيل 15 لوشن 15 مل', '65', '49', 'Nail care', 'Kerasol+vitamin e+panthenol+urea+lactic acid+castor oil+emollients', 'Global napi pharmaceuticals', 'Lotion', 'لوشن', '15 ml', '1', NULL, NULL, '6223002148899', NULL, 2679, '2025-06-12', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23218, 'Nailner nail fungus brush 5 ml', 'نيلنر 5 مل', '210', NULL, 'Antifungal', NULL, 'Trimb healthcare > al ansar for marketing', 'Unknown', 'غير محدد', '5 ml', '1', NULL, 'easy to use brush proven effective against nail fungus: -treats and prevents nail fungus. -fast visible results. -protects the newly grown nail from infection. -no filing required. -clinically testedï-. how to use clean the nail and remove nail varnish be', NULL, NULL, 1239, '2022-08-23', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23219, 'Nailner nail fungus pen 4 ml', 'نيلنر قلم 4 مل', '130', NULL, 'Antifungal', NULL, 'Trimb healthcare > al ansar for marketing', 'Pen', 'قلم', '4 ml', '1', NULL, 'easy to use pen proven effective against nail fungus: -treats and prevents nail fungus. -fast visible results. -protects the newly grown nail from infection. -no filing required. -clinically testedï-. how to use clean the nail and remove nail varnish befo', NULL, NULL, 716, '2022-08-23', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23220, 'Nalbuphine 20mg/2ml 10 amp.', 'نالبيوفين 20مجم/2مل 10 امبولات', '450', '155.5', 'Analgesics.opioid', 'Nalbuphine', 'Serb laboratory-france > united pharma international-egypt', 'Amp', 'أمبول', '20mg', '10', 'مسكن قوي . مخدر . جدول', 'about nalbuphine synthetic opiate agonist/antagonist narcotic analgesics mechanism of action of nalbuphine nalbuphine is a phenanthrene derivative opioid analgesic with mixed opioid agonist and antagonist activity. it inhibits the ascending pain pathways', NULL, NULL, 2864, '2024-11-05', 0, 'For the relief of moderate to severe pain.', 'The exact mechanism of action is unknown, but is believed to interact with an opiate receptor site in the CNS (probably in or associated with the limbic system). The opiate antagonistic effect may result from competitive inhibition at the opiate receptor, but may also be a result of other mechanisms. Nalbuphine is thought primarily to be a kappa agonist. It is also a partial mu antagonist analgesic, with some binding to the delta receptor and minimal agonist activity at the sigma receptor.', 'Nalbuphine is a synthetic opioid agonist-antagonist analgesic of the phenanthrene series. Nalbuphine''s analgesic potency is essentially equivalent to that of [morphine] on a milligram basis. The opoioid antagonist activity of nalbuphine is about one-fourth to that of [nalorphine] and 10 times to that of [pentazocine]. Nalbuphine by itself has potent opioid antagonist activity at doses equal to or lower than its analgesic dose. When administered following or concurrent with mu agonist opioid analgesics (e.g., morphine, oxymorphone, fentanyl), nalbuphine may partially reverse or block opioid-induced respiratory depression from the mu agonist analgesic. Nalbuphine may precipitate withdrawal in patients dependent on opioid drugs. Nalbuphine should be used with caution in patients who have been receiving mu opioid analgesics on a regular basis.', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23221, 'Nalbuphine 20mg/ml i.m./i.v./s.c.amp.', 'نالبوفين 20مجم/مل امبول', '33', '17.25', 'Analgesics.opioid', 'Nalbuphine', 'Cid > spimaco misr', 'Amp', 'أمبول', '20mg', '1', NULL, 'about nalbuphine synthetic opiate agonist/antagonist narcotic analgesics mechanism of action of nalbuphine nalbuphine is a phenanthrene derivative opioid analgesic with mixed opioid agonist and antagonist activity. it inhibits the ascending pain pathways', NULL, NULL, 1117, '2024-11-05', 0, 'For the relief of moderate to severe pain.', 'The exact mechanism of action is unknown, but is believed to interact with an opiate receptor site in the CNS (probably in or associated with the limbic system). The opiate antagonistic effect may result from competitive inhibition at the opiate receptor, but may also be a result of other mechanisms. Nalbuphine is thought primarily to be a kappa agonist. It is also a partial mu antagonist analgesic, with some binding to the delta receptor and minimal agonist activity at the sigma receptor.', 'Nalbuphine is a synthetic opioid agonist-antagonist analgesic of the phenanthrene series. Nalbuphine''s analgesic potency is essentially equivalent to that of [morphine] on a milligram basis. The opoioid antagonist activity of nalbuphine is about one-fourth to that of [nalorphine] and 10 times to that of [pentazocine]. Nalbuphine by itself has potent opioid antagonist activity at doses equal to or lower than its analgesic dose. When administered following or concurrent with mu agonist opioid analgesics (e.g., morphine, oxymorphone, fentanyl), nalbuphine may partially reverse or block opioid-induced respiratory depression from the mu agonist analgesic. Nalbuphine may precipitate withdrawal in patients dependent on opioid drugs. Nalbuphine should be used with caution in patients who have been receiving mu opioid analgesics on a regular basis.', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23222, 'Naleve 375 mg 10 enteric coated tab.', 'ناليف 375مجم 10 اقراص', '5', NULL, 'Nsaid.propionic acid derivatives', 'Naproxen', 'Sigma', 'Tab', 'أقراص', '375 mg', '1', NULL, 'about naproxen nsaid 2-arylpropionic acid (profen) derivative analgesic anti-inflammatory antipyretic. mechanism of action of naproxen naproxen has analgesic anti-inflammatory and antipyretic action. it acts by inhibiting prostaglandin (pgs) synthesis and', NULL, NULL, 786, '2022-07-09', 0, 'Naproxen is indicated for the management of rheumatoid arthritis, osteoarthritis, ankylosing spondylitis, polyarticular juvenile idiopathic arthritis, tendinitis, bursitis, acute gout, primary dysmenorrhea, and for the relief of mild to moderate pain.[L6582][L6583][A178975] Further, it is first-line therapy for osteoarthritis, acute gouty arthritis, dysmenorrhea, and musculoskeletal inflammation and pain.[A178975]', 'As with other non-selective NSAIDs, naproxen exerts it''s clinical effects by blocking COX-1 and COX-2 enzymes leading to decreased prostaglandin synthesis.[A178975] Although both enzymes contribute to prostaglandin production, they have unique functional differences.[A178975] The COX-1 enzymes is constitutively active and can be found in normal tissues such as the stomach lining, while the COX-2 enzyme is inducible and produces prostaglandins that mediate pain, fever and inflammation.[A178990] The COX-2 enzyme mediates the desired antipyretic, analgesic and anti-inflammatory properties offered by Naproxen, while undesired adverse effects such as gastrointestinal upset and renal toxicities are linked to the COX-1 enzyme.[A178990]', 'Naproxen is an established non-selective NSAID and is useful as an analgesic, anti-inflammatory and antipyretic.[A179098] Similar to other NSAIDs, the pharmacological activity of naproxen can be attributed to the inhibition of cyclo-oxygenase, which in turn reduces prostaglandin synthesis in various tissues and fluids including the synovial fluid, gastric mucosa, and the blood.[A179098] 



Although naproxen is an effective analgesic, it can have unintended deleterious effects in the patient. For instance, naproxen can adversely affect blood pressure control.[A179224] A study found that use of naproxen induced an increase in blood pressure, although the increase was not as significant as that found with ibuprofen use.[A179224]



Further, studies have found that the risk of upper gastrointestinal bleeding is on average four-fold higher for individuals taking NSAIDs.[A179227] Other factors that increase the risk of upper gastrointestinal bleeding include concurrent use of corticosteroids or anticoagulants, and a history of gastrointestinal ulcers.[A179227]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23223, 'Nalfin 20mg/ml 10 amps.', 'نالفين 20 مجم / مل 10 امبولات', '450', '85', 'Analgesics.opioid', 'Nalbuphine', 'Memphis', 'Amp', 'أمبول', '20mg', '10', 'مسكن عام قوي -- حالات العمليات الجراحية --يؤخذ تحت اشراف طبي', 'about nalbuphine synthetic opiate agonist/antagonist narcotic analgesics mechanism of action of nalbuphine nalbuphine is a phenanthrene derivative opioid analgesic with mixed opioid agonist and antagonist activity. it inhibits the ascending pain pathways', NULL, NULL, 2286, '2024-11-06', 0, 'For the relief of moderate to severe pain.', 'The exact mechanism of action is unknown, but is believed to interact with an opiate receptor site in the CNS (probably in or associated with the limbic system). The opiate antagonistic effect may result from competitive inhibition at the opiate receptor, but may also be a result of other mechanisms. Nalbuphine is thought primarily to be a kappa agonist. It is also a partial mu antagonist analgesic, with some binding to the delta receptor and minimal agonist activity at the sigma receptor.', 'Nalbuphine is a synthetic opioid agonist-antagonist analgesic of the phenanthrene series. Nalbuphine''s analgesic potency is essentially equivalent to that of [morphine] on a milligram basis. The opoioid antagonist activity of nalbuphine is about one-fourth to that of [nalorphine] and 10 times to that of [pentazocine]. Nalbuphine by itself has potent opioid antagonist activity at doses equal to or lower than its analgesic dose. When administered following or concurrent with mu agonist opioid analgesics (e.g., morphine, oxymorphone, fentanyl), nalbuphine may partially reverse or block opioid-induced respiratory depression from the mu agonist analgesic. Nalbuphine may precipitate withdrawal in patients dependent on opioid drugs. Nalbuphine should be used with caution in patients who have been receiving mu opioid analgesics on a regular basis.', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23227, 'Nalpain 20mg/ml 5 amp.', 'نالبين 20مجم/مل 5 امبول', '60', '37.25', 'Analgesics.opioid', 'Nalbuphine', 'Alfacure pharmaceuticals', 'Amp', 'أمبول', '20mg', '5', NULL, NULL, NULL, NULL, 893, '2025-08-23', 0, 'For the relief of moderate to severe pain.', 'The exact mechanism of action is unknown, but is believed to interact with an opiate receptor site in the CNS (probably in or associated with the limbic system). The opiate antagonistic effect may result from competitive inhibition at the opiate receptor, but may also be a result of other mechanisms. Nalbuphine is thought primarily to be a kappa agonist. It is also a partial mu antagonist analgesic, with some binding to the delta receptor and minimal agonist activity at the sigma receptor.', 'Nalbuphine is a synthetic opioid agonist-antagonist analgesic of the phenanthrene series. Nalbuphine''s analgesic potency is essentially equivalent to that of [morphine] on a milligram basis. The opoioid antagonist activity of nalbuphine is about one-fourth to that of [nalorphine] and 10 times to that of [pentazocine]. Nalbuphine by itself has potent opioid antagonist activity at doses equal to or lower than its analgesic dose. When administered following or concurrent with mu agonist opioid analgesics (e.g., morphine, oxymorphone, fentanyl), nalbuphine may partially reverse or block opioid-induced respiratory depression from the mu agonist analgesic. Nalbuphine may precipitate withdrawal in patients dependent on opioid drugs. Nalbuphine should be used with caution in patients who have been receiving mu opioid analgesics on a regular basis.', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23228, 'Nalufin 20mg/ml 5amps.', 'نالوفين 20مجم/مل 5 امبولات', '225', '150', 'Analgesics.opioid', 'Nalbuphine', 'Amoun', 'Amp', 'أمبول', '20mg', '5', 'مسكن للالام يستخدم لتخفيف الألم المعتدل إلى شديد و لتسكين الألم قبل الجراحة وبعد العملية الجراحية ،وللتسكين الألم أثناء المخاض والولادة.', NULL, '6221025010438', NULL, 37645, '2024-09-17', 0, 'For the relief of moderate to severe pain.', 'The exact mechanism of action is unknown, but is believed to interact with an opiate receptor site in the CNS (probably in or associated with the limbic system). The opiate antagonistic effect may result from competitive inhibition at the opiate receptor, but may also be a result of other mechanisms. Nalbuphine is thought primarily to be a kappa agonist. It is also a partial mu antagonist analgesic, with some binding to the delta receptor and minimal agonist activity at the sigma receptor.', 'Nalbuphine is a synthetic opioid agonist-antagonist analgesic of the phenanthrene series. Nalbuphine''s analgesic potency is essentially equivalent to that of [morphine] on a milligram basis. The opoioid antagonist activity of nalbuphine is about one-fourth to that of [nalorphine] and 10 times to that of [pentazocine]. Nalbuphine by itself has potent opioid antagonist activity at doses equal to or lower than its analgesic dose. When administered following or concurrent with mu agonist opioid analgesics (e.g., morphine, oxymorphone, fentanyl), nalbuphine may partially reverse or block opioid-induced respiratory depression from the mu agonist analgesic. Nalbuphine may precipitate withdrawal in patients dependent on opioid drugs. Nalbuphine should be used with caution in patients who have been receiving mu opioid analgesics on a regular basis.', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23229, 'Nalukemi 10mg/ml 5 ampoules i.m./i.v', 'نالوكيمي 10مجم/مل 5 امبول عضل/وريد', '33', NULL, 'Analgesics.opioid', 'Nalbuphine', 'Chemipharm', 'Ampoule', 'أمبول', '10mg', '5', 'مسكن ومهديء جدول', NULL, NULL, NULL, 4322, '2023-02-04', 0, 'For the relief of moderate to severe pain.', 'The exact mechanism of action is unknown, but is believed to interact with an opiate receptor site in the CNS (probably in or associated with the limbic system). The opiate antagonistic effect may result from competitive inhibition at the opiate receptor, but may also be a result of other mechanisms. Nalbuphine is thought primarily to be a kappa agonist. It is also a partial mu antagonist analgesic, with some binding to the delta receptor and minimal agonist activity at the sigma receptor.', 'Nalbuphine is a synthetic opioid agonist-antagonist analgesic of the phenanthrene series. Nalbuphine''s analgesic potency is essentially equivalent to that of [morphine] on a milligram basis. The opoioid antagonist activity of nalbuphine is about one-fourth to that of [nalorphine] and 10 times to that of [pentazocine]. Nalbuphine by itself has potent opioid antagonist activity at doses equal to or lower than its analgesic dose. When administered following or concurrent with mu agonist opioid analgesics (e.g., morphine, oxymorphone, fentanyl), nalbuphine may partially reverse or block opioid-induced respiratory depression from the mu agonist analgesic. Nalbuphine may precipitate withdrawal in patients dependent on opioid drugs. Nalbuphine should be used with caution in patients who have been receiving mu opioid analgesics on a regular basis.', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23230, 'Nan 1 milk 400 gm', 'نان 1 لبن اطفال 400 جرام', '350', '340', 'Milk products.first stage (age 0-6 months)', 'Milk formula stage 1', 'Nestle', 'Unknown', 'غير محدد', '400 gm', '1', NULL, 'not to replace mother s milk. for infants from birth to 6 months age. to be used within 3 weeks from opening.', '7613036705448', NULL, 1223, '2025-09-02', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23231, 'Nan 2 milk 400 gm', 'نان 2 لبن اطفال 400 جرام', '340', '330', 'Milk products.second stage (age 6-12 months)', 'Milk formula stage 2', 'Nestle', 'Unknown', 'غير محدد', '400 gm', '1', NULL, 'not to replace mother s milk. for infants from 6 months to 1 year age. to be used within 3 weeks from opening.', '7613034759344', NULL, 1223, '2025-07-01', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23232, 'Nan 3 milk 800 gm', 'نان 3 لبن اطفال 800 جرام', '630', '610', 'Milk products.third stage (age 1-3 years)', 'Milk formula stage 3', 'Nestle', 'Unknown', 'غير محدد', '800 gm', '1', NULL, 'not to replace mother s milk. for children from age 1 year and onward. to be used within 3 weeks from opening.', NULL, NULL, 767, '2025-09-03', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23233, 'Nan comfort milk 380 gm', 'نان كومفورت لبن اطفال 380 جم', '370', '360', 'Extra care milk', 'Extra care milk formula', 'Nestle', 'Unknown', 'غير محدد', '380 gm', '1', NULL, 'from birth onwards. it provides complete care for babies experiencing colic flatulence or general digestive discomfort. it has low level of lactose. to be used within 4 weeks of opening.', '7613035722514', NULL, 2106, '2025-09-03', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23234, 'Nan lf milk 400 gm', 'نان ال اف لبن اطفال 400 جم', '375', '365', 'Lactose free milk', 'Lactose free milk formula', 'Nestle', 'Unknown', 'غير محدد', '400 gm', '1', NULL, 'used mainly for diarrhea. from birth onwards. use milk within 4 weeks of opening.', '7613035250888', NULL, 1205, '2025-09-01', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23235, 'Nan pre milk 400 gm', 'نان بري لبن اطفال 400 جم', '380', '370', 'Milk products.prematue milk formula', 'Premature milk formula', 'Nestle', 'Unknown', 'غير محدد', '400 gm', '1', NULL, 'specially formulated for preterm and low birth weight infants. it could be discontinued under medical advice after a weight of 3 kgm has been reached or until 2 months corrected age. to be used within one month from opening.', '8445291109308', NULL, 1665, '2025-09-01', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23239, 'Nandurabolin 25mg/ml oily soln. for i.m inj.', 'ناندورابولين 25مجم/مل محلول للحقن العضلي', '20', '15', 'Anabolic steroid', 'Nandrolone decanoate', 'Cid > el nile.', 'Inj', 'حقن', '25mg', '1', NULL, 'about nandrolone an anabolic steroid erythropoietic. mechanism of action of nandrolone it is an anabolic steroid which have higher anabolic and lower androgenic activity. it is a synthetic testosterone derivative which have anabolic androgenic ratio >1.it', '6221077122318', NULL, 970, '2024-06-27', 0, 'Nandrolone decanoate is indicated in the management of anemia of renal insufficiency.[L32564] In Canada, it is also indicated as an adjunct therapy in the treatment of senile and postmenopausal osteoporosis.[L9464]', 'Nandrolone decanoate is hydrolyzed to [nandrolone], possibly by PDE7B.[A233754,A233774] Nandrolone is brought into cells by receptor mediated endocytosis, where it interacts with the androgen receptor.[A233809,A233814] After binding to the androgen receptor, a conformational change occurs, the androgen receptor enters the nucleus, dimerizes, and can then bind to segments of DNA to regulate transcription.[A233814] Androgens can also regulate transcription through activation of ERK, Akt, and MAPK; or binding to and competitively inhibiting transcription factors.[A233814]', 'Nandrolone decanoate is an alkylated anabolic steroid indicated in the management of anemia of renal insufficiency and as an adjunct therapy in the treatment of senile and postmenopausal osteoporosis.[A233789,L32564,L9464] It has a long duration of action as it is given every 3-4 weeks, and a wide therapeutic window as acute overdoses are rare.[A233789,L9464] Patients should be counselled regarding the risks of giving this drug to patients with cardiac, renal, or hepatic diseases.[L9464]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23241, 'Nano age 28 ml', 'نانو ايج 28 ملي', '263', NULL, 'Moisturizing topicals', NULL, 'Isis pharma > biotech egypt', 'Unknown', 'غير محدد', '28 ml', '4', NULL, 'anti-aging serum with moisturizing effect active ingredient: 2% hyaluronic acid serum due to the low molecular weight hyaluronic acid nano age improves biodynamic properties of the skin: anti-aging low molecular weight hyaluronic acid provides transport o', NULL, NULL, 654, '2022-07-24', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23242, 'Nano pure 4.5 gm', 'نانو بيور 4.5 جم', '285', NULL, 'Skin care', NULL, 'Isis pharma > biotech egypt', 'Unknown', 'غير محدد', '4.5 gm', '1', NULL, 'pure vitamin c active ingredient pure vitamin c in the form of encapsulated powder (magnesium l-ascorbyl-2-phosphate) due to the high absorption capacity of the active substance is extremely nano pure properties in skin care: skin protection nano pure is', '3401395596029', NULL, 690, '2022-08-02', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23243, 'Nanofreq 10 mg 20 f.c. tab.', 'نانوفريك 5مجم 20 اقراص', '50', NULL, 'Urinary incontinence.antispasmodics.muscarinic antagonists', 'Solifenacin succinate', 'Mepaco', 'Tab', 'أقراص', '10 mg', '2', NULL, 'indication for the treatment of overactive bladder with symptoms of urge urinary incontinence urgency and urinary frequency. mechanism of action solifenacin is a competitive muscarinic acetylcholine receptor antagonist. the binding of acetylcholine to the', NULL, NULL, 893, '2022-07-12', 0, 'Solifenacin tablets are indicated to treat an overactive bladder with urinary incontinence, urgency, and frequency.[L7511]', 'Solifenacin is a competitive muscarinic receptor antagonist.[L7511] It has the highest affinity for M3, M1, and M2 muscarinic receptors.[A181247] 80% of the muscarinic receptors in the bladder are M2, while 20% are M3.[A181262] Solifenacin''s antagonism of the M3 receptor prevents contraction of the detrusor muscle, while antagonism of the M2 receptor may prevent contraction of smooth muscle in the bladder.[A181262]', 'Solifenacin antagonizes the M2 and M3 muscarinic receptors in the bladder to treat an overactive bladder.[L7511,A181262] It has a long duration of action as it is usually taken once daily.[L7511] Patients taking solifenacin should be aware of the risks of angioedema and anaphylaxis.[L7511]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23244, 'Nanofreq 5 mg 20 f.c. tab.', 'نانوفريك 5مجم 20 اقراص', '37', NULL, 'Urinary incontinence.antispasmodics.muscarinic antagonists', 'Solifenacin succinate', 'Mepaco', 'Tab', 'أقراص', '5 mg', '2', NULL, 'indication for the treatment of overactive bladder with symptoms of urge urinary incontinence urgency and urinary frequency. mechanism of action solifenacin is a competitive muscarinic acetylcholine receptor antagonist. the binding of acetylcholine to the', NULL, NULL, 873, '2022-07-20', 0, 'Solifenacin tablets are indicated to treat an overactive bladder with urinary incontinence, urgency, and frequency.[L7511]', 'Solifenacin is a competitive muscarinic receptor antagonist.[L7511] It has the highest affinity for M3, M1, and M2 muscarinic receptors.[A181247] 80% of the muscarinic receptors in the bladder are M2, while 20% are M3.[A181262] Solifenacin''s antagonism of the M3 receptor prevents contraction of the detrusor muscle, while antagonism of the M2 receptor may prevent contraction of smooth muscle in the bladder.[A181262]', 'Solifenacin antagonizes the M2 and M3 muscarinic receptors in the bladder to treat an overactive bladder.[L7511,A181262] It has a long duration of action as it is usually taken once daily.[L7511] Patients taking solifenacin should be aware of the risks of angioedema and anaphylaxis.[L7511]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23246, 'Nanova 10 sachets', 'نانوفا 10 كيس', '230', NULL, NULL, 'Marine collagen+vitamin c+vitamin e+calcium', 'Medcare > warnex pharmaceutical', 'Sachet', 'أكياس', NULL, '1', NULL, 'nanova is the first drinkable beauty collagen in the middle east for your skin hair and nails. indication:- for your skin hair and nails beauty reduce the depth of facial wrinkles increase skin elasticity and skin hydration increase in skin firmness after', NULL, NULL, 1003, '2022-07-17', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23247, 'Naphcon a eye drops 15 ml', 'نافكون ايه قطرة عين 15 مل', '12', NULL, 'Corneal vascularity.antihistamine combined with alpha 1 agonist', 'Naphazoline+pheniramine', 'Rameda > alcon', 'Drops', 'نقط', '15 ml', '1', NULL, 'about naphazoline imidazoline derivative alpha-adrenergic agonist a decongestant vasoconstrictor. mechanism of action of naphazoline naphazoline exerts its vasoconstrictor action by acting as a selective alpha-1 adrenergic agonist. thus it reduces blood f', '6223003974220', NULL, 1099, '2022-06-18', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23250, 'Napi-care oint.', 'نابي كير مرهم', '2', NULL, 'Diaper rash', 'Zinc oxide', 'Arab drug company.', 'Oint', 'مرهم', NULL, '1', NULL, 'about zinc oxide zinc compound a sunscreen antipruritic. mechanism of action of zinc oxide it works by providing a skin barrier and helps in healing and prevent skin irritation. it acts as a sunscreen which absorbs incident solar radiation in the uva rang', NULL, NULL, 942, '2022-07-26', 0, 'For adjunctive treatment of diaper dermatitis. Also, it can be used to treat minor skin irritations (eg, cuts, burns, and scrapes, poison ivy).

Zinc oxide can be used in ointments, creams, and lotions to protect against sunburn and other damage to the skin caused by ultraviolet light.', 'It acts by providing a physical barrier to prevent skin irritation and help heal damaged skin.', 'Zinc oxide has astringent, soothing and protective properties and is used in topical preparations for eczema, slight excoriations, wounds and haemorrhoids. It also reflects ultraviolet radiation and can be used as a physical sunscreen.', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23254, 'Napilac 200mg 20 caps.', 'نابيلاك 200مجم 20 كبسول', '16', NULL, 'Nsaid.acetic acid derivatives', 'Etodolac', 'Global napi pharmaceuticals', 'Cap', 'كبسولة', '200mg', '2', NULL, 'about etodolac a member of pyranocarboxylic acid group of nsaid analgesic anti-inflammatory. mechanism of action of etodolac etodolac is an acetic acid derivative. etodolac produces its analgesics and anti-inflammatory actions by inhibiting prostaglandin', '6223002145126', NULL, 775, '2022-12-07', 0, 'For acute and long-term management of signs and symptoms of osteoarthritis and rheumatoid arthritis, as well as for the management of pain.', 'Similar to other NSAIDs, the anti-inflammatory effects of etodolac result from inhibition of the enzyme cycooxygenase (COX). This decreases the synthesis of peripheral prostaglandins involved in mediating inflammation. Etodolac binds to the upper portion of the COX enzyme active site and prevents its substrate, arachidonic acid, from entering the active site. Etodolac was previously thought to be a non-selective COX inhibitor, but it is now known to be 5 – 50 times more selective for COX-2 than COX-1. Antipyresis may occur by central action on the hypothalamus, resulting in peripheral dilation, increased cutaneous blood flow, and subsequent heat loss.', 'Etodolac is an anti-inflammatory agent with analgesic and antipyretic properties. It is used to treat osteoarthritis, rheumatoid arthritis and control acute pain. The therapeutic effects of etodolac are achieved via inhibition of the synthesis of prostaglandins involved in fever, pain, swelling and inflammation. Etodolac is administered as a racemate. As with other NSAIDs, the S-form has been shown to be active while the R-form is inactive. Both enantiomers are stable and there is no evidence of R- to S- conversion _in vivo_.', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23257, 'Napkin lotion 120 ml', 'نابكين لوشن 120 مل', '68', '45', 'Soothing topical', 'Zinc oxide+panthenol+chamomile+nigella sativa', 'Egyptian company for cosmetics > santex pharma', 'Lotion', 'لوشن', '120 ml', '1', NULL, 'indications: napkin dermatitis sun burn anti pruritic insect bites prickly heat nipple fissure', NULL, NULL, 976, '2025-05-06', 0, 'Zinc can be used for the treatment and prevention of zinc deficiency/its consequences, including stunted growth and acute diarrhea in children, and slowed wound healing. It is also utilized for boosting the immune system, treating the common cold and recurrent ear infections, as well as preventing lower respiratory tract infections [L2172].  



', '**Zinc has three primary biological roles**: _catalytic_, _structural_, and _regulatory_. The catalytic and structural role of zinc is well established, and there are various noteworthy reviews on these functions. For example, zinc is a structural constituent in numerous proteins, inclusive of growth factors, cytokines, receptors, enzymes, and transcription factors for different cellular signaling pathways. It is implicated in numerous cellular processes as a cofactor for approximately 3000 human proteins including enzymes, nuclear factors, and hormones [L2096].



Zinc promotes resistance to epithelial apoptosis through cell protection (cytoprotection) against reactive oxygen species and bacterial toxins, likely through the antioxidant activity of the cysteine-rich metallothioneins [A32419].



In HL-60 cells (promyelocytic leukemia cell line), zinc enhances the up-regulation of A20 mRNA, which, via TRAF pathway, decreases NF-kappaB activation, leading to decreased gene expression and generation of tumor necrosis factor-alpha (TNF-alpha), IL-1beta, and IL-8 [A32418].



There are several mechanisms of action of zinc on acute diarrhea. Various mechanisms are specific to the gastrointestinal system: zinc restores mucosal barrier integrity and enterocyte brush-border enzyme activity, it promotes the production of antibodies and circulating lymphocytes against intestinal pathogens, and has a direct effect on ion channels, acting as a potassium channel blocker of adenosine 3-5-cyclic monophosphate-mediated chlorine secretion. Cochrane researchers examined the evidence available up to 30 September 2016 [L2106].



Zinc deficiency in humans decreases the activity of serum _thymulin_ (a hormone of the thymus), which is necessary for the maturation of T-helper cells. T-helper 1 (Th(1)) cytokines are decreased but T-helper 2 (Th(2)) cytokines are not affected by zinc deficiency in humans [A32417].



The change of _Th(1)_ to _Th(2)_ function leads to cell-mediated immune dysfunction. Because IL-2 production (Th(1) cytokine) is decreased, this causes decreased activity of natural-killer-cell (NK cell) and T cytolytic cells, normally involved in killing viruses, bacteria, and malignant cells [A32424]. 



In humans, zinc deficiency may lead to the generation of new CD4+ T cells, produced in the thymus. In cell culture studies (HUT-78, a Th(0) human malignant lymphoblastoid cell line), as a result of zinc deficiency, nuclear factor-kappaB (NF-kappaB) activation, phosphorylation of IkappaB, and binding of NF-kappaB to DNA are decreased and this results in decreased Th(1) cytokine production [A32417].



In another study, zinc supplementation in human subjects suppressed the gene expression and production of pro-inflammatory cytokines and decreased oxidative stress markers [A32424]. In HL-60 cells (a human pro-myelocytic leukemia cell line), zinc deficiency increased the levels of TNF-alpha, IL-1beta, and IL-8 cytokines and mRNA. In such cells, zinc was found to induce A20, a zinc finger protein that inhibited NF-kappaB activation by the tumor necrosis factor receptor-associated factor pathway. This process decreased gene expression of pro-inflammatory cytokines and oxidative stress markers [A32417].



The exact mechanism of zinc in acne treatment is poorly understood. However, zinc is considered to act directly on microbial inflammatory equilibrium and facilitate antibiotic absorption when used in combination with other agents. Topical zinc alone as well as in combination with other agents may be efficacious because of its anti-inflammatory activity and ability to reduce P. acnes bacteria by the inhibition of P. acnes lipases and free fatty acid levels [L2102].', 'Zinc is involved in various aspects of cellular metabolism. It has been estimated that approximately 10% of human proteins may bind zinc, in addition to hundreds of proteins that transport and traffic zinc. It is required for the catalytic activity of more than 200 enzymes, and it plays a role in immune function wound healing, protein synthesis, DNA synthesis, and cell division. Zinc is an essential element for a proper sense of taste and smell and supports normal growth and development during pregnancy, childhood, and adolescence. It is thought to have antioxidant properties, which may be protective against accelerated aging and helps to speed up the healing process after an injury; however, studies differ as to its effectiveness. Zinc ions are effective antimicrobial agents even if administered in low concentrations [L2211].



Studies on oral zinc for specific conditions shows the following evidence in various conditions [L2095]:



**Colds:** Evidence suggests that if zinc lozenges or syrup are taken within 24 hours after cold symptoms start, the supplement may shorten the length of colds. The use intranasal zinc has been associated with the loss of the sense of smell, in some cases long-term or permanently [L2095].



**Wound healing:** Patients with skin ulcers and decreased levels of zinc may benefit from oral zinc supplements [L2095]. 



**Diahrrea**: Oral zinc supplements can reduce the symptoms of diarrhea in children with low levels of zinc, especially in cases of malnutrition [L2095].

', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23258, 'Naprex hair shampoo 120 ml', 'نابركس شامبو للشعر 120 مل', '39', NULL, 'Hair care', NULL, 'El-masria for cosmetics > admin pharma', 'Amp', 'أمبول', '120 ml', '1', NULL, 'anti-dandruff', NULL, NULL, 917, '2022-08-03', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23259, 'Naprofen 250mg 10 tab.', 'نابروفين 250مجم 10 اقراص', '4', NULL, 'Nsaid.propionic acid derivatives', 'Naproxen', 'El nile.', 'Tab', 'أقراص', '250mg', '1', NULL, 'about naproxen nsaid 2-arylpropionic acid (profen) derivative analgesic anti-inflammatory antipyretic. mechanism of action of naproxen naproxen has analgesic anti-inflammatory and antipyretic action. it acts by inhibiting prostaglandin (pgs) synthesis and', NULL, NULL, 1023, '2022-07-25', 0, 'Naproxen is indicated for the management of rheumatoid arthritis, osteoarthritis, ankylosing spondylitis, polyarticular juvenile idiopathic arthritis, tendinitis, bursitis, acute gout, primary dysmenorrhea, and for the relief of mild to moderate pain.[L6582][L6583][A178975] Further, it is first-line therapy for osteoarthritis, acute gouty arthritis, dysmenorrhea, and musculoskeletal inflammation and pain.[A178975]', 'As with other non-selective NSAIDs, naproxen exerts it''s clinical effects by blocking COX-1 and COX-2 enzymes leading to decreased prostaglandin synthesis.[A178975] Although both enzymes contribute to prostaglandin production, they have unique functional differences.[A178975] The COX-1 enzymes is constitutively active and can be found in normal tissues such as the stomach lining, while the COX-2 enzyme is inducible and produces prostaglandins that mediate pain, fever and inflammation.[A178990] The COX-2 enzyme mediates the desired antipyretic, analgesic and anti-inflammatory properties offered by Naproxen, while undesired adverse effects such as gastrointestinal upset and renal toxicities are linked to the COX-1 enzyme.[A178990]', 'Naproxen is an established non-selective NSAID and is useful as an analgesic, anti-inflammatory and antipyretic.[A179098] Similar to other NSAIDs, the pharmacological activity of naproxen can be attributed to the inhibition of cyclo-oxygenase, which in turn reduces prostaglandin synthesis in various tissues and fluids including the synovial fluid, gastric mucosa, and the blood.[A179098] 



Although naproxen is an effective analgesic, it can have unintended deleterious effects in the patient. For instance, naproxen can adversely affect blood pressure control.[A179224] A study found that use of naproxen induced an increase in blood pressure, although the increase was not as significant as that found with ibuprofen use.[A179224]



Further, studies have found that the risk of upper gastrointestinal bleeding is on average four-fold higher for individuals taking NSAIDs.[A179227] Other factors that increase the risk of upper gastrointestinal bleeding include concurrent use of corticosteroids or anticoagulants, and a history of gastrointestinal ulcers.[A179227]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23260, 'Naprofen 500mg 10 tab.', 'نابروفين 500 مجم 10 اقراص', '12', NULL, 'Nsaid.propionic acid derivatives', 'Naproxen', 'El nile.', 'Tab', 'أقراص', '500mg', '1', 'مسكن للالام -- تقليل الالتهابات', 'about naproxen nsaid 2-arylpropionic acid (profen) derivative analgesic anti-inflammatory antipyretic. mechanism of action of naproxen naproxen has analgesic anti-inflammatory and antipyretic action. it acts by inhibiting prostaglandin (pgs) synthesis and', '6221077014316', NULL, 1469, '2022-12-07', 0, 'Naproxen is indicated for the management of rheumatoid arthritis, osteoarthritis, ankylosing spondylitis, polyarticular juvenile idiopathic arthritis, tendinitis, bursitis, acute gout, primary dysmenorrhea, and for the relief of mild to moderate pain.[L6582][L6583][A178975] Further, it is first-line therapy for osteoarthritis, acute gouty arthritis, dysmenorrhea, and musculoskeletal inflammation and pain.[A178975]', 'As with other non-selective NSAIDs, naproxen exerts it''s clinical effects by blocking COX-1 and COX-2 enzymes leading to decreased prostaglandin synthesis.[A178975] Although both enzymes contribute to prostaglandin production, they have unique functional differences.[A178975] The COX-1 enzymes is constitutively active and can be found in normal tissues such as the stomach lining, while the COX-2 enzyme is inducible and produces prostaglandins that mediate pain, fever and inflammation.[A178990] The COX-2 enzyme mediates the desired antipyretic, analgesic and anti-inflammatory properties offered by Naproxen, while undesired adverse effects such as gastrointestinal upset and renal toxicities are linked to the COX-1 enzyme.[A178990]', 'Naproxen is an established non-selective NSAID and is useful as an analgesic, anti-inflammatory and antipyretic.[A179098] Similar to other NSAIDs, the pharmacological activity of naproxen can be attributed to the inhibition of cyclo-oxygenase, which in turn reduces prostaglandin synthesis in various tissues and fluids including the synovial fluid, gastric mucosa, and the blood.[A179098] 



Although naproxen is an effective analgesic, it can have unintended deleterious effects in the patient. For instance, naproxen can adversely affect blood pressure control.[A179224] A study found that use of naproxen induced an increase in blood pressure, although the increase was not as significant as that found with ibuprofen use.[A179224]



Further, studies have found that the risk of upper gastrointestinal bleeding is on average four-fold higher for individuals taking NSAIDs.[A179227] Other factors that increase the risk of upper gastrointestinal bleeding include concurrent use of corticosteroids or anticoagulants, and a history of gastrointestinal ulcers.[A179227]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23261, 'Naprosyn 250 mg 20 tab', 'نابروسين 250مجم 20 قرص', '9', NULL, 'Nsaid.propionic acid derivatives', 'Naproxen', 'Misr > f.hoffman la roche', 'Tab', 'أقراص', '250 mg', '2', NULL, NULL, NULL, NULL, 1130, '2023-01-11', 0, 'Naproxen is indicated for the management of rheumatoid arthritis, osteoarthritis, ankylosing spondylitis, polyarticular juvenile idiopathic arthritis, tendinitis, bursitis, acute gout, primary dysmenorrhea, and for the relief of mild to moderate pain.[L6582][L6583][A178975] Further, it is first-line therapy for osteoarthritis, acute gouty arthritis, dysmenorrhea, and musculoskeletal inflammation and pain.[A178975]', 'As with other non-selective NSAIDs, naproxen exerts it''s clinical effects by blocking COX-1 and COX-2 enzymes leading to decreased prostaglandin synthesis.[A178975] Although both enzymes contribute to prostaglandin production, they have unique functional differences.[A178975] The COX-1 enzymes is constitutively active and can be found in normal tissues such as the stomach lining, while the COX-2 enzyme is inducible and produces prostaglandins that mediate pain, fever and inflammation.[A178990] The COX-2 enzyme mediates the desired antipyretic, analgesic and anti-inflammatory properties offered by Naproxen, while undesired adverse effects such as gastrointestinal upset and renal toxicities are linked to the COX-1 enzyme.[A178990]', 'Naproxen is an established non-selective NSAID and is useful as an analgesic, anti-inflammatory and antipyretic.[A179098] Similar to other NSAIDs, the pharmacological activity of naproxen can be attributed to the inhibition of cyclo-oxygenase, which in turn reduces prostaglandin synthesis in various tissues and fluids including the synovial fluid, gastric mucosa, and the blood.[A179098] 



Although naproxen is an effective analgesic, it can have unintended deleterious effects in the patient. For instance, naproxen can adversely affect blood pressure control.[A179224] A study found that use of naproxen induced an increase in blood pressure, although the increase was not as significant as that found with ibuprofen use.[A179224]



Further, studies have found that the risk of upper gastrointestinal bleeding is on average four-fold higher for individuals taking NSAIDs.[A179227] Other factors that increase the risk of upper gastrointestinal bleeding include concurrent use of corticosteroids or anticoagulants, and a history of gastrointestinal ulcers.[A179227]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23262, 'Naprosyn 500 mg 10 tab.', 'نابروسين 500مجم 10 اقراص', '8', NULL, 'Nsaid.propionic acid derivatives', 'Naproxen', 'Misr > f.hoffman la roche', 'Tab', 'أقراص', '500 mg', '1', NULL, 'about naproxen nsaid 2-arylpropionic acid (profen) derivative analgesic anti-inflammatory antipyretic. mechanism of action of naproxen naproxen has analgesic anti-inflammatory and antipyretic action. it acts by inhibiting prostaglandin (pgs) synthesis and', '6221035009330', NULL, 8727, '2023-01-11', 0, 'Naproxen is indicated for the management of rheumatoid arthritis, osteoarthritis, ankylosing spondylitis, polyarticular juvenile idiopathic arthritis, tendinitis, bursitis, acute gout, primary dysmenorrhea, and for the relief of mild to moderate pain.[L6582][L6583][A178975] Further, it is first-line therapy for osteoarthritis, acute gouty arthritis, dysmenorrhea, and musculoskeletal inflammation and pain.[A178975]', 'As with other non-selective NSAIDs, naproxen exerts it''s clinical effects by blocking COX-1 and COX-2 enzymes leading to decreased prostaglandin synthesis.[A178975] Although both enzymes contribute to prostaglandin production, they have unique functional differences.[A178975] The COX-1 enzymes is constitutively active and can be found in normal tissues such as the stomach lining, while the COX-2 enzyme is inducible and produces prostaglandins that mediate pain, fever and inflammation.[A178990] The COX-2 enzyme mediates the desired antipyretic, analgesic and anti-inflammatory properties offered by Naproxen, while undesired adverse effects such as gastrointestinal upset and renal toxicities are linked to the COX-1 enzyme.[A178990]', 'Naproxen is an established non-selective NSAID and is useful as an analgesic, anti-inflammatory and antipyretic.[A179098] Similar to other NSAIDs, the pharmacological activity of naproxen can be attributed to the inhibition of cyclo-oxygenase, which in turn reduces prostaglandin synthesis in various tissues and fluids including the synovial fluid, gastric mucosa, and the blood.[A179098] 



Although naproxen is an effective analgesic, it can have unintended deleterious effects in the patient. For instance, naproxen can adversely affect blood pressure control.[A179224] A study found that use of naproxen induced an increase in blood pressure, although the increase was not as significant as that found with ibuprofen use.[A179224]



Further, studies have found that the risk of upper gastrointestinal bleeding is on average four-fold higher for individuals taking NSAIDs.[A179227] Other factors that increase the risk of upper gastrointestinal bleeding include concurrent use of corticosteroids or anticoagulants, and a history of gastrointestinal ulcers.[A179227]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23264, 'Naratriptan 2.5 mg 2 f.c. tabs.', 'ناراتريبتان 2.5مجم 2 قرص', '45', '38', 'Antimigraine.vasoconstrictor agents.selective serotonin agonist', 'Naratriptan', 'Chanelle pharmaceuticals > diligence pharma', 'Tab', 'أقراص', '2.5 mg', '1', NULL, 'naratriptan is a triptan drug used for the treatment of migraine headaches. naratriptan is available in 2.5 mg tablets. it is a selective 5-ht1 receptor subtype agonist. naratriptan is used for the treatment of the acute migraine attacks and the symptoms', NULL, NULL, 1234, '2025-04-18', 0, 'For the acute treatment of migraine attacks with or without aura in adults.', 'Three distinct pharmacological actions have been implicated in the antimigraine effect of the triptans: (1) stimulation of presynaptic 5-HT1D receptors, which serves to inhibit both dural vasodilation and inflammation; (2) direct inhibition of trigeminal nuclei cell excitability via 5-HT1B/1D receptor agonism in the brainstem and (3) vasoconstriction of meningeal, dural, cerebral or pial vessels as a result of vascular 5-HT1B receptor agonism.', 'Naratriptan is a selective agonist of serotonin (5-hydroxytryptamine; 5-HT) type 1B and 1D receptors. It is structurally and pharmacologically related to other selective 5-HT1B/1D receptor agonist. Naratriptan has only a weak affinity for 5-HT<sub>1A</sub>, 5-HT<sub>5A</sub>, and 5-HT<sub>7</sub> receptors and no significant affinity or pharmacological activity at 5-HT<sub>2</sub>, 5-HT<sub>3</sub> or 5-HT<sub>4</sub> receptor subtypes or at alpha1-, alpha2-, or beta-adrenergic, dopamine1,; dopamine2; muscarinic, or benzodiazepine receptors. This action in humans correlates with the relief of migraine headache. In addition to causing vasoconstriction, experimental data from animal studies show that Naratriptan also activates 5-HT<sub>1</sub> receptors on peripheral terminals of the trigeminal nerve innervating cranial blood vessels, which may also contribute to the antimigrainous effect of Naratriptan in humans.', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23265, 'Narcotan inhaler 100ml', 'ناركوتان انهيلر 100مل', '40', NULL, 'General anaesthesia', 'Halothane', 'Pharco > eimc', 'Inhaler', 'جهاز استنشاق', '100ml', '1', NULL, 'about halothane haloalkane derivative inhalation general anesthetic. mechanism of action of halothane halothane will alter presynaptic activity and the release of neurotransmitters due to alterations in intracellular signaling. halothane similarly inhibit', NULL, NULL, 740, '2022-07-30', 0, 'For the induction and maintenance of general anesthesia', 'Halothane causes general anaethesia due to its actions on multiple ion channels, which ultimately depresses nerve conduction, breathing, cardiac contractility. Its immobilizing effects have been attributed to its binding to potassium channels in cholinergic neurons. Halothane''s effect are also likely due to binding to NMDA and calcium channels, causing hyperpolarization.', 'Halothane is a general inhalation anesthetic used for induction and maintenance of general anesthesia. It reduces the blood pressure and frequently decreases the pulse rate and depresses respiration. It induces muscle relaxation and reduces pains sensitivity by altering tissue excitability. It does so by decreasing the extent of gap junction mediated cell-cell coupling and altering the activity of the channels that underlie the action potential.', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23266, 'Narcotan inhaler 250 ml', 'ناركوتان انهيلر 250مل', '90', NULL, 'General anaesthesia', 'Halothane', 'Pharco > eimc', 'Inhaler', 'جهاز استنشاق', '250 ml', '1', NULL, 'about halothane haloalkane derivative inhalation general anesthetic. mechanism of action of halothane halothane will alter presynaptic activity and the release of neurotransmitters due to alterations in intracellular signaling. halothane similarly inhibit', NULL, NULL, 785, '2022-07-18', 0, 'For the induction and maintenance of general anesthesia', 'Halothane causes general anaethesia due to its actions on multiple ion channels, which ultimately depresses nerve conduction, breathing, cardiac contractility. Its immobilizing effects have been attributed to its binding to potassium channels in cholinergic neurons. Halothane''s effect are also likely due to binding to NMDA and calcium channels, causing hyperpolarization.', 'Halothane is a general inhalation anesthetic used for induction and maintenance of general anesthesia. It reduces the blood pressure and frequently decreases the pulse rate and depresses respiration. It induces muscle relaxation and reduces pains sensitivity by altering tissue excitability. It does so by decreasing the extent of gap junction mediated cell-cell coupling and altering the activity of the channels that underlie the action potential.', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23267, 'Naredrix 2.5 mg 6 f.c. tabs.', 'ناريدريكس 2.5مجم 6 قرص', '132', '93.5', 'Antimigraine.vasoconstrictor agents.selective serotonin agonist', 'Naratriptan', 'Organopharma', 'Tab', 'أقراص', '2.5 mg', '2', NULL, 'naratriptan is a triptan drug used for the treatment of migraine headaches. naratriptan is available in 2.5 mg tablets. it is a selective 5-ht1 receptor subtype agonist. naratriptan is used for the treatment of the acute migraine attacks and the symptoms', '6224000908416', NULL, 1857, '2024-11-13', 0, 'For the acute treatment of migraine attacks with or without aura in adults.', 'Three distinct pharmacological actions have been implicated in the antimigraine effect of the triptans: (1) stimulation of presynaptic 5-HT1D receptors, which serves to inhibit both dural vasodilation and inflammation; (2) direct inhibition of trigeminal nuclei cell excitability via 5-HT1B/1D receptor agonism in the brainstem and (3) vasoconstriction of meningeal, dural, cerebral or pial vessels as a result of vascular 5-HT1B receptor agonism.', 'Naratriptan is a selective agonist of serotonin (5-hydroxytryptamine; 5-HT) type 1B and 1D receptors. It is structurally and pharmacologically related to other selective 5-HT1B/1D receptor agonist. Naratriptan has only a weak affinity for 5-HT<sub>1A</sub>, 5-HT<sub>5A</sub>, and 5-HT<sub>7</sub> receptors and no significant affinity or pharmacological activity at 5-HT<sub>2</sub>, 5-HT<sub>3</sub> or 5-HT<sub>4</sub> receptor subtypes or at alpha1-, alpha2-, or beta-adrenergic, dopamine1,; dopamine2; muscarinic, or benzodiazepine receptors. This action in humans correlates with the relief of migraine headache. In addition to causing vasoconstriction, experimental data from animal studies show that Naratriptan also activates 5-HT<sub>1</sub> receptors on peripheral terminals of the trigeminal nerve innervating cranial blood vessels, which may also contribute to the antimigrainous effect of Naratriptan in humans.', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23268, 'Naropin 7.5mg/ml (10ml=75mg) 5amps.', 'ناروبين 7.5مجم/مل 5 امبول', '85', NULL, 'Local anaesthetic', 'Ropivacaine', 'Astra zeneca > egyptian pharmaceutical trading company', 'Amp', 'أمبول', '7.5mg', '5', NULL, 'about ropivacaine amide type local anaesthetics mechanism of action of ropivacaine ropivacaine blocks both initiation and conduction of nerve impulses by decreasing the neuronal membrane s permeability to sodium ions resulting in inhibition of depolarisat', NULL, NULL, 749, '2022-07-16', 0, 'Ropivacaine is indicated in adult patients for the induction of regional or local anesthesia for surgery or acute pain management.[L42140]', 'Local anesthetics like ropivacaine block the generation and conduction of nerve impulses, presumably by increasing the threshold for electrical excitation in the nerve, by slowing the propagation of the nerve impulse, and by reducing the rate of rise of the action potential. Specifically, they block the sodium channel and decrease chances of depolarization and consequent action potentials. In general, the progression of anesthesia is related to the diameter, myelination, and conduction velocity of affected nerve fibers.', 'In contrast to most other local anesthetics, the presence of [epinephrine] does not affect the time of onset, duration of action, or the systemic absorption of ropivacaine.[L42140]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23269, 'Naropin 7.5mg/ml (20ml=150mg) 5amps.', 'نابروسين 7.5مجم/مل 5امبول', '170', NULL, 'Local anaesthetic', 'Ropivacaine', 'Astra zeneca > egyptian pharmaceutical trading company', 'Amp', 'أمبول', '7.5mg', '5', NULL, 'about ropivacaine amide type local anaesthetics mechanism of action of ropivacaine ropivacaine blocks both initiation and conduction of nerve impulses by decreasing the neuronal membrane s permeability to sodium ions resulting in inhibition of depolarisat', NULL, NULL, 670, '2022-08-03', 0, 'Ropivacaine is indicated in adult patients for the induction of regional or local anesthesia for surgery or acute pain management.[L42140]', 'Local anesthetics like ropivacaine block the generation and conduction of nerve impulses, presumably by increasing the threshold for electrical excitation in the nerve, by slowing the propagation of the nerve impulse, and by reducing the rate of rise of the action potential. Specifically, they block the sodium channel and decrease chances of depolarization and consequent action potentials. In general, the progression of anesthesia is related to the diameter, myelination, and conduction velocity of affected nerve fibers.', 'In contrast to most other local anesthetics, the presence of [epinephrine] does not affect the time of onset, duration of action, or the systemic absorption of ropivacaine.[L42140]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23270, 'Nasacort aq 55 mcg nasal spray 120 doses', 'نازاكورت ايه كيو 55 مكجم سبراي للانف 120 جرعة', '151', '100', 'Glucocorticoid', 'Triamcinolone', 'Aventis pharma > sanofi', 'Spray', 'بخاخ', '55 mcg', '1', 'راحة من حساسية واحتقان الانف', 'about triamcinolone a synthetic glucocorticoid antiasthmatic anti-inflammatory. mechanism of action of triamcinolone the drug exerts it`s pharmacological action by penetrating and binding to cytoplasmic receptor protein and causes a structural change in s', '3582910081555', NULL, 7016, '2024-06-25', 0, 'Triamcinolone hexacetonide injections are indicated for intralesional administration in alopecia areata, discoid lupus erythematosus, keloids, and necrobiosis lipoidica diabeticorum.[L8246] This formulation can also be used for localized hypertrophic infiltrated inflammatory lesions of granuloma annulare, lichen planus, lichen simplex chronicus, and psoriatic plaques.[L8246]



Triamcinolone acetonide spray and cream are indicated for the treatment of inflammatory and pruritic manifestations of corticosteroid responsive dermatoses.[L8249,L8258] A triamcinolone acetonide 10mg/mL or 40mg/mL injection is indicated intra-articularly for acute gouty arthritis, acute and subacute bursitis, acute nonspecific tenosynovitis, epicondylitis, rheumatoid arthritis, and synovitis of osteoarthritis.[L8252,L8255] The same 10mg/mL injection is indicated by the intralesional route for the treatment of alopecia areata, discoid lupus erythematosus, keloids, necrobiosis lipoidica diabeticorum, and tumors of an aponeurosis or tendon.[L8252] This formulation can also be used for localized hypertrophic infiltrated inflammatory lesions of granuloma annulare, lichen planus, lichen simplex chronicus, and psoriatic plaques.[L8252] The 40mg/mL injection is indicated intramuscularly for controlling severe allergic conditions such as asthma, atopic dermatitis, contact dermatitis, drug hypersensitivity, perennial or seasonal allergic rhinitis, serum sickness, and transfusion reactions; treatment of bullous dermatitis herpetiformis, exfoliative erythroderma, mycosis fungoides, pemphigus, Stevens-Johnson syndrome, congenital adrenal hyperplasia, hypercalcemia in

cancer, nonsuppurative thyroiditis, autoimmune hemolytic anemia, Diamond-Blackfan anemia, pure red cell aplasia, secondary thrombocytopenia, trichinosis, tuberculous meningitis, acute exacerbations of multiple sclerosis or cerebral edema, sympathetic ophthalmia, temporal arteritis, uveitis, ocular inflammation, berylliosis, idiopathic eosinophilic pneumonias, symptomatic sarcoidosis, dermatomyositis, polymyositis, and systemic lupus erythematosus; adjunct treatment of adrenocortical insufficiency, regional enteritis, ulcerative colitis, fulminating or disseminated pulmonary tuberculosis, acute gouty arthritis, acute rheumatic carditis, ankylosing spondylitis, psoriatic arthritis, rheumatoid arthritis; palliative management of leukemia and lymphoma; induction of diuresis or remission of proteinuria in idiopathic nephrotic syndrome or lupus erythematosus.[L8255] A triamcinolone intravitreal injection is indicated for the treatment of sympathetic ophthalmia, temporal arteritis, uveitis, and ocular inflammatory conditions.[L8261] The intravitreal injection is also used for visualization during vitrectomy.[L8261] An extended release suspension is indicated intra-articularly for management of pain in osteoarthritis of the knee.[L8264]



A triamcinolone acetonide suspension for injection into the suprachoroidal space is indicated for the treatment of macular edema associated with uveitis.[L38963]', 'Corticosteroids like triamcinolone inhibit phospholipase A2 on cell membranes, preventing the breakdown of lysosomal membranes of leukocytes, which in turn prevent the formation of arachidonic acid, which decrease expression of cyclooxygenase and lipoxygenase, inhibiting synthesis of prostaglandins and leukotrienes.[A184463] Anti-inflammatory activity occurs via reversal of vascular dilation and reducing permeability, which prevents macrophage and leukocyte migration.[A184463] Triamcinolone also inhibits nuclear factor kappa-B, which decreases the production of pro-inflammatory signals such as interleukin-6, interleukin-8, and monocyte chemoattractant protein-1.[A184463]', 'Triamcinolone is a corticosteroid with anti-inflammatory properties.[A184463] These properties are used to treat inflammation in conditions that affect various organs and tissues.[L8261] Triamcinolone should not be administered as an epidural injection.[L8246,L8252,L8255,L8261,L8264]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23271, 'Nasal clean alkaline wash pd. 6 sachets', 'نازال كلين غسول قلوي للأنف 6 اكياس', '8', NULL, 'Nasal/vaginal wash', 'Borax+sodium bicarbonate+sodium chloride', 'El nile. > arabian international group (aig)', 'Sachet', 'أكياس', NULL, '1', NULL, 'about borax a complex borate mineral antimicrobial.', NULL, NULL, 1254, '2022-08-17', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23272, 'Nashiliv 10 mg 20 f.c.tabs.', 'ناشيليف 10مجم 20 قرص', '198', NULL, 'Farnesoid x receptor (fxr) agonist', 'Obeticholic acid', 'Marcyrl', 'Tab', 'أقراص', '10 mg', '2', 'دهون الكبد وتليف الكبد', 'indicated for primary biliary cholangitis (pbc) in combination with ursodeoxycholic acid (udca) in adults with an inadequate response to udca for at least 1 yr or as monotherapy in adults unable to tolerate udca. mechanism of action fxr is a nuclear recep', '6223003571832', NULL, 7838, '2023-04-26', 0, 'Obeticholic acid is indicated for the treatment of primary biliary cholangitis in combination with ursodeoxycholic acid (UDCA) in adults with an inadequate response to UDCA. It is also used as a monotherapy in adults with PBC that are unable to tolerate UDCA.[L12633]



Obeticholic acid is currently being considered for FDA approval to treat fibrosis caused by non-alcoholic liver steatohepatitis (NASH), and is likely to be approved for this indication in 2020.[L12636]', 'Primary biliary cirrhosis is an autoimmune process by which the bile ducts and liver are damaged progressively, leading to fibrosis and cirrhosis. Bile acids increase the risk of damage and fibrosis to the damaged bile ducts.[A192786,A192795]  



Obeticholic acid is a potent agonist of the farnesoid X receptor, which serves to regulate the hepatic metabolism of bile and cholesterol. This drug acts by binding to the farnesoid X receptor (FXR), found in the nucleus of liver and intestinal cells, which in turn increases liver bile flow, suppressing its production and decreasing hepatocyte exposure to excess levels of bile with cholestasis. Cholestasis is a process that normally causes inflammation and cirrhosis of the liver.[A192792,L12633]', 'The activation of the FXR by obeticholic acid acts to reduce the synthesis of bile acids, inflammation, and the resulting hepatic fibrosis. This may increase the survival of patients with PBC, but to date, an association between obeticholic acid and survival in PBC has not been established.[A192786,L12633]





', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23273, 'Nashiliv 5 mg 20 f.c.tab', 'ناشيليف 5 مجم 20 اقراص', '144', '126', 'Farnesoid x receptor (fxr) agonist . fatty liver and liver cirrhosis', 'Obeticholic acid', 'Marcyrl', 'Tab', 'أقراص', '5 mg', '2', 'دهون الكبد وتليف الكبد', NULL, '6223003571849', NULL, 7866, '2023-08-13', 0, 'Obeticholic acid is indicated for the treatment of primary biliary cholangitis in combination with ursodeoxycholic acid (UDCA) in adults with an inadequate response to UDCA. It is also used as a monotherapy in adults with PBC that are unable to tolerate UDCA.[L12633]



Obeticholic acid is currently being considered for FDA approval to treat fibrosis caused by non-alcoholic liver steatohepatitis (NASH), and is likely to be approved for this indication in 2020.[L12636]', 'Primary biliary cirrhosis is an autoimmune process by which the bile ducts and liver are damaged progressively, leading to fibrosis and cirrhosis. Bile acids increase the risk of damage and fibrosis to the damaged bile ducts.[A192786,A192795]  



Obeticholic acid is a potent agonist of the farnesoid X receptor, which serves to regulate the hepatic metabolism of bile and cholesterol. This drug acts by binding to the farnesoid X receptor (FXR), found in the nucleus of liver and intestinal cells, which in turn increases liver bile flow, suppressing its production and decreasing hepatocyte exposure to excess levels of bile with cholestasis. Cholestasis is a process that normally causes inflammation and cirrhosis of the liver.[A192792,L12633]', 'The activation of the FXR by obeticholic acid acts to reduce the synthesis of bile acids, inflammation, and the resulting hepatic fibrosis. This may increase the survival of patients with PBC, but to date, an association between obeticholic acid and survival in PBC has not been established.[A192786,L12633]





', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23274, 'Nasid gel 50 gm', 'نازيد جل 50جم', '9', NULL, 'Massage', NULL, 'Hi-care > falcon group', 'Gel', 'جل', '50 gm', '1', NULL, NULL, NULL, NULL, 598, '2022-07-12', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23275, 'Naso-cyanocobalamin 500mcg/dose nasal spray 2.3ml', 'نازو-سيانوكوبالامين 500مكجم/جرعة سبراي للانف 2.3 مل', '56', NULL, 'Vitamin b', 'Cyanocobalamine', 'Global napi pharmaceuticals > global advanced pharmaceutical (gap)', 'Spray', 'بخاخ', '500mcg', '1', NULL, 'description cyanocobalamin (commonly known as vitamin b12) is the most chemically complex of all the vitamins. cyanocobalaminï-s structure is based on a corrin ring which although similar to the porphyrin ring found in heme chlorophyll and cytochrome has', NULL, NULL, 1422, '2022-06-28', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23276, 'Nasoflutin nasal spray 120 doses', 'نازوفلوتين بخاخ للانف 120 جرعة', '90', '58.5', 'Bronchodilator.anti-inflammatory.glucocorticoid steroid', 'Fluticasone furoate', 'European egyptian pharm. ind.', 'Spray', 'بخاخ', NULL, '1', 'مضاد للحساسية ومضاد للالتهاب', 'about fluticasone synthetic topical glucocorticoid anti inflammatory and antipruritic in corticosteroid-responsive dermatoses; atopic dermatitis. mechanism of action of fluticasone it reduces prostaglandin synthesis by inhibiting cyclo oxygenase enzymes b', '6221076160793', NULL, 16207, '2024-09-18', 0, 'Fluticasone propionate is indicated as an inhaler for the treatment and management of asthma by prophylaxis[FDA Label]as well as inflammatory and pruritic dermatoses[F4355]. Fluticasone propionate nasal spray is indicated for managing allergic and nonallergic rhinitis[L8309,F4358].', 'Fluticasone propionate works through an unknown mechanism to  affect the action of various cell types and mediators of inflammation[F4358]. Fluticasone propionate activates glucocorticoid receptors and inhibits lung eosinophilia in rats[F4358,F4355].', 'Systemically, fluticasone propionate activates glucocorticoid receptors, and inhibits lung eosinophilia in rats[F4358][FDA Label]. Fluticasone propionate as a topical formulation is also associated with vasoconstriction in the skin[F4355,A177118].', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23278, 'Nasopectra 125/50 mcg nasal spray 120 actuations', 'نازوبكترا 125/50مكجم بخاخ للأنف', '103', '75', 'Antihistamine.mast cell stabilizer plus corticosteroid', 'Azelastine+fluticasone propionate', 'Mdi pharma', 'Spray', 'بخاخ', '50 mcg', '1', 'مضاد لحساسية الانف', 'description: azelastine a phthalazine derivative is an antihistamine and mast cell stabilizer available as a nasal spray for hay fever and as eye drops for allergic conjunctivitis. indication : for the symptomatic treatment of seasonal allergic rhinitis a', '6224002249081', NULL, 10321, '2024-07-13', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23279, 'Nasopharm 0.05% spray', 'نازوفارم 0.05% بخاخ', '3', NULL, 'Nasal congestion.adrenergic alpha-agonist', 'Oxymetazoline', 'Mup > egyptian pharmacists company', 'Spray', 'بخاخ', '0.05%', '1', NULL, 'about oxymetazoline alpha adrenergic agonist imidazoline derivative vasoconstrictor (nasal decongestant). mechanism of action of oxymetazoline it is a nasal decongestant with selective alpha-2 agonistic action. it produces local vasoconstriction reduces b', NULL, NULL, 1126, '2022-07-08', 0, 'Oxymetazoline is indicated for the topical treatment of persistent facial erythema associated with rosacea in adults.[L15062]



Ophthalmic oxymetazoline is indicated for the treatment of acquired blepharoptosis in adults.[L15067]



When used in combination with tetracaine intranasally, oxymetazoline is indicated for regional anesthesia when performing a restorative procedure on Teeth 4-13 and A-J in adults and children who weigh 40 kg or more.[L15057]



Oxymetazoline can be found in over-the-counter nasal products as a nasal decongestant.[L15092]



For off-label uses, oxymetazoline has been used during nasal intubation and during ear, nose, and throat surgery to improve visualization of the airway and to minimize post-operative bleeding.[A215542]', 'Oxymetazoline binds to α<sub>1</sub>- and α<sub>2</sub>-adrenoceptors, which are Gq- and Gi-protein-coupled receptors respectively. α<sub>1</sub>-adrenoceptors agonism promotes vascular smooth muscle contraction by increasing intracellular calcium levels through activating phospholipase C, while α<sub>2</sub>-adrenoceptors agonism, specifically the α<sub>2B</sub>-adrenoceptors, can also elicit vasoconstriction through the inhibition of adenyl cyclase.[L30438,A261986,A261991,A261996]



Rosacea is a condition characterized by transient and persistent facial erythema. By stimulating α<sub>1A</sub>-adrenoceptors and causing vasoconstriction, oxymetazoline is believed to diminish the symptoms of erythema.[A226570] In blepharoptosis, it is hypothesized that oxymetazoline works by stimulating α-adrenergic receptors on the Müller muscle that elevates the upper eyelid, causing muscle contraction.[A226575] Oxymetazoline is used in combination with tetracaine for local anesthesia in dentistry. Such combination use adds beneficial effects: the vasoconstrictor counteracts the local anesthetic agent''s vasodilatory action, thereby constricting dilated arterioles and reducing blood flow to the application area.[A215572, L15057] Oxymetazoline relieves nasal congestion by vasoconstricting the respiratory microvasculature, in both resistance and capacitance blood vessels on the human nasal mucosa, leading to decreased nasal mucosal blood flow, edema, and airflow resistance.[A215592, L30438]', 'Oxymetazoline is an adrenergic α<sub>1</sub>- and α<sub>2</sub>-agonist and a direct-acting sympathomimetic drug. By stimulating adrenergic receptors, oxymetazoline causes vasoconstriction of dilated arterioles and reduces blood flow.[L15057] In a radioligand competition study, oxymetazoline displayed higher affinity at α<sub>1A</sub>-adrenoceptors compared to α<sub>2B</sub>-adrenoceptors, but with higher potency at α<sub>2B</sub>-adrenoceptors.[A6969] When sprayed intranasally, oxymetazoline relieved relief nasal congestion and improved nasal airflow in patients with acute coryzal rhinitis for up to 12 hours following a single dose.[A226580]



An early _in vitro_ study demonstrated oxymetazoline to exert anti-oxidant actions, where it inhibited microsomal lipid peroxidation and mediated hydroxyl radical scavenging activity. This suggests that oxymetazoline has a beneficial effect against oxidants, which play a role in tissue damage in inflammation.[A228538]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23280, 'Nasostop 0.05% paed nasal drops 15 ml', 'نازوستوب 0.05% نقط للانف للاطفال 15مل', '18', '11', 'Nasal congestion.adrenergic alpha-agonist', 'Xylometazoline', 'Hi-pharm', 'Drops', 'نقط', '0.05%', '1', NULL, 'about xylometazoline imidazoline derivative alpha-2 adrenergic agonist topical nasal decongestant. mechanism of action of xylometazoline it is a nasal decongestant with selective alpha-2 agonistic action. it produces local vasoconstriction reduces blood f', '6224001050305', NULL, 1382, '2024-09-28', 0, 'Xylometazoline is indicated for the temporary relief of nasal congestion due to cold, hay fever or other respiratory allergies.[L31598]', 'Nasal congestion is caused by various etiologies, such as rhinosinusitis and allergic or non-allergic rhinitis, leading to congestion of the venous sinusoids lining the nasal mucosa. Activation of α-adrenergic receptors leads to vasoconstriction of the blood vessels of the nasal mucosa and resumption of nasal airflow.[A228533] As the most abundantly expressed in the human nasal mucosa, α<sub>1A</sub>- and α<sub>2B</sub>-adrenoceptors may play the most important role in vasoconstriction of the human nasal mucosa. Xylometazoline is a more selective agonist at α<sub>2B</sub>-adrenoceptors,[A6969, A228533] with affinity at α<sub>1A</sub>-, α<sub>2A</sub>-, α<sub>2C</sub>-, α<sub>1B</sub>-, and α<sub>1D</sub>-adrenoceptors.[A6969] Xylometazoline decreases nasal resistance during inspiration and expiration and increases the volume of nasal airflow. Compared to [oxymetazoline], another imidazoline nasal decongestant, xylometazoline had a slightly faster onset of action although they had a similar duration of action.[A228533] In one study, subjects with nasal congestion reported relief of earache and sore throat in addition to nasal decongestion: it is speculated that oxymetazoline mediates this effect by causing vasoconstriction of the nasal mucosa that contains the venous sinuses and nasal decongestion allows breathing through the nose, providing relief from sore throat caused by mouth breathing that dries and irritates the throat.[A228508]', 'Xylometazoline is a sympathomimetic agent that causes vasoconstriction of the nasal mucosa. In one study comprising subjects with nasal congestion associated with the common cold, the median time of onset of subjective relief of nasal congestion was about 1.7 minutes and the time of subjective peak relief of nasal congestion was 30 minutes.[A228508] Previous studies reported rebound swelling, rebound nasal congestion, rhinitis medicamentosa, and shorter duration of decongestant effect from the long-term use of xylometazoline in healthy volunteers, suggesting that the drug is most effective if used temporarily.[A228508, A228518]



An early _in vitro_ study demonstrated xylometazoline to exert anti-oxidant actions, where it inhibited microsomal lipid peroxidation and mediated hydroxyl radical scavenging activity. This suggests that xylometazoline has a beneficial effect against oxidants, which play a role in tissue damage in inflammation.[A228538]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23284, 'Nassar 8 tabs 1 strip laxative', 'نصار اقراص ملينة شريط 8 اقراص', '13', '9', 'Laxative', 'Aloe+belladonna+colocynth+scammony resin', 'Alexandria', 'Tab', 'أقراص', NULL, '1', '1- علاج حالات الامساك الحاد والمزمن.', NULL, '6223000170748', NULL, 1752, '2024-09-05', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23286, 'Natalo baby lotion 120 ml', 'ناتالو بيبي لوشن 120 مل', '85', '53', 'Soothing topical', NULL, 'Hi-care > avicenna pharm', 'Lotion', 'لوشن', '120 ml', '1', 'لوشن وترطيب الجلد وتنعيمه __ يعمل علي إعطاء ملمس ناعم للجلد', 'soothing lotion', NULL, NULL, 4024, '2025-08-20', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23287, 'Natamet 5% eye drops 5 ml (illegal import)', 'ناتاميت 5% قطرة للعين 5مل', '0', NULL, 'Antifungal', 'Natamycin', 'Sun pharmaceutical ind. ltd.', 'Drops', 'نقط', '5%', '1', 'مضاد للفطريات يستخدم فى علاج التهابات العين', 'about natamycin a naturally occurring polyene macrolide antibiotic antifungal antibiotic. side effects of natamycin: conjunctival hyperemia irritation & chemosis. contra-indications of natamycin: hypersensitivity. special precautions while taking natamyci', NULL, NULL, 960, '2022-07-15', 0, 'For the treatment of fungal blepharitis, conjunctivitis, and keratitis caused by susceptible organisms including <i>Fusarium solani</i> keratitis.', 'Like other polyene antibiotics, Natamycin inhibits fungal growth by binding to sterols. Specifically, Natamycin binds to ergosterol in the plasma membrane, preventing ergosterol-dependent fusion of vacuoles, as well as membrane fusion and fission. This differs from the mechanism of most other polyene antibiotics, which tend to work by altering fungal membrane permeability instead.', 'Natamycin is an antifungal drug for topical ophthalmic administration. It is a tetraene polyene antibiotic derived from <i>Streptomyces natalensis</i>. It possesses in vitro activity against a variety of yeast and filamentous fungi, including <i>Candida</i>, <i>Aspergillus</i>, <i>Cephalosporium</i>, <i>Fusarium</i> and <i>Penicillium</i>. Although the activity against fungi is dose-related, natamycin is predominantly fungicidal. Natamycin is not effective in vitro against gram-positive or gram-negative bacteria. Topical administration appears to produce effective concentrations of natamycin within the corneal stroma but not in intraocular fluid.', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23289, 'Nataria cream 50 gm', 'ناتاريا كريم 50 جم', '90', '75', 'Healing topical', 'Panthenol+calendula extract+chlorhexidine+triclosan+paraffin oil', 'Macro group pharmaceuticals', 'Cream', 'كريم', '50 gm', '1', NULL, '*topical healing stimulator cream with panthenol marvelous effect for skin wounds & burns care *supports normal & healthy skin repair by moisturization power. *renovating formula with antimicrobial & anti-inflammatory ingredients. how to use - a suitable', '6224000437527', NULL, 2663, '2025-02-09', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23290, 'Natead 100mcg/2ml vial', 'ناتياد 100ميكروجرام/2مل فيال', '210', NULL, 'Immunoglobulin g', 'Rho(d)human immunoglobulin', 'Lfb-biomedicaments- france > biovax egypt', 'Vial', 'فيال', '100mcg', '1', NULL, NULL, NULL, NULL, 649, '2022-07-08', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23292, 'Downoprazol 20/1680mg pd. for oral susp. 7 sachets', 'داونوبرازول 20/1680مجم بودر 7 أكياس', '35', '24.5', 'Peptic ulcer - proton pump inhibitor', 'Omeprazole+sodium bicarbonate', 'Medizen pharmaceutical industries > utopia pharmaceuticals company', 'Susp', 'معلق', '1680mg', '7', 'الحموضة وقرحة المعدة', 'about omeprazole proton pump inhibitor substituted benzimidazole anti-secretory antiulcer. mechanism of action of omeprazole omeprazole is a proton pump inhibitor and it is a prodrug. after administration it diffuses in to the parietal cell of the stomach', '6224009687022', NULL, 2171, '2024-06-25', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23294, 'Natrinos nasal spray 20 ml', 'ناترينوس بخاخ سبراي للانف 20 مل', '42', '32.4', 'Nasal care', 'Aloe+potassium chloride+sodium chloride anhydrous', 'Kahira > bioxell pharma', 'Spray', 'بخاخ', '20 ml', '1', 'بخاخ للانف ليساعد علي التنفس في حالات البرد والانفلونزا وانسداد الأنف __ تقليل الكحة __ التخلص من المخاط', 'each nasal spray bottle contains 100 mg of sodium chloride 100 mg of potassium chloride and 100 mg of aloe vera. * to help restore the physiological functions of the nasal mucosa. * to use in case of dry nose stuffy nose and can be used in any season. * c', NULL, NULL, 989, '2024-03-20', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23295, 'Natristazen sr 1.5mg 30 f.c. tabs.', 'ناتريستازين اس ار 1.5مجم 30 اقراص', '17', '11', 'Diuretic', 'Indapamide', 'Medizen pharmaceutical industries', 'Tab', 'أقراص', '1.5mg', '3', NULL, 'about indapamide thiazide-related(a non-thiazide sulphonamide) drug diuretic antihypertensive. mechanism of action of indapamide it exerts thiazides like diuretic action by acting at site-3(central dilating segment of early distal tubule). it binds to na+', NULL, NULL, 1220, '2023-10-12', 0, 'Indapamide is a diuretic indicated for use as monotherapy or in combination with other blood pressure-lowering agents to treat hypertension.[L13982] It may also be used to treat fluid and salt retention associated with congestive heart failure.[L13982]

', 'Indapamide acts on the nephron, specifically at the proximal segment of the distal convoluted tubule where it inhibits the Na+/Cl- cotransporter, leading to reduced sodium reabsorption.[A203519,A16729] As a result, sodium and water are retained in the lumen of the nephron for urinary excretion.[A185180] The effects that follow include reduced plasma volume, reduced venous return, lower cardiac output, and ultimately decreased blood pressure.[A16729]



Interestingly, it is likely that thiazide-like diuretics such as indapamide have additional blood pressure lowering mechanisms that are unrelated to diuresis.[A16729] This is exemplified by the observation that the antihypertensive effects of thiazides are sustained 4-6 weeks after initiation of therapy, despite recovering plasma and extracellular fluid volumes.[A16729] 



Some studies have suggested that indapamide may decrease responsiveness to pressor agents while others have suggested it can decrease peripheral resistance.[A203627] Although it is clear that diuresis contributes to the antihypertensive effects of indapamide, further studies are needed to investigate the medication’s ability to decrease peripheral vascular resistance and relax vascular smooth muscle.[A203627]', 'Classified as a sulfonamide diuretic, indapamide is an effective antihypertensive agent and by extension, has shown efficacy in the prevention of target organ damage.[A203627,A203660]

Administration of indapamide produces water and electrolyte loss, with higher doses associated with increased diuresis.[A203627,A204068] Severe and clinically significant electrolyte disturbances may occur with indapamide use - for example, hypokalemia resulting from renal potassium loss may lead to QTc prolongation.[A203627,A204062] Further electrolyte imbalances may occur due to renal excretion of sodium, chloride, and magnesium.[A203627,A204062,A204068] 



Other indapamide induced changes include increases in plasma renin and aldosterone, and reduced calcium excretion in the urine.[A203627,A204074,A204131] In many studies investigating the effects of indapamide in both non-diabetic and diabetic hypertensive patients, glucose tolerance was not significantly altered.[A203627] However, additional studies are necessary to assess the long term metabolic impacts of indapamide, since thiazide related impaired glucose tolerance can take several years to develop in non-diabetic patients.[A203627]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23296, 'Natrixam m.r. 1.5/10mg 28 f.c. tabs.', 'ناتريكسام ام ار 1.5/10مجم 28 قرص', '102', '88', 'Antihypertensive.combined diuretic with calcium channel blocker', 'Indapamide+amlodipine', 'Servier', 'Tab', 'أقراص', '10mg', '4', 'لعلاج مرضى ارتفاع ضغط الدم', 'amlodipine/indapamide is indicated as substitution therapy for treatment of essential hypertension in patients already controlled with indapamide and amlodipine given concurrently at the same dose level. dosage: one tablet per day as single dose preferabl', '6223003960711', NULL, 2706, '2025-03-05', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23297, 'Natrixam m.r. 1.5/5mg 28 f.c. tabs.', 'ناتريكسام ام ار 1.5/10مجم 28 اقراص', '88', NULL, 'Antihypertensive.combined diuretic with calcium channel blocker', 'Indapamide+amlodipine', 'Servier', 'Tab', 'أقراص', '5mg', '4', NULL, 'amlodipine/indapamide is indicated as substitution therapy for treatment of essential hypertension in patients already controlled with indapamide and amlodipine given concurrently at the same dose level. dosage: one tablet per day as single dose preferabl', '6223003960728', NULL, 1077, '2022-08-02', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23298, 'Natrol 100 mg 10 sachets', 'ناترول 100مجم 10 اكياس', '58', NULL, 'Iron supplement', 'Lactoferrin', 'Topix nutrition > egypharm', 'Sachet', 'أكياس', '100 mg', '1', NULL, 'lactoferrin is a bioactive 80-kda iron binding glycoprotein. dosage: 1 sachet to be dissolved in quarter glass of water and taken twice daily before meals.', NULL, NULL, 1134, '2022-07-07', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23299, 'Natrol 100 mg 30 sachets', 'ناترول 100مجم30كيس', '155', NULL, 'Iron supplement', 'Lactoferrin', 'Topix nutrition > egypharm', 'Sachet', 'أكياس', '100 mg', '3', NULL, 'lactoferrin is a bioactive 80-kda iron binding glycoprotein. dosage: 1 sachet to be dissolved in quarter glass of water and taken twice daily before meals.', NULL, NULL, 849, '2022-07-26', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23300, 'Natry facial wash 250 ml', 'ناتري غسول وجه 250 مل', '165', '145', 'Skin care', 'Zinc sulfate+thyme extract+tea tree oil+salicylic acid+panthenol+glycerin+foaming base', 'Macro group pharmaceuticals', 'Facial wash', 'غسول للوجه', '250 ml', '1', 'للعناية ببشرة الوجه', '- an effective ph balanced facial cleanser for acne prone skin care with extra moisturizing & astringent properties. - helps in alleviation skin redness & irritation resulting from acne - it has a mild exfoliating effect that removes dead cells & prevents', '6224000437640', NULL, 4245, '2025-03-04', 0, 'Zinc can be used for the treatment and prevention of zinc deficiency/its consequences, including stunted growth and acute diarrhea in children, and slowed wound healing. It is also utilized for boosting the immune system, treating the common cold and recurrent ear infections, as well as preventing lower respiratory tract infections [L2172].  



', '**Zinc has three primary biological roles**: _catalytic_, _structural_, and _regulatory_. The catalytic and structural role of zinc is well established, and there are various noteworthy reviews on these functions. For example, zinc is a structural constituent in numerous proteins, inclusive of growth factors, cytokines, receptors, enzymes, and transcription factors for different cellular signaling pathways. It is implicated in numerous cellular processes as a cofactor for approximately 3000 human proteins including enzymes, nuclear factors, and hormones [L2096].



Zinc promotes resistance to epithelial apoptosis through cell protection (cytoprotection) against reactive oxygen species and bacterial toxins, likely through the antioxidant activity of the cysteine-rich metallothioneins [A32419].



In HL-60 cells (promyelocytic leukemia cell line), zinc enhances the up-regulation of A20 mRNA, which, via TRAF pathway, decreases NF-kappaB activation, leading to decreased gene expression and generation of tumor necrosis factor-alpha (TNF-alpha), IL-1beta, and IL-8 [A32418].



There are several mechanisms of action of zinc on acute diarrhea. Various mechanisms are specific to the gastrointestinal system: zinc restores mucosal barrier integrity and enterocyte brush-border enzyme activity, it promotes the production of antibodies and circulating lymphocytes against intestinal pathogens, and has a direct effect on ion channels, acting as a potassium channel blocker of adenosine 3-5-cyclic monophosphate-mediated chlorine secretion. Cochrane researchers examined the evidence available up to 30 September 2016 [L2106].



Zinc deficiency in humans decreases the activity of serum _thymulin_ (a hormone of the thymus), which is necessary for the maturation of T-helper cells. T-helper 1 (Th(1)) cytokines are decreased but T-helper 2 (Th(2)) cytokines are not affected by zinc deficiency in humans [A32417].



The change of _Th(1)_ to _Th(2)_ function leads to cell-mediated immune dysfunction. Because IL-2 production (Th(1) cytokine) is decreased, this causes decreased activity of natural-killer-cell (NK cell) and T cytolytic cells, normally involved in killing viruses, bacteria, and malignant cells [A32424]. 



In humans, zinc deficiency may lead to the generation of new CD4+ T cells, produced in the thymus. In cell culture studies (HUT-78, a Th(0) human malignant lymphoblastoid cell line), as a result of zinc deficiency, nuclear factor-kappaB (NF-kappaB) activation, phosphorylation of IkappaB, and binding of NF-kappaB to DNA are decreased and this results in decreased Th(1) cytokine production [A32417].



In another study, zinc supplementation in human subjects suppressed the gene expression and production of pro-inflammatory cytokines and decreased oxidative stress markers [A32424]. In HL-60 cells (a human pro-myelocytic leukemia cell line), zinc deficiency increased the levels of TNF-alpha, IL-1beta, and IL-8 cytokines and mRNA. In such cells, zinc was found to induce A20, a zinc finger protein that inhibited NF-kappaB activation by the tumor necrosis factor receptor-associated factor pathway. This process decreased gene expression of pro-inflammatory cytokines and oxidative stress markers [A32417].



The exact mechanism of zinc in acne treatment is poorly understood. However, zinc is considered to act directly on microbial inflammatory equilibrium and facilitate antibiotic absorption when used in combination with other agents. Topical zinc alone as well as in combination with other agents may be efficacious because of its anti-inflammatory activity and ability to reduce P. acnes bacteria by the inhibition of P. acnes lipases and free fatty acid levels [L2102].', 'Zinc is involved in various aspects of cellular metabolism. It has been estimated that approximately 10% of human proteins may bind zinc, in addition to hundreds of proteins that transport and traffic zinc. It is required for the catalytic activity of more than 200 enzymes, and it plays a role in immune function wound healing, protein synthesis, DNA synthesis, and cell division. Zinc is an essential element for a proper sense of taste and smell and supports normal growth and development during pregnancy, childhood, and adolescence. It is thought to have antioxidant properties, which may be protective against accelerated aging and helps to speed up the healing process after an injury; however, studies differ as to its effectiveness. Zinc ions are effective antimicrobial agents even if administered in low concentrations [L2211].



Studies on oral zinc for specific conditions shows the following evidence in various conditions [L2095]:



**Colds:** Evidence suggests that if zinc lozenges or syrup are taken within 24 hours after cold symptoms start, the supplement may shorten the length of colds. The use intranasal zinc has been associated with the loss of the sense of smell, in some cases long-term or permanently [L2095].



**Wound healing:** Patients with skin ulcers and decreased levels of zinc may benefit from oral zinc supplements [L2095]. 



**Diahrrea**: Oral zinc supplements can reduce the symptoms of diarrhea in children with low levels of zinc, especially in cases of malnutrition [L2095].

', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23301, 'Natry soap 100 gm', 'ناتري صابون 100 جرام', '60', '50', 'Soap', 'Native hydrated aluminium silicate+irgazan(triclosan)+thyme oil+clove oil+lavender oil+almond oil+le', 'Macro group pharmaceuticals', 'Soap', 'صابون', '100 gm', '1', NULL, 'for acne black heads and dark spots', '6224000437145', NULL, 4172, '2025-03-04', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23302, 'Natuferon 10m.i.u. i.m.vial', 'ناتوفيرون 10وحدة فيال فيال عضل', '600', NULL, 'Antiviral .interferon alfa', 'Interferon alfa', 'Otsuka', 'Vial', 'فيال', NULL, '1', NULL, 'mechanism of action interferon alpha binds to type i interferon receptors (ifnar1 and ifnar2c) which upon dimerization activate two jak (janus kinase) tyrosine kinases (jak1 and tyk2). these transphosphorylate themselves and phosphorylate the receptors. t', NULL, NULL, 762, '2022-07-22', 0, 'For the treatment of venereal or genital warts caused by the Human Papiloma Virus.', 'Interferon alpha binds to type I interferon receptors (IFNAR1 and IFNAR2c) which, upon dimerization, activate two Jak (Janus kinase) tyrosine kinases (Jak1 and Tyk2). These transphosphorylate themselves and phosphorylate the receptors. The phosphorylated INFAR receptors then bind to Stat1 and Stat2 (signal transducers and activators of transcription)which dimerize and activate multiple (~100) immunomodulatory and antiviral proteins. Interferon alpha binds less stably to type I interferon receptors than interferon beta.', 'Upregulates the expression of MHC I proteins, allowing for increased presentation of peptides derived from viral antigens. This enhances the activation of CD8+ T cells that are the precursors for cytotoxic T lymphocytes (CTLs) and makes the macrophage a better target for CTL-mediated killing. Interferon alpha also induce the synthesis of several key antiviral mediators, including 2''-5'' oligoadenylate synthetase (2''-5'' A synthetase) and protein kinase R.', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23303, 'Natuferon 2.5m.i.u. i.m.vial', 'ناتوفيرون 2.5مليون وحدة دولية فيال عضل', '150', NULL, 'Antiviral .interferon alfa', 'Interferon alfa', 'Otsuka', 'Vial', 'فيال', NULL, '1', NULL, 'mechanism of action interferon alpha binds to type i interferon receptors (ifnar1 and ifnar2c) which upon dimerization activate two jak (janus kinase) tyrosine kinases (jak1 and tyk2). these transphosphorylate themselves and phosphorylate the receptors. t', NULL, NULL, 860, '2022-06-18', 0, 'For the treatment of venereal or genital warts caused by the Human Papiloma Virus.', 'Interferon alpha binds to type I interferon receptors (IFNAR1 and IFNAR2c) which, upon dimerization, activate two Jak (Janus kinase) tyrosine kinases (Jak1 and Tyk2). These transphosphorylate themselves and phosphorylate the receptors. The phosphorylated INFAR receptors then bind to Stat1 and Stat2 (signal transducers and activators of transcription)which dimerize and activate multiple (~100) immunomodulatory and antiviral proteins. Interferon alpha binds less stably to type I interferon receptors than interferon beta.', 'Upregulates the expression of MHC I proteins, allowing for increased presentation of peptides derived from viral antigens. This enhances the activation of CD8+ T cells that are the precursors for cytotoxic T lymphocytes (CTLs) and makes the macrophage a better target for CTL-mediated killing. Interferon alpha also induce the synthesis of several key antiviral mediators, including 2''-5'' oligoadenylate synthetase (2''-5'' A synthetase) and protein kinase R.', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23304, 'Natuferon 5m.i.u. i.m.vial', 'ناتوفيرون 5مليون وحدة دولية فيال عضل', '300', NULL, 'Antiviral .interferon alfa', 'Interferon alfa', 'Otsuka', 'Vial', 'فيال', NULL, '1', NULL, 'mechanism of action interferon alpha binds to type i interferon receptors (ifnar1 and ifnar2c) which upon dimerization activate two jak (janus kinase) tyrosine kinases (jak1 and tyk2). these transphosphorylate themselves and phosphorylate the receptors. t', NULL, NULL, 718, '2022-06-18', 0, 'For the treatment of venereal or genital warts caused by the Human Papiloma Virus.', 'Interferon alpha binds to type I interferon receptors (IFNAR1 and IFNAR2c) which, upon dimerization, activate two Jak (Janus kinase) tyrosine kinases (Jak1 and Tyk2). These transphosphorylate themselves and phosphorylate the receptors. The phosphorylated INFAR receptors then bind to Stat1 and Stat2 (signal transducers and activators of transcription)which dimerize and activate multiple (~100) immunomodulatory and antiviral proteins. Interferon alpha binds less stably to type I interferon receptors than interferon beta.', 'Upregulates the expression of MHC I proteins, allowing for increased presentation of peptides derived from viral antigens. This enhances the activation of CD8+ T cells that are the precursors for cytotoxic T lymphocytes (CTLs) and makes the macrophage a better target for CTL-mediated killing. Interferon alpha also induce the synthesis of several key antiviral mediators, including 2''-5'' oligoadenylate synthetase (2''-5'' A synthetase) and protein kinase R.', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23305, 'Natulan 50 mg 50 caps.(illegal import)', 'ناتيولان 50مجم 50 كبسول مستورد', '0', NULL, 'Antineoplastic.alkylating agent', 'Procarbazine', 'Sigma-tau', 'Cap', 'كبسولة', '50 mg', '1', NULL, 'pharmacology inhibits dna rna and protein synthesis by inhibiting transmethylation of methionine into transfer rna; may also damage dna directly through alkylation. labeled indications treatment of hodgkin lymphoma. off label uses: *cns tumors anaplastic', NULL, NULL, 1057, '2022-07-10', 0, 'For use with other anticancer drugs for the treatment of stage III and stage IV Hodgkin''s disease.', 'The precise mode of cytotoxic action of procarbazine has not been clearly defined. There is evidence that the drug may act by inhibition of protein, RNA and DNA synthesis. Studies have suggested that procarbazine may inhibit transmethylation of methyl groups of methionine into t-RNA. The absence of functional t-RNA could cause the cessation of protein synthesis and consequently DNA and RNA synthesis. In addition, procarbazine may directly damage DNA. Hydrogen peroxide, formed during the auto-oxidation of the drug, may attack protein sulfhydryl groups contained in residual protein which is tightly bound to DNA.', 'Procarbazine is an antineoplastic in the class of alkylating agents and is used to treat various forms of cancer. Alkylating agents are so named because of their ability to add alkyl groups to many electronegative groups under conditions present in cells. They stop tumor growth by cross-linking guanine bases in DNA double-helix strands - directly attacking DNA. This makes the strands unable to uncoil and separate. As this is necessary in DNA replication, the cells can no longer divide. In addition, these drugs add methyl or other alkyl groups onto molecules where they do not belong which in turn inhibits their correct utilization by base pairing and causes a miscoding of DNA. Procarbazine is cell-phase specific for the S phase of cell division.', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23306, 'Natural brewer s yeast 7.5 grain 30 tabs.', 'ناتشورال برويرز ييست 7.5 جرين 30 قرص', '26', NULL, 'Vitamins', 'Brewer s yeast', 'Big pharma > s&s pharmaceuticals', 'Tab', 'أقراص', NULL, '3', NULL, NULL, NULL, NULL, 969, '2022-10-22', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23307, 'Natural colon aid 20 tabs.', 'ناتشورال كولون ايد 20 قرص', '35', NULL, 'Git disturbances', NULL, 'Jedco int. co. for pharmaceuticals > nerhadou international co.', 'Tab', 'أقراص', NULL, '2', NULL, NULL, NULL, NULL, 1053, '2022-10-22', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23308, 'Natural flax oil 1000mg 60 soft gels capsules (illegal import)', 'ناتشورال فلاكس اويل 1000مجم 60 كبسولة جيلاتينية', '0', NULL, 'Natural oil', 'Flaxseed oil', 'Puritans pride', 'Capsule', 'كبسولة', '1000mg', '1', 'علاج ارتفاع الكوليسترول -- الحماية من ارتفاع ضغط الدم -- الحماية من امراض القلب -- تقليل الوزن -- مقوي للاعصاب وخاصة لمرضي السكر', NULL, NULL, NULL, 690, '2022-10-22', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23309, 'Natural oyster shell calcium 30 tabs.', 'ناتشورال اويستر شيل كالسيوم 30 قرص', '30', NULL, 'Calcium supplement plus vitamin d', 'Calcium+vitamin d3', 'Big pharma > s&s pharmaceuticals', 'Tab', 'أقراص', NULL, '3', NULL, NULL, NULL, NULL, 957, '2022-10-22', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23310, 'Naudibact ear drops 5 ml', 'ناوديباكت نقط للاذن 5مل', '7', NULL, NULL, 'Dexamethasone+framycetin+gramicidin', 'Pharopharma', 'Drops', 'نقط', '5 ml', '1', NULL, NULL, NULL, NULL, 631, '2022-07-08', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23311, 'Nausetron 0.075mg/1.5ml vial for i.v.', 'نوزيترون 0.075مجم/1.5مل فيال', '128', NULL, 'Antiemetic', 'Palonosetron', 'Eva pharma', 'Vial', 'فيال', '0.075mg', '1', NULL, '*it is a serotonin-3 (5-ht3) receptor antagonist indicated in adults for (moderately to highly) emetogenic cancer chemotherapy and prevention of postoperative nausea and vomiting (ponv) for up to 24 hours following surgery. *it is also indicated in pediat', NULL, NULL, 808, '2022-07-23', 0, 'For the prevention of acute and delayed nausea and vomiting associated with initial and repeat courses of moderately emetogenic cancer chemotherapy, as well as prevention of acute nausea and vomiting associated with highly emetogenic cancer chemotherapy. Also used for the prevention of postoperative nausea and vomiting for up to 24 hours post operation.', 'Palonosetron is a selective serotonin 5-HT<sub>3</sub> receptor antagonist. The antiemetic activity of the drug is brought about through the inhibition of 5-HT<sub>3</sub> receptors present both centrally (medullary chemoreceptor zone) and peripherally (GI tract). This inhibition of 5-HT<sub>3</sub> receptors in turn inhibits the visceral afferent stimulation of the vomiting center, likely indirectly at the level of the area postrema, as well as through direct inhibition of serotonin activity within the area postrema and the chemoreceptor trigger zone. Alternative mechanisms appear to be primarily responsible for delayed nausea and vomiting induced by emetogenic chemotherapy, since similar temporal relationships between between serotonin and emesis beyond the first day after a dose have not been established, and 5-HT<sub>3</sub> receptor antagonists generally have not appeared to be effective alone in preventing or ameliorating delayed effects. It has been hypothesized that palonosetron''s potency and long plasma half-life may contribute to its observed efficacy in preventing delayed nausea and vomiting caused by moderately emetogenic cancer chemotherapy.', 'Palonosetron is an antinauseant and antiemetic agent indicated for the prevention of nausea and vomiting associated with moderately-emetogenic cancer chemotherapy and for the prevention of postoperative nausea and vomiting. Palonosetron is a highly specific and selective serotonin 5-HT<sub>3</sub> receptor antagonist that is pharmacologically related to other 5-HT<sub>3</sub> receptor antagonists, but differs structurally. Palonosetron has a high affinity for 5-HT<sub>3</sub> receptors, but has little to no affinity for other receptors. The serontonin 5-HT<sub>3</sub> receptors are located on the nerve terminals of the vagus in the periphery, and centrally in the chemoreceptor trigger zone of the area postrema. It is suggested that chemotherapeutic agents release serotonin from the enterochromaffin cells of the small intestine by causing degenerative changes in the GI tract. The serotonin then stimulates the vagal and splanchnic nerve receptors that project to the medullary vomiting center, as well as the 5-HT3 receptors in the area postrema, thus initiating the vomiting reflex, causing nausea and vomiting.', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23312, 'Nausetron 0.25mg/5ml vial for i.v.', 'نوزيترون 0.25مجم/5مل فيال', '330', NULL, 'Antiemetic', 'Palonosetron', 'Hikma specialized pharmaceuticals > eva pharma', 'Vial', 'فيال', '0.25mg', '1', NULL, '*it is a serotonin-3 (5-ht3) receptor antagonist indicated in adults for (moderately to highly) emetogenic cancer chemotherapy and prevention of postoperative nausea and vomiting (ponv) for up to 24 hours following surgery. *it is also indicated in pediat', NULL, NULL, 892, '2022-07-24', 0, 'For the prevention of acute and delayed nausea and vomiting associated with initial and repeat courses of moderately emetogenic cancer chemotherapy, as well as prevention of acute nausea and vomiting associated with highly emetogenic cancer chemotherapy. Also used for the prevention of postoperative nausea and vomiting for up to 24 hours post operation.', 'Palonosetron is a selective serotonin 5-HT<sub>3</sub> receptor antagonist. The antiemetic activity of the drug is brought about through the inhibition of 5-HT<sub>3</sub> receptors present both centrally (medullary chemoreceptor zone) and peripherally (GI tract). This inhibition of 5-HT<sub>3</sub> receptors in turn inhibits the visceral afferent stimulation of the vomiting center, likely indirectly at the level of the area postrema, as well as through direct inhibition of serotonin activity within the area postrema and the chemoreceptor trigger zone. Alternative mechanisms appear to be primarily responsible for delayed nausea and vomiting induced by emetogenic chemotherapy, since similar temporal relationships between between serotonin and emesis beyond the first day after a dose have not been established, and 5-HT<sub>3</sub> receptor antagonists generally have not appeared to be effective alone in preventing or ameliorating delayed effects. It has been hypothesized that palonosetron''s potency and long plasma half-life may contribute to its observed efficacy in preventing delayed nausea and vomiting caused by moderately emetogenic cancer chemotherapy.', 'Palonosetron is an antinauseant and antiemetic agent indicated for the prevention of nausea and vomiting associated with moderately-emetogenic cancer chemotherapy and for the prevention of postoperative nausea and vomiting. Palonosetron is a highly specific and selective serotonin 5-HT<sub>3</sub> receptor antagonist that is pharmacologically related to other 5-HT<sub>3</sub> receptor antagonists, but differs structurally. Palonosetron has a high affinity for 5-HT<sub>3</sub> receptors, but has little to no affinity for other receptors. The serontonin 5-HT<sub>3</sub> receptors are located on the nerve terminals of the vagus in the periphery, and centrally in the chemoreceptor trigger zone of the area postrema. It is suggested that chemotherapeutic agents release serotonin from the enterochromaffin cells of the small intestine by causing degenerative changes in the GI tract. The serotonin then stimulates the vagal and splanchnic nerve receptors that project to the medullary vomiting center, as well as the 5-HT3 receptors in the area postrema, thus initiating the vomiting reflex, causing nausea and vomiting.', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23313, 'Nausetron 0.5 mg 1 caps.', 'نوزيترون 0.5مجم 1 كبسول', '236', NULL, 'Antiemetic', 'Palonosetron', 'Eva pharma', 'Cap', 'كبسولة', '0.5 mg', '1', NULL, '*it is a serotonin-3 (5-ht3) receptor antagonist indicated in adults for (moderately to highly) emetogenic cancer chemotherapy and prevention of postoperative nausea and vomiting (ponv) for up to 24 hours following surgery. *it is also indicated in pediat', NULL, NULL, 814, '2022-07-29', 0, 'For the prevention of acute and delayed nausea and vomiting associated with initial and repeat courses of moderately emetogenic cancer chemotherapy, as well as prevention of acute nausea and vomiting associated with highly emetogenic cancer chemotherapy. Also used for the prevention of postoperative nausea and vomiting for up to 24 hours post operation.', 'Palonosetron is a selective serotonin 5-HT<sub>3</sub> receptor antagonist. The antiemetic activity of the drug is brought about through the inhibition of 5-HT<sub>3</sub> receptors present both centrally (medullary chemoreceptor zone) and peripherally (GI tract). This inhibition of 5-HT<sub>3</sub> receptors in turn inhibits the visceral afferent stimulation of the vomiting center, likely indirectly at the level of the area postrema, as well as through direct inhibition of serotonin activity within the area postrema and the chemoreceptor trigger zone. Alternative mechanisms appear to be primarily responsible for delayed nausea and vomiting induced by emetogenic chemotherapy, since similar temporal relationships between between serotonin and emesis beyond the first day after a dose have not been established, and 5-HT<sub>3</sub> receptor antagonists generally have not appeared to be effective alone in preventing or ameliorating delayed effects. It has been hypothesized that palonosetron''s potency and long plasma half-life may contribute to its observed efficacy in preventing delayed nausea and vomiting caused by moderately emetogenic cancer chemotherapy.', 'Palonosetron is an antinauseant and antiemetic agent indicated for the prevention of nausea and vomiting associated with moderately-emetogenic cancer chemotherapy and for the prevention of postoperative nausea and vomiting. Palonosetron is a highly specific and selective serotonin 5-HT<sub>3</sub> receptor antagonist that is pharmacologically related to other 5-HT<sub>3</sub> receptor antagonists, but differs structurally. Palonosetron has a high affinity for 5-HT<sub>3</sub> receptors, but has little to no affinity for other receptors. The serontonin 5-HT<sub>3</sub> receptors are located on the nerve terminals of the vagus in the periphery, and centrally in the chemoreceptor trigger zone of the area postrema. It is suggested that chemotherapeutic agents release serotonin from the enterochromaffin cells of the small intestine by causing degenerative changes in the GI tract. The serotonin then stimulates the vagal and splanchnic nerve receptors that project to the medullary vomiting center, as well as the 5-HT3 receptors in the area postrema, thus initiating the vomiting reflex, causing nausea and vomiting.', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23315, 'Navelbine 10 mg i.v. vial', 'نافيلباين 10مجم فيال وريد', '700', '495.5', 'Antineoplastic', 'Vinorelbine', 'Pierre - fabre france > egyptian pharmaceutical trading company', 'Vial', 'فيال', '10 mg', '1', 'مضاد للاورام -- لعلاج السرطان', 'vinorelbine (nvb) is a chemotherapy medication that is used to treat a number of types of cancer including breast cancer and non-small cell lung cancer. vinorelbine is approved for the treatment of non-small-cell lung cancer. it is used off-label for othe', NULL, NULL, 714, '2025-06-12', 0, '

 Vinorelbine tartrate is indicated for adults in the treatment of advanced non-small cell lung cancer (NSCLC), as a single therapy or in combination with other chemotherapeutic drugs [L1998].



Used in relapsed or refractory Hodgkin lymphoma, in combination with other chemotherapy agents [L2011].

 

For the treatment of desmoid tumor or aggressive fibromatosis, in combination with methotrexate [L2011].



For the treatment of recurrent or metastatic squamous cell head and neck cancer [L2011].



For the treatment of recurrent ovarian cancer [L2011].



For the treatment of metastatic breast cancer, in patients previously treated with anthracyline and/or taxane therapy [L2011].



For the treatment of HER2-positive, trastuzumab-resistant, advanced breast cancer in patients previously treated with a taxane, in combination with trastuzumab and everolimus [L2011].

', 'Vinca alkaloids are structurally similar compounds composed of two multi-ringed units, _vindoline_, and _catharanthine_. _Vinorelbine tartrate_ is a vinca alkaloid in which the catharanthine component is the target of structural modification [L2005], [L2006].



This structural modification contributes to unique pharmacologic properties.The antitumor activity of vinorelbine tartrate is believed to be owed to the inhibition of mitosis at metaphase via its interaction with tubulin [L1998].



Vinorelbine is a mitotic spindle poison that interferes with chromosomal segregation during mitosis, also known as cell division. It pauses cells at the _G2/M_ phases, when present at concentrations close to the half maximal inhibitory concentration (IC50). Microtubules, which are derived from polymers of tubulin, are the main target of vinorelbine. 



The chemical modification used to produce vinorelbine allows for the opening of the eight-member catharanthine ring with the formation of both a covalent and reversible bond with tubulin [L2007].



The relative contribution of different microtubule-associated proteins in the production of tubulin vary between neural tissue and proliferating cells and this has important functional implications. The ability of vinorelbine to bind specifically to mitotic rather than other microtubules has been shown and may suggest that neurotoxicity is less likely to be a problem than with the molecular mechanism of action [L2007]. 



As with other anti-microtubule agents, vinorelbine is known to contribute apoptosis in malignant cells. The exact mechanisms by which this process occurs are complex and many details are yet to be elucidated. The disarray of the microtubule structure has a number of effects, including the induction of tumor suppressor gene _p53_ and activation/inactivation of a number of protein kinases involved in essential signaling pathways, including _p21 WAF1/CIP1_ and _Ras/Raf_, _PKC/PKA_. These molecular changes lead to phosphorylation and consequently inactivation of the apoptosis inhibitor _Bcl2_. This, in turn, results in a decrease in the formation of heterodimers between _Bcl2_ and the pro-apoptotic gene _BAX_, stimulating the sequence of cell apoptosis [L2007].



Vinorelbine tartrate also possibly interferes with amino acid, cyclic AMP and glutathione metabolism, calmodulin-dependent Ca++-transport ATPase activity, cellular respiration, and nucleic acid and lipid biosynthesis [L1998].

', '

Vinorelbine is a semi-synthetic vinca-alkaloid with a wide spectrum of anti-tumor activity. The vinca-alkaloids are considered spindle poisons. They work by interfering with the polymerization of tubulin, a protein responsible for building the microtubule system which appears during cell division in proliferating cancer cells [L2007].', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23316, 'Navelbine 20 mg 1 caps', 'نافيلبين 20 مجم 1 كبسولة', '2,000', '856', 'Antineoplastic', 'Vinorelbine', 'Pierre - fabre france > egyptian pharmaceutical trading company', 'Cap', 'كبسولة', '20 mg', '1', 'مضاد للاورام -- لعلاج السرطان', NULL, NULL, NULL, 1487, '2025-06-12', 0, '

 Vinorelbine tartrate is indicated for adults in the treatment of advanced non-small cell lung cancer (NSCLC), as a single therapy or in combination with other chemotherapeutic drugs [L1998].



Used in relapsed or refractory Hodgkin lymphoma, in combination with other chemotherapy agents [L2011].

 

For the treatment of desmoid tumor or aggressive fibromatosis, in combination with methotrexate [L2011].



For the treatment of recurrent or metastatic squamous cell head and neck cancer [L2011].



For the treatment of recurrent ovarian cancer [L2011].



For the treatment of metastatic breast cancer, in patients previously treated with anthracyline and/or taxane therapy [L2011].



For the treatment of HER2-positive, trastuzumab-resistant, advanced breast cancer in patients previously treated with a taxane, in combination with trastuzumab and everolimus [L2011].

', 'Vinca alkaloids are structurally similar compounds composed of two multi-ringed units, _vindoline_, and _catharanthine_. _Vinorelbine tartrate_ is a vinca alkaloid in which the catharanthine component is the target of structural modification [L2005], [L2006].



This structural modification contributes to unique pharmacologic properties.The antitumor activity of vinorelbine tartrate is believed to be owed to the inhibition of mitosis at metaphase via its interaction with tubulin [L1998].



Vinorelbine is a mitotic spindle poison that interferes with chromosomal segregation during mitosis, also known as cell division. It pauses cells at the _G2/M_ phases, when present at concentrations close to the half maximal inhibitory concentration (IC50). Microtubules, which are derived from polymers of tubulin, are the main target of vinorelbine. 



The chemical modification used to produce vinorelbine allows for the opening of the eight-member catharanthine ring with the formation of both a covalent and reversible bond with tubulin [L2007].



The relative contribution of different microtubule-associated proteins in the production of tubulin vary between neural tissue and proliferating cells and this has important functional implications. The ability of vinorelbine to bind specifically to mitotic rather than other microtubules has been shown and may suggest that neurotoxicity is less likely to be a problem than with the molecular mechanism of action [L2007]. 



As with other anti-microtubule agents, vinorelbine is known to contribute apoptosis in malignant cells. The exact mechanisms by which this process occurs are complex and many details are yet to be elucidated. The disarray of the microtubule structure has a number of effects, including the induction of tumor suppressor gene _p53_ and activation/inactivation of a number of protein kinases involved in essential signaling pathways, including _p21 WAF1/CIP1_ and _Ras/Raf_, _PKC/PKA_. These molecular changes lead to phosphorylation and consequently inactivation of the apoptosis inhibitor _Bcl2_. This, in turn, results in a decrease in the formation of heterodimers between _Bcl2_ and the pro-apoptotic gene _BAX_, stimulating the sequence of cell apoptosis [L2007].



Vinorelbine tartrate also possibly interferes with amino acid, cyclic AMP and glutathione metabolism, calmodulin-dependent Ca++-transport ATPase activity, cellular respiration, and nucleic acid and lipid biosynthesis [L1998].

', '

Vinorelbine is a semi-synthetic vinca-alkaloid with a wide spectrum of anti-tumor activity. The vinca-alkaloids are considered spindle poisons. They work by interfering with the polymerization of tubulin, a protein responsible for building the microtubule system which appears during cell division in proliferating cancer cells [L2007].', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23317, 'Navelbine 30 mg 1 caps', 'نافيلباين 30مجم 1 كبسولة واحدة', '2,900', '1286', 'Antineoplastic', 'Vinorelbine', 'Pierre - fabre france > egyptian pharmaceutical trading company', 'Cap', 'كبسولة', '30 mg', '1', 'مضاد للاورام -- لعلاج السرطان', NULL, NULL, NULL, 4337, '2025-06-12', 0, '

 Vinorelbine tartrate is indicated for adults in the treatment of advanced non-small cell lung cancer (NSCLC), as a single therapy or in combination with other chemotherapeutic drugs [L1998].



Used in relapsed or refractory Hodgkin lymphoma, in combination with other chemotherapy agents [L2011].

 

For the treatment of desmoid tumor or aggressive fibromatosis, in combination with methotrexate [L2011].



For the treatment of recurrent or metastatic squamous cell head and neck cancer [L2011].



For the treatment of recurrent ovarian cancer [L2011].



For the treatment of metastatic breast cancer, in patients previously treated with anthracyline and/or taxane therapy [L2011].



For the treatment of HER2-positive, trastuzumab-resistant, advanced breast cancer in patients previously treated with a taxane, in combination with trastuzumab and everolimus [L2011].

', 'Vinca alkaloids are structurally similar compounds composed of two multi-ringed units, _vindoline_, and _catharanthine_. _Vinorelbine tartrate_ is a vinca alkaloid in which the catharanthine component is the target of structural modification [L2005], [L2006].



This structural modification contributes to unique pharmacologic properties.The antitumor activity of vinorelbine tartrate is believed to be owed to the inhibition of mitosis at metaphase via its interaction with tubulin [L1998].



Vinorelbine is a mitotic spindle poison that interferes with chromosomal segregation during mitosis, also known as cell division. It pauses cells at the _G2/M_ phases, when present at concentrations close to the half maximal inhibitory concentration (IC50). Microtubules, which are derived from polymers of tubulin, are the main target of vinorelbine. 



The chemical modification used to produce vinorelbine allows for the opening of the eight-member catharanthine ring with the formation of both a covalent and reversible bond with tubulin [L2007].



The relative contribution of different microtubule-associated proteins in the production of tubulin vary between neural tissue and proliferating cells and this has important functional implications. The ability of vinorelbine to bind specifically to mitotic rather than other microtubules has been shown and may suggest that neurotoxicity is less likely to be a problem than with the molecular mechanism of action [L2007]. 



As with other anti-microtubule agents, vinorelbine is known to contribute apoptosis in malignant cells. The exact mechanisms by which this process occurs are complex and many details are yet to be elucidated. The disarray of the microtubule structure has a number of effects, including the induction of tumor suppressor gene _p53_ and activation/inactivation of a number of protein kinases involved in essential signaling pathways, including _p21 WAF1/CIP1_ and _Ras/Raf_, _PKC/PKA_. These molecular changes lead to phosphorylation and consequently inactivation of the apoptosis inhibitor _Bcl2_. This, in turn, results in a decrease in the formation of heterodimers between _Bcl2_ and the pro-apoptotic gene _BAX_, stimulating the sequence of cell apoptosis [L2007].



Vinorelbine tartrate also possibly interferes with amino acid, cyclic AMP and glutathione metabolism, calmodulin-dependent Ca++-transport ATPase activity, cellular respiration, and nucleic acid and lipid biosynthesis [L1998].

', '

Vinorelbine is a semi-synthetic vinca-alkaloid with a wide spectrum of anti-tumor activity. The vinca-alkaloids are considered spindle poisons. They work by interfering with the polymerization of tubulin, a protein responsible for building the microtubule system which appears during cell division in proliferating cancer cells [L2007].', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23318, 'Navelbine 50 mg i.v. vial', 'نافيلبين 50مجم/5مل فيال وريد', '1,900', NULL, 'Antineoplastic', 'Vinorelbine', 'Pierre - fabre france > egyptian pharmaceutical trading company', 'Vial', 'فيال', '50 mg', '1', 'مضاد للاورام -- لعلاج السرطان', 'vinorelbine (nvb) is a chemotherapy medication that is used to treat a number of types of cancer including breast cancer and non-small cell lung cancer. vinorelbine is approved for the treatment of non-small-cell lung cancer. it is used off-label for othe', NULL, NULL, 2425, '2022-04-09', 0, '

 Vinorelbine tartrate is indicated for adults in the treatment of advanced non-small cell lung cancer (NSCLC), as a single therapy or in combination with other chemotherapeutic drugs [L1998].



Used in relapsed or refractory Hodgkin lymphoma, in combination with other chemotherapy agents [L2011].

 

For the treatment of desmoid tumor or aggressive fibromatosis, in combination with methotrexate [L2011].



For the treatment of recurrent or metastatic squamous cell head and neck cancer [L2011].



For the treatment of recurrent ovarian cancer [L2011].



For the treatment of metastatic breast cancer, in patients previously treated with anthracyline and/or taxane therapy [L2011].



For the treatment of HER2-positive, trastuzumab-resistant, advanced breast cancer in patients previously treated with a taxane, in combination with trastuzumab and everolimus [L2011].

', 'Vinca alkaloids are structurally similar compounds composed of two multi-ringed units, _vindoline_, and _catharanthine_. _Vinorelbine tartrate_ is a vinca alkaloid in which the catharanthine component is the target of structural modification [L2005], [L2006].



This structural modification contributes to unique pharmacologic properties.The antitumor activity of vinorelbine tartrate is believed to be owed to the inhibition of mitosis at metaphase via its interaction with tubulin [L1998].



Vinorelbine is a mitotic spindle poison that interferes with chromosomal segregation during mitosis, also known as cell division. It pauses cells at the _G2/M_ phases, when present at concentrations close to the half maximal inhibitory concentration (IC50). Microtubules, which are derived from polymers of tubulin, are the main target of vinorelbine. 



The chemical modification used to produce vinorelbine allows for the opening of the eight-member catharanthine ring with the formation of both a covalent and reversible bond with tubulin [L2007].



The relative contribution of different microtubule-associated proteins in the production of tubulin vary between neural tissue and proliferating cells and this has important functional implications. The ability of vinorelbine to bind specifically to mitotic rather than other microtubules has been shown and may suggest that neurotoxicity is less likely to be a problem than with the molecular mechanism of action [L2007]. 



As with other anti-microtubule agents, vinorelbine is known to contribute apoptosis in malignant cells. The exact mechanisms by which this process occurs are complex and many details are yet to be elucidated. The disarray of the microtubule structure has a number of effects, including the induction of tumor suppressor gene _p53_ and activation/inactivation of a number of protein kinases involved in essential signaling pathways, including _p21 WAF1/CIP1_ and _Ras/Raf_, _PKC/PKA_. These molecular changes lead to phosphorylation and consequently inactivation of the apoptosis inhibitor _Bcl2_. This, in turn, results in a decrease in the formation of heterodimers between _Bcl2_ and the pro-apoptotic gene _BAX_, stimulating the sequence of cell apoptosis [L2007].



Vinorelbine tartrate also possibly interferes with amino acid, cyclic AMP and glutathione metabolism, calmodulin-dependent Ca++-transport ATPase activity, cellular respiration, and nucleic acid and lipid biosynthesis [L1998].

', '

Vinorelbine is a semi-synthetic vinca-alkaloid with a wide spectrum of anti-tumor activity. The vinca-alkaloids are considered spindle poisons. They work by interfering with the polymerization of tubulin, a protein responsible for building the microtubule system which appears during cell division in proliferating cancer cells [L2007].', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23319, 'Navesetron 0.25mg/5ml vial for i.v.', 'نافيسيترون 0.25/5مل فيال', '110', NULL, 'Antiemetic', 'Palonosetron', 'Sedico > rameda', 'Vial', 'فيال', '0.25mg', '1', NULL, '*it is a serotonin-3 (5-ht3) receptor antagonist indicated in adults for (moderately to highly) emetogenic cancer chemotherapy and prevention of postoperative nausea and vomiting (ponv) for up to 24 hours following surgery. *it is also indicated in pediat', NULL, NULL, 1110, '2022-07-17', 0, 'For the prevention of acute and delayed nausea and vomiting associated with initial and repeat courses of moderately emetogenic cancer chemotherapy, as well as prevention of acute nausea and vomiting associated with highly emetogenic cancer chemotherapy. Also used for the prevention of postoperative nausea and vomiting for up to 24 hours post operation.', 'Palonosetron is a selective serotonin 5-HT<sub>3</sub> receptor antagonist. The antiemetic activity of the drug is brought about through the inhibition of 5-HT<sub>3</sub> receptors present both centrally (medullary chemoreceptor zone) and peripherally (GI tract). This inhibition of 5-HT<sub>3</sub> receptors in turn inhibits the visceral afferent stimulation of the vomiting center, likely indirectly at the level of the area postrema, as well as through direct inhibition of serotonin activity within the area postrema and the chemoreceptor trigger zone. Alternative mechanisms appear to be primarily responsible for delayed nausea and vomiting induced by emetogenic chemotherapy, since similar temporal relationships between between serotonin and emesis beyond the first day after a dose have not been established, and 5-HT<sub>3</sub> receptor antagonists generally have not appeared to be effective alone in preventing or ameliorating delayed effects. It has been hypothesized that palonosetron''s potency and long plasma half-life may contribute to its observed efficacy in preventing delayed nausea and vomiting caused by moderately emetogenic cancer chemotherapy.', 'Palonosetron is an antinauseant and antiemetic agent indicated for the prevention of nausea and vomiting associated with moderately-emetogenic cancer chemotherapy and for the prevention of postoperative nausea and vomiting. Palonosetron is a highly specific and selective serotonin 5-HT<sub>3</sub> receptor antagonist that is pharmacologically related to other 5-HT<sub>3</sub> receptor antagonists, but differs structurally. Palonosetron has a high affinity for 5-HT<sub>3</sub> receptors, but has little to no affinity for other receptors. The serontonin 5-HT<sub>3</sub> receptors are located on the nerve terminals of the vagus in the periphery, and centrally in the chemoreceptor trigger zone of the area postrema. It is suggested that chemotherapeutic agents release serotonin from the enterochromaffin cells of the small intestine by causing degenerative changes in the GI tract. The serotonin then stimulates the vagal and splanchnic nerve receptors that project to the medullary vomiting center, as well as the 5-HT3 receptors in the area postrema, thus initiating the vomiting reflex, causing nausea and vomiting.', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23321, 'Naviluca 200 mg 14 caps', 'نافيلوكا 200مجم 14 كبسولة', '219', NULL, 'Antifungals.triazoles', 'Fluconazole', 'International drug industries > rotabiogen for pharmaceutical invest.', 'Cap', 'كبسولة', '200 mg', '2', 'مضاد فطريات', NULL, NULL, NULL, 8405, '2023-02-04', 0, 'Fluconazole can be administered in the treatment of the following fungal infections[L11043]:



 1) Vaginal yeast infections caused by Candida

 2) Systemic Candida infections

 3) Both esophageal and oropharyngeal candidiasis 

 4) Cryptococcal meningitis

 5) UTI (urinary tract infection) by Candida

 6) Peritonitis (inflammation of the peritoneum) caused by Candida



**A note on fungal infection prophylaxis**



Patients receiving bone marrow transplantation who are treated with cytotoxic chemotherapy and/or radiation therapy may be predisposed to candida infections, and may receive fluconazole as prophylactic therapy.[L11043]



**A note on laboratory testing**



Obtaining specimens for fungal culture and other important laboratory studies such as serology or pathology is advised before starting fluconazole therapy in order to isolate the organisms to be eliminated through treatment. It is permissible to start therapy before the results are available, however, adjusting the therapy once laboratory results confirm the causative organism may be necessary.[L11043]

', 'Fluconazole is a very selective inhibitor of fungal cytochrome P450 dependent enzyme _lanosterol 14-α-demethylase_. This enzyme normally works to convert _lanosterol_ to _ergosterol_, which is necessary for fungal cell wall synthesis.  The free nitrogen atom located on the azole ring of fluconazole binds with a single iron atom located in the heme group of lanosterol 14-α-demethylase.[A178774] This prevents oxygen activation and, as a result, inhibits the demethylation of lanosterol, halting the process of ergosterol biosynthesis.[A178777]  Methylated sterols are then found to accumulate in the fungal cellular membrane, leading to an arrest of fungal growth.[A178774] These accumulated sterols negatively affect the structure and function of the fungal cell plasma membrane.[A16632]



Fluconazole resistance may arise from an alteration in the amount or function of the target enzyme (lanosterol 14-α-demethylase), altered access to this enzyme, or a combination of the above.[A16632] Other mechanisms may also be implicated, and studies are ongoing.[A178783]', 'Fluconazole has been demonstrated to show fungistatic activity against the majority of strains of the following microorganisms, curing fungal infections[L11043]:



_Candida albicans, Candida glabrata (Many strains are intermediately susceptible), Candida parapsilosis, Candida tropicalis, Cryptococcus neoformans_



This is achieved through steroidal inhibition in fungal cells, interfering with cell wall synthesis and growth as well as cell adhesion, thereby treating fungal infections and their symptoms.[L11043,A174325,A174343]



The fungistatic activity of fluconazole has also been shown in normal and immunocompromised animal models with both systemic and intracranial fungal infections caused by _Cryptococcus neoformans_ and for systemic infections caused by Candida albicans.[L11043]  It is important to note that resistant organisms have been found against various strains of organisms treated with fluconazole.[A178759,A178762,A178765] This further substantiates the need to perform susceptibility testing when fluconazole is considered as an antifungal therapy.[A178768,A178786] 





**A note on steroidal effects of fluconazole**



There has been some concern that fluconazole may interfere with and inactivate human steroids/hormones due to the inhibition of hepatic cytochrome enzymes.[L11034]  Fluconazole has demonstrated to be more selective for _fungal_ cytochrome P-450 enzymes than for a variety of mammalian cytochrome P-450 enzymes. Fluconazole 50 mg administered daily for up to 28 days in individuals of reproductive age has been show to have no effect on testosterone plasma concentrations of males and plasma concentrations of steroids in females. A 200-400 mg dose of fluconazole showed no clinically relevant effect on steroid levels or on ACTH-stimulated steroid response in healthy males, in one clinical study mentioned on the European Medicines Agency label.[L11034] Other studies have shown no significant effects of fluconazole on steroid levels, further confirming these data.[A174358,A178780]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23322, 'Naviluca 2mg/ml vial for i.v. inf. 100 ml', 'نافيلوكا 2مجم/مل فيال 100مل', '147', '81', 'Antifungals.triazoles', 'Fluconazole', 'Arabcomed-egypt > rotabiogen for pharmaceutical invest.', 'Vial', 'فيال', '2mg', '1', NULL, 'about fluconazole a triazole derivative a board range antifungal. mechanism of action of fluconazole fluconazole is fungicidal or fungistatic depending on the drug concentrations. i t inhibits the conversion of lanosterol to 14 demethyl lanosterol by inhi', NULL, NULL, 969, '2024-11-11', 0, 'Fluconazole can be administered in the treatment of the following fungal infections[L11043]:



 1) Vaginal yeast infections caused by Candida

 2) Systemic Candida infections

 3) Both esophageal and oropharyngeal candidiasis 

 4) Cryptococcal meningitis

 5) UTI (urinary tract infection) by Candida

 6) Peritonitis (inflammation of the peritoneum) caused by Candida



**A note on fungal infection prophylaxis**



Patients receiving bone marrow transplantation who are treated with cytotoxic chemotherapy and/or radiation therapy may be predisposed to candida infections, and may receive fluconazole as prophylactic therapy.[L11043]



**A note on laboratory testing**



Obtaining specimens for fungal culture and other important laboratory studies such as serology or pathology is advised before starting fluconazole therapy in order to isolate the organisms to be eliminated through treatment. It is permissible to start therapy before the results are available, however, adjusting the therapy once laboratory results confirm the causative organism may be necessary.[L11043]

', 'Fluconazole is a very selective inhibitor of fungal cytochrome P450 dependent enzyme _lanosterol 14-α-demethylase_. This enzyme normally works to convert _lanosterol_ to _ergosterol_, which is necessary for fungal cell wall synthesis.  The free nitrogen atom located on the azole ring of fluconazole binds with a single iron atom located in the heme group of lanosterol 14-α-demethylase.[A178774] This prevents oxygen activation and, as a result, inhibits the demethylation of lanosterol, halting the process of ergosterol biosynthesis.[A178777]  Methylated sterols are then found to accumulate in the fungal cellular membrane, leading to an arrest of fungal growth.[A178774] These accumulated sterols negatively affect the structure and function of the fungal cell plasma membrane.[A16632]



Fluconazole resistance may arise from an alteration in the amount or function of the target enzyme (lanosterol 14-α-demethylase), altered access to this enzyme, or a combination of the above.[A16632] Other mechanisms may also be implicated, and studies are ongoing.[A178783]', 'Fluconazole has been demonstrated to show fungistatic activity against the majority of strains of the following microorganisms, curing fungal infections[L11043]:



_Candida albicans, Candida glabrata (Many strains are intermediately susceptible), Candida parapsilosis, Candida tropicalis, Cryptococcus neoformans_



This is achieved through steroidal inhibition in fungal cells, interfering with cell wall synthesis and growth as well as cell adhesion, thereby treating fungal infections and their symptoms.[L11043,A174325,A174343]



The fungistatic activity of fluconazole has also been shown in normal and immunocompromised animal models with both systemic and intracranial fungal infections caused by _Cryptococcus neoformans_ and for systemic infections caused by Candida albicans.[L11043]  It is important to note that resistant organisms have been found against various strains of organisms treated with fluconazole.[A178759,A178762,A178765] This further substantiates the need to perform susceptibility testing when fluconazole is considered as an antifungal therapy.[A178768,A178786] 





**A note on steroidal effects of fluconazole**



There has been some concern that fluconazole may interfere with and inactivate human steroids/hormones due to the inhibition of hepatic cytochrome enzymes.[L11034]  Fluconazole has demonstrated to be more selective for _fungal_ cytochrome P-450 enzymes than for a variety of mammalian cytochrome P-450 enzymes. Fluconazole 50 mg administered daily for up to 28 days in individuals of reproductive age has been show to have no effect on testosterone plasma concentrations of males and plasma concentrations of steroids in females. A 200-400 mg dose of fluconazole showed no clinically relevant effect on steroid levels or on ACTH-stimulated steroid response in healthy males, in one clinical study mentioned on the European Medicines Agency label.[L11034] Other studies have shown no significant effects of fluconazole on steroid levels, further confirming these data.[A174358,A178780]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23323, 'Naviluca 2mg/ml vial for i.v. inf. 25 ml', 'نافيلوكا 2مجم/مل فيال 25مل', '21', NULL, 'Antifungals.triazoles', 'Fluconazole', 'Arabcomed-egypt > rotabiogen for pharmaceutical invest.', 'Vial', 'فيال', '2mg', '1', NULL, NULL, NULL, NULL, 978, '2022-07-20', 0, 'Fluconazole can be administered in the treatment of the following fungal infections[L11043]:



 1) Vaginal yeast infections caused by Candida

 2) Systemic Candida infections

 3) Both esophageal and oropharyngeal candidiasis 

 4) Cryptococcal meningitis

 5) UTI (urinary tract infection) by Candida

 6) Peritonitis (inflammation of the peritoneum) caused by Candida



**A note on fungal infection prophylaxis**



Patients receiving bone marrow transplantation who are treated with cytotoxic chemotherapy and/or radiation therapy may be predisposed to candida infections, and may receive fluconazole as prophylactic therapy.[L11043]



**A note on laboratory testing**



Obtaining specimens for fungal culture and other important laboratory studies such as serology or pathology is advised before starting fluconazole therapy in order to isolate the organisms to be eliminated through treatment. It is permissible to start therapy before the results are available, however, adjusting the therapy once laboratory results confirm the causative organism may be necessary.[L11043]

', 'Fluconazole is a very selective inhibitor of fungal cytochrome P450 dependent enzyme _lanosterol 14-α-demethylase_. This enzyme normally works to convert _lanosterol_ to _ergosterol_, which is necessary for fungal cell wall synthesis.  The free nitrogen atom located on the azole ring of fluconazole binds with a single iron atom located in the heme group of lanosterol 14-α-demethylase.[A178774] This prevents oxygen activation and, as a result, inhibits the demethylation of lanosterol, halting the process of ergosterol biosynthesis.[A178777]  Methylated sterols are then found to accumulate in the fungal cellular membrane, leading to an arrest of fungal growth.[A178774] These accumulated sterols negatively affect the structure and function of the fungal cell plasma membrane.[A16632]



Fluconazole resistance may arise from an alteration in the amount or function of the target enzyme (lanosterol 14-α-demethylase), altered access to this enzyme, or a combination of the above.[A16632] Other mechanisms may also be implicated, and studies are ongoing.[A178783]', 'Fluconazole has been demonstrated to show fungistatic activity against the majority of strains of the following microorganisms, curing fungal infections[L11043]:



_Candida albicans, Candida glabrata (Many strains are intermediately susceptible), Candida parapsilosis, Candida tropicalis, Cryptococcus neoformans_



This is achieved through steroidal inhibition in fungal cells, interfering with cell wall synthesis and growth as well as cell adhesion, thereby treating fungal infections and their symptoms.[L11043,A174325,A174343]



The fungistatic activity of fluconazole has also been shown in normal and immunocompromised animal models with both systemic and intracranial fungal infections caused by _Cryptococcus neoformans_ and for systemic infections caused by Candida albicans.[L11043]  It is important to note that resistant organisms have been found against various strains of organisms treated with fluconazole.[A178759,A178762,A178765] This further substantiates the need to perform susceptibility testing when fluconazole is considered as an antifungal therapy.[A178768,A178786] 





**A note on steroidal effects of fluconazole**



There has been some concern that fluconazole may interfere with and inactivate human steroids/hormones due to the inhibition of hepatic cytochrome enzymes.[L11034]  Fluconazole has demonstrated to be more selective for _fungal_ cytochrome P-450 enzymes than for a variety of mammalian cytochrome P-450 enzymes. Fluconazole 50 mg administered daily for up to 28 days in individuals of reproductive age has been show to have no effect on testosterone plasma concentrations of males and plasma concentrations of steroids in females. A 200-400 mg dose of fluconazole showed no clinically relevant effect on steroid levels or on ACTH-stimulated steroid response in healthy males, in one clinical study mentioned on the European Medicines Agency label.[L11034] Other studies have shown no significant effects of fluconazole on steroid levels, further confirming these data.[A174358,A178780]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23324, 'Naviluca 2mg/ml vial for i.v. inf. 50 ml', 'نافيلوكا 2مجم/مل فيال 50مل', '92', '50.5', 'Antifungals.triazoles', 'Fluconazole', 'Arabcomed-egypt > rotabiogen for pharmaceutical invest.', 'Vial', 'فيال', '2mg', '1', NULL, 'about fluconazole a triazole derivative a board range antifungal. mechanism of action of fluconazole fluconazole is fungicidal or fungistatic depending on the drug concentrations. i t inhibits the conversion of lanosterol to 14 demethyl lanosterol by inhi', NULL, NULL, 820, '2024-11-10', 0, 'Fluconazole can be administered in the treatment of the following fungal infections[L11043]:



 1) Vaginal yeast infections caused by Candida

 2) Systemic Candida infections

 3) Both esophageal and oropharyngeal candidiasis 

 4) Cryptococcal meningitis

 5) UTI (urinary tract infection) by Candida

 6) Peritonitis (inflammation of the peritoneum) caused by Candida



**A note on fungal infection prophylaxis**



Patients receiving bone marrow transplantation who are treated with cytotoxic chemotherapy and/or radiation therapy may be predisposed to candida infections, and may receive fluconazole as prophylactic therapy.[L11043]



**A note on laboratory testing**



Obtaining specimens for fungal culture and other important laboratory studies such as serology or pathology is advised before starting fluconazole therapy in order to isolate the organisms to be eliminated through treatment. It is permissible to start therapy before the results are available, however, adjusting the therapy once laboratory results confirm the causative organism may be necessary.[L11043]

', 'Fluconazole is a very selective inhibitor of fungal cytochrome P450 dependent enzyme _lanosterol 14-α-demethylase_. This enzyme normally works to convert _lanosterol_ to _ergosterol_, which is necessary for fungal cell wall synthesis.  The free nitrogen atom located on the azole ring of fluconazole binds with a single iron atom located in the heme group of lanosterol 14-α-demethylase.[A178774] This prevents oxygen activation and, as a result, inhibits the demethylation of lanosterol, halting the process of ergosterol biosynthesis.[A178777]  Methylated sterols are then found to accumulate in the fungal cellular membrane, leading to an arrest of fungal growth.[A178774] These accumulated sterols negatively affect the structure and function of the fungal cell plasma membrane.[A16632]



Fluconazole resistance may arise from an alteration in the amount or function of the target enzyme (lanosterol 14-α-demethylase), altered access to this enzyme, or a combination of the above.[A16632] Other mechanisms may also be implicated, and studies are ongoing.[A178783]', 'Fluconazole has been demonstrated to show fungistatic activity against the majority of strains of the following microorganisms, curing fungal infections[L11043]:



_Candida albicans, Candida glabrata (Many strains are intermediately susceptible), Candida parapsilosis, Candida tropicalis, Cryptococcus neoformans_



This is achieved through steroidal inhibition in fungal cells, interfering with cell wall synthesis and growth as well as cell adhesion, thereby treating fungal infections and their symptoms.[L11043,A174325,A174343]



The fungistatic activity of fluconazole has also been shown in normal and immunocompromised animal models with both systemic and intracranial fungal infections caused by _Cryptococcus neoformans_ and for systemic infections caused by Candida albicans.[L11043]  It is important to note that resistant organisms have been found against various strains of organisms treated with fluconazole.[A178759,A178762,A178765] This further substantiates the need to perform susceptibility testing when fluconazole is considered as an antifungal therapy.[A178768,A178786] 





**A note on steroidal effects of fluconazole**



There has been some concern that fluconazole may interfere with and inactivate human steroids/hormones due to the inhibition of hepatic cytochrome enzymes.[L11034]  Fluconazole has demonstrated to be more selective for _fungal_ cytochrome P-450 enzymes than for a variety of mammalian cytochrome P-450 enzymes. Fluconazole 50 mg administered daily for up to 28 days in individuals of reproductive age has been show to have no effect on testosterone plasma concentrations of males and plasma concentrations of steroids in females. A 200-400 mg dose of fluconazole showed no clinically relevant effect on steroid levels or on ACTH-stimulated steroid response in healthy males, in one clinical study mentioned on the European Medicines Agency label.[L11034] Other studies have shown no significant effects of fluconazole on steroid levels, further confirming these data.[A174358,A178780]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23326, 'Navoban 5mg/5ml amp.', 'نافوبان 5مجم/5مل امبول', '91', NULL, 'Antiemetic', 'Tropisetron', 'Novartis', 'Amp', 'أمبول', '5mg', '1', NULL, 'pharmacology tropisetron is an indole derivative with antiemetic activity. as a selective serotonin receptor antagonist tropisetron competitively blocks the action of serotonin at 5ht3 receptors resulting in suppression of chemotherapy-and radiotherapy-in', NULL, NULL, 690, '2022-08-03', 0, 'For the prevention of nausea and vomiting induced by cytotoxic therapy and postoperative. ', 'Tropisetron competitively binds to and blocks the action of serotonin at 5HT3 receptors peripherally on vagus nerve terminals located in the gastrointestinal (GI) tract as well as centrally in the chemoreceptor trigger zone (CTZ) of the area postrema of the central nervous system (CNS). This results in the suppression of chemotherapy- and radiotherapy-induced nausea and vomiting.', NULL, 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23327, 'Navonausia 0.25mg/5ml i.v. inj. or inf. vial', 'نافونوزيا 0.25مجم/5مل فيال', '138', NULL, 'Antiemetic', 'Palonosetron', 'Global pharmaceutical industries (2)', 'Inj', 'حقن', '0.25mg', '1', 'مضاد للقئ', '*it is a serotonin-3 (5-ht3) receptor antagonist indicated in adults for (moderately to highly) emetogenic cancer chemotherapy and prevention of postoperative nausea and vomiting (ponv) for up to 24 hours following surgery. *it is also indicated in pediat', NULL, NULL, 1396, '2022-05-19', 0, 'For the prevention of acute and delayed nausea and vomiting associated with initial and repeat courses of moderately emetogenic cancer chemotherapy, as well as prevention of acute nausea and vomiting associated with highly emetogenic cancer chemotherapy. Also used for the prevention of postoperative nausea and vomiting for up to 24 hours post operation.', 'Palonosetron is a selective serotonin 5-HT<sub>3</sub> receptor antagonist. The antiemetic activity of the drug is brought about through the inhibition of 5-HT<sub>3</sub> receptors present both centrally (medullary chemoreceptor zone) and peripherally (GI tract). This inhibition of 5-HT<sub>3</sub> receptors in turn inhibits the visceral afferent stimulation of the vomiting center, likely indirectly at the level of the area postrema, as well as through direct inhibition of serotonin activity within the area postrema and the chemoreceptor trigger zone. Alternative mechanisms appear to be primarily responsible for delayed nausea and vomiting induced by emetogenic chemotherapy, since similar temporal relationships between between serotonin and emesis beyond the first day after a dose have not been established, and 5-HT<sub>3</sub> receptor antagonists generally have not appeared to be effective alone in preventing or ameliorating delayed effects. It has been hypothesized that palonosetron''s potency and long plasma half-life may contribute to its observed efficacy in preventing delayed nausea and vomiting caused by moderately emetogenic cancer chemotherapy.', 'Palonosetron is an antinauseant and antiemetic agent indicated for the prevention of nausea and vomiting associated with moderately-emetogenic cancer chemotherapy and for the prevention of postoperative nausea and vomiting. Palonosetron is a highly specific and selective serotonin 5-HT<sub>3</sub> receptor antagonist that is pharmacologically related to other 5-HT<sub>3</sub> receptor antagonists, but differs structurally. Palonosetron has a high affinity for 5-HT<sub>3</sub> receptors, but has little to no affinity for other receptors. The serontonin 5-HT<sub>3</sub> receptors are located on the nerve terminals of the vagus in the periphery, and centrally in the chemoreceptor trigger zone of the area postrema. It is suggested that chemotherapeutic agents release serotonin from the enterochromaffin cells of the small intestine by causing degenerative changes in the GI tract. The serotonin then stimulates the vagal and splanchnic nerve receptors that project to the medullary vomiting center, as well as the 5-HT3 receptors in the area postrema, thus initiating the vomiting reflex, causing nausea and vomiting.', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23328, 'Navoproxin plus 20 f.c. tab.', 'نافوبروكسين بلس 20 قرص', '44', '27', 'Antiemetic', 'Meclizine+vitamin b6', 'Delta pharma', 'Tab', 'أقراص', NULL, '2', NULL, 'about meclizine first generation h1 antagonist piperazine derivative antihistamine antiemetic antinauseant. mechanism of action of meclizine meclizine produces antiemetic action by its central action on chemoreceptor trigger zone (ctz). it decreases the s', '6221163013643', NULL, 4128, '2024-09-18', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23329, 'Vanser 10 sachets', 'فانسير 10 اكياس', '80', NULL, 'Immunity', 'Lactoferrin+colostrium+vitamin c+vitamin e', 'Valley pharma', 'Sachet', 'أكياس', NULL, '1', NULL, NULL, '6224009624058', NULL, 1047, '2023-01-14', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23330, 'Nazine 1mg/ml nasal drops 10 ml', 'نازين 1مجم/مل نقط للانف 10مل', '5', NULL, 'Nasal decongestant', 'Tetrahydrozoline', 'Alexandria', 'Drops', 'نقط', '1mg', '1', NULL, 'tetrahydrozoline is a decongestant used to relieve redness in the eyes caused by minor eye irritations (e.g. smog swimming dust or smoke). it belongs to a class of drugs known as sympathomimetic amines. it works by temporarily narrowing the blood vessels', NULL, NULL, 868, '2022-07-31', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23331, 'Nazocrom nasal spray 15 ml', 'نازوكروم سبراي للانف 15مل', '8', NULL, 'Nasal decongestant', 'Cromolyn+oxymetazoline', 'Sigma', 'Spray', 'بخاخ', '15 ml', '1', NULL, NULL, '6221051060032', NULL, 842, '2022-12-07', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23332, 'Nebasco 5 mg 30 tablets', 'نيباسكو 5مجم 30 قرص', '105', '76.5', 'Antihypertensive.beta blocker.selective b1', 'Nebivolol hydrochloride', 'Future pharmaceutical industries (fpi) > tabuk pharmaceutical manufacturing company', 'Tablet', 'أقراص', '5 mg', '3', 'لعلاج ضغط الدم المرتفع', NULL, '6224011410144', NULL, 4307, '2024-06-25', 0, 'Nebivolol is indicated to treat hypertension.[A2762,A182579,L7985,L7988]', 'Nebivolol is a highly selective beta-1 adrenergic receptor antagonist[A182579] with weak beta-2 adrenergic receptor antagonist activity.[A182585] Blocking beta-1 adrenergic receptors by d-nebivolol leads to decreased resting heart rate, exercise heart rate, myocardial contracility, systolic blood pressure, and diastolic blood pressure.[A182603,A182579,A182585,A182615] The selectivity of d-nebivolol limits the magnitude of beta blocker adverse effects in the airways or relating to insulin sensitivity.[A182615] Nebivolol also inhibits aldosterone, and beta-1 antagonism in the juxtaglomerular apparatus also inhibits the release of renin.[A182615] Decreased aldosterone leads to decreased blood volume, and decreased renin leads to reduced vasoconstriction.[A182615] l-nebivolol is responsible for beta-3 adrenergic receptor agonist activity that stimulates endothelial nitric oxide synthase, increasing nitric oxide levels; leading to vasodilation, decreased peripheral vascular resistance, increased stroke volume, ejection fraction, and cardiac output.[A2762,A182603,A182579,A182585,A182615] The vasodilation, reduced oxidative stress, and reduced platelet volume and aggregation of nebivolol may lead to benefits in heart failure patients.[A182603]', 'Nebivolol is a selective beta-1 adrenergic receptor antagonist that decreases vascular resistance, increases stroke volume and cardiac output, and does not negatively affect left ventricular function.[A182579,A182585] It has a long duration of action as effects can be seen 48 hours after stopping the medication and a wide therapeutic window as patients generally take 5-40mg daily.[A182579,L7985] Patients should not abruptly stop taking this medication as this may lead to exacerbation of coronary artery disease.[L7985] Diabetic patients should monitor their blood glucose levels as beta blockers may mask signs of hypoglycemia.[L7985]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23334, 'Puramax 10 gm 10 sachets', 'بيوراماكس 10 جم 10 اكياس', '120', '100', 'Multivitamin', 'Lactoferrin+iron+vitamin b complex+vitamin c', 'Mb pharma', 'Sachet', 'أكياس', '10 gm', '1', NULL, NULL, '6224010115019', NULL, 1260, '2025-07-22', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23335, 'Nebcin 20mg/2ml vial', 'نيبسين 20مجم/2مل فيال', '6', NULL, 'Antibiotic.aminoglycoside derivative', 'Tobramycin', 'Eli lilly', 'Vial', 'فيال', '20mg', '1', NULL, 'about tobramycin aminoglycoside derivative antibiotic. mechanism of action of tobramycin tobramycin exerts its bactericidal action against gram- negative organisms & some of gram positive organisms by inhibiting bacterial protein synthesis. the process in', NULL, NULL, 741, '2022-08-02', 0, 'Inhaled tobramycin is indicated for the management of cystic fibrosis patients with _Pseudomonas aeruginosa_, but is not recommended in patients under six years of age, those with forced expiratory volume in 1 second (FEV<sub>1</sub>) <25 or >80% predicted, or in those with _Burkholderia cepacia_.[L32739,L45364]



Tobramycin applied topically to the eyes is indicated for the treatment of external eye (and adjoining structure) infections by susceptible bacteria.[L32744] 



Tobramycin injection is indicated in adult and pediatric patients for the treatment of serious bacterial infections, including septicemia (caused by _P. aeruginosa_, _Escherichia coli_, and _Klebsiella_ spp.), lower respiratory tract infections (caused by _P. aeruginosa_, _Klebsiella_ spp., _Enterobacter_ spp., _Serratia_ spp., _E. coli_, and _Staphylococcus aureus_, both penicillinase and non-penicillinase-producing strains), serious central-nervous-system infections (meningitis, caused by susceptible organisms), intra-abdominal infections including peritonitis (caused by _E. coli_, _Klebsiella_ spp., and _Enterobacter_ spp.), skin, bone, and skin structure infections (caused by _P. aeruginosa_, _Proteus_ spp., _E. coli_, _Klebsiella_ spp., _Enterobacter_ spp., _Serratia_ spp. and _S. aureus_), and complicated and recurrent urinary tract infections (caused by _P. aeruginosa_, _Proteus_ spp., _E. coli_, _Klebsiella_ spp., _Enterobacter_ spp., _Serratia_ spp., _S. aureus_, _Providencia_ spp., and _Citrobacter_ spp.).[L32749] Aminoglycosides, including tobramycin, should generally not be used in uncomplicated urinary tract infections or staphylococcal infections unless less toxic antibiotics cannot be used and the bacteria in question are known to be sensitive to aminoglycosides.[L32749,L45359]



As with all antibiotics, tobramycin use should be limited to cases where bacterial infections are known or strongly suspected to be caused by sensitive organisms, and the possible emergence of resistance should be monitored closely.[L32739,L32744,L32749]', 'Tobramycin is a 4,6-disubstituted 2-deoxystreptamine (DOS) ring-containing aminoglycoside antibiotic with activity against various Gram-negative and some Gram-positive bacteria.[L32739, L32744, L32749] The mechanism of action of tobramycin has not been unambiguously elucidated, and some insights into its mechanism rely on results using similar aminoglycosides. In general, like other aminoglycosides, tobramycin is bactericidal and exhibits both immediate and delayed killing, which are attributed to different mechanisms, as outlined below.[A232294, A232299]



Aminoglycosides are polycationic at physiological pH, such that they readily bind to bacterial membranes ("ionic binding"); this includes binding to lipopolysaccharide and phospholipids within the outer membrane of Gram-negative bacteria and to teichoic acid and phospholipids within the cell membrane of Gram-positive bacteria. This binding displaces divalent cations and increases membrane permeability, which allows aminoglycoside entry.[A232294, A232304, A232309, A232314] Additional aminoglycoside entry ("energy-dependent phase I") into the cytoplasm requires the proton-motive force, allowing access of the aminoglycoside to its primary intracellular target of the bacterial 30S ribosome.[A232294, A232314] Mistranslated proteins produced as a result of aminoglycoside binding to the ribosome (see below) integrate into and disrupt the cell membrane, which allows more of the aminoglycoside into the cell ("energy-dependent phase II").[A232294, A232314, A232319] Hence, tobramycin and other aminoglycosides have both immediate bactericidal effects through membrane disruption and delayed bactericidal effects through impaired protein synthesis; observed experimental data and mathematical modelling support this two-mechanism model.[A232294, A232299]



Inhibition of protein synthesis was the first recognized effect of aminoglycoside antibiotics. Structural and cell biological studies suggest that aminoglycosides bind to the 16S rRNA in helix 44 (h44), near the A site of the 30S ribosomal subunit, altering interactions between h44 and h45. This binding also displaces two important residues, A1492 and A1493, from h44, mimicking normal conformational changes that occur with successful codon-anticodon pairing in the A site.[A232324, A232329] Overall, aminoglycoside binding has several negative effects, including inhibiting translation initiation and elongation and ribosome recycling.[A232294, A232334, A232339] Recent evidence suggests that the latter effect is due to a cryptic second binding site situated in h69 of the 23S rRNA of the 50S ribosomal subunit.[A232329, A232339] Also, by stabilizing a conformation that mimics correct codon-anticodon pairing, aminoglycosides promote error-prone translation;[A232344] mistranslated proteins can incorporate into the cell membrane, inducing the damage discussed above.[A232294, A232319]



Although direct mutation of the 16S rRNA is a rare resistance mechanism, due to the gene being present in numerous copies, posttranscriptional 16S rRNA modification by 16S rRNA methyltransferases (16S-RMTases) at the N7 position of G1405 or the N1 position of A1408 are common resistance mechanisms in aminoglycoside-resistant bacteria.[A232294, A232349] These mutants also further support the proposed mechanism of action of aminoglycosides. Direct modification of the aminoglycoside itself through acetylation, adenylation, and phosphorylation by aminoglycoside-modifying enzymes (AMEs) are also commonly encountered resistance mutations.[A232294, A232349] Finally, due to the requirement for active transport of aminoglycosides across bacterial membranes, they are not active against obligately anaerobic bacteria.[A232294]', 'Tobramycin is an aminoglycoside antibiotic derived from the actinomycete _Streptomyces tenebrarius_.[L32749] It has a broad spectrum of activity against Gram-negative bacteria, including _Enterobacteriaceae_, _Escherichia coli_, _Klebsiella pneumoniae_, _Morganella morganii_, _Moraxella lacunata_, _Proteus_ spp., _Haemophilus_ spp., _Acinetobacter_ spp., _Neisseria_ spp., and, importantly, _Pseudomonas aeruginosa_. Aminoglycosides also generally retain activity against the biothreat agents _Yersinia pestis_ and _Francisella tularensis_. In addition, aminoglycosides are active against some Gram-positive bacteria such as _Staphylococcus_ spp., including methicillin-resistant (MRSA) and vancomycin-resistant strains, _Streptococcus_ spp., and _Mycobacterium_ spp.[A232294, L32744]



Like other aminoglycosides, tobramycin is taken up and retained by proximal tubule and cochlear cells in the kidney and ear, respectively, and hence carries a risk of nephrotoxicity and ototoxicity.[A232294, L32749] There is also a risk of neuromuscular block, which may be more pronounced in patients with preexisting neuromuscular disorders such as myasthenia gravis or Parkinson''s disease.[A232294, L32739, L32749] Aminoglycosides can cross the placenta, resulting in total, irreversible, bilateral congenital deafness in babies born to mothers who were administered an aminoglycoside during pregnancy.[L32739, L32749] Due to the low systemic absorption of inhaled and topical tobramycin formulations, these effects are more pronounced with injected tobramycin than with other formulations.[L32739, L32744, L32749] However, all formulations carry a risk of hypersensitivity reactions, including potentially fatal cutaneous reactions such as Stevens-Johnson syndrome and toxic epidermal necrolysis.[L32739, L32744, L32749]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23336, 'Nebcin 80mg/2ml inj.', 'نبسين 80مجم/2مل للحقن', '16', NULL, 'Antibiotic.aminoglycoside derivative', 'Tobramycin', 'Eli lilly > elco for trading and marketing-egypt', 'Inj', 'حقن', '80mg', '1', NULL, 'about tobramycin aminoglycoside derivative antibiotic. mechanism of action of tobramycin tobramycin exerts its bactericidal action against gram- negative organisms & some of gram positive organisms by inhibiting bacterial protein synthesis. the process in', NULL, NULL, 1025, '2022-07-16', 0, 'Inhaled tobramycin is indicated for the management of cystic fibrosis patients with _Pseudomonas aeruginosa_, but is not recommended in patients under six years of age, those with forced expiratory volume in 1 second (FEV<sub>1</sub>) <25 or >80% predicted, or in those with _Burkholderia cepacia_.[L32739,L45364]



Tobramycin applied topically to the eyes is indicated for the treatment of external eye (and adjoining structure) infections by susceptible bacteria.[L32744] 



Tobramycin injection is indicated in adult and pediatric patients for the treatment of serious bacterial infections, including septicemia (caused by _P. aeruginosa_, _Escherichia coli_, and _Klebsiella_ spp.), lower respiratory tract infections (caused by _P. aeruginosa_, _Klebsiella_ spp., _Enterobacter_ spp., _Serratia_ spp., _E. coli_, and _Staphylococcus aureus_, both penicillinase and non-penicillinase-producing strains), serious central-nervous-system infections (meningitis, caused by susceptible organisms), intra-abdominal infections including peritonitis (caused by _E. coli_, _Klebsiella_ spp., and _Enterobacter_ spp.), skin, bone, and skin structure infections (caused by _P. aeruginosa_, _Proteus_ spp., _E. coli_, _Klebsiella_ spp., _Enterobacter_ spp., _Serratia_ spp. and _S. aureus_), and complicated and recurrent urinary tract infections (caused by _P. aeruginosa_, _Proteus_ spp., _E. coli_, _Klebsiella_ spp., _Enterobacter_ spp., _Serratia_ spp., _S. aureus_, _Providencia_ spp., and _Citrobacter_ spp.).[L32749] Aminoglycosides, including tobramycin, should generally not be used in uncomplicated urinary tract infections or staphylococcal infections unless less toxic antibiotics cannot be used and the bacteria in question are known to be sensitive to aminoglycosides.[L32749,L45359]



As with all antibiotics, tobramycin use should be limited to cases where bacterial infections are known or strongly suspected to be caused by sensitive organisms, and the possible emergence of resistance should be monitored closely.[L32739,L32744,L32749]', 'Tobramycin is a 4,6-disubstituted 2-deoxystreptamine (DOS) ring-containing aminoglycoside antibiotic with activity against various Gram-negative and some Gram-positive bacteria.[L32739, L32744, L32749] The mechanism of action of tobramycin has not been unambiguously elucidated, and some insights into its mechanism rely on results using similar aminoglycosides. In general, like other aminoglycosides, tobramycin is bactericidal and exhibits both immediate and delayed killing, which are attributed to different mechanisms, as outlined below.[A232294, A232299]



Aminoglycosides are polycationic at physiological pH, such that they readily bind to bacterial membranes ("ionic binding"); this includes binding to lipopolysaccharide and phospholipids within the outer membrane of Gram-negative bacteria and to teichoic acid and phospholipids within the cell membrane of Gram-positive bacteria. This binding displaces divalent cations and increases membrane permeability, which allows aminoglycoside entry.[A232294, A232304, A232309, A232314] Additional aminoglycoside entry ("energy-dependent phase I") into the cytoplasm requires the proton-motive force, allowing access of the aminoglycoside to its primary intracellular target of the bacterial 30S ribosome.[A232294, A232314] Mistranslated proteins produced as a result of aminoglycoside binding to the ribosome (see below) integrate into and disrupt the cell membrane, which allows more of the aminoglycoside into the cell ("energy-dependent phase II").[A232294, A232314, A232319] Hence, tobramycin and other aminoglycosides have both immediate bactericidal effects through membrane disruption and delayed bactericidal effects through impaired protein synthesis; observed experimental data and mathematical modelling support this two-mechanism model.[A232294, A232299]



Inhibition of protein synthesis was the first recognized effect of aminoglycoside antibiotics. Structural and cell biological studies suggest that aminoglycosides bind to the 16S rRNA in helix 44 (h44), near the A site of the 30S ribosomal subunit, altering interactions between h44 and h45. This binding also displaces two important residues, A1492 and A1493, from h44, mimicking normal conformational changes that occur with successful codon-anticodon pairing in the A site.[A232324, A232329] Overall, aminoglycoside binding has several negative effects, including inhibiting translation initiation and elongation and ribosome recycling.[A232294, A232334, A232339] Recent evidence suggests that the latter effect is due to a cryptic second binding site situated in h69 of the 23S rRNA of the 50S ribosomal subunit.[A232329, A232339] Also, by stabilizing a conformation that mimics correct codon-anticodon pairing, aminoglycosides promote error-prone translation;[A232344] mistranslated proteins can incorporate into the cell membrane, inducing the damage discussed above.[A232294, A232319]



Although direct mutation of the 16S rRNA is a rare resistance mechanism, due to the gene being present in numerous copies, posttranscriptional 16S rRNA modification by 16S rRNA methyltransferases (16S-RMTases) at the N7 position of G1405 or the N1 position of A1408 are common resistance mechanisms in aminoglycoside-resistant bacteria.[A232294, A232349] These mutants also further support the proposed mechanism of action of aminoglycosides. Direct modification of the aminoglycoside itself through acetylation, adenylation, and phosphorylation by aminoglycoside-modifying enzymes (AMEs) are also commonly encountered resistance mutations.[A232294, A232349] Finally, due to the requirement for active transport of aminoglycosides across bacterial membranes, they are not active against obligately anaerobic bacteria.[A232294]', 'Tobramycin is an aminoglycoside antibiotic derived from the actinomycete _Streptomyces tenebrarius_.[L32749] It has a broad spectrum of activity against Gram-negative bacteria, including _Enterobacteriaceae_, _Escherichia coli_, _Klebsiella pneumoniae_, _Morganella morganii_, _Moraxella lacunata_, _Proteus_ spp., _Haemophilus_ spp., _Acinetobacter_ spp., _Neisseria_ spp., and, importantly, _Pseudomonas aeruginosa_. Aminoglycosides also generally retain activity against the biothreat agents _Yersinia pestis_ and _Francisella tularensis_. In addition, aminoglycosides are active against some Gram-positive bacteria such as _Staphylococcus_ spp., including methicillin-resistant (MRSA) and vancomycin-resistant strains, _Streptococcus_ spp., and _Mycobacterium_ spp.[A232294, L32744]



Like other aminoglycosides, tobramycin is taken up and retained by proximal tubule and cochlear cells in the kidney and ear, respectively, and hence carries a risk of nephrotoxicity and ototoxicity.[A232294, L32749] There is also a risk of neuromuscular block, which may be more pronounced in patients with preexisting neuromuscular disorders such as myasthenia gravis or Parkinson''s disease.[A232294, L32739, L32749] Aminoglycosides can cross the placenta, resulting in total, irreversible, bilateral congenital deafness in babies born to mothers who were administered an aminoglycoside during pregnancy.[L32739, L32749] Due to the low systemic absorption of inhaled and topical tobramycin formulations, these effects are more pronounced with injected tobramycin than with other formulations.[L32739, L32744, L32749] However, all formulations carry a risk of hypersensitivity reactions, including potentially fatal cutaneous reactions such as Stevens-Johnson syndrome and toxic epidermal necrolysis.[L32739, L32744, L32749]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23337, 'Nebicard 5mg 14 tab.', 'نبيكارد 5مجم 14 اقراص', '46', NULL, 'Antihypertensive.beta blocker.selective b1', 'Nebivolol hydrochloride', 'Hikma pharma > egyptian promotion center', 'Tab', 'أقراص', '5mg', '2', NULL, 'about nebivolol third generation cardio selective beta-1 receptor antagonist antihypertensive. mechanism of action of nebivolol nebivolol is a 3rd generation cardio selective beta-1 receptor antagonist which reduces vascular resistance acutely lowers arte', '6224000335229', NULL, 1140, '2022-07-12', 0, 'Nebivolol is indicated to treat hypertension.[A2762,A182579,L7985,L7988]', 'Nebivolol is a highly selective beta-1 adrenergic receptor antagonist[A182579] with weak beta-2 adrenergic receptor antagonist activity.[A182585] Blocking beta-1 adrenergic receptors by d-nebivolol leads to decreased resting heart rate, exercise heart rate, myocardial contracility, systolic blood pressure, and diastolic blood pressure.[A182603,A182579,A182585,A182615] The selectivity of d-nebivolol limits the magnitude of beta blocker adverse effects in the airways or relating to insulin sensitivity.[A182615] Nebivolol also inhibits aldosterone, and beta-1 antagonism in the juxtaglomerular apparatus also inhibits the release of renin.[A182615] Decreased aldosterone leads to decreased blood volume, and decreased renin leads to reduced vasoconstriction.[A182615] l-nebivolol is responsible for beta-3 adrenergic receptor agonist activity that stimulates endothelial nitric oxide synthase, increasing nitric oxide levels; leading to vasodilation, decreased peripheral vascular resistance, increased stroke volume, ejection fraction, and cardiac output.[A2762,A182603,A182579,A182585,A182615] The vasodilation, reduced oxidative stress, and reduced platelet volume and aggregation of nebivolol may lead to benefits in heart failure patients.[A182603]', 'Nebivolol is a selective beta-1 adrenergic receptor antagonist that decreases vascular resistance, increases stroke volume and cardiac output, and does not negatively affect left ventricular function.[A182579,A182585] It has a long duration of action as effects can be seen 48 hours after stopping the medication and a wide therapeutic window as patients generally take 5-40mg daily.[A182579,L7985] Patients should not abruptly stop taking this medication as this may lead to exacerbation of coronary artery disease.[L7985] Diabetic patients should monitor their blood glucose levels as beta blockers may mask signs of hypoglycemia.[L7985]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23338, 'Nebido 1000mg/4ml vial', 'نبيدو 1000مجم/4مل فيال', '970', '656', 'Androgen', 'Testosterone undecanoate', 'Bayer healthcare', 'Vial', 'فيال', '1000mg', '1', NULL, 'indications: testosterone replacement therapy for male hypogonadism when testosterone deficiency has been confirmed by clinical features and biochemical tests. posology one ampoule / vial of nebido (corresponding to 1000 mg testosterone undecanoate) is in', NULL, NULL, 6306, '2025-03-24', 0, 'Testosterone is indicated to treat primary hypogonadism and hypogonadotropic hypogonadism.[L8983,L8935,L8938,L8986,L8989,L8992,L8995]', 'The androgen receptor exists in the cytoplasm bound to the heat shock proteins HSP90, HSP70, and other chaperones.[A187114] After binding to an androgen, the androgen receptor dissociates from HSP90 and undergoes a conformational change to slow the rate of dissociation from the androgen receptor.[A187114] The androgen-receptor complex is transported into the nucleus where it binds to DNA and recruits other transcriptional regulators to form a pre-initiation complex and eventually induce expression of specific genes.[A187114]



Testosterone and its active metabolite dihydrotestosterone (DHT) antagonize the androgen receptor to develop masculine sex organs including the prostate, seminal vesicles, penis, and scrotum.[A187111,L8983,L8935,L8938,L8986,L8989,L8992,L8995]



Antagonism of the androgen receptor is also responsible for the development of secondary sexual characteristics including facial and body hair, enlargement of the larynx, thickening of the vocal cords, and changes in muscle and fat distribution.[A187111,L8983,L8935,L8938,L8986,L8989,L8992,L8995]', 'Testosterone antagonizes the androgen receptor to induce gene expression that causes the growth and development of masculine sex organs and secondary sexual characteristics.[A187114,L8983,L8935,L8938,L8986,L8989,L8992,L8995] The duration of action of testosterone is variable from patient to patient with a half life of 10-100 minutes.[L8983,L8935,L8938,L8986,L8989,L8992,L8995] The therapeutic index is wide considering the normal testosterone levels in an adult man range from 300-1000ng/dL.[L8983,L8938,L8986,L8989,L8992,L8995] Counsel patients regarding the risk of secondary exposure of testosterone topical products to children.[L8983,L8938,L8986,L8989,L8992]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23339, 'Nebilet plus 5/12.5mg 14 tab.', 'نيبيليت بلس 5/12.5مجم 14 قرص', '101', '53', 'Antihypertensive.beta blocker.selective b1', 'Nebivolol hydrochloride+hydrochlorothiazide', 'Menarini > egyptian pharmaceutical trading company', 'Tab', 'أقراص', '12.5mg', '2', 'علاج لمرض ارتفاع ضغط الدم', NULL, NULL, NULL, 1629, '2025-01-22', 0, 'Nebivolol is indicated to treat hypertension.[A2762,A182579,L7985,L7988]', 'Nebivolol is a highly selective beta-1 adrenergic receptor antagonist[A182579] with weak beta-2 adrenergic receptor antagonist activity.[A182585] Blocking beta-1 adrenergic receptors by d-nebivolol leads to decreased resting heart rate, exercise heart rate, myocardial contracility, systolic blood pressure, and diastolic blood pressure.[A182603,A182579,A182585,A182615] The selectivity of d-nebivolol limits the magnitude of beta blocker adverse effects in the airways or relating to insulin sensitivity.[A182615] Nebivolol also inhibits aldosterone, and beta-1 antagonism in the juxtaglomerular apparatus also inhibits the release of renin.[A182615] Decreased aldosterone leads to decreased blood volume, and decreased renin leads to reduced vasoconstriction.[A182615] l-nebivolol is responsible for beta-3 adrenergic receptor agonist activity that stimulates endothelial nitric oxide synthase, increasing nitric oxide levels; leading to vasodilation, decreased peripheral vascular resistance, increased stroke volume, ejection fraction, and cardiac output.[A2762,A182603,A182579,A182585,A182615] The vasodilation, reduced oxidative stress, and reduced platelet volume and aggregation of nebivolol may lead to benefits in heart failure patients.[A182603]', 'Nebivolol is a selective beta-1 adrenergic receptor antagonist that decreases vascular resistance, increases stroke volume and cardiac output, and does not negatively affect left ventricular function.[A182579,A182585] It has a long duration of action as effects can be seen 48 hours after stopping the medication and a wide therapeutic window as patients generally take 5-40mg daily.[A182579,L7985] Patients should not abruptly stop taking this medication as this may lead to exacerbation of coronary artery disease.[L7985] Diabetic patients should monitor their blood glucose levels as beta blockers may mask signs of hypoglycemia.[L7985]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23340, 'Nebimoun 10mg 10 f.c. tab.', 'نبيمون 10مجم 10 اقراص', '21', NULL, 'Antihypertensive.beta blocker.selective b1', 'Nebivolol hydrochloride', 'Amoun', 'Tab', 'أقراص', '10mg', '1', 'علاج ارتفاع ضغط الدم', 'about nebivolol third generation cardio selective beta-1 receptor antagonist antihypertensive. mechanism of action of nebivolol nebivolol is a 3rd generation cardio selective beta-1 receptor antagonist which reduces vascular resistance acutely lowers arte', NULL, NULL, 896, '2022-07-13', 0, 'Nebivolol is indicated to treat hypertension.[A2762,A182579,L7985,L7988]', 'Nebivolol is a highly selective beta-1 adrenergic receptor antagonist[A182579] with weak beta-2 adrenergic receptor antagonist activity.[A182585] Blocking beta-1 adrenergic receptors by d-nebivolol leads to decreased resting heart rate, exercise heart rate, myocardial contracility, systolic blood pressure, and diastolic blood pressure.[A182603,A182579,A182585,A182615] The selectivity of d-nebivolol limits the magnitude of beta blocker adverse effects in the airways or relating to insulin sensitivity.[A182615] Nebivolol also inhibits aldosterone, and beta-1 antagonism in the juxtaglomerular apparatus also inhibits the release of renin.[A182615] Decreased aldosterone leads to decreased blood volume, and decreased renin leads to reduced vasoconstriction.[A182615] l-nebivolol is responsible for beta-3 adrenergic receptor agonist activity that stimulates endothelial nitric oxide synthase, increasing nitric oxide levels; leading to vasodilation, decreased peripheral vascular resistance, increased stroke volume, ejection fraction, and cardiac output.[A2762,A182603,A182579,A182585,A182615] The vasodilation, reduced oxidative stress, and reduced platelet volume and aggregation of nebivolol may lead to benefits in heart failure patients.[A182603]', 'Nebivolol is a selective beta-1 adrenergic receptor antagonist that decreases vascular resistance, increases stroke volume and cardiac output, and does not negatively affect left ventricular function.[A182579,A182585] It has a long duration of action as effects can be seen 48 hours after stopping the medication and a wide therapeutic window as patients generally take 5-40mg daily.[A182579,L7985] Patients should not abruptly stop taking this medication as this may lead to exacerbation of coronary artery disease.[L7985] Diabetic patients should monitor their blood glucose levels as beta blockers may mask signs of hypoglycemia.[L7985]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23341, 'Nebimoun 2.5mg 10 f.c. tab.', 'نبيمون 2.5مجم 10 قرص', '11', NULL, 'Antihypertensive.beta blocker.selective b1', 'Nebivolol hydrochloride', 'Amoun', 'Tab', 'أقراص', '2.5mg', '1', NULL, 'about nebivolol third generation cardio selective beta-1 receptor antagonist antihypertensive. mechanism of action of nebivolol nebivolol is a 3rd generation cardio selective beta-1 receptor antagonist which reduces vascular resistance acutely lowers arte', NULL, NULL, 1039, '2022-07-08', 0, 'Nebivolol is indicated to treat hypertension.[A2762,A182579,L7985,L7988]', 'Nebivolol is a highly selective beta-1 adrenergic receptor antagonist[A182579] with weak beta-2 adrenergic receptor antagonist activity.[A182585] Blocking beta-1 adrenergic receptors by d-nebivolol leads to decreased resting heart rate, exercise heart rate, myocardial contracility, systolic blood pressure, and diastolic blood pressure.[A182603,A182579,A182585,A182615] The selectivity of d-nebivolol limits the magnitude of beta blocker adverse effects in the airways or relating to insulin sensitivity.[A182615] Nebivolol also inhibits aldosterone, and beta-1 antagonism in the juxtaglomerular apparatus also inhibits the release of renin.[A182615] Decreased aldosterone leads to decreased blood volume, and decreased renin leads to reduced vasoconstriction.[A182615] l-nebivolol is responsible for beta-3 adrenergic receptor agonist activity that stimulates endothelial nitric oxide synthase, increasing nitric oxide levels; leading to vasodilation, decreased peripheral vascular resistance, increased stroke volume, ejection fraction, and cardiac output.[A2762,A182603,A182579,A182585,A182615] The vasodilation, reduced oxidative stress, and reduced platelet volume and aggregation of nebivolol may lead to benefits in heart failure patients.[A182603]', 'Nebivolol is a selective beta-1 adrenergic receptor antagonist that decreases vascular resistance, increases stroke volume and cardiac output, and does not negatively affect left ventricular function.[A182579,A182585] It has a long duration of action as effects can be seen 48 hours after stopping the medication and a wide therapeutic window as patients generally take 5-40mg daily.[A182579,L7985] Patients should not abruptly stop taking this medication as this may lead to exacerbation of coronary artery disease.[L7985] Diabetic patients should monitor their blood glucose levels as beta blockers may mask signs of hypoglycemia.[L7985]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23342, 'Nebimoun 5mg 10 f.c. tab.', 'نبيمون 5مجم 10 اقراص', '16', NULL, 'Antihypertensive.beta blocker.selective b1', 'Nebivolol hydrochloride', 'Amoun', 'Tab', 'أقراص', '5mg', '1', NULL, 'about nebivolol third generation cardio selective beta-1 receptor antagonist antihypertensive. mechanism of action of nebivolol nebivolol is a 3rd generation cardio selective beta-1 receptor antagonist which reduces vascular resistance acutely lowers arte', NULL, NULL, 943, '2022-07-11', 0, 'Nebivolol is indicated to treat hypertension.[A2762,A182579,L7985,L7988]', 'Nebivolol is a highly selective beta-1 adrenergic receptor antagonist[A182579] with weak beta-2 adrenergic receptor antagonist activity.[A182585] Blocking beta-1 adrenergic receptors by d-nebivolol leads to decreased resting heart rate, exercise heart rate, myocardial contracility, systolic blood pressure, and diastolic blood pressure.[A182603,A182579,A182585,A182615] The selectivity of d-nebivolol limits the magnitude of beta blocker adverse effects in the airways or relating to insulin sensitivity.[A182615] Nebivolol also inhibits aldosterone, and beta-1 antagonism in the juxtaglomerular apparatus also inhibits the release of renin.[A182615] Decreased aldosterone leads to decreased blood volume, and decreased renin leads to reduced vasoconstriction.[A182615] l-nebivolol is responsible for beta-3 adrenergic receptor agonist activity that stimulates endothelial nitric oxide synthase, increasing nitric oxide levels; leading to vasodilation, decreased peripheral vascular resistance, increased stroke volume, ejection fraction, and cardiac output.[A2762,A182603,A182579,A182585,A182615] The vasodilation, reduced oxidative stress, and reduced platelet volume and aggregation of nebivolol may lead to benefits in heart failure patients.[A182603]', 'Nebivolol is a selective beta-1 adrenergic receptor antagonist that decreases vascular resistance, increases stroke volume and cardiac output, and does not negatively affect left ventricular function.[A182579,A182585] It has a long duration of action as effects can be seen 48 hours after stopping the medication and a wide therapeutic window as patients generally take 5-40mg daily.[A182579,L7985] Patients should not abruptly stop taking this medication as this may lead to exacerbation of coronary artery disease.[L7985] Diabetic patients should monitor their blood glucose levels as beta blockers may mask signs of hypoglycemia.[L7985]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23343, 'Neetoderm cream 50 gm', 'نيتوديرم كريم 50 جم', '50', '25', NULL, 'Carbamide+polymeric beads', 'Weiser', 'Cream', 'كريم', '50 gm', '1', NULL, NULL, NULL, NULL, 535, '2024-03-25', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23344, 'Neetoderm plus gel 50 gm', 'نيتوديرم بلس جل 50 جم', '52', '26', 'Skin care.moisturizing', 'Carbamide', 'Weiser', 'Gel', 'جل', '50 gm', '1', NULL, NULL, '6223002261000', NULL, 672, '2024-03-25', 0, 'Indicated as a dental bleaching agent. 



Indicated as an oral wound healing agent in oral mucosal injuries.



Indicated as an aid in the removal of hardened ear wax.', 'Carbamide peroxide release hydrogen peroxide upon contact with teeth, which is a strong oxidizing and bleaching agent. It also release free radicals such as H+ or H3O+ [A32336]. Hydrogen peroxide also acts as an antiseptic, especially in sites with relative anaerobiosis. Following otic administration, carbamide peroxide complex releases hydrogen peroxide that breaks up the hardened wax. The hydrogen peroxide component, which further breaks down into water, is also a cerumenolytic that hydrates the desquamated sheets of corneocytes, which are the major constituent of cerumen plugs [A32340]. The glycerol and urea facilitates softening of the cerumen, either with or without syringing [L1974]. Both hydrogen peroxide and urea mildly induce keratolysis with disintegration of the ear wax to help reduce the keratin-load in the ear debris and allow other active components to reach the skin under the debris [A32340, L1974]. ', 'Carbamide peroxide releases hydrogen peroxide and free radicals upon contact with water or outer surfaces of ear and tooth. Hydrogen peroxide exerts cerumenolytic, enamel-bleaching and antiseptic actions. _In vitro_, the chemical stability of ceramics against bleaching agents was observed after treatment with 15% carbamide peroxide for 56 h, 16% carbamide peroxide for 126 h, 10% or 15% carbamide peroxide and 38% hydrogen peroxide for 30 minutes or 45 minutes, respectively [A32336]. According to _in vitro_ studies, high (37%) or low (10 or 16%) concentrated carbamide peroxide agents were similarly effective as oral bleaching agents [A32337]. Treatment with carbamide peroxide may lead to demineralization which involves decreased mineral content of enamel calcium, phosphate, and fluoride, and alteration of the chemical, structural, and mechanical properties [A32339]. Carbamide peroxide may affect the organic components of the enamel and lead to increased susceptibility to erosion, fracture stability or decreased abrasion resistance of the treated area [A32339].', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23345, 'Nefopam 20mg/ml 3 amp.', 'نيفوبام 20مجم/مل 3 امبول', '5', NULL, 'Analgesic.non opioid', 'Nefopam', 'Eipico', 'Amp', 'أمبول', '20mg', '3', NULL, NULL, NULL, NULL, 763, '2022-07-07', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23346, 'Negacef 1 gm i.m. vial', 'نيجاسيف 1 جم للحقن العضل', '15', NULL, 'Antibiotic.cephalosporin.third-generation', 'Ceftazidime', 'Julphar', 'Vial', 'فيال', '1 gm', '1', 'مضاد حيوي', 'about ceftazidime third generation cephalosporin antibiotic parenteral antibiotic. mechanism of action of ceftazidime ceftazidime is a 3rd generation cephalosporin which exerts its bactericidal action against both gram positive & gram negative organisms b', NULL, NULL, 839, '2022-05-30', 0, 'Ceftazidime is indicated for the treatment of lower respiratory tract infections, skin and skin structure infections, urinary tract infections, bacterial septicemia, bone and joint infections, gynecologic infections, intra-abdominal infections (including peritonitis), and central nervous system infections (including meningitis) caused by susceptible bacteria.[L32935]



Ceftazidime is indicated in combination with [avibactam] to treat infections caused by susceptible Gram-negative organisms, including complicated intra-abdominal infections (cIAI), in conjunction with [metronidazole], and complicated urinary tract infections (cUTI), including pyelonephritis, in patients aged three months and older. This combination is also indicated to treat hospital-acquired and ventilator-associated bacterial pneumonia (HABP/VABP) in patients aged 18 years and older.[L45128]



In all cases, to mitigate the risk of bacterial resistance and preserve clinical efficacy, ceftazidime should only be used for infections that are confirmed or strongly suspected to be caused by susceptible bacterial strains.[L32935, L45128]', 'The bacterial cell wall, which is located at the periphery of Gram-positive bacteria and within the periplasm of Gram-negative bacteria, comprises a glycopeptide polymer synthesized through cross-linking of glycans to peptide stems on alternating saccharides, which is known commonly as peptidoglycan.[A232920] Cell wall formation, recycling, and remodelling require numerous enzymes, including a family of enzymes with similar active site character despite distinct and sometimes overlapping roles as carboxypeptidases, endopeptidases, transpeptidases, and transglycosylases, known as "penicillin-binding proteins" (PBPs). The number of PBPs differs between bacteria, in which some are considered essential and others redundant. In general, inhibition of one or more essential PBPs results in impaired cell wall homeostasis, loss of cell integrity, and is ultimately bactericidal.[A232920, A232925, A232930]



Ceftazidime is a semisynthetic third-generation cephalosporin with broad activity against numerous Gram-negative and some Gram-positive bacteria.[L32935] Like other β-lactam antibiotics, ceftazidime exhibits its bactericidal effect primarily through direct inhibition of specific PBPs in susceptible bacteria.[A232935] _In vitro_ experiments in Gram-negative bacteria such as _Escherichia coli_, _Pseudomonas aeruginosa_, _Acinetobacter baumannii_, and _Klebsiella pneumoniae_ suggest that ceftazidime primarily binds to PBP3, with weaker binding to PBP1a/1b and PBP2 as well; although binding to other PBPs, such as PBP4, is detectable, the concentrations required are much greater than those achieved clinically.[A232935, A16721, A232940, A232945, A232950] Similarly, ceftazidime showed binding to _Staphylococcus aureus_ PBP 1, 2, and 3 with a much lower affinity for PBP4.[A16721] Recent data for _Mycobacterium abcessus_ suggest that ceftazidime can inhibit PonA1, PonA2, and PbpA at intermediate concentrations.[A232930]', 'Ceftazidime is a semisynthetic, broad-spectrum, third-generation cephalosporin antibiotic that is bactericidal through inhibition of enzymes responsible for cell-wall synthesis, primarily penicillin-binding protein 3 (PBP3).[L32935] Among cephalosporins, ceftazidime is notable for its resistance to numerous β-lactamases and its broad spectrum of activity against Gram-negative bacteria, including _Pseudomonas aeruginosa_.[A232935] However, it is less active than first- and second-generation cephalosporins against _Staphylococcus aureus_ and other Gram-positive bacteria and also has low activity against anaerobes.[A232935, A233160] Ceftazidime has confirmed activity against clinically relevant Gram-negative bacteria including _Citrobacter_ spp., _Enterobacter_ spp., _Klebsiella_ spp., _Proteus_ spp., _Serratia spp., _Escherichia coli_, _Haemophilus influenzae_, _Neisseria meningitidis_, _Pseudomonas aeruginosa_, and some Gram-positive bacteria including _Staphylococcus_ spp. and _Streptococcus_ spp. There are also _in vitro_ data for ceftazidime efficacy against a wide variety of other bacteria, such as _Acinetobacter baumannii_ and _Neisseria gonorrhoeae_, but no clear clinical studies to support the use of ceftazidime for infections caused by these bacteria.[L32935]



Although β-lactam antibiotics like ceftazidime are generally well tolerated, there remains a risk of serious acute hypersensitivity reactions, which is higher in patients with a known allergy to ceftazidime or any other β-lactam antibiotic. As with all antibiotics, ceftazidime may result in the overgrowth of non-susceptible organisms and potentially serious effects including _Clostridium difficile_-associated diarrhea (CDAD); CDAD should be considered in patients who develop diarrhea and, in confirmed cases, supportive care initiated immediately. Ceftazidime is primarily renally excreted such that high and prolonged serum concentrations can occur in patients with renal insufficiency, leading to seizures, nonconvulsive status epilepticus (NCSE), encephalopathy, coma, asterixis, neuromuscular excitability, and myoclonia. Treatment may lead to the development or induction of resistance with a risk of treatment failure. Periodic susceptibility testing should be considered, and monotherapy failure may necessitate the addition of another antibiotic such as an aminoglycoside. Cephalosporin use may decrease prothrombin activity, which may be improved by exogenous vitamin K. Inadvertent intra-arterial administration of ceftazidime may result in distal necrosis.[L32935]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23347, 'Negacef 1 gm i.v. vial', 'نيجاسيف 1جم فيال', '15', NULL, 'Antibiotic.cephalosporin.third-generation', 'Ceftazidime', 'Julphar', 'Vial', 'فيال', '1 gm', '1', NULL, 'about ceftazidime third generation cephalosporin antibiotic parenteral antibiotic. mechanism of action of ceftazidime ceftazidime is a 3rd generation cephalosporin which exerts its bactericidal action against both gram positive & gram negative organisms b', NULL, NULL, 877, '2022-07-18', 0, 'Ceftazidime is indicated for the treatment of lower respiratory tract infections, skin and skin structure infections, urinary tract infections, bacterial septicemia, bone and joint infections, gynecologic infections, intra-abdominal infections (including peritonitis), and central nervous system infections (including meningitis) caused by susceptible bacteria.[L32935]



Ceftazidime is indicated in combination with [avibactam] to treat infections caused by susceptible Gram-negative organisms, including complicated intra-abdominal infections (cIAI), in conjunction with [metronidazole], and complicated urinary tract infections (cUTI), including pyelonephritis, in patients aged three months and older. This combination is also indicated to treat hospital-acquired and ventilator-associated bacterial pneumonia (HABP/VABP) in patients aged 18 years and older.[L45128]



In all cases, to mitigate the risk of bacterial resistance and preserve clinical efficacy, ceftazidime should only be used for infections that are confirmed or strongly suspected to be caused by susceptible bacterial strains.[L32935, L45128]', 'The bacterial cell wall, which is located at the periphery of Gram-positive bacteria and within the periplasm of Gram-negative bacteria, comprises a glycopeptide polymer synthesized through cross-linking of glycans to peptide stems on alternating saccharides, which is known commonly as peptidoglycan.[A232920] Cell wall formation, recycling, and remodelling require numerous enzymes, including a family of enzymes with similar active site character despite distinct and sometimes overlapping roles as carboxypeptidases, endopeptidases, transpeptidases, and transglycosylases, known as "penicillin-binding proteins" (PBPs). The number of PBPs differs between bacteria, in which some are considered essential and others redundant. In general, inhibition of one or more essential PBPs results in impaired cell wall homeostasis, loss of cell integrity, and is ultimately bactericidal.[A232920, A232925, A232930]



Ceftazidime is a semisynthetic third-generation cephalosporin with broad activity against numerous Gram-negative and some Gram-positive bacteria.[L32935] Like other β-lactam antibiotics, ceftazidime exhibits its bactericidal effect primarily through direct inhibition of specific PBPs in susceptible bacteria.[A232935] _In vitro_ experiments in Gram-negative bacteria such as _Escherichia coli_, _Pseudomonas aeruginosa_, _Acinetobacter baumannii_, and _Klebsiella pneumoniae_ suggest that ceftazidime primarily binds to PBP3, with weaker binding to PBP1a/1b and PBP2 as well; although binding to other PBPs, such as PBP4, is detectable, the concentrations required are much greater than those achieved clinically.[A232935, A16721, A232940, A232945, A232950] Similarly, ceftazidime showed binding to _Staphylococcus aureus_ PBP 1, 2, and 3 with a much lower affinity for PBP4.[A16721] Recent data for _Mycobacterium abcessus_ suggest that ceftazidime can inhibit PonA1, PonA2, and PbpA at intermediate concentrations.[A232930]', 'Ceftazidime is a semisynthetic, broad-spectrum, third-generation cephalosporin antibiotic that is bactericidal through inhibition of enzymes responsible for cell-wall synthesis, primarily penicillin-binding protein 3 (PBP3).[L32935] Among cephalosporins, ceftazidime is notable for its resistance to numerous β-lactamases and its broad spectrum of activity against Gram-negative bacteria, including _Pseudomonas aeruginosa_.[A232935] However, it is less active than first- and second-generation cephalosporins against _Staphylococcus aureus_ and other Gram-positive bacteria and also has low activity against anaerobes.[A232935, A233160] Ceftazidime has confirmed activity against clinically relevant Gram-negative bacteria including _Citrobacter_ spp., _Enterobacter_ spp., _Klebsiella_ spp., _Proteus_ spp., _Serratia spp., _Escherichia coli_, _Haemophilus influenzae_, _Neisseria meningitidis_, _Pseudomonas aeruginosa_, and some Gram-positive bacteria including _Staphylococcus_ spp. and _Streptococcus_ spp. There are also _in vitro_ data for ceftazidime efficacy against a wide variety of other bacteria, such as _Acinetobacter baumannii_ and _Neisseria gonorrhoeae_, but no clear clinical studies to support the use of ceftazidime for infections caused by these bacteria.[L32935]



Although β-lactam antibiotics like ceftazidime are generally well tolerated, there remains a risk of serious acute hypersensitivity reactions, which is higher in patients with a known allergy to ceftazidime or any other β-lactam antibiotic. As with all antibiotics, ceftazidime may result in the overgrowth of non-susceptible organisms and potentially serious effects including _Clostridium difficile_-associated diarrhea (CDAD); CDAD should be considered in patients who develop diarrhea and, in confirmed cases, supportive care initiated immediately. Ceftazidime is primarily renally excreted such that high and prolonged serum concentrations can occur in patients with renal insufficiency, leading to seizures, nonconvulsive status epilepticus (NCSE), encephalopathy, coma, asterixis, neuromuscular excitability, and myoclonia. Treatment may lead to the development or induction of resistance with a risk of treatment failure. Periodic susceptibility testing should be considered, and monotherapy failure may necessitate the addition of another antibiotic such as an aminoglycoside. Cephalosporin use may decrease prothrombin activity, which may be improved by exogenous vitamin K. Inadvertent intra-arterial administration of ceftazidime may result in distal necrosis.[L32935]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23348, 'Neo- carbotrina 10 tab.', 'نيو كاربوترينا 10 اقراص', '2', NULL, 'Antiflatulent', 'Belladonna+charcoal+di-iodoquinolin+phthalyl sulphathiazole', 'Arab drug company.', 'Tab', 'أقراص', NULL, '1', 'مضاد للانتفاخ', NULL, NULL, NULL, 1337, '2022-12-02', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23350, 'Neo nail cream 50 gm', 'نيو نيل كريم 50جم', '35', NULL, 'Nail care', 'Hydrolyzed collagen+panthenol+glycerin+dimethicone+urea+vitamin e+vitamin a+paraffin oil', 'Macro group pharmaceuticals', 'Cream', 'كريم', '50 gm', '1', NULL, '-it hydrates and strengthen nails and relieves ragged painful cuticles.', NULL, NULL, 953, '2022-07-27', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23351, 'Neo nail plus cream 50 gm', 'نيو نيل بلس كريم 50جم', '40', NULL, 'Nail care', 'Hydrolyzed collagen+panthenol+glycerin+dimethicone+urea+vitamin (e- a)+chlorhexidine+paraffin oil', 'Macro group pharmaceuticals', 'Cream', 'كريم', '50 gm', '1', NULL, 'nail & cuticle care cream with antimicrobial properties.', NULL, NULL, 1317, '2022-07-17', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23352, 'Neo-anoproct 10 supp.', 'نيو انوبروكت 10 لبوس', '11', NULL, 'Haemorrhoids', 'Fluocortolone pivalate+lidocaine', 'Cid', 'Supp', 'لبوس', NULL, '2', NULL, NULL, NULL, NULL, 1013, '2022-07-14', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23353, 'Neo-anoproct topical cream. 10 gm', 'نيو انوبروكت كريم 10جم', '9', NULL, 'Haemorrhoids', 'Chlorquinaldol+fluocortolone pivalate+lidocaine hcl', 'Cid', 'Cream', 'كريم', '10 gm', '1', NULL, NULL, NULL, NULL, 765, '2022-07-14', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23354, 'Neo-bronchophane 125ml syrup.', 'نيو برونكوفين 125 مل شراب', '19', NULL, 'Anti-cough.antitussive and expectorant', 'Diphenhydramine+guaifenesin+oxeladine', 'Eipico', 'Syrup', 'شراب', '125ml', '1', 'حالات الكحة المصحوبة بالبلغم --طارد ومذيب للبلغم -- مهدئ للسعال', NULL, '6221032222046', NULL, 9723, '2023-05-14', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23355, 'Neocate junior powder 400 gm', 'نيوكيت جونيور باودر 400 جم', '470', NULL, 'Hypo-allergenic milk', 'Hypo-allergenic milk formula', 'Nutricia cuijk b.v. > united company for trading & distribution', 'Powder', 'بودرة', '400 gm', '1', NULL, 'for infants 1+ years. neocateï- junior is the first and only hypoallergenic formula that is available with prebiotic fiber to help support digestive health. neocateï- junior is specially formulated for the dietary management of children with cow milk alle', '8410175067180', NULL, 1390, '2022-12-01', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23357, 'Neocate spoon powder 400 gm', 'نيوكيت سبون باودر 400 جم', '362', NULL, 'Hypo-allergenic milk', 'Hypo-allergenic milk formula', 'Nutricia cuijk b.v. > united company for trading & distribution', 'Powder', 'بودرة', '400 gm', '1', NULL, 'for infants 6+ months. neocate spoon is a food for special medical purposes for use under medical supervision. neocate spoon is a hypoallergenic amino acid based powder containing vitamins and minerals that mixes with water to form an unflavoured spoonabl', NULL, NULL, 1100, '2022-12-01', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23358, 'Neocate syneo infants powder 400 gm', 'نيوكيت سينيو باودر لبن اطفال 400 جرام', '980', '693', 'Hypo-allergenic milk', 'Hypo-allergenic milk formula', 'Nutricia cuijk b.v. > united company for trading & distribution', 'Powder', 'بودرة', '400 gm', '1', 'لبن اطفال قليل الحساسية', 'for infants 0-12 months. neocate syneo is a food for special medical purposes for use under medical supervision. neocate syneo is an amino acid-based nutritionally complete unflavoured hypoallergenic infant formula powder for the dietary management of cow', '5016533653519', NULL, 10434, '2024-11-21', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23361, 'Neo-digestin syrup 120 ml', 'نيو-ديجستين شراب 120 مل', '6', NULL, 'Digestive enzymes', 'Papain+pepsin+sanzyme 3500', 'Pharco', 'Syrup', 'شراب', '120 ml', '1', NULL, NULL, '6223000010259', NULL, 2217, '2022-12-07', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23362, 'Endlixaban 5 mg 30 f.c. tabs.', 'اندليكسابان 5 مجم 30 قرص', '269', NULL, 'Anticoagulant', 'Apixaban', 'Atco pharma', 'Tab', 'أقراص', '5 mg', '3', NULL, NULL, '6223000170557', NULL, 902, '2022-12-08', 0, 'Apixaban is indicated for reducing the risk of stroke and systemic embolism in patients who have nonvalvular atrial fibrillation, prophylaxis of deep vein thrombosis(DVT) leading to pulmonary embolism(PE) in patients after a hip or knee replacement surgery, and treatment of DVT and PE to reduce the risk of recurrence[Label,A177565,A6897].', 'Apixaban selectively inhibits factor Xa in its free and bound forms, independant of antithrombin III[Label]. Apixaban also inhibits prothrominase[Label]. These effects prevent the formation of a thrombus[Label].', 'Apixaban selectively inhibits factor Xa in its free and bound forms, independant of antithrombin III[Label]. Apixaban also inhibits prothrominase[Label]. These effects prevent the formation of a thrombus[Label].', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23363, 'Neoflur 250mg/5ml 5 amp.', 'نيوفلور 250مجم/5مل 5 امبول', '34', NULL, 'Antineoplastic', 'Fluorouracil', 'Cipla ltd. - india > star international company', 'Amp', 'أمبول', '250mg', '5', NULL, 'description a pyrimidine analog that is an antineoplastic antimetabolite. it interferes with dna synthesis by blocking the thymidylate synthetase conversion of deoxyuridylic acid to thymidylic acid mechanism of action the precise mechanism of action has n', '8901117140424', NULL, 727, '2022-07-15', 0, 'For the topical treatment of multiple actinic or solar keratoses. In the 5% strength it is also useful in the treatment of superficial basal cell carcinomas when conventional methods are impractical, such as with multiple lesions or difficult treatment sites. Fluorouracil injection is indicated in the palliative management of some types of cancer, including colon, esophageal, gastric, rectum, breast, biliary tract, stomach, head and neck, cervical, pancreas, renal cell, and carcinoid.', 'The precise mechanism of action has not been fully determined, but the main mechanism of fluorouracil is thought to be the binding of the deoxyribonucleotide of the drug (FdUMP) and the folate cofactor, N5–10-methylenetetrahydrofolate, to thymidylate synthase (TS) to form a covalently bound ternary complex. This results in the inhibition of the formation of thymidylate from uracil, which leads to the inhibition of DNA and RNA synthesis and cell death. Fluorouracil can also be incorporated into RNA in place of uridine triphosphate (UTP), producing a fraudulent RNA and interfering with RNA processing and protein synthesis.', 'Fluorouracil is an antineoplastic anti-metabolite. Anti-metabolites masquerade as purine or pyrimidine - which become the building blocks of DNA. They prevent these substances from becoming incorporated into DNA during the "S" phase (of the cell cycle), stopping normal development and division. Fluorouracil blocks an enzyme which converts the cytosine nucleotide into the deoxy derivative. In addition, DNA synthesis is further inhibited because Fluorouracil blocks the incorporation of the thymidine nucleotide into the DNA strand.', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23364, 'Neo-gelco susp. 120ml', 'نيو-جيلكو شراب معلق 120 مل', '4', NULL, 'Antacid', 'Aluminium hydroxide+magnesium oxide', 'Kahira', 'Susp', 'معلق', '120ml', '1', NULL, 'about aluminium hydroxide antacid antidote protectant( topical) in hyperacidity; hyperphosphatemia. mechanism of action of aluminium hydroxide it neutralizes and reduces stomach acid relieving heartburn (acid reflux gerd) and indigestion. this results inc', '6221068402795', NULL, 934, '2022-12-07', 0, NULL, 'Aluminum Acetate is an astringent.  An astrignent is a chemical that tends to shrink or constrict body tissues, usually locally after topical medicinal application.  The shrinkage or constriction is through osmotic flow of water (or other fluids) away from the area where the astringent was applied.  Astringent medicines cause shrinkage of mucous membranes or exposed tissues and are often used internally to check discharge of blood serum or mucous secretions. This can happen with a sore throat, hemorrhages, diarrhea, or with peptic ulcers. Externally applied astringents, which cause mild coagulation of skin proteins, dry, harden, and protect the skin. Acne sufferers are often advised to use astringents if they have oily skin. Astringents also help heal stretch marks and other scars. Mild astringent solutions are used in the relief of such minor skin irritations as those resulting from superficial cuts, allergies, insect bites, or fungal infections such as athlete''s foot. ', NULL, 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23365, 'Neo-graminyst topical cream 15 gm', 'نيو جرامينست كريم 15جم', '7', NULL, NULL, 'Gramicidin+neomycin+nystatin+triamcinolone', 'Sigma', 'Cream', 'كريم', '15 gm', '1', NULL, 'about gramicidin gramicidin is active against most of the gram positive bacteria and some gram negative bacteria. its use is limited to topical use only since systemic use may produce haemolysis.gramicidin produces its action by increasing the permeabilit', NULL, NULL, 885, '2022-07-25', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23366, 'Neo-graminyst topical cream 30 gm', 'نيو جرامينست كريم 30جم', '11', NULL, NULL, 'Gramicidin+neomycin+nystatin+triamcinolone', 'Sigma', 'Cream', 'كريم', '30 gm', '1', NULL, 'about gramicidin gramicidin is active against most of the gram positive bacteria and some gram negative bacteria. its use is limited to topical use only since systemic use may produce haemolysis.gramicidin produces its action by increasing the permeabilit', NULL, NULL, 1141, '2022-07-24', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23368, 'Neo-graminyst topical oint. 30 gm', 'نيو جرامينست مرهم 30جم', '11', NULL, 'Topical care', 'Gramicidin+neomycin+nystatin+triamcinolone', 'Sigma', 'Oint', 'مرهم', '30 gm', '1', NULL, 'about gramicidin gramicidin is active against most of the gram positive bacteria and some gram negative bacteria. its use is limited to topical use only since systemic use may produce haemolysis.gramicidin produces its action by increasing the permeabilit', NULL, NULL, 863, '2022-07-24', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23369, 'Neo-haemorrhan 6 supp.', 'نيو هيموران 6 اقماع', '8', NULL, 'Haemorrhoids', 'Aluminium acetate+lidocaine+prednisolone+ruscus extract+zinc oxide', 'Misr', 'Supp', 'لبوس', NULL, '1', NULL, NULL, '6221035005097', NULL, 1193, '2022-12-07', 0, NULL, 'Aluminum Acetate is an astringent.  An astrignent is a chemical that tends to shrink or constrict body tissues, usually locally after topical medicinal application.  The shrinkage or constriction is through osmotic flow of water (or other fluids) away from the area where the astringent was applied.  Astringent medicines cause shrinkage of mucous membranes or exposed tissues and are often used internally to check discharge of blood serum or mucous secretions. This can happen with a sore throat, hemorrhages, diarrhea, or with peptic ulcers. Externally applied astringents, which cause mild coagulation of skin proteins, dry, harden, and protect the skin. Acne sufferers are often advised to use astringents if they have oily skin. Astringents also help heal stretch marks and other scars. Mild astringent solutions are used in the relief of such minor skin irritations as those resulting from superficial cuts, allergies, insect bites, or fungal infections such as athlete''s foot. ', NULL, 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23371, 'Neo-ketadex 25 mg 20 f.c. tabs.', 'نيو كيتادكس 25مجم 20 اقراص', '28', '16', 'Nsaid.propionic acid derivatives', 'Dexketoprofen', 'Marcyrl co.', 'Tab', 'أقراص', '25 mg', '2', NULL, 'about dexketoprofen nonsteroidal anti-inflammatory drugs analgesic propionic acid derivative. mechanism of action of dexketoprofen dexketoprofen works by blocking the action of a substance in the body called cyclo-oxygenase (cox). cyclo-oxygenase is invol', NULL, NULL, 901, '2024-12-28', 0, 'For short-term treatment of mild to moderate pain, including dysmenorrhoea, musculoskeletal pain and toothache [L1302]. ', ' It is a non-steroidal anti-inflammatory drug (NSAID) that reduces prostaglandin synthesis via inhibition of cyclooxygenase pathway (both COX-1 and COX-2) activity [L1299].', 'This drug is an isomer of ketoprofen.   Dexketoprofen a propionic acid derivative with analgesic, anti-inflammatory, and antipyretic properties [L1299].  ', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23372, 'Savicum 100 ml syrup', 'سافيكيوم 100 مل شراب', '50', '40', 'Cough mix.', 'Ivy ext.+thyme ext.+licorice ext.+acetyl cysteine', 'SAVI PHARMA', 'Syrup', 'شراب', '100 ml', '1', NULL, NULL, NULL, NULL, 809, '2024-10-07', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23373, 'Neo-medanine f.r. 10mg 50 tab.', 'نيو ميدانين اف ار 10مجم 50 قرص', '26', NULL, 'Antipsoriatic', 'Methoxsalen=ammoidin=xanthotoxin', 'Memphis', 'Tab', 'أقراص', '10mg', '5', NULL, NULL, '6221050031125', NULL, 1553, '2023-02-08', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23377, 'Neomint i.v. infusion 250 ml', 'نيومينت وريد 250 مل', '10', NULL, 'Sterile solution', 'Glucose (dextrose)+potassium chloride+sodium chloride', 'Otsuka', 'Unknown', 'غير محدد', '250 ml', '1', 'يستخدم فى علاج نقص السكر في الدم وفقدان الدم والسوائل عن طريق التنقيط الوريدى', NULL, NULL, NULL, 1514, '2022-07-07', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23378, 'Neomycin & polymexin b sulfate cream 10 gm', 'نيومايسين وبوليمكسين ب سلفات كريم 10جم', '4', NULL, 'Antibiotic topical', 'Neomycin+polymyxin', 'Amriya', 'Cream', 'كريم', '10 gm', '1', NULL, 'about neomycin an aminoglycoside antibiotic ammonium detoxicant. mechanism of action of neomycin this aminoglycoside cause protein synthesis inhibition by irreversibly bind to specific 30s-subunit proteins and 16s rrna. specifically neomycin binds to four', NULL, NULL, 780, '2023-04-08', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23380, 'Neomycin & polymyxin b sulfates & bacitracin zinc oint', 'نيومايسين وبوليمكسين بي سلفات و باسيتراسين زنك مرهم', '9', NULL, NULL, 'Bacitracin+neomycin+polymyxin', 'Amriya', 'Oint', 'مرهم', NULL, '1', NULL, 'mechanism of action of bacitracin bacitracin is an antibiotic produced by the strain of bacillus subtilis. it acts by inhibiting bacterial cell wall synthesis. it is active against a variety of gram positive and a few gram negative organisms. mechanism of', NULL, NULL, 1254, '2023-04-08', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23381, 'Bluebell whitening cream 50 gm', 'بلو بيل كريم تفتيح 50 جم', '265', '220', 'Skin care.whitening', NULL, 'Bluebell pharmaceuticals', 'Cream', 'كريم', '50 gm', '1', NULL, NULL, '6221050031101', NULL, 706, '2024-06-20', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23382, 'Neomycin and polymyxin b sulfate 40ml topical spray', 'نيومايسين وبوليميكسن بي سلفات سبراي 40 مل', '11', NULL, 'Antibiotic topical', 'Neomycin+polymyxin', 'European egyptian pharm. ind.', 'Spray', 'بخاخ', '40ml', '1', 'بخاخ مضاد حيوي موضعي', 'about neomycin an aminoglycoside antibiotic ammonium detoxicant. mechanism of action of neomycin this aminoglycoside cause protein synthesis inhibition by irreversibly bind to specific 30s-subunit proteins and 16s rrna. specifically neomycin binds to four', '6221076160199', NULL, 2082, '2023-04-08', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23384, 'Neomycin powder 12 gm', 'نيومايسين باودر 12جم', '5', NULL, 'Antibiotic topical', 'Neomycin', 'Green pharm', 'Powder', 'بودرة', '12 gm', '1', NULL, 'about neomycin an aminoglycoside antibiotic ammonium detoxicant. mechanism of action of neomycin this aminoglycoside cause protein synthesis inhibition by irreversibly bind to specific 30s-subunit proteins and 16s rrna. specifically neomycin binds to four', NULL, NULL, 961, '2023-04-08', 0, 'Oral neomycin sulfate is indicated as an adjunctive therapy in hepatic coma (portal-system encephalopathy) by reducing ammonia-forming bacteria in the intestinal tract. It is strongly recommended that oral neomycin is only used in infections that are proven or strongly suspected to be caused by susceptible bacteria to reduce the risk of the development of drug-resistant bacteria.[L11979]



Neomycin, in combination with polymyxin B sulfates and hydrocortisone in otic suspensions, is used in the treatment of superficial bacterial infections of the external auditory canal caused by organisms susceptible to the antibiotics. This otic formulation is also used in the treatment of infections of mastoidectomy and fenestration cavities caused by organisms susceptible to the antibiotics.[L10532]



The ophthalmic solution containing neomycin in combination with polymyxin B sulfates and dexamethasone is used to treat steroid-responsive inflammatory ocular conditions for which a corticosteroid is indicated and where bacterial infection or a risk of bacterial infection exists.[L10716]', 'Like other aminoglycoside antibiotic drugs, neomycin inhibits bacterial ribosomes by binding to the 30S ribosomal subunit of susceptible bacteria and disrupting the translational machinery of bacterial protein synthesis.[A15783,T28] Bacterial translation is normally initiated by the mRNA binding to the 30S ribosomal subunit and subsequent binding with 50S subunit for elongation.[T28]', 'Neomycin mediates its bactericidal action by inhibiting bacterial protein synthesis, thereby suppressing the growth and survival of susceptible bacteria. Following oral administration, the duration of bactericidal activity of neomycin ranged from 48 to 72 hours.[L11979] By decreasing colonic bacteria that produce ammonia, neomycin was shown to be effective as an adjunctive therapy in hepatic coma to improve neurologic symptoms.[L11979,L11985] 



Neomycin is active against both gram positive and gram negative organisms, including the major _E. coli_ species resident in the colon as well as the enteropathogenic forms of _E. coli_.[L11985] It is also active against _Klebsiella_-_Enterobacter_ group.[L11979] Resistant strains of _E. coli_, _Klebsiella_ and _Proteus spp_. may emerge from neomycin therapy.[A191529] Neomycin has no antifungal activity and has some activity against some protozoa.[A175042]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23385, 'Neo-myxidine eye/ear drops 5 ml', 'نيو مكسدين قطرة للعين والاذن 5مل', '6', NULL, NULL, 'Gramicidin+neomycin+polymyxin', 'Eipico', 'Drops', 'نقط', '5 ml', '1', NULL, 'about gramicidin gramicidin is active against most of the gram positive bacteria and some gram negative bacteria. its use is limited to topical use only since systemic use may produce haemolysis.gramicidin produces its action by increasing the permeabilit', '6221032330659', NULL, 1015, '2022-12-07', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23389, 'Neopolybacin eye oint. 5 gm', 'نيوبوليباسين مرهم للعين 5جم', '5', NULL, NULL, 'Bacitracin+neomycin+polymyxin', 'Eipico', 'Oint', 'مرهم', '5 gm', '1', NULL, 'mechanism of action of bacitracin bacitracin is an antibiotic produced by the strain of bacillus subtilis. it acts by inhibiting bacterial cell wall synthesis. it is active against a variety of gram positive and a few gram negative organisms. mechanism of', NULL, NULL, 758, '2022-07-25', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23390, 'Neopolydex eye susp. 5 ml', 'نيوبوليديكس قطرة للعين 5 مل', '6', NULL, NULL, 'Dexamethasone+neomycin sulphate+polymyxin b sulphate', 'Rameda > pharco', 'Susp', 'معلق', '5 ml', '1', NULL, 'about dexamethasone a potent synthetic glucocorticoid antiasthmatic anti-inflammatory and immunosuppressant. about neomycin an aminoglycoside antibiotic ammonium detoxicant. mechanism of action of neomycin this aminoglycoside cause protein synthesis inhib', NULL, NULL, 880, '2022-08-15', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23392, 'Neo-pulmolar syrup 120ml', 'نيو-بلمولار شراب 120 مل', '14', '4.8', 'Anti-cough', 'Chlorpheniramine+dextromethorphan', 'Memphis', 'Syrup', 'شراب', '120ml', '1', NULL, 'description a histamine h1 antagonist used in allergic reactions hay fever rhinitis urticaria and asthma. indication for the treatment of rhinitis urticaria allergy common cold asthma and hay fever. pharmacodynamics in allergic reactions an allergen inter', NULL, NULL, 1110, '2024-11-09', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23393, 'Neospore p.r topical cream 15 gm', 'نيوسبور كريم 15جم', '8', NULL, 'Antibiotic topical', 'Neomycin+polymyxin+pramoxine', 'Borg', 'Cream', 'كريم', '15 gm', '1', NULL, 'properties: neospore-p.r. cream/ointment are a very effective product containing a good combination of neomycin and polymyxin b sulphate (in addition to bacitracin in neospore-p.r. ointment) which has a wide range of antibacterial activity beside pramoxin', NULL, NULL, 876, '2022-07-15', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23394, 'Neospore p.r topical oint. 15 gm', 'نيوسبور مرهم 15جم', '9', NULL, 'Antibiotic topical', 'Bacitracin+neomycin+polymyxin+pramoxine', 'Borg', 'Oint', 'مرهم', '15 gm', '1', NULL, 'properties: neospore-p.r. cream/ointment are a very effective product containing a good combination of neomycin and polymyxin b sulphate (in addition to bacitracin in neospore-p.r. ointment) which has a wide range of antibacterial activity beside pramoxin', NULL, NULL, 764, '2022-07-25', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23396, 'Neostigmine 1mg/ml vial', 'نيوستجمين 1مجم/مل فيال', '6', NULL, 'Para-sympathomimetic', 'Neostigmine', 'Memphis', 'Vial', 'فيال', '1mg', '1', NULL, 'about neostigmine para-sympathomimetic a reversible anticholinesterase in myasthenia gravis treatment an adjunct in general anaesthesia curare antagonist. mechanism of action of neostigmine it inhibits the destruction of acetylcholine by cholinesterase (b', NULL, NULL, 1454, '2022-07-13', 0, 'Neostigmine is used for the symptomatic treatment of myasthenia gravis by improving muscle tone.', 'Neostigmine is a parasympathomimetic, specifically, a reversible cholinesterase inhibitor. The drug inhibits acetylcholinesterase which is responsible for the degredation of acetylcholine. So, with acetylcholinesterase inhibited, more acetylcholine is present By interfering with the breakdown of acetylcholine, neostigmine indirectly stimulates both nicotinic and muscarinic receptors which are involved in muscle contraction.. It does not cross the blood-brain barrier.', 'Neostigmine is a cholinesterase inhibitor used in the treatment of myasthenia gravis and to reverse the effects of muscle relaxants such as gallamine and tubocurarine. Neostigmine, unlike physostigmine, does not cross the blood-brain barrier. By inhibiting acetylcholinesterase, more acetylcholine is available in the synapse, therefore, more of it can bind to the fewer receptors present in myasthenia gravis and can better trigger muscular contraction.



', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23397, 'Gybenash 300mg 30 caps', 'جايبيناش 300مجم 30 كبسولة', '120', NULL, 'Neuropathic pain', 'Palmitoylethanolamide(pea)', 'Biomed', 'Cap', 'كبسولة', '300mg', '3', NULL, NULL, NULL, NULL, 1683, '2023-04-10', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23398, 'Neotigason 10mg 30 caps.(n/a)', 'نيوتيجازون 10مجم 30 كبسولة', '151', NULL, 'Psoriasis', 'Acitretin', 'Actavis > multipharma', 'Cap', 'كبسولة', '10mg', '3', NULL, 'description: an oral retinoid effective in the treatment of psoriasis. it is the major metabolite of etretinate with the advantage of a much shorter half-life when compared with etretinate. indication : for the treatment of severe psoriasis in adults. mec', '5690528199024', NULL, 997, '2022-12-07', 0, 'For the treatment of severe psoriasis in adults.', 'The mechanism of action of acitretin is unknown, however it is believed to work by targeting specific receptors (retinoid receptors such as RXR and RAR) in the skin which help normalize the growth cycle of skin cells.', 'Acitretin is a retinoid. Retinoids have a structure similar to vitamin A and are involved in the normal growth of skin cells. Acitretin works by inhibiting the excessive cell growth and keratinisation (process by which skin cells become thickened due to the deposition of a protein within them) seen in psoriasis. It therefore reduces the thickening of the skin, plaque formation and scaling.', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23399, 'Neotigason 25mg 30 caps.(n/a)', 'نيوتيجازون 25مجم 30 كبسولة', '336', NULL, 'Psoriasis', 'Acitretin', 'Actavis > multipharma', 'Cap', 'كبسولة', '25mg', '3', 'يستخدم كعلاج لحالات الصدفية الشديدة للبالغين.', 'description: an oral retinoid effective in the treatment of psoriasis. it is the major metabolite of etretinate with the advantage of a much shorter half-life when compared with etretinate. indication : for the treatment of severe psoriasis in adults. mec', NULL, NULL, 2040, '2022-05-13', 0, 'For the treatment of severe psoriasis in adults.', 'The mechanism of action of acitretin is unknown, however it is believed to work by targeting specific receptors (retinoid receptors such as RXR and RAR) in the skin which help normalize the growth cycle of skin cells.', 'Acitretin is a retinoid. Retinoids have a structure similar to vitamin A and are involved in the normal growth of skin cells. Acitretin works by inhibiting the excessive cell growth and keratinisation (process by which skin cells become thickened due to the deposition of a protein within them) seen in psoriasis. It therefore reduces the thickening of the skin, plaque formation and scaling.', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23400, 'Acetylovan syrup 100ml', 'اسيتيلوفان شراب 100 مل', '58', '48', 'Cough syrup and mucolytic', 'N acetyl cysteine+ivy+vitamin c+propolis+msm', 'Phytomed pharma', 'Syrup', 'شراب', '100ml', '1', NULL, NULL, '745314980814', NULL, 1097, '2025-06-24', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23401, 'Neotone eyes 15 ml', 'نيوتون للعين 15 مل', '249', '199', 'Eye contour', NULL, 'Isis pharma > biotech egypt', 'Unknown', 'غير محدد', '15 ml', '1', NULL, 'indications & properties specifically developed for the sensitive skin of the eye contour area neotoneï- eyes reduces effectively vascular dark circles (blue/violet aspect) and pigmented dark circles (brown/black aspect) and also reduces eye bags. thanks', NULL, NULL, 775, '2023-09-03', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23402, 'Neotone radiance spf 50+ 30 ml', 'نيوتون راديانس للحماية من الشمس 30مل', '385', '309', 'Whitening topical', NULL, 'Isis pharma > biotech egypt', 'Unknown', 'غير محدد', '30 ml', '1', NULL, 'indications pigmentation spots very high protection and depigmenting cream use apply neotone radiance on the morning as a daily skin care. very high sun protection spf50+. properties the advanced formula of neotone radiance prevents and treats hyperpigmen', NULL, NULL, 674, '2023-09-06', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23403, 'Neotone serum 30 ml', 'نيوتون سيرم 30مل', '385', '319', 'Whitening topical', 'Diacetyl boldine+pure liquorice extract+niacinamide+glycolic acid+salicylic acid', 'Isis pharma > biotech egypt', 'Serum', 'سيروم', '30 ml', '1', NULL, 'neotone serum effectively reduces dark spots thanks to its innovative depi-act complex. use: on your face neckline and hands use neotone serum every night on darks spots visible . during the treatment period use suitable sun protection : neotone radiance', NULL, NULL, 805, '2023-09-06', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23406, 'Neozoline eye/nose drops', 'نيوزولين نقط للعين والانف', '4', NULL, 'Corneal vascularity.antihistamine combined with alpha 1 agonist', 'Chlorpheniramine+naphazoline', 'Amoun', 'Drops', 'نقط', NULL, '1', NULL, 'indications - rhinitis (acute allergic) sinusitis; - nasal hemorrhage (as vasoconstrictor) to stop and alleviate conduction of rhinoscopy; - hay fever; - conjunctivitis (allergic chronic); - asthenopic disorders (accommodation disturbance in case of enlar', '6221025017086', NULL, 1160, '2023-08-06', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23407, 'Nephroflam 200 mg 30 f.c. tab.', 'نيفروفلام 200مجم 30 قرص', '66', '42', 'Antimuscarinic.urinary bladder antispasmodic', 'Flavoxate hydrochloride', 'Unipharma co.', 'Tab', 'أقراص', '200 mg', '3', 'تخفيف أعراض عسر البول، الحاجة المتكررة للبول ، البوال الليلي، والألم فوق العانة، تواتر وسلس البول المرتبط بالتهاب المثانة, البروستات، التهاب الإحليل , التهاب الإحليل و المثانة .', NULL, '6224000730291', NULL, 3540, '2024-10-09', 0, 'For symptomatic relief of dysuria, urgency, nocturia, suprapubic pain, frequency and incontinence as may occur in cystitis, prostatitis, urethritis, urethrocystitis/urethrotrigonitis.', 'Flavoxate acts as a direct antagonist at muscarinic acetylcholine receptors in cholinergically innervated organs. Its anticholinergic-parasympatholytic action reduces the tonus of smooth muscle in the bladder, effectively reducing the number of required voids, urge incontinence episodes, urge severity and improving retention, facilitating increased volume per void.', 'Flavoxate is a spasmolytic flavone derivative that acts by relaxing the smooth muscle in the urinary tract. Flavoxate is a competitive muscarinic receptor antagonist indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency, and urinary frequency. Muscarinic receptors play an important role in several major cholin-ergically mediated functions, including contractions of urinary bladder smooth muscle and stimulation of salivary secretion.', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23408, 'Nephrosteril 7% i.v.infusion', 'نفروستريل 7% للحقن الوريدي', '64', NULL, 'Sterile solution', NULL, 'Fresenius kabi', 'Unknown', 'غير محدد', '7%', '1', NULL, 'features a special amino acid solution for patients with renal insufficiency.it is 7% amino acid solution without carbohydrates & electrolytes.nephrosteril contains 60% essential 13% conditionally essential & 27% non-essential amino acids. indications bal', NULL, NULL, 877, '2022-07-25', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23409, 'Nephrotect i.v. solution 500 ml', 'نفروتكت محلول للحقن الوريدي 500مل', '116', '72', NULL, NULL, 'Fresenius kabi', 'Solution', 'محلول', '500 ml', '1', NULL, '*indications: -amino acid for use in the parenteral nutrition especially of critically ill patients and patients with renal disorders. -the solution can be used to supply parenteral nutrition of patients with acute or chronic renal failure including patie', NULL, NULL, 726, '2024-11-23', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23410, 'Nepiralin 200 mg 10 tab.', 'نبيرالين 200مجم 10 اقراص', '90', NULL, 'Antiviral.nucleoside', 'Nevirapine', 'Egpi', 'Tab', 'أقراص', '200 mg', '1', NULL, 'about nevirapine a non-nucleoside reverse transcriptase inhibitor (nnrti) antiretroviral. mechanism of action of nevirapine nevirapine noncompetitively binds to a site other than catalytic site in the hiv- 1 reverse transcriptase enzyme .this binding will', NULL, NULL, 727, '2022-07-16', 0, 'For use in combination with other antiretroviral drugs in the ongoing treatment of HIV-1 infection.', 'Nevirapine binds directly to reverse transcriptase (RT) and blocks the RNA-dependent and DNA-dependent DNA polymerase activities by causing a disruption of the enzyme''s catalytic site. The activity of nevirapine does not compete with template or nucleoside triphosphates.', 'Nevirapine is a non-nucleoside reverse transcriptase inhibitor (nNRTI) with activity against Human Immunodeficiency Virus Type 1 (HIV-1). HIV-2 RT and eukaryotic DNA polymerases (such as human DNA polymerases alpha, beta, or sigma) are not inhibited by nevirapine. Nevirapine is, in general, only prescribed after the immune system has declined and infections have become evident. It is always taken with at least one other HIV medication such as Retrovir or Videx. The virus can develop resistance to nevirapine if the drug is taken alone, although even if used properly, nevirapine is effective for only a limited time.', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23411, 'Nepvol 5 mg 10 tabs. (n/a)', 'نيبفول 5مجم 10 اقراص', '22', NULL, 'Antihypertensive.beta blocker.selective b1', 'Nebivolol hydrochloride', 'El-obour > advocure', 'Tab', 'أقراص', '5 mg', '1', NULL, 'about nebivolol third generation cardio selective beta-1 receptor antagonist antihypertensive. mechanism of action of nebivolol nebivolol is a 3rd generation cardio selective beta-1 receptor antagonist which reduces vascular resistance acutely lowers arte', NULL, NULL, 974, '2022-07-12', 0, 'Nebivolol is indicated to treat hypertension.[A2762,A182579,L7985,L7988]', 'Nebivolol is a highly selective beta-1 adrenergic receptor antagonist[A182579] with weak beta-2 adrenergic receptor antagonist activity.[A182585] Blocking beta-1 adrenergic receptors by d-nebivolol leads to decreased resting heart rate, exercise heart rate, myocardial contracility, systolic blood pressure, and diastolic blood pressure.[A182603,A182579,A182585,A182615] The selectivity of d-nebivolol limits the magnitude of beta blocker adverse effects in the airways or relating to insulin sensitivity.[A182615] Nebivolol also inhibits aldosterone, and beta-1 antagonism in the juxtaglomerular apparatus also inhibits the release of renin.[A182615] Decreased aldosterone leads to decreased blood volume, and decreased renin leads to reduced vasoconstriction.[A182615] l-nebivolol is responsible for beta-3 adrenergic receptor agonist activity that stimulates endothelial nitric oxide synthase, increasing nitric oxide levels; leading to vasodilation, decreased peripheral vascular resistance, increased stroke volume, ejection fraction, and cardiac output.[A2762,A182603,A182579,A182585,A182615] The vasodilation, reduced oxidative stress, and reduced platelet volume and aggregation of nebivolol may lead to benefits in heart failure patients.[A182603]', 'Nebivolol is a selective beta-1 adrenergic receptor antagonist that decreases vascular resistance, increases stroke volume and cardiac output, and does not negatively affect left ventricular function.[A182579,A182585] It has a long duration of action as effects can be seen 48 hours after stopping the medication and a wide therapeutic window as patients generally take 5-40mg daily.[A182579,L7985] Patients should not abruptly stop taking this medication as this may lead to exacerbation of coronary artery disease.[L7985] Diabetic patients should monitor their blood glucose levels as beta blockers may mask signs of hypoglycemia.[L7985]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23412, 'Nercefaxon 1 gm i.m. vial', 'نيرسيفاكسون 1جم فيال للحقن العضلي', '56', '43', 'Antibiotic.cephalosporin.third-generation', 'Ceftriaxone', 'Badr pharma', 'Vial', 'فيال', '1 gm', '1', NULL, 'about ceftriaxone third generation cephalosporin antibiotic(parenteral). mechanism of action of ceftriaxone ceftriaxone is a 3rd generation cephalosporin which exerts its bactericidal action against both gram positive & gram negative organisms by inhibiti', '6222018600018', NULL, 1248, '2025-05-28', 0, 'Ceftriaxone is used for the treatment of the infections (respiratory, skin, soft tissue, UTI, ENT) caused by susceptible organisms.[L15082] Organisms that are generally susceptible to ceftriaxone include S. pneumoniae, S. pyogenes (group A beta-hemolytic streptococci), coagulase-negative staphylococci, Some Enterobacter spp, H. influenzae, N. gonorrhoeae, P. mirabilis, E. coli, Klebsiella spp, M. catarrhalis, B. burgdorferi, and some oral anaerobes.[A215582] ', 'Ceftriaxone works by inhibiting the mucopeptide synthesis in the bacterial cell wall.[T324,L15082] The beta-lactam moiety of ceftriaxone binds to carboxypeptidases, endopeptidases, and transpeptidases in the bacterial cytoplasmic membrane. These enzymes are involved in cell-wall synthesis and cell division. Binding of ceftriaxone to these enzymes causes the enzyme to lose activity; therefore, the bacteria produce defective cell walls, causing cell death.', 'Ceftriaxone is a cephalosporin/cephamycin beta-lactam antibiotic used in the treatment of bacterial infections caused by susceptible, usually gram-positive, organisms.[L15082] Ceftriaxone has <i>in vitro</i> activity against gram-positive aerobic, gram-negative aerobic, and anaerobic bacteria.[L15087] The bactericidal activity of ceftriaxone results from the inhibition of cell wall synthesis and is mediated through ceftriaxone binding to penicillin-binding proteins (PBPs).[T324] Ceftriaxone is stable against hydrolysis by a variety of beta-lactamases, including penicillinases, and cephalosporinases and extended-spectrum beta-lactamases.[L15082] However, resistance to ceftriaxone usually occurs through beta-lactamase hydrolysis, altered PBPs, or reduced bacterial cell permeability.[T324] Ceftriaxone should not be mixed with or giving in the same IV line as diluents/products containing calcium as they may cause ceftriaxone to precipitate.[L15082] Ceftriaxone use may also cause biliary sludge or gallbladder pseudolithiasis.[L15082,A215602] ', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23413, 'Nercefaxon 500 mg i.m. vial', 'نيرسيفاكسون 500مجم فيال عضل', '34', '22.5', 'Antibiotic.cephalosporin.third-generation', 'Ceftriaxone', 'Badr pharma', 'Vial', 'فيال', '500 mg', '1', NULL, 'about ceftriaxone third generation cephalosporin antibiotic(parenteral). mechanism of action of ceftriaxone ceftriaxone is a 3rd generation cephalosporin which exerts its bactericidal action against both gram positive & gram negative organisms by inhibiti', NULL, NULL, 780, '2024-06-19', 0, 'Ceftriaxone is used for the treatment of the infections (respiratory, skin, soft tissue, UTI, ENT) caused by susceptible organisms.[L15082] Organisms that are generally susceptible to ceftriaxone include S. pneumoniae, S. pyogenes (group A beta-hemolytic streptococci), coagulase-negative staphylococci, Some Enterobacter spp, H. influenzae, N. gonorrhoeae, P. mirabilis, E. coli, Klebsiella spp, M. catarrhalis, B. burgdorferi, and some oral anaerobes.[A215582] ', 'Ceftriaxone works by inhibiting the mucopeptide synthesis in the bacterial cell wall.[T324,L15082] The beta-lactam moiety of ceftriaxone binds to carboxypeptidases, endopeptidases, and transpeptidases in the bacterial cytoplasmic membrane. These enzymes are involved in cell-wall synthesis and cell division. Binding of ceftriaxone to these enzymes causes the enzyme to lose activity; therefore, the bacteria produce defective cell walls, causing cell death.', 'Ceftriaxone is a cephalosporin/cephamycin beta-lactam antibiotic used in the treatment of bacterial infections caused by susceptible, usually gram-positive, organisms.[L15082] Ceftriaxone has <i>in vitro</i> activity against gram-positive aerobic, gram-negative aerobic, and anaerobic bacteria.[L15087] The bactericidal activity of ceftriaxone results from the inhibition of cell wall synthesis and is mediated through ceftriaxone binding to penicillin-binding proteins (PBPs).[T324] Ceftriaxone is stable against hydrolysis by a variety of beta-lactamases, including penicillinases, and cephalosporinases and extended-spectrum beta-lactamases.[L15082] However, resistance to ceftriaxone usually occurs through beta-lactamase hydrolysis, altered PBPs, or reduced bacterial cell permeability.[T324] Ceftriaxone should not be mixed with or giving in the same IV line as diluents/products containing calcium as they may cause ceftriaxone to precipitate.[L15082] Ceftriaxone use may also cause biliary sludge or gallbladder pseudolithiasis.[L15082,A215602] ', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23414, 'Nerhahair 5% top. lotion 60 ml', 'نير هير 5% محلول موضعي 60 مل', '83', '45', 'Antihypertensives.hair regrowth.vasodilator agents', 'Minoxidil', 'Vetopharm-egypt', 'Lotion', 'لوشن', '5%', '1', NULL, 'about minoxidil a potassium channel agonist direct-acting vasodilator hair- growth stimulant in androgenic alopecia. mechanism of action of minoxidil minoxidil works by activating pghs 1 (prostaglandin endoperoxide synthase-1) which helps promote hair gro', NULL, NULL, 1135, '2024-12-13', 0, 'For the treatment of severe hypertension and in the topical treatment (regrowth) of androgenic alopecia in males and females and stabilisation of hair loss in patients with androgenic alopecia.', 'Minoxidil is thought to promote the survival of human dermal papillary cells (DPCs) or hair cells by activating both extracellular signal-regulated kinase (ERK) and Akt and by preventing cell death by increasing the ratio of BCl<sup>-</sup>2/Bax. Minoxidil may stimulate the growth of human hairs by prolonging anagen through these proliferative and anti-apoptotic effects on DPCs. Minoxidil, when used as a vasodilator, acts by opening adenosine triphosphate-sensitive potassium channels in vascular smooth muscle cells. This vasodilation may also improve the viability of hair cells or hair follicles.', 'Minoxidil is an orally effective direct acting peripheral vasodilator that reduces elevated systolic and diastolic blood pressure by decreasing peripheral vascular resistance. Minoxidil is also used topically to treat androgenetic alopecia. Microcirculatory blood flow in animals is enhanced or maintained in all systemic vascular beds. In man, forearm and renal vascular resistance decline; forearm blood flow increases while renal blood flow and glomerular filtration rate are preserved. The predominant site of minoxidil action is arterial. Venodilation does not occur with minoxidil; thus, postural hypotension is unusual with its administration. The antihypertensive activity of minoxidil is due to its sulphate metabolite, minoxidil sulfate.', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23416, 'Nerhasilda 25 mg 16 orodispersible films', 'نيرهاسيلدا 25مجم 16 فيلم', '88', '48', 'Tonic for men', 'Sildenafil', 'Nerhadou international co.', 'Film', 'فيلم', '25 mg', '16', NULL, 'about sildenafil citrate phosphodiesterase-5 enzyme inhibitor anti-erectile dysfunction agent. mechanism of action of sildenafil citrate sildenafil is a phosphodiesterase enzyme (pde5) inhibitor. this enzyme is responsible for the degradation cyclic guano', NULL, NULL, 1709, '2023-10-15', 0, 'Sildenafil is a phosphodiesterase-5 (PDE5) inhibitor that is predominantly employed for two primary indications:



(1) the treatment of erectile dysfunction [A175582, L5611, F3853, F3856, F3886]; and



(2) treatment of pulmonary hypertension, where:

a) the US FDA specifically indicates sildenafil for the treatment of pulmonary arterial hypertension (PAH) (WHO Group I) in adults to improve exercise ability and delay clinical worsening [F3850]. The delay in clinical worsening was demonstrated when sildenafil was added to background epoprostenol therapy [F3850]. Studies establishing effectiveness were short-term (12 to 16 weeks), and included predominately patients with New York Heart Association (NYHA) Functional Class II-III symptoms and idiopathic etiology (71%) or associated with connective tissue disease (CTD) (25%) [F3850];



b) the Canadian product monograph specifically indicates sildenafil for the treatment of primary pulmonary arterial hypertension (PPH) or pulmonary hypertension secondary to connective tissue disease (CTD) in adult patients with WHO functional class II or III who have not responded to conventional therapy [F3859]. In addition, improvement in exercise ability and delay in clinical worsening was demonstrated in adult patients who were already stabilized on background epoprostenol therapy [F3859]; and



c) the EMA product information specifically indicates sildenafil for the treatment of adult patients with pulmonary arterial hypertension classified as WHO functional class II and III, to improve exercise capacity [F3883]. Efficacy has been shown in primary pulmonary hypertension and pulmonary hypertension associated with connective tissue disease [F3883]. The EMA label also indicates sildenafil for the treatment of pediatric patients aged 1 year to 17 years old with pulmonary arterial hypertension [F3883]. Efficacy in terms of improvement of exercise capacity or pulmonary hemodynamics has been shown in primary pulmonary hypertension and pulmonary hypertension associated with congenital heart disease [F3883].', 'Sildenafil is an oral therapy for erectile dysfunction [A175582, F3853, F3856, F3886, L5611]. In the natural setting, i.e. with sexual stimulation, it restores impaired erectile function by increasing blood flow to the penis [A175582, F3853, F3856, F3886, L5611].



The physiological mechanism responsible for the erection of the penis involves the release of nitric oxide (NO) in the corpus cavernosum during sexual stimulation [A175582, F3853, F3856, F3886, L5611]. Nitric oxide then activates the enzyme guanylate cyclase, which results in increased levels of cyclic guanosine monophosphate (cGMP), producing smooth muscle relaxation in the corpus cavernosum and allowing inflow of blood [A175582, F3853, F3856, F3886, L5611].



Sildenafil is a potent and selective inhibitor of cGMP specific phosphodiesterase type 5 (PDE5) in the corpus cavernosum, where PDE5 is responsible for degradation of cGMP [A175582, F3853, F3856, F3886, L5611]. Sildenafil has a peripheral site of action on erections [A175582, F3853, F3856, F3886, L5611]. Sildenafil has no direct relaxant effect on isolated human corpus cavernosum but potently enhances the relaxant effect of NO on this tissue [A175582, F3853, F3856, F3886, L5611]. When the NO/cGMP pathway is activated, as occurs with sexual stimulation, inhibition of PDE5 by sildenafil results in increased corpus cavernosum levels of cGMP [A175582, F3853, F3856, F3886, L5611]. Therefore sexual stimulation is required in order for sildenafil to produce its intended beneficial pharmacological effects [A175582, F3853, F3856, F3886, L5611].



Moreover, apart from the presence of PDE5 in the corpus cavernosum of the penis, PDE5 is also present in the pulmonary vasculature [A175579, F3850, F3859, F3883, L5614]. Sildenafil, therefore, increases cGMP within pulmonary vascular smooth muscle cells resulting in relaxation [A175579, F3850, F3859, F3883, L5614]. In patients with pulmonary arterial hypertension, this can lead to vasodilation of the pulmonary vascular bed and, to a lesser degree, vasodilatation in the systemic circulation [A175579, F3850, F3859, F3883, L5614].', 'In vitro studies have shown that sildenafil is selective for phosphodiesterase-5 (PDE5) [F3850, F3853, F3856, F3859, F3883, F3886, L5611, L5614]. Its effect is more potent on PDE5 than on other known phosphodiesterases [F3850, F3853, F3856, F3859, F3883, F3886, L5611, L5614]. In particular, there is a 10-times selectivity over PDE6 which is involved in the phototransduction pathway in the retina [F3850, F3853, F3856, F3859, F3883, F3886, L5611, L5614]. There is an 80-times selectivity over PDE1, and over 700-times over PDE 2, 3, 4, 7, 8, 9, 10 and 11 [F3850, F3853, F3856, F3859, F3883, F3886, L5611, L5614]. And finally, sildenafil has greater than 4,000-times selectivity for PDE5 over PDE3, the cAMP-specific phosphodiesterase isoform involved in the control of cardiac contractility [F3850, F3853, F3856, F3859, F3883, F3886, L5611, L5614].



In eight double-blind, placebo-controlled crossover studies of patients with either organic or psychogenic erectile dysfunction, sexual stimulation resulted in improved erections, as assessed by an objective measurement of hardness and duration of erections (via the use of RigiScan®), after sildenafil administration compared with placebo [F3850, F3853, F3856, F3859, F3883, F3886, L5611, L5614]. Most studies assessed the efficacy of sildenafil approximately 60 minutes post-dose [F3850, F3853, F3856, F3859, F3883, F3886, L5611, L5614]. The erectile response, as assessed by RigiScan®, generally increased with increasing sildenafil dose and plasma concentration [F3850, F3853, F3856, F3859, F3883, F3886, L5611, L5614]. The time course of effect was examined in one study, showing an effect for up to 4 hours but the response was diminished compared to 2 hours [F3850, F3853, F3856, F3859, F3883, F3886, L5611, L5614].



Sildenafil causes mild and transient decreases in systemic blood pressure which, in the majority of cases, do not translate into clinical effects [F3850, F3853, F3856, F3859, F3883, F3886, L5611, L5614]. After chronic dosing of 80 mg, three times a day to patients with systemic hypertension the mean change from baseline in systolic and diastolic blood pressure was a decrease of 9.4 mmHg and 9.1 mmHg respectively [F3850, F3853, F3856, F3859, F3883, F3886, L5611, L5614]. After chronic dosing of 80 mg, three times a day to patients with pulmonary arterial hypertension lesser effects in blood pressure reduction were observed (a reduction in both systolic and diastolic pressure of 2 mmHg)[F3850, F3853, F3856, F3859, F3883, F3886, L5611, L5614] . At the recommended dose of 20 mg three times a day no reductions in systolic or diastolic pressure were seen [F3850, F3853, F3856, F3859, F3883, F3886, L5611, L5614].



Single oral doses of sildenafil up to 100 mg in healthy volunteers produced no clinically relevant effects on ECG [F3850, F3853, F3856, F3859, F3883, F3886, L5611, L5614]. After chronic dosing of 80 mg three times a day to patients with pulmonary arterial hypertension no clinically relevant effects on the ECG were reported either [F3850, F3853, F3856, F3859, F3883, F3886, L5611, L5614].



In a study of the hemodynamic effects of a single oral 100 mg dose of sildenafil in 14 patients with severe coronary artery disease (CAD) (> 70 % stenosis of at least one coronary artery), the mean resting systolic and diastolic blood pressures decreased by 7 % and 6 % respectively compared to baseline [F3850, F3853, F3856, F3859, F3883, F3886, L5611, L5614]. Mean pulmonary systolic blood pressure decreased by 9% [F3850, F3853, F3856, F3859, F3883, F3886, L5611, L5614]. Sildenafil showed no effect on cardiac output and did not impair blood flow through the stenosed coronary arteries [F3850, F3853, F3856, F3859, F3883, F3886, L5611, L5614].



Mild and transient differences in color discrimination (blue/green) were detected in some subjects using the Farnsworth-Munsell 100 hue test at 1 hour following a 100 mg dose, with no effects evident after 2 hours post-dose [F3850, F3853, F3856, F3859, F3883, F3886, L5611, L5614]. The postulated mechanism for this change in color discrimination is related to inhibition of PDE6, which is involved in the phototransduction cascade of the retina [F3850, F3853, F3856, F3859, F3883, F3886, L5611, L5614]. Sildenafil has no effect on visual acuity or contrast sensitivity. In a small size placebo-controlled study of patients with documented early age-related macular degeneration (n = 9), sildenafil (single dose, 100 mg) demonstrated no significant changes in visual tests conducted (which included visual acuity, Amsler grid, color discrimination simulated traffic light, and the Humphrey perimeter and photostress test) [F3850, F3853, F3856, F3859, F3883, F3886, L5611, L5614].', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23417, 'Nerhasilda 50 mg 16 orodispersible films', 'نيرهاسيلدا 50مجم 16 شريحة ذائبة بالفم', '128', '96', 'Tonic for men', 'Sildenafil', 'Nerhadou international co.', 'Film', 'فيلم', '50 mg', '16', 'مقوى للرجال', 'about sildenafil citrate phosphodiesterase-5 enzyme inhibitor anti-erectile dysfunction agent. mechanism of action of sildenafil citrate sildenafil is a phosphodiesterase enzyme (pde5) inhibitor. this enzyme is responsible for the degradation cyclic guano', '6224011153072', NULL, 6233, '2024-07-12', 0, 'Sildenafil is a phosphodiesterase-5 (PDE5) inhibitor that is predominantly employed for two primary indications:



(1) the treatment of erectile dysfunction [A175582, L5611, F3853, F3856, F3886]; and



(2) treatment of pulmonary hypertension, where:

a) the US FDA specifically indicates sildenafil for the treatment of pulmonary arterial hypertension (PAH) (WHO Group I) in adults to improve exercise ability and delay clinical worsening [F3850]. The delay in clinical worsening was demonstrated when sildenafil was added to background epoprostenol therapy [F3850]. Studies establishing effectiveness were short-term (12 to 16 weeks), and included predominately patients with New York Heart Association (NYHA) Functional Class II-III symptoms and idiopathic etiology (71%) or associated with connective tissue disease (CTD) (25%) [F3850];



b) the Canadian product monograph specifically indicates sildenafil for the treatment of primary pulmonary arterial hypertension (PPH) or pulmonary hypertension secondary to connective tissue disease (CTD) in adult patients with WHO functional class II or III who have not responded to conventional therapy [F3859]. In addition, improvement in exercise ability and delay in clinical worsening was demonstrated in adult patients who were already stabilized on background epoprostenol therapy [F3859]; and



c) the EMA product information specifically indicates sildenafil for the treatment of adult patients with pulmonary arterial hypertension classified as WHO functional class II and III, to improve exercise capacity [F3883]. Efficacy has been shown in primary pulmonary hypertension and pulmonary hypertension associated with connective tissue disease [F3883]. The EMA label also indicates sildenafil for the treatment of pediatric patients aged 1 year to 17 years old with pulmonary arterial hypertension [F3883]. Efficacy in terms of improvement of exercise capacity or pulmonary hemodynamics has been shown in primary pulmonary hypertension and pulmonary hypertension associated with congenital heart disease [F3883].', 'Sildenafil is an oral therapy for erectile dysfunction [A175582, F3853, F3856, F3886, L5611]. In the natural setting, i.e. with sexual stimulation, it restores impaired erectile function by increasing blood flow to the penis [A175582, F3853, F3856, F3886, L5611].



The physiological mechanism responsible for the erection of the penis involves the release of nitric oxide (NO) in the corpus cavernosum during sexual stimulation [A175582, F3853, F3856, F3886, L5611]. Nitric oxide then activates the enzyme guanylate cyclase, which results in increased levels of cyclic guanosine monophosphate (cGMP), producing smooth muscle relaxation in the corpus cavernosum and allowing inflow of blood [A175582, F3853, F3856, F3886, L5611].



Sildenafil is a potent and selective inhibitor of cGMP specific phosphodiesterase type 5 (PDE5) in the corpus cavernosum, where PDE5 is responsible for degradation of cGMP [A175582, F3853, F3856, F3886, L5611]. Sildenafil has a peripheral site of action on erections [A175582, F3853, F3856, F3886, L5611]. Sildenafil has no direct relaxant effect on isolated human corpus cavernosum but potently enhances the relaxant effect of NO on this tissue [A175582, F3853, F3856, F3886, L5611]. When the NO/cGMP pathway is activated, as occurs with sexual stimulation, inhibition of PDE5 by sildenafil results in increased corpus cavernosum levels of cGMP [A175582, F3853, F3856, F3886, L5611]. Therefore sexual stimulation is required in order for sildenafil to produce its intended beneficial pharmacological effects [A175582, F3853, F3856, F3886, L5611].



Moreover, apart from the presence of PDE5 in the corpus cavernosum of the penis, PDE5 is also present in the pulmonary vasculature [A175579, F3850, F3859, F3883, L5614]. Sildenafil, therefore, increases cGMP within pulmonary vascular smooth muscle cells resulting in relaxation [A175579, F3850, F3859, F3883, L5614]. In patients with pulmonary arterial hypertension, this can lead to vasodilation of the pulmonary vascular bed and, to a lesser degree, vasodilatation in the systemic circulation [A175579, F3850, F3859, F3883, L5614].', 'In vitro studies have shown that sildenafil is selective for phosphodiesterase-5 (PDE5) [F3850, F3853, F3856, F3859, F3883, F3886, L5611, L5614]. Its effect is more potent on PDE5 than on other known phosphodiesterases [F3850, F3853, F3856, F3859, F3883, F3886, L5611, L5614]. In particular, there is a 10-times selectivity over PDE6 which is involved in the phototransduction pathway in the retina [F3850, F3853, F3856, F3859, F3883, F3886, L5611, L5614]. There is an 80-times selectivity over PDE1, and over 700-times over PDE 2, 3, 4, 7, 8, 9, 10 and 11 [F3850, F3853, F3856, F3859, F3883, F3886, L5611, L5614]. And finally, sildenafil has greater than 4,000-times selectivity for PDE5 over PDE3, the cAMP-specific phosphodiesterase isoform involved in the control of cardiac contractility [F3850, F3853, F3856, F3859, F3883, F3886, L5611, L5614].



In eight double-blind, placebo-controlled crossover studies of patients with either organic or psychogenic erectile dysfunction, sexual stimulation resulted in improved erections, as assessed by an objective measurement of hardness and duration of erections (via the use of RigiScan®), after sildenafil administration compared with placebo [F3850, F3853, F3856, F3859, F3883, F3886, L5611, L5614]. Most studies assessed the efficacy of sildenafil approximately 60 minutes post-dose [F3850, F3853, F3856, F3859, F3883, F3886, L5611, L5614]. The erectile response, as assessed by RigiScan®, generally increased with increasing sildenafil dose and plasma concentration [F3850, F3853, F3856, F3859, F3883, F3886, L5611, L5614]. The time course of effect was examined in one study, showing an effect for up to 4 hours but the response was diminished compared to 2 hours [F3850, F3853, F3856, F3859, F3883, F3886, L5611, L5614].



Sildenafil causes mild and transient decreases in systemic blood pressure which, in the majority of cases, do not translate into clinical effects [F3850, F3853, F3856, F3859, F3883, F3886, L5611, L5614]. After chronic dosing of 80 mg, three times a day to patients with systemic hypertension the mean change from baseline in systolic and diastolic blood pressure was a decrease of 9.4 mmHg and 9.1 mmHg respectively [F3850, F3853, F3856, F3859, F3883, F3886, L5611, L5614]. After chronic dosing of 80 mg, three times a day to patients with pulmonary arterial hypertension lesser effects in blood pressure reduction were observed (a reduction in both systolic and diastolic pressure of 2 mmHg)[F3850, F3853, F3856, F3859, F3883, F3886, L5611, L5614] . At the recommended dose of 20 mg three times a day no reductions in systolic or diastolic pressure were seen [F3850, F3853, F3856, F3859, F3883, F3886, L5611, L5614].



Single oral doses of sildenafil up to 100 mg in healthy volunteers produced no clinically relevant effects on ECG [F3850, F3853, F3856, F3859, F3883, F3886, L5611, L5614]. After chronic dosing of 80 mg three times a day to patients with pulmonary arterial hypertension no clinically relevant effects on the ECG were reported either [F3850, F3853, F3856, F3859, F3883, F3886, L5611, L5614].



In a study of the hemodynamic effects of a single oral 100 mg dose of sildenafil in 14 patients with severe coronary artery disease (CAD) (> 70 % stenosis of at least one coronary artery), the mean resting systolic and diastolic blood pressures decreased by 7 % and 6 % respectively compared to baseline [F3850, F3853, F3856, F3859, F3883, F3886, L5611, L5614]. Mean pulmonary systolic blood pressure decreased by 9% [F3850, F3853, F3856, F3859, F3883, F3886, L5611, L5614]. Sildenafil showed no effect on cardiac output and did not impair blood flow through the stenosed coronary arteries [F3850, F3853, F3856, F3859, F3883, F3886, L5611, L5614].



Mild and transient differences in color discrimination (blue/green) were detected in some subjects using the Farnsworth-Munsell 100 hue test at 1 hour following a 100 mg dose, with no effects evident after 2 hours post-dose [F3850, F3853, F3856, F3859, F3883, F3886, L5611, L5614]. The postulated mechanism for this change in color discrimination is related to inhibition of PDE6, which is involved in the phototransduction cascade of the retina [F3850, F3853, F3856, F3859, F3883, F3886, L5611, L5614]. Sildenafil has no effect on visual acuity or contrast sensitivity. In a small size placebo-controlled study of patients with documented early age-related macular degeneration (n = 9), sildenafil (single dose, 100 mg) demonstrated no significant changes in visual tests conducted (which included visual acuity, Amsler grid, color discrimination simulated traffic light, and the Humphrey perimeter and photostress test) [F3850, F3853, F3856, F3859, F3883, F3886, L5611, L5614].', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23420, 'Nerhasilda 75 mg 8 orodispersible films', 'نيرهاسيلدا 75مجم 8 افلام ذائبة بالفم', '88', '64', 'Tonic for men', 'Sildenafil', 'Nerhadou international co.', 'Film', 'فيلم', '75 mg', '8', 'مقوي للرجال', NULL, '6224011153065', NULL, 9957, '2024-07-12', 0, 'Sildenafil is a phosphodiesterase-5 (PDE5) inhibitor that is predominantly employed for two primary indications:



(1) the treatment of erectile dysfunction [A175582, L5611, F3853, F3856, F3886]; and



(2) treatment of pulmonary hypertension, where:

a) the US FDA specifically indicates sildenafil for the treatment of pulmonary arterial hypertension (PAH) (WHO Group I) in adults to improve exercise ability and delay clinical worsening [F3850]. The delay in clinical worsening was demonstrated when sildenafil was added to background epoprostenol therapy [F3850]. Studies establishing effectiveness were short-term (12 to 16 weeks), and included predominately patients with New York Heart Association (NYHA) Functional Class II-III symptoms and idiopathic etiology (71%) or associated with connective tissue disease (CTD) (25%) [F3850];



b) the Canadian product monograph specifically indicates sildenafil for the treatment of primary pulmonary arterial hypertension (PPH) or pulmonary hypertension secondary to connective tissue disease (CTD) in adult patients with WHO functional class II or III who have not responded to conventional therapy [F3859]. In addition, improvement in exercise ability and delay in clinical worsening was demonstrated in adult patients who were already stabilized on background epoprostenol therapy [F3859]; and



c) the EMA product information specifically indicates sildenafil for the treatment of adult patients with pulmonary arterial hypertension classified as WHO functional class II and III, to improve exercise capacity [F3883]. Efficacy has been shown in primary pulmonary hypertension and pulmonary hypertension associated with connective tissue disease [F3883]. The EMA label also indicates sildenafil for the treatment of pediatric patients aged 1 year to 17 years old with pulmonary arterial hypertension [F3883]. Efficacy in terms of improvement of exercise capacity or pulmonary hemodynamics has been shown in primary pulmonary hypertension and pulmonary hypertension associated with congenital heart disease [F3883].', 'Sildenafil is an oral therapy for erectile dysfunction [A175582, F3853, F3856, F3886, L5611]. In the natural setting, i.e. with sexual stimulation, it restores impaired erectile function by increasing blood flow to the penis [A175582, F3853, F3856, F3886, L5611].



The physiological mechanism responsible for the erection of the penis involves the release of nitric oxide (NO) in the corpus cavernosum during sexual stimulation [A175582, F3853, F3856, F3886, L5611]. Nitric oxide then activates the enzyme guanylate cyclase, which results in increased levels of cyclic guanosine monophosphate (cGMP), producing smooth muscle relaxation in the corpus cavernosum and allowing inflow of blood [A175582, F3853, F3856, F3886, L5611].



Sildenafil is a potent and selective inhibitor of cGMP specific phosphodiesterase type 5 (PDE5) in the corpus cavernosum, where PDE5 is responsible for degradation of cGMP [A175582, F3853, F3856, F3886, L5611]. Sildenafil has a peripheral site of action on erections [A175582, F3853, F3856, F3886, L5611]. Sildenafil has no direct relaxant effect on isolated human corpus cavernosum but potently enhances the relaxant effect of NO on this tissue [A175582, F3853, F3856, F3886, L5611]. When the NO/cGMP pathway is activated, as occurs with sexual stimulation, inhibition of PDE5 by sildenafil results in increased corpus cavernosum levels of cGMP [A175582, F3853, F3856, F3886, L5611]. Therefore sexual stimulation is required in order for sildenafil to produce its intended beneficial pharmacological effects [A175582, F3853, F3856, F3886, L5611].



Moreover, apart from the presence of PDE5 in the corpus cavernosum of the penis, PDE5 is also present in the pulmonary vasculature [A175579, F3850, F3859, F3883, L5614]. Sildenafil, therefore, increases cGMP within pulmonary vascular smooth muscle cells resulting in relaxation [A175579, F3850, F3859, F3883, L5614]. In patients with pulmonary arterial hypertension, this can lead to vasodilation of the pulmonary vascular bed and, to a lesser degree, vasodilatation in the systemic circulation [A175579, F3850, F3859, F3883, L5614].', 'In vitro studies have shown that sildenafil is selective for phosphodiesterase-5 (PDE5) [F3850, F3853, F3856, F3859, F3883, F3886, L5611, L5614]. Its effect is more potent on PDE5 than on other known phosphodiesterases [F3850, F3853, F3856, F3859, F3883, F3886, L5611, L5614]. In particular, there is a 10-times selectivity over PDE6 which is involved in the phototransduction pathway in the retina [F3850, F3853, F3856, F3859, F3883, F3886, L5611, L5614]. There is an 80-times selectivity over PDE1, and over 700-times over PDE 2, 3, 4, 7, 8, 9, 10 and 11 [F3850, F3853, F3856, F3859, F3883, F3886, L5611, L5614]. And finally, sildenafil has greater than 4,000-times selectivity for PDE5 over PDE3, the cAMP-specific phosphodiesterase isoform involved in the control of cardiac contractility [F3850, F3853, F3856, F3859, F3883, F3886, L5611, L5614].



In eight double-blind, placebo-controlled crossover studies of patients with either organic or psychogenic erectile dysfunction, sexual stimulation resulted in improved erections, as assessed by an objective measurement of hardness and duration of erections (via the use of RigiScan®), after sildenafil administration compared with placebo [F3850, F3853, F3856, F3859, F3883, F3886, L5611, L5614]. Most studies assessed the efficacy of sildenafil approximately 60 minutes post-dose [F3850, F3853, F3856, F3859, F3883, F3886, L5611, L5614]. The erectile response, as assessed by RigiScan®, generally increased with increasing sildenafil dose and plasma concentration [F3850, F3853, F3856, F3859, F3883, F3886, L5611, L5614]. The time course of effect was examined in one study, showing an effect for up to 4 hours but the response was diminished compared to 2 hours [F3850, F3853, F3856, F3859, F3883, F3886, L5611, L5614].



Sildenafil causes mild and transient decreases in systemic blood pressure which, in the majority of cases, do not translate into clinical effects [F3850, F3853, F3856, F3859, F3883, F3886, L5611, L5614]. After chronic dosing of 80 mg, three times a day to patients with systemic hypertension the mean change from baseline in systolic and diastolic blood pressure was a decrease of 9.4 mmHg and 9.1 mmHg respectively [F3850, F3853, F3856, F3859, F3883, F3886, L5611, L5614]. After chronic dosing of 80 mg, three times a day to patients with pulmonary arterial hypertension lesser effects in blood pressure reduction were observed (a reduction in both systolic and diastolic pressure of 2 mmHg)[F3850, F3853, F3856, F3859, F3883, F3886, L5611, L5614] . At the recommended dose of 20 mg three times a day no reductions in systolic or diastolic pressure were seen [F3850, F3853, F3856, F3859, F3883, F3886, L5611, L5614].



Single oral doses of sildenafil up to 100 mg in healthy volunteers produced no clinically relevant effects on ECG [F3850, F3853, F3856, F3859, F3883, F3886, L5611, L5614]. After chronic dosing of 80 mg three times a day to patients with pulmonary arterial hypertension no clinically relevant effects on the ECG were reported either [F3850, F3853, F3856, F3859, F3883, F3886, L5611, L5614].



In a study of the hemodynamic effects of a single oral 100 mg dose of sildenafil in 14 patients with severe coronary artery disease (CAD) (> 70 % stenosis of at least one coronary artery), the mean resting systolic and diastolic blood pressures decreased by 7 % and 6 % respectively compared to baseline [F3850, F3853, F3856, F3859, F3883, F3886, L5611, L5614]. Mean pulmonary systolic blood pressure decreased by 9% [F3850, F3853, F3856, F3859, F3883, F3886, L5611, L5614]. Sildenafil showed no effect on cardiac output and did not impair blood flow through the stenosed coronary arteries [F3850, F3853, F3856, F3859, F3883, F3886, L5611, L5614].



Mild and transient differences in color discrimination (blue/green) were detected in some subjects using the Farnsworth-Munsell 100 hue test at 1 hour following a 100 mg dose, with no effects evident after 2 hours post-dose [F3850, F3853, F3856, F3859, F3883, F3886, L5611, L5614]. The postulated mechanism for this change in color discrimination is related to inhibition of PDE6, which is involved in the phototransduction cascade of the retina [F3850, F3853, F3856, F3859, F3883, F3886, L5611, L5614]. Sildenafil has no effect on visual acuity or contrast sensitivity. In a small size placebo-controlled study of patients with documented early age-related macular degeneration (n = 9), sildenafil (single dose, 100 mg) demonstrated no significant changes in visual tests conducted (which included visual acuity, Amsler grid, color discrimination simulated traffic light, and the Humphrey perimeter and photostress test) [F3850, F3853, F3856, F3859, F3883, F3886, L5611, L5614].', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23421, 'Nericid 0.1% cream 10 gm', 'نيريسيد 0.1% كريم 10جم', '9', NULL, 'Topical corticosteroid', 'Diflucortolone', 'Cid', 'Cream', 'كريم', '0.1%', '1', NULL, 'about diflucortolone type of medicine : potent topical corticosteroid used for inflammatory skin conditions such as severe eczema diflucortolone is a strong topical corticosteroid (also referred to as a topical steroid). topical steroids are used in addit', NULL, NULL, 583, '2022-07-31', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23422, 'Nericid 0.1% fatty ointment 10 gm', 'نيريسيد 0.1% مرهم 10جم', '9', NULL, 'Glucocorticoid', 'Diflucortolone', 'Cid', 'Ointment', 'مرهم', '0.1%', '1', NULL, 'about diflucortolone type of medicine : potent topical corticosteroid used for inflammatory skin conditions such as severe eczema diflucortolone is a strong topical corticosteroid (also referred to as a topical steroid). topical steroids are used in addit', NULL, NULL, 611, '2022-07-09', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23423, 'Nericid 0.1% oint. 10 gm', 'نيريسيد 0.1% مرهم 10جم', '9', NULL, 'Glucocorticoid', 'Diflucortolone', 'Cid', 'Oint', 'مرهم', '0.1%', '1', NULL, 'about diflucortolone type of medicine : potent topical corticosteroid used for inflammatory skin conditions such as severe eczema diflucortolone is a strong topical corticosteroid (also referred to as a topical steroid). topical steroids are used in addit', NULL, NULL, 677, '2022-07-27', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23424, 'Nericid c cream 10 gm', 'نيريسيد سي كريم 10جم', '9', NULL, NULL, 'Chlorquinaldol+diflucortolone', 'Cid', 'Cream', 'كريم', '10 gm', '1', NULL, NULL, '6221043012735', NULL, 652, '2022-12-07', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23425, 'Nericid forte 0.3% fatty oint. 10 gm', 'نيريسيد فورت 0.3% مرهم 10جم', '12', NULL, 'Glucocorticoid', 'Diflucortolone', 'Cid', 'Oint', 'مرهم', '0.3%', '1', NULL, 'about diflucortolone type of medicine : potent topical corticosteroid used for inflammatory skin conditions such as severe eczema diflucortolone is a strong topical corticosteroid (also referred to as a topical steroid). topical steroids are used in addit', NULL, NULL, 554, '2022-07-25', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23426, 'Nermostar shampoo 120 ml', 'نرموستار شامبو 120 مل', '95', '75', 'Hair care', NULL, 'Cosmopack > ibm pharma', 'Amp', 'أمبول', '120 ml', '1', 'شامبو للشعر لنظافته -- للحفلظ علي الرائحة الذكية للشعر -- الحفاظ علي رونق الشعر و حمايته من التقصف و الهيشان', NULL, '6224011371247', NULL, 5071, '2025-08-09', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23427, 'Neroschiz 1mg/ml syrup 30 ml', 'نيروشيز 1مجم/مل شراب 30مل', '11', NULL, 'Psychiatric.antipsychotics', 'Risperidone', 'Debeiky > pharmachemic pharmaceutical development', 'Syrup', 'شراب', '1mg', '1', NULL, 'about risperidone second-generation antipsychotic benzisoxazole derivative antimanic atypical antipsychotic. mechanism of action of risperidone risperidone exerts its antipsychotic activity by blocking dopamine and serotonin (5ht2) receptors. the drug has', NULL, NULL, 787, '2022-07-28', 0, 'Risperidone is indicated for the treatment of schizophrenia [L12885,L44692,L46297] and irritability associated with autistic disorder.[L12885] It is also indicated as monotherapy, or adjunctly with lithium or valproic acid, for the treatment of acute mania or mixed episodes associated with bipolar I disorder.[L12885,L44692]



Risperidone is additionally indicated in Canada for the short-term symptomatic management of aggression or psychotic symptoms in patients with severe dementia of the Alzheimer type unresponsive to nonpharmacological approaches.[L12906]



Risperidone is also used off-label for a number of conditions including as an adjunct to antidepressants in treatment-resistant depression.[A177226]', 'Though its precise mechanism of action is not fully understood, current focus is on the ability of risperidone to inhibit the D2 dopaminergic receptors and 5-HT2A serotonergic receptors in the brain. Schizophrenia is thought to result from an excess of dopaminergic D2 and serotonergic 5-HT2A activity, resulting in overactivity of central mesolimbic pathways and mesocortical pathways, respectively.[A1115, A1116, A1117]



D2 dopaminergic receptors are transiently inhibited by risperidone, reducing dopaminergic neurotransmission, therefore decreasing positive symptoms of schizophrenia, such as delusions and hallucinations.[A251765] Risperidone binds transiently and with loose affinity to the dopaminergic D2 receptor, with an ideal receptor occupancy of 60-70% for optimal effect.[A1119,A31773] Rapid dissociation of risperidone from the D2 receptors contributes to decreased risk of extrapyramidal symptoms (EPS), which occur with permanent and high occupancy blockade of D2 dopaminergic receptors.[A1118,A1119] Low-affinity binding and rapid dissociation from the D2 receptor distinguish risperidone from the traditional antipsychotic drugs. A higher occupancy rate of D2 receptors is said to increase the risk of extrapyramidal symptoms and is therefore to be avoided.[A1118,A1119,A31771] 

 

Increased serotonergic mesocortical activity in schizophrenia results in negative symptoms, such as depression and decreased motivation. The high-affinity binding of risperidone to 5-HT2A receptors leads to a decrease in serotonergic activity. In addition, 5-HT2A receptor blockade results in decreased risk of extrapyramidal symptoms, likely by increasing dopamine release from the frontal cortex, and not the nigrostriatal tract. Dopamine level is therefore not completely inhibited.[A1117,A1119] Through the above mechanisms, both serotonergic and D2 blockade by risperidone are thought to synergistically work to decrease the risk of extrapyramidal symptoms. 

 

Risperidone has also been said to be an antagonist of alpha-1 (α1), alpha-2 (α2), and histamine (H1) receptors.[A37034] Blockade of these receptors is thought to improve symptoms of schizophrenia, however the exact mechanism of action on these receptors is not fully understood at this time.[L12885]', 'The primary action of risperidone is to decrease dopaminergic and serotonergic pathway activity in the brain, therefore decreasing symptoms of schizophrenia and mood disorders.[A1115,A1116]



Risperidone has a high binding affinity for serotonergic 5-HT2A receptors when compared to dopaminergic D2 receptors in the brain.[A1114,A1115] Risperidone binds to D2 receptors with a lower affinity than first-generation antipsychotic drugs, which bind with very high affinity. A reduction in extrapyramidal symptoms with risperidone, when compared to its predecessors, is likely a result of its moderate affinity for dopaminergic D2 receptors.[A1119,A1117]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23428, 'Nerso shampoo 150 ml', 'نيرسو شامبو 150مل', '70', NULL, 'Hair care', NULL, 'Cosmopack for cosmetics > go pharma', 'Amp', 'أمبول', '150 ml', '1', NULL, 'anti-dandruff shampoo', NULL, NULL, 1339, '2022-08-05', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23429, 'Nervagab 75 mg 30 caps.', 'نيرفاجاب 75مجم 30 كبسولة', '69', NULL, 'Anti-epileptic.gaba analogs', 'Pregabalin', 'Hygint pharmaceuticals-egypt', 'Cap', 'كبسولة', '75 mg', '3', NULL, 'about pregabalin a gaba agonist anticonvulsant. mechanism of action of pregabalin pregabalin is a gaba neurotransmitter analog. it produces its action by modulating calcium channels and also reduces the release of neurotransmitters such as glutamate norep', NULL, NULL, 910, '2022-07-07', 0, 'Pregabalin is indicated for the management of neuropathic pain associated with diabetic peripheral neuropathy, postherpetic neuralgia, fibromyalgia, neuropathic pain associated with spinal cord injury, and as adjunctive therapy for the treatment of partial-onset seizures in patients 1 month of age and older.[L7066]', 'Although the mechanism of action has not been fully elucidated, studies involving structurally related drugs suggest that presynaptic binding of pregabalin to voltage-gated calcium channels is key to the antiseizure and antinociceptive effects observed in animal models.[L7066]  



By binding presynaptically to the alpha2-delta subunit of voltage-gated calcium channels in the central nervous system, pregabalin modulates the release of several excitatory neurotransmitters including glutamate, substance-P, norepinephrine, and calcitonin gene related peptide.[A31163] In addition, pregabalin prevents the alpha2-delta subunit from being trafficked from the dorsal root ganglia to the spinal dorsal horn, which may also contribute to the mechanism of action.[A36628] 



Although pregabalin is a structural derivative of the inhibitory neurotransmitter gamma-aminobutyric acid (GABA), it does not bind directly to GABA or benzodiazepine receptors.[A31165]  ', 'Although the structure of pregabalin is similar to gamma-aminobutyric acid (GABA), it does not bind to GABA receptors.[A31163,A187190] Instead, it binds the alpha2-delta subunit of presynaptic voltage-gated calcium channels in the central nervous system.[A31163,A187190] Pregabalin does not modulate dopamine receptors, serotonin receptors, opiate receptors, sodium channels or cyclooxygenase activity.[A187190] ', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23430, 'Nervalta 60 mg 10 del. rel. caps.', 'نيرفالتا 60 مجم 10 كبسولات', '102', '78', 'Psychiatric.antidepressants', 'Duloxetine', 'Pharco', 'Cap', 'كبسولة', '60 mg', '1', 'مضاد للإكتئاب', 'about duloxetine a serotonin-norepinephrine reuptake inhibitor thiophene derivative antidepressant. mechanism of action of duloxetine duloxetine preferentially inhibits the re-uptake of noradrenaline and serotonin (5 ht) in the cns nerve terminals .this w', '6221151002475', NULL, 1790, '2024-11-08', 0, '**Indicated** for:



1) Management of Major Depressive Disorder.[label]



2) Management of Generalized Anxiety Disorder.[label]



3) Management of diabetic peripheral neuropathy.[label]



4) Management of fibromyalgia.[label]



5) Management of chronic musculoskeletal pain.[label]



6) Management of osteoarthritis of the knee in adults.[L6364]



7) Management of chronic lower back pain in adults.[L6364]



8) Management of stress urinary incontinence in adult women.[L6367]



**Off-label** uses include:



1) Management of chemotherapy-induced peripheral neuropathy.[A178603]



2) Management of stress urinary incontinence in adult men after prostatectomy until recovery is complete.[L6370]', 'Duloxetine is a potent inhibitor of neuronal serotonin and norepinephrine reuptake and a less potent inhibitor of dopamine reuptake.[A178714] Duloxetine has no significant affinity for dopaminergic, adrenergic, cholinergic, histaminergic, opioid, glutamate, and GABA receptors.



Action on the external urinary sphincter is mediated via duloxetine''s CNS effects. Increased serotonin and norepinephrine concentrations in Onuf''s nucleus leads to increased activation of 5-HT<sub>2</sub>, 5-HT<sub>3</sub>, and α<sub>1</sub> adrenergic receptors.[A178663,A178666] 5-HT<sub>2</sub> and α<sub>1</sub> are both G<sub>q</sub> coupled and their activation increases the activity of the inositol trisphosphate/phospholipase C (IP<sub>3</sub>/PLC) pathway.[T116] This pathway leads to release of intracellular calcium stores, increasing intracellular calcium concentrations, and facilitating neuronal excitability. 5-HT<sub>3</sub> functions as a ligand-gated sodium channel which allows sodium to flow into the neuron when activated. Increased flow of sodium into the neuron contributes to depolarization and activation of voltage gated channels involved in action potential generation. The combined action of these three receptors contributes to increased excitability of the pudendal motor nerve in response to glutamate.



Also related to duloxetine''s action at the spinal cord is its modulation of pain. Increasing the concentration of serotonin and norepinephrine in the dorsal horn of the spinal cord increases descending inhibition of pain through activation of 5-HT<sub>1A</sub>, 5-HT<sub>1B</sub>, 5-HT<sub>1D</sub>, 5-HT<sub>2</sub>, 5-HT<sub>3</sub>, α<sub>1</sub>-adrenergic, and α<sub>2</sub>-adrenergic receptors.[A178705] 5-HT<sub>2</sub>, 5-HT<sub>3</sub>, and α<sub>1</sub>-adrenergic mediate neuronal activation as described above. The activated neuron in this case is the GABAergic inhibitory interneuron which synapses onto the nociceptive projection neuron to inhibit the transmission of painful stimuli to the brain. The 5-HT<sub>1</sub> and α<sub>2</sub> receptors are G<sub>i</sub>/G<sub>o</sub> coupled and their activation leads to increased potassium current through inward rectifier channels and decreased adenylyl cyclase/protein kinase A signaling which contributes to neuronal inhibition.[A178705,T116] These inhibitory receptors are present on the projection neuron itself as well as the dorsal root ganglion which precedes it and serves to directly suppress the transmission of painful stimuli.



The mechanisms involved in duloxetine''s benefits in depression and anxiety have not been fully elucidated. Dysfunctional serotonin and norepinephrine signaling are thought to be involved and increases in the availability of these neurotransmitters at the synaptic cleft thought to mediate a therapeutic effect.[A178666] It is postulated that the involvement of serotonin and norepinephrine in area responsible for emotional modulation such as the limbic system contributes to the effects in mood disorders specifically but this has yet to be confirmed.



Duloxetine''s hypertensive effect is related to its intended pharmacological effect. Increased availability of norepinephrine leads to activation of adrenergic receptors on the vascular endothelium. Since the action of α<sub>1</sub> receptors predominates, vasoconstriction results as the G<sub>q</sub> coupled receptor mediates calcium release from the sarcoplasmic reticulum to facilitate smooth muscle contraction.[T116]', 'Duloxetine, through increasing serotonin and norepinephrine concentrations in Onuf''s nucleus, enhances glutamatergic activation of the pudendal motor nerve which innervates the external urethral sphinter.[A178663,A178666] This enhanced signaling allows for stronger contraction. Increased contraction of this sphincter increases the pressure needed to produce an incontinence episode in stress urinary incontinence. Duloxetine has been shown to improve Patient Global Impression of Improvement and Incontinence Quality of Life scores.[A178669] It has also been shown to reduce the median incontinence episode frequency at doses of 40 and 80 mg.



Action at the dorsal horn of the spinal cord allows duloxetine to strengthen the the serotonergic and adrenergic pathways involved in descending inhibition of pain.[A178666,A178705] This results in an increased threshold of activation necessary to transmit painful stimuli to the brain and effective relief of pain, particularly in neuropathic pain. Pain relief has been noted in a variety of painful conditions including diabetic peripheral neuropathy, fibromyalgia, and osteoarthritis using a range of pain assessment surveys.[A178711]



While duloxetine has been shown to be effective in both animal models of mood disorders and in clinical trials for the treatment of these disorders in humans, the broad scope of its pharmacodynamic effects on mood regulation in the brain has yet to be explained.[A178714]



Increased blood pressure is a common side effect with duloxetine due to vasoconstriction mediated by the intended increase in norepinephrine signaling.[label,T116]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23431, 'Nervatin 150mg 20 caps.', 'نيرفاتين 150مجم 20 كبسول', '56', NULL, 'Anti-epileptic.gaba analogs', 'Pregabalin', 'Pharopharma', 'Cap', 'كبسولة', '150mg', '2', NULL, 'about pregabalin a gaba agonist anticonvulsant. mechanism of action of pregabalin pregabalin is a gaba neurotransmitter analog. it produces its action by modulating calcium channels and also reduces the release of neurotransmitters such as glutamate norep', NULL, NULL, 893, '2022-07-14', 0, 'Pregabalin is indicated for the management of neuropathic pain associated with diabetic peripheral neuropathy, postherpetic neuralgia, fibromyalgia, neuropathic pain associated with spinal cord injury, and as adjunctive therapy for the treatment of partial-onset seizures in patients 1 month of age and older.[L7066]', 'Although the mechanism of action has not been fully elucidated, studies involving structurally related drugs suggest that presynaptic binding of pregabalin to voltage-gated calcium channels is key to the antiseizure and antinociceptive effects observed in animal models.[L7066]  



By binding presynaptically to the alpha2-delta subunit of voltage-gated calcium channels in the central nervous system, pregabalin modulates the release of several excitatory neurotransmitters including glutamate, substance-P, norepinephrine, and calcitonin gene related peptide.[A31163] In addition, pregabalin prevents the alpha2-delta subunit from being trafficked from the dorsal root ganglia to the spinal dorsal horn, which may also contribute to the mechanism of action.[A36628] 



Although pregabalin is a structural derivative of the inhibitory neurotransmitter gamma-aminobutyric acid (GABA), it does not bind directly to GABA or benzodiazepine receptors.[A31165]  ', 'Although the structure of pregabalin is similar to gamma-aminobutyric acid (GABA), it does not bind to GABA receptors.[A31163,A187190] Instead, it binds the alpha2-delta subunit of presynaptic voltage-gated calcium channels in the central nervous system.[A31163,A187190] Pregabalin does not modulate dopamine receptors, serotonin receptors, opiate receptors, sodium channels or cyclooxygenase activity.[A187190] ', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23432, 'Nervatin 75mg 20 caps.', 'نيرفاتين 75مجم 20 كبسول', '46', NULL, 'Anti-epileptic.gaba analogs', 'Pregabalin', 'Pharopharma', 'Cap', 'كبسولة', '75mg', '2', NULL, 'about pregabalin a gaba agonist anticonvulsant. mechanism of action of pregabalin pregabalin is a gaba neurotransmitter analog. it produces its action by modulating calcium channels and also reduces the release of neurotransmitters such as glutamate norep', NULL, NULL, 801, '2022-07-17', 0, 'Pregabalin is indicated for the management of neuropathic pain associated with diabetic peripheral neuropathy, postherpetic neuralgia, fibromyalgia, neuropathic pain associated with spinal cord injury, and as adjunctive therapy for the treatment of partial-onset seizures in patients 1 month of age and older.[L7066]', 'Although the mechanism of action has not been fully elucidated, studies involving structurally related drugs suggest that presynaptic binding of pregabalin to voltage-gated calcium channels is key to the antiseizure and antinociceptive effects observed in animal models.[L7066]  



By binding presynaptically to the alpha2-delta subunit of voltage-gated calcium channels in the central nervous system, pregabalin modulates the release of several excitatory neurotransmitters including glutamate, substance-P, norepinephrine, and calcitonin gene related peptide.[A31163] In addition, pregabalin prevents the alpha2-delta subunit from being trafficked from the dorsal root ganglia to the spinal dorsal horn, which may also contribute to the mechanism of action.[A36628] 



Although pregabalin is a structural derivative of the inhibitory neurotransmitter gamma-aminobutyric acid (GABA), it does not bind directly to GABA or benzodiazepine receptors.[A31165]  ', 'Although the structure of pregabalin is similar to gamma-aminobutyric acid (GABA), it does not bind to GABA receptors.[A31163,A187190] Instead, it binds the alpha2-delta subunit of presynaptic voltage-gated calcium channels in the central nervous system.[A31163,A187190] Pregabalin does not modulate dopamine receptors, serotonin receptors, opiate receptors, sodium channels or cyclooxygenase activity.[A187190] ', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23434, 'Nervatyca 75 mg 20 caps.', 'نيرفاتيكا 75مجم 20 كبسول', '49', NULL, 'Anti-epileptic.gaba analogs', 'Pregabalin', 'Alfacure pharmaceuticals', 'Cap', 'كبسولة', '75 mg', '2', NULL, 'about pregabalin a gaba agonist anticonvulsant. mechanism of action of pregabalin pregabalin is a gaba neurotransmitter analog. it produces its action by modulating calcium channels and also reduces the release of neurotransmitters such as glutamate norep', '6224000875329', NULL, 809, '2022-12-07', 0, 'Pregabalin is indicated for the management of neuropathic pain associated with diabetic peripheral neuropathy, postherpetic neuralgia, fibromyalgia, neuropathic pain associated with spinal cord injury, and as adjunctive therapy for the treatment of partial-onset seizures in patients 1 month of age and older.[L7066]', 'Although the mechanism of action has not been fully elucidated, studies involving structurally related drugs suggest that presynaptic binding of pregabalin to voltage-gated calcium channels is key to the antiseizure and antinociceptive effects observed in animal models.[L7066]  



By binding presynaptically to the alpha2-delta subunit of voltage-gated calcium channels in the central nervous system, pregabalin modulates the release of several excitatory neurotransmitters including glutamate, substance-P, norepinephrine, and calcitonin gene related peptide.[A31163] In addition, pregabalin prevents the alpha2-delta subunit from being trafficked from the dorsal root ganglia to the spinal dorsal horn, which may also contribute to the mechanism of action.[A36628] 



Although pregabalin is a structural derivative of the inhibitory neurotransmitter gamma-aminobutyric acid (GABA), it does not bind directly to GABA or benzodiazepine receptors.[A31165]  ', 'Although the structure of pregabalin is similar to gamma-aminobutyric acid (GABA), it does not bind to GABA receptors.[A31163,A187190] Instead, it binds the alpha2-delta subunit of presynaptic voltage-gated calcium channels in the central nervous system.[A31163,A187190] Pregabalin does not modulate dopamine receptors, serotonin receptors, opiate receptors, sodium channels or cyclooxygenase activity.[A187190] ', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23435, 'Nervidox 30 sublingual tabs.', 'نيرفيدوكس 30 قرص تحت اللسان', '22', NULL, 'Vitamins', 'Folic acid+vitamin b6+vitamin b12', 'Debeiky > lamar pharma', 'Tab', 'أقراص', NULL, '3', NULL, 'about folic acid dietary supplement folate derivative( b9 ) water soluble vitamin. mechanism of action of folic acid folic acid reduced by enzymes folate reductase and dihydrofolate reductase and forms dihydrofolic acid tetrahydrofolic acid respectively.', '6224001095009', NULL, 2229, '2022-12-07', 0, 'Folic acid is indicated for the treatment of folic acid deficiency, megaloblastic anemia, and in anemias of nutritional origins, pregnancy, infancy, or childhood.', 'Folic acid, as it is biochemically inactive, is converted to tetrahydrofolic acid and methyltetrahydrofolate by dihydrofolate reductase (DHFR). These folic acid congeners are transported across cells by receptor-mediated endocytosis where they are needed to maintain normal erythropoiesis, synthesize purine and thymidylate nucleic acids, interconvert amino acids, methylate tRNA, and generate and use formate. Using vitamin B12 as a cofactor, folic acid can normalize high homocysteine levels by remethylation of homocysteine to methionine via methionine synthetase.', 'Folic acid is a water-soluble B-complex vitamin found in foods such as liver, kidney, yeast, and leafy, green vegetables. Also known as folate or Vitamin B9, folic acid is an essential cofactor for enzymes involved in DNA and RNA synthesis. More specifically, folic acid is required by the body for the synthesis of purines, pyrimidines, and methionine before incorporation into DNA or protein. Folic acid is the precursor of tetrahydrofolic acid, which is involved as a cofactor for transformylation reactions in the biosynthesis of purines and thymidylates of nucleic acids. Impairment of thymidylate synthesis in patients with folic acid deficiency is thought to account for the defective deoxyribonucleic acid (DNA) synthesis that leads to megaloblast formation and megaloblastic and macrocytic anemias. Folic acid is particularly important during phases of rapid cell division, such as infancy, pregnancy, and erythropoiesis, and plays a protective factor in the development of cancer. As humans are unable to synthesize folic acid endogenously, diet and supplementation is necessary to prevent deficiencies. In order to function properly within the body, folic acid must first be reduced by the enzyme dihydrofolate reductase (DHFR) into the cofactors dihydrofolate (DHF) and tetrahydrofolate (THF). This important pathway, which is required for de novo synthesis of nucleic acids and amino acids, is disrupted by anti-metabolite therapies such as [DB00563] as they function as DHFR inhibitors to prevent DNA synthesis in rapidly dividing cells, and therefore prevent the formation of DHF and THF. 



In general, folate serum levels below 5 ng/mL indicate folate deficiency, and levels below 2 ng/mL usually result in megaloblastic anemia.', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23437, 'Nestacoran 2mg 20 f.c. tabs.', 'نيستاكوران 2مجم 20 قرص', '40', '27', 'Psychiatric.anxiolytics-hypnotics', 'Eszopiclone', 'Hi-pharm', 'Tab', 'أقراص', '2mg', '2', NULL, NULL, NULL, NULL, 1277, '2025-08-23', 0, 'Eszopiclone is indicated for the treatment of insomnia.[L6769]', 'The exact mechanism of action of eszopiclone is unknown at this time but is thought to occur via binding with the GABA receptor complexes at binding sites located near benzodiazepine receptors, possibly explaining its hypnotic and sedative effects.[A179659,L6769] It has particular affinity for GABA-A (or GABAA) receptor subunits 1, 3 and 5.[A179788,A15625,A15626] Eszopiclone increases GABA-A channel currents significantly.[A179788] GABA-A channels are major inhibitory channels that cause CNS depression when their receptors are activated.[A179800]', 'Eszopiclone rapidly induces sleep and decreases sleep latency. It also aids in the maintenance of sleep, preventing frequent awakenings.[A179659,A179662,L6769] This drug has shown anticonvulsant and muscle relaxant properties in animals but is used in humans for its sedating effects.[A179827]



Eszopiclone is a central nervous system depressant with various effects. These include changes in alertness and motor coordination and the risk of next morning impairment, increasing with the amount of eszopiclone administered.  Exercise caution and advise against driving a motor vehicle or activities that require full mental alertness the next morning.[L6769] Complex sleep behaviors may result from eszopiclone use. Eszopiclone should be discontinued in these cases.[L6874] Avoid the use of alcohol and other CNS depressants when eszopiclone is administered. Advise patients to skip the eszopiclone dose if alcohol has been consumed before bed or during the evening. Use the smallest dose of eszopiclone as possible, especially in elderly patients, who may experience exaggerated drug effects. Though the potential for dependence and abuse with eszopiclone is lower than for other hypnotic drugs, this drug has been abused and is known to cause dependence.[L6868]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23438, 'Nestogen 1 milk 400 gm', 'نيستوجين 1 لبن اطفال 400 جم', '260', '255', 'Milk products.first stage (age 0-6 months)', 'Milk formula stage 1', 'Nestle', 'Unknown', 'غير محدد', '400 gm', '1', 'لبن اطفال المرحلة الاولى', 'not to replace mother s milk. for infants from birth to 6 months age. to be used within one month from opening.', '7506475114417', NULL, 6624, '2025-10-01', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23439, 'Nestogen 2 milk 400 gm', 'نيستوجين 2 لبن اطفال 400 جم', '260', '255', 'Milk products.second stage (age 6-12 months)', 'Milk formula stage 2', 'Nestle', 'Unknown', 'غير محدد', '400 gm', '1', 'لبن اطفال المرحلة 2', 'not to replace mother s milk. for infants from 6 to 12 months age. to be used within one month from opening.', '7506475114424', NULL, 2836, '2025-10-01', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23440, 'Nestogen 3 milk 200 gm', 'نيستوجين 3 لبن اطفال 200 جم', '125', '120', 'Milk products.third stage (age 1-3 years)', 'Milk formula stage 3', 'Nestle', 'Unknown', 'غير محدد', '200 gm', '1', NULL, 'not to replace mother s milk. for children from age 1 year and onward. to be used within 3 weeks from opening.', '6221007033042', NULL, 1744, '2025-08-20', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23441, 'Netlook 10mg 20 soft gelatin caps.', 'نت لوك 10مجم 20 كبسول', '150', '115', 'Anti-acne', 'Isotretinoin', 'Medizen pharmaceutical industries > andalous pharma', 'Cap', 'كبسولة', '10mg', '2', NULL, 'about isotretinoin vitamin a isomer retinoic acid derivative anti-acne. mechanism of action of isotretinoin isotretinoin is a 13-cis-retinoic acid and is used in the treatment of severe nodulocystic acne. isotretinoin decreases sebocyte number and reduces', '6223004691935', NULL, 5010, '2024-10-26', 0, 'Isotretinoin is indicated to treat severe recalcitrant nodular acne and patients ≥12 years enrolled in the iPLEDGE program.[Label,L6579]', 'Isotretinoin produces its effects through altering progress through the cell cycle, cell differentiation, survival, and apoptosis.[A179091] These actions reduce sebum production, preventing the blockage of pores, and growth of acne causing bacteria.[A179091] Isotretinoin and 4-oxo-isotretinoin both significantly reduce the production of sebum.[A179091,Label] Isotretinoin has little to no affinity for retinol binding proteins (RBPs) and retinoic acid nuclear receptors (RARs).[A179091] Tretinoin and 4-oxo-tretinion bind to the RAR-γ receptor, which is suspected to be part of the action of acne treatment by isotretinoin.[A179091] Isotretinoin induces apoptosis in sebocytes, leading to a decrease in sebum production.[A179091] Isotretinoin also reduces the formation of comedones by reducing hyperkeratinization through an unknown mechanism.[A179091] Isotretinoin does not directly kill bacteria but it does reduce the size of sebum ducts and makes the microenvironment less hospitable to acne causing bacteria.[A179091] It may also increase immune mechanisms and alter chemotaxis of monocytes to reduce inflammation.[A179091]



There is preliminary evidence suggesting isotretinoin may interact with FoxO1, which may explain a substantial number of isotretinoin''s unexplained actions.[A179122]', 'The pharmacodynamics of isotretinoin are poorly understood.[Label]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23442, 'Netlook 20mg 20 soft gelatin caps.', 'نت لوك 20مجم 20 كبسولة', '274', '212', 'Anti-acne', 'Isotretinoin', 'Medizen pharmaceutical industries > andalous pharma', 'Cap', 'كبسولة', '20mg', '2', NULL, 'about isotretinoin vitamin a isomer retinoic acid derivative anti-acne. mechanism of action of isotretinoin isotretinoin is a 13-cis-retinoic acid and is used in the treatment of severe nodulocystic acne. isotretinoin decreases sebocyte number and reduces', '6223004691935', NULL, 7344, '2024-09-25', 0, 'Isotretinoin is indicated to treat severe recalcitrant nodular acne and patients ≥12 years enrolled in the iPLEDGE program.[Label,L6579]', 'Isotretinoin produces its effects through altering progress through the cell cycle, cell differentiation, survival, and apoptosis.[A179091] These actions reduce sebum production, preventing the blockage of pores, and growth of acne causing bacteria.[A179091] Isotretinoin and 4-oxo-isotretinoin both significantly reduce the production of sebum.[A179091,Label] Isotretinoin has little to no affinity for retinol binding proteins (RBPs) and retinoic acid nuclear receptors (RARs).[A179091] Tretinoin and 4-oxo-tretinion bind to the RAR-γ receptor, which is suspected to be part of the action of acne treatment by isotretinoin.[A179091] Isotretinoin induces apoptosis in sebocytes, leading to a decrease in sebum production.[A179091] Isotretinoin also reduces the formation of comedones by reducing hyperkeratinization through an unknown mechanism.[A179091] Isotretinoin does not directly kill bacteria but it does reduce the size of sebum ducts and makes the microenvironment less hospitable to acne causing bacteria.[A179091] It may also increase immune mechanisms and alter chemotaxis of monocytes to reduce inflammation.[A179091]



There is preliminary evidence suggesting isotretinoin may interact with FoxO1, which may explain a substantial number of isotretinoin''s unexplained actions.[A179122]', 'The pharmacodynamics of isotretinoin are poorly understood.[Label]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23443, 'Netlook 40mg 20 soft gelatin capsule', 'نت لوك 40مجم 20 كبسول لحب الشباب', '394', '302', 'Anti-acne', 'Isotretinoin', 'Medizen pharmaceutical industries > andalous pharma', 'Capsule', 'كبسولة', '40mg', '2', NULL, 'about isotretinoin vitamin a isomer retinoic acid derivative anti-acne. mechanism of action of isotretinoin isotretinoin is a 13-cis-retinoic acid and is used in the treatment of severe nodulocystic acne. isotretinoin decreases sebocyte number and reduces', '6223004691942', NULL, 6087, '2024-10-28', 0, 'Isotretinoin is indicated to treat severe recalcitrant nodular acne and patients ≥12 years enrolled in the iPLEDGE program.[Label,L6579]', 'Isotretinoin produces its effects through altering progress through the cell cycle, cell differentiation, survival, and apoptosis.[A179091] These actions reduce sebum production, preventing the blockage of pores, and growth of acne causing bacteria.[A179091] Isotretinoin and 4-oxo-isotretinoin both significantly reduce the production of sebum.[A179091,Label] Isotretinoin has little to no affinity for retinol binding proteins (RBPs) and retinoic acid nuclear receptors (RARs).[A179091] Tretinoin and 4-oxo-tretinion bind to the RAR-γ receptor, which is suspected to be part of the action of acne treatment by isotretinoin.[A179091] Isotretinoin induces apoptosis in sebocytes, leading to a decrease in sebum production.[A179091] Isotretinoin also reduces the formation of comedones by reducing hyperkeratinization through an unknown mechanism.[A179091] Isotretinoin does not directly kill bacteria but it does reduce the size of sebum ducts and makes the microenvironment less hospitable to acne causing bacteria.[A179091] It may also increase immune mechanisms and alter chemotaxis of monocytes to reduce inflammation.[A179091]



There is preliminary evidence suggesting isotretinoin may interact with FoxO1, which may explain a substantial number of isotretinoin''s unexplained actions.[A179122]', 'The pharmacodynamics of isotretinoin are poorly understood.[Label]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23444, 'Neulastim 6 mg / 0.6 ml 1 prefilled syringe', 'نيولاستيم 6 مجم / 0.6 مل سرنجة معبأة', '8,130', '4900', 'Colony stimulating factor', 'Pegfilgrastim', 'Amgen > multipharma', 'Syringe', 'حقنة', '6 mg', '1', 'علاج مرض حمي نقص الخلايا المتعادلة الناتج عن العلاج الكميائي', NULL, NULL, NULL, 1293, '2025-08-23', 0, 'Pegfilgrastim is indicated to decrease the incidence of infection, as manifested by febrile neutropenia, in patients with non­ myeloid malignancies receiving myelosuppressive anti-cancer drugs associated with a clinically significant incidence of febrile neutropenia.[L44221]



It is also indicated to increase survival in patients acutely exposed to myelosuppressive doses of radiation (Hematopoietic Subsyndrome of Acute Radiation Syndrome).[L44221]', 'Neutrophils are short-lived immune cells that are highly susceptible to cell death following myelosuppressive chemotherapy. This marked reduction in neutrophil numbers during chemotherapy increases the risk of hospitalization, infection, and infection-related mortality. It also directly impacts the clinical outcome of patients if cases of febrile neutropenia requires dose reductions or schedule delay of chemotherapy, thus reducing the clinical efficacy of chemotherapy and patient benefit from receiving appropriate treatment.[A187631] 



G-CSF is an endogenous haematopoietic growth factor that stimulates granulopoietic cells of the neutrophil lineage. Pegfilgrastim mimics its biological actions and binds to the same G-CSF receptor expressed on cells of myeloid lineage, such as granulocytic precursors and mature neutrophils.[A29] Upon binding of the ligand, G-CSF receptor undergoes a conformational change and activates several downstream signalling pathways including JAK/STAT, PI3K/AKT and MAPK/ERK.[A187868] These pathways work to increase proliferation and differentiation of granulocyte progenitor cells, induce maturation of the progenitor cells, and enhance survival and function of mature neutrophils.[A29]', 'Pegfilgrastim is a recombinant human granulocyte colony-stimulating factor (G-CSF) that promotes the production, proliferation, and maturation of neutrophils, which are white blood cells involved in both innate and adaptive immune responses.[A187631,A248855] The safety and efficacy of pegfilgrastim in reducing the risk of febrile neutropenia and infections have been demonstrated in various tumor types and settings.[A187631] 



During chemotherapy-induced neutropenia, the clearance of pegfilgrastim is significantly reduced and the concentration of pegfilgrastim is sustained until the onset of neutrophil recovery.[A29] Serum concentrations of pegfilgrastim decline as the neutrophil count increases as neutrophil and neutrophil precursors are involved in cell-mediated clearance of the drug.[A187601] Due the addition of polyethylene glycol group to its structure, Pegfilgrastim is a long-acting form of filgrastim with an extended serum half-life and reduced renal clearance.[A187607] Although it is more slowly absorbed than filgrastim, self-regulation of pegfilgrastim is more efficient and the drug effects are maintained during one chemotherapy cycle (2-3 weeks).[A29]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23445, 'Neupogen 30miu/0.5ml pref. syringe', 'نيوبوجن 30 مليون وحدة دولية سرنجة معبأة مسبقاً', '1,294', '906', 'Granulocyte colony-stimulating factor (g-csf)', 'Filgrastim', 'Amgen > multipharma', 'Syringe', 'حقنة', '0.5ml', '1', 'يستخدم لمرضى الكانسر', 'about filgrastim a cytokine glycoprotein a human granulocyte colony-stimulating factor (g-csf) analog immunostimulant. mechanism of action of filgrastim filgrastim is a cytokine glycoprotein that stimulates proliferation differentiation and functional act', NULL, NULL, 6807, '2025-08-20', 0, 'Filgrastim is indicated to decrease the incidence of infection‚ as manifested by febrile neutropenia‚ in patients with nonmyeloid malignancies receiving myelosuppressive anti-cancer drugs associated with a significant incidence of severe neutropenia with fever.[L40714]



Filgrastim is indicated for reducing the time to neutrophil recovery and the duration of fever, following induction or consolidation chemotherapy treatment of patients with acute myeloid leukemia.[L40714]



Filgrastim is indicated to reduce the duration of neutropenia and neutropenia-related clinical sequelae‚ e.g.‚ febrile neutropenia, in patients with nonmyeloid malignancies undergoing myeloablative chemotherapy followed by bone marrow transplantation.[L40714]



Filgrastim is indicated for the mobilization of autologous hematopoietic progenitor cells into the peripheral blood for collection by leukapheresis.[L40714]



Filgrastim is indicated for chronic administration to reduce the incidence and duration of sequelae of neutropenia (e.g.‚ fever‚ infections‚ oropharyngeal ulcers) in symptomatic patients with congenital neutropenia‚ cyclic neutropenia‚ or idiopathic neutropenia.[L40714]



Filgrastim is indicated to increase survival in patients acutely exposed to myelosuppressive doses of radiation.[L40714]', 'Neutrophils are critical granulocytes involved in the acute inflammatory response and host defences against bacterial infections.[A245873] They also contribute to long-term adaptive immunity by promoting immediate host immune response and attracting other cells, such as macrophages and dendritic cells. As neutrophils promote both the initiation and the maintenance of inflammation at sites of infection, suppressed neutrophil responses lead to extreme susceptibility to infection.[A35605] Low neutrophil levels, or neutropenia, caused by chronic neutropenia, myelosuppressive chemotherapy, and radiation therapy increases the risk of infection and related events.[A245868] Neutropenia caused by chemotherapy or radiation therapy can further progress into febrile neutropenia, which is associated with an elevated risk for life-threatening systemic infections and chemotherapy-associated morbidity and mortality.[A35591]



The production and release of functional neutrophils from the bone marrow are normally regulated by granulocyte colony-stimulating factors (G-CSF), which are major cytokine regulators of neutrophilic granulocytes.[A35605] G-CSFs act on hematopoietic cells by binding to specific cell surface receptors to stimulate the proliferation‚ differentiation‚ and maturation of neutrophil progenitors. G-CSF also induces some end-cell functional activation of neutrophils, including enhanced phagocytic ability‚ priming of the cellular metabolism associated with respiratory burst‚ antibody-dependent killing, and the increased expression of some cell surface antigens.[L40714]  Filgrastim is a short-acting recombinant G-CSF that mimics the biological actions of endogenous G-CSF. It also facilitates the release of neutrophils from the bone marrow into the blood to reduce the incidence of infection and manage neutropenia.[A245858, A245868]', 'Filgrastim is used to reduce the incidence, severity and duration of neutropenia and febrile neutropenia in patients undergoing cytotoxic chemotherapy. In clinical trials in patients, filgrastim reduced the duration of febrile neutropenia, antibiotic use, and hospitalization after induction chemotherapy for acute myelogenous leukemia or myeloablative therapy followed by bone marrow transplantation; however, the incidence of fever and documented infections were not reduced in either setting.[L40719] 



Filgrastim is also used to mobilize hematopoietic progenitor cells into the peripheral blood in order to reduce the risk for bleeding complications and the need for platelet transfusions. Recipients of allogeneic PBPCs mobilized with filgrastim experienced significantly more rapid hematological recovery, leading to a significant decrease in time to unsupported platelet recovery when compared with allogeneic bone marrow transplantation.[L40719] 



Filgrastim causes a dose-dependent increase in circulating neutrophil counts within 24 hours of administration. Filgrastim can also cause a minor increase in monocyte and lymphocyte counts, but the clinical significance of these effects is unknown.[L40714] In some patients, filgrastim also caused a minor increase in the number of circulating eosinophils and basophils relative to baseline; however, these patients may already have had elevated eosinophils and basophils prior to filgrastim treatment. Following termination of filgrastim therapy, circulating neutrophil counts decrease by 50% within one to two days, and to normal levels within one to seven days. As with other hematopoietic growth factors, G-CSF has shown _in vitro_ stimulating properties on human endothelial cells.[L40719] ', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23446, 'Neuragabalin 150 mg 10 caps', 'نيوراجابالين 150مجم 10 كبسول', '48', NULL, 'Anti-epileptic.gaba analogs', 'Pregabalin', 'Delta grand pharma', 'Cap', 'كبسولة', '150 mg', '1', NULL, NULL, NULL, NULL, 823, '2022-07-29', 0, 'Pregabalin is indicated for the management of neuropathic pain associated with diabetic peripheral neuropathy, postherpetic neuralgia, fibromyalgia, neuropathic pain associated with spinal cord injury, and as adjunctive therapy for the treatment of partial-onset seizures in patients 1 month of age and older.[L7066]', 'Although the mechanism of action has not been fully elucidated, studies involving structurally related drugs suggest that presynaptic binding of pregabalin to voltage-gated calcium channels is key to the antiseizure and antinociceptive effects observed in animal models.[L7066]  



By binding presynaptically to the alpha2-delta subunit of voltage-gated calcium channels in the central nervous system, pregabalin modulates the release of several excitatory neurotransmitters including glutamate, substance-P, norepinephrine, and calcitonin gene related peptide.[A31163] In addition, pregabalin prevents the alpha2-delta subunit from being trafficked from the dorsal root ganglia to the spinal dorsal horn, which may also contribute to the mechanism of action.[A36628] 



Although pregabalin is a structural derivative of the inhibitory neurotransmitter gamma-aminobutyric acid (GABA), it does not bind directly to GABA or benzodiazepine receptors.[A31165]  ', 'Although the structure of pregabalin is similar to gamma-aminobutyric acid (GABA), it does not bind to GABA receptors.[A31163,A187190] Instead, it binds the alpha2-delta subunit of presynaptic voltage-gated calcium channels in the central nervous system.[A31163,A187190] Pregabalin does not modulate dopamine receptors, serotonin receptors, opiate receptors, sodium channels or cyclooxygenase activity.[A187190] ', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23447, 'Neuragabalin 50 mg 10 caps.', 'نيوراجابالين 50مجم 10 كبسول', '16', NULL, 'Anti-epileptic.gaba analogs', 'Pregabalin', 'Delta grand pharma', 'Cap', 'كبسولة', '50 mg', '1', NULL, 'about pregabalin a gaba agonist anticonvulsant. mechanism of action of pregabalin pregabalin is a gaba neurotransmitter analog. it produces its action by modulating calcium channels and also reduces the release of neurotransmitters such as glutamate norep', NULL, NULL, 1069, '2022-07-11', 0, 'Pregabalin is indicated for the management of neuropathic pain associated with diabetic peripheral neuropathy, postherpetic neuralgia, fibromyalgia, neuropathic pain associated with spinal cord injury, and as adjunctive therapy for the treatment of partial-onset seizures in patients 1 month of age and older.[L7066]', 'Although the mechanism of action has not been fully elucidated, studies involving structurally related drugs suggest that presynaptic binding of pregabalin to voltage-gated calcium channels is key to the antiseizure and antinociceptive effects observed in animal models.[L7066]  



By binding presynaptically to the alpha2-delta subunit of voltage-gated calcium channels in the central nervous system, pregabalin modulates the release of several excitatory neurotransmitters including glutamate, substance-P, norepinephrine, and calcitonin gene related peptide.[A31163] In addition, pregabalin prevents the alpha2-delta subunit from being trafficked from the dorsal root ganglia to the spinal dorsal horn, which may also contribute to the mechanism of action.[A36628] 



Although pregabalin is a structural derivative of the inhibitory neurotransmitter gamma-aminobutyric acid (GABA), it does not bind directly to GABA or benzodiazepine receptors.[A31165]  ', 'Although the structure of pregabalin is similar to gamma-aminobutyric acid (GABA), it does not bind to GABA receptors.[A31163,A187190] Instead, it binds the alpha2-delta subunit of presynaptic voltage-gated calcium channels in the central nervous system.[A31163,A187190] Pregabalin does not modulate dopamine receptors, serotonin receptors, opiate receptors, sodium channels or cyclooxygenase activity.[A187190] ', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23448, 'Neuragabalin 75 mg 10 caps.', 'نيوراجابالين 75مجم 10 كبسول', '23', NULL, 'Anti-epileptic.gaba analogs', 'Pregabalin', 'Delta grand pharma', 'Cap', 'كبسولة', '75 mg', '1', NULL, 'about pregabalin a gaba agonist anticonvulsant. mechanism of action of pregabalin pregabalin is a gaba neurotransmitter analog. it produces its action by modulating calcium channels and also reduces the release of neurotransmitters such as glutamate norep', NULL, NULL, 707, '2022-07-13', 0, 'Pregabalin is indicated for the management of neuropathic pain associated with diabetic peripheral neuropathy, postherpetic neuralgia, fibromyalgia, neuropathic pain associated with spinal cord injury, and as adjunctive therapy for the treatment of partial-onset seizures in patients 1 month of age and older.[L7066]', 'Although the mechanism of action has not been fully elucidated, studies involving structurally related drugs suggest that presynaptic binding of pregabalin to voltage-gated calcium channels is key to the antiseizure and antinociceptive effects observed in animal models.[L7066]  



By binding presynaptically to the alpha2-delta subunit of voltage-gated calcium channels in the central nervous system, pregabalin modulates the release of several excitatory neurotransmitters including glutamate, substance-P, norepinephrine, and calcitonin gene related peptide.[A31163] In addition, pregabalin prevents the alpha2-delta subunit from being trafficked from the dorsal root ganglia to the spinal dorsal horn, which may also contribute to the mechanism of action.[A36628] 



Although pregabalin is a structural derivative of the inhibitory neurotransmitter gamma-aminobutyric acid (GABA), it does not bind directly to GABA or benzodiazepine receptors.[A31165]  ', 'Although the structure of pregabalin is similar to gamma-aminobutyric acid (GABA), it does not bind to GABA receptors.[A31163,A187190] Instead, it binds the alpha2-delta subunit of presynaptic voltage-gated calcium channels in the central nervous system.[A31163,A187190] Pregabalin does not modulate dopamine receptors, serotonin receptors, opiate receptors, sodium channels or cyclooxygenase activity.[A187190] ', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23449, 'Neurazine 100 mg 20 tabs', 'نيورازين 100 مجم 20 قرص', '46', '35', 'Psychiatric.antipsychotics', 'Chlorpromazine', 'Misr', 'Tab', 'أقراص', '100 mg', '2', 'امراض نفسية', NULL, '6221035009361', NULL, 4816, '2024-12-15', 0, 'For the treatment of schizophrenia; to control nausea and vomiting; for relief of restlessness and apprehension before surgery; for acute intermittent porphyria; as an adjunct in the treatment of tetanus; to control the manifestations of the manic type of manic-depressive illness; for relief of intractable hiccups; for the treatment of severe behavioral problems in children (1 to 12 years of age) marked by combativeness and/or explosive hyperexcitable behavior (out of proportion to immediate provocations), and in the short-term treatment of hyperactive children who show excessive motor activity with accompanying conduct disorders consisting of some or all of the following symptoms: impulsivity, difficulty sustaining attention, aggressivity, mood lability, and poor frustration tolerance.', 'Chlorpromazine acts as an antagonist (blocking agent) on different postsysnaptic receptors -on dopaminergic-receptors (subtypes D1, D2, D3 and D4 - different antipsychotic properties on productive and unproductive symptoms), on serotonergic-receptors (5-HT1 and 5-HT2, with anxiolytic, antidepressive and antiaggressive properties as well as an attenuation of extrapypramidal side-effects, but also leading to weight gain, fall in blood pressure, sedation and ejaculation difficulties), on histaminergic-receptors (H1-receptors, sedation, antiemesis, vertigo, fall in blood pressure and weight gain), alpha1/alpha2-receptors (antisympathomimetic properties, lowering of blood pressure, reflex tachycardia, vertigo, sedation, hypersalivation and incontinence as well as sexual dysfunction, but may also attenuate pseudoparkinsonism - controversial) and finally on muscarinic (cholinergic) M1/M2-receptors (causing anticholinergic symptoms like dry mouth, blurred vision, obstipation, difficulty/inability to urinate, sinus tachycardia, ECG-changes and loss of memory, but the anticholinergic action may attenuate extrapyramidal side-effects).

Additionally, Chlorpromazine is a weak presynaptic inhibitor of Dopamine reuptake, which may lead to (mild) antidepressive and antiparkinsonian effects. This action could also account for psychomotor agitation and amplification of psychosis (very rarely noted in clinical use).', 'Chlorpromazine is a psychotropic agent indicated for the treatment of schizophrenia. It also exerts sedative and antiemetic activity. Chlorpromazine has actions at all levels of the central nervous system-primarily at subcortical levels-as well as on multiple organ systems. Chlorpromazine has strong antiadrenergic and weaker peripheral anticholinergic activity; ganglionic blocking action is relatively slight. It also possesses slight antihistaminic and antiserotonin activity.', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23451, 'Neurazine 50mg/2ml 100 i.m. amps.', 'نيورازين 50مجم/2مل 100 امبول', '46', NULL, 'Psychiatric.antipsychotics', 'Chlorpromazine', 'Misr', 'Amp', 'أمبول', '50mg', '100', 'امراض نفسية', NULL, NULL, NULL, 1121, '2022-07-13', 0, 'For the treatment of schizophrenia; to control nausea and vomiting; for relief of restlessness and apprehension before surgery; for acute intermittent porphyria; as an adjunct in the treatment of tetanus; to control the manifestations of the manic type of manic-depressive illness; for relief of intractable hiccups; for the treatment of severe behavioral problems in children (1 to 12 years of age) marked by combativeness and/or explosive hyperexcitable behavior (out of proportion to immediate provocations), and in the short-term treatment of hyperactive children who show excessive motor activity with accompanying conduct disorders consisting of some or all of the following symptoms: impulsivity, difficulty sustaining attention, aggressivity, mood lability, and poor frustration tolerance.', 'Chlorpromazine acts as an antagonist (blocking agent) on different postsysnaptic receptors -on dopaminergic-receptors (subtypes D1, D2, D3 and D4 - different antipsychotic properties on productive and unproductive symptoms), on serotonergic-receptors (5-HT1 and 5-HT2, with anxiolytic, antidepressive and antiaggressive properties as well as an attenuation of extrapypramidal side-effects, but also leading to weight gain, fall in blood pressure, sedation and ejaculation difficulties), on histaminergic-receptors (H1-receptors, sedation, antiemesis, vertigo, fall in blood pressure and weight gain), alpha1/alpha2-receptors (antisympathomimetic properties, lowering of blood pressure, reflex tachycardia, vertigo, sedation, hypersalivation and incontinence as well as sexual dysfunction, but may also attenuate pseudoparkinsonism - controversial) and finally on muscarinic (cholinergic) M1/M2-receptors (causing anticholinergic symptoms like dry mouth, blurred vision, obstipation, difficulty/inability to urinate, sinus tachycardia, ECG-changes and loss of memory, but the anticholinergic action may attenuate extrapyramidal side-effects).

Additionally, Chlorpromazine is a weak presynaptic inhibitor of Dopamine reuptake, which may lead to (mild) antidepressive and antiparkinsonian effects. This action could also account for psychomotor agitation and amplification of psychosis (very rarely noted in clinical use).', 'Chlorpromazine is a psychotropic agent indicated for the treatment of schizophrenia. It also exerts sedative and antiemetic activity. Chlorpromazine has actions at all levels of the central nervous system-primarily at subcortical levels-as well as on multiple organ systems. Chlorpromazine has strong antiadrenergic and weaker peripheral anticholinergic activity; ganglionic blocking action is relatively slight. It also possesses slight antihistaminic and antiserotonin activity.', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23456, 'Neurimax 6 i.m. amp.', 'نيوريماكس 6 امبول للحقن العضلي', '60', '36', 'Multivitamins', 'Vitamin(b1+b2+b6+b12)', 'Chemipharm', 'Amp', 'أمبول', NULL, '6', NULL, 'contains lidocaine .... 10 mg each 2 ml solution contains: -thiamine hcl (vitamin b1) ... 200 mg -riboflavin sodium phosphate (vitamin b2) ... 4 mg -pyridoxine hcl (vitamin b6) ... 100 mg -cyanocobalamine (vitamin b12) ... 1000 mcg (1 mg)', '6222006502546', NULL, 4456, '2024-07-30', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23457, 'Neurobion 20 coated tab.', 'نيوروبيون 20 قرص مغلف', '21', NULL, 'Vitamin b', 'Vitamin b1+vitamin b6+vitamin b12', 'Glaxo smithkline > merck kgaa f.r.germany', 'Tab', 'أقراص', NULL, '2', 'مكمل غذائى يدعم الجهاز العصبى والمناعى ويمد الجسم بالطاقة', 'about vit b1 physiological functions: thiamine pyrophosphate is a coenzyme and the active form of vitamin b. it functions as coenzyme in decarboxylation of a-keto acid and in hexose monophosphate shunt. deficiency symptoms: in severe vitamin b1 deficiency', '6221045009818', NULL, 7140, '2022-12-07', 0, 'For the treatment of vitamin A deficiency.', 'Vision:Vitamin A (all-<i>trans</i> retinol) is converted in the retina to the 11-<i>cis</i>-isomer of retinaldehyde or 11-<i>cis</i>-retinal. 11-<i>cis</i>-retinal functions in the retina in the transduction of light into the neural signals necessary for vision. 11-<i>cis</i>-retinal, while attached to opsin in rhodopsin is isomerized to all-<i>trans</i>-retinal by light. This is the event that triggers the nerve impulse to the brain which allows for the perception of light. All-<i>trans</i>-retinal is then released from opsin and reduced to all-<i>trans</i>-retinol. All-<i>trans</i>-retinol is isomerized to 11-<i>cis</i>-retinol in the dark, and then oxidized to 11-<i>cis</i>-retinal. 11-<i>cis</i>-retinal recombines with opsin to re-form rhodopsin. Night blindness or defective vision at low illumination results from a failure to re-synthesize 11-<i>cis</i> retinal rapidly. Epithelial differentiation: The role of Vitamin A in epithelial differentiation, as well as in other physiological processes, involves the binding of Vitamin A to two families of nuclear retinoid receptors (retinoic acid receptors, RARs; and retinoid-X receptors, RXRs). These receptors function as ligand-activated transcription factors that modulate gene transcription. When there is not enough Vitamin A to bind these receptors, natural cell differentiation and growth are interrupted.', 'Vitamin A is effective for the treatment of Vitamin A deficiency. Vitamin A refers to a group of fat-soluble substances that are structurally related to and possess the biological activity of the parent substance of the group called all-<i>trans</i> retinol or retinol. Vitamin A plays vital roles in vision, epithelial differentiation, growth, reproduction, pattern formation during embryogenesis, bone development, hematopoiesis and brain development. It is also important for the maintenance of the proper functioning of the immune system.', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23459, 'Neurobus 10mg 10 tab.', 'نيوروباس 10مجم 10 اقراص', '11', NULL, 'Psychiatric.anxiolytics-hypnotics', 'Buspirone', 'El-obour', 'Tab', 'أقراص', '10mg', '1', NULL, 'about buspirone psychotropic drug serotonin 5-ht1a receptor partial agonist weak dopamine (d2) antagonist azaspirodecanediones derivative sedative anxiolytic agent. mechanism of action of buspirone buspirone has a partial agonistic action on 5ht1a recepto', NULL, NULL, 1062, '2022-10-29', 0, 'Indicated for the management of anxiety disorders or the short-term relief of the symptoms of anxiety.[L4478]', 'The therapeutic action of buspirone in generalized anxiety disorders is thought to be mainly derived from its interaction with two major 5-HT<sub>1A</sub> receptor subtypes that are involved in the brain''s anxiety and fear circuitry to enhance the serotonergic activity in these brain areas.[L7375] Buspirone acts as a full agonist at presynaptic 5-HT<sub>1A</sub> receptors, or 5-HT<sub>1A</sub> autoreceptors, expressed at dorsal raphe while acting as a partial agonist at the postsynaptic 5-HT<sub>1A</sub> receptors expressed on hippocampus and cortex.[A182315,A182420] 5-HT<sub>1A</sub> receptors function as inhibitory autoreceptors by being expressed on the soma or dendrites of serotonergic neurons or mediate postsynaptic actions of 5-HT by being highly expressed on the corticolimbic circuits.[T28] They are inhibitory G-protein coupled receptors that couple to Gi/Go proteins. When activated, presynaptic 5-HT<sub>1A</sub> autoreceptors causes neuron hyperpolarization and reduces the firing rate of the serotonergic neuron, thereby decreasing extracellular 5-HT levels in the neuron''s projection areas. Activated postsynaptic 5-HT<sub>1A</sub> receptors promote hyperpolarization to released 5-HT on pyramidal neurons.[A182420] 



The anxiolytic action of buspirone is mainly thought to arise from the interaction at presynaptic 5-HT<sub>1A</sub> autoreceptors. Acting as a potent agonist in these receptors, buspirone initially causes activation of these autoreceptors and inhibition of 5-HT release. It is proposed that buspirone induces desensitization of somatodendritic autoreceptors over time, which may explain the delayed onset of action of the drug. Desensitization of the autoreceptors ultimately results in heightened excitation of serotonergic neurons and enhanced 5-HT release.[T28] Buspirone also displays a weak affinity for serotonin 5HT2 receptors and acts as a weak antagonist on dopamine D2 autoreceptors,[L7375] although there is not much evidence that the action at these receptors contribute to the anxiolytic effect of buspirone.[A182312] It acts as an antagonist at presynaptic dopamine D3 and D4 receptors and may bind to alpha-1 adrenergic receptors as a partial agonist.[A181751]', 'The clinical effect of buspirone in alleviating the symptoms of generalized anxiety disorders typically takes 2 to 4 weeks to achieve.[L7375] The delayed onset of action of buspirone suggests that the therapeutic effectiveness in generalized anxiety may involved more than its molecular mechanism of action at the 5-HT<sub>1A</sub> receptors,[T28] or buspirone may induce adaptations of 5-HT<sub>1A</sub> receptors.[L7375] Buspirone was not shown to alter the psychomotor or cognitive function in healthy volunteers, and the risk of developing sedation is relatively low compared to other anxiolytics, such as benzodiazepines.[A180985] Unlike benzodiazepines and barbiturates used in anxiety disorders, buspirone is not associated with a risk for developing physical dependence or withdrawal, or any significant interaction with central nervous system depressants such as ethanol. This is due to the lack of effects on GABA receptors.[A180985,L7375] Buspirone also does not exhibit any anticonvulsant or muscle-relaxing properties,[A182309] but may interfere with arousal reactions due to its inhibitory action on the aactivity of noradrenergic locus coerulus neurons.[T28]



Despite its clinical effectiveness in generalized anxiety, buspirone demonstrated limited clinical effectiveness on panic disorders, severe anxiety, phobias, and obsessive compulsive disorders.[A181751,T28] The clinical effectiveness of the long-term use of buspirone, for more than 3 to 4 weeks, has not demonstrated in controlled trials but there were no observable significant adverse events in patients receiving buspirone for a year in a study of long-term use.[L4478]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23461, 'Neurocet 20% syrup 120 ml', 'نيوروسيت 20% شراب 120 مل', '11', NULL, 'Cerebral circulatory inhancer', 'Piracetam', 'Misr', 'Syrup', 'شراب', '20%', '1', NULL, NULL, '6221035003093', NULL, 1029, '2022-12-26', 0, 'Indicated in adult patients suffering from myoclonus of cortical origin, irrespective of aetiology, and should be used in combination with other anti-myoclonic therapies [L1125].', 'Piracetam interacts with the polar heads in the phospholipids membrane and the resulting mobile drug-lipid complexes are thought to reorganize the lipids and influence membrane function and fluidity [A31532]. Such interaction has been reported in a study that investigated the effects of neuronal outgrowth induced by beta amyloid peptides; while amyloid peptides cause lipid disorganization within the cell membranes leading to neuronal death, piracetam demonstrated to decrease the destabilizing effects of amyloid peptide [A31534]. The authors suggest that piracetam induces a positive curvature of the membrane by occupying the polar groups in the phospholipids to counteract the negative curvature induced by amyloid peptides , which in turn would decrease the likelihood of membrane fusion [A31532]. This mechanism of action is thought to improve membrane stability, allowing the membrane and transmembrane proteins to maintain and recover the three-dimensional structure or folding for normal function [L1124] such as membrane transport, chemical secretion, and receptor binding and stimulation [A31532]. 



Through restored membrane fluidity, piracetam promotes restored neurotransmission such as glutamatergic and cholinergic systems, enhances neuroplasticity and mediates neuroprotective and anticonvulsant effects at the neuronal level [A31532]. It is also demonstrated that piracetam also improves the fluidity of platelet membranes. At the vascular level, piracetam decreases adhesion of erythrocytes to cell wall and reduces vasospasm which in turn improves microcirculation including cerebral and renal blood flow [A31532]. ', 'Piracetam is known to mediate various pharmacodynamic actions:



**Neuronal effects**: 



Piracetam modulates the cholinergic, serotonergic, noradrenergic, and glutamatergic neurotransmission although the drug does not display high affinity to any of the associated receptors (Ki >10μM). Instead, piracetam increases the density of postsynaptic receptors and/or restore the function of these receptors through stabilizing the membrane fluidity [A31532]. In the forebrain of aging mice, the density of NMDA receptors was increased by approximately 20% following 14 days of piracetam treatment. Based on the findings of various animal and human studies, the cognitive processses including learning, memory, attention and consciousness were enhanced from piracetam therapy without inducing sedation and psychostimulant effects [L1125]. Piracetam mediate neuroprotective effects against hypoxia-induced damage, intoxication, and electroconvulsive therapy [L1125]. 



In two studies involving alcohol-treated rats with evidences of withdrawal-related neuronal loss, piracetam was shown to reduce the extent of neuronal loss and increase the numbers of synapses in the hippocampus by up to 20% relative to alcohol-treated or alcohol-withdrawn rats [A31532]. This suggests that piracetam is capable in promoting neuroplasticity when recoverable neural circuits are present [A31532]. Although the mechanism of action is not fully understood, administration of piracetam prior to a convulsant stimulus reduces the seizure severity and enhances the anticonvulsant effectiveness of conventional antiepileptics such as carbamazepine and diazepam [A31535]. 



**Vascular effects**: 



Piracetam is shown to increase the deformability of erythrocytes, reduce platelet aggregation in a dose-dependent manner, reduce the adhesion of erythrocytes to vascular endothelium and capillary vasospasm. In healthy volunteers, piracetam mediated a direct stimulant effect on prostacycline synthesis and reduced the plasma levels of fibrinogen and von Willebrand’s factors (VIII: C; VIII R: AG; VIII R: vW) by 30 to 40% [L1125]. Potentiated microcirculation is thought to arise from a combination of effects on erythrocytes, blood vessels and blood coagulation [A31532]. ', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23462, 'Neurocet 400mg 30 caps.', 'نيوروسيت 400مجم 30 كبسولة', '8', NULL, 'Cerebral circulatory inhancer', 'Piracetam', 'Misr', 'Cap', 'كبسولة', '400mg', '3', 'حماية المخ والجهاز العصبي من نقص الاكسجين', 'the way piracetam works is not fully understood. it may work by altering the availability of the brain s supply of neurochemicals (neurotransmitters enzymes and hormones) or by improving the brain s oxygen supply. what is it used for? uncontrollable twitc', NULL, NULL, 1837, '2022-10-28', 0, 'Indicated in adult patients suffering from myoclonus of cortical origin, irrespective of aetiology, and should be used in combination with other anti-myoclonic therapies [L1125].', 'Piracetam interacts with the polar heads in the phospholipids membrane and the resulting mobile drug-lipid complexes are thought to reorganize the lipids and influence membrane function and fluidity [A31532]. Such interaction has been reported in a study that investigated the effects of neuronal outgrowth induced by beta amyloid peptides; while amyloid peptides cause lipid disorganization within the cell membranes leading to neuronal death, piracetam demonstrated to decrease the destabilizing effects of amyloid peptide [A31534]. The authors suggest that piracetam induces a positive curvature of the membrane by occupying the polar groups in the phospholipids to counteract the negative curvature induced by amyloid peptides , which in turn would decrease the likelihood of membrane fusion [A31532]. This mechanism of action is thought to improve membrane stability, allowing the membrane and transmembrane proteins to maintain and recover the three-dimensional structure or folding for normal function [L1124] such as membrane transport, chemical secretion, and receptor binding and stimulation [A31532]. 



Through restored membrane fluidity, piracetam promotes restored neurotransmission such as glutamatergic and cholinergic systems, enhances neuroplasticity and mediates neuroprotective and anticonvulsant effects at the neuronal level [A31532]. It is also demonstrated that piracetam also improves the fluidity of platelet membranes. At the vascular level, piracetam decreases adhesion of erythrocytes to cell wall and reduces vasospasm which in turn improves microcirculation including cerebral and renal blood flow [A31532]. ', 'Piracetam is known to mediate various pharmacodynamic actions:



**Neuronal effects**: 



Piracetam modulates the cholinergic, serotonergic, noradrenergic, and glutamatergic neurotransmission although the drug does not display high affinity to any of the associated receptors (Ki >10μM). Instead, piracetam increases the density of postsynaptic receptors and/or restore the function of these receptors through stabilizing the membrane fluidity [A31532]. In the forebrain of aging mice, the density of NMDA receptors was increased by approximately 20% following 14 days of piracetam treatment. Based on the findings of various animal and human studies, the cognitive processses including learning, memory, attention and consciousness were enhanced from piracetam therapy without inducing sedation and psychostimulant effects [L1125]. Piracetam mediate neuroprotective effects against hypoxia-induced damage, intoxication, and electroconvulsive therapy [L1125]. 



In two studies involving alcohol-treated rats with evidences of withdrawal-related neuronal loss, piracetam was shown to reduce the extent of neuronal loss and increase the numbers of synapses in the hippocampus by up to 20% relative to alcohol-treated or alcohol-withdrawn rats [A31532]. This suggests that piracetam is capable in promoting neuroplasticity when recoverable neural circuits are present [A31532]. Although the mechanism of action is not fully understood, administration of piracetam prior to a convulsant stimulus reduces the seizure severity and enhances the anticonvulsant effectiveness of conventional antiepileptics such as carbamazepine and diazepam [A31535]. 



**Vascular effects**: 



Piracetam is shown to increase the deformability of erythrocytes, reduce platelet aggregation in a dose-dependent manner, reduce the adhesion of erythrocytes to vascular endothelium and capillary vasospasm. In healthy volunteers, piracetam mediated a direct stimulant effect on prostacycline synthesis and reduced the plasma levels of fibrinogen and von Willebrand’s factors (VIII: C; VIII R: AG; VIII R: vW) by 30 to 40% [L1125]. Potentiated microcirculation is thought to arise from a combination of effects on erythrocytes, blood vessels and blood coagulation [A31532]. ', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23463, 'Neurofenac 30 caps.', 'نيوروفيناك 30 كبسولة', '26', NULL, 'Nsaid combined with vitamin b', 'Diclofenac sodium+vitamin b1+vitamin b6+vitamin b12', 'Amoun > merck kgaa f.r.germany', 'Cap', 'كبسولة', NULL, '3', 'مسكن وخافض للحرارة ومضاد للالتهابات ومصدر لفيتامين ب لذا يستخدم كداعم للجهاز العصبى ويمد الجسم بالطاقة', 'mechanism of action of diclofenac sodium diclofenac possess analgesic anti-inflammatory and antipyretic action. it inhibits the enzyme cyclo-oxygenase and there by inhibits the synthesis of prostaglandins (pgs). it is more potent against cyclo-oxygenase-2', '6221025009852', NULL, 1907, '2022-12-07', 0, 'Diclofenac is indicated for use in the treatment of pain and inflammation from varying sources including inflammatory conditions such as osteoarthritis, rheumatoid arthritis, and ankylosing spondylitis, as well as injury-related inflammation due to surgery and physical trauma. It is often used in combination with [misoprostol] as a gastro-protective agent in patients with high risk of developing NSAID-induced ulcers.', 'Diclofenac inhibits cyclooxygenase-1 and -2, the enzymes responsible for production of prostaglandin (PG) G<sub>2</sub> which is the precursor to other PGs.[label,T116] These molecules have broad activity in pain and inflammation and the inhibition of their production is the common mechanism linking each effect of diclofenac.



PGE<sub>2</sub> is the primary PG involved in modulation of nociception.[A179023] It mediates peripheral sensitization through a variety of effects.[T116,A179023] PGE<sub>2</sub> activates the G<sub>q</sub>-coupled EP<sub>1</sub> receptor leading to increased activity of the inositol trisphosphate/phospholipase C pathway. Activation of this pathway releases intracellular stores of calcium which directly reduces action potential threshold and activates protein kinase C (PKC) which contributes to several indirect mechanisms. PGE<sub>2</sub> also activates the EP<sub>4</sub> receptor, coupled to G<sub>s</sub>, which activates the adenylyl cyclase/protein kinase A (AC/PKA) signaling pathway. PKA and PKC both contribute to the potentiation of transient receptor potential cation channel subfamily V member 1 (TRPV1) potentiation, which increases sensitivity to heat stimuli. They also activate tetrodotoxin-resistant sodium channels and inhibit inward potassium currents. PKA further contributes to the activation of the P2X3 purine receptor and sensitization of T-type calcium channels. The activation and sensitization of depolarizing ion channels and inhibition of inward potassium currents serve to reduce the intensity of stimulus necessary to generate action potentials in nociceptive sensory afferents. PGE<sub>2</sub> act via EP<sub>3</sub> to increase sensitivity to bradykinin and via EP<sub>2</sub> to further increase heat sensitivity. Central sensitization occurs in the dorsal horn of the spinal cord and is mediated by the EP<sub>2</sub> receptor which couples to G<sub>s</sub>. Pre-synaptically, this receptor increases the release of pro-nociceptive neurotransmitters glutamate, CGRP, and substance P. Post-synaptically it increases the activity of AMPA and NMDA receptors and produces inhibition of inhibitory glycinergic neurons. Together these lead to a reduced threshold of activating, allowing low intensity stimuli to generate pain signals. PGI<sub>2</sub> is known to play a role via its G<sub>s</sub>-coupled IP receptor although the magnitude of its contribution varies. It has been proposed to be of greater importance in painful inflammatory conditions such as arthritis. By limiting sensitization, both peripheral and central, via these pathways NSAIDs can effectively reduce inflammatory pain.



PGI<sub>2</sub> and PGE<sub>2</sub> contribute to acute inflammation via their IP and EP<sub>2</sub> receptors.[T116,A179044] Similarly to β adrenergic receptors these are G<sub>s</sub>-coupled and mediate vasodilation through the AC/PKA pathway. PGE<sub>2</sub> also contributes by increasing leukocyte adhesion to the endothelium and attracts the cells to the site of injury.[T116] PGD<sub>2</sub> plays a role in the activation of endothelial cell release of cytokines through its DP<sub>1</sub> receptor.[A179044] PGI<sub>2</sub> and PGE<sub>2</sub> modulate T-helper cell activation and differentiation through IP, EP<sub>2</sub>, and EP<sub>4</sub> receptors which is believed to be an important activity in the pathology of arthritic conditions. By limiting the production of these PGs at the site of injury, NSAIDs can reduce inflammation.



PGE<sub>2</sub> can cross the blood-brain barrier and act on excitatory G<sub>q</sub> EP<sub>3</sub> receptors on thermoregulatory neurons in the hypothalamus.[T116] This activation triggers an increase in heat-generation and a reduction in heat-loss to produce a fever. NSAIDs prevent the generation of PGE<sub>2</sub> thereby reducing the activity of these neurons.

', 'Diclofenac reduces inflammation and by extension reduces nociceptive pain and combats fever.[label,T116] It also increases the risk of developing a gastrointestinal ulcer by inhibiting the production of protective mucus in the stomach.', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23465, 'Neurofutal sr 400 mg 10 f.c. tabs.', 'نيوروفيوتال اس ار 400مجم 10 اقراص', '8', NULL, 'Anti-epileptic.carboxamides', 'Carbamazepine', 'Future pharmaceutical industries (fpi)', 'Tab', 'أقراص', '400 mg', '1', NULL, 'about carbamazepine tricyclic anticonvulsant iminostilbene derivative anticonvulsant in trigeminal neuralgia. mechanism of action of carbamazepine carbamazepine prolongs the inactivated state of voltage sensitive neuronal sodium ion channel either by incr', NULL, NULL, 1133, '2022-07-05', 0, 'Carbamazepine is indicated for the treatment of epilepsy and pain associated with true trigeminal neuralgia.[L1335] In particular, carbamazepine has shown efficacy in treating mixed seizures, partial seizures with complex symptoms, and generalized tonic-clonic seizures.[A180301,L1335] Carbamazepine is also indicated for the treatment of manic episodes and mixed manic-depressive episodes caused by bipolar I disorder.[L1335] Some off-label, unapproved uses of carbamazepine include the treatment of alcohol withdrawal syndrome and restless leg syndrome.[A180415,A180421]', 'Carbamazepine''s mechanism of action is not fully elucidated and is widely debated.[A180310,L9713] One major hypothesis is that carbamazepine inhibits sodium channel firing, treating seizure activity. Animal research studies have demonstrated that carbamazepine exerts its effects by lowering polysynaptic nerve response and inhibiting post-tetanic potentiation. In both cats and rats, carbamazepine was shown to decrease pain caused by infraorbital nerve stimulation. A decrease in the action potential in the nucleus ventralis of the thalamus in the brain and inhibition of the lingual mandibular reflex were observed in other studies after carbamazepine use. Carbamazepine causes the above effects by binding to voltage-dependent sodium channels and preventing action potentials, which normally lead to stimulatory effects on nerves.[A180403,T634] In bipolar disorder, carbamazepine is thought to increase dopamine turnover and increase GABA transmission, treating manic and depressive symptoms.[L7216]



A common issue that has arisen is resistance to this drug in up to 30% of epileptic patients, which may occur to altered metabolism in patients with variant genotypes.[A180436] A potential therapeutic target to combat carbamazepine resistance has recently been identified as the EPHX1 gene promoter, potentially conferring resistance to carbamazepine through methylation.[A180439]', '**General effects**



Carbamazepine treats seizures and the symptoms of trigeminal neuralgia by inhibiting sodium channels.  In bipolar 1 disorder, carbamazepine has been found to decrease mania symptoms in a clinically significant manner according to the Young Mania Rating Scale (YMRS).[L1335] Carbamazepine has a narrow therapeutic index.[A180301]



**A note on genetic variation and carbamazepine use**



In studies of Han Chinese ancestry patients, a pronounced association between the HLA-B*1502 genotype and Steven Johnson syndrome and/or toxic epidermal necrolysis (SJS/TEN) resulting from carbamazepine use was observed.[A180397]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23467, 'Neuroglopentin 300 mg 30 caps.', 'نيوروجلوبنتين 300مجم 30 كبسولة', '111', '69', 'Anti-epileptic.gaba analogs', 'Gabapentin', 'Global napi pharmaceuticals', 'Cap', 'كبسولة', '300 mg', '3', 'علاج الالام الحادة -- تقليل التشنجات في حالات الصرع -- علاج التهاب الاعصاب', 'about gabapentin a gaba analogue anticonvulsant mood stabilizer. mechanism of action of gabapentinsgabapentin is a gaba derivative and it bounds to lipophilic molecule. the mechanism of action of gabapentin is not exactly known. it crosses blood brain bar', '6223002145621', NULL, 7375, '2024-09-16', 0, 'In the United States, gabapentin is officially indicated for the treatment of postherpetic neuralgia in adults and for the adjunctive treatment of partial-onset seizures, with or without secondary generalization, in patients 3 years of age and older.[L8717] In Europe, gabapentin is indicated for adjunctive therapy in the treatment of partial-onset seizures, with or without secondary generalization, in patients 6 years of age and older and as monotherapy in patients 12 years of age and older. It is also used in adults for the treatment of various types of peripheral neuropathic pain, such as painful diabetic neuropathy.[L8732]', 'The precise mechanism through which gabapentin exerts its therapeutic effects is unclear.[L8717,L8720] The primary mode of action appears to be at the auxillary α2δ-1 subunit of voltage-gated calcium channels (though a low affinity for the α2δ-2 subunit has also been reported).[A186179,A14097,A186277] The major function of these subunits is to facilitate the movement of pore-forming α1 subunits of calcium channels from the endoplasmic reticulum to the cell membrane of pre-synaptic neurons.[A186179] There is evidence that chronic pain states can cause an increase in the expression of α2δ subunits and that these changes correlate with hyperalgesia.[A14097] Gabapentin appears to inhibit the action of α2δ-1 subunits, thus decreasing the density of pre-synaptic voltage-gated calcium channels and subsequent release of excitatory neurotransmitters.[A186179] It is likely that this inhibition is also responsible for the anti-epileptic action of gabapentin.[A186277]



There is some evidence that gabapentin also acts on adenosine receptors[A11009, A186209] and voltage-gated potassium channels,[A186212] though the clinical relevance of its action at these sites is unclear.', 'Gabapentin is an anti-convulsant medication that inhibits the release of excitatory neurotransmitters, allowing for its use against pathologic neurotransmission such as that seen in neuropathic pain and seizure disorders.[L8717,L8732] It has a wide therapeutic index, with doses in excess of 8000 mg/kg failing to cause a fatal reaction in rats.[L8765]



Gabapentin is ineffective in absence seizures and should be used in caution in patients with mixed seizure disorders involving absence seizures. Gabapentin has been associated with drug reaction with eosinophilia and systemic symptoms (DRESS), otherwise known as multi-organ hypersensitivity. This reaction can prove fatal and early symptoms such as fever, lymphadenopathy, and rash should be promptly investigated.[L8717,L8720,L8732]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23469, 'Neurontin 300mg 20 caps', 'نيورونتين 300مجم 20 كبسولة', '108', '80', 'Anti-epileptic.gaba analogs', 'Gabapentin', 'Pfizer', 'Cap', 'كبسولة', '300mg', '2', 'التحكم في بعض أنواع نوبات الصرع. ويستخدم أيضًا لتخفيف الألم', NULL, '6221180000596', NULL, 7514, '2024-11-30', 0, 'In the United States, gabapentin is officially indicated for the treatment of postherpetic neuralgia in adults and for the adjunctive treatment of partial-onset seizures, with or without secondary generalization, in patients 3 years of age and older.[L8717] In Europe, gabapentin is indicated for adjunctive therapy in the treatment of partial-onset seizures, with or without secondary generalization, in patients 6 years of age and older and as monotherapy in patients 12 years of age and older. It is also used in adults for the treatment of various types of peripheral neuropathic pain, such as painful diabetic neuropathy.[L8732]', 'The precise mechanism through which gabapentin exerts its therapeutic effects is unclear.[L8717,L8720] The primary mode of action appears to be at the auxillary α2δ-1 subunit of voltage-gated calcium channels (though a low affinity for the α2δ-2 subunit has also been reported).[A186179,A14097,A186277] The major function of these subunits is to facilitate the movement of pore-forming α1 subunits of calcium channels from the endoplasmic reticulum to the cell membrane of pre-synaptic neurons.[A186179] There is evidence that chronic pain states can cause an increase in the expression of α2δ subunits and that these changes correlate with hyperalgesia.[A14097] Gabapentin appears to inhibit the action of α2δ-1 subunits, thus decreasing the density of pre-synaptic voltage-gated calcium channels and subsequent release of excitatory neurotransmitters.[A186179] It is likely that this inhibition is also responsible for the anti-epileptic action of gabapentin.[A186277]



There is some evidence that gabapentin also acts on adenosine receptors[A11009, A186209] and voltage-gated potassium channels,[A186212] though the clinical relevance of its action at these sites is unclear.', 'Gabapentin is an anti-convulsant medication that inhibits the release of excitatory neurotransmitters, allowing for its use against pathologic neurotransmission such as that seen in neuropathic pain and seizure disorders.[L8717,L8732] It has a wide therapeutic index, with doses in excess of 8000 mg/kg failing to cause a fatal reaction in rats.[L8765]



Gabapentin is ineffective in absence seizures and should be used in caution in patients with mixed seizure disorders involving absence seizures. Gabapentin has been associated with drug reaction with eosinophilia and systemic symptoms (DRESS), otherwise known as multi-organ hypersensitivity. This reaction can prove fatal and early symptoms such as fever, lymphadenopathy, and rash should be promptly investigated.[L8717,L8720,L8732]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23471, 'Neuropride 50 mg 30 caps.', 'نيوروبرايد 50مجم 30 كبسول', '8', NULL, 'Psychiatric.antipsychotics', 'Sulpiride', 'Memphis', 'Cap', 'كبسولة', '50 mg', '3', NULL, 'about sulpiride synthetic origin d2 antagonist. mechanism of action of sulpiride sulpride block both dopamine d1 and d2 receptors sulpiride is more selective and acts primarily as a dopamine d2 antagonist. sulpiride appears to lack effects on norepinephri', NULL, NULL, 830, '2022-07-15', 0, 'Sulpiride is indicated for the treatment of acute and chronic schizophrenia.[L31933]', 'Sulpiride is a selective dopamine D2 and D3 receptor antagonist.[A229678,A229683,A229688] _In silico_ studies show that sulpiride may interact with the Asp-119 and Phe-417 amino acid residues of these receptors.[A229688] It is estimated that D2 receptors should be 65-80% occupied for optimal treatment and minimal adverse effects.[A229693]', 'Sulpiride is a substituted benzamide derivative and a selective dopamine D2 antagonist indicated to treat acute and chronic schizophrenia.[A229678,A229683,A229688,L31933] It has a short duration of action as it is given twice daily, and a wide therapeutic window as patients have survived single doses as high as 16g.[L31933] Patients should be counselled regarding increased motor agitation, extrapyramidal reactions, and neuroleptic malignant syndrome.[L31933]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23476, 'Neurotop 200mg 100 tab.', 'نيوروتوب 200مجم 100 اقراص', '260', '75', 'Anti-epileptic.carboxamides', 'Carbamazepine', 'Gerot pharma > b.p pharma', 'Tab', 'أقراص', '200mg', '10', NULL, 'about carbamazepine tricyclic anticonvulsant iminostilbene derivative anticonvulsant in trigeminal neuralgia. mechanism of action of carbamazepine carbamazepine prolongs the inactivated state of voltage sensitive neuronal sodium ion channel either by incr', NULL, NULL, 1063, '2024-11-12', 0, 'Carbamazepine is indicated for the treatment of epilepsy and pain associated with true trigeminal neuralgia.[L1335] In particular, carbamazepine has shown efficacy in treating mixed seizures, partial seizures with complex symptoms, and generalized tonic-clonic seizures.[A180301,L1335] Carbamazepine is also indicated for the treatment of manic episodes and mixed manic-depressive episodes caused by bipolar I disorder.[L1335] Some off-label, unapproved uses of carbamazepine include the treatment of alcohol withdrawal syndrome and restless leg syndrome.[A180415,A180421]', 'Carbamazepine''s mechanism of action is not fully elucidated and is widely debated.[A180310,L9713] One major hypothesis is that carbamazepine inhibits sodium channel firing, treating seizure activity. Animal research studies have demonstrated that carbamazepine exerts its effects by lowering polysynaptic nerve response and inhibiting post-tetanic potentiation. In both cats and rats, carbamazepine was shown to decrease pain caused by infraorbital nerve stimulation. A decrease in the action potential in the nucleus ventralis of the thalamus in the brain and inhibition of the lingual mandibular reflex were observed in other studies after carbamazepine use. Carbamazepine causes the above effects by binding to voltage-dependent sodium channels and preventing action potentials, which normally lead to stimulatory effects on nerves.[A180403,T634] In bipolar disorder, carbamazepine is thought to increase dopamine turnover and increase GABA transmission, treating manic and depressive symptoms.[L7216]



A common issue that has arisen is resistance to this drug in up to 30% of epileptic patients, which may occur to altered metabolism in patients with variant genotypes.[A180436] A potential therapeutic target to combat carbamazepine resistance has recently been identified as the EPHX1 gene promoter, potentially conferring resistance to carbamazepine through methylation.[A180439]', '**General effects**



Carbamazepine treats seizures and the symptoms of trigeminal neuralgia by inhibiting sodium channels.  In bipolar 1 disorder, carbamazepine has been found to decrease mania symptoms in a clinically significant manner according to the Young Mania Rating Scale (YMRS).[L1335] Carbamazepine has a narrow therapeutic index.[A180301]



**A note on genetic variation and carbamazepine use**



In studies of Han Chinese ancestry patients, a pronounced association between the HLA-B*1502 genotype and Steven Johnson syndrome and/or toxic epidermal necrolysis (SJS/TEN) resulting from carbamazepine use was observed.[A180397]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23477, 'Neurotop 400mg 100 tab.', 'نيوروتوب ريتارد 400 مجم 100 قرص', '450', '162.5', 'Anti-epileptic.carboxamides', 'Carbamazepine', 'Gerot pharma > b.p pharma', 'Tab', 'أقراص', '400mg', '10', NULL, 'about carbamazepine tricyclic anticonvulsant iminostilbene derivative anticonvulsant in trigeminal neuralgia. mechanism of action of carbamazepine carbamazepine prolongs the inactivated state of voltage sensitive neuronal sodium ion channel either by incr', NULL, NULL, 1051, '2024-11-12', 0, 'Carbamazepine is indicated for the treatment of epilepsy and pain associated with true trigeminal neuralgia.[L1335] In particular, carbamazepine has shown efficacy in treating mixed seizures, partial seizures with complex symptoms, and generalized tonic-clonic seizures.[A180301,L1335] Carbamazepine is also indicated for the treatment of manic episodes and mixed manic-depressive episodes caused by bipolar I disorder.[L1335] Some off-label, unapproved uses of carbamazepine include the treatment of alcohol withdrawal syndrome and restless leg syndrome.[A180415,A180421]', 'Carbamazepine''s mechanism of action is not fully elucidated and is widely debated.[A180310,L9713] One major hypothesis is that carbamazepine inhibits sodium channel firing, treating seizure activity. Animal research studies have demonstrated that carbamazepine exerts its effects by lowering polysynaptic nerve response and inhibiting post-tetanic potentiation. In both cats and rats, carbamazepine was shown to decrease pain caused by infraorbital nerve stimulation. A decrease in the action potential in the nucleus ventralis of the thalamus in the brain and inhibition of the lingual mandibular reflex were observed in other studies after carbamazepine use. Carbamazepine causes the above effects by binding to voltage-dependent sodium channels and preventing action potentials, which normally lead to stimulatory effects on nerves.[A180403,T634] In bipolar disorder, carbamazepine is thought to increase dopamine turnover and increase GABA transmission, treating manic and depressive symptoms.[L7216]



A common issue that has arisen is resistance to this drug in up to 30% of epileptic patients, which may occur to altered metabolism in patients with variant genotypes.[A180436] A potential therapeutic target to combat carbamazepine resistance has recently been identified as the EPHX1 gene promoter, potentially conferring resistance to carbamazepine through methylation.[A180439]', '**General effects**



Carbamazepine treats seizures and the symptoms of trigeminal neuralgia by inhibiting sodium channels.  In bipolar 1 disorder, carbamazepine has been found to decrease mania symptoms in a clinically significant manner according to the Young Mania Rating Scale (YMRS).[L1335] Carbamazepine has a narrow therapeutic index.[A180301]



**A note on genetic variation and carbamazepine use**



In studies of Han Chinese ancestry patients, a pronounced association between the HLA-B*1502 genotype and Steven Johnson syndrome and/or toxic epidermal necrolysis (SJS/TEN) resulting from carbamazepine use was observed.[A180397]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23480, 'Neurovit 6 i.m. amps', 'نيوروفيت حقن 6 امبولات', '66', '45', 'Vitamin b', 'Vitamin b1+vitamin b6+vitamin b12', 'Amriya', 'Amp', 'أمبول', NULL, '6', 'حالات الضعف العام والخمول والارهاق.', NULL, '6221075052600', NULL, 19827, '2024-10-30', 0, 'For the treatment of vitamin A deficiency.', 'Vision:Vitamin A (all-<i>trans</i> retinol) is converted in the retina to the 11-<i>cis</i>-isomer of retinaldehyde or 11-<i>cis</i>-retinal. 11-<i>cis</i>-retinal functions in the retina in the transduction of light into the neural signals necessary for vision. 11-<i>cis</i>-retinal, while attached to opsin in rhodopsin is isomerized to all-<i>trans</i>-retinal by light. This is the event that triggers the nerve impulse to the brain which allows for the perception of light. All-<i>trans</i>-retinal is then released from opsin and reduced to all-<i>trans</i>-retinol. All-<i>trans</i>-retinol is isomerized to 11-<i>cis</i>-retinol in the dark, and then oxidized to 11-<i>cis</i>-retinal. 11-<i>cis</i>-retinal recombines with opsin to re-form rhodopsin. Night blindness or defective vision at low illumination results from a failure to re-synthesize 11-<i>cis</i> retinal rapidly. Epithelial differentiation: The role of Vitamin A in epithelial differentiation, as well as in other physiological processes, involves the binding of Vitamin A to two families of nuclear retinoid receptors (retinoic acid receptors, RARs; and retinoid-X receptors, RXRs). These receptors function as ligand-activated transcription factors that modulate gene transcription. When there is not enough Vitamin A to bind these receptors, natural cell differentiation and growth are interrupted.', 'Vitamin A is effective for the treatment of Vitamin A deficiency. Vitamin A refers to a group of fat-soluble substances that are structurally related to and possess the biological activity of the parent substance of the group called all-<i>trans</i> retinol or retinol. Vitamin A plays vital roles in vision, epithelial differentiation, growth, reproduction, pattern formation during embryogenesis, bone development, hematopoiesis and brain development. It is also important for the maintenance of the proper functioning of the immune system.', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23483, 'Neuth anti-acne absolute purifying exfoliator gel 150 ml (step 1)', 'نيوث لعلاج حب الشباب جل 150مل', '220', NULL, 'Skin care', NULL, 'Neuth > eva pharma', 'Gel', 'جل', '150 ml', '1', NULL, 'gentle exfoliator removes dead skin cells and the impurities responsible for bacterial growth and new breakouts formation it helps removing the excessive sebum from pores for visible reduction in breakouts size and regaining skin clarity smoothness and hy', NULL, NULL, 926, '2022-07-13', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23485, 'Neuth anti-acne multi- resolving concentrate 30 ml (step 4)', 'نيوث لعلاج حب الشباب 30مل', '260', NULL, 'Skin care', NULL, 'Neuth > eva pharma', 'Sol', 'محلول', '30 ml', '1', NULL, 'high performance concentrate that provides multiple effectiveness on active acne at a deeper level to fight the source of where acne breakouts emerge. it works instantly and visibly to reduce the number size and pain of acne breakouts and effectively regu', NULL, NULL, 1020, '2022-07-15', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23487, 'Neuth anti-acne pore minimizing and mattifying toner 200 ml (step 3)', 'نيوث لعلاج حب الشباب تونر 150مل', '225', NULL, 'Skin care', NULL, 'Neuth > eva pharma', 'Unknown', 'غير محدد', '200 ml', '1', NULL, 'follows skin cleansing to sweep away the remaining pore-clogging impurities regaining skin clarity and helping achieve a balanced skin ph. exerts visible reduction and correction of pores size with enhanced reduction of excess sebum outpouring for guarant', NULL, NULL, 1191, '2022-07-13', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23490, 'Neuth anti-acne renovating sunscreen spf 50+ 50 ml (step 5)', 'نيوث لعلاج حب الشباب للحماية من الشمس 50مل', '285', NULL, 'Sun block', 'Silver citrate+ niacinamide+ cetiol cc+ hydrolite 5 penthylene glycol', 'Neuth > eva pharma', 'Unknown', 'غير محدد', '50 ml', '1', NULL, 'light formula that is absorbed quickly and provides a long lasting anti-shine finish with the delivery of a broad spectrum protection from harmful sun rays (uva uvb). gets new acne breakouts under control for a consistently healthier looking skin. it also', NULL, NULL, 808, '2022-08-02', 0, 'Indicated as an adjunct for the prevention and treatment of wound sepsis in patients with second- and third-degree burns.', 'Studies utilizing radioactive micronized silver sulfadiazine, electron microscopy, and biochemical techniques have revealed that the mechanism of action of silver sulfadiazine on bacteria differs from silver nitrate and sodium sulfadiazine. Silver sulfadiazine acts only on the cell membrane and cell wall to produce its bactericidal effect. A specific mechanism of action has not been determined, but silver sulfadiazine''s effectiveness may possibly be from a synergistic interaction, or the action of each component. Silver is a biocide, which binds to a broad range of targets. Silver ions bind to nucleophilic amino acids, as well as sulfhydryl, amino, imidazole, phosphate, and carboxyl groups in proteins, causing protein denaturation and enzyme inhibition. 

Silver binds to surface membranes and proteins, causing proton leaks in the membrane, leading to cell death. 

Sulfadiazine is a competitive inhibitor of bacterial para-aminobenzoic acid (PABA), a substrate of the enzyme dihydropteroate synthetase. The inhibited reaction is necessary in these organisms for the synthesis of folic acid.', 'Silver sulfadiazine has broad antimicrobial activity. It is bactericidal for many gram- negative and gram-positive bacteria as well as being effective against yeast. Silver sulfadiazine is not a carbonic anhydrase inhibitor and may be useful in situations where such agents are contraindicated.', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23492, 'Neuth anti-acne revitalizing facial wash 200 ml (step 2)', 'نيوث لعلاج حب الشباب غسول للوجه 200مل', '198', NULL, 'Skin care', 'Saw palmetto extract+silver citrate+niacinamide+salicylic acid', 'Neuth > eva pharma', 'Facial wash', 'غسول للوجه', '200 ml', '1', NULL, 'ultra gentle soap free gel that effectively dissolves and eliminates impurities excess sebum and acne-causing substances leaving skin clean and protected. it provides long lasting sebum secretion control that lasts for hours with deep moisturizing for a s', NULL, NULL, 804, '2022-07-25', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23493, 'Neuth anti-aging reprogramming system 50 ml', 'نيوث لعلاج الشيخوخ والتجاعيد واثار التقدم في السن 50مل', '415', NULL, 'Skin care', NULL, 'Neuth > eva pharma', 'Unknown', 'غير محدد', '50 ml', '1', NULL, 'neuth anti ageing reprogramming system is a complete system that works on all internal causes of skin ageing simultaneously. it also helps your skin protect itself from external factors as well as contains micro reflectors that give you an instant visual', NULL, NULL, 705, '2022-07-15', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23494, 'Neuth dna sun protection lotion spf 50+ - 100 ml', 'نيوث للحماية من الشمس لوشن بمعامل حماية 50 100مل', '285', NULL, 'Sun block', NULL, 'Neuth > eva pharma', 'Lotion', 'لوشن', '100 ml', '1', NULL, 'neuth dna sun protection system is a complete system of protection that provides broad spectrum protection against uva & uvb rays. in addition tit stimulates the skins natural defense mechanisms to counteract any damage. directions apply a generous amount', NULL, NULL, 858, '2022-07-20', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23495, 'Neuth dual express cleansing makeup remover 200 ml', 'نيوث دوال اكسبريس نظام التنظيف مزيل مكياج العيون والشفاه 200 مل', '195', NULL, 'Skin care', NULL, 'Neuth > eva pharma', 'Unknown', 'غير محدد', '200 ml', '1', NULL, 'dual express cleansing system biphasic makeup remover allows optimal and instant removal of persistent waterproof makeup without leaving any traces. fragrance free. directions apply a generous amount of the solution on a cotton pad and use it to remove ma', NULL, NULL, 688, '2022-07-11', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23497, 'Neuth gold anti-wrinkle synergistic system 50 ml', 'نيوث جولد مضاد التجاعيد 50 مل', '548', NULL, 'Skin care', NULL, 'Neuth > eva pharma', 'Unknown', 'غير محدد', '50 ml', '1', NULL, 'micronized 24k gold for the renewal of skin cells and correction of ageing signs. low molecular weight hyaluronic acid penetrates layers of the skin to plump out wrinkles and improve skin hydration and firmness. marine collagen to fight back the look of w', NULL, NULL, 1024, '2022-07-09', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23498, 'Neuth lightening intelligence system day cream spf 15 - 30 ml', 'نيوث لايتينجج كريم لتفتيح البشرة 30مل', '350', NULL, 'Skin care', NULL, 'Neuth > eva pharma', 'Cream', 'كريم', '30 ml', '1', NULL, 'neuth lightening intelligence system is a complete system that inhibits all steps of skin darkening leaving skin even toned. formula does not contain hydroquinone or kojic acid which are proven to be harmful to the skin. formula contains a stable form of', NULL, NULL, 863, '2022-07-15', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23499, 'Neuth lightening intelligence system night cream 30 ml', 'نيوث كريم تفتيح ليلي 30 مل', '330', NULL, 'Skin care', NULL, 'Neuth > eva pharma', 'Cream', 'كريم', '30 ml', '1', NULL, 'neuth lightening intelligence system is a complete system that inhibits all steps of skin darkening leaving skin even toned. formula does not contain hydroquinone or kojic acid which are proven to be harmful to the skin. formula contains a stable form of', NULL, NULL, 1116, '2022-07-09', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23500, 'Neuth purifying cleansing gel system 150 ml', 'نيوث جل 150مل', '175', NULL, 'Skin care', NULL, 'Neuth > eva pharma', 'Gel', 'جل', '150 ml', '1', NULL, 'de-clogs pores dissolves excess oil and makeup traces without stripping the face from essential moisture. directions 1.wash your hands before cleansing your face to eliminate all traces of bacteria and dirt. 2.splash water all over your face squeeze a sma', NULL, NULL, 746, '2022-07-17', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23503, 'Neuth restorative system anti-aging eye cream 18 ml', 'نيوث لعلاج اثار التقدم في السن كريم 18مل', '320', NULL, 'Eye contour', 'Coming soon..', 'Neuth > eva pharma', 'Cream', 'كريم', '18 ml', '1', NULL, NULL, NULL, NULL, 687, '2022-07-12', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23504, 'Neuth restorative system anti-aging hand cream 50 ml', 'نيوث كريم مضاد التجاعيد وعلامات الشيخوخه 50 مل', '295', NULL, 'Skin care', 'Coming soon..', 'Neuth > eva pharma', 'Cream', 'كريم', '50 ml', '1', NULL, NULL, NULL, NULL, 688, '2022-07-07', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23505, 'Neuth sun reflection cream spf 50+ - 50 ml', 'نيوث نظام انعكاس الشمس عامل حماية 50+ 50 مل', '265', NULL, 'Sun block', NULL, 'Neuth > eva pharma', 'Cream', 'كريم', '50 ml', '1', NULL, 'neuth dna sun protection system is a complete system of protection that provides broad spectrum protection against uva & uvb rays. in addition tit stimulates the skins natural defense mechanisms to counteract uv damage. for dry skin. directions apply a ge', NULL, NULL, 804, '2022-07-09', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23506, 'Neutri-soft cream 30 gm', 'نيوتري-سوفت كريم 30 جم', '70', '45', 'Skin care', 'Mineral oil+dexpanthenol+thyme oil+tocopherol(vitamin e)', 'Kato prestige cosmetics > egypharma-egypt', 'Cream', 'كريم', '30 gm', '1', 'ترطيب وتهدئة البشرة -- مضاد للاكسدة -- يساعد علي التئام الجروح', 'mineral oil 10% panthenol 5% tocopherol acetate 0.30% thyme oil 0.50% 1-2 times daily. indications: - dry skin . - eczema (atopic dermatitis) - urticaria - contact dermatitis - nipple fissures', '6224000870249', NULL, 1796, '2023-10-16', 0, 'Mineral oil is not considered an active pharmacological ingredient in pharmaceutical preparations and so has no official indication. It is typically present in topical formulations as an emollient and occlusive agent [T182].', 'Mineral oil sits on the surface of the skin and in spaces between cells and provides a hydrophobic barrier [T182]. This barrier prevents trans-epidermal water loss to trap water in the skin. Overall this leads to greater hydration, flexibility, and softness of the stratum corneum.', 'Mineral oil blocks the loss of water from the skin allowing greater hydration of the epidermis [T182].', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23507, 'Nevanac 1mg/ml eye dps. 5 ml', 'نيفاناك قطرة عين 5 مل', '45', '27.6', 'Nsaid', 'Nepafenac', 'Novartis > novartis scientific office', 'Unknown', 'غير محدد', '1mg', '1', NULL, 'about nepafenac nsaid anti inflammatory eye preparation mechanism of action of nepafenac nepafenac is a prodrug. after penetrating the cornea nepafenac undergoes rapid bioactivation to amfenac which is a potent nsaid that uniformly inhibits the cox1 and c', '7612797416969', NULL, 2507, '2024-08-10', 0, 'For the treatment of pain and inflammation associated with cataract surgery.', 'Nepafenac is a prodrug. After penetrating the cornea, nepafenac undergoes rapid bioactivation to amfenac, which is a potent NSAID that uniformly inhibits the COX1 and COX2 activity.', 'Low but quantifiable plasma concentrations of nepafenac and amfenac were observed in the majority of subjects 2 and 3 hours postdose, respectively, following bilateral topical ocular TID dosing of nepafenac ophthalmic suspension, 0.1%. The mean steady-state Cmax for nepafenac and for amfenac were 0.310 ± 0.104 ng/ml and 0.422 ± 0.121 ng/ml, respectively, following ocular administration.', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23508, 'Neverty 11.5 % topical cream 30 gm', 'نيفيرتي 11.5% كريم 30جم', '150', NULL, 'Hirsutism', 'Eflornithine', 'Al esraa pharmaceutical optima', 'Cream', 'كريم', '11.5 %', '1', NULL, 'used in treatment of facial hirsutism (excessive hair growth) as well as in african trypanosomiasis (sleeping sickness). eflornithine hydrochloride cream for topical application is meant for women suffering from facial hirsutism. eflornithine for injectio', NULL, NULL, 742, '2022-08-01', 0, 'Eflornithine is indicated to reduce the risk of relapse in adult and pediatric patients with high-risk neuroblastoma (HRNB) who have demonstrated at least a partial response to prior multiagent, multimodality therapy including anti-GD2 immunotherapy.[L49288]  It was also previously indicated for the treatment of female hirsutism and African trypanosomiasis but has since been discontinued.[L49318]', 'Eflornithine is an irreversible inhibitor of the enzyme ornithine decarboxylase (ODC), the first and rate-limiting enzyme in the biosynthesis of polyamines and a transcriptional target of MYCN. Polyamines are involved in the differentiation and proliferation of mammalian cells and are important for neoplastic transformation.[L49288] ', 'Inhibition of polyamine synthesis by eflornithine restored the balance of the LIN28/Let-7 metabolic pathway, which is involved in the regulation of cancer stem cells and glycolytic metabolism, by decreasing expression of the oncogenic drivers MYCN and LIN28B in MYCN-amplified neuroblastoma. In vitro, eflornithine induced senescence and suppressed neurosphere formation in MYCN-amplified and MYCN non-amplified neuroblastoma cells, indicating a cytostatic effect. Treatment with eflornithine prevented or delayed tumor formation in mice injected with limiting dilutions of MYCN-amplified neuroblastoma cells.[L49288]



Additionally, polyamines are also involved in keratin synthesis, and inhibition of polyamines can decrease the proliferation of hair matrix cells and thus inhibit the anagen phase of hair production.[A4113]



', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23510, 'Nevilob 5 mg 14 tab', 'نيفيلوب 5مجم 14 قرص', '66', NULL, 'Antihypertensive.beta blocker.selective b1', 'Nebivolol hydrochloride', 'Marcyrl co.', 'Tab', 'أقراص', '5 mg', '2', 'يعالج ارتفاع ضغط الدم', NULL, '6223003579883', NULL, 10847, '2023-05-25', 0, 'Nebivolol is indicated to treat hypertension.[A2762,A182579,L7985,L7988]', 'Nebivolol is a highly selective beta-1 adrenergic receptor antagonist[A182579] with weak beta-2 adrenergic receptor antagonist activity.[A182585] Blocking beta-1 adrenergic receptors by d-nebivolol leads to decreased resting heart rate, exercise heart rate, myocardial contracility, systolic blood pressure, and diastolic blood pressure.[A182603,A182579,A182585,A182615] The selectivity of d-nebivolol limits the magnitude of beta blocker adverse effects in the airways or relating to insulin sensitivity.[A182615] Nebivolol also inhibits aldosterone, and beta-1 antagonism in the juxtaglomerular apparatus also inhibits the release of renin.[A182615] Decreased aldosterone leads to decreased blood volume, and decreased renin leads to reduced vasoconstriction.[A182615] l-nebivolol is responsible for beta-3 adrenergic receptor agonist activity that stimulates endothelial nitric oxide synthase, increasing nitric oxide levels; leading to vasodilation, decreased peripheral vascular resistance, increased stroke volume, ejection fraction, and cardiac output.[A2762,A182603,A182579,A182585,A182615] The vasodilation, reduced oxidative stress, and reduced platelet volume and aggregation of nebivolol may lead to benefits in heart failure patients.[A182603]', 'Nebivolol is a selective beta-1 adrenergic receptor antagonist that decreases vascular resistance, increases stroke volume and cardiac output, and does not negatively affect left ventricular function.[A182579,A182585] It has a long duration of action as effects can be seen 48 hours after stopping the medication and a wide therapeutic window as patients generally take 5-40mg daily.[A182579,L7985] Patients should not abruptly stop taking this medication as this may lead to exacerbation of coronary artery disease.[L7985] Diabetic patients should monitor their blood glucose levels as beta blockers may mask signs of hypoglycemia.[L7985]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23511, 'Nevilob plus 5/12.5 mg 20 tab', 'نيفيلوب بلس 5/12.5مجم 20 قرص', '86', '65', 'Antihypertensive.combined beta blocker with diuretic', 'Nebivolol hydrochloride+hydrochlorothiazide', 'Marcyrl co.', 'Tab', 'أقراص', '12.5 mg', '2', 'علاج ارتفاع ضغط الدم', NULL, '6223003571290', NULL, 11091, '2024-06-13', 0, 'Nebivolol is indicated to treat hypertension.[A2762,A182579,L7985,L7988]', 'Nebivolol is a highly selective beta-1 adrenergic receptor antagonist[A182579] with weak beta-2 adrenergic receptor antagonist activity.[A182585] Blocking beta-1 adrenergic receptors by d-nebivolol leads to decreased resting heart rate, exercise heart rate, myocardial contracility, systolic blood pressure, and diastolic blood pressure.[A182603,A182579,A182585,A182615] The selectivity of d-nebivolol limits the magnitude of beta blocker adverse effects in the airways or relating to insulin sensitivity.[A182615] Nebivolol also inhibits aldosterone, and beta-1 antagonism in the juxtaglomerular apparatus also inhibits the release of renin.[A182615] Decreased aldosterone leads to decreased blood volume, and decreased renin leads to reduced vasoconstriction.[A182615] l-nebivolol is responsible for beta-3 adrenergic receptor agonist activity that stimulates endothelial nitric oxide synthase, increasing nitric oxide levels; leading to vasodilation, decreased peripheral vascular resistance, increased stroke volume, ejection fraction, and cardiac output.[A2762,A182603,A182579,A182585,A182615] The vasodilation, reduced oxidative stress, and reduced platelet volume and aggregation of nebivolol may lead to benefits in heart failure patients.[A182603]', 'Nebivolol is a selective beta-1 adrenergic receptor antagonist that decreases vascular resistance, increases stroke volume and cardiac output, and does not negatively affect left ventricular function.[A182579,A182585] It has a long duration of action as effects can be seen 48 hours after stopping the medication and a wide therapeutic window as patients generally take 5-40mg daily.[A182579,L7985] Patients should not abruptly stop taking this medication as this may lead to exacerbation of coronary artery disease.[L7985] Diabetic patients should monitor their blood glucose levels as beta blockers may mask signs of hypoglycemia.[L7985]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23512, 'Nevilob plus 5/25 mg 20 tab', 'نيفيلوب بلس 5/25مجم 20 قرص', '92', '70', 'Antihypertensive.combined beta blocker with diuretic', 'Nebivolol hydrochloride+hydrochlorothiazide', 'Marcyrl co.', 'Tab', 'أقراص', '25 mg', '2', NULL, NULL, '6223003571306', NULL, 2581, '2024-12-07', 0, 'Nebivolol is indicated to treat hypertension.[A2762,A182579,L7985,L7988]', 'Nebivolol is a highly selective beta-1 adrenergic receptor antagonist[A182579] with weak beta-2 adrenergic receptor antagonist activity.[A182585] Blocking beta-1 adrenergic receptors by d-nebivolol leads to decreased resting heart rate, exercise heart rate, myocardial contracility, systolic blood pressure, and diastolic blood pressure.[A182603,A182579,A182585,A182615] The selectivity of d-nebivolol limits the magnitude of beta blocker adverse effects in the airways or relating to insulin sensitivity.[A182615] Nebivolol also inhibits aldosterone, and beta-1 antagonism in the juxtaglomerular apparatus also inhibits the release of renin.[A182615] Decreased aldosterone leads to decreased blood volume, and decreased renin leads to reduced vasoconstriction.[A182615] l-nebivolol is responsible for beta-3 adrenergic receptor agonist activity that stimulates endothelial nitric oxide synthase, increasing nitric oxide levels; leading to vasodilation, decreased peripheral vascular resistance, increased stroke volume, ejection fraction, and cardiac output.[A2762,A182603,A182579,A182585,A182615] The vasodilation, reduced oxidative stress, and reduced platelet volume and aggregation of nebivolol may lead to benefits in heart failure patients.[A182603]', 'Nebivolol is a selective beta-1 adrenergic receptor antagonist that decreases vascular resistance, increases stroke volume and cardiac output, and does not negatively affect left ventricular function.[A182579,A182585] It has a long duration of action as effects can be seen 48 hours after stopping the medication and a wide therapeutic window as patients generally take 5-40mg daily.[A182579,L7985] Patients should not abruptly stop taking this medication as this may lead to exacerbation of coronary artery disease.[L7985] Diabetic patients should monitor their blood glucose levels as beta blockers may mask signs of hypoglycemia.[L7985]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23513, 'Nevxal 0.1% eye dpops 5 ml', 'نيفكسال 0.1% قطرة عين 5 مل', '26', '18.6', 'Nsaid', 'Nepafenac', 'Orchidia pharmaceutical industries', 'Unknown', 'غير محدد', '0.1%', '1', 'قطرة عين مسكنة للآلام', NULL, '6224000219666', NULL, 2377, '2024-01-02', 0, 'For the treatment of pain and inflammation associated with cataract surgery.', 'Nepafenac is a prodrug. After penetrating the cornea, nepafenac undergoes rapid bioactivation to amfenac, which is a potent NSAID that uniformly inhibits the COX1 and COX2 activity.', 'Low but quantifiable plasma concentrations of nepafenac and amfenac were observed in the majority of subjects 2 and 3 hours postdose, respectively, following bilateral topical ocular TID dosing of nepafenac ophthalmic suspension, 0.1%. The mean steady-state Cmax for nepafenac and for amfenac were 0.310 ± 0.104 ng/ml and 0.422 ± 0.121 ng/ml, respectively, following ocular administration.', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23514, 'New akim hair oil 120 ml', 'نيو اكيم زيت للشعر 120مل', '100', '60', 'Hair care', 'Tea tree oil+lavender oil+rosemary oil+thyme oil+olive oil+vitamin e', 'Hi-care > prima pharm', 'Hair oil', 'زيت شعر', '120 ml', '1', NULL, 'safe formula that strengthens and activates hair follicles.', '6224008966289', NULL, 905, '2025-08-23', 0, 'Indicated for topical use to help protect against infection in minor cuts, scrapes, and burns. No FDA-approved therapeutic indications.', 'The components of tea tree oil, particularly terpinen-4-ol and α-terpineol, mediate antimicrobial actions by disrupting the structural and functional integrity of bacterial membrane. Hydrocarbons are capable of partitioning into the cell and cytoplasmic membrane of microorganisms and disrupt their vital functions, which may result in leakage of ions such as potassium, and the inhibition of respiration [A32439]. Eventually, cell lysis may occur due to weakening of the cell wall, and loss of turgor pressure and subsequent rupture of the cytoplasmic membrane [A32441]. The loss of 260-nm-absorbing material may be indicative of a damaged cytoplasmic membrane and loss of nucleic acids [A32441]. In _E. coli_, perturbed potassium homeostasis, glucose-dependent respiration, cell morphology, and ability to exclude propidium iodide was observed. 



Tea tree oil also mediates its antifungal actions in a similar way, where it alters the permeability of Candida albicans and inhibits its respiration in a dose-dependent manner [A32439]. Plasma and mitochondrial membranes of fungal species are also thought to be negatively affected by inhibition of glucose-induced medium acidification by tea tree oil, which involves inhibition of membrane ATPase responsible for the expulsion of protons [A32439]. Tea tree oil also inhibits the formation of germ tubes, or mycelial conversion, in _C. albicans_, thereby disrupting cell morphogenesis [A32439]. Water-soluble fraction of TTO, terpinen-4-ol, and α-terpineol, can inhibit the lipopolysaccharide-induced production of the inflammatory mediators such as TNF-α, IL-1β and IL-10 by human peripheral monocytes by approximately 50% and that of prostaglandin E2 by about 30% after 40 h [A32439]. These components of tea tree oil may also suppress superoxide production by agonist-stimulated monocytes and decrease the production of reactive oxygen species by both stimulated neutrophils and monocytes [A32439].', 'Tea tree oil exhibits antibacterial, antifungal, antiviral, and antiprotozoal activities [A32439]. It mostly mediates bactericidal actions at concentrations of 1.0% or less in most bacteria such as _Staphylococcus aureus_ and _Escherichia coli_, and causes bacteriostatic effects at lower concentrations [A32439]. Organisms such as commensal skin staphylococci and micrococci, _Enterococcus faecalis_, and Pseudomonas aeruginosa_emphasized text_ were susceptible to tea tree oil concentrations of 2% [A32439]. It is proposed that water-soluble components of tea tree oil are capable in inducing anti-inflammatory actions; terpinen-4-ol attenuates the vasodilation and plasma extravasation associated with histamine-induced inflammation in humans [A32438].', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23515, 'New akim hair oil 60ml', 'نيو اكيم زيت للشعر 60مل', '80', '65', 'Hair care', 'Tea tree oil+lavender oil+rosemary oil+thyme oil+olive oil+vitamin e', 'Hi-care > prima pharm', 'Hair oil', 'زيت شعر', '60ml', '1', NULL, 'safe formula that strengthens and activates hair follicles.', '6224008966289', NULL, 1317, '2025-06-29', 0, 'Indicated for topical use to help protect against infection in minor cuts, scrapes, and burns. No FDA-approved therapeutic indications.', 'The components of tea tree oil, particularly terpinen-4-ol and α-terpineol, mediate antimicrobial actions by disrupting the structural and functional integrity of bacterial membrane. Hydrocarbons are capable of partitioning into the cell and cytoplasmic membrane of microorganisms and disrupt their vital functions, which may result in leakage of ions such as potassium, and the inhibition of respiration [A32439]. Eventually, cell lysis may occur due to weakening of the cell wall, and loss of turgor pressure and subsequent rupture of the cytoplasmic membrane [A32441]. The loss of 260-nm-absorbing material may be indicative of a damaged cytoplasmic membrane and loss of nucleic acids [A32441]. In _E. coli_, perturbed potassium homeostasis, glucose-dependent respiration, cell morphology, and ability to exclude propidium iodide was observed. 



Tea tree oil also mediates its antifungal actions in a similar way, where it alters the permeability of Candida albicans and inhibits its respiration in a dose-dependent manner [A32439]. Plasma and mitochondrial membranes of fungal species are also thought to be negatively affected by inhibition of glucose-induced medium acidification by tea tree oil, which involves inhibition of membrane ATPase responsible for the expulsion of protons [A32439]. Tea tree oil also inhibits the formation of germ tubes, or mycelial conversion, in _C. albicans_, thereby disrupting cell morphogenesis [A32439]. Water-soluble fraction of TTO, terpinen-4-ol, and α-terpineol, can inhibit the lipopolysaccharide-induced production of the inflammatory mediators such as TNF-α, IL-1β and IL-10 by human peripheral monocytes by approximately 50% and that of prostaglandin E2 by about 30% after 40 h [A32439]. These components of tea tree oil may also suppress superoxide production by agonist-stimulated monocytes and decrease the production of reactive oxygen species by both stimulated neutrophils and monocytes [A32439].', 'Tea tree oil exhibits antibacterial, antifungal, antiviral, and antiprotozoal activities [A32439]. It mostly mediates bactericidal actions at concentrations of 1.0% or less in most bacteria such as _Staphylococcus aureus_ and _Escherichia coli_, and causes bacteriostatic effects at lower concentrations [A32439]. Organisms such as commensal skin staphylococci and micrococci, _Enterococcus faecalis_, and Pseudomonas aeruginosa_emphasized text_ were susceptible to tea tree oil concentrations of 2% [A32439]. It is proposed that water-soluble components of tea tree oil are capable in inducing anti-inflammatory actions; terpinen-4-ol attenuates the vasodilation and plasma extravasation associated with histamine-induced inflammation in humans [A32438].', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23516, 'New cleanse vag.douche 120 ml', 'نيو كلينز دوش مهبلي 120مل', '22', NULL, 'Vaginal wash', 'Chlorohexidine+triclosan+sodium lauryl sulphate', 'Tagamo3 saidaly (taj)', 'Unknown', 'غير محدد', '120 ml', '1', NULL, 'by drug eye team', NULL, NULL, 702, '2022-07-18', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23517, 'New cleanse vag.douche 250 ml', 'نيو كلينز دوش مهبلي 250مل', '30', NULL, 'Vaginal wash', 'Chlorohexidine+triclosan+sodium lauryl sulphate', 'Tagamo3 saidaly (taj)', 'Unknown', 'غير محدد', '250 ml', '1', NULL, NULL, NULL, NULL, 906, '2022-07-11', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23518, 'New ecavit b12 1mg/2ml 6 amp. i.m', 'نيو ايكافيت ب12 - 6 امبولات عضل', '20', NULL, 'Vitamin b', 'Hydroxocobalamin', 'El nile.', 'Amp', 'أمبول', '1mg', '6', 'حالات نقص فيتامين ب -- مصدر للطاقة -- مقوي للاعصاب -- آلام العمود الفقري.', 'description injectable form of vitamin b 12 that has been used therapeutically to treat vitamin b 12 deficiency. mechanism of action vitamin b12 exists in four major forms referred to collectively as cobalamins- deoxyadenosylcobalamin methylcobalamin hydr', NULL, NULL, 10499, '2022-08-04', 0, 'For treatment of pernicious anemia and the prevention and treatment of vitamin B12 deficiency arising from alcoholism, malabsorption, tapeworm infestation, celiac, hyperthyroidism, hepatic-biliary tract disease, persistent diarrhea, ileal resection, pancreatic cancer, renal disease, prolonged stress, vegan diets, macrobiotic diets or other restrictive diets. Also for the treatment of known or suspected cyanide poisoning.', 'Vitamin B12 exists in four major forms referred to collectively as cobalamins; deoxyadenosylcobalamin, methylcobalamin, hydroxocobalamin, and cyanocobalamin. Two of these, methylcobalamin and 5-deoxyadenosyl cobalamin, are primarily used by the body. Methionine synthase needs methylcobalamin as a cofactor. This enzyme is involved in the conversion of the amino acid homocysteine into methionine. Methionine in turn is required for DNA methylation. 5-Deoxyadenosyl cobalamin is a cofactor needed by the enzyme that converts L-methylmalonyl-CoA to succinyl-CoA. This conversion is an important step in the extraction of energy from proteins and fats. Furthermore, succinyl CoA is necessary for the production of hemoglobin, the substances that carries oxygen in red blood cells.', 'Hydroxocobalamin is a synthetic, injectable form of Vitamin B12. Hydroxocobalamin is actually a precursor of two cofactors or vitamins (Vitamin B12 and Methylcobalamin) which are involved in various biological systems in man. Vitamin B12 is required for the conversion of methylmalonate to succinate. Deficiency of this enzyme could therefore interfere with the production of lipoprotein in myelin sheath tissue and so give rise to neurological lesions. The second cofactor, Methylcobalamin, is necessary for the conversion of homocysteine to methionine which is essential for the metabolism of folic acid. Deficiency of tetrahydrafolate leads to reduced synthesis of thymidylate resulting in reduced synthesis of DNA which is essential for cell maturation. Vitamin B12 is also concerned in the maintenance of sulphydryl groups in reduced form, deficiency leading to decreased amounts of reduced SH content of erythrocytes and liver cells. Overall, vitamin B12 acts as a coenzyme for various metabolic functions, including fat and carbohydrate metabolism and protein synthesis. It is necessary for growth, cell replication, hematopoiesis, and nucleoprotein as well as myelin synthesis. This is largely due to its effects on metabolism of methionine folic acid, and malonic acid.', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23519, 'New gel+ clear (ng-301s) silicone strips 4pcs', 'نيو جل + كلير شرائط سليكون 4 قطع', '1,550', '1490', 'Scar therapy', 'Medical grade polymerized siloxanes (silicone gel)+clear polyurethane backing', 'New medical technology > pharma cruise medical', 'Gel', 'جل', NULL, '1', NULL, 'silicone gel sheeting (2.5 x 15.2 cm) for scar management .. clinically proven to help fade flatten & soften scars .. self-adhesive and reusable', NULL, NULL, 1156, '2024-07-12', 0, 'For use as a source of clean air [FDA Label].', 'Air is approximately 21% oxygen which enters the body through the lungs, crossing the alveolar membrane to reach systemic circulation [T36]. One there it is bound by hemoglobin and transported to tissues thoughout the body where it is used as a terminal electron acceptor in oxidative phosphorylation. This allows efficient generation of adenosine triphosphate, the primary storage molecule for energy, in the mitochondria.', 'Acts as a source of clean air to support respiration [FDA Label].', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23520, 'New gel+ e (ngo-800) silicone gel 15 gm', 'نيو جل + اي سليكون 15 جم', '900', NULL, 'Scar therapy', 'Polymerized siloxanes (silicone gel)+tocopherol (vitamin e)', 'New medical technology > pharma cruise medical', 'Gel', 'جل', '15 gm', '1', 'علاج اثار العمليات الجراحية -- علاج اثار الحروق -- علاج الندبات', 'advanced gel for scars: reduces and fades old & new scars', NULL, NULL, 1717, '2022-08-18', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23521, 'New gel+ e (ngo-810) silicone gel 30 gm', 'نيو جل + اي جل سيليكون جل 30جم', '1,480', NULL, 'Scar therapy', 'Polymerized siloxanes (silicone gel)+tocopherol (vitamin e)', 'New medical technology > pharma cruise medical', 'Gel', 'جل', '30 gm', '1', NULL, 'advanced gel for scars: reduces and fades old & new scars', NULL, NULL, 2211, '2022-12-30', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23523, 'New hair shampoo 150 ml', 'نيو هير شامبو 150 مل', '120', NULL, 'Hair care', NULL, 'Debeiky', 'Amp', 'أمبول', '150 ml', '1', NULL, NULL, NULL, NULL, 646, '2022-08-16', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23524, 'New hair solution 150 ml', 'نيو هير سوليوشن 150 مل', '230', NULL, 'Hair care', NULL, 'Debeiky', 'Solution', 'محلول', '150 ml', '1', 'منتج للعناية بالشعر', NULL, NULL, NULL, 1139, '2022-08-16', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23525, 'New jolly hair oil 120 ml', 'نيو جولي زيت شعر 120 مل', '110', '90', 'Hair care', 'Olive oil+chamomile oil+coconut oil+sage oil+snake oil', 'Hi-care > top.z pharma', 'Hair oil', 'زيت شعر', '120 ml', '1', NULL, 'hair tonic oil - nourishes hair follicles. ** application: suitable amount to be rubbed on scalp & hair for 2-3 minutes once daily. also can make oil bath after washing hair twice weekly. continue treatment for 3-6 months.', '6225000029149', NULL, 3934, '2024-06-21', 0, 'In a clinical context, olive oil is used as a source of calories and fatty acids in patients requiring parenteral nutrition. A formulation called Clinolipid, comprising olive oil and [soybean oil], is indicated in all age groups, including term and preterm neonates, as a source of calories and essential fatty acids for parenteral nutrition (PN) when oral or enteral nutrition is not possible, insufficient, or contraindicated.[L51013]', 'Fatty acids act as a substrate in energy production through beta-oxidation as well as important components of cell membrane structures and prescursors for bioactive molecules like prostaglandins.', 'Provides a source of calories and fatty acids.[L51013]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23526, 'New sorbilax 5 gm 20 sachets', 'نيو سوربيلاكس 5مجم 20 كيس', '50', NULL, 'Laxative', 'Sorbitol', 'Nutrixia > trustmar pharma', 'Sachet', 'أكياس', '5 gm', '1', NULL, 'about sorbitol a sugar alcohol sweetener non-stimulant laxative osmotic diuretic genitourinary irrigant. mechanism of action of sorbitol sorbitol is hydrolysed in the colon to short chain fatty acids. this fatty acid stimulates colonic propulsive motility', NULL, NULL, 1032, '2022-07-07', 0, 'Used as a non-stimulant laxative via an oral suspension or enema.', 'Sorbitol exerts its laxative effect by drawing water into the large intestine, thereby stimulating bowel movements.', NULL, 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23527, 'New stracyl 20 sachets', 'نيو ستراسيل 20 كيس', '45', NULL, 'Weight loss', 'Psyllium husks powder+glucose (dextrose)+carboxy methyl cellulose+sucralose+orange flavour', 'Nutrixia > trustmar pharma', 'Sachet', 'أكياس', NULL, '1', NULL, 'soluble fibre that is used in weight loss', NULL, NULL, 1826, '2022-07-28', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23528, 'New tiger porous plaster', 'نيو تايجر بوروس بلاستر', '20', '17', 'Analgesic.antirheumatic', 'Arnica tincture+belladonna tincture+capsicum extract', 'Alexandria', 'Unknown', 'غير محدد', NULL, '1', NULL, 'belladonna is a plant. the leaf and root are used to make medicine. belladonna is used as a sedative to stop bronchial spasms in asthma and whooping cough and as a cold and hay fever remedy. it is also used for parkinson s disease colic motion sickness an', NULL, NULL, 1055, '2025-08-23', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23529, 'New tonoscalpine scalp lotion 190 ml', 'نيو تونوسكالبين لوشن 190 مل', '22', NULL, 'Hair care', 'Cantharides+pilocarpine+quinine+salicylic acid', 'El nile.', 'Lotion', 'لوشن', '190 ml', '1', NULL, NULL, NULL, NULL, 3137, '2023-04-27', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23530, 'New vitall 10 caps.', 'نيو فيتال 10 كبسول', '37', NULL, 'Multivitamins', 'Ginseng+royal jelly+wheat germ oil+dried garlic powder+lecithin', 'Arab caps > ibn sina', 'Cap', 'كبسولة', NULL, '1', NULL, NULL, NULL, NULL, 763, '2022-08-03', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23532, 'Newcid 1% 60ml shampoo', 'نيوسيد 1% 60ملي شامبو', '9', NULL, 'Scabicide', 'Permethrin', 'Cid', 'Amp', 'أمبول', '1%', '1', NULL, 'about permethrin synthetic pyrethroid antiparasitic pediculicide scabicide. mechanism of action of permethrin permethrin exerts its action by inhibiting sodium ion channel and delays depolarization. this will leads to (neuronal) paralysis of insects. perm', NULL, NULL, 866, '2022-08-01', 0, 'For the treatment of infestation with <i>Sarcoptes scabiei</i> (scabies).', 'Permethrin acts on the nerve cell membrane to disrupt the sodium channel current by which the polarization of the membrane is regulated. Delayed repolarization and paralysis of the pests are the consequences of this disturbance.', 'Permethrin, a pyrethroid, is active against a broad range of pests including lice, ticks, fleas, mites, and other arthropods.', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23534, 'New-clav 1gm 10 disp. tabs', 'نيو-كلاف 1جم 10 اقراص', '57', NULL, 'Penicillins.penicillin with b-lactamase inhibitor', 'Amoxicillin+clavulanic acid', 'Sigma tec > andalous pharma', 'Tab', 'أقراص', '1gm', '1', NULL, NULL, '6223004691195', NULL, 2291, '2023-04-15', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23536, 'New-clav extra strength 642.9mg/5ml susp. 100ml', 'نيو-كلاف اكسترا 642.9مجم/5مل معلق 100 مل', '132', '92', 'Penicillins.penicillin with b-lactamase inhibitor', 'Amoxicillin+clavulanic acid', 'Sigma tec > andalous pharma', 'Susp', 'معلق', '642.9mg', '1', NULL, 'amoxicillin is an analog of ampicillin derived from the basic penicillin nucleus 6-aminopenicillanic acid clavulanic acid is produced by the fermentation of streptomyces clavuligerus. it is a beta-lactam structurally related to the penicillins and possess', '6224000396404', NULL, 1103, '2024-07-13', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23537, 'New-flotan inhaled anaesthetic liquid 100 ml', 'نيو-فلوتان سائل استنشاق 100 مل', '140', NULL, 'General anaesthesia', 'Halothane', 'Kahira', 'Unknown', 'غير محدد', '100 ml', '1', NULL, NULL, '6221068905630', NULL, 737, '2022-12-07', 0, 'For the induction and maintenance of general anesthesia', 'Halothane causes general anaethesia due to its actions on multiple ion channels, which ultimately depresses nerve conduction, breathing, cardiac contractility. Its immobilizing effects have been attributed to its binding to potassium channels in cholinergic neurons. Halothane''s effect are also likely due to binding to NMDA and calcium channels, causing hyperpolarization.', 'Halothane is a general inhalation anesthetic used for induction and maintenance of general anesthesia. It reduces the blood pressure and frequently decreases the pulse rate and depresses respiration. It induces muscle relaxation and reduces pains sensitivity by altering tissue excitability. It does so by decreasing the extent of gap junction mediated cell-cell coupling and altering the activity of the channels that underlie the action potential.', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23538, 'Newpix hair lotion 120 ml', 'نيوبيكس لوشن للشعر 120 مل', '149', NULL, 'Hair care', NULL, 'Egyptian company for cosmetics > compete pharm', 'Lotion', 'لوشن', '120 ml', '1', NULL, 'hair moisturizer', NULL, NULL, 468, '2022-08-05', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23540, 'Nexicure 20 mg 14 f.c.tabs.', 'نيكسيكيور 20مجم 14 قرص', '64', '60', 'Peptic ulcer.proton pump inhibitor', 'Esomeprazole', 'Atco pharma > zeta pharm', 'Tab', 'أقراص', '20 mg', '2', 'يستخدم في علاج عسر الهضم والتهاب المريء والحموضة المعوية والقضاء على بكتيريا هيليكوباكتر بيلوري (جرثومة المعدة) ومرض القرحة المعدية ومرض الارتجاع المعدي المريئي', 'about esomeprazole a proton pump inhibitor substituted benzimidazole antiulcer antisecretory drug. mechanism of action of esomeprazole esomeprazole is the s enantiomer of omeprazole and is a proton pump inhibitor. it is a prodrug. after administration it', '6223015000139', NULL, 9272, '2024-09-16', 0, 'Esomeprazole is indicated for the treatment of acid-reflux disorders including healing and maintenance of erosive esophagitis, and symptomatic gastroesophageal reflux disease (GERD), peptic ulcer disease, H. pylori eradication, prevention of gastrointestinal bleeds with NSAID use, and for the long-term treatment of pathological hypersecretory conditions including Zollinger-Ellison Syndrome. ', 'Esomeprazole exerts its stomach acid-suppressing effects by preventing the final step in gastric acid production by covalently binding to sulfhydryl groups of cysteines found on the (H+, K+)-ATPase enzyme at the secretory surface of gastric parietal cells. This effect leads to inhibition of both basal and stimulated gastric acid secretion, irrespective of the stimulus. As the binding of esomeprazole to the (H+, K+)-ATPase enzyme is irreversible and new enzyme needs to be expressed in order to resume acid secretion, esomeprazole''s duration of antisecretory effect that persists longer than 24 hours.[FDA Label]

', 'Esomeprazole is a compound that inhibits gastric acid secretion and is indicated in the treatment of gastroesophageal reflux disease (GERD), the healing of erosive esophagitis, and <i>H. pylori</i> eradication to reduce the risk of duodenal ulcer recurrence. Esomeprazole belongs to a new class of antisecretory compounds, the substituted benzimidazoles, that do not exhibit anticholinergic or H2 histamine antagonistic properties, but that suppress gastric acid secretion by specific inhibition of the H<sup>+</sup>/K<sup>+</sup> ATPase at the secretory surface of the gastric parietal cell. By doing so, it inhibits acid secretion into the gsatric lumen. This effect is dose-related and leads to inhibition of both basal and stimulated acid secretion irrespective of the stimulus.



Esomeprazole is the s-isomer of [DB00338], which is a racemate of the S- and R-enantiomer. Esomeprazole has been shown to inhibit acid secretion to a similar extent as [DB00338], without any significant differences between the two compounds _in vitro_. 



PPIs such as esomeprazole have also been shown to inhibit the activity of dimethylarginine dimethylaminohydrolase (DDAH), an enzyme necessary for cardiovascular health. DDAH inhibition causes a consequent accumulation of the nitric oxide synthase inhibitor asymmetric dimethylarginie (ADMA), which is thought to cause the association of PPIs with increased risk of cardiovascular events in patients with unstable coronary syndromes.[A177577, A177580]



Due to their good safety profile and as several PPIs are available over the counter without a prescription, their current use in North America is widespread. Long term use of PPIs such as esomeprazole has been associated with possible adverse effects, however, including increased susceptibility to bacterial infections (including gastrointestinal _C. difficile_), reduced absorption of micronutrients including iron and B12, and an increased risk of developing hypomagnesemia and hypocalcemia which may contribute to osteoporosis and bone fractures later in life.[A177571]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23541, 'Nexicure 40 mg 20 f.c. tablets', 'نيكسيكيور 40 مجم 20 قرص', '152', '103', 'Peptic ulcer.proton pump inhibitor', 'Esomeprazole', 'Atco pharma > zeta pharm', 'Tablet', 'أقراص', '40 mg', '2', 'قرحة المعدة والحموضة', NULL, '6224008407041', NULL, 31888, '2024-07-12', 0, 'Esomeprazole is indicated for the treatment of acid-reflux disorders including healing and maintenance of erosive esophagitis, and symptomatic gastroesophageal reflux disease (GERD), peptic ulcer disease, H. pylori eradication, prevention of gastrointestinal bleeds with NSAID use, and for the long-term treatment of pathological hypersecretory conditions including Zollinger-Ellison Syndrome. ', 'Esomeprazole exerts its stomach acid-suppressing effects by preventing the final step in gastric acid production by covalently binding to sulfhydryl groups of cysteines found on the (H+, K+)-ATPase enzyme at the secretory surface of gastric parietal cells. This effect leads to inhibition of both basal and stimulated gastric acid secretion, irrespective of the stimulus. As the binding of esomeprazole to the (H+, K+)-ATPase enzyme is irreversible and new enzyme needs to be expressed in order to resume acid secretion, esomeprazole''s duration of antisecretory effect that persists longer than 24 hours.[FDA Label]

', 'Esomeprazole is a compound that inhibits gastric acid secretion and is indicated in the treatment of gastroesophageal reflux disease (GERD), the healing of erosive esophagitis, and <i>H. pylori</i> eradication to reduce the risk of duodenal ulcer recurrence. Esomeprazole belongs to a new class of antisecretory compounds, the substituted benzimidazoles, that do not exhibit anticholinergic or H2 histamine antagonistic properties, but that suppress gastric acid secretion by specific inhibition of the H<sup>+</sup>/K<sup>+</sup> ATPase at the secretory surface of the gastric parietal cell. By doing so, it inhibits acid secretion into the gsatric lumen. This effect is dose-related and leads to inhibition of both basal and stimulated acid secretion irrespective of the stimulus.



Esomeprazole is the s-isomer of [DB00338], which is a racemate of the S- and R-enantiomer. Esomeprazole has been shown to inhibit acid secretion to a similar extent as [DB00338], without any significant differences between the two compounds _in vitro_. 



PPIs such as esomeprazole have also been shown to inhibit the activity of dimethylarginine dimethylaminohydrolase (DDAH), an enzyme necessary for cardiovascular health. DDAH inhibition causes a consequent accumulation of the nitric oxide synthase inhibitor asymmetric dimethylarginie (ADMA), which is thought to cause the association of PPIs with increased risk of cardiovascular events in patients with unstable coronary syndromes.[A177577, A177580]



Due to their good safety profile and as several PPIs are available over the counter without a prescription, their current use in North America is widespread. Long term use of PPIs such as esomeprazole has been associated with possible adverse effects, however, including increased susceptibility to bacterial infections (including gastrointestinal _C. difficile_), reduced absorption of micronutrients including iron and B12, and an increased risk of developing hypomagnesemia and hypocalcemia which may contribute to osteoporosis and bone fractures later in life.[A177571]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23543, 'Neximash 40 mg 28 caps.', 'نيكسيماش 40مجم 28 كبسولة', '220', '148', 'Peptic ulcer.proton pump inhibitor', 'Esomeprazole', 'Mash premiere', 'Cap', 'كبسولة', '40 mg', '4', NULL, 'about esomeprazole a proton pump inhibitor substituted benzimidazole antiulcer antisecretory drug. mechanism of action of esomeprazole esomeprazole is the s enantiomer of omeprazole and is a proton pump inhibitor. it is a prodrug. after administration it', '6222001407662', NULL, 2533, '2024-07-07', 0, 'Esomeprazole is indicated for the treatment of acid-reflux disorders including healing and maintenance of erosive esophagitis, and symptomatic gastroesophageal reflux disease (GERD), peptic ulcer disease, H. pylori eradication, prevention of gastrointestinal bleeds with NSAID use, and for the long-term treatment of pathological hypersecretory conditions including Zollinger-Ellison Syndrome. ', 'Esomeprazole exerts its stomach acid-suppressing effects by preventing the final step in gastric acid production by covalently binding to sulfhydryl groups of cysteines found on the (H+, K+)-ATPase enzyme at the secretory surface of gastric parietal cells. This effect leads to inhibition of both basal and stimulated gastric acid secretion, irrespective of the stimulus. As the binding of esomeprazole to the (H+, K+)-ATPase enzyme is irreversible and new enzyme needs to be expressed in order to resume acid secretion, esomeprazole''s duration of antisecretory effect that persists longer than 24 hours.[FDA Label]

', 'Esomeprazole is a compound that inhibits gastric acid secretion and is indicated in the treatment of gastroesophageal reflux disease (GERD), the healing of erosive esophagitis, and <i>H. pylori</i> eradication to reduce the risk of duodenal ulcer recurrence. Esomeprazole belongs to a new class of antisecretory compounds, the substituted benzimidazoles, that do not exhibit anticholinergic or H2 histamine antagonistic properties, but that suppress gastric acid secretion by specific inhibition of the H<sup>+</sup>/K<sup>+</sup> ATPase at the secretory surface of the gastric parietal cell. By doing so, it inhibits acid secretion into the gsatric lumen. This effect is dose-related and leads to inhibition of both basal and stimulated acid secretion irrespective of the stimulus.



Esomeprazole is the s-isomer of [DB00338], which is a racemate of the S- and R-enantiomer. Esomeprazole has been shown to inhibit acid secretion to a similar extent as [DB00338], without any significant differences between the two compounds _in vitro_. 



PPIs such as esomeprazole have also been shown to inhibit the activity of dimethylarginine dimethylaminohydrolase (DDAH), an enzyme necessary for cardiovascular health. DDAH inhibition causes a consequent accumulation of the nitric oxide synthase inhibitor asymmetric dimethylarginie (ADMA), which is thought to cause the association of PPIs with increased risk of cardiovascular events in patients with unstable coronary syndromes.[A177577, A177580]



Due to their good safety profile and as several PPIs are available over the counter without a prescription, their current use in North America is widespread. Long term use of PPIs such as esomeprazole has been associated with possible adverse effects, however, including increased susceptibility to bacterial infections (including gastrointestinal _C. difficile_), reduced absorption of micronutrients including iron and B12, and an increased risk of developing hypomagnesemia and hypocalcemia which may contribute to osteoporosis and bone fractures later in life.[A177571]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23544, 'Neximerican 20 mg 21 caps.', 'نيكسيمريكان 20مجم 21 كبسولة', '78', NULL, 'Peptic ulcer.proton pump inhibitor', 'Esomeprazole', 'Medizen pharmaceutical industries > paxal pharmaceutical', 'Cap', 'كبسولة', '20 mg', '3', 'علاج إرتجاع المريء: ارتداد الحمض من المعدة إلى المريء والذي قد يلتهب ويؤلم. قد يسبب لك ذلك أعراض مثل الإحساس بالألم في الصدر الذي يصل إلى الحلق وطعم لاذع في الفم.', 'about esomeprazole a proton pump inhibitor substituted benzimidazole antiulcer antisecretory drug. mechanism of action of esomeprazole esomeprazole is the s enantiomer of omeprazole and is a proton pump inhibitor. it is a prodrug. after administration it', NULL, NULL, 1128, '2022-07-07', 0, 'Esomeprazole is indicated for the treatment of acid-reflux disorders including healing and maintenance of erosive esophagitis, and symptomatic gastroesophageal reflux disease (GERD), peptic ulcer disease, H. pylori eradication, prevention of gastrointestinal bleeds with NSAID use, and for the long-term treatment of pathological hypersecretory conditions including Zollinger-Ellison Syndrome. ', 'Esomeprazole exerts its stomach acid-suppressing effects by preventing the final step in gastric acid production by covalently binding to sulfhydryl groups of cysteines found on the (H+, K+)-ATPase enzyme at the secretory surface of gastric parietal cells. This effect leads to inhibition of both basal and stimulated gastric acid secretion, irrespective of the stimulus. As the binding of esomeprazole to the (H+, K+)-ATPase enzyme is irreversible and new enzyme needs to be expressed in order to resume acid secretion, esomeprazole''s duration of antisecretory effect that persists longer than 24 hours.[FDA Label]

', 'Esomeprazole is a compound that inhibits gastric acid secretion and is indicated in the treatment of gastroesophageal reflux disease (GERD), the healing of erosive esophagitis, and <i>H. pylori</i> eradication to reduce the risk of duodenal ulcer recurrence. Esomeprazole belongs to a new class of antisecretory compounds, the substituted benzimidazoles, that do not exhibit anticholinergic or H2 histamine antagonistic properties, but that suppress gastric acid secretion by specific inhibition of the H<sup>+</sup>/K<sup>+</sup> ATPase at the secretory surface of the gastric parietal cell. By doing so, it inhibits acid secretion into the gsatric lumen. This effect is dose-related and leads to inhibition of both basal and stimulated acid secretion irrespective of the stimulus.



Esomeprazole is the s-isomer of [DB00338], which is a racemate of the S- and R-enantiomer. Esomeprazole has been shown to inhibit acid secretion to a similar extent as [DB00338], without any significant differences between the two compounds _in vitro_. 



PPIs such as esomeprazole have also been shown to inhibit the activity of dimethylarginine dimethylaminohydrolase (DDAH), an enzyme necessary for cardiovascular health. DDAH inhibition causes a consequent accumulation of the nitric oxide synthase inhibitor asymmetric dimethylarginie (ADMA), which is thought to cause the association of PPIs with increased risk of cardiovascular events in patients with unstable coronary syndromes.[A177577, A177580]



Due to their good safety profile and as several PPIs are available over the counter without a prescription, their current use in North America is widespread. Long term use of PPIs such as esomeprazole has been associated with possible adverse effects, however, including increased susceptibility to bacterial infections (including gastrointestinal _C. difficile_), reduced absorption of micronutrients including iron and B12, and an increased risk of developing hypomagnesemia and hypocalcemia which may contribute to osteoporosis and bone fractures later in life.[A177571]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23545, 'Neximerican 40 mg 21 caps.', 'نيكسيمريكان 40مجم 21 كبسولة', '79', NULL, 'Peptic ulcer.proton pump inhibitor', 'Esomeprazole', 'Medizen pharmaceutical industries > paxal pharmaceutical', 'Cap', 'كبسولة', '40 mg', '3', 'مضاد للحموضة ولعلاج حرقان الصدر وقرحة المعدة وارتجاع المريء', 'about esomeprazole a proton pump inhibitor substituted benzimidazole antiulcer antisecretory drug. mechanism of action of esomeprazole esomeprazole is the s enantiomer of omeprazole and is a proton pump inhibitor. it is a prodrug. after administration it', '6224011379021', NULL, 3917, '2022-08-01', 0, 'Esomeprazole is indicated for the treatment of acid-reflux disorders including healing and maintenance of erosive esophagitis, and symptomatic gastroesophageal reflux disease (GERD), peptic ulcer disease, H. pylori eradication, prevention of gastrointestinal bleeds with NSAID use, and for the long-term treatment of pathological hypersecretory conditions including Zollinger-Ellison Syndrome. ', 'Esomeprazole exerts its stomach acid-suppressing effects by preventing the final step in gastric acid production by covalently binding to sulfhydryl groups of cysteines found on the (H+, K+)-ATPase enzyme at the secretory surface of gastric parietal cells. This effect leads to inhibition of both basal and stimulated gastric acid secretion, irrespective of the stimulus. As the binding of esomeprazole to the (H+, K+)-ATPase enzyme is irreversible and new enzyme needs to be expressed in order to resume acid secretion, esomeprazole''s duration of antisecretory effect that persists longer than 24 hours.[FDA Label]

', 'Esomeprazole is a compound that inhibits gastric acid secretion and is indicated in the treatment of gastroesophageal reflux disease (GERD), the healing of erosive esophagitis, and <i>H. pylori</i> eradication to reduce the risk of duodenal ulcer recurrence. Esomeprazole belongs to a new class of antisecretory compounds, the substituted benzimidazoles, that do not exhibit anticholinergic or H2 histamine antagonistic properties, but that suppress gastric acid secretion by specific inhibition of the H<sup>+</sup>/K<sup>+</sup> ATPase at the secretory surface of the gastric parietal cell. By doing so, it inhibits acid secretion into the gsatric lumen. This effect is dose-related and leads to inhibition of both basal and stimulated acid secretion irrespective of the stimulus.



Esomeprazole is the s-isomer of [DB00338], which is a racemate of the S- and R-enantiomer. Esomeprazole has been shown to inhibit acid secretion to a similar extent as [DB00338], without any significant differences between the two compounds _in vitro_. 



PPIs such as esomeprazole have also been shown to inhibit the activity of dimethylarginine dimethylaminohydrolase (DDAH), an enzyme necessary for cardiovascular health. DDAH inhibition causes a consequent accumulation of the nitric oxide synthase inhibitor asymmetric dimethylarginie (ADMA), which is thought to cause the association of PPIs with increased risk of cardiovascular events in patients with unstable coronary syndromes.[A177577, A177580]



Due to their good safety profile and as several PPIs are available over the counter without a prescription, their current use in North America is widespread. Long term use of PPIs such as esomeprazole has been associated with possible adverse effects, however, including increased susceptibility to bacterial infections (including gastrointestinal _C. difficile_), reduced absorption of micronutrients including iron and B12, and an increased risk of developing hypomagnesemia and hypocalcemia which may contribute to osteoporosis and bone fractures later in life.[A177571]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23546, 'Nexipro 20/1680mg 7 sachets', 'نيكسيبرو 20/1680مجم 7 اكياس', '34', NULL, 'Peptic ulcer.proton pump inhibitor', 'Omeprazole+sodium bicarbonate', 'Marcyrl co. > pharma right group', 'Sachet', 'أكياس', '1680mg', '1', NULL, 'powder for oral suspension about omeprazole proton pump inhibitor substituted benzimidazole anti-secretory antiulcer. mechanism of action of omeprazole omeprazole is a proton pump inhibitor and it is a prodrug. after administration it diffuses in to the p', '6224007733004', NULL, 1356, '2023-04-23', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23547, 'Nexium 10 mg 28 sachets', 'نيكسيوم 10مجم 28 اكياس', '364', '280', 'Peptic ulcer.proton pump inhibitor', 'Esomeprazole', 'Astra zeneca', 'Sachet', 'أكياس', '10 mg', '28', 'قرحة المعدة والحموضة', 'about esomeprazole a proton pump inhibitor substituted benzimidazole antiulcer antisecretory drug. mechanism of action of esomeprazole esomeprazole is the s enantiomer of omeprazole and is a proton pump inhibitor. it is a prodrug. after administration it', '6223003270551', NULL, 9638, '2023-09-12', 0, 'Esomeprazole is indicated for the treatment of acid-reflux disorders including healing and maintenance of erosive esophagitis, and symptomatic gastroesophageal reflux disease (GERD), peptic ulcer disease, H. pylori eradication, prevention of gastrointestinal bleeds with NSAID use, and for the long-term treatment of pathological hypersecretory conditions including Zollinger-Ellison Syndrome. ', 'Esomeprazole exerts its stomach acid-suppressing effects by preventing the final step in gastric acid production by covalently binding to sulfhydryl groups of cysteines found on the (H+, K+)-ATPase enzyme at the secretory surface of gastric parietal cells. This effect leads to inhibition of both basal and stimulated gastric acid secretion, irrespective of the stimulus. As the binding of esomeprazole to the (H+, K+)-ATPase enzyme is irreversible and new enzyme needs to be expressed in order to resume acid secretion, esomeprazole''s duration of antisecretory effect that persists longer than 24 hours.[FDA Label]

', 'Esomeprazole is a compound that inhibits gastric acid secretion and is indicated in the treatment of gastroesophageal reflux disease (GERD), the healing of erosive esophagitis, and <i>H. pylori</i> eradication to reduce the risk of duodenal ulcer recurrence. Esomeprazole belongs to a new class of antisecretory compounds, the substituted benzimidazoles, that do not exhibit anticholinergic or H2 histamine antagonistic properties, but that suppress gastric acid secretion by specific inhibition of the H<sup>+</sup>/K<sup>+</sup> ATPase at the secretory surface of the gastric parietal cell. By doing so, it inhibits acid secretion into the gsatric lumen. This effect is dose-related and leads to inhibition of both basal and stimulated acid secretion irrespective of the stimulus.



Esomeprazole is the s-isomer of [DB00338], which is a racemate of the S- and R-enantiomer. Esomeprazole has been shown to inhibit acid secretion to a similar extent as [DB00338], without any significant differences between the two compounds _in vitro_. 



PPIs such as esomeprazole have also been shown to inhibit the activity of dimethylarginine dimethylaminohydrolase (DDAH), an enzyme necessary for cardiovascular health. DDAH inhibition causes a consequent accumulation of the nitric oxide synthase inhibitor asymmetric dimethylarginie (ADMA), which is thought to cause the association of PPIs with increased risk of cardiovascular events in patients with unstable coronary syndromes.[A177577, A177580]



Due to their good safety profile and as several PPIs are available over the counter without a prescription, their current use in North America is widespread. Long term use of PPIs such as esomeprazole has been associated with possible adverse effects, however, including increased susceptibility to bacterial infections (including gastrointestinal _C. difficile_), reduced absorption of micronutrients including iron and B12, and an increased risk of developing hypomagnesemia and hypocalcemia which may contribute to osteoporosis and bone fractures later in life.[A177571]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23549, 'Nexium 20 mg 14 f.c.tabs. (n/a)', 'نيكسيوم 20مجم 14 قرص', '98', NULL, 'Peptic ulcer.proton pump inhibitor', 'Esomeprazole', 'Astra zeneca', 'Tab', 'أقراص', '20 mg', '2', 'قرحة المعدة والحموضة', NULL, '6223003270308', NULL, 1782, '2023-08-02', 0, 'Esomeprazole is indicated for the treatment of acid-reflux disorders including healing and maintenance of erosive esophagitis, and symptomatic gastroesophageal reflux disease (GERD), peptic ulcer disease, H. pylori eradication, prevention of gastrointestinal bleeds with NSAID use, and for the long-term treatment of pathological hypersecretory conditions including Zollinger-Ellison Syndrome. ', 'Esomeprazole exerts its stomach acid-suppressing effects by preventing the final step in gastric acid production by covalently binding to sulfhydryl groups of cysteines found on the (H+, K+)-ATPase enzyme at the secretory surface of gastric parietal cells. This effect leads to inhibition of both basal and stimulated gastric acid secretion, irrespective of the stimulus. As the binding of esomeprazole to the (H+, K+)-ATPase enzyme is irreversible and new enzyme needs to be expressed in order to resume acid secretion, esomeprazole''s duration of antisecretory effect that persists longer than 24 hours.[FDA Label]

', 'Esomeprazole is a compound that inhibits gastric acid secretion and is indicated in the treatment of gastroesophageal reflux disease (GERD), the healing of erosive esophagitis, and <i>H. pylori</i> eradication to reduce the risk of duodenal ulcer recurrence. Esomeprazole belongs to a new class of antisecretory compounds, the substituted benzimidazoles, that do not exhibit anticholinergic or H2 histamine antagonistic properties, but that suppress gastric acid secretion by specific inhibition of the H<sup>+</sup>/K<sup>+</sup> ATPase at the secretory surface of the gastric parietal cell. By doing so, it inhibits acid secretion into the gsatric lumen. This effect is dose-related and leads to inhibition of both basal and stimulated acid secretion irrespective of the stimulus.



Esomeprazole is the s-isomer of [DB00338], which is a racemate of the S- and R-enantiomer. Esomeprazole has been shown to inhibit acid secretion to a similar extent as [DB00338], without any significant differences between the two compounds _in vitro_. 



PPIs such as esomeprazole have also been shown to inhibit the activity of dimethylarginine dimethylaminohydrolase (DDAH), an enzyme necessary for cardiovascular health. DDAH inhibition causes a consequent accumulation of the nitric oxide synthase inhibitor asymmetric dimethylarginie (ADMA), which is thought to cause the association of PPIs with increased risk of cardiovascular events in patients with unstable coronary syndromes.[A177577, A177580]



Due to their good safety profile and as several PPIs are available over the counter without a prescription, their current use in North America is widespread. Long term use of PPIs such as esomeprazole has been associated with possible adverse effects, however, including increased susceptibility to bacterial infections (including gastrointestinal _C. difficile_), reduced absorption of micronutrients including iron and B12, and an increased risk of developing hypomagnesemia and hypocalcemia which may contribute to osteoporosis and bone fractures later in life.[A177571]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23550, 'Nexium 40 mg powder for i.v. inf. vial', 'نيكسيوم 40مجم فيال وريد', '100', '70', 'Peptic ulcer.proton pump inhibitor', 'Esomeprazole', 'Astra zeneca', 'Vial', 'فيال', '40 mg', '1', 'قرحة المعدة والحموضة', 'about esomeprazole a proton pump inhibitor substituted benzimidazole antiulcer antisecretory drug. mechanism of action of esomeprazole esomeprazole is the s enantiomer of omeprazole and is a proton pump inhibitor. it is a prodrug. after administration it', '7321839711404', NULL, 2172, '2024-08-27', 0, 'Esomeprazole is indicated for the treatment of acid-reflux disorders including healing and maintenance of erosive esophagitis, and symptomatic gastroesophageal reflux disease (GERD), peptic ulcer disease, H. pylori eradication, prevention of gastrointestinal bleeds with NSAID use, and for the long-term treatment of pathological hypersecretory conditions including Zollinger-Ellison Syndrome. ', 'Esomeprazole exerts its stomach acid-suppressing effects by preventing the final step in gastric acid production by covalently binding to sulfhydryl groups of cysteines found on the (H+, K+)-ATPase enzyme at the secretory surface of gastric parietal cells. This effect leads to inhibition of both basal and stimulated gastric acid secretion, irrespective of the stimulus. As the binding of esomeprazole to the (H+, K+)-ATPase enzyme is irreversible and new enzyme needs to be expressed in order to resume acid secretion, esomeprazole''s duration of antisecretory effect that persists longer than 24 hours.[FDA Label]

', 'Esomeprazole is a compound that inhibits gastric acid secretion and is indicated in the treatment of gastroesophageal reflux disease (GERD), the healing of erosive esophagitis, and <i>H. pylori</i> eradication to reduce the risk of duodenal ulcer recurrence. Esomeprazole belongs to a new class of antisecretory compounds, the substituted benzimidazoles, that do not exhibit anticholinergic or H2 histamine antagonistic properties, but that suppress gastric acid secretion by specific inhibition of the H<sup>+</sup>/K<sup>+</sup> ATPase at the secretory surface of the gastric parietal cell. By doing so, it inhibits acid secretion into the gsatric lumen. This effect is dose-related and leads to inhibition of both basal and stimulated acid secretion irrespective of the stimulus.



Esomeprazole is the s-isomer of [DB00338], which is a racemate of the S- and R-enantiomer. Esomeprazole has been shown to inhibit acid secretion to a similar extent as [DB00338], without any significant differences between the two compounds _in vitro_. 



PPIs such as esomeprazole have also been shown to inhibit the activity of dimethylarginine dimethylaminohydrolase (DDAH), an enzyme necessary for cardiovascular health. DDAH inhibition causes a consequent accumulation of the nitric oxide synthase inhibitor asymmetric dimethylarginie (ADMA), which is thought to cause the association of PPIs with increased risk of cardiovascular events in patients with unstable coronary syndromes.[A177577, A177580]



Due to their good safety profile and as several PPIs are available over the counter without a prescription, their current use in North America is widespread. Long term use of PPIs such as esomeprazole has been associated with possible adverse effects, however, including increased susceptibility to bacterial infections (including gastrointestinal _C. difficile_), reduced absorption of micronutrients including iron and B12, and an increased risk of developing hypomagnesemia and hypocalcemia which may contribute to osteoporosis and bone fractures later in life.[A177571]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23552, 'Nexium 40 mg 14 f.c.tabs. (n/a)', 'نيكسيوم 40مجم 14 قرص', '244', NULL, 'Peptic ulcer.proton pump inhibitor', 'Esomeprazole', 'Astra zeneca', 'Tab', 'أقراص', '40 mg', '2', 'قرحة المعدة والحموضة', NULL, '5000456055383', NULL, 14999, '2023-08-02', 0, 'Esomeprazole is indicated for the treatment of acid-reflux disorders including healing and maintenance of erosive esophagitis, and symptomatic gastroesophageal reflux disease (GERD), peptic ulcer disease, H. pylori eradication, prevention of gastrointestinal bleeds with NSAID use, and for the long-term treatment of pathological hypersecretory conditions including Zollinger-Ellison Syndrome. ', 'Esomeprazole exerts its stomach acid-suppressing effects by preventing the final step in gastric acid production by covalently binding to sulfhydryl groups of cysteines found on the (H+, K+)-ATPase enzyme at the secretory surface of gastric parietal cells. This effect leads to inhibition of both basal and stimulated gastric acid secretion, irrespective of the stimulus. As the binding of esomeprazole to the (H+, K+)-ATPase enzyme is irreversible and new enzyme needs to be expressed in order to resume acid secretion, esomeprazole''s duration of antisecretory effect that persists longer than 24 hours.[FDA Label]

', 'Esomeprazole is a compound that inhibits gastric acid secretion and is indicated in the treatment of gastroesophageal reflux disease (GERD), the healing of erosive esophagitis, and <i>H. pylori</i> eradication to reduce the risk of duodenal ulcer recurrence. Esomeprazole belongs to a new class of antisecretory compounds, the substituted benzimidazoles, that do not exhibit anticholinergic or H2 histamine antagonistic properties, but that suppress gastric acid secretion by specific inhibition of the H<sup>+</sup>/K<sup>+</sup> ATPase at the secretory surface of the gastric parietal cell. By doing so, it inhibits acid secretion into the gsatric lumen. This effect is dose-related and leads to inhibition of both basal and stimulated acid secretion irrespective of the stimulus.



Esomeprazole is the s-isomer of [DB00338], which is a racemate of the S- and R-enantiomer. Esomeprazole has been shown to inhibit acid secretion to a similar extent as [DB00338], without any significant differences between the two compounds _in vitro_. 



PPIs such as esomeprazole have also been shown to inhibit the activity of dimethylarginine dimethylaminohydrolase (DDAH), an enzyme necessary for cardiovascular health. DDAH inhibition causes a consequent accumulation of the nitric oxide synthase inhibitor asymmetric dimethylarginie (ADMA), which is thought to cause the association of PPIs with increased risk of cardiovascular events in patients with unstable coronary syndromes.[A177577, A177580]



Due to their good safety profile and as several PPIs are available over the counter without a prescription, their current use in North America is widespread. Long term use of PPIs such as esomeprazole has been associated with possible adverse effects, however, including increased susceptibility to bacterial infections (including gastrointestinal _C. difficile_), reduced absorption of micronutrients including iron and B12, and an increased risk of developing hypomagnesemia and hypocalcemia which may contribute to osteoporosis and bone fractures later in life.[A177571]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23553, 'Nexpress 10/320 mg 20 f.c. tabs.', 'نيكسبريس 10/320مجم 20 قرص', '95', '46', 'Antihypertensive. combined angiotensin blocker with calcium channel blocker', 'Amlodipine+valsartan', 'Eva pharma > next pharma', 'Tab', 'أقراص', '320 mg', '1', NULL, NULL, NULL, NULL, 1013, '2024-02-04', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23554, 'Neytrido hair spray 120 ml', 'نيتريدو سبراي للشعر 120مل', '150', NULL, 'Hair care', 'Argan oil+caffeine', 'Egyptian co. for cosmetics > eureka', 'Spray', 'بخاخ', '120 ml', '1', NULL, NULL, NULL, NULL, 348, '2022-08-06', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23555, 'Icolact 30 capsules', 'ايكولاكت 30 كبسولة', '97', NULL, 'Dietary supplements', 'Fenugreek seeds extract + fennel seeds extract', 'Iconic pharmaceutical', 'Capsule', 'كبسولة', NULL, '3', NULL, NULL, NULL, NULL, 1120, '2022-08-01', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23556, 'Niaspan 375mg 14 prolonged release tab.s', 'نياسبان 375مجم 14 اقراص', '37', NULL, 'Nicotinic acid', 'Nicotinic acid', 'Aeropharm technology llc-usa > abbott laboratories', 'Tab', 'أقراص', '375mg', '2', NULL, NULL, NULL, NULL, 662, '2022-07-27', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23557, 'Liqiveem syrup 120 ml', 'ليكيفيم شراب 120 مل', '50', '35', 'Cough products', 'Ivy leaves + licorice + thyme', 'Acs', 'Syrup', 'شراب', '120 ml', '1', 'مكمل غذائى مضاد للسعال ,يخفف اعراض البرد ويدعم الجهاز التنفسي', NULL, NULL, NULL, 1201, '2025-01-18', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23558, 'Niaspan 750mg 14 prolonged release tabs.', 'نياسبان 750مجم 14 اقراص', '50', NULL, 'Nicotinic acid', 'Nicotinic acid', 'Aeropharm technology llc-usa > abbott laboratories', 'Tab', 'أقراص', '750mg', '2', NULL, 'mechanism of action of nicotinic acid niacin refers to nicotinic acid as well as nicotinamide which exerts it`s action by influencing metabolic reactions. it is converted in to coenzymes ncotinamide adenine dinucleotide (nad) and its phosphate ncotinamide', NULL, NULL, 688, '2022-07-27', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23560, 'Nice body lotion 60ml', 'نايس بادي لوشن للجسم 60 مل', '12', NULL, 'Moisturizing topicals', NULL, 'Zad', 'Lotion', 'لوشن', '60ml', '1', NULL, 'moisturizing skin lotion', NULL, NULL, 776, '2022-06-18', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23561, 'Nice feel cream 30 gm', 'نايس فيل كريم 30 جم', '70', '40', 'Wound healing cream', 'Shikonin+dexpanthenol+chlorohexidine+sesame oil+hyaluronic acid+collagen+vitamin e', 'Dreams el habboba > dawa egypt pharma', 'Cream', 'كريم', '30 gm', '1', 'علاج الجروح والتقرحات -- ترطيب وتلطيف الجلد -- تقليل الالتهابات والاحمرار', 'wound healing cream', NULL, NULL, 1849, '2025-08-20', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23562, 'Nice hair lotion 150 ml', 'نايس هير لوشن للشعر 150 مل', '30', NULL, 'Hair care', 'Coal tar+propylene glycol+piroctone olamine', 'Zad', 'Lotion', 'لوشن', '150 ml', '1', NULL, 'anti-dandruff', NULL, NULL, 999, '2022-07-07', 0, 'Relieving itching, irritation, redness, dryness, scaling, and flaking of the skin caused by psoriasis, seborrhea, or eczema. ', 'Coal tar ointment is a keratolytic. It works by slowing bacterial growth and loosening and softening scales and crust.', 'Decrease bacterial growth. ', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23563, 'Nice hair plus shampoo 200ml', 'نايس هير بلس شامبو 200مل', '30', NULL, 'Hair care', 'Coal tar+salicylic acid', 'Zad', 'Amp', 'أمبول', '200ml', '1', NULL, 'anti-dandruff', NULL, NULL, 714, '2022-07-14', 0, 'Relieving itching, irritation, redness, dryness, scaling, and flaking of the skin caused by psoriasis, seborrhea, or eczema. ', 'Coal tar ointment is a keratolytic. It works by slowing bacterial growth and loosening and softening scales and crust.', 'Decrease bacterial growth. ', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23564, 'Ometrival syrup 100 ml', 'اوميتروفال شراب 100 مل', '69', NULL, 'Omega-3 multivitamin', 'Omega 3 fish oil+vitamin d3+vitamin k2+vitamin e+vitamin a', 'Nutra medical', 'Syrup', 'شراب', '100 ml', '1', NULL, NULL, NULL, NULL, 1207, '2022-08-17', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23565, 'Niclosan 500 mg 20 chewable tabs', 'نيكلوزان 500مجم 20 قرص مضغ', '40', '11', 'Anthelmintic', 'Niclosamide', 'Misr', 'Tab', 'أقراص', '500 mg', '2', NULL, NULL, '6221035009378', NULL, 1609, '2024-01-11', 0, 'For the treatment of tapeworm and intestinal fluke infections: Taenia saginata (Beef Tapeworm), Taenia solium (Pork Tapeworm), Diphyllobothrium latum (Fish Tapeworm), Fasciolopsis buski (large intestinal fluke). Niclosamide is also used as a molluscicide in the control of schistosomiasis.', 'Niclosamide works by killing tapeworms on contact. Adult worms (but not ova) are rapidly killed, presumably due to uncoupling of oxidative phosphorylation or stimulation of ATPase activity. The killed worms are then passed in the stool or sometimes destroyed in the intestine. Niclosamide may work as a molluscicide by binding to and damaging DNA.', 'Niclosamide is an antihelminth used against tapeworm infections. It may act by the uncoupling of the electron transport chain to ATP synthase. The disturbance of this crucial metabolic pathway prevents creation of adenosine tri-phosphate (ATP), an essential molecule that supplies energy for metabolism. ', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23568, 'Nicotinell tts 10 cm.square', 'نيكوتينيل تتس 10', '8', NULL, 'Smoking cessation.nicotinic agonist', 'Nicotine', 'Novartis > glaxo smithkline', 'Unknown', 'غير محدد', NULL, '1', NULL, NULL, NULL, NULL, 818, '2022-07-09', 0, 'For the relief of nicotine withdrawal symptoms and as an aid to smoking cessation.', 'Nicotine is a stimulant drug that acts as an agonist at nicotinic acetylcholine receptors. These are ionotropic receptors composed up of five homomeric or heteromeric subunits. In the brain, nicotine binds to nicotinic acetylcholine receptors on dopaminergic neurons in the cortico-limbic pathways. This causes the channel to open and allow conductance of multiple cations including sodium, calcium, and potassium. This leads to depolarization, which activates voltage-gated calcium channels and allows more calcium to enter the axon terminal. Calcium stimulates vesicle trafficking towards the plasma membrane and the release of dopamine into the synapse. Dopamine binding to its receptors is responsible the euphoric and addictive properties of nicotine.

Nicotine also binds to nicotinic acetylcholine receptors on the chromaffin cells in the adrenal medulla. Binding opens the ion channel allowing influx of sodium, causing depolarization of the cell, which activates voltage-gated calcium channels. Calcium triggers the release of epinephrine from intracellular vesicles into the bloodstream, which causes vasoconstriction, increased blood pressure, increased heart rate, and increased blood sugar.', 'Nicotine, the primary alkaloid in tobacco products binds stereo-selectively to nicotinic-cholinergic receptors on autonomic ganglia, the adrenal medulla, neuromuscular junctions and in the brain. Nicotine exerts two effects, a stimulant effect exerted at the locus ceruleus and a reward effect in the limbic system. Itranvenous administration of nicotine causes release of acetylcholine, norepinephrine, dopamine, serotonine, vasopressin, beta-endorphin and ACTH. Nicotine is a highly addictive substance. Nicotine also induces peripheral vasoconstriction, tachycardia and elevated blood pressure. Nicotine inhalers and patches are used to treat smoking withdrawl syndrome. Nicotine is classified as a stimulant of autonomic ganglia.', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23569, 'Nicotinell tts 20 cm square', 'نيكوتينيل تتس 20سم.مربع', '8', NULL, 'Smoking cessation.nicotinic agonist', 'Nicotine', 'Novartis > glaxo smithkline', 'Unknown', 'غير محدد', NULL, '1', NULL, NULL, NULL, NULL, 1191, '2022-07-14', 0, 'For the relief of nicotine withdrawal symptoms and as an aid to smoking cessation.', 'Nicotine is a stimulant drug that acts as an agonist at nicotinic acetylcholine receptors. These are ionotropic receptors composed up of five homomeric or heteromeric subunits. In the brain, nicotine binds to nicotinic acetylcholine receptors on dopaminergic neurons in the cortico-limbic pathways. This causes the channel to open and allow conductance of multiple cations including sodium, calcium, and potassium. This leads to depolarization, which activates voltage-gated calcium channels and allows more calcium to enter the axon terminal. Calcium stimulates vesicle trafficking towards the plasma membrane and the release of dopamine into the synapse. Dopamine binding to its receptors is responsible the euphoric and addictive properties of nicotine.

Nicotine also binds to nicotinic acetylcholine receptors on the chromaffin cells in the adrenal medulla. Binding opens the ion channel allowing influx of sodium, causing depolarization of the cell, which activates voltage-gated calcium channels. Calcium triggers the release of epinephrine from intracellular vesicles into the bloodstream, which causes vasoconstriction, increased blood pressure, increased heart rate, and increased blood sugar.', 'Nicotine, the primary alkaloid in tobacco products binds stereo-selectively to nicotinic-cholinergic receptors on autonomic ganglia, the adrenal medulla, neuromuscular junctions and in the brain. Nicotine exerts two effects, a stimulant effect exerted at the locus ceruleus and a reward effect in the limbic system. Itranvenous administration of nicotine causes release of acetylcholine, norepinephrine, dopamine, serotonine, vasopressin, beta-endorphin and ACTH. Nicotine is a highly addictive substance. Nicotine also induces peripheral vasoconstriction, tachycardia and elevated blood pressure. Nicotine inhalers and patches are used to treat smoking withdrawl syndrome. Nicotine is classified as a stimulant of autonomic ganglia.', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23570, 'Nicotinell tts 30 cm square', 'نيكوتينيل تتس 30سم.مربع', '9', NULL, 'Smoking cessation.nicotinic agonist', 'Nicotine', 'Novartis > glaxo smithkline', 'Unknown', 'غير محدد', NULL, '1', NULL, NULL, NULL, NULL, 914, '2022-07-14', 0, 'For the relief of nicotine withdrawal symptoms and as an aid to smoking cessation.', 'Nicotine is a stimulant drug that acts as an agonist at nicotinic acetylcholine receptors. These are ionotropic receptors composed up of five homomeric or heteromeric subunits. In the brain, nicotine binds to nicotinic acetylcholine receptors on dopaminergic neurons in the cortico-limbic pathways. This causes the channel to open and allow conductance of multiple cations including sodium, calcium, and potassium. This leads to depolarization, which activates voltage-gated calcium channels and allows more calcium to enter the axon terminal. Calcium stimulates vesicle trafficking towards the plasma membrane and the release of dopamine into the synapse. Dopamine binding to its receptors is responsible the euphoric and addictive properties of nicotine.

Nicotine also binds to nicotinic acetylcholine receptors on the chromaffin cells in the adrenal medulla. Binding opens the ion channel allowing influx of sodium, causing depolarization of the cell, which activates voltage-gated calcium channels. Calcium triggers the release of epinephrine from intracellular vesicles into the bloodstream, which causes vasoconstriction, increased blood pressure, increased heart rate, and increased blood sugar.', 'Nicotine, the primary alkaloid in tobacco products binds stereo-selectively to nicotinic-cholinergic receptors on autonomic ganglia, the adrenal medulla, neuromuscular junctions and in the brain. Nicotine exerts two effects, a stimulant effect exerted at the locus ceruleus and a reward effect in the limbic system. Itranvenous administration of nicotine causes release of acetylcholine, norepinephrine, dopamine, serotonine, vasopressin, beta-endorphin and ACTH. Nicotine is a highly addictive substance. Nicotine also induces peripheral vasoconstriction, tachycardia and elevated blood pressure. Nicotine inhalers and patches are used to treat smoking withdrawl syndrome. Nicotine is classified as a stimulant of autonomic ganglia.', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23571, 'Cilozinc 30 caps.', 'سيلوزينك', '144', '33', NULL, 'Zinc Citrate 14mg Vitamin C 500mg Ferrous Fumarate 56.18mg Cupric Sulphate Pentahydrate1.37mg', 'Multicare', 'Cap', 'كبسولة', NULL, '1', NULL, 'vitamin c - 500 mg zinc - 5 mg dose: 2 capsules per day.', NULL, NULL, 823, '2024-12-11', 0, 'Zinc can be used for the treatment and prevention of zinc deficiency/its consequences, including stunted growth and acute diarrhea in children, and slowed wound healing. It is also utilized for boosting the immune system, treating the common cold and recurrent ear infections, as well as preventing lower respiratory tract infections [L2172].  



', '**Zinc has three primary biological roles**: _catalytic_, _structural_, and _regulatory_. The catalytic and structural role of zinc is well established, and there are various noteworthy reviews on these functions. For example, zinc is a structural constituent in numerous proteins, inclusive of growth factors, cytokines, receptors, enzymes, and transcription factors for different cellular signaling pathways. It is implicated in numerous cellular processes as a cofactor for approximately 3000 human proteins including enzymes, nuclear factors, and hormones [L2096].



Zinc promotes resistance to epithelial apoptosis through cell protection (cytoprotection) against reactive oxygen species and bacterial toxins, likely through the antioxidant activity of the cysteine-rich metallothioneins [A32419].



In HL-60 cells (promyelocytic leukemia cell line), zinc enhances the up-regulation of A20 mRNA, which, via TRAF pathway, decreases NF-kappaB activation, leading to decreased gene expression and generation of tumor necrosis factor-alpha (TNF-alpha), IL-1beta, and IL-8 [A32418].



There are several mechanisms of action of zinc on acute diarrhea. Various mechanisms are specific to the gastrointestinal system: zinc restores mucosal barrier integrity and enterocyte brush-border enzyme activity, it promotes the production of antibodies and circulating lymphocytes against intestinal pathogens, and has a direct effect on ion channels, acting as a potassium channel blocker of adenosine 3-5-cyclic monophosphate-mediated chlorine secretion. Cochrane researchers examined the evidence available up to 30 September 2016 [L2106].



Zinc deficiency in humans decreases the activity of serum _thymulin_ (a hormone of the thymus), which is necessary for the maturation of T-helper cells. T-helper 1 (Th(1)) cytokines are decreased but T-helper 2 (Th(2)) cytokines are not affected by zinc deficiency in humans [A32417].



The change of _Th(1)_ to _Th(2)_ function leads to cell-mediated immune dysfunction. Because IL-2 production (Th(1) cytokine) is decreased, this causes decreased activity of natural-killer-cell (NK cell) and T cytolytic cells, normally involved in killing viruses, bacteria, and malignant cells [A32424]. 



In humans, zinc deficiency may lead to the generation of new CD4+ T cells, produced in the thymus. In cell culture studies (HUT-78, a Th(0) human malignant lymphoblastoid cell line), as a result of zinc deficiency, nuclear factor-kappaB (NF-kappaB) activation, phosphorylation of IkappaB, and binding of NF-kappaB to DNA are decreased and this results in decreased Th(1) cytokine production [A32417].



In another study, zinc supplementation in human subjects suppressed the gene expression and production of pro-inflammatory cytokines and decreased oxidative stress markers [A32424]. In HL-60 cells (a human pro-myelocytic leukemia cell line), zinc deficiency increased the levels of TNF-alpha, IL-1beta, and IL-8 cytokines and mRNA. In such cells, zinc was found to induce A20, a zinc finger protein that inhibited NF-kappaB activation by the tumor necrosis factor receptor-associated factor pathway. This process decreased gene expression of pro-inflammatory cytokines and oxidative stress markers [A32417].



The exact mechanism of zinc in acne treatment is poorly understood. However, zinc is considered to act directly on microbial inflammatory equilibrium and facilitate antibiotic absorption when used in combination with other agents. Topical zinc alone as well as in combination with other agents may be efficacious because of its anti-inflammatory activity and ability to reduce P. acnes bacteria by the inhibition of P. acnes lipases and free fatty acid levels [L2102].', 'Zinc is involved in various aspects of cellular metabolism. It has been estimated that approximately 10% of human proteins may bind zinc, in addition to hundreds of proteins that transport and traffic zinc. It is required for the catalytic activity of more than 200 enzymes, and it plays a role in immune function wound healing, protein synthesis, DNA synthesis, and cell division. Zinc is an essential element for a proper sense of taste and smell and supports normal growth and development during pregnancy, childhood, and adolescence. It is thought to have antioxidant properties, which may be protective against accelerated aging and helps to speed up the healing process after an injury; however, studies differ as to its effectiveness. Zinc ions are effective antimicrobial agents even if administered in low concentrations [L2211].



Studies on oral zinc for specific conditions shows the following evidence in various conditions [L2095]:



**Colds:** Evidence suggests that if zinc lozenges or syrup are taken within 24 hours after cold symptoms start, the supplement may shorten the length of colds. The use intranasal zinc has been associated with the loss of the sense of smell, in some cases long-term or permanently [L2095].



**Wound healing:** Patients with skin ulcers and decreased levels of zinc may benefit from oral zinc supplements [L2095]. 



**Diahrrea**: Oral zinc supplements can reduce the symptoms of diarrhea in children with low levels of zinc, especially in cases of malnutrition [L2095].

', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23572, 'Nicotipan 500 mg 20 extended release f.c. tabs.', 'نيكوتيبان 500مجم 20 اقراص', '42', NULL, 'Nicotinic acid', 'Nicotinic acid', 'Eva pharma', 'Tab', 'أقراص', '500 mg', '2', NULL, 'mechanism of action of nicotinic acid niacin refers to nicotinic acid as well as nicotinamide which exerts it`s action by influencing metabolic reactions. it is converted in to coenzymes ncotinamide adenine dinucleotide (nad) and its phosphate ncotinamide', NULL, NULL, 1067, '2022-07-14', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23573, 'Nicotipan 750 mg 20 extended release f.c. tabs.', 'نيكوتيبان 750مجم 20 اقراص', '48', NULL, 'Nicotinic acid', 'Nicotinic acid', 'Eva pharma', 'Tab', 'أقراص', '750 mg', '2', NULL, 'mechanism of action of nicotinic acid niacin refers to nicotinic acid as well as nicotinamide which exerts it`s action by influencing metabolic reactions. it is converted in to coenzymes ncotinamide adenine dinucleotide (nad) and its phosphate ncotinamide', NULL, NULL, 828, '2022-07-14', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23574, 'Nido-1 plus milk 145 gm', 'نيدو 1 بلس لبن اطفال 145 جم', '70', '62', 'Milk products.third stage (age 1-3 years)', 'Milk formula stage 3', 'Nestle', 'Unknown', 'غير محدد', '145 gm', '1', NULL, 'not to replace mother s milk. for infants from 1 year age onward. to be used within one month from opening.', NULL, NULL, 880, '2023-08-08', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23575, 'Nido-1 plus milk 288 gm', 'نيدو 1 بلس لبن اطفال 288 جم', '165', '160', 'Milk products.third stage (age 1-3 years)', 'Milk formula stage 3', 'Nestle', 'Unknown', 'غير محدد', '288 gm', '1', NULL, 'not to replace mother s milk. for infants from 1 year age onward. to be used within one month from opening.', '6221007034513', NULL, 1084, '2025-09-01', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23576, 'Nido-1 plus milk 576 gm', 'نيدو 1 بلس لبن اطفال 576 جم', '310', '299', 'Milk products.third stage (age 1-3 years)', 'Milk formula stage 3', 'Nestle', 'Unknown', 'غير محدد', '576 gm', '1', NULL, 'not to replace mother s milk. for infants from 1 year age onward. to be used within one month from opening.', NULL, NULL, 832, '2025-09-01', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23577, 'Nifedipine 30 mg sr 10 caps.', 'نيفيدبين 30مجم اس ار 10 كبسولات', '7', NULL, 'Antihypertensive.selective calcium channel blocker', 'Nifedipine', 'Sigma', 'Cap', 'كبسولة', '30 mg', '1', NULL, 'about nifedipine a dihydropyridine calcium channel blocker antianginal antihypertensive tocolytic. mechanism of action of nifedipine nifedipine is a dihydropyridine ca channel blocker. it exerts it`s antianginal antihypertensive actions through blocking t', NULL, NULL, 2248, '2022-06-22', 0, 'Nifedipine capsules are indicated to treat vasospastic angina and chronic stable angina.[L11383] Extended release tablets are indicated to treat vasospastic angina, chronic stable angina, and hypertension.[L11389,L1245]', 'Nifedipine blocks voltage gated L-type calcium channels in vascular smooth muscle and myocardial cells.[A190204] This blockage prevents the entry of calcium ions into cells during depolarization, reducing peripheral arterial vascular resistance and dilating coronary arteries.[A190204] These actions reduce blood pressure and increase the supply of oxygen to the heart, alleviating angina.[A190204]', 'Nifedipine is an inhibitor of L-type voltage gated calcium channels that reduces blood pressure and increases oxygen supply to the heart.[A190204] Immediate release nifedipine''s duration of action requires dosing 3 times daily.[L11383] Nifedipine dosing is generally 10-120mg daily.[L11383] Patients should be counselled regarding the risk of excessive hypotension, angina, and myocardial infarction.[L11383]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23578, 'Nifedipine 60 mg sr 10 caps.', 'نفيدبين 60مجم 10 كبسول', '10', NULL, 'Antihypertensive.selective calcium channel blocker', 'Nifedipine', 'Sigma', 'Cap', 'كبسولة', '60 mg', '1', NULL, 'about nifedipine a dihydropyridine calcium channel blocker antianginal antihypertensive tocolytic. mechanism of action of nifedipine nifedipine is a dihydropyridine ca channel blocker. it exerts it`s antianginal antihypertensive actions through blocking t', NULL, NULL, 771, '2022-07-28', 0, 'Nifedipine capsules are indicated to treat vasospastic angina and chronic stable angina.[L11383] Extended release tablets are indicated to treat vasospastic angina, chronic stable angina, and hypertension.[L11389,L1245]', 'Nifedipine blocks voltage gated L-type calcium channels in vascular smooth muscle and myocardial cells.[A190204] This blockage prevents the entry of calcium ions into cells during depolarization, reducing peripheral arterial vascular resistance and dilating coronary arteries.[A190204] These actions reduce blood pressure and increase the supply of oxygen to the heart, alleviating angina.[A190204]', 'Nifedipine is an inhibitor of L-type voltage gated calcium channels that reduces blood pressure and increases oxygen supply to the heart.[A190204] Immediate release nifedipine''s duration of action requires dosing 3 times daily.[L11383] Nifedipine dosing is generally 10-120mg daily.[L11383] Patients should be counselled regarding the risk of excessive hypotension, angina, and myocardial infarction.[L11383]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23579, 'Nifluma 2.5% gel 20 gm', 'نيفلوما 2.5%جل 20جم', '6', NULL, 'Nsaid.fenamates', 'Niflumic acid', 'Pharopharma', 'Gel', 'جل', '2.5%', '1', NULL, 'indication used in the treatment of rheumatoid arthritis. pharmacodynamics niflumic acid a nonsteroidal anti-inflammatory fenamate is a ca2+-activated cl- channel blocker. mechanism of action niflumic acid is able to inhibit both phospholipase a2 as well', '6221094113757', NULL, 736, '2022-08-02', 0, 'Used in the treatment of rheumatoid arthritis.', 'Niflumic acid is able to inhibit both phospholipase A2 as well as COX-2, thereby acting as an antiinflamatory and pain reduction agent.', 'Niflumic acid, a nonsteroidal anti-inflammatory fenamate, is a Ca<sup>2+</sup>-activated Cl<sup>-</sup> channel blocker.', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23580, 'Nifluma 3% cream 20 gm', 'نيفلوما 3%كريم 20 جم', '6', NULL, 'Nsaid.fenamates', 'Niflumic acid', 'Pharopharma', 'Cream', 'كريم', '3%', '1', NULL, 'indication used in the treatment of rheumatoid arthritis. pharmacodynamics niflumic acid a nonsteroidal anti-inflammatory fenamate is a ca2+-activated cl- channel blocker. mechanism of action niflumic acid is able to inhibit both phospholipase a2 as well', NULL, NULL, 637, '2022-08-04', 0, 'Used in the treatment of rheumatoid arthritis.', 'Niflumic acid is able to inhibit both phospholipase A2 as well as COX-2, thereby acting as an antiinflamatory and pain reduction agent.', 'Niflumic acid, a nonsteroidal anti-inflammatory fenamate, is a Ca<sup>2+</sup>-activated Cl<sup>-</sup> channel blocker.', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23581, 'Nifunal 200mg 12 caps.', 'نيفيونال 200مجم 14 كبسولة', '12', NULL, 'Antidiarrheal', 'Nifuroxazide', 'Amriya', 'Cap', 'كبسولة', '200mg', '1', NULL, 'indications infectious diarrhea in children and adults chronic colitis enterocolitis as an adjunctive treatment in combined therapy of intestinal dysbiosis. contraindication hypersensitivity to 5-nitrofurane derivatives and/or other components of the drug', '6221075020784', NULL, 1222, '2022-12-30', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23582, 'Nifunal 4% susp. 60 ml', 'نيفيونال 4% معلق 60 مل', '11', NULL, 'Antidiarrheal', 'Nifuroxazide', 'Amriya', 'Susp', 'معلق', '4%', '1', NULL, NULL, '6221075200339', NULL, 857, '2022-12-07', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23583, 'Nifunal 4% susp. 90 ml', 'نيفيونال 4% معلق 90 مل', '9', NULL, 'Antidiarrheal', 'Nifuroxazide', 'Amriya', 'Susp', 'معلق', '4%', '1', NULL, NULL, '6221075020784', NULL, 905, '2022-12-02', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23584, 'Nifunazide 220mg/5ml susp. 60 ml', 'نيفونازيد 220مجم/5مل شراب معلق 60مل', '13', '10.5', 'Antidiarrheal', 'Nifuroxazide', 'Mash premiere', 'Susp', 'معلق', '220mg', '1', NULL, 'indications infectious diarrhea in children and adults chronic colitis enterocolitis as an adjunctive treatment in combined therapy of intestinal dysbiosis. contraindication hypersensitivity to 5-nitrofurane derivatives and/or other components of the drug', NULL, NULL, 921, '2025-01-15', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23585, 'Nifurox 200mg/5ml 100ml susp.', 'نيفيوروكس 200مجم/5مل 100 مل معلق', '23', '14', 'Antidiarrheal', 'Nifuroxazide', 'Eipico', 'Susp', 'معلق', '200mg', '1', NULL, NULL, '6221032222220', NULL, 936, '2025-08-23', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23586, 'Nifuroxazide 200 mg 20 caps.', 'نيفيوروكسازيد 200مجم 20 كبسول', '18', NULL, 'Antidiarrheal', 'Nifuroxazide', 'El-obour', 'Cap', 'كبسولة', '200 mg', '2', 'يعمل علي علاج الاسهال __ الحفاظ علي الأملاح والمعادن في الجسم __ عدم الإصابة بالجفاف', 'indications infectious diarrhea in children and adults chronic colitis enterocolitis as an adjunctive treatment in combined therapy of intestinal dysbiosis. contraindication hypersensitivity to 5-nitrofurane derivatives and/or other components of the drug', '6221032222220', NULL, 2310, '2022-04-11', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23587, 'Nifuroxazide 220mg/5ml 60ml susp.', 'نيفيوروكسازيد 220مجم/5مل 60 مل معلق', '11', NULL, 'Antidiarrheal', 'Nifuroxazide', 'El-obour', 'Susp', 'معلق', '220mg', '1', 'علاج الاسهال', 'indications infectious diarrhea in children and adults chronic colitis enterocolitis as an adjunctive treatment in combined therapy of intestinal dysbiosis. contraindication hypersensitivity to 5-nitrofurane derivatives and/or other components of the drug', NULL, NULL, 1809, '2022-08-02', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23589, 'Night calm 1mg 30 f.c. tabs.', 'نايت كالم 1مجم 30 قرص', '60', '43.5', 'Psychiatric.anxiolytics-hypnotics', 'Eszopiclone', 'Medizen pharmaceutical industries', 'Tab', 'أقراص', '1mg', '3', NULL, NULL, '6222012401833', NULL, 2914, '2024-06-03', 0, 'Eszopiclone is indicated for the treatment of insomnia.[L6769]', 'The exact mechanism of action of eszopiclone is unknown at this time but is thought to occur via binding with the GABA receptor complexes at binding sites located near benzodiazepine receptors, possibly explaining its hypnotic and sedative effects.[A179659,L6769] It has particular affinity for GABA-A (or GABAA) receptor subunits 1, 3 and 5.[A179788,A15625,A15626] Eszopiclone increases GABA-A channel currents significantly.[A179788] GABA-A channels are major inhibitory channels that cause CNS depression when their receptors are activated.[A179800]', 'Eszopiclone rapidly induces sleep and decreases sleep latency. It also aids in the maintenance of sleep, preventing frequent awakenings.[A179659,A179662,L6769] This drug has shown anticonvulsant and muscle relaxant properties in animals but is used in humans for its sedating effects.[A179827]



Eszopiclone is a central nervous system depressant with various effects. These include changes in alertness and motor coordination and the risk of next morning impairment, increasing with the amount of eszopiclone administered.  Exercise caution and advise against driving a motor vehicle or activities that require full mental alertness the next morning.[L6769] Complex sleep behaviors may result from eszopiclone use. Eszopiclone should be discontinued in these cases.[L6874] Avoid the use of alcohol and other CNS depressants when eszopiclone is administered. Advise patients to skip the eszopiclone dose if alcohol has been consumed before bed or during the evening. Use the smallest dose of eszopiclone as possible, especially in elderly patients, who may experience exaggerated drug effects. Though the potential for dependence and abuse with eszopiclone is lower than for other hypnotic drugs, this drug has been abused and is known to cause dependence.[L6868]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23590, 'Night calm 3mg 30 f.c. tabs.', 'نايت كالم 3مجم 30 قرص', '105', '78', 'Psychiatric.anxiolytics-hypnotics', 'Eszopiclone', 'Medizen pharmaceutical industries', 'Tab', 'أقراص', '3mg', '3', 'منوم . مهديء عصبي', NULL, '6222012401840', NULL, 12326, '2024-06-03', 0, 'Eszopiclone is indicated for the treatment of insomnia.[L6769]', 'The exact mechanism of action of eszopiclone is unknown at this time but is thought to occur via binding with the GABA receptor complexes at binding sites located near benzodiazepine receptors, possibly explaining its hypnotic and sedative effects.[A179659,L6769] It has particular affinity for GABA-A (or GABAA) receptor subunits 1, 3 and 5.[A179788,A15625,A15626] Eszopiclone increases GABA-A channel currents significantly.[A179788] GABA-A channels are major inhibitory channels that cause CNS depression when their receptors are activated.[A179800]', 'Eszopiclone rapidly induces sleep and decreases sleep latency. It also aids in the maintenance of sleep, preventing frequent awakenings.[A179659,A179662,L6769] This drug has shown anticonvulsant and muscle relaxant properties in animals but is used in humans for its sedating effects.[A179827]



Eszopiclone is a central nervous system depressant with various effects. These include changes in alertness and motor coordination and the risk of next morning impairment, increasing with the amount of eszopiclone administered.  Exercise caution and advise against driving a motor vehicle or activities that require full mental alertness the next morning.[L6769] Complex sleep behaviors may result from eszopiclone use. Eszopiclone should be discontinued in these cases.[L6874] Avoid the use of alcohol and other CNS depressants when eszopiclone is administered. Advise patients to skip the eszopiclone dose if alcohol has been consumed before bed or during the evening. Use the smallest dose of eszopiclone as possible, especially in elderly patients, who may experience exaggerated drug effects. Though the potential for dependence and abuse with eszopiclone is lower than for other hypnotic drugs, this drug has been abused and is known to cause dependence.[L6868]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23591, 'Nilopenem 1 gm i.v. vial', 'نيلوبينيم 1000مجم وريد فيال', '295', '140', 'Antibiotic', 'Meropenem', 'El nile.', 'Vial', 'فيال', '1 gm', '1', NULL, NULL, '6221077172016', NULL, 1327, '2024-08-07', 0, 'For use as single agent therapy for the treatment of the following infections when caused by susceptible isolates of the designated microorganisms: <b>complicated skin and skin structure infections</b> due to <i>Staphylococcus aureus</i> (b-lactamase and non-b-lactamase producing, methicillin-susceptible isolates only), <i>Streptococcus pyogenes</i>, <i>Streptococcus agalactiae</i>, viridans group streptococci, <i>Enterococcus faecalis</i> (excluding vancomycin-resistant isolates), <i>Pseudomonas aeruginosa</i>, <i>Escherichia coli</i>, <i>Proteus mirabilis</i>, <i>Bacteroides fragilis</i> and <i>Peptostreptococcus</i> species; <b>complicated appendicitis and peritonitis</b> caused by viridans group streptococci, <i>Escherichia coli</i>, <i>Klebsiella pneumoniae</i>, <i>Pseudomonas aeruginosa</i>, <i>Bacteroides fragilis</i>, <i>B. thetaiotaomicron</i>, and <i>Peptostreptococcus</i> species. Also for use in the treatment of bacterial meningitis caused by <i>Streptococcus pneumoniae</i>, <i>Haemophilus influenzae</i> (b-lactamase and non-b-lactamase-producing isolates), and <i>Neisseria meningitidis</i>.', 'The bactericidal activity of meropenem results from the inhibition of cell wall synthesis. Meropenem readily penetrates the cell wall of most Gram-positive and Gram-negative bacteria to reach penicillin-binding- protein (PBP) targets. Its strongest affinities are toward PBPs 2, 3 and 4 of <i>Escherichia coli</i> and <i>Pseudomonas aeruginosa</i>; and PBPs 1, 2 and 4 of <i>Staphylococcus aureus</i>.', 'Meropenem is a broad-spectrum carbapenem antibiotic. It is active against Gram-positive and Gram-negative bacteria. Meropenem exerts its action by penetrating bacterial cells readily and interfering with the synthesis of vital cell wall components, which leads to cell death.', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23593, 'Vepicle 20 tabs', 'فيبيكل 20 قرص', '260', NULL, 'Multivitamin', 'L-carnitine+co enzyme -q10+betacarotene+flaxseed oil powder+garlic extract+vitamin d3+vitamin e+vitamin c+vitamin b1+vitamin b2+vitamin b3+vitamin b6+folic acid as dfe+vitamin b12+magnesium++ iron+zinc+copper+manganese+selenium+chromium+lodine', 'Master pharma', 'Tab', 'أقراص', NULL, '2', NULL, NULL, NULL, NULL, 1202, '2023-01-14', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23594, 'Zyma colin 120 ml syrup', 'زيما كولين شراب 120 مل', '280', '160', 'Supports normal brain functions', 'Citicoline', 'Zyma pharma', 'Syrup', 'شراب', '120 ml', '1', NULL, NULL, NULL, NULL, 2275, '2024-09-02', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23595, 'Nerkardou 5 mg 30 orodispersible films', 'نيركاردو 5مجم 30 فيلم ذائب بالفم', '90', '60', 'Anti-hypertensive.beta blocker.selective b1', 'Bisoprolol fumarate', 'nerhadou international co.', 'Film', 'فيلم', '5 mg', '1', NULL, NULL, '6224011153331', NULL, 1549, '2024-08-14', 0, 'Bisoprolol is indicated for the treatment of mild to moderate hypertension.[L7219] It may be used off-label to treat heart failure, atrial fibrillation, and angina pectoris.[A180460,A180463]', 'Though the mechanism of action of bisoprolol has not been fully elucidated in hypertension, it is thought that therapeutic effects are achieved through the antagonism of β-1adrenoceptors to result in lower cardiac output. Bisoprolol is a competitive, cardioselective β1-adrenergic antagonist. When β1-receptors (located mainly in the heart)[T640] are activated by adrenergic neurotransmitters such as epinephrine, both the blood pressure and heart rate increase, leading to greater cardiovascular work, increasing the demand for oxygen.  Bisoprolol reduces cardiac workload by decreasing contractility and the need for oxygen through competitive inhibition of β1-adrenergic receptors.[A180502,T640]



Bisoprolol is also thought to reduce the output of renin in the kidneys, which normally increases blood pressure. Additionally, some central nervous system effects of bisoprolol may include diminishing sympathetic nervous system output from the brain, decreasing blood pressure and heart rate.[L7219]', 'Bisoprolol decreases heart rate (chronotropy), decreases contractility (inotropy), and reduces blood pressure.[T640,L7219] The results of various clinical studies indicate that bisoprolol reduces cardiovascular mortality and all-cause mortality in patients with heart failure and decreased cardiac ejection fraction (EF).[A180466,A180505] ', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23596, 'Brexpiprazole clavita pharma 2 mg 30 f.c.tabs.', 'بريكسبيبرازول كلافيتا فارما 2 مجم 30 قرص', '216', '166.5', 'Psychiatric.antipsychotics', 'Brexpiprazole', 'Clavita pharma', 'Tab', 'أقراص', '2 mg', '3', NULL, NULL, NULL, NULL, 932, '2024-11-20', 0, 'Brexpiprazole is indicated as adjunctive therapy to antidepressants for the treatment of major depressive disorder in adults.[L39568] It is also indicated for the treatment of schizophrenia in patients 13 years of age and older.[L39568]



Brexpiprazole is also indicated for the treatment of agitation associated with dementia due to Alzheimer’s disease; however, it is not indicated as an as-needed (“prn”) treatment for this condition.[L46417]', 'Although the exact mechanism of action of brexpiprazole in psychiatric disorders has not been fully elucidated, the efficacy of brexpiprazole may be attributed to combined partial agonist activity at 5-HT<sub>1A</sub> and dopamine D2 receptors, and antagonist activity at 5-HT<sub>2A</sub> receptors. Brexpiprazole binds to these receptors with subnanomolar affinities.[A7782, A259626, L46417] These therapeutic targets have been implicated in psychiatric conditions such as schizophrenia and depression. Partial D2 receptor agonism allows the drug to stimulate D2 receptors under low dopamine conditions, while attenuating their activation when dopamine levels are high. Partial agonism at 5-HT<sub>1A</sub> receptors may be tied to improved memory function and cognitive performance. Antagonism at α-adrenergic receptors has also been implicated in schizophrenia and depression.[A182186, A259641]', 'Brexpiprazole is an atypical antipsychotic agent used to ameliorate the symptoms of psychiatric conditions, such as cognitive deficits and affective symptoms.[A182186] Brexpiprazole has affinity (expressed as Ki) for multiple monoaminergic receptors including serotonin 5-HT<sub>1A</sub> (0.12 nM), 5-HT<sub>2A</sub> (0.47 nM), 5-HT<sub>2B</sub> (1.9 nM), 5-HT<sub>7</sub> (3.7 nM), dopamine D2 (0.30 nM), D3 (1.1 nM), and noradrenergic α<sub>1A</sub> (3.8 nM), α<sub>1B</sub> (0.17 nM), α<sub>1D</sub> (2.6 nM), and α<sub>2C</sub> (0.59 nM) receptors. Brexpiprazole acts as a partial agonist at the 5-HT<sub>1A</sub>, D2, and D3 receptors and as an antagonist at 5-HT<sub>2A</sub>, 5-HT<sub>2B</sub>, 5-HT<sub>7</sub>, α<sub>1A</sub>, α<sub>1B</sub>, α<sub>1D</sub>, and α<sub>2C</sub> receptors. Brexpiprazole also exhibits affinity for histamine H1 receptor (19 nM) and for muscarinic M1 receptor (67% inhibition at 10 µM).[L46417]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23597, 'Vitamin d3 240.000 iu 15 ml drops', 'فيتامين د3 240000 وحدة دولية 15 مل نقط فم', '70', NULL, 'Vitamin d', 'Vitamin d', 'Sehha pharma', 'Drops', 'نقط', '240.000 iu', '1', NULL, NULL, NULL, NULL, 777, '2022-12-07', 0, 'Vitamin D is indicated for use in the treatment of hypoparathyroidism, refractory rickets (also known as vitamin D resistant rickets), and familial hypophosphatemia [FDA Label].', 'Most individuals naturally generate adequate amounts of vitamin D through ordinary dietary intake of vitamin D (in some foods like eggs, fish, and cheese) and natural photochemical conversion of the vitamin D3 precursor 7-dehydrocholesterol in the skin via exposure to sunlight.[A223]



Conversely, vitamin D deficiency can often occur from a combination of insufficient exposure to sunlight, inadequate dietary intake of vitamin D, genetic defects with endogenous vitamin D receptor, or even severe liver or kidney disease [A243]. Such deficiency is known for resulting in conditions like rickets or osteomalacia, all of which reflect inadequate mineralization of bone, enhanced compensatory skeletal demineralization, resultant decreased calcium ion blood concentrations, and increases in the production and secretion of parathyroid hormone [A223]. Increases in parathyroid hormone stimulates the mobilization of skeletal calcium and the renal excretion of phosphorus [A223]. This enhanced mobilization of skeletal calcium leads towards porotic bone conditions [A223].



Ordinarily, while vitamin D3 is made naturally via photochemical processes in the skin, both itself and vitamin D2 can be found in various food and pharmaceutical sources as dietary supplements. The principal biological function of vitamin D is the maintenance of normal levels of serum calcium and phosphorus in the bloodstream by enhancing the efficacy of the small intestine to absorb these minerals from the diet [A223]. At the liver, vitamin D3 or D2 is hydroxylated to 25-hydroxyvitamin D and then finally to the primary active metabolite 1,25-dihydroxyvitamin D in the kidney via further hydroxylation [A223, A243]. This final metabolite binds to endogenous vitamin d receptors, which results in a variety of regulatory roles - including maintaining  calcium balance, the regulation of parathyroid hormone, the promotion of the renal reabsorption of calcium, increased intestinal absorption of calcium and phosphorus, and increased calcium and phosphorus mobilization of calcium and phosphorus from bone to plasma to maintain balanced levels of each in bone and the plasma [A223, A243].', 'The in vivo synthesis of the predominant two biologically active metabolites of vitamin D occurs in two steps. The first hydroxylation of vitamin D3 or D2 occurs in the liver to yield 25-hydroxyvitamin D while the second hydroxylation happens in the kidneys to give 1, 25-dihydroxyvitamin D [FDA Label]. These vitamin D metabolites subsequently facilitate the active absorption of calcium and phosphorus in the small intestine, serving to increase serum calcium and phosphate levels sufficiently to allow bone mineralization [FDA Label]. Conversely, these vitamin D metabolites also assist in mobilizing calcium and phosphate from bone and likely increase the reabsorption of calcium and perhaps also of phosphate via the renal tubules [FDA Label]. There exists a period of 10 to 24 hours between the administration of vitamin D and the initiation of its action in the body due to the necessity of synthesis of the active vitamin D metabolites in the liver and kidneys [FDA Label]. It is parathyroid hormone that is responsible for the regulation of such metabolism at the level of the kidneys [FDA Label].', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23598, 'Capixy anti-hair loss vials 7*10ml (70ml)', 'كابيكسي مضاد لتساقط الشعر فيال 7*10 مل (70 مل)', '950', NULL, 'Hair care', 'Redensyl+capixyl+anagain+baicapil+aminexil+procapil', 'Majestic biopharma', 'Cap', 'كبسولة', '10ml', '7', NULL, NULL, '6224001455247', NULL, 648, '2023-01-14', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23599, 'Roqarik 90 mg 20 tabs', 'روكاريك 30مجم 20 قرص', '159', '104', 'Cox-2 selective inhibitor', 'Etoricoxib', 'Hp pharma', 'Tab', 'أقراص', '90 mg', '2', NULL, NULL, '224011394314', NULL, 4733, '2025-08-20', 0, 'For the treatment of rheumatoid arthritis, osteoarthritis, ankylosing spondylitis, chronic low back pain, acute pain and gout.', 'Like any other COX-2 selective inhibitor Etoricoxib selectively inhibits isoform 2 of cyclo-oxigenase enzyme (COX-2), preventing production of prostaglandins (PGs) from arachidonic acid.', 'Etoricoxib is a COX-2 selective inhibitor (approximately 106 times more selective for COX-2 inhibition over COX-1).', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23600, 'Nimbex 2mg/ml (10ml=20mg) 5amps.', 'نيمبكس 2مجم/مل (10مل=20مجم) 5 امبول', '250', NULL, 'Anesthetic.muscle relaxant.non depolarizing', 'Cisatracurium besylate', 'Glaxo smithkline > phoenix-egypt', 'Amp', 'أمبول', '2mg', '5', NULL, NULL, NULL, NULL, 920, '2022-08-16', 0, 'Cisatracurium is indicated as an adjunct to general anesthesia to facilitate tracheal intubation in adults and pediatric patients 1 month to 12 years of age. Cisatracurium is also indicated to provide skeletal muscle relaxation during surgery in adults and pediatric patients 2 to 12 years of age as a bolus or infusion maintenance and for mechanical ventilation in the ICU in adults.[L43577]', 'Like other non-depolarising neuromuscular blocking agents, cisatracurium binds competitively to cholinergic receptors in motor end-plate neurons, blocking acetylcholine from accessing the receptors.[L43577] Therefore, in the presence of cisatracurium, an end-plate potential cannot be developed. Ion channels remain closed, the cell does not depolarize, and an action potential is not transmitted.[A243416]', 'The dose required to produce 95% suppression of twitch response to nerve stimulation (ED<sub>95</sub>) of cisatracurium is 0.05 mg/kg in adults receiving opioid/nitrous oxide/oxygen anesthesia.[A253597,L43577] The degree and duration of the neuromuscular block produced by cisatracurium increases in a dose-dependent manner, while the time to maximum neuromuscular block decreases.[A253597] Compared to other neuromuscular blocking agents, it is intermediate in its onset and duration of action.[A253592] Cisatracurium acts on cholinergic receptors, blocking neuromuscular transmission. This action is antagonized by acetylcholinesterase inhibitors such as neostigmine.[A243416]



The use of cisatracurium may lead to residual paralysis, as well as a higher risk of seizure. Medication errors increase the risk of death, and the use of certain drugs may potentiate the neuromuscular blocking action of cisatracurium.[L43577]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23601, 'Nimbex 2mg/ml (2.5ml=5mg) 5 amps.', 'نيمبكس 2مجم/مل (2.5مل=5مجم) 5 امبولات', '138', NULL, 'Anesthetic.muscle relaxant.non depolarizing', 'Cisatracurium besylate', 'Glaxo smithkline > phoenix-egypt', 'Amp', 'أمبول', '2mg', '5', NULL, 'description cisatracurium besylate is a nondepolarizing skeletal muscle relaxant for intravenous administration. indication for inpatients and outpatients as an adjunct to general anesthesia to facilitate tracheal intubation and to provide skeletal muscle', NULL, NULL, 672, '2022-08-16', 0, 'Cisatracurium is indicated as an adjunct to general anesthesia to facilitate tracheal intubation in adults and pediatric patients 1 month to 12 years of age. Cisatracurium is also indicated to provide skeletal muscle relaxation during surgery in adults and pediatric patients 2 to 12 years of age as a bolus or infusion maintenance and for mechanical ventilation in the ICU in adults.[L43577]', 'Like other non-depolarising neuromuscular blocking agents, cisatracurium binds competitively to cholinergic receptors in motor end-plate neurons, blocking acetylcholine from accessing the receptors.[L43577] Therefore, in the presence of cisatracurium, an end-plate potential cannot be developed. Ion channels remain closed, the cell does not depolarize, and an action potential is not transmitted.[A243416]', 'The dose required to produce 95% suppression of twitch response to nerve stimulation (ED<sub>95</sub>) of cisatracurium is 0.05 mg/kg in adults receiving opioid/nitrous oxide/oxygen anesthesia.[A253597,L43577] The degree and duration of the neuromuscular block produced by cisatracurium increases in a dose-dependent manner, while the time to maximum neuromuscular block decreases.[A253597] Compared to other neuromuscular blocking agents, it is intermediate in its onset and duration of action.[A253592] Cisatracurium acts on cholinergic receptors, blocking neuromuscular transmission. This action is antagonized by acetylcholinesterase inhibitors such as neostigmine.[A243416]



The use of cisatracurium may lead to residual paralysis, as well as a higher risk of seizure. Medication errors increase the risk of death, and the use of certain drugs may potentiate the neuromuscular blocking action of cisatracurium.[L43577]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23602, 'Nimbex 2mg/ml (5ml=10mg) 5 amps.', 'نيمبيكس 2مجم/مل(5مل=10مجم) 5 امبول', '235', NULL, 'Anesthetic.muscle relaxant.non depolarizing', 'Cisatracurium besylate', 'Glaxo smithkline > phoenix-egypt', 'Amp', 'أمبول', '2mg', '5', NULL, 'description cisatracurium besylate is a nondepolarizing skeletal muscle relaxant for intravenous administration. indication for inpatients and outpatients as an adjunct to general anesthesia to facilitate tracheal intubation and to provide skeletal muscle', '8021961013061', NULL, 982, '2022-12-07', 0, 'Cisatracurium is indicated as an adjunct to general anesthesia to facilitate tracheal intubation in adults and pediatric patients 1 month to 12 years of age. Cisatracurium is also indicated to provide skeletal muscle relaxation during surgery in adults and pediatric patients 2 to 12 years of age as a bolus or infusion maintenance and for mechanical ventilation in the ICU in adults.[L43577]', 'Like other non-depolarising neuromuscular blocking agents, cisatracurium binds competitively to cholinergic receptors in motor end-plate neurons, blocking acetylcholine from accessing the receptors.[L43577] Therefore, in the presence of cisatracurium, an end-plate potential cannot be developed. Ion channels remain closed, the cell does not depolarize, and an action potential is not transmitted.[A243416]', 'The dose required to produce 95% suppression of twitch response to nerve stimulation (ED<sub>95</sub>) of cisatracurium is 0.05 mg/kg in adults receiving opioid/nitrous oxide/oxygen anesthesia.[A253597,L43577] The degree and duration of the neuromuscular block produced by cisatracurium increases in a dose-dependent manner, while the time to maximum neuromuscular block decreases.[A253597] Compared to other neuromuscular blocking agents, it is intermediate in its onset and duration of action.[A253592] Cisatracurium acts on cholinergic receptors, blocking neuromuscular transmission. This action is antagonized by acetylcholinesterase inhibitors such as neostigmine.[A243416]



The use of cisatracurium may lead to residual paralysis, as well as a higher risk of seizure. Medication errors increase the risk of death, and the use of certain drugs may potentiate the neuromuscular blocking action of cisatracurium.[L43577]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23603, 'Nimenrix vial powder for i.m.', 'نيمينريكس باودر فيال عضل', '1,275', '851', 'Vaccine', 'Meningitidis groups (a+c+w-135+y) polysaccharide', 'Glaxo smithkline > pfizer scientific office', 'Vial', 'فيال', NULL, '1', 'مصل للحمي الشوكية', 'nimenrix is a vaccine used to protect adults adolescents and children from the age of 6 weeks against invasive meningococcal disease caused by four groups of the bacterium neisseria meningitidis (group a c w-135 and y). invasive disease occurs when the ba', NULL, NULL, 2245, '2024-11-29', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23604, 'Nimo 30 mg 10 caps.', 'نيمو 30مجم 10 قرص', '18', NULL, 'Calcium channel blocker', 'Nimodipine', 'Grand pharma > delta grand pharma', 'Cap', 'كبسولة', '30 mg', '1', NULL, 'about nimodipine a dihydropyridine calcium channel blocker treatment of neurologic defects associated with subarachnoid hemorrhage. mechanism of action of nimodipine nimodipine is a ca channel blocker. it exerts its actions through blocking the influx of', NULL, NULL, 857, '2022-07-08', 0, 'For use as an adjunct to improve neurologic outcome following subarachnoid hemorrhage (SAH) from ruptured intracranial berry aneurysms by reducing the incidence and severity of ischemic deficits.', 'Although the precise mechanism of action is not known, nimodipine blocks intracellular influx of calcium through voltage-dependent and receptor-operated slow calcium channels across the membranes of myocardial, vascular smooth muscle, and neuronal cells. By specifically binding to L-type voltage-gated calcium channels, nimodipine inhibits the calcium ion transfer, resulting in the inhibition of vascular smooth muscle contraction. Evidence suggests that the dilation of small cerebral resistance vessels, with a resultant increase in collateral circulation, and/or a direct effect involving the prevention of calcium overload in neurons may be responsible for nimodipine''s clinical effect in patients with subarachnoid hemorrhage.', 'Nimodipine belongs to the class of pharmacological agents known as calcium channel blockers. Nimodipine is indicated for the improvement of neurological outcome by reducing the incidence and severity of ischemic deficits in patients with subarachnoid hemorrhage from ruptured congenital aneurysms who are in good neurological condition post-ictus (e.g., Hunt and Hess Grades I-III). The contractile processes of smooth muscle cells are dependent upon calcium ions, which enter these cells during depolarization as slow ionic transmembrane currents. Nimodipine inhibits calcium ion transfer into these cells and thus inhibits contractions of vascular smooth muscle. In animal experiments, nimodipine had a greater effect on cerebral arteries than on arteries elsewhere in the body perhaps because it is highly lipophilic, allowing it to cross the blood brain barrier. ', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23605, 'Nimodipine 30mg 30 tabs.', 'نيموديبين 30مجم 30 قرص', '60', NULL, 'Calcium channel blocker', 'Nimodipine', 'Pharco', 'Tab', 'أقراص', '30mg', '3', 'علاج ارتفاع ضغط الدم', NULL, NULL, NULL, 2853, '2022-12-21', 0, 'For use as an adjunct to improve neurologic outcome following subarachnoid hemorrhage (SAH) from ruptured intracranial berry aneurysms by reducing the incidence and severity of ischemic deficits.', 'Although the precise mechanism of action is not known, nimodipine blocks intracellular influx of calcium through voltage-dependent and receptor-operated slow calcium channels across the membranes of myocardial, vascular smooth muscle, and neuronal cells. By specifically binding to L-type voltage-gated calcium channels, nimodipine inhibits the calcium ion transfer, resulting in the inhibition of vascular smooth muscle contraction. Evidence suggests that the dilation of small cerebral resistance vessels, with a resultant increase in collateral circulation, and/or a direct effect involving the prevention of calcium overload in neurons may be responsible for nimodipine''s clinical effect in patients with subarachnoid hemorrhage.', 'Nimodipine belongs to the class of pharmacological agents known as calcium channel blockers. Nimodipine is indicated for the improvement of neurological outcome by reducing the incidence and severity of ischemic deficits in patients with subarachnoid hemorrhage from ruptured congenital aneurysms who are in good neurological condition post-ictus (e.g., Hunt and Hess Grades I-III). The contractile processes of smooth muscle cells are dependent upon calcium ions, which enter these cells during depolarization as slow ionic transmembrane currents. Nimodipine inhibits calcium ion transfer into these cells and thus inhibits contractions of vascular smooth muscle. In animal experiments, nimodipine had a greater effect on cerebral arteries than on arteries elsewhere in the body perhaps because it is highly lipophilic, allowing it to cross the blood brain barrier. ', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23606, 'Oxitruhans 60 capsules', 'اوكسيتروهانز 60 كبسولة', '299', NULL, 'Multivitamin for skin hair and nails', 'Biotin+vitamin d3+zinc+selenium+vitamin e', 'Medcare pharmaceuticals', 'Capsule', 'كبسولة', NULL, '6', NULL, NULL, NULL, NULL, 2058, '2022-07-15', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23608, 'Ninlaro 2.3 mg 3 caps.', 'نينلارو2.3مجم3كبسولات', '40,540', NULL, 'Proteasome inhibitor', 'Ixazomib', 'Takeda', 'Cap', 'كبسولة', '2.3 mg', '1', NULL, 'ninlaro is a prescription medicine used to treat multiple myeloma in combination with the medicines revlimidï- (lenalidomide) and dexamethasone in people who have received at least one prior treatment for their multiple myeloma. -ixazomib: 4 mg po on days', '5414752101963', NULL, 408, '2022-08-06', 0, 'Ixazomib is indicated in combination with lenalidomide and dexamethasone for the treatment of patients with multiple myeloma who have received at least one prior therapy.[L51234, L51239, L51244]', 'The ubiquitin-proteasome signalling pathway regulates cellular homeostasis and survival: It promotes protein degradation, activates the transcriptional factor nuclear factor (NF)-κB to upregulate the expression of growth and angiogenic factors, and blocks apoptosis. Made up of identical alpha (α)- and beta (β)-rings, the 20S proteasome catalytic core is part of the proteasome.[A7948]



Ixazomib is a selective, potent, and reversible inhibitor of the 20S proteasome. It preferentially binds to the β5 chymotrypsin-like proteolytic site with a half-maximal inhibitory concentration (IC50) value of 3.4 nmol/L.[A264329, L51234] At higher concentrations, ixazomib may inhibit the caspase-like (β1) and trypsin-like (β2) proteolytic sites.[A7948] ', 'Ixazomib exerts antimyeloma effects with time-dependent reversible proteasome inhibition.[A7948] Ixazomib induced apoptosis of multiple myeloma cell lines in vitro.[A264319] Ixazomib demonstrated in vitro cytotoxicity against myeloma cells from patients who had relapsed after multiple prior therapies, including bortezomib, lenalidomide, and dexamethasone. The combination of ixazomib and lenalidomide demonstrated synergistic cytotoxic effects in multiple myeloma cell lines. In vivo, ixazomib demonstrated antitumour activity in a mouse multiple myeloma tumour xenograft model.[L51234]



Studies show that ixazomib exhibits an antiangiogenic activity and blocks osteoclastogenesis and osteoclast reabsorption.[A7948]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23609, 'Ninlaro 3 mg 3 caps.', 'نينلارو 3مجم 3 كبسول', '51,645', NULL, 'Proteasome inhibitor', 'Ixazomib', 'Takeda', 'Cap', 'كبسولة', '3 mg', '1', NULL, 'ninlaro is a prescription medicine used to treat multiple myeloma in combination with the medicines revlimidï- (lenalidomide) and dexamethasone in people who have received at least one prior treatment for their multiple myeloma. -ixazomib: 4 mg po on days', '5414752101970', NULL, 402, '2022-08-05', 0, 'Ixazomib is indicated in combination with lenalidomide and dexamethasone for the treatment of patients with multiple myeloma who have received at least one prior therapy.[L51234, L51239, L51244]', 'The ubiquitin-proteasome signalling pathway regulates cellular homeostasis and survival: It promotes protein degradation, activates the transcriptional factor nuclear factor (NF)-κB to upregulate the expression of growth and angiogenic factors, and blocks apoptosis. Made up of identical alpha (α)- and beta (β)-rings, the 20S proteasome catalytic core is part of the proteasome.[A7948]



Ixazomib is a selective, potent, and reversible inhibitor of the 20S proteasome. It preferentially binds to the β5 chymotrypsin-like proteolytic site with a half-maximal inhibitory concentration (IC50) value of 3.4 nmol/L.[A264329, L51234] At higher concentrations, ixazomib may inhibit the caspase-like (β1) and trypsin-like (β2) proteolytic sites.[A7948] ', 'Ixazomib exerts antimyeloma effects with time-dependent reversible proteasome inhibition.[A7948] Ixazomib induced apoptosis of multiple myeloma cell lines in vitro.[A264319] Ixazomib demonstrated in vitro cytotoxicity against myeloma cells from patients who had relapsed after multiple prior therapies, including bortezomib, lenalidomide, and dexamethasone. The combination of ixazomib and lenalidomide demonstrated synergistic cytotoxic effects in multiple myeloma cell lines. In vivo, ixazomib demonstrated antitumour activity in a mouse multiple myeloma tumour xenograft model.[L51234]



Studies show that ixazomib exhibits an antiangiogenic activity and blocks osteoclastogenesis and osteoclast reabsorption.[A7948]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23610, 'Ninlaro 4 mg 3 caps.', 'نينلارو 4مجم3 كبسولات', '57,375', NULL, 'Proteasome inhibitor', 'Ixazomib', 'Takeda', 'Cap', 'كبسولة', '4 mg', '1', NULL, 'ninlaro is a prescription medicine used to treat multiple myeloma in combination with the medicines revlimidï- (lenalidomide) and dexamethasone in people who have received at least one prior treatment for their multiple myeloma. -ixazomib: 4 mg po on days', '5020535005368', NULL, 418, '2022-08-06', 0, 'Ixazomib is indicated in combination with lenalidomide and dexamethasone for the treatment of patients with multiple myeloma who have received at least one prior therapy.[L51234, L51239, L51244]', 'The ubiquitin-proteasome signalling pathway regulates cellular homeostasis and survival: It promotes protein degradation, activates the transcriptional factor nuclear factor (NF)-κB to upregulate the expression of growth and angiogenic factors, and blocks apoptosis. Made up of identical alpha (α)- and beta (β)-rings, the 20S proteasome catalytic core is part of the proteasome.[A7948]



Ixazomib is a selective, potent, and reversible inhibitor of the 20S proteasome. It preferentially binds to the β5 chymotrypsin-like proteolytic site with a half-maximal inhibitory concentration (IC50) value of 3.4 nmol/L.[A264329, L51234] At higher concentrations, ixazomib may inhibit the caspase-like (β1) and trypsin-like (β2) proteolytic sites.[A7948] ', 'Ixazomib exerts antimyeloma effects with time-dependent reversible proteasome inhibition.[A7948] Ixazomib induced apoptosis of multiple myeloma cell lines in vitro.[A264319] Ixazomib demonstrated in vitro cytotoxicity against myeloma cells from patients who had relapsed after multiple prior therapies, including bortezomib, lenalidomide, and dexamethasone. The combination of ixazomib and lenalidomide demonstrated synergistic cytotoxic effects in multiple myeloma cell lines. In vivo, ixazomib demonstrated antitumour activity in a mouse multiple myeloma tumour xenograft model.[L51234]



Studies show that ixazomib exhibits an antiangiogenic activity and blocks osteoclastogenesis and osteoclast reabsorption.[A7948]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23611, 'Nipal cream 30gm', 'نيبال كريم 30جم', '9', NULL, 'Moisturizing topicals', 'Stearic acid+cetyl alcohol+triethanolamine+sesame oil+almond oil+jojoba oil+wheat germ oil+panthenol', 'Hi-care > falcon group', 'Cream', 'كريم', '30gm', '1', NULL, 'moisturizing cream for cracked nipples.', NULL, NULL, 763, '2022-07-11', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23612, 'Niplo cream 30gm', 'نيبلو كريم 30 جم', '14', NULL, 'Moisturizing topicals', 'Stearic acid+cetyl alcohol+triethanolamine+sesame oil+almond oil+jojoba oil+wheat germ oil+panthenol', 'Egyptian canadian for drug', 'Cream', 'كريم', '30gm', '1', NULL, 'moisturizing cream for cracked nipples.', NULL, NULL, 729, '2022-07-09', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23613, 'Nipruss 60mg 5 amp.', 'نيبراس 60مجم 5 امبول', '139', NULL, 'Antihypertensive.direct vasodilator', 'Sodium nitroprusside', 'Schwarz > amc', 'Amp', 'أمبول', '60mg', '5', NULL, NULL, NULL, NULL, 650, '2022-08-17', 0, 'For the treatment of small uncomplicated varicose veins of the lower extremities that show simple dilation with competent valves.', 'Sodium tetradecyl sulfate is a potent toxin for endothelial cells in that brief exposure to even low concentrations are effective in stripping endothelium over a considerable distance and exposing highly thrombogenic endothelium in the process. Diluted sodium tetradecyl sulfate is also able to induce a hypercoagulable state, possibly by selective inhibition of protein C, and can also promote platelet aggregation.', 'Sodium tetradecyl sulfate is an anionic surfactant which occurs as a white, waxy solid. It is used as a sclerosing agent in sclerotherapy. Sclerotherapy is an injection of a sclerosing agent directly through the skin into a lesion and is used primarily for slow-flow vascular anomalies, particularly for venous malformation and lymphatic malformation. Intravenous injection causes intima inflammation and thrombus formation. This usually occludes the injected vein. Subsequent formation of fibrous tissue results in partial or complete vein obliteration that may or may not be permanent.', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23614, 'Niramar feminine intimate wash 120 ml', 'نيرامار فيمينين انتيميت غسول للسيدات 120 مل', '19', NULL, 'Vaginal care', 'Triclosan+menthol+propolis+tea tree oil+aloe vera extract+chamomile extract.', 'Hi-care > octabiotic pharma', 'Unknown', 'غير محدد', '120 ml', '1', 'غسول مهبلي يساعد علي المحافظة علي معدلات الحموضة في المهبل', NULL, NULL, NULL, 1603, '2022-05-21', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23615, 'Nirena intimate feminine wash 250ml', 'نرينا غسول 250مل', '67', NULL, 'Vaginal wash', 'Aloe vera extract+thyme ext+chamomile ext+rose ext+sage oil+menthol+triclosan+citric acid+glycerin', 'Hi-care > scin.off scientific office', 'Unknown', 'غير محدد', '250ml', '1', NULL, 'how to use: use a measure of the wash on 200 ml of warm water for rinsing then rinse thoroughly with water. use as needed.', NULL, NULL, 699, '2022-08-04', 0, 'Indicated for use as a topical agent to soothe sensitive skin and to relieve symptoms of various skin conditions, including contact or atopic dermatitis, eczema, dermatitis and acne urticata, first- and second-degree burns, radiation dermatitis, and sunburn. ', 'It is suggested that aloe polysaccharides mediate skin-protectant effects in damaged skin, induced by internal or other external factors such as radiation, via inhibiting apoptosis of normal cell lines _in vitro_ and thrombocytes _in vivo_ [A32473]. Following irradiation, aloe polysaccharides block the upregulation of pro-apoptotic p53, Bax, and Bad while blocking downregulating anti-apoptotic Bcl-2 [A32473]. _In vivo_, aloe polysaccharides may act as a scavenger for oxygen free radicals including DPPH, alkyl radicals, superoxides, and singlet oxygen and hydroxyl radicals that may also be generated by superoxides [A32470, A32476]. Hydrogen peroxide, which is a weak initiate lipid peroxidation, may also be effectively scavenged by aloe polysaccharides [A32476]. In a Fenton reaction system, aloe polysaccharides demonstrated a concentration-dependent scavenging activity against hydroxyl radical that were generated during the reaction [A32476]. Aloe polysaccharides may also compete with oxygen to react with nitric oxide (NO), thereby inhibiting the generation of nitrite and peroxynitrite anions that act as free radicals [A32476]. 



Findings from a study investigating the effects of aloe polysaccharides on doxorubicin-induced oxidative stress suggest that aloe polysaccharides mediate potent antioxidant actions _in vivo_ [A32476]. Doxorubicin, known to generate reactive oxygen species such as superoxide and hydroxy radicals, was administered to albino rats. This led to myocardial oxidative stress and cardiac injury accompanied by leakage of LDH and CPK from cardiac myocytes and to serum due to lipid peroxidation of cardiac membranes, reduced levels of antioxidant coenzyme GSH, and increased levels of SOD from a compensatory and combative mechanism of oxidative stress [A32476]. Treatment with aloe polysaccharides resulted in a significant decrease in serum LDH and CPK levels, indicating that aloe polysaccharides are capable in stabilizing cardiac membranes from peroxidative damage. Restored levels of endogenous GSH and SOD in a dose-dependent manner were also observed with the treatment of aloe polysaccharides, suggesting that aloe polysaccharides exhibit potent antioxidant properties [A32476].



In a study of rats with open cutaneous back wounds, treatment with aloe polysaccharides decreased the levels of matrix metalloproteinase-3 (MMP-3) and induced tissue inhibitors of matrix metalloproteinase-2 (TIMP-2) during the early stage of wound repair, resulting in decreased collagen breakdown and increased preservation of collagen content in the injured area [A32471]. A study proposes that acemannan, a common aloe polysaccharide, stimulates BMSC proliferation, ALPase activity, expression of VEGF, BMP-2, OPN, BSP, and mineralization leading to osteoblast differentiation and bone formation during socket healing [A32475]. ', 'Aloe polysaccharides mediate antioxidant and anti-inflammatory actions, as well as immunoregulatory activities. Various studies indicate that aloe polysaccharides possess effective free radical scavenging activity _in vitro_, and produce potent antioxidant potential during oxidative stress _in vivo_ [A32476]. According to the findings of studies _in vitro_ and _in vivo_, aloe polysaccharides exhibit radioprotective activity. Treatment with acemmanan, which is a common aloe polysaccharide, on CH3 mice with radiation-induced skin reactions resulted in reduced signs of those reactions [A32473]. Studies suggest that aloe polysaccharides may evidently attenuate tumor growth in mice [A32473]. Treatment of aloe polysaccharides in Vero cells as well as in the in vivo zebrafish model led to protective effects against AAPH-indued oxidative stress resulting from accumulation of free radical species and improved cell viability [A32470]. ', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23616, 'Nisaprofen 25 mg 30 f.c.tab.', 'نيسابروفين 25مجم 30 اقراص', '36', NULL, 'Nsaid.propionic acid derivatives', 'Dexketoprofen', 'Sabaa > loxxess-egypt', 'Tab', 'أقراص', '25 mg', '3', NULL, 'about dexketoprofen nonsteroidal anti-inflammatory drugs analgesic propionic acid derivative. mechanism of action of dexketoprofen dexketoprofen works by blocking the action of a substance in the body called cyclo-oxygenase (cox). cyclo-oxygenase is invol', NULL, NULL, 830, '2022-07-16', 0, 'For short-term treatment of mild to moderate pain, including dysmenorrhoea, musculoskeletal pain and toothache [L1302]. ', ' It is a non-steroidal anti-inflammatory drug (NSAID) that reduces prostaglandin synthesis via inhibition of cyclooxygenase pathway (both COX-1 and COX-2) activity [L1299].', 'This drug is an isomer of ketoprofen.   Dexketoprofen a propionic acid derivative with analgesic, anti-inflammatory, and antipyretic properties [L1299].  ', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23617, 'Nit clean 100mg/5ml pd. for oral susp. 60 ml', 'نت كلين 100مجم/5مل للاطفال معلق 60 مل', '32', '20.5', 'Antihelminthic', 'Nitazoxanide', 'Sedico > western pharmaceuticals industries', 'Susp', 'معلق', '100mg', '1', NULL, 'about nitazoxanide a synthetic nitrothiazolyl-salicylamide derivative antihelminthics in schistosomiasis. mechanism of action of nitazoxanide it excerts its action by blocking anaerobic energy metabolism. the drug interfering with the pyruvate-ferredoxin', '6224007308400', NULL, 1210, '2024-12-01', 0, 'For the treatment of diarrhea in adults and children caused by the protozoa <i>Giardia lamblia</i>,  and for the treatment of diarrhea in children caused by the protozoan,  <i>Cryptosporidium parvum</i> [FDA label].



Nitazoxanide has not been shown to be superior to placebo medication for the management of diarrhea caused by Cryptosporidium parvum in patients with HIV/immunodeficiency [FDA label, A31973, A31976]. ', 'The most widely accepted mechanism of NTZ is believed to be the disruption of the energy metabolism in anaerobic microbes by inhibition of the pyruvate: ferredoxin/flavodoxin oxidoreductase (PFOR) cycle [A31981]. In parasitic-protozoa, Nitazoxanide also induces lesions in the cell membranes and depolarizes the mitochondrial membrane while inhibiting quinone oxidoreductase NQO1, nitroreductase-1 and protein disulphide isomerase enzymes. In addition, this drug also inhibits the glutathione-S-transferase (a major detoxifying enzyme) and modulates the Avr-14 gene, encoding for the alpha-type subunit of glutamate-gated chloride ion channel present in nematodes. Aside from its well understood non-competitive inhibition of the PFOR in anaerobic bacteria, NTZ also demonstrates various other antibacterial mechanisms. It inhibits pyruvate dehydrogenase in E Coli, disrupts the membrane potential and pH homeostasis in the Mycobacterium tuberculosis, suppresses the chaperone/usher (CU) pathway of the gram-negative bacteria,  and stimulates host macrophage autophagy in tuberculosis patients [A31976]. NTZ also suppresses viral replication by inhibiting the maturation of the viral hemagglutinin and the viral transcription factor immediate early 2 (IE2) as well as by activating the eukaryotic translation initiation factor 2α (an antiviral intracellular protein). Lastly, NTZ exhibits an inhibitory effect on tumor cell progression by altering drug detoxification (glutathione-S-transferase P1), unfolded protein response, autophagy, anti-cytokines activity, and c-Myc inhibition [A31976].', 'The general effect of this medication is the prevention of microbe activity through disruption of important energy pathways for survival and proliferation [FDA label, A31976].  Nitazoxanide exhibits antiprotozoal activity by interfering with the pyruvate ferredoxin/flavodoxin oxidoreductase dependent electron transfer reaction, an essential reaction need for anaerobic energy metabolism of various microorganisms.  Sporozoites of Cryptosporidium parvum and trophozoites of Giardia lamblia are therefore inhibited, relieving symptoms of diahrrea [L1425]. Interference with the PFOR enzyme-dependent electron transfer reaction may only be one of the many pathways by which nitazoxanide exhibits antiprotozoal activity [FDA label, A31973, L1425]. ', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23618, 'Enhertu 100 mg pwd. i.v. inf. vial', 'انهريتو 100 مجم فيال وريد', '43,575', '0', 'Antineoplastic', 'Trastuzumab deruxtecan', 'Egyptian pharmaceutical trading company', 'Vial', 'فيال', '100 mg', '1', NULL, NULL, NULL, NULL, 2706, '2023-04-28', 0, 'Trastuzumab deruxtecan is indicated for the following conditions: 



**HER2-Positive Breast Cancer**



- This indication is approved in the US, Canada, and Europe.

- It is indicated for the treatment of adult patients with unresectable or metastatic HER2-positive (IHC 3+ or ISH positive) breast cancer who have received a prior anti-HER2-based regimen.[L50662, L42240, L48576] In the US and Canada, it is used either in the metastatic setting or in the neoadjuvant or adjuvant setting in patients who have developed disease recurrence during or within six months of completing therapy.[L50662, L42240]

- In Canada, it is also used in patients who have received prior treatment with trastuzumab emtansine (T-DM1).[L42240]



**HER2-Low Breast Cancer**



- This indication is approved in the US, Canada, and Europe.

- It is indicated for the treatment of adult patients with unresectable or metastatic HER2-low (IHC 1+ or IHC 2+/ISH-) breast cancer, as determined by an FDA-approved test, who have received prior chemotherapy in the metastatic setting or developed disease recurrence during or within 6 months of completing adjuvant chemotherapy.[L50662, L42240, L48576]



**Non-small cell lung cancer (NSCLC)**



- This indication is approved in the US and Europe.

- It is indicated for the treatment of adult patients with unresectable or metastatic non-small cell lung cancer (NSCLC) whose tumours have activating HER2 (ERBB2) mutations and who have received prior systemic therapy.[L50662, L48576] In Europe, it is used in patients who require systemic therapy following platinum-based chemotherapy with or without immunotherapy.[L48576]



**Gastric cancer**



- This indication is approved in the US and Europe.

- It is indicated for the treatment of adult patients with locally advanced or metastatic HER2-positive (IHC 3+ or IHC 2+/ISH positive) gastric or gastroesophageal junction (GEJ) adenocarcinoma who have received a prior trastuzumab-based regimen.[L50662, L48576]



**Solid Tumors**



- This indication is approved in the US.

- It is indicated for the treatment of adult patients with unresectable or metastatic HER2-positive (IHC 3+) solid tumours who have received prior systemic treatment and have no satisfactory alternative treatment options.[L50662]', 'Trastuzumab deruxtecan is a humanized anti-HER2 IgG1 antibody, targeting cancer cause by mutation of the HER2 gene. In addition, the small molecule portion of this drug, deruxtecan (DXd), is a topoisomerase I inhibitor.[A188976,L10842]  It is attached to the antibody by a peptide linker. After trastuzumab deruxtecan binds to HER2 found on malignant cells, it is internalized and linker cleavage occurs through the actions of lysosomal enzymes. After it is released through cleavage, DXd causes targeted DNA damage and apoptosis in cancer cells, due to the ability to cross cell membranes.[A188988,L10842]



Normally, drugs in this class (antibody-drug conjugates) present a challenge. The monoclonal antibody accurately targets cancer cells, however exert limited killing action. The addition of a cytotoxic agent (a topoisomerase I inhibitor in this case) effectively kills dividing cancer cells, including those in the healthy tissues, leading to various adverse effects.  The peptide linker used to formulate this drug is cleavable, which is unique to other antibody-drug conjugates, allowing for increased efficacy and reduced drug resistance to topoisomerase.[A188988]', 'Trastuzumab demonstrates antitumor activity against certain types of HER2 positive breast cancer, however, clinical trials are still ongoing to confirm its efficacy.[A188982,L10842,L10845]  By exploiting both targeted antibody and cytotoxic effects, trastuzumab deruxtecan can effectively destroy tumors.[A188988] 



The FDA label warns of a potential risk for neutropenia, interstitial lung disease/pneumonitis, and left ventricular dysfunction following the use of this drug.[L10842]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23620, 'Nitazode 100mg/5ml 60ml susp.', 'نيتازود 100مجم/5مل 60مل معلق', '44', '28.5', 'Antihelminthic', 'Nitazoxanide', 'Sigma > andalous pharma', 'Susp', 'معلق', '100mg', '1', NULL, 'about nitazoxanide a synthetic nitrothiazolyl-salicylamide derivative antihelminthics in schistosomiasis. mechanism of action of nitazoxanide it excerts its action by blocking anaerobic energy metabolism. the drug interfering with the pyruvate-ferredoxin', '6224000908393', NULL, 2576, '2024-08-13', 0, 'For the treatment of diarrhea in adults and children caused by the protozoa <i>Giardia lamblia</i>,  and for the treatment of diarrhea in children caused by the protozoan,  <i>Cryptosporidium parvum</i> [FDA label].



Nitazoxanide has not been shown to be superior to placebo medication for the management of diarrhea caused by Cryptosporidium parvum in patients with HIV/immunodeficiency [FDA label, A31973, A31976]. ', 'The most widely accepted mechanism of NTZ is believed to be the disruption of the energy metabolism in anaerobic microbes by inhibition of the pyruvate: ferredoxin/flavodoxin oxidoreductase (PFOR) cycle [A31981]. In parasitic-protozoa, Nitazoxanide also induces lesions in the cell membranes and depolarizes the mitochondrial membrane while inhibiting quinone oxidoreductase NQO1, nitroreductase-1 and protein disulphide isomerase enzymes. In addition, this drug also inhibits the glutathione-S-transferase (a major detoxifying enzyme) and modulates the Avr-14 gene, encoding for the alpha-type subunit of glutamate-gated chloride ion channel present in nematodes. Aside from its well understood non-competitive inhibition of the PFOR in anaerobic bacteria, NTZ also demonstrates various other antibacterial mechanisms. It inhibits pyruvate dehydrogenase in E Coli, disrupts the membrane potential and pH homeostasis in the Mycobacterium tuberculosis, suppresses the chaperone/usher (CU) pathway of the gram-negative bacteria,  and stimulates host macrophage autophagy in tuberculosis patients [A31976]. NTZ also suppresses viral replication by inhibiting the maturation of the viral hemagglutinin and the viral transcription factor immediate early 2 (IE2) as well as by activating the eukaryotic translation initiation factor 2α (an antiviral intracellular protein). Lastly, NTZ exhibits an inhibitory effect on tumor cell progression by altering drug detoxification (glutathione-S-transferase P1), unfolded protein response, autophagy, anti-cytokines activity, and c-Myc inhibition [A31976].', 'The general effect of this medication is the prevention of microbe activity through disruption of important energy pathways for survival and proliferation [FDA label, A31976].  Nitazoxanide exhibits antiprotozoal activity by interfering with the pyruvate ferredoxin/flavodoxin oxidoreductase dependent electron transfer reaction, an essential reaction need for anaerobic energy metabolism of various microorganisms.  Sporozoites of Cryptosporidium parvum and trophozoites of Giardia lamblia are therefore inhibited, relieving symptoms of diahrrea [L1425]. Interference with the PFOR enzyme-dependent electron transfer reaction may only be one of the many pathways by which nitazoxanide exhibits antiprotozoal activity [FDA label, A31973, L1425]. ', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23621, 'Nitazode 500mg 18 f.c. tabs.', 'نيتازود 500مجم 18 قرص', '99', '64.5', 'Antihelminthic', 'Nitazoxanide', 'Andalous pharma', 'Tab', 'أقراص', '500mg', '3', 'علاج الديدان', NULL, '6223004690495', NULL, 6231, '2025-08-11', 0, 'For the treatment of diarrhea in adults and children caused by the protozoa <i>Giardia lamblia</i>,  and for the treatment of diarrhea in children caused by the protozoan,  <i>Cryptosporidium parvum</i> [FDA label].



Nitazoxanide has not been shown to be superior to placebo medication for the management of diarrhea caused by Cryptosporidium parvum in patients with HIV/immunodeficiency [FDA label, A31973, A31976]. ', 'The most widely accepted mechanism of NTZ is believed to be the disruption of the energy metabolism in anaerobic microbes by inhibition of the pyruvate: ferredoxin/flavodoxin oxidoreductase (PFOR) cycle [A31981]. In parasitic-protozoa, Nitazoxanide also induces lesions in the cell membranes and depolarizes the mitochondrial membrane while inhibiting quinone oxidoreductase NQO1, nitroreductase-1 and protein disulphide isomerase enzymes. In addition, this drug also inhibits the glutathione-S-transferase (a major detoxifying enzyme) and modulates the Avr-14 gene, encoding for the alpha-type subunit of glutamate-gated chloride ion channel present in nematodes. Aside from its well understood non-competitive inhibition of the PFOR in anaerobic bacteria, NTZ also demonstrates various other antibacterial mechanisms. It inhibits pyruvate dehydrogenase in E Coli, disrupts the membrane potential and pH homeostasis in the Mycobacterium tuberculosis, suppresses the chaperone/usher (CU) pathway of the gram-negative bacteria,  and stimulates host macrophage autophagy in tuberculosis patients [A31976]. NTZ also suppresses viral replication by inhibiting the maturation of the viral hemagglutinin and the viral transcription factor immediate early 2 (IE2) as well as by activating the eukaryotic translation initiation factor 2α (an antiviral intracellular protein). Lastly, NTZ exhibits an inhibitory effect on tumor cell progression by altering drug detoxification (glutathione-S-transferase P1), unfolded protein response, autophagy, anti-cytokines activity, and c-Myc inhibition [A31976].', 'The general effect of this medication is the prevention of microbe activity through disruption of important energy pathways for survival and proliferation [FDA label, A31976].  Nitazoxanide exhibits antiprotozoal activity by interfering with the pyruvate ferredoxin/flavodoxin oxidoreductase dependent electron transfer reaction, an essential reaction need for anaerobic energy metabolism of various microorganisms.  Sporozoites of Cryptosporidium parvum and trophozoites of Giardia lamblia are therefore inhibited, relieving symptoms of diahrrea [L1425]. Interference with the PFOR enzyme-dependent electron transfer reaction may only be one of the many pathways by which nitazoxanide exhibits antiprotozoal activity [FDA label, A31973, L1425]. ', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23622, 'Nitazoxin 100mg/5ml pd. for oral susp. 60ml', 'نيتازوكسين 100مجم/5مل معلق 60 مل', '22', '9.5', 'Antihelminthic', 'Nitazoxanide', 'Mepaco', 'Susp', 'معلق', '100mg', '1', NULL, 'about nitazoxanide a synthetic nitrothiazolyl-salicylamide derivative antihelminthics in schistosomiasis. mechanism of action of nitazoxanide it excerts its action by blocking anaerobic energy metabolism. the drug interfering with the pyruvate-ferredoxin', NULL, NULL, 859, '2024-03-29', 0, 'For the treatment of diarrhea in adults and children caused by the protozoa <i>Giardia lamblia</i>,  and for the treatment of diarrhea in children caused by the protozoan,  <i>Cryptosporidium parvum</i> [FDA label].



Nitazoxanide has not been shown to be superior to placebo medication for the management of diarrhea caused by Cryptosporidium parvum in patients with HIV/immunodeficiency [FDA label, A31973, A31976]. ', 'The most widely accepted mechanism of NTZ is believed to be the disruption of the energy metabolism in anaerobic microbes by inhibition of the pyruvate: ferredoxin/flavodoxin oxidoreductase (PFOR) cycle [A31981]. In parasitic-protozoa, Nitazoxanide also induces lesions in the cell membranes and depolarizes the mitochondrial membrane while inhibiting quinone oxidoreductase NQO1, nitroreductase-1 and protein disulphide isomerase enzymes. In addition, this drug also inhibits the glutathione-S-transferase (a major detoxifying enzyme) and modulates the Avr-14 gene, encoding for the alpha-type subunit of glutamate-gated chloride ion channel present in nematodes. Aside from its well understood non-competitive inhibition of the PFOR in anaerobic bacteria, NTZ also demonstrates various other antibacterial mechanisms. It inhibits pyruvate dehydrogenase in E Coli, disrupts the membrane potential and pH homeostasis in the Mycobacterium tuberculosis, suppresses the chaperone/usher (CU) pathway of the gram-negative bacteria,  and stimulates host macrophage autophagy in tuberculosis patients [A31976]. NTZ also suppresses viral replication by inhibiting the maturation of the viral hemagglutinin and the viral transcription factor immediate early 2 (IE2) as well as by activating the eukaryotic translation initiation factor 2α (an antiviral intracellular protein). Lastly, NTZ exhibits an inhibitory effect on tumor cell progression by altering drug detoxification (glutathione-S-transferase P1), unfolded protein response, autophagy, anti-cytokines activity, and c-Myc inhibition [A31976].', 'The general effect of this medication is the prevention of microbe activity through disruption of important energy pathways for survival and proliferation [FDA label, A31976].  Nitazoxanide exhibits antiprotozoal activity by interfering with the pyruvate ferredoxin/flavodoxin oxidoreductase dependent electron transfer reaction, an essential reaction need for anaerobic energy metabolism of various microorganisms.  Sporozoites of Cryptosporidium parvum and trophozoites of Giardia lamblia are therefore inhibited, relieving symptoms of diahrrea [L1425]. Interference with the PFOR enzyme-dependent electron transfer reaction may only be one of the many pathways by which nitazoxanide exhibits antiprotozoal activity [FDA label, A31973, L1425]. ', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23623, 'Nitolic head lice treatment system 50 ml', 'نيتوليك هيد لايس 50مل', '450', '349', 'Anti-lice', 'Cyclomethicone+polysorbate 80+isopropyl myristate', 'Icb pharma > x factor medical', 'Unknown', 'غير محدد', '50 ml', '1', NULL, 'medical device intended for the treatment of head lice infestations. 100% efficacy against head lice and nits. complete treatment after single usage. efficacy in elimination of the eggs provided by o-effect technology. safe insecticide-free. 2+: for child', NULL, NULL, 805, '2025-01-07', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23624, 'Nitolic prevent plus head lice solution 50 ml', 'نيتوليك بريفينت بلس محلول للرأس 50 مل', '299', '210', 'Anti-lice', 'Peg 12 dimethicone+hydrolyzed wheat protein+tea tree oil+peppermintoil+lavender oil', 'Icb pharma > x factor medical', 'Solution', 'محلول', '50 ml', '1', NULL, 'prevents infestation of head lice (pediculosis) - without heavy feeling of hair stainless - made with natural ingredients - for everyday us.', NULL, NULL, 944, '2024-01-22', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23625, 'Maddomor eye contour cream 30 gm', 'مادومور كريم لمحيط العين 30 جم', '230', NULL, 'Eye contour', 'Caffeine+vitamin c+hyaluronic acid+glycerin', 'Loxymore pharma', 'Cream', 'كريم', '30 gm', '1', NULL, NULL, '6223002450503', NULL, 971, '2023-01-04', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23626, 'Nitrastron 2gm gr. in 7 sachets', 'نيتراسترون 2جم فوار 7 كيس', '35', NULL, 'Osteoporosis.antiresorptives', 'Strontium ranelate', 'Bioriginal international group pharma egypt > arabian international group (aig)', 'Sachet', 'أكياس', '2gm', '1', NULL, 'about strontium ranel bone metabolism modulator antiosteoporotic agent mechanism of action of strontium ranel strontium ranelate is an antiosteoporotic agent which both increases bone formation and reduces bone resorption. strontium ranelate stimulates th', NULL, NULL, 759, '2022-07-09', 0, 'Strontium ranelate is therapeutically indicated for the treatment of severe osteoperosis in: a) postmenopasual women, and b) adult men, who are at high risk of fractures, for whom treatment with other medical products approved for the treatment of osteoperosis is not possible due to, for example, contraindications or intolerance. [L1127]



In postmenopausal women, strontium ranelate can also reduce the risk of vertebral and hip fractures [L1127].', 'The underlying pathogenesis of osteperosis involves an imbalance between bone resorption and bone formation. Osteoclasts are a kind of differentiated or specialized bone cell that breaks down bone tissue while osteoblasts are another set of differentiated bone cells that synthesize and rebuild bone tissue. When osteoclasts degrade bone tissue faster than the osteoblasts are capable of rebuilding the bone tissue, low or inadequate bone mass density and osteoperosis can resula One of the mechanisms with which strontium ranelate is thought to act is its functionality as an agonist of the extracellular calcium sensing receptors (CaSRs) [A31553] of osteoblasts and osteoclasts [A31542]. Ordinary interaction between calcium 2+ divalent cations with mature osteoclast CaSRs is known to induce osteoclast apoptosis. Subsequently, strontium 2+ divalent cations from strontium ranelate use can also bind CaSRs on osteoclasts to induce their apoptosis because of the strontium 2+ cation''s close resemeblance to calcium 2+. Contact between extracelluar calcium 2+ and osteoclast CaSRs stimulates the phospholipase C (PLC) dependant breakdown of phosphatidylinositol 4,5-biphosphate (PIP2) into the two secondary messengers inositol 1,4,5-trisphosphate (IP3) and diacylglycerol (DAG). Whereas the calcium-CaSRs interaction then performs IP3 Adependent translocation of nuclear factor NF-kB from the cytoplasm to the nucleus in mature osteoclasts, strontium-CaSRs interactions involves a DAG-PKC beta II (protein kinase C beta II) signalling pathway for translocating NF-kB from the cytoplasm to the nucleus in an IP3-independent manner. Although the calcium 2+ and strontium 2+ mediated signalling pathways are different, both CaSR interactions induce osteoclast apoptosis and are in fact capable of potentiating each other, leading to enhanced osteoclast apoptosis and decreased bone tissue degradation [A31565].



At the same time, given the similarity between the calcium 2+ and strontium 2+ cations, strontium 2+ cations from strontium ranelate are seemingly also able to act as an agonist and stimulate the CaSRs on osteoblasts, possibly in tandem with various local osteoblast stimulatory growth factors like transforming growth factor β (TGF β) and/or bone morphogenetic proteins (BMPs), to stimulate cyclic D genes and early oncogenes like c-fos and egr-1 that can mediate the mitogenesis and proliferation of new or more osteoblasts [A31580]. Moreover, although the involvement of the PLC mediated pathway may be a part of the signalling mechanism in osteoblasts following the stimulation of their CaSRs, this has not yet been fully elucidated [A31580].



Furthermore, strontium ranelate is also thought to be capable of stimulating osteoblasts to enhance the expression of osteoprotegerin while also concurrently reducing the expression of receptor activator of nuclear factor kappa-Β ligand (RANKL) in primary human osteoblastic cells. As osteoprotegerin can competitively bind to RANKL as a decoy receptor, which can prevent RANKL from binding to RANK, which is an activity that facilitates the signaling pathway for the differentiation and activaiton of osteoclasts. The subsequent net effect of these actions ultiamtely results in decreased osteoclastogenesis. [A31553]



Moreover, bone biopsies obtained from patients treated with stronatium ranelate in clinical study reveal improvements in intrinsic bone tissue quality and microarchitecutre in ostepoerosis as evidenced by increased trabecular number, decreased trabecular separation, lower structure model index, and increased cortical thickness associated with a shift in trabecular structure from rod to plate like configurations compared with control patients [A31553].



Additionally, strontium from administered strontium ranelate is absorbed onto the crystal surface of treated bones and only slightly substitiutes for calcium in the apatite crystal of newly formed bone. As a result, there is an increased X-ray absorption of strontium as compared to calcium, which can lead to an amplification of bone mineral density (BMD) measurement by dual-proton X-ray absorptiometry. In essence, although strontium ranelate use can increase BMD some of the observations may be overestimations due to skeletal accretion of strontium in strontium ranelate treated patients [A31553].



Having the ability to both generate more osetoblasts and decrease the number of osteoclasts gives strontium ranelate an apparent dual mechanism of action when used to treat osteoperosis.', 'In general, it is believed that strontium ranelate is capable of affecting a rebalance in bone turnover in favour of bone formation by: (1) increasing osteoblast differentiation from progenitors, osteoblast activity and survival, as well as regulating osteoblast-induced osteoclastogenesis, and (2) decreasing osteoclast differentiation and activity, as well as increasing osteoclast apoptosis [A31541]. 



It has also been shown that strontium ranelate is capable of improving and strengthening various components of overall bone tissue quality like bone mineral density and bone microarchitecture [A31541, A31542, A31553].   ', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23627, 'Nitriate 50mg vial', 'نيتراييت 50مجم فيال', '30', NULL, 'Antihypertensive.direct vasodilator', 'Sodium nitroprusside', 'Serb laboratory-france > united partners company', 'Vial', 'فيال', '50mg', '1', NULL, NULL, NULL, NULL, 1062, '2022-08-16', 0, 'For the treatment of small uncomplicated varicose veins of the lower extremities that show simple dilation with competent valves.', 'Sodium tetradecyl sulfate is a potent toxin for endothelial cells in that brief exposure to even low concentrations are effective in stripping endothelium over a considerable distance and exposing highly thrombogenic endothelium in the process. Diluted sodium tetradecyl sulfate is also able to induce a hypercoagulable state, possibly by selective inhibition of protein C, and can also promote platelet aggregation.', 'Sodium tetradecyl sulfate is an anionic surfactant which occurs as a white, waxy solid. It is used as a sclerosing agent in sclerotherapy. Sclerotherapy is an injection of a sclerosing agent directly through the skin into a lesion and is used primarily for slow-flow vascular anomalies, particularly for venous malformation and lymphatic malformation. Intravenous injection causes intima inflammation and thrombus formation. This usually occludes the injected vein. Subsequent formation of fibrous tissue results in partial or complete vein obliteration that may or may not be permanent.', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23628, 'Nitrocare 2.5mg 30 s.r.caps.', 'نيتروكير 2.5مجم 30 كبسول', '14', NULL, 'Anti-ischemic', 'Nitroglycerin', 'T3a pharma', 'Cap', 'كبسولة', '2.5mg', '3', NULL, 'indication for the prevention of angina pharmacodynamics nitroglycerin an organic nitrate is available in many forms as a vasodilator. nitroglycerin is used in the treatement of angina pectoris and perioperative hypertension to produce controlled hypotens', NULL, NULL, 1253, '2022-07-16', 0, 'Sublingual nitroglycerin is indicated for the acute relief of an attack or acute prophylaxis of angina pectoris due to coronary artery disease.[L7102,L38369,L42320] Transdermal nitroglycerin is indicated for the prevention of angina pectoris due to coronary artery disease.[L7141]



Intravenous nitroglycerin is indicated for the treatment of peri-operative hypertension; for control of congestive heart failure in the setting of acute myocardial infarction; for treatment of angina pectoris in patients who have not responded to sublingual nitroglycerin and beta (β)-blockers; and for induction of intraoperative hypotension.[L7099] 



Topical nitroglycerin ointment is used to treat moderate to severe pain associated with chronic anal fissure.[L42445]', 'Nitroglycerin is converted by mitochondrial aldehyde dehydrogenase in smooth muscle cells to nitric oxide (NO), a potent vasodilator. NO activates the enzyme guanylate cyclase, which converts guanosine triphosphate (GTP) to cyclic guanosine 3'',5''-monophosphate (cGMP) in vascular smooth muscle and other tissues.[A180166,A180169,A249970] cGMP is an endogenous vasodilator of vascular smooth muscle:[A180172] it causes protein kinase-dependent phosphorylation and activates downstream cascades that promote relaxation and increased blood flow in veins, arteries and cardiac tissue.[A180172,A249970] An _in vitro_ study using mouse aorta suggests that nitric oxide, an active metabolite of nitroglycerin, targets the natriuretic peptide receptors.[A5526] ', 'Nitroglycerin causes the relaxation of vascular smooth muscles, causing arteriolar and venous dilatation.[L38369] It increases blood flow to the myocardium and reduces cardiac preload and afterload, decreasing myocardial wall stress and ameliorating anginal symptoms.[A180172,A249970,L7102] Nitroglycerin also reduces coronary artery spasm, decreasing systemic vascular resistance as well as systolic and diastolic blood pressure.[L38369]



Like other organic nitrates, repeated and prolonged administration of nitroglycerin can lead to the development of tolerance or desensitization of vascular smooth muscle to further nitroglycerin-induced vasorelaxation. This loss of efficacy may be associated with the inhibition of mitochondrial aldehyde dehydrogenase, which is an important enzyme involved in the bioactivation of nitroglycerin.[A180166,A180169,A180172] Nitroglycerin tolerance may be accompanied by pro-oxidant effects, endothelial dysfunction, and increased sensitivity to vasoconstrictors.[A180172]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23629, 'Nitrocare 6.5mg 30 s.r.caps.', 'نيتروكير 6.5مجم 30 كبسول', '26', NULL, 'Anti-ischemic', 'Nitroglycerin', 'T3a pharma', 'Cap', 'كبسولة', '6.5mg', '3', NULL, 'indication for the prevention of angina pharmacodynamics nitroglycerin an organic nitrate is available in many forms as a vasodilator. nitroglycerin is used in the treatement of angina pectoris and perioperative hypertension to produce controlled hypotens', '6221014001782', NULL, 829, '2022-12-07', 0, 'Sublingual nitroglycerin is indicated for the acute relief of an attack or acute prophylaxis of angina pectoris due to coronary artery disease.[L7102,L38369,L42320] Transdermal nitroglycerin is indicated for the prevention of angina pectoris due to coronary artery disease.[L7141]



Intravenous nitroglycerin is indicated for the treatment of peri-operative hypertension; for control of congestive heart failure in the setting of acute myocardial infarction; for treatment of angina pectoris in patients who have not responded to sublingual nitroglycerin and beta (β)-blockers; and for induction of intraoperative hypotension.[L7099] 



Topical nitroglycerin ointment is used to treat moderate to severe pain associated with chronic anal fissure.[L42445]', 'Nitroglycerin is converted by mitochondrial aldehyde dehydrogenase in smooth muscle cells to nitric oxide (NO), a potent vasodilator. NO activates the enzyme guanylate cyclase, which converts guanosine triphosphate (GTP) to cyclic guanosine 3'',5''-monophosphate (cGMP) in vascular smooth muscle and other tissues.[A180166,A180169,A249970] cGMP is an endogenous vasodilator of vascular smooth muscle:[A180172] it causes protein kinase-dependent phosphorylation and activates downstream cascades that promote relaxation and increased blood flow in veins, arteries and cardiac tissue.[A180172,A249970] An _in vitro_ study using mouse aorta suggests that nitric oxide, an active metabolite of nitroglycerin, targets the natriuretic peptide receptors.[A5526] ', 'Nitroglycerin causes the relaxation of vascular smooth muscles, causing arteriolar and venous dilatation.[L38369] It increases blood flow to the myocardium and reduces cardiac preload and afterload, decreasing myocardial wall stress and ameliorating anginal symptoms.[A180172,A249970,L7102] Nitroglycerin also reduces coronary artery spasm, decreasing systemic vascular resistance as well as systolic and diastolic blood pressure.[L38369]



Like other organic nitrates, repeated and prolonged administration of nitroglycerin can lead to the development of tolerance or desensitization of vascular smooth muscle to further nitroglycerin-induced vasorelaxation. This loss of efficacy may be associated with the inhibition of mitochondrial aldehyde dehydrogenase, which is an important enzyme involved in the bioactivation of nitroglycerin.[A180166,A180169,A180172] Nitroglycerin tolerance may be accompanied by pro-oxidant effects, endothelial dysfunction, and increased sensitivity to vasoconstrictors.[A180172]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23630, 'Nitrocare 9mg 30 s.r.caps.', 'نيتروكير 9مجم 30 كبسول', '33', NULL, 'Anti-ischemic', 'Nitroglycerin', 'T3a pharma', 'Cap', 'كبسولة', '9mg', '3', NULL, 'indication for the prevention of angina pharmacodynamics nitroglycerin an organic nitrate is available in many forms as a vasodilator. nitroglycerin is used in the treatement of angina pectoris and perioperative hypertension to produce controlled hypotens', NULL, NULL, 689, '2022-07-13', 0, 'Sublingual nitroglycerin is indicated for the acute relief of an attack or acute prophylaxis of angina pectoris due to coronary artery disease.[L7102,L38369,L42320] Transdermal nitroglycerin is indicated for the prevention of angina pectoris due to coronary artery disease.[L7141]



Intravenous nitroglycerin is indicated for the treatment of peri-operative hypertension; for control of congestive heart failure in the setting of acute myocardial infarction; for treatment of angina pectoris in patients who have not responded to sublingual nitroglycerin and beta (β)-blockers; and for induction of intraoperative hypotension.[L7099] 



Topical nitroglycerin ointment is used to treat moderate to severe pain associated with chronic anal fissure.[L42445]', 'Nitroglycerin is converted by mitochondrial aldehyde dehydrogenase in smooth muscle cells to nitric oxide (NO), a potent vasodilator. NO activates the enzyme guanylate cyclase, which converts guanosine triphosphate (GTP) to cyclic guanosine 3'',5''-monophosphate (cGMP) in vascular smooth muscle and other tissues.[A180166,A180169,A249970] cGMP is an endogenous vasodilator of vascular smooth muscle:[A180172] it causes protein kinase-dependent phosphorylation and activates downstream cascades that promote relaxation and increased blood flow in veins, arteries and cardiac tissue.[A180172,A249970] An _in vitro_ study using mouse aorta suggests that nitric oxide, an active metabolite of nitroglycerin, targets the natriuretic peptide receptors.[A5526] ', 'Nitroglycerin causes the relaxation of vascular smooth muscles, causing arteriolar and venous dilatation.[L38369] It increases blood flow to the myocardium and reduces cardiac preload and afterload, decreasing myocardial wall stress and ameliorating anginal symptoms.[A180172,A249970,L7102] Nitroglycerin also reduces coronary artery spasm, decreasing systemic vascular resistance as well as systolic and diastolic blood pressure.[L38369]



Like other organic nitrates, repeated and prolonged administration of nitroglycerin can lead to the development of tolerance or desensitization of vascular smooth muscle to further nitroglycerin-induced vasorelaxation. This loss of efficacy may be associated with the inhibition of mitochondrial aldehyde dehydrogenase, which is an important enzyme involved in the bioactivation of nitroglycerin.[A180166,A180169,A180172] Nitroglycerin tolerance may be accompanied by pro-oxidant effects, endothelial dysfunction, and increased sensitivity to vasoconstrictors.[A180172]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23631, 'Nitroderm tts 10mg 7 patches', 'نيتروديرم تي تي اس 10مجم 7 باتش', '133', '66.5', 'Anti-ischemic', 'Nitroglycerin', 'Novartis > sandoz', 'Patch', 'لصقة', '10mg', '7', NULL, NULL, '6223002640959', NULL, 2035, '2024-11-18', 0, 'Sublingual nitroglycerin is indicated for the acute relief of an attack or acute prophylaxis of angina pectoris due to coronary artery disease.[L7102,L38369,L42320] Transdermal nitroglycerin is indicated for the prevention of angina pectoris due to coronary artery disease.[L7141]



Intravenous nitroglycerin is indicated for the treatment of peri-operative hypertension; for control of congestive heart failure in the setting of acute myocardial infarction; for treatment of angina pectoris in patients who have not responded to sublingual nitroglycerin and beta (β)-blockers; and for induction of intraoperative hypotension.[L7099] 



Topical nitroglycerin ointment is used to treat moderate to severe pain associated with chronic anal fissure.[L42445]', 'Nitroglycerin is converted by mitochondrial aldehyde dehydrogenase in smooth muscle cells to nitric oxide (NO), a potent vasodilator. NO activates the enzyme guanylate cyclase, which converts guanosine triphosphate (GTP) to cyclic guanosine 3'',5''-monophosphate (cGMP) in vascular smooth muscle and other tissues.[A180166,A180169,A249970] cGMP is an endogenous vasodilator of vascular smooth muscle:[A180172] it causes protein kinase-dependent phosphorylation and activates downstream cascades that promote relaxation and increased blood flow in veins, arteries and cardiac tissue.[A180172,A249970] An _in vitro_ study using mouse aorta suggests that nitric oxide, an active metabolite of nitroglycerin, targets the natriuretic peptide receptors.[A5526] ', 'Nitroglycerin causes the relaxation of vascular smooth muscles, causing arteriolar and venous dilatation.[L38369] It increases blood flow to the myocardium and reduces cardiac preload and afterload, decreasing myocardial wall stress and ameliorating anginal symptoms.[A180172,A249970,L7102] Nitroglycerin also reduces coronary artery spasm, decreasing systemic vascular resistance as well as systolic and diastolic blood pressure.[L38369]



Like other organic nitrates, repeated and prolonged administration of nitroglycerin can lead to the development of tolerance or desensitization of vascular smooth muscle to further nitroglycerin-induced vasorelaxation. This loss of efficacy may be associated with the inhibition of mitochondrial aldehyde dehydrogenase, which is an important enzyme involved in the bioactivation of nitroglycerin.[A180166,A180169,A180172] Nitroglycerin tolerance may be accompanied by pro-oxidant effects, endothelial dysfunction, and increased sensitivity to vasoconstrictors.[A180172]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23633, 'Nitrofurinal 200mg 12 caps.', 'نيتروفورينال 200مجم 12 كبسول', '5', NULL, 'Antidiarrheal', 'Nifuroxazide', 'Pharopharma', 'Cap', 'كبسولة', '200mg', '1', NULL, 'indicationsssinfectious diarrhea in children and adults chronic colitis enterocolitis as an adjunctive treatment in combined therapy of intestinal dysbiosis.sscontraindicationsshypersensitivity to 5-nitrofurane derivatives and/or other components of the d', NULL, NULL, 1034, '2022-07-11', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23634, 'Nitrofurinal 220mg/5ml 60ml susp.', 'نيتروفيونال 220مجم/5مل 60مل معلق', '7', NULL, 'Antidiarrheal', 'Nifuroxazide', 'Pharopharma', 'Susp', 'معلق', '220mg', '1', NULL, 'indications infectious diarrhea in children and adults chronic colitis enterocolitis as an adjunctive treatment in combined therapy of intestinal dysbiosis. contraindication hypersensitivity to 5-nitrofurane derivatives and/or other components of the drug', NULL, NULL, 1263, '2022-07-06', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23635, 'Nitrolingual 0.4mg/dose oral spray', 'نيترولينجوال 0.4مجم/جرعة بخاخ للفم', '30', NULL, 'Anti-ischemic', 'Nitroglycerin', 'G.pohl boskamp - germany > sunny medical', 'Spray', 'بخاخ', '0.4mg', '1', NULL, 'indication for the prevention of angina pharmacodynamics nitroglycerin an organic nitrate is available in many forms as a vasodilator. nitroglycerin is used in the treatement of angina pectoris and perioperative hypertension to produce controlled hypotens', NULL, NULL, 1118, '2022-07-10', 0, 'Sublingual nitroglycerin is indicated for the acute relief of an attack or acute prophylaxis of angina pectoris due to coronary artery disease.[L7102,L38369,L42320] Transdermal nitroglycerin is indicated for the prevention of angina pectoris due to coronary artery disease.[L7141]



Intravenous nitroglycerin is indicated for the treatment of peri-operative hypertension; for control of congestive heart failure in the setting of acute myocardial infarction; for treatment of angina pectoris in patients who have not responded to sublingual nitroglycerin and beta (β)-blockers; and for induction of intraoperative hypotension.[L7099] 



Topical nitroglycerin ointment is used to treat moderate to severe pain associated with chronic anal fissure.[L42445]', 'Nitroglycerin is converted by mitochondrial aldehyde dehydrogenase in smooth muscle cells to nitric oxide (NO), a potent vasodilator. NO activates the enzyme guanylate cyclase, which converts guanosine triphosphate (GTP) to cyclic guanosine 3'',5''-monophosphate (cGMP) in vascular smooth muscle and other tissues.[A180166,A180169,A249970] cGMP is an endogenous vasodilator of vascular smooth muscle:[A180172] it causes protein kinase-dependent phosphorylation and activates downstream cascades that promote relaxation and increased blood flow in veins, arteries and cardiac tissue.[A180172,A249970] An _in vitro_ study using mouse aorta suggests that nitric oxide, an active metabolite of nitroglycerin, targets the natriuretic peptide receptors.[A5526] ', 'Nitroglycerin causes the relaxation of vascular smooth muscles, causing arteriolar and venous dilatation.[L38369] It increases blood flow to the myocardium and reduces cardiac preload and afterload, decreasing myocardial wall stress and ameliorating anginal symptoms.[A180172,A249970,L7102] Nitroglycerin also reduces coronary artery spasm, decreasing systemic vascular resistance as well as systolic and diastolic blood pressure.[L38369]



Like other organic nitrates, repeated and prolonged administration of nitroglycerin can lead to the development of tolerance or desensitization of vascular smooth muscle to further nitroglycerin-induced vasorelaxation. This loss of efficacy may be associated with the inhibition of mitochondrial aldehyde dehydrogenase, which is an important enzyme involved in the bioactivation of nitroglycerin.[A180166,A180169,A180172] Nitroglycerin tolerance may be accompanied by pro-oxidant effects, endothelial dysfunction, and increased sensitivity to vasoconstrictors.[A180172]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23637, 'Nitromak retard 5mg 30 caps.', 'نيتروماك ريتارد 5مجم 30 كبسول', '72', '54', 'Anti-ischemic', 'Nitroglycerin', 'October pharma', 'Cap', 'كبسولة', '5mg', '3', NULL, 'indication for the prevention of angina pharmacodynamics nitroglycerin an organic nitrate is available in many forms as a vasodilator. nitroglycerin is used in the treatement of angina pectoris and perioperative hypertension to produce controlled hypotens', '6221088021495', NULL, 2461, '2024-07-12', 0, 'Sublingual nitroglycerin is indicated for the acute relief of an attack or acute prophylaxis of angina pectoris due to coronary artery disease.[L7102,L38369,L42320] Transdermal nitroglycerin is indicated for the prevention of angina pectoris due to coronary artery disease.[L7141]



Intravenous nitroglycerin is indicated for the treatment of peri-operative hypertension; for control of congestive heart failure in the setting of acute myocardial infarction; for treatment of angina pectoris in patients who have not responded to sublingual nitroglycerin and beta (β)-blockers; and for induction of intraoperative hypotension.[L7099] 



Topical nitroglycerin ointment is used to treat moderate to severe pain associated with chronic anal fissure.[L42445]', 'Nitroglycerin is converted by mitochondrial aldehyde dehydrogenase in smooth muscle cells to nitric oxide (NO), a potent vasodilator. NO activates the enzyme guanylate cyclase, which converts guanosine triphosphate (GTP) to cyclic guanosine 3'',5''-monophosphate (cGMP) in vascular smooth muscle and other tissues.[A180166,A180169,A249970] cGMP is an endogenous vasodilator of vascular smooth muscle:[A180172] it causes protein kinase-dependent phosphorylation and activates downstream cascades that promote relaxation and increased blood flow in veins, arteries and cardiac tissue.[A180172,A249970] An _in vitro_ study using mouse aorta suggests that nitric oxide, an active metabolite of nitroglycerin, targets the natriuretic peptide receptors.[A5526] ', 'Nitroglycerin causes the relaxation of vascular smooth muscles, causing arteriolar and venous dilatation.[L38369] It increases blood flow to the myocardium and reduces cardiac preload and afterload, decreasing myocardial wall stress and ameliorating anginal symptoms.[A180172,A249970,L7102] Nitroglycerin also reduces coronary artery spasm, decreasing systemic vascular resistance as well as systolic and diastolic blood pressure.[L38369]



Like other organic nitrates, repeated and prolonged administration of nitroglycerin can lead to the development of tolerance or desensitization of vascular smooth muscle to further nitroglycerin-induced vasorelaxation. This loss of efficacy may be associated with the inhibition of mitochondrial aldehyde dehydrogenase, which is an important enzyme involved in the bioactivation of nitroglycerin.[A180166,A180169,A180172] Nitroglycerin tolerance may be accompanied by pro-oxidant effects, endothelial dysfunction, and increased sensitivity to vasoconstrictors.[A180172]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23639, 'Nitrotard 2.5mg 60 caps.', 'نيتروتارد 2.5مجم 60 كبسولة', '35', '18', 'Anti-ischemic', 'Nitroglycerin', 'Mup', 'Cap', 'كبسولة', '2.5mg', '6', NULL, 'indication for the prevention of angina pharmacodynamics nitroglycerin an organic nitrate is available in many forms as a vasodilator. nitroglycerin is used in the treatement of angina pectoris and perioperative hypertension to produce controlled hypotens', '6221508022118', NULL, 4473, '2023-09-03', 0, 'Sublingual nitroglycerin is indicated for the acute relief of an attack or acute prophylaxis of angina pectoris due to coronary artery disease.[L7102,L38369,L42320] Transdermal nitroglycerin is indicated for the prevention of angina pectoris due to coronary artery disease.[L7141]



Intravenous nitroglycerin is indicated for the treatment of peri-operative hypertension; for control of congestive heart failure in the setting of acute myocardial infarction; for treatment of angina pectoris in patients who have not responded to sublingual nitroglycerin and beta (β)-blockers; and for induction of intraoperative hypotension.[L7099] 



Topical nitroglycerin ointment is used to treat moderate to severe pain associated with chronic anal fissure.[L42445]', 'Nitroglycerin is converted by mitochondrial aldehyde dehydrogenase in smooth muscle cells to nitric oxide (NO), a potent vasodilator. NO activates the enzyme guanylate cyclase, which converts guanosine triphosphate (GTP) to cyclic guanosine 3'',5''-monophosphate (cGMP) in vascular smooth muscle and other tissues.[A180166,A180169,A249970] cGMP is an endogenous vasodilator of vascular smooth muscle:[A180172] it causes protein kinase-dependent phosphorylation and activates downstream cascades that promote relaxation and increased blood flow in veins, arteries and cardiac tissue.[A180172,A249970] An _in vitro_ study using mouse aorta suggests that nitric oxide, an active metabolite of nitroglycerin, targets the natriuretic peptide receptors.[A5526] ', 'Nitroglycerin causes the relaxation of vascular smooth muscles, causing arteriolar and venous dilatation.[L38369] It increases blood flow to the myocardium and reduces cardiac preload and afterload, decreasing myocardial wall stress and ameliorating anginal symptoms.[A180172,A249970,L7102] Nitroglycerin also reduces coronary artery spasm, decreasing systemic vascular resistance as well as systolic and diastolic blood pressure.[L38369]



Like other organic nitrates, repeated and prolonged administration of nitroglycerin can lead to the development of tolerance or desensitization of vascular smooth muscle to further nitroglycerin-induced vasorelaxation. This loss of efficacy may be associated with the inhibition of mitochondrial aldehyde dehydrogenase, which is an important enzyme involved in the bioactivation of nitroglycerin.[A180166,A180169,A180172] Nitroglycerin tolerance may be accompanied by pro-oxidant effects, endothelial dysfunction, and increased sensitivity to vasoconstrictors.[A180172]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23641, 'Nivestim 300 mcg/0.5ml 5 prefilled syringe', 'نيفستيم 300مكجم/0.5مل 5 سرنجات معبأة', '1,625', NULL, 'Granulocyte colony-stimulating factor (g-csf)', 'Filgrastim', 'Hospira inc.-uk > pfizer', 'Syringe', 'حقنة', '300 mcg', '5', NULL, 'about filgrastim a cytokine glycoprotein a human granulocyte colony-stimulating factor (g-csf) analog immunostimulant. mechanism of action of filgrastim filgrastim is a cytokine glycoprotein that stimulates proliferation differentiation and functional act', NULL, NULL, 971, '2022-05-18', 0, 'Filgrastim is indicated to decrease the incidence of infection‚ as manifested by febrile neutropenia‚ in patients with nonmyeloid malignancies receiving myelosuppressive anti-cancer drugs associated with a significant incidence of severe neutropenia with fever.[L40714]



Filgrastim is indicated for reducing the time to neutrophil recovery and the duration of fever, following induction or consolidation chemotherapy treatment of patients with acute myeloid leukemia.[L40714]



Filgrastim is indicated to reduce the duration of neutropenia and neutropenia-related clinical sequelae‚ e.g.‚ febrile neutropenia, in patients with nonmyeloid malignancies undergoing myeloablative chemotherapy followed by bone marrow transplantation.[L40714]



Filgrastim is indicated for the mobilization of autologous hematopoietic progenitor cells into the peripheral blood for collection by leukapheresis.[L40714]



Filgrastim is indicated for chronic administration to reduce the incidence and duration of sequelae of neutropenia (e.g.‚ fever‚ infections‚ oropharyngeal ulcers) in symptomatic patients with congenital neutropenia‚ cyclic neutropenia‚ or idiopathic neutropenia.[L40714]



Filgrastim is indicated to increase survival in patients acutely exposed to myelosuppressive doses of radiation.[L40714]', 'Neutrophils are critical granulocytes involved in the acute inflammatory response and host defences against bacterial infections.[A245873] They also contribute to long-term adaptive immunity by promoting immediate host immune response and attracting other cells, such as macrophages and dendritic cells. As neutrophils promote both the initiation and the maintenance of inflammation at sites of infection, suppressed neutrophil responses lead to extreme susceptibility to infection.[A35605] Low neutrophil levels, or neutropenia, caused by chronic neutropenia, myelosuppressive chemotherapy, and radiation therapy increases the risk of infection and related events.[A245868] Neutropenia caused by chemotherapy or radiation therapy can further progress into febrile neutropenia, which is associated with an elevated risk for life-threatening systemic infections and chemotherapy-associated morbidity and mortality.[A35591]



The production and release of functional neutrophils from the bone marrow are normally regulated by granulocyte colony-stimulating factors (G-CSF), which are major cytokine regulators of neutrophilic granulocytes.[A35605] G-CSFs act on hematopoietic cells by binding to specific cell surface receptors to stimulate the proliferation‚ differentiation‚ and maturation of neutrophil progenitors. G-CSF also induces some end-cell functional activation of neutrophils, including enhanced phagocytic ability‚ priming of the cellular metabolism associated with respiratory burst‚ antibody-dependent killing, and the increased expression of some cell surface antigens.[L40714]  Filgrastim is a short-acting recombinant G-CSF that mimics the biological actions of endogenous G-CSF. It also facilitates the release of neutrophils from the bone marrow into the blood to reduce the incidence of infection and manage neutropenia.[A245858, A245868]', 'Filgrastim is used to reduce the incidence, severity and duration of neutropenia and febrile neutropenia in patients undergoing cytotoxic chemotherapy. In clinical trials in patients, filgrastim reduced the duration of febrile neutropenia, antibiotic use, and hospitalization after induction chemotherapy for acute myelogenous leukemia or myeloablative therapy followed by bone marrow transplantation; however, the incidence of fever and documented infections were not reduced in either setting.[L40719] 



Filgrastim is also used to mobilize hematopoietic progenitor cells into the peripheral blood in order to reduce the risk for bleeding complications and the need for platelet transfusions. Recipients of allogeneic PBPCs mobilized with filgrastim experienced significantly more rapid hematological recovery, leading to a significant decrease in time to unsupported platelet recovery when compared with allogeneic bone marrow transplantation.[L40719] 



Filgrastim causes a dose-dependent increase in circulating neutrophil counts within 24 hours of administration. Filgrastim can also cause a minor increase in monocyte and lymphocyte counts, but the clinical significance of these effects is unknown.[L40714] In some patients, filgrastim also caused a minor increase in the number of circulating eosinophils and basophils relative to baseline; however, these patients may already have had elevated eosinophils and basophils prior to filgrastim treatment. Following termination of filgrastim therapy, circulating neutrophil counts decrease by 50% within one to two days, and to normal levels within one to seven days. As with other hematopoietic growth factors, G-CSF has shown _in vitro_ stimulating properties on human endothelial cells.[L40719] ', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23642, 'Nivestim 480 mcg/0.5ml 5 prefilled syringe', 'نيفيستيم 480مكجم/0.5مل 5 سرنجات معبأة', '2,100', NULL, 'Granulocyte colony-stimulating factor (g-csf)', 'Filgrastim', 'Hospira inc.-uk > pfizer', 'Syringe', 'حقنة', '480 mcg', '5', 'عامل نمو مكون للدم -- يستخدم في مرضي السرطان لعلاج اغتراس نخاع العظم -- يستخدم في حالة نقص عدلات الدم المزمن', 'about filgrastim a cytokine glycoprotein a human granulocyte colony-stimulating factor (g-csf) analog immunostimulant. mechanism of action of filgrastim filgrastim is a cytokine glycoprotein that stimulates proliferation differentiation and functional act', NULL, NULL, 1127, '2022-05-19', 0, 'Filgrastim is indicated to decrease the incidence of infection‚ as manifested by febrile neutropenia‚ in patients with nonmyeloid malignancies receiving myelosuppressive anti-cancer drugs associated with a significant incidence of severe neutropenia with fever.[L40714]



Filgrastim is indicated for reducing the time to neutrophil recovery and the duration of fever, following induction or consolidation chemotherapy treatment of patients with acute myeloid leukemia.[L40714]



Filgrastim is indicated to reduce the duration of neutropenia and neutropenia-related clinical sequelae‚ e.g.‚ febrile neutropenia, in patients with nonmyeloid malignancies undergoing myeloablative chemotherapy followed by bone marrow transplantation.[L40714]



Filgrastim is indicated for the mobilization of autologous hematopoietic progenitor cells into the peripheral blood for collection by leukapheresis.[L40714]



Filgrastim is indicated for chronic administration to reduce the incidence and duration of sequelae of neutropenia (e.g.‚ fever‚ infections‚ oropharyngeal ulcers) in symptomatic patients with congenital neutropenia‚ cyclic neutropenia‚ or idiopathic neutropenia.[L40714]



Filgrastim is indicated to increase survival in patients acutely exposed to myelosuppressive doses of radiation.[L40714]', 'Neutrophils are critical granulocytes involved in the acute inflammatory response and host defences against bacterial infections.[A245873] They also contribute to long-term adaptive immunity by promoting immediate host immune response and attracting other cells, such as macrophages and dendritic cells. As neutrophils promote both the initiation and the maintenance of inflammation at sites of infection, suppressed neutrophil responses lead to extreme susceptibility to infection.[A35605] Low neutrophil levels, or neutropenia, caused by chronic neutropenia, myelosuppressive chemotherapy, and radiation therapy increases the risk of infection and related events.[A245868] Neutropenia caused by chemotherapy or radiation therapy can further progress into febrile neutropenia, which is associated with an elevated risk for life-threatening systemic infections and chemotherapy-associated morbidity and mortality.[A35591]



The production and release of functional neutrophils from the bone marrow are normally regulated by granulocyte colony-stimulating factors (G-CSF), which are major cytokine regulators of neutrophilic granulocytes.[A35605] G-CSFs act on hematopoietic cells by binding to specific cell surface receptors to stimulate the proliferation‚ differentiation‚ and maturation of neutrophil progenitors. G-CSF also induces some end-cell functional activation of neutrophils, including enhanced phagocytic ability‚ priming of the cellular metabolism associated with respiratory burst‚ antibody-dependent killing, and the increased expression of some cell surface antigens.[L40714]  Filgrastim is a short-acting recombinant G-CSF that mimics the biological actions of endogenous G-CSF. It also facilitates the release of neutrophils from the bone marrow into the blood to reduce the incidence of infection and manage neutropenia.[A245858, A245868]', 'Filgrastim is used to reduce the incidence, severity and duration of neutropenia and febrile neutropenia in patients undergoing cytotoxic chemotherapy. In clinical trials in patients, filgrastim reduced the duration of febrile neutropenia, antibiotic use, and hospitalization after induction chemotherapy for acute myelogenous leukemia or myeloablative therapy followed by bone marrow transplantation; however, the incidence of fever and documented infections were not reduced in either setting.[L40719] 



Filgrastim is also used to mobilize hematopoietic progenitor cells into the peripheral blood in order to reduce the risk for bleeding complications and the need for platelet transfusions. Recipients of allogeneic PBPCs mobilized with filgrastim experienced significantly more rapid hematological recovery, leading to a significant decrease in time to unsupported platelet recovery when compared with allogeneic bone marrow transplantation.[L40719] 



Filgrastim causes a dose-dependent increase in circulating neutrophil counts within 24 hours of administration. Filgrastim can also cause a minor increase in monocyte and lymphocyte counts, but the clinical significance of these effects is unknown.[L40714] In some patients, filgrastim also caused a minor increase in the number of circulating eosinophils and basophils relative to baseline; however, these patients may already have had elevated eosinophils and basophils prior to filgrastim treatment. Following termination of filgrastim therapy, circulating neutrophil counts decrease by 50% within one to two days, and to normal levels within one to seven days. As with other hematopoietic growth factors, G-CSF has shown _in vitro_ stimulating properties on human endothelial cells.[L40719] ', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23643, 'Nixeleco 10 sachets', 'نيكسليلكو 10 اكياس', '69', NULL, 'Iron supplement', 'Lactoferrin+colostrum+vitamin (a+c+d3+e)+zinc+selenium+whey protein', 'Medcare > salix pharma', 'Sachet', 'أكياس', NULL, '1', 'تقوية المناعة لمقاومة المراض والفيروسات -- علاج الانيميا ونقص الحديد في الاطفال', 'lactoferrin is a bioactive 80-kda iron binding glycoprotein. indication & dosage: **for prophylaxis: 1-6 years: 1 sachet / day for 3-4 weeks. over 6 years: 2 sachet / day for 3-4 weeks. **during infections (upper respiratory diarrhea): 1-6 years: 1 sachet', '6225000299313', NULL, 3644, '2023-02-05', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23644, 'Nixprazole 40 mg 14 delayed rel. caps.', 'نيكسبرازول 40مجم 14 كبسولة ممتد المفعول', '152', '79', 'Peptic ulcer.proton pump inhibitor', 'Esomeprazole', 'Sigma > hochster pharmaceutical industries', 'Cap', 'كبسولة', '40 mg', '2', 'علاج تقرحات المعدة --علاج ارتجاع المرئ -- علاج الالام القولون والمعدة', 'about esomeprazole a proton pump inhibitor substituted benzimidazole antiulcer antisecretory drug. mechanism of action of esomeprazole esomeprazole is the s enantiomer of omeprazole and is a proton pump inhibitor. it is a prodrug. after administration it', '6224007751213', NULL, 3857, '2024-08-29', 0, 'Esomeprazole is indicated for the treatment of acid-reflux disorders including healing and maintenance of erosive esophagitis, and symptomatic gastroesophageal reflux disease (GERD), peptic ulcer disease, H. pylori eradication, prevention of gastrointestinal bleeds with NSAID use, and for the long-term treatment of pathological hypersecretory conditions including Zollinger-Ellison Syndrome. ', 'Esomeprazole exerts its stomach acid-suppressing effects by preventing the final step in gastric acid production by covalently binding to sulfhydryl groups of cysteines found on the (H+, K+)-ATPase enzyme at the secretory surface of gastric parietal cells. This effect leads to inhibition of both basal and stimulated gastric acid secretion, irrespective of the stimulus. As the binding of esomeprazole to the (H+, K+)-ATPase enzyme is irreversible and new enzyme needs to be expressed in order to resume acid secretion, esomeprazole''s duration of antisecretory effect that persists longer than 24 hours.[FDA Label]

', 'Esomeprazole is a compound that inhibits gastric acid secretion and is indicated in the treatment of gastroesophageal reflux disease (GERD), the healing of erosive esophagitis, and <i>H. pylori</i> eradication to reduce the risk of duodenal ulcer recurrence. Esomeprazole belongs to a new class of antisecretory compounds, the substituted benzimidazoles, that do not exhibit anticholinergic or H2 histamine antagonistic properties, but that suppress gastric acid secretion by specific inhibition of the H<sup>+</sup>/K<sup>+</sup> ATPase at the secretory surface of the gastric parietal cell. By doing so, it inhibits acid secretion into the gsatric lumen. This effect is dose-related and leads to inhibition of both basal and stimulated acid secretion irrespective of the stimulus.



Esomeprazole is the s-isomer of [DB00338], which is a racemate of the S- and R-enantiomer. Esomeprazole has been shown to inhibit acid secretion to a similar extent as [DB00338], without any significant differences between the two compounds _in vitro_. 



PPIs such as esomeprazole have also been shown to inhibit the activity of dimethylarginine dimethylaminohydrolase (DDAH), an enzyme necessary for cardiovascular health. DDAH inhibition causes a consequent accumulation of the nitric oxide synthase inhibitor asymmetric dimethylarginie (ADMA), which is thought to cause the association of PPIs with increased risk of cardiovascular events in patients with unstable coronary syndromes.[A177577, A177580]



Due to their good safety profile and as several PPIs are available over the counter without a prescription, their current use in North America is widespread. Long term use of PPIs such as esomeprazole has been associated with possible adverse effects, however, including increased susceptibility to bacterial infections (including gastrointestinal _C. difficile_), reduced absorption of micronutrients including iron and B12, and an increased risk of developing hypomagnesemia and hypocalcemia which may contribute to osteoporosis and bone fractures later in life.[A177571]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23647, 'Nizatect 300mg 20 caps.', 'نزانيكت 300مجم 20 كبسول', '43', NULL, 'Peptic ulcer.anti-histamine.h2 antagonist', 'Nizatidine', 'Marcyrl co.', 'Cap', 'كبسولة', '300mg', '2', NULL, 'indication for the treatment of acid-reflux disorders (gerd) peptic ulcer disease active benign gastric ulcer and active duodenal ulcer. pharmacodynamics nizatidine is a competitive reversible inhibitor of histamine at the histamine h2-receptors particula', '6223003570477', NULL, 722, '2022-12-07', 0, 'For the treatment of acid-reflux disorders (GERD), peptic ulcer disease, active benign gastric ulcer, and active duodenal ulcer.', 'Nizatidine competes with histamine for binding at the H<sub>2</sub>-receptors on the gastric basolateral membrane of parietal cells. Competitive inhibition results in reduction of basal and nocturnal gastric acid secretions. The drug also decreases the gastric acid response to stimuli such as food, caffeine, insulin, betazole, or pentagastrin.', 'Nizatidine is a competitive, reversible inhibitor of histamine at the histamine H2-receptors, particularly those in the gastric parietal cells. By inhibiting the action of histamine on stomach cells, nizatidine reduces stomach acid production. Nizatidine had no demonstrable antiandrogenic action. Full-dose therapy for the problems treated by nizatidine lasts no longer than 8 weeks. It has been demonstrated that treatment with a reduced dose of nizatidine is effective as maintenance therapy following healing of active duodenal ulcers.', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23648, 'Nizatine 150mg 20 caps.', 'نيزاتين 150مجم 20 كبسولة', '21', NULL, 'Peptic ulcer.anti-histamine.h2 antagonist', 'Nizatidine', 'Hi-pharm', 'Cap', 'كبسولة', '150mg', '2', NULL, NULL, NULL, NULL, 768, '2023-01-08', 0, 'For the treatment of acid-reflux disorders (GERD), peptic ulcer disease, active benign gastric ulcer, and active duodenal ulcer.', 'Nizatidine competes with histamine for binding at the H<sub>2</sub>-receptors on the gastric basolateral membrane of parietal cells. Competitive inhibition results in reduction of basal and nocturnal gastric acid secretions. The drug also decreases the gastric acid response to stimuli such as food, caffeine, insulin, betazole, or pentagastrin.', 'Nizatidine is a competitive, reversible inhibitor of histamine at the histamine H2-receptors, particularly those in the gastric parietal cells. By inhibiting the action of histamine on stomach cells, nizatidine reduces stomach acid production. Nizatidine had no demonstrable antiandrogenic action. Full-dose therapy for the problems treated by nizatidine lasts no longer than 8 weeks. It has been demonstrated that treatment with a reduced dose of nizatidine is effective as maintenance therapy following healing of active duodenal ulcers.', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23649, 'Nizatine 300mg 20 caps.', 'نيزاتين 300مجم 20 كبسولة', '30', NULL, 'Peptic ulcer.anti-histamine.h2 antagonist', 'Nizatidine', 'Hi-pharm', 'Cap', 'كبسولة', '300mg', '2', NULL, NULL, '6224001050336', NULL, 774, '2023-01-08', 0, 'For the treatment of acid-reflux disorders (GERD), peptic ulcer disease, active benign gastric ulcer, and active duodenal ulcer.', 'Nizatidine competes with histamine for binding at the H<sub>2</sub>-receptors on the gastric basolateral membrane of parietal cells. Competitive inhibition results in reduction of basal and nocturnal gastric acid secretions. The drug also decreases the gastric acid response to stimuli such as food, caffeine, insulin, betazole, or pentagastrin.', 'Nizatidine is a competitive, reversible inhibitor of histamine at the histamine H2-receptors, particularly those in the gastric parietal cells. By inhibiting the action of histamine on stomach cells, nizatidine reduces stomach acid production. Nizatidine had no demonstrable antiandrogenic action. Full-dose therapy for the problems treated by nizatidine lasts no longer than 8 weeks. It has been demonstrated that treatment with a reduced dose of nizatidine is effective as maintenance therapy following healing of active duodenal ulcers.', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23650, 'Nizaxid 15 mg/ml syrup 90 ml', 'نيزاكسيد 15مجم/مل شراب 90مل', '47', '29', 'Peptic ulcer.anti-histamine.h2 antagonist', 'Nizatidine', 'Sabaa > activa therapeutics', 'Syrup', 'شراب', '15 mg', '1', NULL, 'indication for the treatment of acid-reflux disorders (gerd) peptic ulcer disease active benign gastric ulcer and active duodenal ulcer. pharmacodynamics nizatidine is a competitive reversible inhibitor of histamine at the histamine h2-receptors particula', '6224000808280', NULL, 1082, '2023-12-22', 0, 'For the treatment of acid-reflux disorders (GERD), peptic ulcer disease, active benign gastric ulcer, and active duodenal ulcer.', 'Nizatidine competes with histamine for binding at the H<sub>2</sub>-receptors on the gastric basolateral membrane of parietal cells. Competitive inhibition results in reduction of basal and nocturnal gastric acid secretions. The drug also decreases the gastric acid response to stimuli such as food, caffeine, insulin, betazole, or pentagastrin.', 'Nizatidine is a competitive, reversible inhibitor of histamine at the histamine H2-receptors, particularly those in the gastric parietal cells. By inhibiting the action of histamine on stomach cells, nizatidine reduces stomach acid production. Nizatidine had no demonstrable antiandrogenic action. Full-dose therapy for the problems treated by nizatidine lasts no longer than 8 weeks. It has been demonstrated that treatment with a reduced dose of nizatidine is effective as maintenance therapy following healing of active duodenal ulcers.', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23652, 'Vapvolpe 50gm skin ointment', 'فابفولب مرهم للجلد 50 جم', '135', NULL, NULL, 'Eculaptus glabulus oil -menthol-camphor oil-garlic oil-lavandula asgustifolia oil-thymol-vitamin e- nutmeg', 'Volpe cure', 'Ointment', 'مرهم', '50gm', '1', NULL, NULL, NULL, NULL, 735, '2023-02-06', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23654, 'Dapilart 10 mg 28 tabs', 'دابيلارت 10مجم 28 قرص', '216', NULL, 'Anti-diabetic.secretagogues.sglt2 inhibitors', 'Dapagliflozin', 'Mash premier', 'Tab', 'أقراص', '10 mg', '4', NULL, NULL, '6222001402858', NULL, 1943, '2023-02-06', 0, 'Dapagliflozin is indicated as an adjunct treatment, alongside diet and exercise, to improve glycemic control in patients ≥10 years of age with type 2 diabetes mellitus.[L51023,A6757,A6758] For patients with chronic kidney disease at risk of progression, dapagliflozin in used to reduce the risk of sustained eGFR decline, end-stage kidney disease, cardiovascular death, and hospitalization for heart failure.[L46372] Dapagliflozin is also indicated to either reduce the risk of cardiovascular death, hospitalization for heart failure, and urgent heart failure visit in adults with heart failure or reduce the risk of hospitalization for heart failure in adults with type 2 diabetes mellitus and either established cardiovascular disease or multiple cardiovascular risk factors.[L46372] Combination products with dapagliflozin also exist, either as a dapagliflozin-saxagliptin or dapagliflozin-metformin hydrochloride formulation.[L38724,L38729] Both are used as an adjunct treatment to diet and exercise to improve glycemic control in adults with type 2 diabetes.[L38724,L38729]', 'Dapagliflozin inhibits the sodium-glucose cotransporter 2(SGLT2) which is primarily located in the proximal tubule of the nephron.[A6757] SGLT2 facilitates 90% of glucose reabsorption in the kidneys and so its inhibition allows for glucose to be excreted in the urine.[A6757] This excretion allows for better glycemic control and potentially weight loss in patients with type 2 diabetes mellitus.[A6757] ', 'Dapagliflozin also reduces sodium reabsorption and increases the delivery of sodium to the distal tubule. This may influence several physiological functions including, but not restricted to, lowering both pre- and afterload of the heart and downregulation of sympathetic activity, and decreased intraglomerular pressure which is believed to be mediated by increased tubuloglomerular feedback.[L48246]



Increases in the amount of glucose excreted in the urine were observed in healthy subjects and in patients with type 2 diabetes mellitus following the administration of dapagliflozin. Dapagliflozin doses of 5 or 10 mg per day in patients with type 2 diabetes mellitus for 12 weeks resulted in excretion of approximately 70 grams of glucose in the urine per day at Week 12. A near-maximum glucose excretion was observed at the dapagliflozin daily dose of 20 mg. This urinary glucose excretion with dapagliflozin also results in increases in urinary volume. After discontinuation of dapagliflozin, on average, the elevation in urinary glucose excretion approaches baseline by about 3 days for the 10 mg dose.[L48246]



Dapagliflozin was not associated with clinically meaningful prolongation of QTc interval at daily doses up to 150 mg (15 times the recommended maximum dose) in a study of healthy subjects. In addition, no clinically meaningful effect on QTc interval was observed following single doses of up to 500 mg (50 times the recommended maximum dose) of dapagliflozin in healthy subjects.[L48246]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23655, 'Devart zinc 50mg 30 tab', 'ديفارت زنك 50مجم 30 قرص', '70', '70', 'Zinc supplement', 'Zinc', 'Devartlab pharma', 'Tab', 'أقراص', '50mg', '1', NULL, NULL, '6223006935747', NULL, 1781, '2023-11-30', 0, 'Zinc can be used for the treatment and prevention of zinc deficiency/its consequences, including stunted growth and acute diarrhea in children, and slowed wound healing. It is also utilized for boosting the immune system, treating the common cold and recurrent ear infections, as well as preventing lower respiratory tract infections [L2172].  



', '**Zinc has three primary biological roles**: _catalytic_, _structural_, and _regulatory_. The catalytic and structural role of zinc is well established, and there are various noteworthy reviews on these functions. For example, zinc is a structural constituent in numerous proteins, inclusive of growth factors, cytokines, receptors, enzymes, and transcription factors for different cellular signaling pathways. It is implicated in numerous cellular processes as a cofactor for approximately 3000 human proteins including enzymes, nuclear factors, and hormones [L2096].



Zinc promotes resistance to epithelial apoptosis through cell protection (cytoprotection) against reactive oxygen species and bacterial toxins, likely through the antioxidant activity of the cysteine-rich metallothioneins [A32419].



In HL-60 cells (promyelocytic leukemia cell line), zinc enhances the up-regulation of A20 mRNA, which, via TRAF pathway, decreases NF-kappaB activation, leading to decreased gene expression and generation of tumor necrosis factor-alpha (TNF-alpha), IL-1beta, and IL-8 [A32418].



There are several mechanisms of action of zinc on acute diarrhea. Various mechanisms are specific to the gastrointestinal system: zinc restores mucosal barrier integrity and enterocyte brush-border enzyme activity, it promotes the production of antibodies and circulating lymphocytes against intestinal pathogens, and has a direct effect on ion channels, acting as a potassium channel blocker of adenosine 3-5-cyclic monophosphate-mediated chlorine secretion. Cochrane researchers examined the evidence available up to 30 September 2016 [L2106].



Zinc deficiency in humans decreases the activity of serum _thymulin_ (a hormone of the thymus), which is necessary for the maturation of T-helper cells. T-helper 1 (Th(1)) cytokines are decreased but T-helper 2 (Th(2)) cytokines are not affected by zinc deficiency in humans [A32417].



The change of _Th(1)_ to _Th(2)_ function leads to cell-mediated immune dysfunction. Because IL-2 production (Th(1) cytokine) is decreased, this causes decreased activity of natural-killer-cell (NK cell) and T cytolytic cells, normally involved in killing viruses, bacteria, and malignant cells [A32424]. 



In humans, zinc deficiency may lead to the generation of new CD4+ T cells, produced in the thymus. In cell culture studies (HUT-78, a Th(0) human malignant lymphoblastoid cell line), as a result of zinc deficiency, nuclear factor-kappaB (NF-kappaB) activation, phosphorylation of IkappaB, and binding of NF-kappaB to DNA are decreased and this results in decreased Th(1) cytokine production [A32417].



In another study, zinc supplementation in human subjects suppressed the gene expression and production of pro-inflammatory cytokines and decreased oxidative stress markers [A32424]. In HL-60 cells (a human pro-myelocytic leukemia cell line), zinc deficiency increased the levels of TNF-alpha, IL-1beta, and IL-8 cytokines and mRNA. In such cells, zinc was found to induce A20, a zinc finger protein that inhibited NF-kappaB activation by the tumor necrosis factor receptor-associated factor pathway. This process decreased gene expression of pro-inflammatory cytokines and oxidative stress markers [A32417].



The exact mechanism of zinc in acne treatment is poorly understood. However, zinc is considered to act directly on microbial inflammatory equilibrium and facilitate antibiotic absorption when used in combination with other agents. Topical zinc alone as well as in combination with other agents may be efficacious because of its anti-inflammatory activity and ability to reduce P. acnes bacteria by the inhibition of P. acnes lipases and free fatty acid levels [L2102].', 'Zinc is involved in various aspects of cellular metabolism. It has been estimated that approximately 10% of human proteins may bind zinc, in addition to hundreds of proteins that transport and traffic zinc. It is required for the catalytic activity of more than 200 enzymes, and it plays a role in immune function wound healing, protein synthesis, DNA synthesis, and cell division. Zinc is an essential element for a proper sense of taste and smell and supports normal growth and development during pregnancy, childhood, and adolescence. It is thought to have antioxidant properties, which may be protective against accelerated aging and helps to speed up the healing process after an injury; however, studies differ as to its effectiveness. Zinc ions are effective antimicrobial agents even if administered in low concentrations [L2211].



Studies on oral zinc for specific conditions shows the following evidence in various conditions [L2095]:



**Colds:** Evidence suggests that if zinc lozenges or syrup are taken within 24 hours after cold symptoms start, the supplement may shorten the length of colds. The use intranasal zinc has been associated with the loss of the sense of smell, in some cases long-term or permanently [L2095].



**Wound healing:** Patients with skin ulcers and decreased levels of zinc may benefit from oral zinc supplements [L2095]. 



**Diahrrea**: Oral zinc supplements can reduce the symptoms of diarrhea in children with low levels of zinc, especially in cases of malnutrition [L2095].

', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23658, 'No hair cream 75 ml', 'نو هير كريم 75 مل', '50', NULL, 'Hair removal', 'Ceteareth-23+glyceryl monostearate+decyl oleate+p.p.+b.h.t+carbomer+glycerin+m.p.sodium+silicon oil+', 'Mash premiere', 'Cream', 'كريم', '75 ml', '1', NULL, 'the cream attacks hair roots and slow down hair growth', '6222001405200', NULL, 891, '2022-08-05', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23659, 'No hair lotion 250 ml', 'نو هير لوشن 250مل', '74', NULL, 'Hair removal', 'Ceteareth-23+glyceryl monostearate+decyl oleate+p.p.+b.h.t+carbomer+glycerin+m.p.sodium+silicon oil+', 'Mash premiere', 'Lotion', 'لوشن', '250 ml', '1', NULL, 'the cream attacks hair roots and slow down hair growth', NULL, NULL, 530, '2022-08-05', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23660, 'No more acne cleanser 250 ml', 'نو مور اكني غسول 250 مل', '165', '145', 'Anti-acne', 'Vitamins(a+c+e)+myristic acid+lauric acid+palmitic acid+salicylic acid+panthenol+tea tree oil', 'Italian co. for cosemetics > hexa group', 'Cleanser', 'منظف', '250 ml', '1', 'علاج حب الشباب', 'for oily & acne prone skin. unique new formula gentle on skin. use: apply a small amount to a clean fingertip and gently rub into a damp face then wash with water.', NULL, NULL, 2530, '2025-01-22', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23661, 'No plac mouth wash 250 ml', 'نو بلاك غسول للفم 250مل', '65', '25', 'Oral care', 'Chlorhexidine+sodium monoflurophosphate+sodium citrate+sodium borate+dimethicone+menthol crystals', 'City pharma > cosmo pack', 'Mouth wash', 'غسول للفم', '250 ml', '1', NULL, NULL, NULL, NULL, 1432, '2024-04-05', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23664, 'Nobur cream 50 gm', 'نوبر كريم 50 جرام', '90', '60', 'Moisturizing topicals', 'Chlorhexidine+myrrh+yarrow extract+centtela assiatica+hypericum perforatum extract+plantain extract+', 'El-helou perfumes & cosmetics > healthy care egypt pharma', 'Cream', 'كريم', '50 gm', '1', 'مرطب وملطف للجلد', 'moisturizing skin cream', NULL, NULL, 4914, '2025-08-20', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23665, 'Nocandida 10 m.i.u. cream 20 gm', 'نوكانديدا 10وحدة كريم 20جم', '4', NULL, 'Antifungal.polyene', 'Nystatin', 'Pharopharma', 'Cream', 'كريم', '20 gm', '1', NULL, 'about nystatin polyene antifungal. mechanism of action of nystatin nystatin is a fungicidal as well as a fungistatic drug. it has high affinity for ergosterol present in the fungal cell membrane and bind with it and they orients in such a way that micropo', NULL, NULL, 904, '2022-07-16', 0, 'Nystatin is available in oral formulations for the treatment and/or prevention of oral candidiasis (a.k.a. thrush), intestinal candidiasis, and anal candidiasis.[L10686,L10728] It is indicated topically for the treatment of vulvovaginal candidiasis and other cutaneous candida infections.[L10728] A combination product containing nystatin alongside [neomycin], [gramicidin D], and [triamcinolone] (Viaderm K.C.®) is indicated in the treatment of corticosteroid-responsive dermatoses caused by bacterial or candidal infections and for pruritus ani/vulvae.[L10731] It is also available in combination with [metronidazole] for the treatment of mixed infections due to _Trichomonas vaginalis_ and _Candida albicans_.[L10776]



Nystatin is also sometimes used off-label for the prevention of invasive candidiasis in low birth weight neonates,[A188565] though it is generally reserved as a second-line option after [fluconazole].', 'Nystatin is a channel-forming ionophore, meaning it exerts its therapeutic effect via formation of a membrane-spanning pore in the fungal plasma membrane.[A188592] The formation of this pore results in a change in membrane permeability that allows for leakage of intracellular contents and the subsequent disruption of electrochemical gradients necessary for proper cell function.[L10686,A188562] Selectivity for fungal cells over mammalian cells is due to nystatin’s greater binding affinity for ergosterol, a key sterol found in fungal cell walls, as opposed to its mammalian counterpart, cholesterol.[A16808]', 'Nystatin is an antifungal that is both fungistatic and fungicidal in vitro against a wide variety of yeasts and yeast-like fungi. It exerts its antifungal effects via disruption of the fungal cell membrane. Resistance to nystatin is minimal in _Candida albicans_, but tends to develop in other species of _Candida_.[L10686] Nystatin carries no significant activity against bacteria, protozoa, or viruses. It carries significant systemic toxicity and is currently unavailable in a formula appropriate for systemic use - its efficacy is currently restricted, therefore, to topical, oral, and gastrointestinal infections.[A188562]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23666, 'Nocandida 100 000 i.u. 7 vaginal supp.', 'نوكانديدا 100000 وحدة دولية 7 اقماع مهبلية', '4', NULL, 'Antifungal.polyene', 'Nystatin', 'Pharopharma', 'Supp', 'لبوس', NULL, '1', NULL, 'about nystatin polyene antifungal. mechanism of action of nystatin nystatin is a fungicidal as well as a fungistatic drug. it has high affinity for ergosterol present in the fungal cell membrane and bind with it and they orients in such a way that micropo', NULL, NULL, 757, '2022-07-13', 0, 'Nystatin is available in oral formulations for the treatment and/or prevention of oral candidiasis (a.k.a. thrush), intestinal candidiasis, and anal candidiasis.[L10686,L10728] It is indicated topically for the treatment of vulvovaginal candidiasis and other cutaneous candida infections.[L10728] A combination product containing nystatin alongside [neomycin], [gramicidin D], and [triamcinolone] (Viaderm K.C.®) is indicated in the treatment of corticosteroid-responsive dermatoses caused by bacterial or candidal infections and for pruritus ani/vulvae.[L10731] It is also available in combination with [metronidazole] for the treatment of mixed infections due to _Trichomonas vaginalis_ and _Candida albicans_.[L10776]



Nystatin is also sometimes used off-label for the prevention of invasive candidiasis in low birth weight neonates,[A188565] though it is generally reserved as a second-line option after [fluconazole].', 'Nystatin is a channel-forming ionophore, meaning it exerts its therapeutic effect via formation of a membrane-spanning pore in the fungal plasma membrane.[A188592] The formation of this pore results in a change in membrane permeability that allows for leakage of intracellular contents and the subsequent disruption of electrochemical gradients necessary for proper cell function.[L10686,A188562] Selectivity for fungal cells over mammalian cells is due to nystatin’s greater binding affinity for ergosterol, a key sterol found in fungal cell walls, as opposed to its mammalian counterpart, cholesterol.[A16808]', 'Nystatin is an antifungal that is both fungistatic and fungicidal in vitro against a wide variety of yeasts and yeast-like fungi. It exerts its antifungal effects via disruption of the fungal cell membrane. Resistance to nystatin is minimal in _Candida albicans_, but tends to develop in other species of _Candida_.[L10686] Nystatin carries no significant activity against bacteria, protozoa, or viruses. It carries significant systemic toxicity and is currently unavailable in a formula appropriate for systemic use - its efficacy is currently restricted, therefore, to topical, oral, and gastrointestinal infections.[A188562]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23667, 'Nocandida 100.000i.u./ml susp. 30 ml', 'نوكانديدا 100000وحدة/مل شراب معلق 30مل', '5', NULL, 'Antifungal.polyene', 'Nystatin', 'Pharopharma', 'Susp', 'معلق', '30 ml', '1', NULL, 'about nystatin polyene antifungal. mechanism of action of nystatin nystatin is a fungicidal as well as a fungistatic drug. it has high affinity for ergosterol present in the fungal cell membrane and bind with it and they orients in such a way that micropo', NULL, NULL, 841, '2022-07-09', 0, 'Nystatin is available in oral formulations for the treatment and/or prevention of oral candidiasis (a.k.a. thrush), intestinal candidiasis, and anal candidiasis.[L10686,L10728] It is indicated topically for the treatment of vulvovaginal candidiasis and other cutaneous candida infections.[L10728] A combination product containing nystatin alongside [neomycin], [gramicidin D], and [triamcinolone] (Viaderm K.C.®) is indicated in the treatment of corticosteroid-responsive dermatoses caused by bacterial or candidal infections and for pruritus ani/vulvae.[L10731] It is also available in combination with [metronidazole] for the treatment of mixed infections due to _Trichomonas vaginalis_ and _Candida albicans_.[L10776]



Nystatin is also sometimes used off-label for the prevention of invasive candidiasis in low birth weight neonates,[A188565] though it is generally reserved as a second-line option after [fluconazole].', 'Nystatin is a channel-forming ionophore, meaning it exerts its therapeutic effect via formation of a membrane-spanning pore in the fungal plasma membrane.[A188592] The formation of this pore results in a change in membrane permeability that allows for leakage of intracellular contents and the subsequent disruption of electrochemical gradients necessary for proper cell function.[L10686,A188562] Selectivity for fungal cells over mammalian cells is due to nystatin’s greater binding affinity for ergosterol, a key sterol found in fungal cell walls, as opposed to its mammalian counterpart, cholesterol.[A16808]', 'Nystatin is an antifungal that is both fungistatic and fungicidal in vitro against a wide variety of yeasts and yeast-like fungi. It exerts its antifungal effects via disruption of the fungal cell membrane. Resistance to nystatin is minimal in _Candida albicans_, but tends to develop in other species of _Candida_.[L10686] Nystatin carries no significant activity against bacteria, protozoa, or viruses. It carries significant systemic toxicity and is currently unavailable in a formula appropriate for systemic use - its efficacy is currently restricted, therefore, to topical, oral, and gastrointestinal infections.[A188562]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23669, 'Noctopex 2mg 10 f.c.tab.', 'نوكتوبكس 2مجم 10 اقراص', '11', NULL, 'Urinary incontinence.antispasmodics.muscarinic antagonists', 'Tolterodine l tartarate', 'Multi-apex', 'Tab', 'أقراص', '2mg', '1', NULL, NULL, NULL, NULL, 986, '2022-11-27', 0, 'For the treatment of overactive bladder (with symptoms of urinary frequency, urgency, or urge incontinence).', 'Both tolterodine and its active metabolite, 5-hydroxymethyltolterodine, act as competitive antagonists at muscarinic receptors. This antagonism results in inhibition of bladder contraction, decrease in detrusor pressure, and an incomplete emptying of the bladder.', 'Tolterodine is a competitive muscarinic receptor antagonist. Both urinary bladder contraction and salivation are mediated via cholinergic muscarinic receptors. After oral administration, tolterodine is metabolized in the liver, resulting in the formation of the 5-hydroxymethyl derivative, a major pharmacologically active metabolite. The 5-hydroxymethyl metabolite, which exhibits an antimuscarinic activity similar to that of tolterodine, contributes significantly to the therapeutic effect. Both tolterodine and the 5-hydroxymethyl metabolite exhibit a high specificity for muscarinic receptors, since both show negligible activity or affinity for other neurotransmitter receptors and other potential cellular targets, such as calcium channels. Tolterodine has a pronounced effect on bladder function. The main effects of tolterodine are an increase in residual urine, reflecting an incomplete emptying of the bladder, and a decrease in detrusor pressure, consistent with an antimuscarinic action on the lower urinary tract.', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23670, 'Noctorelief 10mg 10 tab.', 'نوكتوريليف 10مجم 10 اقراص', '10', NULL, 'Bronchodilator.long acting beta 2 agonist', 'Bambuterol', 'Pharopharma', 'Tab', 'أقراص', '10mg', '1', NULL, 'about bambuterol long acting beta 2-adrenoceptor agonist anti asthmatic-bronchodilators. mechanism of action of bambuterol this prodrug of the 2-agonist terbutaline undergoes oxidation and hydrolysis in the body and converted into terbutaline. this terbut', NULL, NULL, 746, '2022-07-22', 0, 'For the prevention and reversal of bronchospasm in patients 12 years of age and older with asthma and reversible bronchospasm associated with bronchitis and emphysema.', 'The pharmacologic effects of bambuterol are at least in part attributable to stimulation through beta-adrenergic receptors (beta 2 receptors) of intracellular adenyl cyclase, the enzyme that catalyzes the conversion of adenosine triphosphate (ATP) to cyclic AMP. Increased cyclic AMP levels are associated with relaxation of bronchial smooth muscle and inhibition of release of mediators of immediate hypersensitivity from cells, especially from mast cells.', 'Bambuterol is a long acting beta2-adrenoceptor agonist used in the treatment of asthma. It is a prodrug of terbutaline. Bambuterol causes smooth muscle relaxation, resulting in dilation of bronchial passages.', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23671, 'Node ds+ anti recurrence shampoo 125 ml', 'نود دي اس شامبو 125مل', '245', NULL, 'Hair care', NULL, 'Bioderma dermatological laboratories > biotech egypt', 'Amp', 'أمبول', '125 ml', '1', NULL, 'the first anti-recurrence shampoo for severe dandruff with intense itching. ï- the exclusive formula of nodï- ds+ makes it highly effective against persistent dandruff. ï- the patented dsactivï- complex guarantees double effectiveness thanks to its action', NULL, NULL, 614, '2022-08-03', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23672, 'Mavilor 10mg 30 tab.', 'مافيلور 10مجم 30 قرص', '159', '117', 'Anti-hypertensive.beta blocker.selective b1', 'Nebivolol hydrochloride', 'Multi-apex', 'Tab', 'أقراص', '10mg', '3', NULL, 'about nebivolol third generation cardio selective beta-1 receptor antagonist antihypertensive. mechanism of action of nebivolol nebivolol is a 3rd generation cardio selective beta-1 receptor antagonist which reduces vascular resistance acutely lowers arte', '6223003207649', NULL, 1771, '2024-09-18', 0, 'Nebivolol is indicated to treat hypertension.[A2762,A182579,L7985,L7988]', 'Nebivolol is a highly selective beta-1 adrenergic receptor antagonist[A182579] with weak beta-2 adrenergic receptor antagonist activity.[A182585] Blocking beta-1 adrenergic receptors by d-nebivolol leads to decreased resting heart rate, exercise heart rate, myocardial contracility, systolic blood pressure, and diastolic blood pressure.[A182603,A182579,A182585,A182615] The selectivity of d-nebivolol limits the magnitude of beta blocker adverse effects in the airways or relating to insulin sensitivity.[A182615] Nebivolol also inhibits aldosterone, and beta-1 antagonism in the juxtaglomerular apparatus also inhibits the release of renin.[A182615] Decreased aldosterone leads to decreased blood volume, and decreased renin leads to reduced vasoconstriction.[A182615] l-nebivolol is responsible for beta-3 adrenergic receptor agonist activity that stimulates endothelial nitric oxide synthase, increasing nitric oxide levels; leading to vasodilation, decreased peripheral vascular resistance, increased stroke volume, ejection fraction, and cardiac output.[A2762,A182603,A182579,A182585,A182615] The vasodilation, reduced oxidative stress, and reduced platelet volume and aggregation of nebivolol may lead to benefits in heart failure patients.[A182603]', 'Nebivolol is a selective beta-1 adrenergic receptor antagonist that decreases vascular resistance, increases stroke volume and cardiac output, and does not negatively affect left ventricular function.[A182579,A182585] It has a long duration of action as effects can be seen 48 hours after stopping the medication and a wide therapeutic window as patients generally take 5-40mg daily.[A182579,L7985] Patients should not abruptly stop taking this medication as this may lead to exacerbation of coronary artery disease.[L7985] Diabetic patients should monitor their blood glucose levels as beta blockers may mask signs of hypoglycemia.[L7985]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23673, 'Nodouleur topical cream 120 gm', 'نوديولر كريم موضعي 120 جم', '100', '75', 'Massage cream', 'Eucalyptus oil+menthol oil+camphor oil+clove oil+thymol oil', 'Egyptian co. for cosmetics > beam pharma', 'Cream', 'كريم', '120 gm', '1', 'كريم مساج للجسم -- يعمل علي تخفيف الالام والالتهابات -- يحسن من الدورة الدموية بالجسم -- يعمل علي استرخاء الجسم', 'anti rheumatic anti inflammatory and analgesic', NULL, NULL, 1235, '2024-03-04', 0, 'As an active agent, eucalyptus oil has been indicated for relief of the symptoms of catarrhal colds, and/or the relief of the symptoms of minor muscular sprains and cramps [L1857].', 'The general consensus is that the exact mechanism of action of eucalyptus oil is largely unknown at this time but comprises various hypotheses from various studies.



Cineol containing preparations of eucalyptus oil may contain up to 80% (or more) 1,8-cineole [A32243] and is one of the most common types of eucalyptus oil formulations used. As an active agent indicated for relieving certain cold symptoms and/or certain muscular sprains and cramps, it is believed that eucalyptus oil may possess some antimicrobial and anti-inflammatory activities.



Some in vitro studies of human blood monocytes suggest a dose-dependent effect of eucalyptus oil to elicit significant inhibition of multiple cytokines, perhaps in the treatment of airway inflammation [A32244, A32245]. Moreover, other studies in animal models discuss the possibility of eucalyptus oil demonstrating anti-inflammatory and anti-nociceptive effects that potentially account for inhibiting the formation of prostaglandins and cytokines by stimulated monocytes in vitro [A32246, A32247].



Furthermore, additional studies have observed eucalyptus oil anti-viral activity against herpes simplex virus (HSV-1, HSV-2) in cell cultures as well as the demonstration of broad antimicrobial activity of eucalyptus medicinal plant extracts against Alicyclobacillus acidoterretris, Bacillus cereus, E. coli, Enterococcus faecalis, MRSA, Propionibacterium acnes, S. aureus, fungus including C. albicans isolates, Trichophyton mentagrophytes, and other Gram-positive bacteria. Specific activity against periodontopathic bacteria, such as Porphyromonas gingivalis, Actinobacillus actinomycetemcomitans, Fusobacterium nucleatum, Streptococcus mutans, and Streptococcus sobrinus has also been observed [A32250, A32251, A32252, A32253, A32254].', 'Lipophilic monoterpene formulations of eucalyptus oil appear to be readily absorbed orally, with a primarily oxidative metabolism that might necessitate induction of the cytochrome P450 enzyme system and subsequent urinary excretion [A32236]. Gastrointestinal absorption of eucalyptus appears to be rapid and may be enhanced by the intake of lipids and milk. 1,8-cineole (which makes up to as much as 90% of most commonly used cineole-based eucalyptus oils) [A32227] has also been found in vitro and in animals to possess cytochrome P450 inducing activity [A32237, A32238, A32239].', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23674, 'Nody orax mouth spray 60 ml', 'نودي اوراكس بخاخ للفم 60 مل', '50', '45', 'Oral care', 'Clove oil+menthol oil+chlorhexidine+cinnamon oil+vit e', 'Italian co. for cosmetics > s3r pharma', 'Spray', 'بخاخ', '60 ml', '1', 'بخاخ مطهر للفم', '4 to 6 times daily for oral cavity care', NULL, NULL, 5617, '2025-08-03', 0, 'Clove oil is primarily indicated in conditions like colic, flatulence, and toothache [L2849].', 'The chief constituent present in clove oil is the phenol "_eugenol_" which is present in amounts up to 85%. Clove oil acts as a germicide [L2849] to Escherichia coli, Staphylococcus aureus and Pseudomonas aeruginosa [A24841]. 



Clove oil is thought to inhibit prostaglandin synthesis, thereby reducing painful symptoms [A33145].



Eugenol, the main constituent of clove oil is purported to have anticancer action. In one study, eugenol-treated HL-60 cells showed features of apoptosis including DNA fragmentation and formation of DNA ladders in agarose gel electrophoresis. It was observed that eugenol transduced the apoptotic signal via reactive oxygen species (ROS) generation, inducing mitochondrial permeability transition (MPT), decreasing anti-apoptotic protein _bcl-2_ level, inducing _cytochrome c_ release to the cytosol, and subsequent apoptotic cell death. When taken together, the study showed that ROS plays a critical role in eugenol-induced apoptosis in _HL-60_, and this is the first report on the mechanism of the anticancer effect of eugenol [A33146].', 'Clove (Eugenia caryophyllata Thunb. [Myrtaceae]) essential oil (CEO) has been demonstrated to possess antimicrobial, antifungal, antiviral, antioxidant, anti-inflammatory, anti-histamine, and anticancer properties. However, few studies have focused on its topical use [A33133], [L2850].



Clove essential oil, used as an antiseptic in oral infections, inhibits gram-negative and gram-positive bacteria as well as yeast [A24841].



', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23676, 'Loxybeauty collagen drinkable ampoules 20 x 25 ml', 'لوكسي بيوتي كولاجين امبولات للشرب 20 * 25 مل', '1,790', '1490', 'Multivitamin', 'Collagen+vitamin c+hyaluronic acid+biotin+zinc+selenium', 'Loxymore pharma', 'Ampoule', 'أمبول', '25 ml', '20', NULL, NULL, NULL, NULL, 655, '2024-06-24', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23677, 'Nofibra 200mg 20 caps.', 'نوفيبرا 200مجم 20 كبسول', '16', NULL, 'Antihyperlipidemic.fibrates', 'Fenofibrate', 'Pharopharma', 'Cap', 'كبسولة', '200mg', '2', NULL, 'about fenofibrate fibric acid derivative ppara agonist antilipemic agent antigout.ssmechanism of action of fenofibratesit is prodrug which has greater ldl (low density lipoprotein) cholesterol lowering potential. it lowers circulating triglyceride levels', NULL, NULL, 799, '2022-07-27', 0, 'Fenofibrate is indicated as adjunctive therapy to diet:[L51464]



- To reduce triglyceride (TG) levels in adults with severe hypertriglyceridemia (TG greater than or equal to 500 mg/dL)

- To reduce elevated low-density lipoprotein cholesterol (LDL-C) in adults with primary hyperlipidemia when the use of recommended LDL-C lowering therapy is not possible', 'Fenofibrate activates peroxisome proliferator activated receptor alpha (PPARα), increasing lipolysis, activating lipoprotein lipase, and reducing apoprotein C-III.[A186002,L8588,L8591] PPARα is a nuclear receptor and its activation alters lipid, glucose, and amino acid homeostasis.[A186002] Activation of PPARα activates transcription of gene transcription and translation that generates peroxisomes filled with hydrogen peroxide, reactive oxygen species, and hydroxyl radicals that also participate in lipolysis.[A186005] This mechanism of increased lipid metabolism is also associated with increased oxidative stress on the liver.[A186005] In rare cases this stress can lead to cirrhosis and chronic active hepatitis.[A186002,L8588,L8591]', 'Fenofibrate is a fibrate that activates peroxisome proliferator activated receptor alpha (PPARα) to alter lipid metabolism and treat primary hypercholesterolemia, mixed dyslipidemia, and severe hypertriglyceridemia.[A186002,L8588,L8591] Fenofibrate requires once daily dosing and has a half life of 19-27 hours so its duration of action is long.[A36366,L8588,L8591] Fenofibrate capsules are given at a dose of 50-150mg daily so the therapeutic index is wide.[L8591] Patients should be counselled about the risk of rhabdomyolysis, myopathy, and cholelithiasis when taking fibrates.[L8588,L8591]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23678, 'Nofibra 67mg 20 caps.', 'نوفيبرا 67مجم 20 كبسول', '9', NULL, 'Antihyperlipidemic.fibrates', 'Fenofibrate', 'Pharopharma', 'Cap', 'كبسولة', '67mg', '2', NULL, 'about fenofibratesfibric acid derivative ppara agonist antilipemic agent antigout.ssmechanism of action of fenofibratesit is prodrug which has greater ldl (low density lipoprotein) cholesterol lowering potential. it lowers circulating triglyceride levels', NULL, NULL, 847, '2022-07-15', 0, 'Fenofibrate is indicated as adjunctive therapy to diet:[L51464]



- To reduce triglyceride (TG) levels in adults with severe hypertriglyceridemia (TG greater than or equal to 500 mg/dL)

- To reduce elevated low-density lipoprotein cholesterol (LDL-C) in adults with primary hyperlipidemia when the use of recommended LDL-C lowering therapy is not possible', 'Fenofibrate activates peroxisome proliferator activated receptor alpha (PPARα), increasing lipolysis, activating lipoprotein lipase, and reducing apoprotein C-III.[A186002,L8588,L8591] PPARα is a nuclear receptor and its activation alters lipid, glucose, and amino acid homeostasis.[A186002] Activation of PPARα activates transcription of gene transcription and translation that generates peroxisomes filled with hydrogen peroxide, reactive oxygen species, and hydroxyl radicals that also participate in lipolysis.[A186005] This mechanism of increased lipid metabolism is also associated with increased oxidative stress on the liver.[A186005] In rare cases this stress can lead to cirrhosis and chronic active hepatitis.[A186002,L8588,L8591]', 'Fenofibrate is a fibrate that activates peroxisome proliferator activated receptor alpha (PPARα) to alter lipid metabolism and treat primary hypercholesterolemia, mixed dyslipidemia, and severe hypertriglyceridemia.[A186002,L8588,L8591] Fenofibrate requires once daily dosing and has a half life of 19-27 hours so its duration of action is long.[A36366,L8588,L8591] Fenofibrate capsules are given at a dose of 50-150mg daily so the therapeutic index is wide.[L8591] Patients should be counselled about the risk of rhabdomyolysis, myopathy, and cholelithiasis when taking fibrates.[L8588,L8591]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23679, 'Noflu 20 tab.', 'نوفلو 20 قرص', '36', '22', 'Cold drugs', 'Chlorpheniramine+paracetamol(acetaminophen)+pseudoephedrine', 'Kahira', 'Tab', 'أقراص', NULL, '2', '1- مضاد للزكام ومزيل للاحتقان.', NULL, '6221068000465', NULL, 8768, '2024-12-07', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23680, 'Noflu syrup 100ml', 'نوفلو شراب 100 مل', '17', '9.5', 'Cold drugs', 'Chlorpheniramine+paracetamol(acetaminophen)+phenylpropanolamine', 'Kahira', 'Syrup', 'شراب', '100ml', '1', NULL, 'description a histamine h1 antagonist used in allergic reactions hay fever rhinitis urticaria and asthma. indication for the treatment of rhinitis urticaria allergy common cold asthma and hay fever. pharmacodynamics in allergic reactions an allergen inter', '6221068402931', NULL, 1067, '2024-12-07', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23681, 'Nofract 70 mg oral soln. 75 ml', 'نوفراكت 70مجم شرب 75 مل', '32', '22.5', 'Osteoporosis.bisphosphonates', 'Alendronate', 'Egpi > jasper for pharmaceutical industries', 'Sol', 'محلول', '70 mg', '1', 'علاج لهشاشة العظام.', 'indication for the treatment and prevention of osteoporosis in women and paget s disease of bone in both men and women. mechanism of action the action of alendronate on bone tissue is based partly on its affinity for hydroxyapatite which is part of the mi', '6224007884188', NULL, 1750, '2025-03-04', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23682, 'Nolaver cream 50 gm', 'نولافير كريم 50 جرام', '90', '75', 'Healing topical', 'Panthenol+rosemary oil+honey extract+sesame oil+aloe vera extract+beeswax+paraffin oil', 'Egyptian company for cosmetics > parkville pharmaceuticals', 'Cream', 'كريم', '50 gm', '1', 'علاج والتئام الجروح', 'nolaver cream is the tissue-healing agent that insures fast healing with minimum scar formation and guarantees 100% of patient satisfaction with risk-free due to its natural components formulated by effective combination of organic extracts and therapeuti', '6224001133923', NULL, 2297, '2024-01-28', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23683, 'Nolice 0.4gm/100 ml lotion 60 ml', 'نولايس 0.4جم/100مل لوشن 60مل', '7', NULL, 'Scabicide', 'Phenothrin', 'Eva pharma', 'Lotion', 'لوشن', '0.4gm', '1', NULL, 'phenothrin is a chemical that kills insects (an insecticide). it is a man-made (synthetic) chemical similar to the natural insecticides called pyrethrins. phenothrin is one of a group of insecticides known as pyrethroids. it is also used to control scabie', NULL, NULL, 738, '2022-08-02', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23684, 'Nolice 0.4gm/100ml shampoo 100 ml', 'نولايس 0.4مجم/100مل شامبو 100مل', '9', NULL, 'Anti-lice', 'Phenothrin', 'Eva pharma', 'Amp', 'أمبول', '0.4gm', '1', NULL, 'phenothrin is a chemical that kills insects (an insecticide). it is a man-made (synthetic) chemical similar to the natural insecticides called pyrethrins. phenothrin is one of a group of insecticides known as pyrethroids. it is also used to control scabie', NULL, NULL, 699, '2022-07-30', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23685, 'Asmazon cream 30 gm', 'اسمازون كريم 30 جم', '40', NULL, NULL, 'Climbazol', 'Pharmakon', 'Cream', 'كريم', '30 gm', '1', NULL, NULL, '6224008056843', NULL, 841, '2024-07-12', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23688, 'No-migrain z 5mg 2 f.c.tab', 'نو ميجران زد 5مجم 2 قرص', '35', NULL, 'Antimigraine.vasoconstrictor agents.selective serotonin agonist', 'Zolmitriptan', 'Amoun', 'Tab', 'أقراص', '5mg', '1', NULL, 'about zolmitriptan selective serotonin (5ht1) agonists anti migraine mechanism of action of zolmitriptan zolmitriptan is a selective agonist for serotonin (5ht1 receptors). it relieves migraine by selective constriction of intracranial blood vessels neuro', NULL, NULL, 949, '2022-10-28', 0, 'Zolmitriptan is indicated for the acute treatment of migraine with or without auras in patients aged 18 and over.[L12978]', 'Migraines are complex physiological events characterized by unilateral throbbing headaches combined with photophobia and other aversions to sensory input. Migraine attacks are generally divided into phases: the premonitory phase, which typically involves irritability, fatigue, yawning, and stiff neck; the headache phase, which lasts for between four and 72 hours; and the postdrome phase, which lasts for up to a day following resolution of pain and whose symptoms are similar to those of the premonitory phase. In addition, neurological deficits, collectively termed migraine aura, may precede the headache phase.[A193797, A193794]



The underlying pathophysiology of migraines is a matter of active research but involves both neurological and vascular components. The head pain associated with migraine is thought to be a consequence of activation of the nociceptive nerves comprising the trigeminocervical complex (TCC).[A193794] Terminals of nociceptive nerves that innervate the dura matter release vasoactive peptides, such as calcitonin gene-related peptide (CGRP), resulting in cranial vasodilation. Finally, when present, migraine aura appears to correlate with a transient wave(s) of cortical depolarization, termed cortical spreading depression (CSD).[A193794,A193851]



Triptans, including zolmitriptan, are proposed to act in three ways. The main mechanism is through modulation of nociceptive nerve signalling in the central nervous system through 5-HT<sub>1B/1D</sub> receptors throughout the TCC and associated areas of the brain. In addition, triptans can enhance vasoconstriction, both through direct 5-HT<sub>1B</sub>-mediated dilation of cranial blood vessels,[A462, A198741] as well as through 5-HT<sub>1D</sub>-mediated suppression of CGRP release.[A193794, L12978]



Although triptans are classically described solely in terms of their effects on 5-HT<sub>1B/1D</sub> receptors, they also act as 5-HT<sub>1F</sub> agonists as well. This 5-HT subtype is also found throughout the TCC, but is not present appreciably in cerebral vasculature; the significance of triptan-mediated 5-HT<sub>1F</sub> activation is currently not well described.[A193791] Additionally, CSD that initiates in the ipsilateral parietal region may exert its effects in a manner that relies on 5-HT<sub>1B/1D</sub> receptor activation, suggesting that triptans may have some effect on CSD-mediated symptoms.[A193794, A198738]', 'Zolmitriptan, like other triptans, is a serotonin (5-hydroxytryptamine; 5-HT) receptor agonist, with enhanced specificity for the 5-HT<sub>1B</sub> and 5-HT<sub>1D</sub> receptor subtypes. It is through the downstream effects of 5-HT<sub>1B/1D</sub> activation that triptans are proposed to provide acute relief of migraines.[L12978,A462,A193791] Zolmitriptan is also a vasoconstrictor,[A193803] leading to possible adverse cardiovascular effects such as myocardial ischemia/infarction, arrhythmias, cerebral and subarachnoid hemorrhage, stroke, gastrointestinal ischemia, and peripheral vasospastic reactions. In addition, chest/throat/neck/jaw pain, tightness, and/or pressure has been reported, along with the possibility of medication overuse headaches and serotonin syndrome. Patients with phenylketonuria should be advised that ZOMIG-ZMT contains phenylalanine.[L12978]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23689, 'Nonan i.v. infusion', 'نونان محلول وريد', '23', NULL, NULL, 'Ammonium molybdate+cobalt+copper+iron+magnesium+sodium fluoride+sodium iodide+zinc gluconate', 'Laborataire aguettant > multi-apex', 'Unknown', 'غير محدد', NULL, '1', NULL, NULL, NULL, NULL, 893, '2022-07-30', 0, '1. Expectorant in cough syrups.

2. The ammonium ion (NH4+) in the body plays an important role in the maintenance of acid-base balance. The kidney uses ammonium (NH4+) in place of sodium (Na+) to combine with fixed anions in maintaining acid-base balance, especially as a homeostatic compensatory mechanism in metabolic acidosis.

The therapeutic effects of Ammonium Chloride depend upon the ability of the kidney to utilize ammonia in the excretion of an excess of fixed anions and the conversion of ammonia to urea by the liver, thereby liberating hydrogen (H+) and chloride (Cl–) ions into the extracellular fluid.

Ammonium Chloride Injection, USP, after dilution in isotonic sodium chloride injection, may be indicated in the treatment of patients with:

 (1) hypochloremic states and (2) metabolic alkalosis.', 'Ammonium chloride increases acidity by increasing the amount of hydrogen ion concentrations.



Ammonium chloride can be used as an expectorant due to its irritative action on the bronchial mucosa. This effect causes the production of respiratory tract fluid which in order facilitates the effective cough.', 'Systemic acidifier. In liver ammonium chloride is converted into urea with the liberation of hydrogen ions ( which lowers the pH) and chloride. ', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23690, 'Nonato baby soap 100 gm', 'نوناتو بيبي صابون 100جم', '55', '25', 'Baby care', NULL, 'Hi-care > pixel pharmaceutical company', 'Soap', 'صابون', '100 gm', '1', 'صابون غنى بالمرطبات وملطف لبشرة الطفل', 'cleansing & moisturizing soap', NULL, NULL, 1056, '2024-04-19', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23691, 'Nonem 10 sachet', 'نونيم 10 أكياس', '69', NULL, 'Multivitamins', 'Lactoferrin 100 mg+iron+vit b complex+folic acid+zinc+vit c', 'Medcare > top care pharma', 'Sachet', 'أكياس', NULL, '1', 'فيتامينات متعددة', NULL, NULL, NULL, 529, '2022-05-30', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23692, 'Nono water syrup 120 ml', 'ماء نونو شراب 120 مل', '42', '22', 'Git disturbances', 'Caraway oil+dill oil+sodium bicarbonate', 'Debeiky', 'Syrup', 'شراب', '120 ml', '1', NULL, 'to improve gastro-intestinal functions', '6225000005419', NULL, 1326, '2024-02-21', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23693, 'Noodril 250mg 10 tab.', 'نودريل 250مجم 10 اقراص', '4', NULL, 'Cerebral circulatory inhancer', 'Meclofenoxate', 'Alfacure pharmaceuticals', 'Tab', 'أقراص', '250mg', '1', 'يعمل على زيادة تدفق الدم للمخ', 'one of the most used nootropics. the only drug reported to cause lipofuscin regression. has a unique mechanism of action used in cases of cerebral insufficiency dementia stroke and cerebral aging. indications: 1- manifestations of cerebral insufficiency ï', NULL, NULL, 2076, '2022-05-19', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23695, 'Nootropil 20% syrup 120ml (cancelled)', 'نوتروبيل 20% شراب 120 مل', '19', NULL, 'Cerebral circulatory inhancer', 'Piracetam', 'Cid > ucb-belgium', 'Syrup', 'شراب', '20%', '1', 'علاج انخفاض التركيز وضعف الذاكرة', NULL, '6221043070018', NULL, 2363, '2023-02-06', 0, 'Indicated in adult patients suffering from myoclonus of cortical origin, irrespective of aetiology, and should be used in combination with other anti-myoclonic therapies [L1125].', 'Piracetam interacts with the polar heads in the phospholipids membrane and the resulting mobile drug-lipid complexes are thought to reorganize the lipids and influence membrane function and fluidity [A31532]. Such interaction has been reported in a study that investigated the effects of neuronal outgrowth induced by beta amyloid peptides; while amyloid peptides cause lipid disorganization within the cell membranes leading to neuronal death, piracetam demonstrated to decrease the destabilizing effects of amyloid peptide [A31534]. The authors suggest that piracetam induces a positive curvature of the membrane by occupying the polar groups in the phospholipids to counteract the negative curvature induced by amyloid peptides , which in turn would decrease the likelihood of membrane fusion [A31532]. This mechanism of action is thought to improve membrane stability, allowing the membrane and transmembrane proteins to maintain and recover the three-dimensional structure or folding for normal function [L1124] such as membrane transport, chemical secretion, and receptor binding and stimulation [A31532]. 



Through restored membrane fluidity, piracetam promotes restored neurotransmission such as glutamatergic and cholinergic systems, enhances neuroplasticity and mediates neuroprotective and anticonvulsant effects at the neuronal level [A31532]. It is also demonstrated that piracetam also improves the fluidity of platelet membranes. At the vascular level, piracetam decreases adhesion of erythrocytes to cell wall and reduces vasospasm which in turn improves microcirculation including cerebral and renal blood flow [A31532]. ', 'Piracetam is known to mediate various pharmacodynamic actions:



**Neuronal effects**: 



Piracetam modulates the cholinergic, serotonergic, noradrenergic, and glutamatergic neurotransmission although the drug does not display high affinity to any of the associated receptors (Ki >10μM). Instead, piracetam increases the density of postsynaptic receptors and/or restore the function of these receptors through stabilizing the membrane fluidity [A31532]. In the forebrain of aging mice, the density of NMDA receptors was increased by approximately 20% following 14 days of piracetam treatment. Based on the findings of various animal and human studies, the cognitive processses including learning, memory, attention and consciousness were enhanced from piracetam therapy without inducing sedation and psychostimulant effects [L1125]. Piracetam mediate neuroprotective effects against hypoxia-induced damage, intoxication, and electroconvulsive therapy [L1125]. 



In two studies involving alcohol-treated rats with evidences of withdrawal-related neuronal loss, piracetam was shown to reduce the extent of neuronal loss and increase the numbers of synapses in the hippocampus by up to 20% relative to alcohol-treated or alcohol-withdrawn rats [A31532]. This suggests that piracetam is capable in promoting neuroplasticity when recoverable neural circuits are present [A31532]. Although the mechanism of action is not fully understood, administration of piracetam prior to a convulsant stimulus reduces the seizure severity and enhances the anticonvulsant effectiveness of conventional antiepileptics such as carbamazepine and diazepam [A31535]. 



**Vascular effects**: 



Piracetam is shown to increase the deformability of erythrocytes, reduce platelet aggregation in a dose-dependent manner, reduce the adhesion of erythrocytes to vascular endothelium and capillary vasospasm. In healthy volunteers, piracetam mediated a direct stimulant effect on prostacycline synthesis and reduced the plasma levels of fibrinogen and von Willebrand’s factors (VIII: C; VIII R: AG; VIII R: vW) by 30 to 40% [L1125]. Potentiated microcirculation is thought to arise from a combination of effects on erythrocytes, blood vessels and blood coagulation [A31532]. ', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23696, 'Nootropil 400mg 30 capsules.(cancelled)', 'نوتروبيل 400مجم 30 كبسولة', '9', NULL, 'Cerebral circulatory inhancer', 'Piracetam', 'Cid > ucb-belgium', 'Capsule', 'كبسولة', '400mg', '3', 'علاج انخفاض التركيز وضعف الذاكرة', NULL, '6221043070001', NULL, 2558, '2022-12-07', 0, 'Indicated in adult patients suffering from myoclonus of cortical origin, irrespective of aetiology, and should be used in combination with other anti-myoclonic therapies [L1125].', 'Piracetam interacts with the polar heads in the phospholipids membrane and the resulting mobile drug-lipid complexes are thought to reorganize the lipids and influence membrane function and fluidity [A31532]. Such interaction has been reported in a study that investigated the effects of neuronal outgrowth induced by beta amyloid peptides; while amyloid peptides cause lipid disorganization within the cell membranes leading to neuronal death, piracetam demonstrated to decrease the destabilizing effects of amyloid peptide [A31534]. The authors suggest that piracetam induces a positive curvature of the membrane by occupying the polar groups in the phospholipids to counteract the negative curvature induced by amyloid peptides , which in turn would decrease the likelihood of membrane fusion [A31532]. This mechanism of action is thought to improve membrane stability, allowing the membrane and transmembrane proteins to maintain and recover the three-dimensional structure or folding for normal function [L1124] such as membrane transport, chemical secretion, and receptor binding and stimulation [A31532]. 



Through restored membrane fluidity, piracetam promotes restored neurotransmission such as glutamatergic and cholinergic systems, enhances neuroplasticity and mediates neuroprotective and anticonvulsant effects at the neuronal level [A31532]. It is also demonstrated that piracetam also improves the fluidity of platelet membranes. At the vascular level, piracetam decreases adhesion of erythrocytes to cell wall and reduces vasospasm which in turn improves microcirculation including cerebral and renal blood flow [A31532]. ', 'Piracetam is known to mediate various pharmacodynamic actions:



**Neuronal effects**: 



Piracetam modulates the cholinergic, serotonergic, noradrenergic, and glutamatergic neurotransmission although the drug does not display high affinity to any of the associated receptors (Ki >10μM). Instead, piracetam increases the density of postsynaptic receptors and/or restore the function of these receptors through stabilizing the membrane fluidity [A31532]. In the forebrain of aging mice, the density of NMDA receptors was increased by approximately 20% following 14 days of piracetam treatment. Based on the findings of various animal and human studies, the cognitive processses including learning, memory, attention and consciousness were enhanced from piracetam therapy without inducing sedation and psychostimulant effects [L1125]. Piracetam mediate neuroprotective effects against hypoxia-induced damage, intoxication, and electroconvulsive therapy [L1125]. 



In two studies involving alcohol-treated rats with evidences of withdrawal-related neuronal loss, piracetam was shown to reduce the extent of neuronal loss and increase the numbers of synapses in the hippocampus by up to 20% relative to alcohol-treated or alcohol-withdrawn rats [A31532]. This suggests that piracetam is capable in promoting neuroplasticity when recoverable neural circuits are present [A31532]. Although the mechanism of action is not fully understood, administration of piracetam prior to a convulsant stimulus reduces the seizure severity and enhances the anticonvulsant effectiveness of conventional antiepileptics such as carbamazepine and diazepam [A31535]. 



**Vascular effects**: 



Piracetam is shown to increase the deformability of erythrocytes, reduce platelet aggregation in a dose-dependent manner, reduce the adhesion of erythrocytes to vascular endothelium and capillary vasospasm. In healthy volunteers, piracetam mediated a direct stimulant effect on prostacycline synthesis and reduced the plasma levels of fibrinogen and von Willebrand’s factors (VIII: C; VIII R: AG; VIII R: vW) by 30 to 40% [L1125]. Potentiated microcirculation is thought to arise from a combination of effects on erythrocytes, blood vessels and blood coagulation [A31532]. ', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23699, 'Nopecia 1mg 30 capsules', 'نوبيشيا 1مجم 30 كبسولة', '36', NULL, 'Anti-androgen.alopecia ttt', 'Finasteride', 'Adwia', 'Capsule', 'كبسولة', '1mg', '3', 'علاج الصلع وتساقط الشعر', NULL, '6223002976584', NULL, 4585, '2022-12-07', 0, 'Finasteride is indicated for the treatment of symptomatic benign prostatic hyperplasia (BPH) in men with an enlarged prostate to improve symptoms, reduce the risk of acute urinary retention, and reduce the risk of the need for surgery including transurethral resection of the prostate (TURP) and prostatectomy.[L10565] A combination product with [tadalafil] is also used for the symptomatic treatment of BPH for up to 26 weeks.[L39439]



Finasteride is also indicated for the treatment of male pattern hair loss (androgenetic alopecia, hereditary alopecia, or common male baldness) in male patients.[L6235]', 'Finasteride acts as a competitive and specific inhibitor of Type II 5α-reductase, a nuclear-bound steroid intracellular enzyme primarily located in the prostatic stromal cell that converts the androgen testosterone into the more active metabolite, 5α-dihydrotestosterone (DHT).[A2132] DHT is considered to be the primary androgen playing a role in the development and enlargement of the prostate gland. It serves as the hormonal mediator for the hyperplasia upon accumulation within the prostate gland.[A178270] DHT displays a higher affinity towards androgen receptors in the prostate gland compared to testosterone[T28] and by acting on the androgen receptors, DHT modulates genes that are responsible for cell proliferation.[A178279] Responsible for the production of DHT together with type I 5α-reductase, the type II 5α-reductase isozyme is primarily found in the prostate, seminal vesicles, epididymides, and hair follicles as well as liver.[L6235] Although finasteride is 100-fold more selective for type II 5α-reductase than for the type I isoenzyme,[A178183] chronic treatment with this drug may have some effect on type I 5α-reductase, which is predominantly expressed in sebaceous glands of most regions of skin, including the scalp, and liver. It is proposed that the type I 5α-reductase and type II 5α-reductase is responsible for the production of one-third and two-thirds of circulating DHT, respectively. 



The mechanism of action of Finasteride is based on its preferential inhibition of Type II 5α-reductase through the formation of a stable complex with the enzyme _in vitro_ and _in vivo_.[L10565] Finasteride works selectively, where it preferentially displays a 100-fold selectivity for the human Type II 5α-reductase over type I enzyme.[L6235] Inhibition of Type II 5α-reductase blocks the peripheral conversion of testosterone to DHT, resulting in significant decreases in serum and tissue DHT concentrations, minimal to moderate increase in serum testosterone concentrations, and substantial increases in prostatic testosterone concentrations. As DHT appears to be the principal androgen responsible for stimulation of prostatic growth, a decrease in DHT concentrations will result in a decrease in prostatic volume (approximately 20-30% after 6-24 months of continued therapy). It is suggested that increased levels of DHT can lead to potentiated transcription of prostaglandin D2, which promotes the proliferation of prostate cancer cells.[A178189] In men with androgenic alopecia, the mechanism of action has not been fully determined, but finasteride has shown to decrease scalp DHT concentration to the levels found in the hairy scalp, reduce serum DHT, increase hair regrowth, and slow hair loss. Another study suggests that finasteride may work to reduce bleeding of prostatic origin by inhibiting vascular endothelial growth factor (VEGF) in the prostate, leading to atrophy and programmed cell death.[A178183] This may bestow the drug therapeutic benefits in patients idiopathic prostatic bleeding, bleeding during anticoagulation, or bleeding after instrumentation.[A178183]', 'Finasteride is an antiandrogenic compound that works by suppressing the production of serum and intraprostatic dihydrotestosterone (DHT) in men via inhibiting the enzyme responsible for the biosynthesis of DHT. The maximum effect of a rapid reduction in serum DHT concentration is expected to be observed 8 hours following administration of the first dose.[L10565] In a single man receiving a single oral dose of 5 mg finasteride for up to 4 years, there was a reduction in the serum DHT concentrations by approximately 70% and the median circulating level of testosterone increased by approximately 10-20% within the physiologic range. [L10565] In a double-blind, placebo-controlled study, finasteride reduced intraprostatic DHT level by 91.4% but finasteride is not expected to decrease the DHT levels to castrate levels since circulating testosterone is also converted to DHT by the type 1 isoenzyme expressed in other tissues.[A2132] It is expected that DHT levels return to normal within 14 days upon discontinuation of the drug.[L6244] In a study of male patients with benign prostatic hyperplasia prior to prostatectomy, the treatment with finasteride resulted in an approximate 80% lower DHT content was measured in prostatic tissue removed at surgery compared to placebo.[L10565] While finasteride reduces the size of the prostate gland by 20%, this may not correlate well with improvement in symptoms.[A178273] The effects of finasteride are reported to be more pronounced in male patients with enlarged prostates (>25 mL) who are at the greatest risk of disease progression.[A2132]



In phase III clinical studies, oral administration of finasteride in male patients with male pattern hair loss promoted hair growth and prevented further hair loss by 66% and 83% of the subjects, respectively, which lasted during two years'' treatment.[A178222] The incidences of these effects in treatment groups were significantly higher than that of the group receiving a placebo.[A178222] Following finasteride administration, the levels of DHT in the scalp skin was shown to be reduced by more than 60%, indicating that the DHT found in scalp is derived from both local DHT production and circulating DHT.[A178195] The effect of finasteride on scalp DHT is likely seen because of its effect on both local follicular DHT levels as well as serum DHT levels.[A178195]. There is evidence from early clinical observations and controlled studies that finasteride may reduce bleeding of prostatic origin.[A178183]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23700, 'Nopel cream 150 gm', 'نوبيل كريم 150جم', '48', NULL, 'Analgesic', 'Emu oil+menthol crystals', 'Hi-care > go scientific office', 'Cream', 'كريم', '150 gm', '1', NULL, 'for pain.', NULL, NULL, 886, '2022-08-03', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23701, 'Noracin 400mg 10 f.c.tab.', 'نوراسين 400مجم 10 اقراص', '23', NULL, 'Antibiotic.quinolone', 'Norfloxacin', 'Memphis', 'Tab', 'أقراص', '400mg', '1', NULL, 'about norfloxacin a synthetic second generation synthetic fluoroquinolone (quinolone) broad spectrum antibiotic. mechanism of action of norfloxacin norfloxacin is a bacteriostatic at low concentration and bactericidal at high concentration. it act by inhi', '6221050031019', NULL, 1169, '2022-12-07', 0, 'For the treatment of urinary tract infection', 'The bactericidal action of Norfloxacin results from inhibition of the enzymes topoisomerase II (DNA gyrase) and topoisomerase IV, which are required for bacterial DNA replication, transcription, repair, and recombination. Norfloxacin is a broad-spectrum antibiotic agent that is shown to be effective against various Gram-positive and Gram-negative bacterial species. The fluorine atom at the 6 position increases potency against gram-negative organisms, and the piperazine moiety at the 7 position is responsible for anti-pseudomonal activity', 'Norfloxacin is a quinolone/fluoroquinolone antibiotic. Norfloxacin is bactericidal and its mode of action depends on blocking of bacterial DNA replication by binding itself to an enzyme called DNA gyrase, which allows the untwisting required to replicate one DNA double helix into two. Notably the drug has 100 times higher affinity for bacterial DNA gyrase than for mammalian.', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23702, 'Noradrenaline mylan 8mg/4ml i.v 50 amp.', 'نورادرينالين ميلان 8مجم/4مل 50 امبول', '2,360', '1650', 'Adrenergic alpha/beta agonist', 'Noradrenaline', 'Mylan s.a.s-uk > egyptian pharmaceutical trading company', 'Amp', 'أمبول', '8mg', '50', NULL, 'about noradrenaline directly acting catecholamine adrenergic alpha/beta agonist vasopressor. mechanism of action of noradrenaline noradrenaline exerts it`s pharmacological action by acting as an alpha (alpha1 & alpha2) and beta (beta1 &beta3) adrenergic r', NULL, NULL, 3200, '2024-12-24', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23703, 'Fly d.p.i.c mouth wash spray 50 ml', 'فلاي غسول للفم سبراي 50 مل', '55', '50', NULL, 'Clove oil+peppermint+thyme+propolis extract+chamomile', 'Dream pharma', 'Spray', 'بخاخ', '50 ml', '1', NULL, NULL, NULL, NULL, 1111, '2025-09-08', 0, 'Clove oil is primarily indicated in conditions like colic, flatulence, and toothache [L2849].', 'The chief constituent present in clove oil is the phenol "_eugenol_" which is present in amounts up to 85%. Clove oil acts as a germicide [L2849] to Escherichia coli, Staphylococcus aureus and Pseudomonas aeruginosa [A24841]. 



Clove oil is thought to inhibit prostaglandin synthesis, thereby reducing painful symptoms [A33145].



Eugenol, the main constituent of clove oil is purported to have anticancer action. In one study, eugenol-treated HL-60 cells showed features of apoptosis including DNA fragmentation and formation of DNA ladders in agarose gel electrophoresis. It was observed that eugenol transduced the apoptotic signal via reactive oxygen species (ROS) generation, inducing mitochondrial permeability transition (MPT), decreasing anti-apoptotic protein _bcl-2_ level, inducing _cytochrome c_ release to the cytosol, and subsequent apoptotic cell death. When taken together, the study showed that ROS plays a critical role in eugenol-induced apoptosis in _HL-60_, and this is the first report on the mechanism of the anticancer effect of eugenol [A33146].', 'Clove (Eugenia caryophyllata Thunb. [Myrtaceae]) essential oil (CEO) has been demonstrated to possess antimicrobial, antifungal, antiviral, antioxidant, anti-inflammatory, anti-histamine, and anticancer properties. However, few studies have focused on its topical use [A33133], [L2850].



Clove essential oil, used as an antiseptic in oral infections, inhibits gram-negative and gram-positive bacteria as well as yeast [A24841].



', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23704, 'Hydrofix gel 15 gm', 'هيدروفيكس جل 15 جم', '170', NULL, 'Healing', 'Water+carbomer+algin+propylene glycol+dmdm hydantoin+triethanolamine+hydrolyzed hyaluronic acid+sodium methylparaben', 'Prt scientific office', 'Gel', 'جل', '15 gm', '1', NULL, NULL, NULL, NULL, 964, '2024-09-07', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23705, 'Norcuron 4mg/ml 10 amp.', 'نوركيورون 4مجم/مل 10 امبول', '180', NULL, 'Anesthetic.muscle relaxant.non depolarizing steroids', 'Vecuronium bromide', 'Schering plough > merck sharp & dohme scientific office', 'Amp', 'أمبول', '4mg', '10', NULL, NULL, NULL, NULL, 803, '2022-07-09', 0, 'Vecuronium is a muscle relaxing agent and is used as an adjunct in general anesthesia.', 'Vecuronium is a bisquaternary nitrogen compound that acts by competitively binding to nicotinic cholinergic receptors. The binding of vecuronium decreases the opportunity for acetylcholine to bind to the nicotinic receptor at the postjunctional membrane of the myoneural junction. As a result, depolarization is prevented, calcium ions are not released and muscle contraction does not occur.', 'The principal pharmacologic effects demonstrated by vecuronium revolve around its competitive binding of cholinergic receptors located at motor end plates. This competitive binding results in muscle relaxant effects that are typically employed as an adjunct to general anesthesia. ', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23706, 'Nordette 5*21 tab.', 'نورديت 5*21 قرص', '15', NULL, 'Contraceptives', 'Ethinyl estradiol+levonorgestrel', 'El nile. > pfizer', 'Tab', 'أقراص', NULL, '1', NULL, 'about ethinyl estradiol synthetic estrogen(a derivative of estradiol) in combined oral contraceptive anti neoplastic. mechanism of action of ethinyl estradiol the drug exerts it`s pharmacological action by binding to specific nuclear estrogen receptors pr', '6221077020911', NULL, 1068, '2022-12-26', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23707, 'Norditropin nordiflex 5mg/1.5ml prefilled pen s.c.', 'نورديتروبين نورديفليكس 5مجم/1.5مجم قلم معبأ', '1,146', '917', 'Human growth hormone', 'Somatropin', 'Novo nordisk', 'Pen', 'قلم', '5mg', '1', 'هرمون النمو البشري', 'about somatropin synthetic human growth hormone treatment of growth hormone deficiency. mechanism of action of somatropin it is a purified growth hormone (gh) of recombinant dna origin that stimulates skeletal linear bone muscle and organ growth. it promo', NULL, NULL, 6943, '2024-04-13', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23708, 'Norepezil 10mg 30 f.c. tabs', 'نوريبيزيل 10مجم 30 قرص', '225', '195', 'Central acetylcholinesterase inhibitor', 'Donepezil', 'Mash premiere > tabarak trade pharma', 'Tab', 'أقراص', '10mg', '3', NULL, NULL, NULL, NULL, 933, '2024-06-19', 0, 'Donepezil, administered orally[L7916] or via transdermal delivery system,[L41125] is indicated for the treatment of dementia of the Alzheimer''s type. It is also available as an extended-release capsule in combination with [memantine] for the treatment of moderate-to-severe dementia of the Alzheimer''s type in patients previously stabilized on 10mg of donepezil hydrochloride once daily.[L7937] 



Off-label uses include the management of vascular dementia, Parkinson''s Disease-associated dementia, and Lewy body dementia, amongst others.[A182333,T668]', '

The commonly accepted cholinergic hypothesis[A182369] proposes that a portion of the cognitive and behavioral decline associated with Alzheimer''s are the result of decreased cholinergic transmission in the central nervous system. Donepezil selectively and reversibly inhibits the acetylcholinesterase enzyme, which normally breaks down acetylcholine. The main pharmacological actions of this drug are believed to occur as the result of this enzyme inhibition, enhancing cholinergic transmission, which relieves the symptoms of Alzheimer''s dementia. In addition to the above, other mechanisms of action of donepezil are possible, including the opposition of glutamate-induced excitatory transmission via downregulation of NMDA receptors and the regulation of amyloid proteins, which have demonstrated significant effects on the disease process of Alzheimer''s.[A182333,A182351,A182444] Other possible targets for donepezil may also include the inhibition various inflammatory signaling pathways, exerting neuroprotective effects.[A182339,A182393]', 'By inhibiting the acetylcholinesterase enzyme, donepezil improves the cognitive and behavioral signs and symptoms of Alzheimer''s Disease, which may include apathy, aggression, confusion, and psychosis.[A182333,A182408]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23709, 'Norflex 100mg 20 tab.', 'نورفلكس 100مجم 20 قرص', '26', '18', 'Cns.analgesic.skeletal muscle relaxant.antimuscarinic', 'Orphenadrin', 'Eipico > meda ab', 'Tab', 'أقراص', '100mg', '2', NULL, NULL, '6221032114310', NULL, 1839, '2024-11-27', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23710, 'Norfact syrup 75 ml', 'نورفاكت شراب 75 مل', '32', NULL, NULL, NULL, 'Kmt pharma', 'Syrup', 'شراب', '75 ml', '1', NULL, NULL, NULL, NULL, 1123, '2024-07-02', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23712, 'Janomer 20 tabs', 'جانومير 20 قرص', '110', '95', 'Dietary supplement', 'Lactoferrin+iron+zinc+vitamin c+folic acid', 'Aspire', 'Tab', 'أقراص', NULL, '1', NULL, NULL, NULL, NULL, 2342, '2025-07-03', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23713, 'Norgestadiol 0.25/0.035mg 21 tabs.', 'نورجيستاديول 0.25/0.035مجم 21 قرص', '69', '52.5', 'Contraceptives', 'Ethinyl estradiol+norgestimate', 'Technopharma', 'Tab', 'أقراص', '0.035mg', '1', NULL, 'this combination hormone medication is used to prevent pregnancy. it contains 2 hormones: a progestin and an estrogen. it works mainly by preventing the release of an egg (ovulation) during your menstrual cycle. it also makes vaginal fluid thicker to help', '6224008302292', NULL, 1756, '2025-02-15', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23714, 'Norgin sunblock cream 50+ spf 100 ml', 'نورجين صن بلوك كريم50 100مل', '115', NULL, 'Sun block', NULL, 'Egyptian company for cosmetics > excel pharma', 'Cream', 'كريم', '100 ml', '1', 'واقى شمس يحمى البشرة من الاشعة الضارة ويمنع الكلف والتصبغات', NULL, NULL, NULL, 1984, '2022-07-13', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23715, 'Norhinose 50mcg/dose nasal spray 120 doses', 'نورينوز 50مكجم/جرعة بخاخ للأنف 120 جرعة', '90', '58.5', 'Anti-inflammatory.glucocorticoid.', 'Mometasone furoate', 'European egyptian pharm. ind. > amriya', 'Spray', 'بخاخ', '50mcg', '1', 'مضاد التهابات', 'about mometasone a glucocorticoid steroid anti psoriatic anti asthma anti inflammatory. mechanism of action of mometasone mometasone is a topical medium potency glucocorticoid. the drug exerts its pharmacological action by penetrating and binding to cytop', '6221075160091', NULL, 11745, '2024-07-24', 0, 'The inhaler is indicated for the maintenance treatment of asthma as prophylactic therapy. The nasal spray is indicated for the treatment of the nasal symptoms of seasonal allergic and perennial allergic rhinitis.', 'Unbound corticosteroids cross cell membranes and bind with high affinity to specific cytoplasmic receptors. Inflammation is decreased by diminishing the release of leukocytic acid hydrolases, prevention of macrophage accumulation at inflamed sites, interference with leukocyte adhesion to the capillary wall, reduction of capillary membrane permeability, reduction of complement components, inhibition of histamine and kinin release, and interference with the formation of scar tissue. The antiinflammatory actions of corticosteroids are thought to involve phospholipase A<sub>2</sub> inhibitory proteins, lipocortins, which control the biosynthesis of potent mediators of inflammation such as prostaglandins and leukotrienes. Mometasone furoate has been shown in vitro to exhibit a binding affinity for the human glucocorticoid receptor which is approximately 12 times that of dexamethasone, 7 times that of triamcinolone acetonide, 5 times that of budesonide, and 1.5 times that of fluticasone.', 'Mometasone is a medium-potency synthetic corticosteroid with antiinflammatory, antipruritic, and vasoconstrictive properties. Studies in asthmatic patients have demonstrated that mometasone provides a favorable ratio of topical to systemic activity due to its primary local effect along with the extensive hepatic metabolism and the lack of active metabolites. Though effective for the treatment of asthma, glucocorticoids do not affect asthma symptoms immediately. Maximum improvement in symptoms following inhaled administration of mometasone furoate may not be achieved for 1 to 2 weeks or longer after starting treatment. When glucocorticoids are discontinued, asthma stability may persist for several days or longer. Mometasone has been shown in vitro to exhibit a binding affinity for the human glucocorticoid receptor which is approximately 12 times that of dexamethasone, 7 times that of triamcinolone acetonide, 5 times that of budesonide, and 1.5 times that of fluticasone. The clinical significance of these findings is unknown.', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23719, 'Normal saline 0.9% inj. 500 ml', 'نورمال سالين 0.9% 500 مل', '24', '7.5', 'Normal saline', 'Sodium chloride', 'Haidylena for advanced medical industries > vacsera', 'Inj', 'حقن', '0.9%', '1', NULL, NULL, NULL, NULL, 1749, '2023-08-20', 0, 'This intravenous solution is indicated for use in adults and pediatric patients as a source of electrolytes and water for hydration. Also, designed for use as a diluent and delivery system for intermittent intravenous administration of compatible drug additives. ', 'Sodium and chloride — major electrolytes of the fluid compartment outside of cells (i.e., extracellular) — work together to control extracellular volume and blood pressure. Disturbances in sodium concentrations in the extracellular fluid are associated with disorders of water balance.', 'Sodium, the major cation of the extracellular fluid, functions primarily in the control of water distribution, fluid balance, and osmotic pressure of body fluids. Sodium is also associated with chloride and bicarbonate in the regulation of the acid-base equilibrium of body fluid.

Chloride, the major extracellular anion, closely follows the metabolism of sodium, and changes in the acid-base balance of the body are reflected by changes in the chloride concentration. ', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23720, 'Normalax 0.75% oral drops 15 ml', 'نورمالاكس 0.75% نقط للفم 15 مل', '12', '3.75', 'Laxative', 'Sodium picosulphate', 'Pharopharma', 'Drops', 'نقط', '0.75%', '1', NULL, 'about sodium picosulphate a locally acting bowel preparation a stimulant laxative. mechanism of action of sodium picosulphate sodium picosulphate is a stimulant laxative. after oral administration it is activated by the bacteria present in the large intes', '6221094010025', NULL, 1278, '2024-12-20', 0, 'For the treatment of small uncomplicated varicose veins of the lower extremities that show simple dilation with competent valves.', 'Sodium tetradecyl sulfate is a potent toxin for endothelial cells in that brief exposure to even low concentrations are effective in stripping endothelium over a considerable distance and exposing highly thrombogenic endothelium in the process. Diluted sodium tetradecyl sulfate is also able to induce a hypercoagulable state, possibly by selective inhibition of protein C, and can also promote platelet aggregation.', 'Sodium tetradecyl sulfate is an anionic surfactant which occurs as a white, waxy solid. It is used as a sclerosing agent in sclerotherapy. Sclerotherapy is an injection of a sclerosing agent directly through the skin into a lesion and is used primarily for slow-flow vascular anomalies, particularly for venous malformation and lymphatic malformation. Intravenous injection causes intima inflammation and thrombus formation. This usually occludes the injected vein. Subsequent formation of fibrous tissue results in partial or complete vein obliteration that may or may not be permanent.', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23721, 'Normapafenone 300 mg 10 f.c. tabs', 'نورمابافينون 300مجم 10 اقراص', '19', NULL, 'Antiarrhythmias.class ic', 'Propafenone', 'International drug agency (idi) > biocapital pharma', 'Tab', 'أقراص', '300 mg', '1', NULL, 'about propafenone membrane stabilizing agent antiarrhythmic(class ic). indications for propafenone arrhythmia typical dosage for propafenone adults: 150mg 3 times daily and if sufficient response is not obtained dose can be increased to 225mg 3 times dail', NULL, NULL, 958, '2022-07-09', 0, 'Used to prolong the time to recurrence of paroxysmal atrial fibrillation/flutter (PAF) associated with disabling symptoms in patients without structural heart disease. Also used for the treatment of life-threatening documented ventricular arrhythmias, such as sustained ventricular tachycardia.', 'The electrophysiological effect of propafenone manifests itself in a reduction of upstroke velocity (Phase 0) of the monophasic action potential. In Purkinje fibers, and to a lesser extent myocardial fibers, propafenone reduces the fast inward current carried by sodium ions, which is responsible for the drugs antiarrhythmic actions. Diastolic excitability threshold is increased and effective refractory period prolonged. Propafenone reduces spontaneous automaticity and depresses triggered activity. At very high concentrations in vitro, propafenone can inhibit the slow inward current carried by calcium but this calcium antagonist effect probably does not contribute to antiarrhythmic efficacy.', 'Propafenone is a Class 1C antiarrhythmic drug with local anesthetic effects, and a direct stabilizing action on myocardial membranes. It is used in the treatment of atrial and ventricular arrhythmias. It acts by inhibiting sodium channels to restrict the entry of sodium into cardiac cells resulting in reduced excitation. Propafenone has local anesthetic activity approximately equal to procaine.', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23722, 'Normash 400mg 10 f.c. tab.', 'نورماش 400مجم 10 اقراص', '18', NULL, 'Antibiotic.quinolone', 'Norfloxacin', 'Mash premiere', 'Tab', 'أقراص', '400mg', '1', NULL, 'about norfloxacin a synthetic second generation synthetic fluoroquinolone (quinolone) broad spectrum antibiotic. mechanism of action of norfloxacin norfloxacin is a bacteriostatic at low concentration and bactericidal at high concentration. it act by inhi', NULL, NULL, 781, '2022-07-13', 0, 'For the treatment of urinary tract infection', 'The bactericidal action of Norfloxacin results from inhibition of the enzymes topoisomerase II (DNA gyrase) and topoisomerase IV, which are required for bacterial DNA replication, transcription, repair, and recombination. Norfloxacin is a broad-spectrum antibiotic agent that is shown to be effective against various Gram-positive and Gram-negative bacterial species. The fluorine atom at the 6 position increases potency against gram-negative organisms, and the piperazine moiety at the 7 position is responsible for anti-pseudomonal activity', 'Norfloxacin is a quinolone/fluoroquinolone antibiotic. Norfloxacin is bactericidal and its mode of action depends on blocking of bacterial DNA replication by binding itself to an enzyme called DNA gyrase, which allows the untwisting required to replicate one DNA double helix into two. Notably the drug has 100 times higher affinity for bacterial DNA gyrase than for mammalian.', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23723, 'Normass syrup 120 ml', 'نورماس شراب 120مل', '22', NULL, 'Cough drugs', 'Guava leaves+tilia flower', 'El-obour > sea pharm for pharmaceuticals', 'Syrup', 'شراب', '120 ml', '1', NULL, 'for childern 2 years and above. helps in improving respiratory functions.', '6223004608209', NULL, 808, '2022-08-03', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23726, 'Normesar 20mg 30 f.c. tabs.', 'نورميسار 20مجم 30 اقراص', '63', NULL, 'Antihypertensive.angiotensin blocker', 'Olmesartan', 'Jedco int. co. for pharmaceuticals > four a pharma', 'Tab', 'أقراص', '20mg', '3', NULL, 'about olmesartan an angiotensin ii receptor antagonist imidazole derivative antihypertensive. mechanism of action of olmesartan olmesartan is a competitive antagonist of angiotensin-ii at at-1 receptor. it decreases peripheral resistance and lowers bp in', '6225000086685', NULL, 910, '2022-12-07', 0, 'Olmesartan is indicated for the treatment of hypertension either alone or in combination with other antihypertensive agents.[F4709,F4712,A173869] 



Olmesartan is also used off-label for the management Type 2 Diabetes-associated nephropathy, heart failure, and post-myocardial infarction, particularly in patients who are unable to tolerate ACE inhibitors.[A178153,A185912,A185915] ARBs such as olmesartan have been shown in a number of large-scale clinical outcomes trials to improve cardiovascular outcomes including reducing risk of myocardial infarction, stroke, the progression of heart failure, and hospitalization.[A174124,A178153,A173869,A185324,A185327,A185333,A185342,A185345] Like other ARBs, olmesartan blockade of RAAS slows the progression of diabetic nephropathy due to its renoprotective effects.[A185906,A185909,A185912] ', 'Olmesartan belongs to the angiotensin II receptor blocker (ARB) family of drugs, which also includes [telmisartan], [candesartan], [losartan], [valsartan], and [irbesartan]. ARBs selectively bind to angiotensin receptor 1 (AT1) and prevent the protein angiotensin II from binding and exerting its hypertensive effects. As the principal pressor agent of the renin-angiotensin system, Angiotensin II causes vasoconstriction, stimulation of synthesis and release of aldosterone, cardiac stimulation and renal reabsorption of sodium. Olmesartan blocks the vasoconstrictor effects of angiotensin II by selectively blocking the binding of angiotensin II to the AT1 receptor in vascular smooth muscle. Its action is, therefore, independent of the pathways for angiotensin II synthesis.[F4709] Overall, olmesartan''s physiologic effects lead to reduced blood pressure, lower aldosterone levels, reduced cardiac activity, and increased excretion of sodium. 



Olmesartan also effects on the renin-angiotensin aldosterone system (RAAS) plays an important role in hemostasis and regulation of kidney, vascular, and cardiac functions. Pharmacological blockade of RAAS via  AT1 receptor blockade inhibits negative regulatory feedback within RAAS, which is a contributing factor to the pathogenesis and progression of cardiovascular disease, heart failure, and renal disease. In particular, heart failure is associated with chronic activation of RAAS, leading to inappropriate fluid retention, vasoconstriction, and ultimately a further decline in left ventricular function. ARBs have been shown to have a protective effect on the heart by improving cardiac function, reducing afterload, increasing cardiac output and preventing ventricular hypertrophy and remodelling.[A174154] ', 'Overall, olmesartan''s physiologic effects lead to reduced blood pressure, lower aldosterone levels, reduced cardiac activity, and increased excretion of sodium. 





**Hypotension in Volume- or Salt-Depleted Patients**



In patients with an activated renin-angiotensin aldosterone system, such as volume-and/or salt-depleted patients (e.g., those being treated with high doses of diuretics), symptomatic hypotension may be anticipated after initiation of treatment with olmesartan. Initiate treatment under close medical supervision. If hypotension does occur, place the patient in the supine position and, if necessary, give an intravenous infusion of normal saline. A transient hypotensive response is not a contraindication to further treatment, which usually can be continued without difficulty once the blood pressure has stabilized.[F4709,F4712]



Valvular Stenosis: there is concern on theoretical grounds that patients with aortic stenosis might be at a particular risk of decreased coronary perfusion, because they do not develop as much afterload reduction.[F4712]





**Impaired Renal Function**



As a consequence of inhibiting the renin-angiotensin-aldosterone system, changes in renal function may be anticipated in susceptible individuals treated with olmesartan. In patients whose renal function may depend upon the activity of the renin-angiotensin- aldosterone system (e.g., patients with severe congestive heart failure), treatment with angiotensin converting enzyme (ACE) inhibitors and angiotensin receptor antagonists has been associated with oliguria and/or progressive azotemia and rarely with acute renal failure and/or death. Similar results may be anticipated in patients treated with olmesartan.



In studies of ACE inhibitors in patients with unilateral or bilateral renal artery stenosis, increases in serum creatinine or blood urea nitrogen (BUN) have been reported. There has been no long-term use of olmesartan medoxomil in patients with unilateral or bilateral renal artery stenosis, but similar results may be expected.[F4709,F4712]





**Sprue-like Enteropathy**



Severe, chronic diarrhea with substantial weight loss has been reported in patients taking olmesartan months to years after drug initiation. Intestinal biopsies of patients often demonstrated villous atrophy. If a patient develops these symptoms during treatment with olmesartan, exclude other etiologies. Consider discontinuation of olmesartan medoxomil in cases where no other etiology is identified.[F4709,F4712]





**Electrolyte Imbalances**



Olmesartan medoxomil contains olmesartan, a drug that inhibits the renin-angiotensin system (RAS). Drugs that inhibit the RAS can cause hyperkalemia. Monitor serum electrolytes periodically.[F4709,F4712]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23727, 'Normesar 40mg 30 f.c. tabs.', 'نورميسار 40مجم 30 اقراص', '82', NULL, 'Antihypertensive.angiotensin blocker', 'Olmesartan', 'Jedco int. co. for pharmaceuticals > four a pharma', 'Tab', 'أقراص', '40mg', '3', NULL, 'about olmesartan an angiotensin ii receptor antagonist imidazole derivative antihypertensive. mechanism of action of olmesartan olmesartan is a competitive antagonist of angiotensin-ii at at-1 receptor. it decreases peripheral resistance and lowers bp in', '6225000086678', NULL, 713, '2022-12-07', 0, 'Olmesartan is indicated for the treatment of hypertension either alone or in combination with other antihypertensive agents.[F4709,F4712,A173869] 



Olmesartan is also used off-label for the management Type 2 Diabetes-associated nephropathy, heart failure, and post-myocardial infarction, particularly in patients who are unable to tolerate ACE inhibitors.[A178153,A185912,A185915] ARBs such as olmesartan have been shown in a number of large-scale clinical outcomes trials to improve cardiovascular outcomes including reducing risk of myocardial infarction, stroke, the progression of heart failure, and hospitalization.[A174124,A178153,A173869,A185324,A185327,A185333,A185342,A185345] Like other ARBs, olmesartan blockade of RAAS slows the progression of diabetic nephropathy due to its renoprotective effects.[A185906,A185909,A185912] ', 'Olmesartan belongs to the angiotensin II receptor blocker (ARB) family of drugs, which also includes [telmisartan], [candesartan], [losartan], [valsartan], and [irbesartan]. ARBs selectively bind to angiotensin receptor 1 (AT1) and prevent the protein angiotensin II from binding and exerting its hypertensive effects. As the principal pressor agent of the renin-angiotensin system, Angiotensin II causes vasoconstriction, stimulation of synthesis and release of aldosterone, cardiac stimulation and renal reabsorption of sodium. Olmesartan blocks the vasoconstrictor effects of angiotensin II by selectively blocking the binding of angiotensin II to the AT1 receptor in vascular smooth muscle. Its action is, therefore, independent of the pathways for angiotensin II synthesis.[F4709] Overall, olmesartan''s physiologic effects lead to reduced blood pressure, lower aldosterone levels, reduced cardiac activity, and increased excretion of sodium. 



Olmesartan also effects on the renin-angiotensin aldosterone system (RAAS) plays an important role in hemostasis and regulation of kidney, vascular, and cardiac functions. Pharmacological blockade of RAAS via  AT1 receptor blockade inhibits negative regulatory feedback within RAAS, which is a contributing factor to the pathogenesis and progression of cardiovascular disease, heart failure, and renal disease. In particular, heart failure is associated with chronic activation of RAAS, leading to inappropriate fluid retention, vasoconstriction, and ultimately a further decline in left ventricular function. ARBs have been shown to have a protective effect on the heart by improving cardiac function, reducing afterload, increasing cardiac output and preventing ventricular hypertrophy and remodelling.[A174154] ', 'Overall, olmesartan''s physiologic effects lead to reduced blood pressure, lower aldosterone levels, reduced cardiac activity, and increased excretion of sodium. 





**Hypotension in Volume- or Salt-Depleted Patients**



In patients with an activated renin-angiotensin aldosterone system, such as volume-and/or salt-depleted patients (e.g., those being treated with high doses of diuretics), symptomatic hypotension may be anticipated after initiation of treatment with olmesartan. Initiate treatment under close medical supervision. If hypotension does occur, place the patient in the supine position and, if necessary, give an intravenous infusion of normal saline. A transient hypotensive response is not a contraindication to further treatment, which usually can be continued without difficulty once the blood pressure has stabilized.[F4709,F4712]



Valvular Stenosis: there is concern on theoretical grounds that patients with aortic stenosis might be at a particular risk of decreased coronary perfusion, because they do not develop as much afterload reduction.[F4712]





**Impaired Renal Function**



As a consequence of inhibiting the renin-angiotensin-aldosterone system, changes in renal function may be anticipated in susceptible individuals treated with olmesartan. In patients whose renal function may depend upon the activity of the renin-angiotensin- aldosterone system (e.g., patients with severe congestive heart failure), treatment with angiotensin converting enzyme (ACE) inhibitors and angiotensin receptor antagonists has been associated with oliguria and/or progressive azotemia and rarely with acute renal failure and/or death. Similar results may be anticipated in patients treated with olmesartan.



In studies of ACE inhibitors in patients with unilateral or bilateral renal artery stenosis, increases in serum creatinine or blood urea nitrogen (BUN) have been reported. There has been no long-term use of olmesartan medoxomil in patients with unilateral or bilateral renal artery stenosis, but similar results may be expected.[F4709,F4712]





**Sprue-like Enteropathy**



Severe, chronic diarrhea with substantial weight loss has been reported in patients taking olmesartan months to years after drug initiation. Intestinal biopsies of patients often demonstrated villous atrophy. If a patient develops these symptoms during treatment with olmesartan, exclude other etiologies. Consider discontinuation of olmesartan medoxomil in cases where no other etiology is identified.[F4709,F4712]





**Electrolyte Imbalances**



Olmesartan medoxomil contains olmesartan, a drug that inhibits the renin-angiotensin system (RAS). Drugs that inhibit the RAS can cause hyperkalemia. Monitor serum electrolytes periodically.[F4709,F4712]', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23728, 'Normesar plus 20/12.5mg 10 f.c.tab.', 'نورميسار بلس 20/12.5مجم 10 اقراص', '14', NULL, 'Antihypertensive. combined angiotensin blocker with diuretic', 'Hydrochlorothiazide+olmesartan', 'Jedco int. co. for pharmaceuticals > four a pharma', 'Tab', 'أقراص', '12.5mg', '1', NULL, 'this drug is used to treat high blood pressure (hypertension). lowering high blood pressure helps prevent strokes heart attacks and kidney problems. this product contains two medications: olmesartan and hydrochlorothiazide. olmesartan is an angiotensin re', NULL, NULL, 819, '2022-07-13', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23732, 'Normocard 10mg 30 tab.', 'نورموكارد 10مجم 30 اقراص', '84', '58.5', 'Antihypertensive.beta blocker.selective b1', 'Bisoprolol fumarate', 'Pharma cure pharmaceuticals', 'Tab', 'أقراص', '10mg', '3', NULL, NULL, NULL, NULL, 1315, '2025-10-06', 0, 'Bisoprolol is indicated for the treatment of mild to moderate hypertension.[L7219] It may be used off-label to treat heart failure, atrial fibrillation, and angina pectoris.[A180460,A180463]', 'Though the mechanism of action of bisoprolol has not been fully elucidated in hypertension, it is thought that therapeutic effects are achieved through the antagonism of β-1adrenoceptors to result in lower cardiac output. Bisoprolol is a competitive, cardioselective β1-adrenergic antagonist. When β1-receptors (located mainly in the heart)[T640] are activated by adrenergic neurotransmitters such as epinephrine, both the blood pressure and heart rate increase, leading to greater cardiovascular work, increasing the demand for oxygen.  Bisoprolol reduces cardiac workload by decreasing contractility and the need for oxygen through competitive inhibition of β1-adrenergic receptors.[A180502,T640]



Bisoprolol is also thought to reduce the output of renin in the kidneys, which normally increases blood pressure. Additionally, some central nervous system effects of bisoprolol may include diminishing sympathetic nervous system output from the brain, decreasing blood pressure and heart rate.[L7219]', 'Bisoprolol decreases heart rate (chronotropy), decreases contractility (inotropy), and reduces blood pressure.[T640,L7219] The results of various clinical studies indicate that bisoprolol reduces cardiovascular mortality and all-cause mortality in patients with heart failure and decreased cardiac ejection fraction (EF).[A180466,A180505] ', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23733, 'Normocard 2.5 mg 30 tab.', 'نورموكارد 2.5مجم 30 قرص', '51', '42', 'Antihypertensive.beta blocker.selective b1', 'Bisoprolol fumarate', 'Pharma cure pharmaceuticals', 'Tab', 'أقراص', '2.5 mg', '3', NULL, 'about bisoprolol beta1-selective adrenergic blocker antihypertensive. mechanism of action of bisoprolol bisoprolol is a cardio selective beta-1 adrenergic antagonist.it has negative chronotropic and negative inotropic effects on heart. it decreases oxygen', NULL, NULL, 1814, '2025-07-25', 0, 'Bisoprolol is indicated for the treatment of mild to moderate hypertension.[L7219] It may be used off-label to treat heart failure, atrial fibrillation, and angina pectoris.[A180460,A180463]', 'Though the mechanism of action of bisoprolol has not been fully elucidated in hypertension, it is thought that therapeutic effects are achieved through the antagonism of β-1adrenoceptors to result in lower cardiac output. Bisoprolol is a competitive, cardioselective β1-adrenergic antagonist. When β1-receptors (located mainly in the heart)[T640] are activated by adrenergic neurotransmitters such as epinephrine, both the blood pressure and heart rate increase, leading to greater cardiovascular work, increasing the demand for oxygen.  Bisoprolol reduces cardiac workload by decreasing contractility and the need for oxygen through competitive inhibition of β1-adrenergic receptors.[A180502,T640]



Bisoprolol is also thought to reduce the output of renin in the kidneys, which normally increases blood pressure. Additionally, some central nervous system effects of bisoprolol may include diminishing sympathetic nervous system output from the brain, decreasing blood pressure and heart rate.[L7219]', 'Bisoprolol decreases heart rate (chronotropy), decreases contractility (inotropy), and reduces blood pressure.[T640,L7219] The results of various clinical studies indicate that bisoprolol reduces cardiovascular mortality and all-cause mortality in patients with heart failure and decreased cardiac ejection fraction (EF).[A180466,A180505] ', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23734, 'Normocard 5mg 30 tab.', 'نورموكارد 5مجم 30 قرص', '54', '42', 'Antihypertensive.beta blocker.selective b1', 'Bisoprolol fumarate', 'Pharma cure pharmaceuticals', 'Tab', 'أقراص', '5mg', '3', NULL, NULL, '6224000651015', NULL, 1590, '2025-03-05', 0, 'Bisoprolol is indicated for the treatment of mild to moderate hypertension.[L7219] It may be used off-label to treat heart failure, atrial fibrillation, and angina pectoris.[A180460,A180463]', 'Though the mechanism of action of bisoprolol has not been fully elucidated in hypertension, it is thought that therapeutic effects are achieved through the antagonism of β-1adrenoceptors to result in lower cardiac output. Bisoprolol is a competitive, cardioselective β1-adrenergic antagonist. When β1-receptors (located mainly in the heart)[T640] are activated by adrenergic neurotransmitters such as epinephrine, both the blood pressure and heart rate increase, leading to greater cardiovascular work, increasing the demand for oxygen.  Bisoprolol reduces cardiac workload by decreasing contractility and the need for oxygen through competitive inhibition of β1-adrenergic receptors.[A180502,T640]



Bisoprolol is also thought to reduce the output of renin in the kidneys, which normally increases blood pressure. Additionally, some central nervous system effects of bisoprolol may include diminishing sympathetic nervous system output from the brain, decreasing blood pressure and heart rate.[L7219]', 'Bisoprolol decreases heart rate (chronotropy), decreases contractility (inotropy), and reduces blood pressure.[T640,L7219] The results of various clinical studies indicate that bisoprolol reduces cardiovascular mortality and all-cause mortality in patients with heart failure and decreased cardiac ejection fraction (EF).[A180466,A180505] ', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23735, 'Normocard 7.5mg 20 tab.', 'نورموكارد 7.5مجم 20 قرص', '36', '25', 'Antihypertensive.beta blocker.selective b1', 'Bisoprolol fumarate', 'Sigma > pharma cure pharmaceuticals', 'Tab', 'أقراص', '7.5mg', '2', NULL, 'about bisoprolol beta1-selective adrenergic blocker antihypertensive. mechanism of action of bisoprolol bisoprolol is a cardio selective beta-1 adrenergic antagonist.it has negative chronotropic and negative inotropic effects on heart. it decreases oxygen', NULL, NULL, 1194, '2025-03-06', 0, 'Bisoprolol is indicated for the treatment of mild to moderate hypertension.[L7219] It may be used off-label to treat heart failure, atrial fibrillation, and angina pectoris.[A180460,A180463]', 'Though the mechanism of action of bisoprolol has not been fully elucidated in hypertension, it is thought that therapeutic effects are achieved through the antagonism of β-1adrenoceptors to result in lower cardiac output. Bisoprolol is a competitive, cardioselective β1-adrenergic antagonist. When β1-receptors (located mainly in the heart)[T640] are activated by adrenergic neurotransmitters such as epinephrine, both the blood pressure and heart rate increase, leading to greater cardiovascular work, increasing the demand for oxygen.  Bisoprolol reduces cardiac workload by decreasing contractility and the need for oxygen through competitive inhibition of β1-adrenergic receptors.[A180502,T640]



Bisoprolol is also thought to reduce the output of renin in the kidneys, which normally increases blood pressure. Additionally, some central nervous system effects of bisoprolol may include diminishing sympathetic nervous system output from the brain, decreasing blood pressure and heart rate.[L7219]', 'Bisoprolol decreases heart rate (chronotropy), decreases contractility (inotropy), and reduces blood pressure.[T640,L7219] The results of various clinical studies indicate that bisoprolol reduces cardiovascular mortality and all-cause mortality in patients with heart failure and decreased cardiac ejection fraction (EF).[A180466,A180505] ', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23736, 'Normolepsy 150mg 20 caps.', 'نورموليبسي 150مجم 20 كبسولة', '76', '28.2', 'Anti-epileptic.gaba analogs', 'Pregabalin', 'Eipico', 'Cap', 'كبسولة', '150mg', '2', NULL, 'about pregabalin a gaba agonist anticonvulsant. mechanism of action of pregabalin pregabalin is a gaba neurotransmitter analog. it produces its action by modulating calcium channels and also reduces the release of neurotransmitters such as glutamate norep', NULL, NULL, 935, '2024-11-09', 0, 'Pregabalin is indicated for the management of neuropathic pain associated with diabetic peripheral neuropathy, postherpetic neuralgia, fibromyalgia, neuropathic pain associated with spinal cord injury, and as adjunctive therapy for the treatment of partial-onset seizures in patients 1 month of age and older.[L7066]', 'Although the mechanism of action has not been fully elucidated, studies involving structurally related drugs suggest that presynaptic binding of pregabalin to voltage-gated calcium channels is key to the antiseizure and antinociceptive effects observed in animal models.[L7066]  



By binding presynaptically to the alpha2-delta subunit of voltage-gated calcium channels in the central nervous system, pregabalin modulates the release of several excitatory neurotransmitters including glutamate, substance-P, norepinephrine, and calcitonin gene related peptide.[A31163] In addition, pregabalin prevents the alpha2-delta subunit from being trafficked from the dorsal root ganglia to the spinal dorsal horn, which may also contribute to the mechanism of action.[A36628] 



Although pregabalin is a structural derivative of the inhibitory neurotransmitter gamma-aminobutyric acid (GABA), it does not bind directly to GABA or benzodiazepine receptors.[A31165]  ', 'Although the structure of pregabalin is similar to gamma-aminobutyric acid (GABA), it does not bind to GABA receptors.[A31163,A187190] Instead, it binds the alpha2-delta subunit of presynaptic voltage-gated calcium channels in the central nervous system.[A31163,A187190] Pregabalin does not modulate dopamine receptors, serotonin receptors, opiate receptors, sodium channels or cyclooxygenase activity.[A187190] ', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23737, 'Normolepsy 75mg 20 caps.', 'نورموليبسي 75مجم 20 كبسولة', '44', '20', 'Anti-epileptic.gaba analogs', 'Pregabalin', 'Eipico', 'Cap', 'كبسولة', '75mg', '2', NULL, 'about pregabalin a gaba agonist anticonvulsant. mechanism of action of pregabalin pregabalin is a gaba neurotransmitter analog. it produces its action by modulating calcium channels and also reduces the release of neurotransmitters such as glutamate norep', NULL, NULL, 845, '2024-11-09', 0, 'Pregabalin is indicated for the management of neuropathic pain associated with diabetic peripheral neuropathy, postherpetic neuralgia, fibromyalgia, neuropathic pain associated with spinal cord injury, and as adjunctive therapy for the treatment of partial-onset seizures in patients 1 month of age and older.[L7066]', 'Although the mechanism of action has not been fully elucidated, studies involving structurally related drugs suggest that presynaptic binding of pregabalin to voltage-gated calcium channels is key to the antiseizure and antinociceptive effects observed in animal models.[L7066]  



By binding presynaptically to the alpha2-delta subunit of voltage-gated calcium channels in the central nervous system, pregabalin modulates the release of several excitatory neurotransmitters including glutamate, substance-P, norepinephrine, and calcitonin gene related peptide.[A31163] In addition, pregabalin prevents the alpha2-delta subunit from being trafficked from the dorsal root ganglia to the spinal dorsal horn, which may also contribute to the mechanism of action.[A36628] 



Although pregabalin is a structural derivative of the inhibitory neurotransmitter gamma-aminobutyric acid (GABA), it does not bind directly to GABA or benzodiazepine receptors.[A31165]  ', 'Although the structure of pregabalin is similar to gamma-aminobutyric acid (GABA), it does not bind to GABA receptors.[A31163,A187190] Instead, it binds the alpha2-delta subunit of presynaptic voltage-gated calcium channels in the central nervous system.[A31163,A187190] Pregabalin does not modulate dopamine receptors, serotonin receptors, opiate receptors, sodium channels or cyclooxygenase activity.[A187190] ', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23739, 'Normonat 30 mg 7 tabs.', 'نورمونات 30مجم 7 اقراص', '800', NULL, 'Arginine vasopressin receptor 2 antagonist . hyponatremia associated with congestive heart failure, cirrhosis, and the syndrome of inappropriate antidiuretic hormone', 'Tolvaptan', 'Marcyrl co.', 'Tab', 'أقراص', '30 mg', '1', '-- حالات امراض القلب', 'tolvaptan is used to treat low blood sodium levels (hyponatremia) associated with various conditions like congestive heart failure cirrhosis and syndrome of inappropriate antidiuretic hormones (siadh). tolvaptan is a selective and competitive arginine vas', NULL, NULL, 2348, '2023-04-08', 0, 'Treatment of symptomatic and resistant to fluid restriction euvolemic or hypervolemic hyponatremia associated with congestive heart failure, SIADH, and cirrhosis. ', 'Tolvaptan is a selective and competitive arginine vasopressin receptor 2 antagonist. Vasopressin acts on the V2 receptors found in the walls of the vasculature and luminal membranes of renal collecting ducts. By blocking V2 receptors in the renal collecting ducts, aquaporins do not insert themselves into the walls thus preventing water absorption. This action ultimately results in an increase in urine volume, decrease urine osmolality, and increase electrolyte-free water clearance to reduce intravascular volume and an increase serum sodium levels. Tolvaptan is especially useful for heart failure patients as they have higher serum levels of vasopressin. ', 'Urine volume and fluid intake increase in a dose dependent manner which results in overall negative fluid balance in patients taking tolvaptan. Increases in serum sodium and osmolality can be observed 4-8 hours post-administration and is maintained for 24 hours. The magnitude of serum sodium and osmolality change increases with escalating doses. Furthermore, a decrease in urine osmolality and increase in free water clearance can be observed 4 hours after post-administration of tolvaptan. The affinity for V2 receptors is 29x greater than that of V1a receptors and does not have any appreciable affinity for V2 receptors. ', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23740, 'Normo-strike massage cream 100 gm', 'نورموسترايك مساج كريم 100 جم', '80', NULL, 'Massage', 'Menthol+peppermint+eucalyptus+clove+avocado+glycerin', 'Aug pharma', 'Cream', 'كريم', '100 gm', '1', NULL, NULL, NULL, NULL, 648, '2022-07-15', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23741, 'Normotensil 2mg 7 f.c. tabs.', 'نورموتنسيل 2مجم 7 اقراص', '6', NULL, 'Antihypertensive.selective calcium channel blocker', 'Lacidipine', 'Unipharma co.', 'Tab', 'أقراص', '2mg', '1', 'علاج ارتفاع ضغط الدم', 'about lacidipine selective calcium channel blocker dihydropyridine derivative antihypertensive. mechanism of action of lacidipine lacidipine is a vasoselective long acting dihydropyridine ca channel blocker. it exerts antihypertensive action through block', NULL, NULL, 951, '2022-07-15', 0, 'Indicated for the treatment of hypertension either alone or in combination with other antihypertensive agents, including β-adrenoceptor antagonists, diuretics, and ACE-inhibitors [L1126].', 'By blocking the voltage-dependent L-type calcium channels, it prevents the transmembrane calcium influx [A31537]. Normally, calcium ions serve as intracellular messengers or activators in exictable cells including vascular smooth muscles. The influx of calcium ultimately causes the excitation and depolarization of the tissues. Lacidipine inhibits the contractile function in the vascular smooth muscle and reduce blood pressure. Due to its high membrane partition coefficient, some studies suggest that lacidipine may reach the receptor via a two-step process; it first binds and accumulates in the membrane lipid bilayer and then diffuses within the membrane to the calcium channel receptor [A31543]. It is proposed that lacidipine preferentially blocks the inactivated state of the calcium channel [A31543].



Through its antioxidant properties shared amongst other dihydropyridine calcium channel blockers, lacidipine demonstrates an additional clinical benefit. Its antiatherosclerotic effects are mediated by suppressing the formation of reactive oxygen species (ROS) and subsequent inflammatory actions by chemokines, cytokines and adhesion molecules, thus reducing atherosclerotic lesion formation [A31540]. Lacidipine may also suppress cell proliferation and migration in smooth muscle cells and suppress the expression of matrix metalloproteinases, which affects the stability of atheromatous plaques [A31540]. ', 'acidipine is a specific and potent calcium antagonist with a predominant selectivity for calcium channels in the vascular smooth muscle. Its main action is to dilate predominantly peripheral and coronary arteries, reducing peripheral vascular resistance and lowering blood pressure [L1126]. 



Following the oral administration of 4 mg lacidipine to volunteer subjects, a minimal prolongation of QTc interval has been observed (mean QTcF increase between 3.44 and 9.60 ms in young and elderly volunteers) [L1126].', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23742, 'Norocarmena 0.02/3mg 28 f.c.tab', 'نوروكارمينا 28 قرص', '103', '78', 'Contraceptives', 'Ethinyl estradiol+drospirenone', 'Laboratoires leon > amriya', 'Tab', 'أقراص', '3mg', '1', 'حبوب منع حمل عن طريق الفم', NULL, NULL, NULL, 1558, '2025-08-23', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23743, 'Norocarmena 0.03/3mg 21 f.c.tab', 'نوروكارمينا 21 قرص', '102', '70', 'Contraceptives', 'Ethinyl estradiol+drospirenone', 'Laboratoires leon > amriya', 'Tab', 'أقراص', '3mg', '1', 'حبوب منع حمل عن طريق الفم', NULL, '6224001616112', NULL, 11104, '2025-03-25', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23744, 'Norpregna 30 mg 2 tabs', 'نوربريجنا 30مجم 2 قرص', '90', NULL, 'Contraceptives', 'Ulipristal acetate', 'Technopharm > zeta pharm', 'Tab', 'أقراص', '30 mg', '1', NULL, NULL, NULL, NULL, 2439, '2022-06-16', 0, 'As the product Ella (available in Canada and the US), ulipristal is indicated for use as emergency contraception after unprotected intercourse or possible contraceptive failure when administered within 120 hours (5 days) after unprotected intercourse or a known or suspected contraceptive failure. As the product Fibristal (available in Canada), ulipristal is indicated for treatment of the signs and symptoms of uterine fibroids in adult women.', 'The exact mechanism of action of ulipristal has been heavily debated [FDA Label] [A18504, A175372, A175375, A175378]. On one hand, the majority of official prescribing information labels, monographs, and prior research studies for ulipristal indicated as an emergency contraceptive suggest that its primary mechanism of action revolves around inhibiting or delaying ovulation by suppressing surges in LH that result in the postponement of follicular rupture [A18504, L5575, F3772].



Conversely, some of the latest investigations pertaining to ulipristal''s mechanism of action as an emergency contraceptive propose that it principally elicits its action by preventing embryo implantation, as opposed to preventing ovulation [A175372, A175375, A175378]. Although previous investigations have shown that ulipristal essentially has the ability to prevent ovulation equivalent to placebo (ie. null effect or ability) when administered during LH peaks one to two days before ovulation, the agent still demonstrates a stable and consistently high contraceptive effect of approximately >=80% when used at this time [A175372]. Subsequently, current studies attempt to investigate how ulipristal could elicit emergency contraception via ovulation prevention under circumstances where ovulation had already clearly been observed [A175372, A175375, A175378]. Endometrial biopsy samples studied from such circumstances in such investigations subsequently show that the administered ulipristal causes endometrial tissue to become inhospitable and unsuitable for embryo implantation where a variety of genes characteristic of receptive, pro-gestational endometrium are downregulated [A175372, A175375, A175378]. 



Nevertheless, most if not all proposed mechanisms commonly agree that ulipristal ultimately demonstrates its pharmacological effects by binding to human progesterone receptors and prevents natural, endogenous progesterone from occupying such receptors [A18504, L5575, F3772, A175372, A175375, A175378]. Regardless, however, considering current and on-going research into ulipristal''s ability to prevent embryo implantation, the notion that the medication can elicit post-fertilization effects potentially raises alerts and/or ethical debates over the use of ulipristal owing to potential abortifacient activity [A18504, A175372, A175375, A175378], which is considered to be on par or equipotent to that of mifepristone [F3769]. Attention should be drawn to the fact that some prescribing information, however, such as the US FDA label for ulipristal indicated for emergency contraception, has included new supplementary commentary since 2018 that directly warns about ulipristal not being indicated for termination of existing pregnancies and suggesting that ulipristal use may confer alterations to the endometrium that may affect implantation and contribute to efficacy [FDA Label]. 



In the treatment of fibroids, ulipristal has been shown to exert direct actions on fibroids reducing their size through inhibition of cell proliferation and induction of apoptosis.', 'Ulipristal is a selective, reversible progestin receptor modulator and its tissue targets include the uterus, cervix, ovaries, and hypothalamus. Ulipristal may act as an agonist or antagonist in the presence or absence of progesterone based on the tissue target. If given mid-follicular phase, development of the follicle growth is delayed and estradiol concentrations decrease. If given at the time when luteinizing hormone peaks, follicular rapture is delayed by several days.  If given early-luteal phase, a decrease in endometrial thickness can be observed. ', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23745, 'Norpregna 5 mg 10 tabs.', 'نوربريجنا 5مجم 10 قرص', '108', NULL, 'Contraceptives', 'Ulipristal acetate', 'Technopharm > zeta pharm', 'Tab', 'أقراص', '5 mg', '1', NULL, 'ulipristal acetate is a selective progesterone receptor modulator (sprm). indications: 1. emergency contraception: for emergency contraception a 30 mg tablet is used within 120 hours (5 days) after an unprotected intercourse or contraceptive failure. it h', NULL, NULL, 1043, '2022-07-08', 0, 'As the product Ella (available in Canada and the US), ulipristal is indicated for use as emergency contraception after unprotected intercourse or possible contraceptive failure when administered within 120 hours (5 days) after unprotected intercourse or a known or suspected contraceptive failure. As the product Fibristal (available in Canada), ulipristal is indicated for treatment of the signs and symptoms of uterine fibroids in adult women.', 'The exact mechanism of action of ulipristal has been heavily debated [FDA Label] [A18504, A175372, A175375, A175378]. On one hand, the majority of official prescribing information labels, monographs, and prior research studies for ulipristal indicated as an emergency contraceptive suggest that its primary mechanism of action revolves around inhibiting or delaying ovulation by suppressing surges in LH that result in the postponement of follicular rupture [A18504, L5575, F3772].



Conversely, some of the latest investigations pertaining to ulipristal''s mechanism of action as an emergency contraceptive propose that it principally elicits its action by preventing embryo implantation, as opposed to preventing ovulation [A175372, A175375, A175378]. Although previous investigations have shown that ulipristal essentially has the ability to prevent ovulation equivalent to placebo (ie. null effect or ability) when administered during LH peaks one to two days before ovulation, the agent still demonstrates a stable and consistently high contraceptive effect of approximately >=80% when used at this time [A175372]. Subsequently, current studies attempt to investigate how ulipristal could elicit emergency contraception via ovulation prevention under circumstances where ovulation had already clearly been observed [A175372, A175375, A175378]. Endometrial biopsy samples studied from such circumstances in such investigations subsequently show that the administered ulipristal causes endometrial tissue to become inhospitable and unsuitable for embryo implantation where a variety of genes characteristic of receptive, pro-gestational endometrium are downregulated [A175372, A175375, A175378]. 



Nevertheless, most if not all proposed mechanisms commonly agree that ulipristal ultimately demonstrates its pharmacological effects by binding to human progesterone receptors and prevents natural, endogenous progesterone from occupying such receptors [A18504, L5575, F3772, A175372, A175375, A175378]. Regardless, however, considering current and on-going research into ulipristal''s ability to prevent embryo implantation, the notion that the medication can elicit post-fertilization effects potentially raises alerts and/or ethical debates over the use of ulipristal owing to potential abortifacient activity [A18504, A175372, A175375, A175378], which is considered to be on par or equipotent to that of mifepristone [F3769]. Attention should be drawn to the fact that some prescribing information, however, such as the US FDA label for ulipristal indicated for emergency contraception, has included new supplementary commentary since 2018 that directly warns about ulipristal not being indicated for termination of existing pregnancies and suggesting that ulipristal use may confer alterations to the endometrium that may affect implantation and contribute to efficacy [FDA Label]. 



In the treatment of fibroids, ulipristal has been shown to exert direct actions on fibroids reducing their size through inhibition of cell proliferation and induction of apoptosis.', 'Ulipristal is a selective, reversible progestin receptor modulator and its tissue targets include the uterus, cervix, ovaries, and hypothalamus. Ulipristal may act as an agonist or antagonist in the presence or absence of progesterone based on the tissue target. If given mid-follicular phase, development of the follicle growth is delayed and estradiol concentrations decrease. If given at the time when luteinizing hormone peaks, follicular rapture is delayed by several days.  If given early-luteal phase, a decrease in endometrial thickness can be observed. ', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23747, 'Nortens 5 mg 20 tab.', 'نورتنس 5مجم 20 اقراص', '19', NULL, 'Antihypertensive.selective calcium channel blocker', 'Amlodipine', 'Logestic pharma for pharmaceuticals', 'Tab', 'أقراص', '5 mg', '2', NULL, 'about amlodipine calcium channel blocker anti hypertensive anti angina. mechanism of action of amlodipine amlodipine is a second generation dihydropyridine ca channel blocker. it exerts it`s antihypertensive antianginal actions through blocking the influx', NULL, NULL, 808, '2022-07-12', 0, 'Amlodipine may be used alone or in combination with other antihypertensive and antianginal agents for the treatment of the following conditions [FDA label]:



• Hypertension 



• Coronary artery disease



• Chronic stable angina



• Vasospastic angina (Prinzmetal’s or Variant angina) 



• Angiographically documented coronary artery disease in patients without heart failure or an ejection fraction < 40%', '**Mechanism of action on blood pressure**



Amlodipine is considered a peripheral arterial vasodilator that exerts its action directly on vascular smooth muscle to lead to a reduction in peripheral vascular resistance, causing a decrease in blood pressure. Amlodipine is a dihydropyridine calcium antagonist (calcium ion antagonist or slow-channel blocker) that inhibits the influx of calcium ions into both vascular smooth muscle and cardiac muscle. Experimental studies imply that amlodipine binds to both _dihydropyridine_ and _nondihydropyridine_ binding sites, located on cell membranes. The contraction of cardiac muscle and vascular smooth muscle are dependent on the movement of extracellular calcium ions into these cells by specific ion channels. Amlodipine blocks calcium ion influx across cell membranes with selectivity. A stronger effect of amlodipine is exerted on vascular smooth muscle cells than on cardiac muscle cells [FDA label]. Direct actions of amlodipine on vascular smooth muscle result in reduced blood pressure [F3757]. 



**Mechanism of action in angina**



The exact mechanism by which amlodipine relieves the symptoms of angina have not been fully elucidated to this date, however, the mechanism of action is likely twofold:



Amlodipine has a dilating effect on peripheral arterioles, reducing the total peripheral resistance (afterload) against which the cardiac muscle functions. Since the heart rate remains stable during amlodipine administration, the reduced work of the heart reduces both myocardial energy use and oxygen requirements [F3757].



Dilatation of the main coronary arteries and coronary arterioles, both in healthy and ischemic areas, is another possible mechanism of amlodipine reduction of blood pressure. The dilatation causes an increase in myocardial oxygen delivery in patients experiencing coronary artery spasm (Prinzmetal''s or variant angina) and reduces coronary vasoconstriction caused by smoking [F3757].', '**General pharmacodynamic effects**



Amlodipine has a strong affinity for cell membranes, modulating calcium influx by inhibiting selected membrane calcium channels. This drug''s unique binding properties allow for its long-acting action and less frequent dosing regimen [A573], [FDA label].  



**Hemodynamic effects**



After the administration of therapeutic doses of amlodipine to patients diagnosed with hypertension, amlodipine causes vasodilation, which results in a reduction of supine and standing blood pressure. During these blood pressure reductions, there are no clinically significant changes in heart rate or plasma catecholamine levels with long-term use. Acute intravenous administration of amlodipine reduces arterial blood pressure and increases heart rate in patients with chronic stable angina, however, chronic oral administration of amlodipine in clinical studies did not cause clinically significant alterations in heart rate or blood pressures in patients diagnosed with angina and normal blood pressure. With long-term, once daily oral administration, antihypertensive effectiveness is maintained for at least 24 hours [FDA label]. 



**Electrophysiologic effects**



Amlodipine does not change sinoatrial (SA) nodal function or atrioventricular (AV) conduction in animals or humans. In patients who were diagnosed with chronic stable angina, the intravenous administration of 10 mg of amlodipine did not cause clinically significant alterations A-H and H-V conduction and sinus node recovery time after cardiac pacing. Patients administered amlodipine with concomitant beta-blockers produced similar results. In clinical trials in which amlodipine was given in combination with beta-blockers to patients diagnosed with hypertension or angina, no adverse effects on electrocardiographic parameters were noted. In clinical studies comprised of angina patients alone, amlodipine did not change electrocardiographic intervals or produce high degrees of AV block [FDA label]. 



**Effects on angina**



Amlodipine relieves the symptoms of chest pain associated with angina. In patients diagnosed with angina, daily administration of a single amlodipine dose increases total exercise time, the time to angina onset, and the time to 1 mm ST-segment depression on ECG studies, decreases anginal attack frequency, and decreases the requirement for nitroglycerin tablets [F3757]. ', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23748, 'Norvapril 5/10mg 30 caps.', 'نورفابريل 5/10مجم 30 كبسول', '53', '42', 'Antihypertensive.combined ace with calcium channel blocker', 'Amlodipine+benazepril', 'Marcyrl co. > geopharma-egypt', 'Cap', 'كبسولة', '10mg', '3', NULL, 'mechanism of action of amlodipine amlodipine is a second generation dihydropyridine ca channel blocker. it exerts it`s antihypertensive antianginal actions through blocking the influx of ca ions through voltage gated l-type ca channels to the peripheral v', NULL, NULL, 763, '2024-12-28', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23749, 'Norvapril 5/20mg 30 caps.', 'نورفابريل 5/20 مجم 30 كبسولة', '72', '48', 'Antihypertensive.combined ace with calcium channel blocker', 'Amlodipine+benazepril', 'Marcyrl co. > geopharma-egypt', 'Cap', 'كبسولة', '20mg', '3', NULL, 'mechanism of action of amlodipine amlodipine is a second generation dihydropyridine ca channel blocker. it exerts it`s antihypertensive antianginal actions through blocking the influx of ca ions through voltage gated l-type ca channels to the peripheral v', NULL, NULL, 779, '2024-12-28', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23753, 'Nosemys nasal spray 10 ml', 'نوزيميس سبراي للانف 10 مل', '26', NULL, 'Bronchodilator.anti-inflammatory.glucocorticoid steroid', 'Fluticasone furoate', 'Sigma tec > andalous pharma', 'Spray', 'بخاخ', '10 ml', '1', NULL, 'about fluticasone synthetic topical glucocorticoid anti inflammatory and antipruritic in corticosteroid-responsive dermatoses; atopic dermatitis. mechanism of action of fluticasone it reduces prostaglandin synthesis by inhibiting cyclo oxygenase enzymes b', NULL, NULL, 2142, '2022-07-01', 0, 'Fluticasone propionate is indicated as an inhaler for the treatment and management of asthma by prophylaxis[FDA Label]as well as inflammatory and pruritic dermatoses[F4355]. Fluticasone propionate nasal spray is indicated for managing allergic and nonallergic rhinitis[L8309,F4358].', 'Fluticasone propionate works through an unknown mechanism to  affect the action of various cell types and mediators of inflammation[F4358]. Fluticasone propionate activates glucocorticoid receptors and inhibits lung eosinophilia in rats[F4358,F4355].', 'Systemically, fluticasone propionate activates glucocorticoid receptors, and inhibits lung eosinophilia in rats[F4358][FDA Label]. Fluticasone propionate as a topical formulation is also associated with vasoconstriction in the skin[F4355,A177118].', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23755, 'Nostifix 0.5mg 2 tablets', 'نوستيفيكس 0.5مجم 2 قرص', '68', '45.5', 'Dopamine agonist and prolactin inhibitor', 'Cabergoline', 'Marcyrl co.', 'Tablet', 'أقراص', '0.5mg', '1', 'تنشيف اللبن و بعض حالات تأخر الحمل', NULL, '6223003573683', NULL, 5381, '2024-09-26', 0, 'For the treatment of hyperprolactinemic disorders, either idiopathic or due to prolactinoma (prolactin-secreting adenomas). May also be used to manage symptoms of Parkinsonian Syndrome as monotherapy during initial symptomatic management or as an adjunct to levodopa therapy during advanced stages of disease. ', 'The dopamine D<sub>2</sub> receptor is a 7-transmembrane G-protein coupled receptor associated with G<sub>i</sub> proteins. In lactotrophs, stimulation of dopamine D<sub>2</sub> causes inhibition of adenylyl cyclase, which decreases intracellular cAMP concentrations and blocks IP3-dependent release of Ca<sup>2+</sup> from intracellular stores. Decreases in intracellular calcium levels may also be brought about via inhibition of calcium influx through voltage-gated calcium channels, rather than via inhibition of adenylyl cyclase. Additionally, receptor activation blocks phosphorylation of p42/p44 MAPK and decreases MAPK/ERK kinase phosphorylation. Inhibition of MAPK appears to be mediated by c-Raf and B-Raf-dependent inhibition of MAPK/ERK kinase. Dopamine-stimulated growth hormone release from the pituitary gland is mediated by a decrease in intracellular calcium influx through voltage-gated calcium channels rather than via adenylyl cyclase inhibition. Stimulation of dopamine D<sub>2</sub> receptors in the nigrostriatal pathway leads to improvements in coordinated muscle activity in those with movement disorders. Cabergoline is a long-acting dopamine receptor agonist with a high affinity for D2 receptors. Receptor-binding studies indicate that cabergoline has low affinity for dopamine D1, &alpha;<sub>1</sub>,- and &alpha;<sub>2</sub>- adrenergic, and 5-HT<sub>1</sub>- and 5-HT<sub>2</sub>-serotonin receptors.', 'Cabergoline stimulates centrally-located dopaminergic receptors resulting in a number of pharmacologic effects. Five dopamine receptor types from two dopaminergic subfamilies have been identified. The dopaminergic D1 receptor subfamily consists of D<sub>1</sub> and D<sub>5</sub> subreceptors, which are associated with dyskinesias. The dopaminergic D2 receptor subfamily consists of D<sub>2</sub>, D<sub>3</sub> and D<sub>4</sub> subreceptors, which are associated with improvement of symptoms of movement disorders. Thus, agonist activity specific for D2 subfamily receptors, primarily D<sub>2</sub> and D<sub>3</sub> receptor subtypes, are the primary targets of dopaminergic antiparkinsonian agents. It is thought that postsynaptic D2 stimulation is primarily responsible for the antiparkinsonian effect of dopamine agonists, while presynaptic D2 stimulation confers neuroprotective effects. This semisynthetic ergot derivative exhibits potent agonist activity on dopamine D<sub>2</sub>- and D<sub>3</sub>-receptors. It also exhibits: agonist activity (in order of decreasing binding affinities) on 5-hydroxytryptamine (5-HT)<sub>2B</sub>, 5-HT<sub>2A</sub>, 5-HT<sub>1D</sub>, dopamine D<sub>4</sub>, 5-HT<sub>1A</sub>, dopamine D<sub>1</sub>, 5-HT<sub>1B</sub> and 5-HT<sub>2C</sub> receptors and antagonist activity on &alpha;<sub>2B</sub>, &alpha;<sub>2A</sub>, and &alpha;<sub>2C</sub> receptors. Parkinsonian Syndrome manifests when approximately 80% of dopaminergic activity in the nigrostriatal pathway of the brain is lost. As this striatum is involved in modulating the intensity of coordinated muscle activity (e.g. movement, balance, walking), loss of activity may result in dystonia (acute muscle contraction), Parkinsonism (including symptoms of bradykinesia, tremor, rigidity, and flattened affect), akathesia (inner restlessness), tardive dyskinesia (involuntary muscle movements usually associated with long-term loss of dopaminergic activity), and neuroleptic malignant syndrome, which manifests when complete blockage of nigrostriatal dopamine occurs. High dopaminergic activity in the mesolimbic pathway of the brain causes hallucinations and delusions; these side effects of dopamine agonists are manifestations seen in patients with schizophrenia who have overractivity in this area of the brain. The hallucinogenic side effects of dopamine agonists may also be due to 5-HT<sub>2A</sub> agonism. The tuberoinfundibular pathway of the brain originates in the hypothalamus and terminates in the pituitary gland. In this pathway, dopamine inhibits lactotrophs in anterior pituitary from secreting prolactin. Increased dopaminergic activity in the tuberoinfundibular pathway inhibits prolactin secretion. ', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23756, 'No-tuss 10 soft gelatin cap.', 'نو تس 10 كبسول', '7', NULL, 'Cough drugs', 'Benzonatate+diphenhydramine+guaifenesin+phenylephrine', 'Grand pharma > delta pharma', 'Cap', 'كبسولة', NULL, '1', NULL, NULL, NULL, NULL, 877, '2022-07-24', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23758, 'No-uric 100mg 50 tab.', 'نو-يوريك 100مجم 50 قرص', '65', '42.5', 'Antigout.xanthine oxidase inhibitor', 'Allopurinol', 'Eipico', 'Tab', 'أقراص', '100mg', '5', NULL, NULL, '6221032114204', NULL, 3677, '2025-04-03', 0, 'Allopurinol is indicated in [FDA label]:



1) the management of patients with signs and symptoms of primary or secondary gout (acute attacks, tophi, joint destruction, uric acid lithiasis, and/or nephropathy).



2) the management of patients with leukemia, lymphoma and malignancies who are receiving cancer therapy which causes elevations of serum and urinary uric acid levels. Treatment with allopurinol should be discontinued when the potential for overproduction of uric acid is no longer present.



3) the management of patients with recurrent calcium oxalate calculi whose daily uric acid excretion exceeds 800 mg/day in male patients and 750 mg/day in female patients. Therapy in such patients should be carefully assessed initially and reassessed periodically to determine in each case that treatment is beneficial and that the benefits outweigh the risks.', 'Allopurinol is a structural analog of the natural purine base, hypoxanthine.  After ingestion, allopurinol is metabolized to its active metabolite, oxypurinol (_alloxanthine_) in the liver [T508], which acts as an inhibitor of xanthine oxidase enzyme [FDA label]. 



Allopurinol and its active metabolite inhibit xanthine oxidase, the enzyme that converts hypoxanthine to xanthine and xanthine to uric acid. Inhibition of this enzyme is responsible for the effects of allopurinol. This drug increases the reutilization of hypoxanthine and xanthine for nucleotide and nucleic acid synthesis by a process that involves the enzyme hypoxanthine-guanine phosphoribosyltransferase (HGPRTase).  This process results in an increased nucleotide concentration, which causes feedback inhibition of de novo purine synthesis. The end result is decreased urine and serum uric acid concentrations [F3988], which decreases the incidence of gout symptoms. 



Accompanying the reduction of serum uric acid by allopurinol is an increase in the serum and urine concentrations of hypoxanthine and xanthine (due to inhibition of xanthine oxidase).  In the absence of allopurinol, regular urinary excretion of oxypurines almost entirely occurs in the form of uric acid. After the ingestion of allopurinol, the contents of excreted urine are hypoxanthine, xanthine, and uric acid. Because each substance has its own individual solubility, the concentration of uric acid in plasma is decreased without exposing the renal tissues to a high load of uric acid, thereby decreasing the risk of crystalluria. By lowering the uric acid concentration in the plasma below its limits of solubility, allopurinol encourages the dissolution of gout tophi. Although the levels of hypoxanthine and xanthine are found to be increased after allopurinol ingestion, the risk of deposition in renal tissues is less than that of uric acid, as they become more soluble and are rapidly excreted by the kidney [F3988]. ', '

Allopurinol decreases the production of uric acid by stopping the biochemical reactions that precede its formation [FDA label].  This process decreases urate and relieves the symptoms of gout, which may include painful tophi, joint pain, inflammation, redness, decreased range of motion, and swelling [A665].



', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23760, 'Nouvelle anti-aging cream 120 ml', 'نوفيلي كريم لعلاج اثار التقدم في السن 120مل', '95', NULL, 'Firming topical', 'Collagen+elastin+cyclopentasiloxane+glycerin+niacinamide+dimethicone', 'Hi-care > smart marketing', 'Cream', 'كريم', '120 ml', '1', NULL, NULL, NULL, NULL, 709, '2022-07-13', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23761, 'Nouvelle eye contour cream 40 gm', 'نوفيلي كريم 40جم', '70', NULL, 'Eye contour', 'Ascorbic acid+green tea ext.+cucumber ext.+liquorice+ivy ext.+tobaco leaf ext.', 'Hi-care > smart marketing', 'Cream', 'كريم', '40 gm', '1', NULL, NULL, NULL, NULL, 716, '2022-07-20', 0, 'Used to treat vitamin C deficiency, scurvy, delayed wound and bone healing, urine acidification, and in general as an antioxidant. It has also been suggested to be an effective antiviral agent.', 'In humans, an exogenous source of ascorbic acid is required for collagen formation and tissue repair by acting as a cofactor in the posttranslational formation of 4-hydroxyproline in -Xaa-Pro-Gly- sequences in collagens and other proteins. Ascorbic acid is reversibly oxidized to dehydroascorbic acid in the body. These two forms of the vitamin are believed to be important in oxidation-reduction reactions. The vitamin is involved in tyrosine metabolism, conversion of folic acid to folinic acid, carbohydrate metabolism, synthesis of lipids and proteins, iron metabolism, resistance to infections, and cellular respiration.', 'Ascorbic Acid (vitamin C) is a water-soluble vitamin indicated for the prevention and treatment of scurvy, as ascorbic acid deficiency results in scurvy. Collagenous structures are primarily affected, and lesions develop in bones and blood vessels. Administration of ascorbic acid completely reverses the symptoms of ascorbic acid deficiency.', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23762, 'Nouvelle firming anti-cellulite cream 120 ml', 'نوفيل فيرمينج للسيلولايت كريم 120 مل', '50', NULL, 'Firming topical', 'Tripeptide-1+caffeine+carnitine+glycyl glycine+glycerin+triethanolamine+paraffin oil+cetyl alcohol', 'Hi-care > smart marketing', 'Cream', 'كريم', '120 ml', '1', 'حالات الاسترتش ماركس.', NULL, NULL, NULL, 2125, '2022-12-19', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23763, 'Nouvelle oral gel 30 gm', 'نوفل جل بالفم 30 جم', '40', NULL, 'Oral care', 'Tea tree oil+glycerin+vitamin c+chamomile+pepperment oil+sodium fluoride', 'Hi-care > smart marketing', 'Gel', 'جل', '30 gm', '1', 'جل مطهر للفم -- يقلل الرائحة الكريهة -- يقلل الالتهابات الاسنان واللثة -- يقلل الالام الاسنان واللثة', NULL, NULL, NULL, 1213, '2023-07-15', 0, 'Indicated for topical use to help protect against infection in minor cuts, scrapes, and burns. No FDA-approved therapeutic indications.', 'The components of tea tree oil, particularly terpinen-4-ol and α-terpineol, mediate antimicrobial actions by disrupting the structural and functional integrity of bacterial membrane. Hydrocarbons are capable of partitioning into the cell and cytoplasmic membrane of microorganisms and disrupt their vital functions, which may result in leakage of ions such as potassium, and the inhibition of respiration [A32439]. Eventually, cell lysis may occur due to weakening of the cell wall, and loss of turgor pressure and subsequent rupture of the cytoplasmic membrane [A32441]. The loss of 260-nm-absorbing material may be indicative of a damaged cytoplasmic membrane and loss of nucleic acids [A32441]. In _E. coli_, perturbed potassium homeostasis, glucose-dependent respiration, cell morphology, and ability to exclude propidium iodide was observed. 



Tea tree oil also mediates its antifungal actions in a similar way, where it alters the permeability of Candida albicans and inhibits its respiration in a dose-dependent manner [A32439]. Plasma and mitochondrial membranes of fungal species are also thought to be negatively affected by inhibition of glucose-induced medium acidification by tea tree oil, which involves inhibition of membrane ATPase responsible for the expulsion of protons [A32439]. Tea tree oil also inhibits the formation of germ tubes, or mycelial conversion, in _C. albicans_, thereby disrupting cell morphogenesis [A32439]. Water-soluble fraction of TTO, terpinen-4-ol, and α-terpineol, can inhibit the lipopolysaccharide-induced production of the inflammatory mediators such as TNF-α, IL-1β and IL-10 by human peripheral monocytes by approximately 50% and that of prostaglandin E2 by about 30% after 40 h [A32439]. These components of tea tree oil may also suppress superoxide production by agonist-stimulated monocytes and decrease the production of reactive oxygen species by both stimulated neutrophils and monocytes [A32439].', 'Tea tree oil exhibits antibacterial, antifungal, antiviral, and antiprotozoal activities [A32439]. It mostly mediates bactericidal actions at concentrations of 1.0% or less in most bacteria such as _Staphylococcus aureus_ and _Escherichia coli_, and causes bacteriostatic effects at lower concentrations [A32439]. Organisms such as commensal skin staphylococci and micrococci, _Enterococcus faecalis_, and Pseudomonas aeruginosa_emphasized text_ were susceptible to tea tree oil concentrations of 2% [A32439]. It is proposed that water-soluble components of tea tree oil are capable in inducing anti-inflammatory actions; terpinen-4-ol attenuates the vasodilation and plasma extravasation associated with histamine-induced inflammation in humans [A32438].', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23764, 'Nouvelle whitening cream 120 ml', 'نوفيل كريم تبييض 120 مل', '68', NULL, 'Whitening topical', 'Kojic acid+liquorice+lactic acid+paraffin oil+vitamin (c+e)+aloe vera+olive oil+castor oil', 'Hi-care > smart marketing', 'Cream', 'كريم', '120 ml', '1', NULL, NULL, '6225000141537', NULL, 785, '2022-12-07', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23766, 'Nova t cu380 ag i.u.d', 'نوفا تي 380 لولب', '308', NULL, 'Iud', 'Copper', 'Bayer schering > bayer healthcare', 'Unknown', 'غير محدد', NULL, '1', NULL, NULL, NULL, NULL, 2569, '2022-07-09', 0, 'For use in the supplementation of total parenteral nutrition and in contraception with intrauterine devices [FDA Label] [L801].', 'Copper is absorbed from the gut via high affinity copper uptake protein and likely through low affinity copper uptake protein and natural resistance-associated macrophage protein-2 [A19528]. It is believed that copper is reduced to the Cu1+ form prior to transport. Once inside the enterocyte, it is bound to copper transport protein ATOX1 which shuttles the ion to copper transporting ATPase-1 on the golgi membrane which take up copper into the golgi apparatus. Once copper has been secreted by enterocytes into the systemic circulation it remain largely bound by ceruloplasmin (65-90%), albumin (18%), and alpha 2-macroglobulin (12%). 



Copper is an essential element in the body and is incorporated into many oxidase enzymes as a cofactor [A19518]. It is also a component of zinc/copper super oxide dismutase, giving it an anti-oxidant role. Copper defiency occurs in Occipital Horn Syndrome and Menke''s disease both of which are associated with impaired development of connective tissue due to the lack of copper to act as a cofactor in protein-lysine-6-oxidase. Menke''s disease is also associated with progressive neurological impairment leading to death in infancy. The precise mechanisms of the effects of copper deficiency are vague due to the wide range of enzymes which use the ion as a cofactor.



Copper appears to reduce the viabilty and motility of spermatozoa [A19526]. This reduces the likelihood of fertilization with a copper IUD, producing copper''s contraceptive effect [A19526]. The exact mechanism of copper''s effect on sperm are unknown.', 'Copper is incorporated into many enzymes throughout the body as an essential part of their function [A19518]. Copper ions are known to reduce fertility when released from copper-containing IUDs [A19526].', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23767, 'Nova t cu200 ag i.u.d', 'نوفا تي 200 لولب نحاسي', '120', NULL, 'Iud', 'Copper', 'Bayer > bayer healthcare', 'Unknown', 'غير محدد', NULL, '1', NULL, NULL, NULL, NULL, 1846, '2022-07-06', 0, 'For use in the supplementation of total parenteral nutrition and in contraception with intrauterine devices [FDA Label] [L801].', 'Copper is absorbed from the gut via high affinity copper uptake protein and likely through low affinity copper uptake protein and natural resistance-associated macrophage protein-2 [A19528]. It is believed that copper is reduced to the Cu1+ form prior to transport. Once inside the enterocyte, it is bound to copper transport protein ATOX1 which shuttles the ion to copper transporting ATPase-1 on the golgi membrane which take up copper into the golgi apparatus. Once copper has been secreted by enterocytes into the systemic circulation it remain largely bound by ceruloplasmin (65-90%), albumin (18%), and alpha 2-macroglobulin (12%). 



Copper is an essential element in the body and is incorporated into many oxidase enzymes as a cofactor [A19518]. It is also a component of zinc/copper super oxide dismutase, giving it an anti-oxidant role. Copper defiency occurs in Occipital Horn Syndrome and Menke''s disease both of which are associated with impaired development of connective tissue due to the lack of copper to act as a cofactor in protein-lysine-6-oxidase. Menke''s disease is also associated with progressive neurological impairment leading to death in infancy. The precise mechanisms of the effects of copper deficiency are vague due to the wide range of enzymes which use the ion as a cofactor.



Copper appears to reduce the viabilty and motility of spermatozoa [A19526]. This reduces the likelihood of fertilization with a copper IUD, producing copper''s contraceptive effect [A19526]. The exact mechanism of copper''s effect on sperm are unknown.', 'Copper is incorporated into many enzymes throughout the body as an essential part of their function [A19518]. Copper ions are known to reduce fertility when released from copper-containing IUDs [A19526].', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23768, 'Novacid 50mg/ml syrup 120ml', 'نوفاسيد 50مجم/مل شراب 120مل', '4', NULL, 'Antipyretic', 'Dipyrone(metamizole)', 'Cid', 'Syrup', 'شراب', '50mg', '1', NULL, 'indication used in the past as a powerful painkiller and fever reducer. pharmacodynamics dipyrone is a non-steroidal anti-inflammatory drug (nsaid) commonly used in the past as a powerful painkiller and fever reducer.', '6221043011547', NULL, 778, '2022-07-23', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23769, 'Novacid oblong 500 mg 10 tab.', 'نوفاسيد اوبلونج 500مجم 10 اقراص', '4', NULL, 'Antipyretic', 'Dipyrone(metamizole)', 'Cid', 'Tab', 'أقراص', '500 mg', '1', NULL, NULL, '6221043011530', NULL, 965, '2022-12-07', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23771, 'Novacortin 1% cream 15 gm', 'نوفاكورتين 1% كريم 15جم', '5', NULL, 'Glucocorticoid', 'Hydrocortisone acetate', 'Pharopharma', 'Cream', 'كريم', '1%', '1', 'كورتيزون', 'this medication is used to treat hemorrhoids and itching/swelling in the rectum and anus. it is also used with other medications to treat certain intestinal problems (such as ulcerative colitis of the rectum and other rectal/anal inflammatory conditions).', '6221094000149', NULL, 5668, '2022-07-07', 0, 'For the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses. Also used to treat endocrine (hormonal) disorders (adrenal insufficiency, Addisons disease). It is also used to treat many immune and allergic disorders, such as arthritis, lupus, severe psoriasis, severe asthma, ulcerative colitis, and Crohn''s disease.', 'Hydrocortisone binds to the cytosolic glucocorticoid receptor. After binding the receptor the newly formed receptor-ligand complex translocates itself into the cell nucleus, where it binds to many glucocorticoid response elements (GRE) in the promoter region of the target genes. The DNA bound receptor then interacts with basic transcription factors, causing the increase in expression of specific target genes. The anti-inflammatory actions of corticosteroids are thought to involve lipocortins, phospholipase A2 inhibitory proteins which, through inhibition arachidonic acid, control the biosynthesis of prostaglandins and leukotrienes. Specifically glucocorticoids induce lipocortin-1 (annexin-1) synthesis, which then binds to cell membranes preventing the phospholipase A2 from coming into contact with its substrate arachidonic acid. This leads to diminished eicosanoid production. The cyclooxygenase (both COX-1 and COX-2) expression is also suppressed, potentiating the effect. In other words, the two main products in inflammation Prostaglandins and Leukotrienes are inhibited by the action of Glucocorticoids. Glucocorticoids also stimulate the lipocortin-1 escaping to the extracellular space, where it binds to the leukocyte membrane receptors and inhibits various inflammatory events: epithelial adhesion, emigration, chemotaxis, phagocytosis, respiratory burst and the release of various inflammatory mediators (lysosomal enzymes, cytokines, tissue plasminogen activator, chemokines etc.) from neutrophils, macrophages and mastocytes. Additionally the immune system is suppressed by corticosteroids due to a decrease in the function of the lymphatic system, a reduction in immunoglobulin and complement concentrations, the precipitation of lymphocytopenia, and interference with antigen-antibody binding.', 'Hydrocortisone is the most important human glucocorticoid. It is essential for life and regulates or supports a variety of important cardiovascular, metabolic, immunologic and homeostatic functions. Topical hydrocortisone is used for its anti-inflammatory or immunosuppressive properties to treat inflammation due to corticosteroid-responsive dermatoses. Glucocorticoids are a class of steroid hormones characterised by an ability to bind with the cortisol receptor and trigger a variety of important cardiovascular, metabolic, immunologic and homeostatic effects. Glucocorticoids are distinguished from mineralocorticoids and sex steroids by having different receptors, target cells, and effects. Technically, the term corticosteroid refers to both glucocorticoids and mineralocorticoids, but is often used as a synonym for glucocorticoid. Glucocorticoids suppress cell-mediated immunity. They act by inhibiting genes that code for the cytokines IL-1, IL-2, IL-3, IL-4, IL-5, IL-6, IL-8 and TNF-alpha, the most important of which is the IL-2. Reduced cytokine production limits T cell proliferation. Glucocorticoids also suppress humoral immunity, causing B cells to express lower amounts of IL-2 and IL-2 receptors. This diminishes both B cell clonal expansion and antibody synthesis. The diminished amounts of IL-2 also leads to fewer T lymphocyte cells being activated.', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23772, 'Novacortin 1% oint. 15 gm', 'نوفاكورتين 1% مرهم 15جم', '5', NULL, 'Glucocorticoid', 'Hydrocortisone acetate', 'Pharopharma', 'Oint', 'مرهم', '1%', '1', NULL, 'this medication is used to treat hemorrhoids and itching/swelling in the rectum and anus. it is also used with other medications to treat certain intestinal problems (such as ulcerative colitis of the rectum and other rectal/anal inflammatory conditions).', NULL, NULL, 1846, '2022-07-18', 0, 'For the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses. Also used to treat endocrine (hormonal) disorders (adrenal insufficiency, Addisons disease). It is also used to treat many immune and allergic disorders, such as arthritis, lupus, severe psoriasis, severe asthma, ulcerative colitis, and Crohn''s disease.', 'Hydrocortisone binds to the cytosolic glucocorticoid receptor. After binding the receptor the newly formed receptor-ligand complex translocates itself into the cell nucleus, where it binds to many glucocorticoid response elements (GRE) in the promoter region of the target genes. The DNA bound receptor then interacts with basic transcription factors, causing the increase in expression of specific target genes. The anti-inflammatory actions of corticosteroids are thought to involve lipocortins, phospholipase A2 inhibitory proteins which, through inhibition arachidonic acid, control the biosynthesis of prostaglandins and leukotrienes. Specifically glucocorticoids induce lipocortin-1 (annexin-1) synthesis, which then binds to cell membranes preventing the phospholipase A2 from coming into contact with its substrate arachidonic acid. This leads to diminished eicosanoid production. The cyclooxygenase (both COX-1 and COX-2) expression is also suppressed, potentiating the effect. In other words, the two main products in inflammation Prostaglandins and Leukotrienes are inhibited by the action of Glucocorticoids. Glucocorticoids also stimulate the lipocortin-1 escaping to the extracellular space, where it binds to the leukocyte membrane receptors and inhibits various inflammatory events: epithelial adhesion, emigration, chemotaxis, phagocytosis, respiratory burst and the release of various inflammatory mediators (lysosomal enzymes, cytokines, tissue plasminogen activator, chemokines etc.) from neutrophils, macrophages and mastocytes. Additionally the immune system is suppressed by corticosteroids due to a decrease in the function of the lymphatic system, a reduction in immunoglobulin and complement concentrations, the precipitation of lymphocytopenia, and interference with antigen-antibody binding.', 'Hydrocortisone is the most important human glucocorticoid. It is essential for life and regulates or supports a variety of important cardiovascular, metabolic, immunologic and homeostatic functions. Topical hydrocortisone is used for its anti-inflammatory or immunosuppressive properties to treat inflammation due to corticosteroid-responsive dermatoses. Glucocorticoids are a class of steroid hormones characterised by an ability to bind with the cortisol receptor and trigger a variety of important cardiovascular, metabolic, immunologic and homeostatic effects. Glucocorticoids are distinguished from mineralocorticoids and sex steroids by having different receptors, target cells, and effects. Technically, the term corticosteroid refers to both glucocorticoids and mineralocorticoids, but is often used as a synonym for glucocorticoid. Glucocorticoids suppress cell-mediated immunity. They act by inhibiting genes that code for the cytokines IL-1, IL-2, IL-3, IL-4, IL-5, IL-6, IL-8 and TNF-alpha, the most important of which is the IL-2. Reduced cytokine production limits T cell proliferation. Glucocorticoids also suppress humoral immunity, causing B cells to express lower amounts of IL-2 and IL-2 receptors. This diminishes both B cell clonal expansion and antibody synthesis. The diminished amounts of IL-2 also leads to fewer T lymphocyte cells being activated.', 'DrugBank', 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23773, 'Novactam 1500mg vial i.m/i.v', 'نوفاكتام 1500مجم فيال', '46', '31', 'Penicillins.penicillin with b-lactamase inhibitor', 'Ampicillin+sulbactam', 'Eipico', 'Vial', 'فيال', '1500mg', '1', 'مضاد حيوي', NULL, '6221032315458', NULL, 4473, '2024-10-01', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction) VALUES (23774, 'Novactam 250mg/5ml susp. 60 ml', 'نوفاكتام 250مجم/5مل معلق 60 مل', '69', '38', 'Penicillins.penicillin with b-lactamase inhibitor', 'Ampicillin+sulbactam', 'Eipico', 'Susp', 'معلق', '250mg', '1', NULL, 'about sultamicillin penicillins mechanism of action of sultamicillin sultamicillin is an oral form of the antibiotic combination ampicillin/sulbactam. it contains esterified ampicillin and sulbactam. sulbactam is an irreversible inhibitor of most importan', NULL, NULL, 1313, '2025-04-29', 0, NULL, NULL, NULL, NULL, 0, 0, 0);
